drug_1_CID,drug_1_name,drug_1_SMILES,relationship,drug_2_CID,drug_2_name,drug_2_SMILES
CID000005453,thiotepa,C1CN1P(=S)(N2CC2)N3CC3,respiratory alkalosis,CID000005978,vincristine,CCC1(CC2CC(C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)C78CCN9C7C(C=CC9)(C(C(C8N6C=O)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O
CID000005453,thiotepa,C1CN1P(=S)(N2CC2)N3CC3,edema,CID005311048,SCHEMBL11440306,C(N)(N)(Cl)Cl
CID000005453,thiotepa,C1CN1P(=S)(N2CC2)N3CC3,Acute Respiratory Distress Syndrome,CID000005645,"3,7-Dihydroxycholan-24-oic acid",CC(CCC(=O)O)C1CCC2C1(CCC3C2C(CC4C3(CCC(C4)O)C)O)C
CID000005453,thiotepa,C1CN1P(=S)(N2CC2)N3CC3,abnormal EEG,CID000038904,Carboplatinum,C1CC(C1)(C(=O)O)C(=O)O.N.N.[Pt]
CID000003823,ketoconazole,CC(=O)N1CCN(CC1)C2=CC=C(C=C2)OCC3COC(O3)(CN4C=CN=C4)C5=C(C=C(C=C5)Cl)Cl,nervous tension,CID000004585,"2-methyl-4-(4-methylpiperazin-1-yl)-5H-thieno[3,2-c][1,5]benzodiazepine",CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C
CID000003823,ketoconazole,CC(=O)N1CCN(CC1)C2=CC=C(C=C2)OCC3COC(O3)(CN4C=CN=C4)C5=C(C=C(C=C5)Cl)Cl,gastric inflammation,CID000087177,"D-Fructose, 4-O-alpha-D-glucopyranosyl-",C(C1C(C(C(C(O1)OC(C(CO)O)C(C(=O)CO)O)O)O)O)O
CID000003823,ketoconazole,CC(=O)N1CCN(CC1)C2=CC=C(C=C2)OCC3COC(O3)(CN4C=CN=C4)C5=C(C=C(C=C5)Cl)Cl,loss of weight,CID005481350,Tenofovir disoproxil,CC(C)OC(=O)OCOP(=O)(COC(C)CN1C=NC2=C(N=CN=C21)N)OCOC(=O)OC(C)C
CID000003823,ketoconazole,CC(=O)N1CCN(CC1)C2=CC=C(C=C2)OCC3COC(O3)(CN4C=CN=C4)C5=C(C=C(C=C5)Cl)Cl,Back Ache,CID000004691,"3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine",C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4
CID000003823,ketoconazole,CC(=O)N1CCN(CC1)C2=CC=C(C=C2)OCC3COC(O3)(CN4C=CN=C4)C5=C(C=C(C=C5)Cl)Cl,Dyspnea exertional,CID000003937,N~2~-(1-carboxy-3-phenylpropyl)lysylproline,C1CC(N(C1)C(=O)C(CCCCN)NC(CCC2=CC=CC=C2)C(=O)O)C(=O)O
CID000003823,ketoconazole,CC(=O)N1CCN(CC1)C2=CC=C(C=C2)OCC3COC(O3)(CN4C=CN=C4)C5=C(C=C(C=C5)Cl)Cl,Superficial thrombophlebitis,CID000003883,lansoprazole,CC1=C(C=CN=C1CS(=O)C2=NC3=CC=CC=C3N2)OCC(F)(F)F
CID000003823,ketoconazole,CC(=O)N1CCN(CC1)C2=CC=C(C=C2)OCC3COC(O3)(CN4C=CN=C4)C5=C(C=C(C=C5)Cl)Cl,allergic dermatitis,CID000004885,104617-86-9,CCCNC1CCC2=C(C1)SC(=N2)N
CID000003823,ketoconazole,CC(=O)N1CCN(CC1)C2=CC=C(C=C2)OCC3COC(O3)(CN4C=CN=C4)C5=C(C=C(C=C5)Cl)Cl,eruption,CID000003962,79952-43-5,CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C
CID000003823,ketoconazole,CC(=O)N1CCN(CC1)C2=CC=C(C=C2)OCC3COC(O3)(CN4C=CN=C4)C5=C(C=C(C=C5)Cl)Cl,angiitis,CID000062924,"S-(fluoromethyl) (6S,9R,10S,11S,13S,14S,16R,17R)-6,9-difluoro-11,17-dihydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthrene-17-carbothioate",CC1CC2C3CC(C4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)SCF)O)C)O)F)C)F
CID000003823,ketoconazole,CC(=O)N1CCN(CC1)C2=CC=C(C=C2)OCC3COC(O3)(CN4C=CN=C4)C5=C(C=C(C=C5)Cl)Cl,weight gain,CID000012536,638-94-8,CC1(OC2CC3C4CCC5=CC(=O)C=CC5(C4C(CC3(C2(O1)C(=O)CO)C)O)C)C
CID000003823,ketoconazole,CC(=O)N1CCN(CC1)C2=CC=C(C=C2)OCC3COC(O3)(CN4C=CN=C4)C5=C(C=C(C=C5)Cl)Cl,Acne,CID000003958,lorazepam,C1=CC=C(C(=C1)C2=NC(C(=O)NC3=C2C=C(C=C3)Cl)O)Cl
CID000003823,ketoconazole,CC(=O)N1CCN(CC1)C2=CC=C(C=C2)OCC3COC(O3)(CN4C=CN=C4)C5=C(C=C(C=C5)Cl)Cl,apoplexy,CID000010631,medroxyprogesterone,CC1CC2C(CCC3(C2CCC3(C(=O)C)O)C)C4(C1=CC(=O)CC4)C
CID000003823,ketoconazole,CC(=O)N1CCN(CC1)C2=CC=C(C=C2)OCC3COC(O3)(CN4C=CN=C4)C5=C(C=C(C=C5)Cl)Cl,apoplexy,CID000005245,Risedronic acid,C1=CC(=CN=C1)CC(O)(P(=O)(O)O)P(=O)(O)O
CID000003823,ketoconazole,CC(=O)N1CCN(CC1)C2=CC=C(C=C2)OCC3COC(O3)(CN4C=CN=C4)C5=C(C=C(C=C5)Cl)Cl,weight gain,CID000004679,pantoprazole,COC1=C(C(=NC=C1)CS(=O)C2=NC3=C(N2)C=C(C=C3)OC(F)F)OC
CID000003823,ketoconazole,CC(=O)N1CCN(CC1)C2=CC=C(C=C2)OCC3COC(O3)(CN4C=CN=C4)C5=C(C=C(C=C5)Cl)Cl,cholelithiasis,CID000004829,Pioglitazone,CCC1=CN=C(C=C1)CCOC2=CC=C(C=C2)CC3C(=O)NC(=O)S3
CID000003823,ketoconazole,CC(=O)N1CCN(CC1)C2=CC=C(C=C2)OCC3COC(O3)(CN4C=CN=C4)C5=C(C=C(C=C5)Cl)Cl,Pain,CID003468412,SCHEMBL1176571,CC1C=CC=CCCC=CC=CC=CC=CC(CC(C(C(CC(=O)CC(C(CCC(CC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)C(=O)O)O)OC2C(C(C(C(O2)C)O)N)O
CID000003823,ketoconazole,CC(=O)N1CCN(CC1)C2=CC=C(C=C2)OCC3COC(O3)(CN4C=CN=C4)C5=C(C=C(C=C5)Cl)Cl,atelectasis,CID000004205,mirtazapine,CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4
CID000003823,ketoconazole,CC(=O)N1CCN(CC1)C2=CC=C(C=C2)OCC3COC(O3)(CN4C=CN=C4)C5=C(C=C(C=C5)Cl)Cl,dysarthria,CID000054454,simvastatin,CCC(C)(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C
CID000003823,ketoconazole,CC(=O)N1CCN(CC1)C2=CC=C(C=C2)OCC3COC(O3)(CN4C=CN=C4)C5=C(C=C(C=C5)Cl)Cl,Bilirubinaemia,CID000005544,Mycolog,CC12CC(C3(C(C1CC(C2(C(=O)CO)O)O)CCC4=CC(=O)C=CC43C)F)O
CID000003823,ketoconazole,CC(=O)N1CCN(CC1)C2=CC=C(C=C2)OCC3COC(O3)(CN4C=CN=C4)C5=C(C=C(C=C5)Cl)Cl,apoplexy,CID000077999,rosiglitazone,CN(CCOC1=CC=C(C=C1)CC2C(=O)NC(=O)S2)C3=CC=CC=N3
CID000003823,ketoconazole,CC(=O)N1CCN(CC1)C2=CC=C(C=C2)OCC3COC(O3)(CN4C=CN=C4)C5=C(C=C(C=C5)Cl)Cl,loss of weight,CID000019090,megestrol,CC1=CC2C(CCC3(C2CCC3(C(=O)C)O)C)C4(C1=CC(=O)CC4)C
CID000003823,ketoconazole,CC(=O)N1CCN(CC1)C2=CC=C(C=C2)OCC3COC(O3)(CN4C=CN=C4)C5=C(C=C(C=C5)Cl)Cl,thrombocytopenia,CID000065999,Telmisartan,CCCC1=NC2=C(N1CC3=CC=C(C=C3)C4=CC=CC=C4C(=O)O)C=C(C=C2C)C5=NC6=CC=CC=C6N5C
CID000003823,ketoconazole,CC(=O)N1CCN(CC1)C2=CC=C(C=C2)OCC3COC(O3)(CN4C=CN=C4)C5=C(C=C(C=C5)Cl)Cl,eruption,CID000005391,temazepam,CN1C2=C(C=C(C=C2)Cl)C(=NC(C1=O)O)C3=CC=CC=C3
CID000003823,ketoconazole,CC(=O)N1CCN(CC1)C2=CC=C(C=C2)OCC3COC(O3)(CN4C=CN=C4)C5=C(C=C(C=C5)Cl)Cl,acute pancreatitis,CID000004894,"11,17,21-Trihydroxypregna-1,4-diene-3,20-dione",CC12CC(C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C)O
CID000003823,ketoconazole,CC(=O)N1CCN(CC1)C2=CC=C(C=C2)OCC3COC(O3)(CN4C=CN=C4)C5=C(C=C(C=C5)Cl)Cl,Back Ache,CID000005732,zolpidem,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C
CID000003823,ketoconazole,CC(=O)N1CCN(CC1)C2=CC=C(C=C2)OCC3COC(O3)(CN4C=CN=C4)C5=C(C=C(C=C5)Cl)Cl,apoplexy,CID000004927,promethazine,CC(CN1C2=CC=CC=C2SC3=CC=CC=C31)N(C)C
CID000003823,ketoconazole,CC(=O)N1CCN(CC1)C2=CC=C(C=C2)OCC3COC(O3)(CN4C=CN=C4)C5=C(C=C(C=C5)Cl)Cl,erythema,CID000004173,metronidazole,CC1=NC=C(N1CCO)[N+](=O)[O-]
CID000003823,ketoconazole,CC(=O)N1CCN(CC1)C2=CC=C(C=C2)OCC3COC(O3)(CN4C=CN=C4)C5=C(C=C(C=C5)Cl)Cl,loss of weight,CID000005076,162990-01-4,CC(C)C1=NC(=CS1)CN(C)C(=O)NC(C(C)C)C(=O)NC(CC2=CC=CC=C2)CC(C(CC3=CC=CC=C3)NC(=O)OCC4=CN=CS4)O
CID000003823,ketoconazole,CC(=O)N1CCN(CC1)C2=CC=C(C=C2)OCC3COC(O3)(CN4C=CN=C4)C5=C(C=C(C=C5)Cl)Cl,Pain,CID000005523,Ultram,CN(C)CC1CCCCC1(C2=CC(=CC=C2)OC)O
CID000003823,ketoconazole,CC(=O)N1CCN(CC1)C2=CC=C(C=C2)OCC3COC(O3)(CN4C=CN=C4)C5=C(C=C(C=C5)Cl)Cl,deglutition disorder,CID000004189,miconazole,C1=CC(=C(C=C1Cl)Cl)COC(CN2C=CN=C2)C3=C(C=C(C=C3)Cl)Cl
CID000003823,ketoconazole,CC(=O)N1CCN(CC1)C2=CC=C(C=C2)OCC3COC(O3)(CN4C=CN=C4)C5=C(C=C(C=C5)Cl)Cl,weight gain,CID000004510,nitroglycerin,C(C(CO[N+](=O)[O-])O[N+](=O)[O-])O[N+](=O)[O-]
CID000003823,ketoconazole,CC(=O)N1CCN(CC1)C2=CC=C(C=C2)OCC3COC(O3)(CN4C=CN=C4)C5=C(C=C(C=C5)Cl)Cl,apoplexy,CID000005073,risperidone,CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F
CID000003823,ketoconazole,CC(=O)N1CCN(CC1)C2=CC=C(C=C2)OCC3COC(O3)(CN4C=CN=C4)C5=C(C=C(C=C5)Cl)Cl,gastric inflammation,CID000005650,N-pentanoyl-N-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-L-valine,CCCCC(=O)N(CC1=CC=C(C=C1)C2=CC=CC=C2C3=NNN=N3)C(C(C)C)C(=O)O
CID000003823,ketoconazole,CC(=O)N1CCN(CC1)C2=CC=C(C=C2)OCC3COC(O3)(CN4C=CN=C4)C5=C(C=C(C=C5)Cl)Cl,angiitis,CID000003890,TRANS (15S)-LATANOPROST,CC(C)OC(=O)CCCC=CCC1C(CC(C1CCC(CCC2=CC=CC=C2)O)O)O
CID000003823,ketoconazole,CC(=O)N1CCN(CC1)C2=CC=C(C=C2)OCC3COC(O3)(CN4C=CN=C4)C5=C(C=C(C=C5)Cl)Cl,Dyspnea exertional,CID000004889,Pravastatin Impurity A,CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC(CC(CC(=O)O)O)O)O
CID000003823,ketoconazole,CC(=O)N1CCN(CC1)C2=CC=C(C=C2)OCC3COC(O3)(CN4C=CN=C4)C5=C(C=C(C=C5)Cl)Cl,dizziness,CID005311297,SCHEMBL1133011,CC(C)(C1=CC=CC=C1CCC(C2=CC=CC(=C2)C=CC3=NC4=C(C=CC(=C4)Cl)C=C3)S)O
CID000003823,ketoconazole,CC(=O)N1CCN(CC1)C2=CC=C(C=C2)OCC3COC(O3)(CN4C=CN=C4)C5=C(C=C(C=C5)Cl)Cl,erythema,CID000004900,Fernisone,CC12CC(=O)C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C
CID000003823,ketoconazole,CC(=O)N1CCN(CC1)C2=CC=C(C=C2)OCC3COC(O3)(CN4C=CN=C4)C5=C(C=C(C=C5)Cl)Cl,aseptic necrosis bone,CID000004158,methylphenidate,COC(=O)C(C1CCCCN1)C2=CC=CC=C2
CID000003823,ketoconazole,CC(=O)N1CCN(CC1)C2=CC=C(C=C2)OCC3COC(O3)(CN4C=CN=C4)C5=C(C=C(C=C5)Cl)Cl,angiitis,CID000003961,losartan,CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)CO)Cl
CID000003823,ketoconazole,CC(=O)N1CCN(CC1)C2=CC=C(C=C2)OCC3COC(O3)(CN4C=CN=C4)C5=C(C=C(C=C5)Cl)Cl,muscle disorder,CID000152945,Dutasteride?,CC12CCC3C(C1CCC2C(=O)NC4=C(C=CC(=C4)C(F)(F)F)C(F)(F)F)CCC5C3(C=CC(=O)N5)C
CID000060815,REMIFENTANIL,CCC(=O)N(C1=CC=CC=C1)C2(CCN(CC2)CCC(=O)OC)C(=O)OC,thrombocytopenia,CID005381226,"[(7S,9E,11S,12R,13S,14R,15R,16R,17S,18S,19E,21Z,26E)-2,15,17,29-tetrahydroxy-11-methoxy-3,7,12,14,16,18,22-heptamethyl-26-[[(4-methylpiperazin-1-yl)amino]methylidene]-6,23,27-trioxo-8,30-dioxa-24-azatetracyclo[23.3.1.14,7.05,28]triaconta-1(28),2,4,9,19,21,25(29)-heptaen-13-yl] acetate",CC1C=CC=C(C(=O)NC2=C(C3=C(C4=C(C(=C3O)C)OC(C4=O)(OC=CC(C(C(C(C(C(C1O)C)O)C)OC(=O)C)C)OC)C)C(=O)C2=CNN5CCN(CC5)C)O)C
CID000060815,REMIFENTANIL,CCC(=O)N(C1=CC=CC=C1)C2(CCN(CC2)CCC(=O)OC)C(=O)OC,thrombocytopenia,CID000163742,SCHEMBL1650579,COC1C(C(C(C(O1)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)COS(=O)(=O)O)OC4C(C(C(C(O4)C(=O)O)OC5C(C(C(C(O5)COS(=O)(=O)O)O)O)NS(=O)(=O)O)O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O)NS(=O)(=O)O
CID000060815,REMIFENTANIL,CCC(=O)N(C1=CC=CC=C1)C2(CCN(CC2)CCC(=O)OC)C(=O)OC,drowsiness,CID004659568,"2-cyano-3-(3,4-dihydroxy-5-nitrophenyl)-N,N-diethylprop-2-enamide",CCN(CC)C(=O)C(=CC1=CC(=C(C(=C1)O)O)[N+](=O)[O-])C#N
CID000005078,rizatriptan,CN(C)CCC1=CNC2=C1C=C(C=C2)CN3C=NC=N3,cholecystitis,CID000054454,simvastatin,CCC(C)(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C
CID000005078,rizatriptan,CN(C)CCC1=CNC2=C1C=C(C=C2)CN3C=NC=N3,abnormal EEG,CID000005650,N-pentanoyl-N-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-L-valine,CCCCC(=O)N(CC1=CC=C(C=C1)C2=CC=CC=C2C3=NNN=N3)C(C(C)C)C(=O)O
CID000005078,rizatriptan,CN(C)CCC1=CNC2=C1C=C(C=C2)CN3C=NC=N3,neumonia,CID000170361,Varenicline,C1C2CNCC1C3=CC4=NC=CN=C4C=C23
CID000005078,rizatriptan,CN(C)CCC1=CNC2=C1C=C(C=C2)CN3C=NC=N3,angiitis,CID006398525,,C(C1C(C(C(C(O1)OC2(C(C(C(O2)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)COS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.[Al].[Al].[Al].[Al].[Al].[Al].[Al].[Al].[Al]
CID000005078,rizatriptan,CN(C)CCC1=CNC2=C1C=C(C=C2)CN3C=NC=N3,nasopharyngitis,CID000005391,temazepam,CN1C2=C(C=C(C=C2)Cl)C(=NC(C1=O)O)C3=CC=CC=C3
CID000005078,rizatriptan,CN(C)CCC1=CNC2=C1C=C(C=C2)CN3C=NC=N3,cholecystitis,CID000005732,zolpidem,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C
CID000005078,rizatriptan,CN(C)CCC1=CNC2=C1C=C(C=C2)CN3C=NC=N3,gastric inflammation,CID000010631,medroxyprogesterone,CC1CC2C(CCC3(C2CCC3(C(=O)C)O)C)C4(C1=CC(=O)CC4)C
CID000005078,rizatriptan,CN(C)CCC1=CNC2=C1C=C(C=C2)CN3C=NC=N3,panic attack,CID000005487,tizanidine,C1CN=C(N1)NC2=C(C=CC3=NSN=C32)Cl
CID000005078,rizatriptan,CN(C)CCC1=CNC2=C1C=C(C=C2)CN3C=NC=N3,Paraesthesia,CID000077992,Frovatriptan,CNC1CCC2=C(C1)C3=C(N2)C=CC(=C3)C(=O)N
CID000005078,rizatriptan,CN(C)CCC1=CNC2=C1C=C(C=C2)CN3C=NC=N3,gastric inflammation,CID000005523,Ultram,CN(C)CC1CCCCC1(C2=CC(=CC=C2)OC)O
CID000005078,rizatriptan,CN(C)CCC1=CNC2=C1C=C(C=C2)CN3C=NC=N3,palsies,CID000005717,zafirlukast,CC1=CC=CC=C1S(=O)(=O)NC(=O)C2=CC(=C(C=C2)CC3=CN(C4=C3C=C(C=C4)NC(=O)OC5CCCC5)C)OC
CID000005078,rizatriptan,CN(C)CCC1=CNC2=C1C=C(C=C2)CN3C=NC=N3,cholecystitis,CID000005512,124936-74-9,CC1=CC(=C(C=C1)O)C(CCN(C(C)C)C(C)C)C2=CC=CC=C2
CID000005078,rizatriptan,CN(C)CCC1=CNC2=C1C=C(C=C2)CN3C=NC=N3,cholecystitis,CID000005544,Mycolog,CC12CC(C3(C(C1CC(C2(C(=O)CO)O)O)CCC4=CC(=O)C=CC43C)F)O
CID000005078,rizatriptan,CN(C)CCC1=CNC2=C1C=C(C=C2)CN3C=NC=N3,cholecystitis,CID000005358,sumatriptan,CNS(=O)(=O)CC1=CC2=C(C=C1)NC=C2CCN(C)C
CID000005078,rizatriptan,CN(C)CCC1=CNC2=C1C=C(C=C2)CN3C=NC=N3,loss of weight,CID003468412,SCHEMBL1176571,CC1C=CC=CCCC=CC=CC=CC=CC(CC(C(C(CC(=O)CC(C(CCC(CC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)C(=O)O)O)OC2C(C(C(C(O2)C)O)N)O
CID000005078,rizatriptan,CN(C)CCC1=CNC2=C1C=C(C=C2)CN3C=NC=N3,cholecystitis,CID000062924,"S-(fluoromethyl) (6S,9R,10S,11S,13S,14S,16R,17R)-6,9-difluoro-11,17-dihydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthrene-17-carbothioate",CC1CC2C3CC(C4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)SCF)O)C)O)F)C)F
CID000005078,rizatriptan,CN(C)CCC1=CNC2=C1C=C(C=C2)CN3C=NC=N3,abnormal EEG,CID000060854,Ziprasidone,C1CN(CCN1CCC2=C(C=C3C(=C2)CC(=O)N3)Cl)C4=NSC5=CC=CC=C54
CID000005078,rizatriptan,CN(C)CCC1=CNC2=C1C=C(C=C2)CN3C=NC=N3,cholecystitis,CID005311297,SCHEMBL1133011,CC(C)(C1=CC=CC=C1CCC(C2=CC=CC(=C2)C=CC3=NC4=C(C=CC(=C4)Cl)C=C3)S)O
CID000005078,rizatriptan,CN(C)CCC1=CNC2=C1C=C(C=C2)CN3C=NC=N3,paranoia,CID000005245,Risedronic acid,C1=CC(=CN=C1)CC(O)(P(=O)(O)O)P(=O)(O)O
CID000216239,Sorafenib,CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F,loss of weight,CID006398525,,C(C1C(C(C(C(O1)OC2(C(C(C(O2)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)COS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.[Al].[Al].[Al].[Al].[Al].[Al].[Al].[Al].[Al]
CID000216239,Sorafenib,CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F,thrombocytopenia,CID005311048,SCHEMBL11440306,C(N)(N)(Cl)Cl
CID000216239,Sorafenib,CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F,abdominal pain upper,CID003468412,SCHEMBL1176571,CC1C=CC=CCCC=CC=CC=CC=CC(CC(C(C(CC(=O)CC(C(CCC(CC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)C(=O)O)O)OC2C(C(C(C(O2)C)O)N)O
CID000216239,Sorafenib,CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F,erythema,CID005311297,SCHEMBL1133011,CC(C)(C1=CC=CC=C1CCC(C2=CC=CC(=C2)C=CC3=NC4=C(C=CC(=C4)Cl)C=C3)S)O
CID000004058,meperidine,CCOC(=O)C1(CCN(CC1)C)C2=CC=CC=C2,elevated cholesterol,CID000060854,Ziprasidone,C1CN(CCN1CCC2=C(C=C3C(=C2)CC(=O)N3)Cl)C4=NSC5=CC=CC=C54
CID000004058,meperidine,CCOC(=O)C1(CCN(CC1)C)C2=CC=CC=C2,insulin dependent diabetes mellitus,CID000008953,sodium;hydrogen carbonate,C(=O)(O)[O-].[Na+]
CID000004058,meperidine,CCOC(=O)C1(CCN(CC1)C)C2=CC=CC=C2,weight gain,CID000170361,Varenicline,C1C2CNCC1C3=CC4=NC=CN=C4C=C23
CID000004058,meperidine,CCOC(=O)C1(CCN(CC1)C)C2=CC=CC=C2,insulin dependent diabetes mellitus,CID000087177,"D-Fructose, 4-O-alpha-D-glucopyranosyl-",C(C1C(C(C(C(O1)OC(C(CO)O)C(C(=O)CO)O)O)O)O)O
CID000004058,meperidine,CCOC(=O)C1(CCN(CC1)C)C2=CC=CC=C2,loss of weight,CID000004543,nortriptyline,CNCCC=C1C2=CC=CC=C2CCC3=CC=CC=C31
CID000004058,meperidine,CCOC(=O)C1(CCN(CC1)C)C2=CC=CC=C2,dysarthria,CID003468412,SCHEMBL1176571,CC1C=CC=CCCC=CC=CC=CC=CC(CC(C(C(CC(=O)CC(C(CCC(CC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)C(=O)O)O)OC2C(C(C(C(O2)C)O)N)O
CID000004058,meperidine,CCOC(=O)C1(CCN(CC1)C)C2=CC=CC=C2,gastric inflammation,CID000004679,pantoprazole,COC1=C(C(=NC=C1)CS(=O)C2=NC3=C(N2)C=C(C=C3)OC(F)F)OC
CID000004058,meperidine,CCOC(=O)C1(CCN(CC1)C)C2=CC=CC=C2,apoplexy,CID000004889,Pravastatin Impurity A,CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC(CC(CC(=O)O)O)O)O
CID000004058,meperidine,CCOC(=O)C1(CCN(CC1)C)C2=CC=CC=C2,apoplexy,CID000005650,N-pentanoyl-N-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-L-valine,CCCCC(=O)N(CC1=CC=C(C=C1)C2=CC=CC=C2C3=NNN=N3)C(C(C)C)C(=O)O
CID000004058,meperidine,CCOC(=O)C1(CCN(CC1)C)C2=CC=CC=C2,gastric inflammation,CID006398525,,C(C1C(C(C(C(O1)OC2(C(C(C(O2)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)COS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.[Al].[Al].[Al].[Al].[Al].[Al].[Al].[Al].[Al]
CID000004058,meperidine,CCOC(=O)C1(CCN(CC1)C)C2=CC=CC=C2,gastric inflammation,CID000005073,risperidone,CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F
CID000004058,meperidine,CCOC(=O)C1(CCN(CC1)C)C2=CC=CC=C2,Back Ache,CID005311082,"2-[(1R,4S,10S,13S,19S)-19-[4-(diaminomethylideneamino)butyl]-10-(1H-indol-3-ylmethyl)-3,9,12,15,18,21,27-heptaoxo-24,25-dithia-2,8,11,14,17,20-hexazatricyclo[18.6.1.04,8]heptacosan-13-yl]acetic acid",C1CC2C(=O)NC3CSSCCC(=O)N(C3=O)C(C(=O)NCC(=O)NC(C(=O)NC(C(=O)N2C1)CC4=CNC5=CC=CC=C54)CC(=O)O)CCCCN=C(N)N
CID000004058,meperidine,CCOC(=O)C1(CCN(CC1)C)C2=CC=CC=C2,loss of weight,CID000004736,Talwin,CC1C2CC3=C(C1(CCN2CC=C(C)C)C)C=C(C=C3)O
CID000004058,meperidine,CCOC(=O)C1(CCN(CC1)C)C2=CC=CC=C2,atelectasis,CID000062924,"S-(fluoromethyl) (6S,9R,10S,11S,13S,14S,16R,17R)-6,9-difluoro-11,17-dihydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthrene-17-carbothioate",CC1CC2C3CC(C4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)SCF)O)C)O)F)C)F
CID000004058,meperidine,CCOC(=O)C1(CCN(CC1)C)C2=CC=CC=C2,insulin dependent diabetes mellitus,CID000004856,"3-[hydroxy-(pyridin-2-ylamino)methylidene]-2-methyl-1,1-dioxo-1lambda6,2-benzothiazin-4-one",CN1C(=C(NC2=CC=CC=N2)O)C(=O)C3=CC=CC=C3S1(=O)=O
CID000004058,meperidine,CCOC(=O)C1(CCN(CC1)C)C2=CC=CC=C2,gastric inflammation,CID000005732,zolpidem,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C
CID000004058,meperidine,CCOC(=O)C1(CCN(CC1)C)C2=CC=CC=C2,gastric inflammation,CID000004691,"3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine",C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4
CID000004058,meperidine,CCOC(=O)C1(CCN(CC1)C)C2=CC=CC=C2,cerebral vascular disorder,CID000005152,Salmeterol,C1=CC=C(C=C1)CCCCOCCCCCCNCC(C2=CC(=C(C=C2)O)CO)O
CID000004058,meperidine,CCOC(=O)C1(CCN(CC1)C)C2=CC=CC=C2,weight gain,CID000004170,metolazone,CC1NC2=CC(=C(C=C2C(=O)N1C3=CC=CC=C3C)S(=O)(=O)N)Cl
CID000004058,meperidine,CCOC(=O)C1(CCN(CC1)C)C2=CC=CC=C2,coronary angioplasty,CID000004616,oxazepam,C1=CC=C(C=C1)C2=NC(C(=O)NC3=C2C=C(C=C3)Cl)O
CID000004058,meperidine,CCOC(=O)C1(CCN(CC1)C)C2=CC=CC=C2,gastric inflammation,CID005311297,SCHEMBL1133011,CC(C)(C1=CC=CC=C1CCC(C2=CC=CC(=C2)C=CC3=NC4=C(C=CC(=C4)Cl)C=C3)S)O
CID000004058,meperidine,CCOC(=O)C1(CCN(CC1)C)C2=CC=CC=C2,erythema,CID000010631,medroxyprogesterone,CC1CC2C(CCC3(C2CCC3(C(=O)C)O)C)C4(C1=CC(=O)CC4)C
CID000004058,meperidine,CCOC(=O)C1(CCN(CC1)C)C2=CC=CC=C2,cholecystitis,CID000004900,Fernisone,CC12CC(=O)C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C
CID000004058,meperidine,CCOC(=O)C1(CCN(CC1)C)C2=CC=CC=C2,disorder Renal,CID000041781,Torasemide,CC1=CC(=CC=C1)NC2=C(C=NC=C2)S(=O)(=O)NC(=O)NC(C)C
CID000004058,meperidine,CCOC(=O)C1(CCN(CC1)C)C2=CC=CC=C2,thrombocytopenia,CID000004236,modafinil,C1=CC=C(C=C1)C(C2=CC=CC=C2)S(=O)CC(=O)N
CID000004058,meperidine,CCOC(=O)C1(CCN(CC1)C)C2=CC=CC=C2,gastric inflammation,CID000005391,temazepam,CN1C2=C(C=C(C=C2)Cl)C(=NC(C1=O)O)C3=CC=CC=C3
CID000004058,meperidine,CCOC(=O)C1(CCN(CC1)C)C2=CC=CC=C2,erythema,CID000004666,7-Epi Paclitaxel,CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C
CID000004058,meperidine,CCOC(=O)C1(CCN(CC1)C)C2=CC=CC=C2,Small intestinal obstruction,CID000667490,6-Mercaptopurine,C1=NC2=C(N1)C(=S)N=CN2
CID000004058,meperidine,CCOC(=O)C1(CCN(CC1)C)C2=CC=CC=C2,insulin dependent diabetes mellitus,CID000005719,zaleplon,CCN(C1=CC=CC(=C1)C2=CC=NC3=C(C=NN23)C#N)C(=O)C
CID000004058,meperidine,CCOC(=O)C1(CCN(CC1)C)C2=CC=CC=C2,apoplexy,CID000077999,rosiglitazone,CN(CCOC1=CC=C(C=C1)CC2C(=O)NC(=O)S2)C3=CC=CC=N3
CID000004058,meperidine,CCOC(=O)C1(CCN(CC1)C)C2=CC=CC=C2,gastric inflammation,CID000054454,simvastatin,CCC(C)(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C
CID000004058,meperidine,CCOC(=O)C1(CCN(CC1)C)C2=CC=CC=C2,proctalgia,CID005311048,SCHEMBL11440306,C(N)(N)(Cl)Cl
CID000004058,meperidine,CCOC(=O)C1(CCN(CC1)C)C2=CC=CC=C2,loss of weight,CID000005245,Risedronic acid,C1=CC(=CN=C1)CC(O)(P(=O)(O)O)P(=O)(O)O
CID000004058,meperidine,CCOC(=O)C1(CCN(CC1)C)C2=CC=CC=C2,erythema,CID000004585,"2-methyl-4-(4-methylpiperazin-1-yl)-5H-thieno[3,2-c][1,5]benzodiazepine",CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C
CID000004058,meperidine,CCOC(=O)C1(CCN(CC1)C)C2=CC=CC=C2,gastric inflammation,CID000004927,promethazine,CC(CN1C2=CC=CC=C2SC3=CC=CC=C31)N(C)C
CID000004058,meperidine,CCOC(=O)C1(CCN(CC1)C)C2=CC=CC=C2,gastric inflammation,CID000005523,Ultram,CN(C)CC1CCCCC1(C2=CC(=CC=C2)OC)O
CID000004058,meperidine,CCOC(=O)C1(CCN(CC1)C)C2=CC=CC=C2,gastric inflammation,CID000005487,tizanidine,C1CN=C(N1)NC2=C(C=CC3=NSN=C32)Cl
CID000004058,meperidine,CCOC(=O)C1(CCN(CC1)C)C2=CC=CC=C2,cholecystectomies,CID000124087,Desloratadine,C1CC2=C(C=CC(=C2)Cl)C(=C3CCNCC3)C4=C1C=CC=N4
CID000004058,meperidine,CCOC(=O)C1(CCN(CC1)C)C2=CC=CC=C2,eruption,CID000004107,methocarbamol,COC1=CC=CC=C1OCC(COC(=O)N)O
CID000004058,meperidine,CCOC(=O)C1(CCN(CC1)C)C2=CC=CC=C2,road traffic accident,CID000038904,Carboplatinum,C1CC(C1)(C(=O)O)C(=O)O.N.N.[Pt]
CID000004058,meperidine,CCOC(=O)C1(CCN(CC1)C)C2=CC=CC=C2,angiitis,CID000005771,Oxytocin acetate salt hydrate,CCC(C)C1C(=O)NC(C(=O)NC(C(=O)NC(CSSCC(C(=O)NC(C(=O)N1)CC2=CC=C(C=C2)O)N)C(=O)N3CCCC3C(=O)NC(CC(C)C)C(=O)NCC(=O)N)CC(=O)N)CCC(=O)N
CID000004058,meperidine,CCOC(=O)C1(CCN(CC1)C)C2=CC=CC=C2,gastric inflammation,CID000004205,mirtazapine,CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4
CID000004058,meperidine,CCOC(=O)C1(CCN(CC1)C)C2=CC=CC=C2,gastric inflammation,CID000004173,metronidazole,CC1=NC=C(N1CCO)[N+](=O)[O-]
CID000004058,meperidine,CCOC(=O)C1(CCN(CC1)C)C2=CC=CC=C2,eruption,CID000004829,Pioglitazone,CCC1=CN=C(C=C1)CCOC2=CC=C(C=C2)CC3C(=O)NC(=O)S3
CID000004058,meperidine,CCOC(=O)C1(CCN(CC1)C)C2=CC=CC=C2,gastric inflammation,CID000004510,nitroglycerin,C(C(CO[N+](=O)[O-])O[N+](=O)[O-])O[N+](=O)[O-]
CID000004058,meperidine,CCOC(=O)C1(CCN(CC1)C)C2=CC=CC=C2,insulin dependent diabetes mellitus,CID000005544,Mycolog,CC12CC(C3(C(C1CC(C2(C(=O)CO)O)O)CCC4=CC(=O)C=CC43C)F)O
CID000004058,meperidine,CCOC(=O)C1(CCN(CC1)C)C2=CC=CC=C2,apoplexy,CID000005512,124936-74-9,CC1=CC(=C(C=C1)O)C(CCN(C(C)C)C(C)C)C2=CC=CC=C2
CID000004058,meperidine,CCOC(=O)C1(CCN(CC1)C)C2=CC=CC=C2,angioedema,CID000005978,vincristine,CCC1(CC2CC(C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)C78CCN9C7C(C=CC9)(C(C(C8N6C=O)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O
CID000004058,meperidine,CCOC(=O)C1(CCN(CC1)C)C2=CC=CC=C2,abnormal ECG,CID000005358,sumatriptan,CNS(=O)(=O)CC1=CC2=C(C=C1)NC=C2CCN(C)C
CID000000453,Hexitol,C(C(C(C(C(CO)O)O)O)O)O,insulin dependent diabetes mellitus,CID000004894,"11,17,21-Trihydroxypregna-1,4-diene-3,20-dione",CC12CC(C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C)O
CID000000453,Hexitol,C(C(C(C(C(CO)O)O)O)O)O,apoplexy,CID000003676,lidocaine,CCN(CC)CC(=O)NC1=C(C=CC=C1C)C
CID000000453,Hexitol,C(C(C(C(C(CO)O)O)O)O)O,increased white blood cell count,CID000004510,nitroglycerin,C(C(CO[N+](=O)[O-])O[N+](=O)[O-])O[N+](=O)[O-]
CID000000453,Hexitol,C(C(C(C(C(CO)O)O)O)O)O,Hepatic failure,CID000005645,"3,7-Dihydroxycholan-24-oic acid",CC(CCC(=O)O)C1CCC2C1(CCC3C2C(CC4C3(CCC(C4)O)C)O)C
CID000000453,Hexitol,C(C(C(C(C(CO)O)O)O)O)O,erythema,CID000003883,lansoprazole,CC1=C(C=CN=C1CS(=O)C2=NC3=CC=CC=C3N2)OCC(F)(F)F
CID000000453,Hexitol,C(C(C(C(C(CO)O)O)O)O)O,gastric inflammation,CID000004666,7-Epi Paclitaxel,CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C
CID000000453,Hexitol,C(C(C(C(C(CO)O)O)O)O)O,erythema,CID000004497,nimodipine,CC1=C(C(C(=C(N1)C)C(=O)OC(C)C)C2=CC(=CC=C2)[N+](=O)[O-])C(=O)OCCOC
CID000000453,Hexitol,C(C(C(C(C(CO)O)O)O)O)O,apoplexy,CID000003961,losartan,CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)CO)Cl
CID000000453,Hexitol,C(C(C(C(C(CO)O)O)O)O)O,angiitis,CID000003345,fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3
CID000000453,Hexitol,C(C(C(C(C(CO)O)O)O)O)O,apoplexy,CID003468412,SCHEMBL1176571,CC1C=CC=CCCC=CC=CC=CC=CC(CC(C(C(CC(=O)CC(C(CCC(CC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)C(=O)O)O)OC2C(C(C(C(O2)C)O)N)O
CID000000453,Hexitol,C(C(C(C(C(CO)O)O)O)O)O,metabolic encephalopathy,CID000004927,promethazine,CC(CN1C2=CC=CC=C2SC3=CC=CC=C31)N(C)C
CID000000453,Hexitol,C(C(C(C(C(CO)O)O)O)O)O,angiitis,CID000002022,2-amino-9-(2-hydroxyethoxymethyl)-3H-purin-6-one,C1=NC2=C(N1COCCO)NC(=NC2=O)N
CID000000453,Hexitol,C(C(C(C(C(CO)O)O)O)O)O,gastric inflammation,CID000054454,simvastatin,CCC(C)(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C
CID000000453,Hexitol,C(C(C(C(C(CO)O)O)O)O)O,gastric inflammation,CID000003062,Lanicor,CC1C(C(CC(O1)OC2C(OC(CC2O)OC3C(OC(CC3O)OC4CCC5(C(C4)CCC6C5CC(C7(C6(CCC7C8=CC(=O)OC8)O)C)O)C)C)C)O)O
CID000000453,Hexitol,C(C(C(C(C(CO)O)O)O)O)O,Cardiomyopathy,CID000039765,Vecuronium,CC(=O)OC1CC2CCC3C(C2(CC1N4CCCCC4)C)CCC5(C3CC(C5OC(=O)C)[N+]6(CCCCC6)C)C
CID000000453,Hexitol,C(C(C(C(C(CO)O)O)O)O)O,gastric inflammation,CID000003958,lorazepam,C1=CC=C(C(=C1)C2=NC(C(=O)NC3=C2C=C(C=C3)Cl)O)Cl
CID000000453,Hexitol,C(C(C(C(C(CO)O)O)O)O)O,loss of weight,CID000003763,isoflurane,C(C(F)(F)F)(OC(F)F)Cl
CID000000453,Hexitol,C(C(C(C(C(CO)O)O)O)O)O,myelodysplasia,CID000003440,furosemide,C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl
CID000000453,Hexitol,C(C(C(C(C(CO)O)O)O)O)O,elevated erythrocyte sedimentation rate,CID000002474,bupivacaine,CCCCN1CCCCC1C(=O)NC2=C(C=CC=C2C)C
CID000000453,Hexitol,C(C(C(C(C(CO)O)O)O)O)O,myelodysplasia,CID000002478,busulfan,CS(=O)(=O)OCCCCOS(=O)(=O)C
CID000000453,Hexitol,C(C(C(C(C(CO)O)O)O)O)O,aortic regurgitation,CID000005719,zaleplon,CCN(C1=CC=CC(=C1)C2=CC=NC3=C(C=NN23)C#N)C(=O)C
CID000000453,Hexitol,C(C(C(C(C(CO)O)O)O)O)O,erythema,CID000003405,2-[[4-[(2-amino-4-oxo-1H-pteridin-6-yl)methylamino]benzoyl]amino]pentanedioic acid,C1=CC(=CC=C1C(=O)NC(CCC(=O)O)C(=O)O)NCC2=CN=C3C(=N2)C(=O)N=C(N3)N
CID000000453,Hexitol,C(C(C(C(C(CO)O)O)O)O)O,insulin dependent diabetes mellitus,CID000002771,citalopram,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F
CID000000453,Hexitol,C(C(C(C(C(CO)O)O)O)O)O,gastric inflammation,CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N
CID000000453,Hexitol,C(C(C(C(C(CO)O)O)O)O)O,thrombocytopenia,CID000003869,labetalol,CC(CCC1=CC=CC=C1)NCC(C2=CC(=C(C=C2)O)C(=O)N)O
CID000000453,Hexitol,C(C(C(C(C(CO)O)O)O)O)O,thrombocytopenia,CID000002803,clonidine,C1CN=C(N1)NC2=C(C=CC=C2Cl)Cl
CID000000453,Hexitol,C(C(C(C(C(CO)O)O)O)O)O,apoplexy,CID000002806,90055-48-4,COC(=O)C(C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3
CID000000453,Hexitol,C(C(C(C(C(CO)O)O)O)O)O,erythema,CID000003325,famotidine,C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N
CID000000453,Hexitol,C(C(C(C(C(CO)O)O)O)O)O,apoplexy,CID000004900,Fernisone,CC12CC(=O)C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C
CID000000453,Hexitol,C(C(C(C(C(CO)O)O)O)O)O,gastric inflammation,CID000003661,L-Hyoscyamine,CN1C2CCC1CC(C2)OC(=O)C(CO)C3=CC=CC=C3
CID000000453,Hexitol,C(C(C(C(C(CO)O)O)O)O)O,odynophagia,CID000002662,celecoxib,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F
CID000000453,Hexitol,C(C(C(C(C(CO)O)O)O)O)O,angiitis,CID000002550,1-(2-methyl-3-sulfanylpropanoyl)pyrrolidine-2-carboxylic acid,CC(CS)C(=O)N1CCCC1C(=O)O
CID000000453,Hexitol,C(C(C(C(C(CO)O)O)O)O)O,aortic regurgitation,CID000002088,ALENDRONIC ACID,C(CC(O)(P(=O)(O)O)P(=O)(O)O)CN
CID000000453,Hexitol,C(C(C(C(C(CO)O)O)O)O)O,apoplexy,CID000005391,temazepam,CN1C2=C(C=C(C=C2)Cl)C(=NC(C1=O)O)C3=CC=CC=C3
CID000000453,Hexitol,C(C(C(C(C(CO)O)O)O)O)O,increased white blood cell count,CID000005732,zolpidem,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C
CID000000453,Hexitol,C(C(C(C(C(CO)O)O)O)O)O,drug toxicity NOS,CID000004691,"3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine",C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4
CID000000453,Hexitol,C(C(C(C(C(CO)O)O)O)O)O,Adenopathy,CID000002656,"7-[[2-(2-amino-1,3-thiazol-4-yl)-2-methoxyiminoacetyl]amino]-3-[(2-methyl-6-oxido-5-oxo-1,2,4-triazin-3-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CN1C(=NC(=O)C(=N1)[O-])SCC2=C(N3C(C(C3=O)NC(=O)C(=NOC)C4=CSC(=N4)N)SC2)C(=O)[O-]
CID000000453,Hexitol,C(C(C(C(C(CO)O)O)O)O)O,loss of weight,CID000004585,"2-methyl-4-(4-methylpiperazin-1-yl)-5H-thieno[3,2-c][1,5]benzodiazepine",CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C
CID000000453,Hexitol,C(C(C(C(C(CO)O)O)O)O)O,neumonia,CID000001690,Doxorubicin (Adriamycin) HCl,CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)[NH3+])O
CID000000453,Hexitol,C(C(C(C(C(CO)O)O)O)O)O,dry skin,CID000002524,32222-06-3,CC(CCCC(C)(C)O)C1CCC2C1(CCCC2=CC=C3CC(CC(C3=C)O)O)C
CID000000453,Hexitol,C(C(C(C(C(CO)O)O)O)O)O,gastric inflammation,CID005311048,SCHEMBL11440306,C(N)(N)(Cl)Cl
CID000000453,Hexitol,C(C(C(C(C(CO)O)O)O)O)O,haemorrhage rectum,CID000001117,sulfate,[O-]S(=O)(=O)[O-]
CID000000453,"hexane-1,2,3,4,5,6-hexol",C(C(C(C(C(CO)O)O)O)O)O,Bleeding,CID000000596,Cytosar,C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)O
CID000000453,Hexitol,C(C(C(C(C(CO)O)O)O)O)O,gastric inflammation,CID000087177,"D-Fructose, 4-O-alpha-D-glucopyranosyl-",C(C1C(C(C(C(O1)OC(C(CO)O)C(C(=O)CO)O)O)O)O)O
CID000000453,Hexitol,C(C(C(C(C(CO)O)O)O)O)O,thrombocytopenia,CID000003148,dolasetron,C1C2CC3CC(CC1N3CC2=O)OC(=O)C4=CNC5=CC=CC=C54
CID000000453,Hexitol,C(C(C(C(C(CO)O)O)O)O)O,thrombocytopenia,CID000002578,carmustine,C(CCl)NC(=O)N(CCCl)N=O
CID000000453,Hexitol,C(C(C(C(C(CO)O)O)O)O)O,insulin dependent diabetes mellitus,CID000004679,pantoprazole,COC1=C(C(=NC=C1)CS(=O)C2=NC3=C(N2)C=C(C=C3)OC(F)F)OC
CID000000453,Hexitol,C(C(C(C(C(CO)O)O)O)O)O,gastric inflammation,CID000008953,sodium;hydrogen carbonate,C(=O)(O)[O-].[Na+]
CID000000453,Hexitol,C(C(C(C(C(CO)O)O)O)O)O,metabolic encephalopathy,CID000003075,"2-[3-acetyloxy-2-(4-methoxyphenyl)-4-oxo-2,3-dihydro-1,5-benzothiazepin-5-yl]ethyl-dimethylazanium",CC(=O)OC1C(SC2=CC=CC=C2N(C1=O)CC[NH+](C)C)C3=CC=C(C=C3)OC
CID000000453,Hexitol,C(C(C(C(C(CO)O)O)O)O)O,hiccough,CID000003750,"4,11-diethyl-4-hydroxy-3,14-dioxo-3,4,12,14-tetrahydro-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinolin-9-yl 1,4'-bipiperidine-1'-carboxylate",CCC1=C2CN3C(=CC4=C(C3=O)COC(=O)C4(CC)O)C2=NC5=C1C=C(C=C5)OC(=O)N6CCC(CC6)N7CCCCC7
CID000000453,Hexitol,C(C(C(C(C(CO)O)O)O)O)O,thrombocytopenia,CID000019090,megestrol,CC1=CC2C(CCC3(C2CCC3(C(=O)C)O)C)C4(C1=CC(=O)CC4)C
CID000000453,Hexitol,C(C(C(C(C(CO)O)O)O)O)O,insulin dependent diabetes mellitus,CID000003954,loperamide(1+),CN(C)C(=O)C(CC[NH+]1CCC(CC1)(C2=CC=C(C=C2)Cl)O)(C3=CC=CC=C3)C4=CC=CC=C4
CID000000453,Hexitol,C(C(C(C(C(CO)O)O)O)O)O,thrombocytopenia,CID000038904,Carboplatinum,C1CC(C1)(C(=O)O)C(=O)O.N.N.[Pt]
CID000000453,Hexitol,C(C(C(C(C(CO)O)O)O)O)O,respiratory alkalosis,CID000005394,temozolomide,CN1C(=O)N2C=NC(=C2N=N1)C(=O)N
CID000000453,Hexitol,C(C(C(C(C(CO)O)O)O)O)O,myelodysplasia,CID000001983,acetaminophen,CC(=O)NC1=CC=C(C=C1)O
CID000000453,Hexitol,C(C(C(C(C(CO)O)O)O)O)O,metabolic encephalopathy,CID000003937,N~2~-(1-carboxy-3-phenylpropyl)lysylproline,C1CC(N(C1)C(=O)C(CCCCN)NC(CCC2=CC=CC=C2)C(=O)O)C(=O)O
CID000000453,Hexitol,C(C(C(C(C(CO)O)O)O)O)O,heart attack,CID006398525,,C(C1C(C(C(C(O1)OC2(C(C(C(O2)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)COS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.[Al].[Al].[Al].[Al].[Al].[Al].[Al].[Al].[Al]
CID000000453,Hexitol,C(C(C(C(C(CO)O)O)O)O)O,angiitis,CID000004173,metronidazole,CC1=NC=C(N1CCO)[N+](=O)[O-]
CID000000453,Hexitol,C(C(C(C(C(CO)O)O)O)O)O,edema,CID000004170,metolazone,CC1NC2=CC(=C(C=C2C(=O)N1C3=CC=CC=C3C)S(=O)(=O)N)Cl
CID000000453,Hexitol,C(C(C(C(C(CO)O)O)O)O)O,hypermagnesemia,CID000003310,33419-42-0,CC1OCC2C(O1)C(C(C(O2)OC3C4COC(=O)C4C(C5=CC6=C(C=C35)OCO6)C7=CC(=C(C(=C7)OC)O)OC)O)O
CID000000453,Hexitol,C(C(C(C(C(CO)O)O)O)O)O,angiitis,CID000002907,cyclophosphamide,C1CNP(=O)(OC1)N(CCCl)CCCl
CID000000453,Hexitol,C(C(C(C(C(CO)O)O)O)O)O,gastric inflammation,CID000000581,N-Acetyl-DL-cysteine,CC(=O)NC(CS)C(=O)O
CID000000453,Hexitol,C(C(C(C(C(CO)O)O)O)O)O,Bleeding,CID000002658,3-(carbamoyloxymethyl)-7-[[2-(furan-2-yl)-2-methoxyiminoacetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate,CON=C(C1=CC=CO1)C(=O)NC2C3N(C2=O)C(=C(CS3)COC(=O)N)C(=O)[O-]
CID000000206,Hexose,C(C1C(C(C(C(O1)O)O)O)O)O,eruption,CID000003075,"2-[3-acetyloxy-2-(4-methoxyphenyl)-4-oxo-2,3-dihydro-1,5-benzothiazepin-5-yl]ethyl-dimethylazanium",CC(=O)OC1C(SC2=CC=CC=C2N(C1=O)CC[NH+](C)C)C3=CC=C(C=C3)OC
CID000000206,Hexose,C(C1C(C(C(C(O1)O)O)O)O)O,cholecystitis,CID000003958,lorazepam,C1=CC=C(C(=C1)C2=NC(C(=O)NC3=C2C=C(C=C3)Cl)O)Cl
CID000000206,Hexose,C(C1C(C(C(C(O1)O)O)O)O)O,atelectasis,CID000003954,loperamide(1+),CN(C)C(=O)C(CC[NH+]1CCC(CC1)(C2=CC=C(C=C2)Cl)O)(C3=CC=CC=C3)C4=CC=CC=C4
CID000000206,Hexose,C(C1C(C(C(C(O1)O)O)O)O)O,neumonia,CID000019090,megestrol,CC1=CC2C(CCC3(C2CCC3(C(=O)C)O)C)C4(C1=CC(=O)CC4)C
CID000000206,Hexose,C(C1C(C(C(C(O1)O)O)O)O)O,thrombocytopenia,CID000005391,temazepam,CN1C2=C(C=C(C=C2)Cl)C(=NC(C1=O)O)C3=CC=CC=C3
CID000000206,Hexose,C(C1C(C(C(C(O1)O)O)O)O)O,increased white blood cell count,CID000065999,Telmisartan,CCCC1=NC2=C(N1CC3=CC=C(C=C3)C4=CC=CC=C4C(=O)O)C=C(C=C2C)C5=NC6=CC=CC=C6N5C
CID000000206,Hexose,C(C1C(C(C(C(O1)O)O)O)O)O,acute brain syndrome,CID000004900,Fernisone,CC12CC(=O)C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C
CID000000206,Hexose,C(C1C(C(C(C(O1)O)O)O)O)O,elevated cholesterol,CID005381226,"[(7S,9E,11S,12R,13S,14R,15R,16R,17S,18S,19E,21Z,26E)-2,15,17,29-tetrahydroxy-11-methoxy-3,7,12,14,16,18,22-heptamethyl-26-[[(4-methylpiperazin-1-yl)amino]methylidene]-6,23,27-trioxo-8,30-dioxa-24-azatetracyclo[23.3.1.14,7.05,28]triaconta-1(28),2,4,9,19,21,25(29)-heptaen-13-yl] acetate",CC1C=CC=C(C(=O)NC2=C(C3=C(C4=C(C(=C3O)C)OC(C4=O)(OC=CC(C(C(C(C(C(C1O)C)O)C)OC(=O)C)C)OC)C)C(=O)C2=CNN5CCN(CC5)C)O)C
CID000000206,Hexose,C(C1C(C(C(C(O1)O)O)O)O)O,elevated cholesterol,CID000074989,ATOVAQUONE,C1CC(CCC1C2=CC=C(C=C2)Cl)C3=C(C4=CC=CC=C4C(=O)C3=O)O
CID000000206,Hexose,C(C1C(C(C(C(O1)O)O)O)O)O,Adenopathy,CID000005732,zolpidem,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C
CID000000206,Hexose,C(C1C(C(C(C(O1)O)O)O)O)O,thrombocytopenia,CID000004691,"3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine",C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4
CID000000206,Hexose,C(C1C(C(C(C(O1)O)O)O)O)O,drug toxicity NOS,CID000087177,"D-Fructose, 4-O-alpha-D-glucopyranosyl-",C(C1C(C(C(C(O1)OC(C(CO)O)C(C(=O)CO)O)O)O)O)O
CID000000206,Hexose,C(C1C(C(C(C(O1)O)O)O)O)O,Back Ache,CID000038904,Carboplatinum,C1CC(C1)(C(=O)O)C(=O)O.N.N.[Pt]
CID000000206,Hexose,C(C1C(C(C(C(O1)O)O)O)O)O,Adenopathy,CID000003405,2-[[4-[(2-amino-4-oxo-1H-pteridin-6-yl)methylamino]benzoyl]amino]pentanedioic acid,C1=CC(=CC=C1C(=O)NC(CCC(=O)O)C(=O)O)NCC2=CN=C3C(=N2)C(=O)N=C(N3)N
CID000000206,Hexose,C(C1C(C(C(C(O1)O)O)O)O)O,angiitis,CID000001983,acetaminophen,CC(=O)NC1=CC=C(C=C1)O
CID000000206,Hexose,C(C1C(C(C(C(O1)O)O)O)O)O,atelectasis,CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N
CID000000206,Hexose,C(C1C(C(C(C(O1)O)O)O)O)O,lung infiltration,CID003468412,SCHEMBL1176571,CC1C=CC=CCCC=CC=CC=CC=CC(CC(C(C(CC(=O)CC(C(CCC(CC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)C(=O)O)O)OC2C(C(C(C(O2)C)O)N)O
CID000000206,Hexose,C(C1C(C(C(C(O1)O)O)O)O)O,septic shock,CID000002907,cyclophosphamide,C1CNP(=O)(OC1)N(CCCl)CCCl
CID000000206,Hexose,C(C1C(C(C(C(O1)O)O)O)O)O,haematoma,CID000002474,bupivacaine,CCCCN1CCCCC1C(=O)NC2=C(C=CC=C2C)C
CID000000206,Hexose,C(C1C(C(C(C(O1)O)O)O)O)O,gastric inflammation,CID005311048,SCHEMBL11440306,C(N)(N)(Cl)Cl
CID000000206,Hexose,C(C1C(C(C(C(O1)O)O)O)O)O,cholecystitis,CID000004679,pantoprazole,COC1=C(C(=NC=C1)CS(=O)C2=NC3=C(N2)C=C(C=C3)OC(F)F)OC
CID000000206,Hexose,C(C1C(C(C(C(O1)O)O)O)O)O,Abnormal Gait,CID000002656,"7-[[2-(2-amino-1,3-thiazol-4-yl)-2-methoxyiminoacetyl]amino]-3-[(2-methyl-6-oxido-5-oxo-1,2,4-triazin-3-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CN1C(=NC(=O)C(=N1)[O-])SCC2=C(N3C(C(C3=O)NC(=O)C(=NOC)C4=CSC(=N4)N)SC2)C(=O)[O-]
CID000000206,Hexose,C(C1C(C(C(C(O1)O)O)O)O)O,atelectasis,CID000003345,fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3
CID000000206,Hexose,C(C1C(C(C(C(O1)O)O)O)O)O,hiccough,CID000003661,L-Hyoscyamine,CN1C2CCC1CC(C2)OC(=O)C(CO)C3=CC=CC=C3
CID000000206,Hexose,C(C1C(C(C(C(O1)O)O)O)O)O,right heart failure,CID000003062,Lanicor,CC1C(C(CC(O1)OC2C(OC(CC2O)OC3C(OC(CC3O)OC4CCC5(C(C4)CCC6C5CC(C7(C6(CCC7C8=CC(=O)OC8)O)C)O)C)C)C)O)O
CID000000206,Hexose,C(C1C(C(C(C(O1)O)O)O)O)O,gastric inflammation,CID000001117,sulfate,[O-]S(=O)(=O)[O-]
CID000000206,Hexose,C(C1C(C(C(C(O1)O)O)O)O)O,atelectasis,CID000003890,TRANS (15S)-LATANOPROST,CC(C)OC(=O)CCCC=CCC1C(CC(C1CCC(CCC2=CC=CC=C2)O)O)O
CID000000206,Hexose,C(C1C(C(C(C(O1)O)O)O)O)O,Adenopathy,CID000002022,2-amino-9-(2-hydroxyethoxymethyl)-3H-purin-6-one,C1=NC2=C(N1COCCO)NC(=NC2=O)N
CID000000206,Hexose,C(C1C(C(C(C(O1)O)O)O)O)O,cholecystitis,CID000003325,famotidine,C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N
CID000000206,Hexose,C(C1C(C(C(C(O1)O)O)O)O)O,thrombocytopenia,CID000002806,90055-48-4,COC(=O)C(C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3
CID000000206,Hexose,C(C1C(C(C(C(O1)O)O)O)O)O,drug toxicity NOS,CID000002803,clonidine,C1CN=C(N1)NC2=C(C=CC=C2Cl)Cl
CID000000206,Hexose,C(C1C(C(C(C(O1)O)O)O)O)O,atelectasis,CID000005523,Ultram,CN(C)CC1CCCCC1(C2=CC(=CC=C2)OC)O
CID000000206,Hexose,C(C1C(C(C(C(O1)O)O)O)O)O,Arrhythmia,CID000004510,nitroglycerin,C(C(CO[N+](=O)[O-])O[N+](=O)[O-])O[N+](=O)[O-]
CID000000206,Hexose,C(C1C(C(C(C(O1)O)O)O)O)O,enlarged liver,CID000005645,"3,7-Dihydroxycholan-24-oic acid",CC(CCC(=O)O)C1CCC2C1(CCC3C2C(CC4C3(CCC(C4)O)C)O)C
CID000000206,Hexose,C(C1C(C(C(C(O1)O)O)O)O)O,elevated cholesterol,CID000004894,"11,17,21-Trihydroxypregna-1,4-diene-3,20-dione",CC12CC(C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C)O
CID000000206,Hexose,C(C1C(C(C(C(O1)O)O)O)O)O,elevated cholesterol,CID000003658,hydroxyzine,C1CN(CCN1CCOCCO)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl
CID000000206,Hexose,C(C1C(C(C(C(O1)O)O)O)O)O,Adenopathy,CID000003440,furosemide,C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl
CID000000206,Hexose,C(C1C(C(C(C(O1)O)O)O)O)O,thrombocytopenia,CID005311297,SCHEMBL1133011,CC(C)(C1=CC=CC=C1CCC(C2=CC=CC(=C2)C=CC3=NC4=C(C=CC(=C4)Cl)C=C3)S)O
CID000000206,Hexose,C(C1C(C(C(C(O1)O)O)O)O)O,angioedema,CID000003937,N~2~-(1-carboxy-3-phenylpropyl)lysylproline,C1CC(N(C1)C(=O)C(CCCCN)NC(CCC2=CC=CC=C2)C(=O)O)C(=O)O
CID000000206,Hexose,C(C1C(C(C(C(O1)O)O)O)O)O,eruption,CID000001690,Doxorubicin (Adriamycin) HCl,CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)[NH3+])O
CID000000206,Hexose,C(C1C(C(C(C(O1)O)O)O)O)O,cholecystitis,CID000004927,promethazine,CC(CN1C2=CC=CC=C2SC3=CC=CC=C31)N(C)C
CID000000206,Hexose,C(C1C(C(C(C(O1)O)O)O)O)O,dizziness,CID000002088,ALENDRONIC ACID,C(CC(O)(P(=O)(O)O)P(=O)(O)O)CN
CID000000206,Hexose,C(C1C(C(C(C(O1)O)O)O)O)O,loss of weight,CID000001971,914348-29-1,C1CC1NC2=C3C(=NC(=N2)N)N(C=N3)C4CC(C=C4)CO
CID000000206,Hexose,C(C1C(C(C(C(O1)O)O)O)O)O,cholecystitis,CID000004173,metronidazole,CC1=NC=C(N1CCO)[N+](=O)[O-]
CID000000206,Hexose,C(C1C(C(C(C(O1)O)O)O)O)O,cholecystitis,CID000054454,simvastatin,CCC(C)(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C
CID000000206,Hexose,C(C1C(C(C(C(O1)O)O)O)O)O,eating disorder,CID000002771,citalopram,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F
CID000000206,Hexose,C(C1C(C(C(C(O1)O)O)O)O)O,cholecystitis,CID000003883,lansoprazole,CC1=C(C=CN=C1CS(=O)C2=NC3=CC=CC=C3N2)OCC(F)(F)F
CID000000206,Hexose,C(C1C(C(C(C(O1)O)O)O)O)O,elevated cholesterol,CID000003414,phosphonatoformate,C(=O)([O-])P(=O)([O-])[O-]
CID000000206,Hexose,C(C1C(C(C(C(O1)O)O)O)O)O,elevated cholesterol,CID000005076,162990-01-4,CC(C)C1=NC(=CS1)CN(C)C(=O)NC(C(C)C)C(=O)NC(CC2=CC=CC=C2)CC(C(CC3=CC=CC=C3)NC(=O)OCC4=CN=CS4)O
CID000000206,Hexose,C(C1C(C(C(C(O1)O)O)O)O)O,thrombocytopenia,CID000005073,risperidone,CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F
CID000000206,Hexose,C(C1C(C(C(C(O1)O)O)O)O)O,arterial pressure NOS decreased,CID000003961,losartan,CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)CO)Cl
CID000000206,Hexose,C(C1C(C(C(C(O1)O)O)O)O)O,acute kidney failure,CID006398525,,C(C1C(C(C(C(O1)OC2(C(C(C(O2)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)COS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.[Al].[Al].[Al].[Al].[Al].[Al].[Al].[Al].[Al]
CID000000206,Hexose,C(C1C(C(C(C(O1)O)O)O)O)O,elevated cholesterol,CID000003706,SCHEMBL1176257,CC(C)(C)NC(=O)C1CN(CCN1CC(CC(CC2=CC=CC=C2)C(=O)NC3C(CC4=CC=CC=C34)O)O)CC5=CN=CC=C5
CID000000206,Hexose,C(C1C(C(C(C(O1)O)O)O)O)O,thrombocytopenia,CID000002891,"cobalt(2+);[5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] 1-[3-[2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2,7,12,17-tetrahydro-1H-corrin-21-id-3-yl]propanoylamino]propan-2-yl hydrogen phosphate;cyanide",CC1=CC2=C(C=C1C)N(C=N2)C3C(C(C(O3)CO)OP(=O)(O)OC(C)CNC(=O)CCC4(C(C5C6(C(C(C(=N6)C(=C7C(C(C(=N7)C=C8C(C(C(=N8)C(=C4[N-]5)C)CCC(=O)N)(C)C)CCC(=O)N)(C)CC(=O)N)C)CCC(=O)N)(C)CC(=O)N)C)CC(=O)N)C)O.[C-]#N.[Co+2]
CID000000206,Hexose,C(C1C(C(C(C(O1)O)O)O)O)O,muscle inflammation,CID000003339,fenofibrate,CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C2=CC=C(C=C2)Cl
CID000000206,Hexose,C(C1C(C(C(C(O1)O)O)O)O)O,Pain,CID000004666,7-Epi Paclitaxel,CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C
CID000000206,Hexose,C(C1C(C(C(C(O1)O)O)O)O)O,aspiration pneumonia,CID000008953,sodium;hydrogen carbonate,C(=O)(O)[O-].[Na+]
CID000000206,Hexose,C(C1C(C(C(C(O1)O)O)O)O)O,heart rate increased,CID000003676,lidocaine,CCN(CC)CC(=O)NC1=C(C=CC=C1C)C
CID000041781,Torasemide,CC1=CC(=CC=C1)NC2=C(C=NC=C2)S(=O)(=O)NC(=O)NC(C)C,nephrotic syndrome,CID000163742,SCHEMBL1650579,COC1C(C(C(C(O1)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)COS(=O)(=O)O)OC4C(C(C(C(O4)C(=O)O)OC5C(C(C(C(O5)COS(=O)(=O)O)O)O)NS(=O)(=O)O)O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O)NS(=O)(=O)O
CID000041781,Torasemide,CC1=CC(=CC=C1)NC2=C(C=NC=C2)S(=O)(=O)NC(=O)NC(C)C,gastric inflammation,CID003468412,SCHEMBL1176571,CC1C=CC=CCCC=CC=CC=CC=CC(CC(C(C(CC(=O)CC(C(CCC(CC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)C(=O)O)O)OC2C(C(C(C(O2)C)O)N)O
CID000041781,Torasemide,CC1=CC(=CC=C1)NC2=C(C=NC=C2)S(=O)(=O)NC(=O)NC(C)C,loss of weight,CID005311048,SCHEMBL11440306,C(N)(N)(Cl)Cl
CID000041781,Torasemide,CC1=CC(=CC=C1)NC2=C(C=NC=C2)S(=O)(=O)NC(=O)NC(C)C,weight gain,CID000071329,Dofetilide,CN(CCC1=CC=C(C=C1)NS(=O)(=O)C)CCOC2=CC=C(C=C2)NS(=O)(=O)C
CID000041781,Torasemide,CC1=CC(=CC=C1)NC2=C(C=NC=C2)S(=O)(=O)NC(=O)NC(C)C,cholecystitis,CID005311297,SCHEMBL1133011,CC(C)(C1=CC=CC=C1CCC(C2=CC=CC(=C2)C=CC3=NC4=C(C=CC(=C4)Cl)C=C3)S)O
CID000041781,Torasemide,CC1=CC(=CC=C1)NC2=C(C=NC=C2)S(=O)(=O)NC(=O)NC(C)C,loss of weight,CID006398525,,C(C1C(C(C(C(O1)OC2(C(C(C(O2)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)COS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.[Al].[Al].[Al].[Al].[Al].[Al].[Al].[Al].[Al]
CID000041781,Torasemide,CC1=CC(=CC=C1)NC2=C(C=NC=C2)S(=O)(=O)NC(=O)NC(C)C,cholecystitis,CID000062924,"S-(fluoromethyl) (6S,9R,10S,11S,13S,14S,16R,17R)-6,9-difluoro-11,17-dihydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthrene-17-carbothioate",CC1CC2C3CC(C4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)SCF)O)C)O)F)C)F
CID000041781,Torasemide,CC1=CC(=CC=C1)NC2=C(C=NC=C2)S(=O)(=O)NC(=O)NC(C)C,hyperglycaemia,CID000152945,Dutasteride?,CC12CCC3C(C1CCC2C(=O)NC4=C(C=CC(=C4)C(F)(F)F)C(F)(F)F)CCC5C3(C=CC(=O)N5)C
CID000041781,Torasemide,CC1=CC(=CC=C1)NC2=C(C=NC=C2)S(=O)(=O)NC(=O)NC(C)C,hyperuricaemia,CID000071616,Voriconazole,CC(C1=NC=NC=C1F)C(CN2C=NC=N2)(C3=C(C=C(C=C3)F)F)O
CID000041781,Torasemide,CC1=CC(=CC=C1)NC2=C(C=NC=C2)S(=O)(=O)NC(=O)NC(C)C,cholecystitis,CID000054454,simvastatin,CCC(C)(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C
CID000041781,Torasemide,CC1=CC(=CC=C1)NC2=C(C=NC=C2)S(=O)(=O)NC(=O)NC(C)C,confusion,CID004659568,"2-cyano-3-(3,4-dihydroxy-5-nitrophenyl)-N,N-diethylprop-2-enamide",CCN(CC)C(=O)C(=CC1=CC(=C(C(=C1)O)O)[N+](=O)[O-])C#N
CID000041781,Torasemide,CC1=CC(=CC=C1)NC2=C(C=NC=C2)S(=O)(=O)NC(=O)NC(C)C,weight gain,CID005493444,Aliskiren,CC(C)C(CC1=CC(=C(C=C1)OC)OCCCOC)CC(C(CC(C(C)C)C(=O)NCC(C)(C)C(=O)N)O)N
CID000041781,Torasemide,CC1=CC(=CC=C1)NC2=C(C=NC=C2)S(=O)(=O)NC(=O)NC(C)C,loss of weight,CID000077999,rosiglitazone,CN(CCOC1=CC=C(C=C1)CC2C(=O)NC(=O)S2)C3=CC=CC=N3
CID000041781,Torasemide,CC1=CC(=CC=C1)NC2=C(C=NC=C2)S(=O)(=O)NC(=O)NC(C)C,apoplexy,CID000087177,"D-Fructose, 4-O-alpha-D-glucopyranosyl-",C(C1C(C(C(C(O1)OC(C(CO)O)C(C(=O)CO)O)O)O)O)O
CID000041781,Torasemide,CC1=CC(=CC=C1)NC2=C(C=NC=C2)S(=O)(=O)NC(=O)NC(C)C,edema,CID000060852,Ibandronic Acid,CCCCCN(C)CCC(O)(P(=O)(O)O)P(=O)(O)O
CID000041781,Torasemide,CC1=CC(=CC=C1)NC2=C(C=NC=C2)S(=O)(=O)NC(=O)NC(C)C,apoplexy,CID000065999,Telmisartan,CCCC1=NC2=C(N1CC3=CC=C(C=C3)C4=CC=CC=C4C(=O)O)C=C(C=C2C)C5=NC6=CC=CC=C6N5C
CID000005717,zafirlukast,CC1=CC=CC=C1S(=O)(=O)NC(=O)C2=CC(=C(C=C2)CC3=CN(C4=C3C=C(C=C4)NC(=O)OC5CCCC5)C)OC,apoplexy,CID005311297,SCHEMBL1133011,CC(C)(C1=CC=CC=C1CCC(C2=CC=CC(=C2)C=CC3=NC4=C(C=CC(=C4)Cl)C=C3)S)O
CID000005717,zafirlukast,CC1=CC=CC=C1S(=O)(=O)NC(=O)C2=CC(=C(C=C2)CC3=CN(C4=C3C=C(C=C4)NC(=O)OC5CCCC5)C)OC,apoplexy,CID003468412,SCHEMBL1176571,CC1C=CC=CCCC=CC=CC=CC=CC(CC(C(C(CC(=O)CC(C(CCC(CC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)C(=O)O)O)OC2C(C(C(C(O2)C)O)N)O
CID000005717,zafirlukast,CC1=CC=CC=C1S(=O)(=O)NC(=O)C2=CC(=C(C=C2)CC3=CN(C4=C3C=C(C=C4)NC(=O)OC5CCCC5)C)OC,gastric inflammation,CID000170361,Varenicline,C1C2CNCC1C3=CC4=NC=CN=C4C=C23
CID000005717,zafirlukast,CC1=CC=CC=C1S(=O)(=O)NC(=O)C2=CC(=C(C=C2)CC3=CN(C4=C3C=C(C=C4)NC(=O)OC5CCCC5)C)OC,erythema,CID000005732,zolpidem,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C
CID000005717,zafirlukast,CC1=CC=CC=C1S(=O)(=O)NC(=O)C2=CC(=C(C=C2)CC3=CN(C4=C3C=C(C=C4)NC(=O)OC5CCCC5)C)OC,weight gain,CID000077999,rosiglitazone,CN(CCOC1=CC=C(C=C1)CC2C(=O)NC(=O)S2)C3=CC=CC=N3
CID000005717,zafirlukast,CC1=CC=CC=C1S(=O)(=O)NC(=O)C2=CC(=C(C=C2)CC3=CN(C4=C3C=C(C=C4)NC(=O)OC5CCCC5)C)OC,loss of weight,CID000124087,Desloratadine,C1CC2=C(C=CC(=C2)Cl)C(=C3CCNCC3)C4=C1C=CC=N4
CID000005717,zafirlukast,CC1=CC=CC=C1S(=O)(=O)NC(=O)C2=CC(=C(C=C2)CC3=CN(C4=C3C=C(C=C4)NC(=O)OC5CCCC5)C)OC,palsies,CID006398525,,C(C1C(C(C(C(O1)OC2(C(C(C(O2)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)COS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.[Al].[Al].[Al].[Al].[Al].[Al].[Al].[Al].[Al]
CID000005717,zafirlukast,CC1=CC=CC=C1S(=O)(=O)NC(=O)C2=CC(=C(C=C2)CC3=CN(C4=C3C=C(C=C4)NC(=O)OC5CCCC5)C)OC,weight gain,CID000010631,medroxyprogesterone,CC1CC2C(CCC3(C2CCC3(C(=O)C)O)C)C4(C1=CC(=O)CC4)C
CID000005717,zafirlukast,CC1=CC=CC=C1S(=O)(=O)NC(=O)C2=CC(=C(C=C2)CC3=CN(C4=C3C=C(C=C4)NC(=O)OC5CCCC5)C)OC,nausea,CID000060854,Ziprasidone,C1CN(CCN1CCC2=C(C=C3C(=C2)CC(=O)N3)Cl)C4=NSC5=CC=CC=C54
CID000005717,zafirlukast,CC1=CC=CC=C1S(=O)(=O)NC(=O)C2=CC(=C(C=C2)CC3=CN(C4=C3C=C(C=C4)NC(=O)OC5CCCC5)C)OC,gastric inflammation,CID000027686,CHEMBL4088679,C1=CC2=C(C(=C1)OCC(COC3=CC4=C(C=C3)OC(=CC4=O)C(=O)O)O)C(=O)C=C(O2)C(=O)O
CID000005717,zafirlukast,CC1=CC=CC=C1S(=O)(=O)NC(=O)C2=CC(=C(C=C2)CC3=CN(C4=C3C=C(C=C4)NC(=O)OC5CCCC5)C)OC,cholecystectomies,CID000062924,"S-(fluoromethyl) (6S,9R,10S,11S,13S,14S,16R,17R)-6,9-difluoro-11,17-dihydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthrene-17-carbothioate",CC1CC2C3CC(C4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)SCF)O)C)O)F)C)F
CID000005717,zafirlukast,CC1=CC=CC=C1S(=O)(=O)NC(=O)C2=CC(=C(C=C2)CC3=CN(C4=C3C=C(C=C4)NC(=O)OC5CCCC5)C)OC,apoplexy,CID000160051,Colesevelam,CCCCCCCCCCNCC=C.C[N+](C)(C)CCCCCCNCC=C.C=CCN.C1C(O1)CCl.Cl.[Cl-]
CID000005717,zafirlukast,CC1=CC=CC=C1S(=O)(=O)NC(=O)C2=CC(=C(C=C2)CC3=CN(C4=C3C=C(C=C4)NC(=O)OC5CCCC5)C)OC,apoplexy,CID000054454,simvastatin,CCC(C)(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C
CID000002800,clomiphene,CCN(CC)CCOC1=CC=C(C=C1)C(=C(C2=CC=CC=C2)Cl)C3=CC=CC=C3,glaucoma,CID000005358,sumatriptan,CNS(=O)(=O)CC1=CC2=C(C=C1)NC=C2CCN(C)C
CID000002800,clomiphene,CCN(CC)CCOC1=CC=C(C=C1)C(=C(C2=CC=CC=C2)Cl)C3=CC=CC=C3,Hypoventilation,CID000062924,"S-(fluoromethyl) (6S,9R,10S,11S,13S,14S,16R,17R)-6,9-difluoro-11,17-dihydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthrene-17-carbothioate",CC1CC2C3CC(C4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)SCF)O)C)O)F)C)F
CID000002800,clomiphene,CCN(CC)CCOC1=CC=C(C=C1)C(=C(C2=CC=CC=C2)Cl)C3=CC=CC=C3,weight gain,CID000004691,"3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine",C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4
CID000002800,clomiphene,CCN(CC)CCOC1=CC=C(C=C1)C(=C(C2=CC=CC=C2)Cl)C3=CC=CC=C3,agitated,CID000003440,furosemide,C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl
CID000002800,clomiphene,CCN(CC)CCOC1=CC=C(C=C1)C(=C(C2=CC=CC=C2)Cl)C3=CC=CC=C3,abortion spontaneous,CID000004894,"11,17,21-Trihydroxypregna-1,4-diene-3,20-dione",CC12CC(C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C)O
CID000002800,clomiphene,CCN(CC)CCOC1=CC=C(C=C1)C(=C(C2=CC=CC=C2)Cl)C3=CC=CC=C3,elevated cholesterol,CID000010631,medroxyprogesterone,CC1CC2C(CCC3(C2CCC3(C(=O)C)O)C)C4(C1=CC(=O)CC4)C
CID000002800,clomiphene,CCN(CC)CCOC1=CC=C(C=C1)C(=C(C2=CC=CC=C2)Cl)C3=CC=CC=C3,Bleeding,CID000003405,2-[[4-[(2-amino-4-oxo-1H-pteridin-6-yl)methylamino]benzoyl]amino]pentanedioic acid,C1=CC(=CC=C1C(=O)NC(CCC(=O)O)C(=O)O)NCC2=CN=C3C(=N2)C(=O)N=C(N3)N
CID000002800,clomiphene,CCN(CC)CCOC1=CC=C(C=C1)C(=C(C2=CC=CC=C2)Cl)C3=CC=CC=C3,loss of weight,CID000004920,"1-acetyl-9a,11a-dimethyl-1H,2H,3H,3aH,3bH,4H,5H,7H,8H,9H,9aH,9bH,10H,11H,11aH-cyclopenta[a]phenanthren-7-one",CC(=O)C1CCC2C1(CCC3C2CCC4=CC(=O)CCC34C)C
CID000004829,Pioglitazone,CCC1=CN=C(C=C1)CCOC2=CC=C(C=C2)CC3C(=O)NC(=O)S3,cholecystitis,CID000005512,124936-74-9,CC1=CC(=C(C=C1)O)C(CCN(C(C)C)C(C)C)C2=CC=CC=C2
CID000004829,Pioglitazone,CCC1=CN=C(C=C1)CCOC2=CC=C(C=C2)CC3C(=O)NC(=O)S3,difficulty in walking,CID000005376,(E/Z)-Tamoxifen,CCC(=C(C1=CC=CC=C1)C2=CC=C(C=C2)OCCN(C)C)C3=CC=CC=C3
CID000004829,Pioglitazone,CCC1=CN=C(C=C1)CCOC2=CC=C(C=C2)CC3C(=O)NC(=O)S3,loss of weight,CID000005095,ropinirole,CCCN(CCC)CCC1=C2CC(=O)NC2=CC=C1
CID000004829,Pioglitazone,CCC1=CN=C(C=C1)CCOC2=CC=C(C=C2)CC3C(=O)NC(=O)S3,gastric inflammation,CID000060184,"2'-epi-Perindopril, (2'R)-",CCCC(C(=O)OCC)NC(C)C(=O)N1C2CCCCC2CC1C(=O)O
CID000004829,Pioglitazone,CCC1=CN=C(C=C1)CCOC2=CC=C(C=C2)CC3C(=O)NC(=O)S3,elevated cholesterol,CID000005352,38194-50-2,CC1=C(C2=C(C1=CC3=CC=C(C=C3)S(=O)C)C=CC(=C2)F)CC(=O)O
CID000004829,Pioglitazone,CCC1=CN=C(C=C1)CCOC2=CC=C(C=C2)CC3C(=O)NC(=O)S3,cholecystitis,CID000005358,sumatriptan,CNS(=O)(=O)CC1=CC2=C(C=C1)NC=C2CCN(C)C
CID000004829,Pioglitazone,CCC1=CN=C(C=C1)CCOC2=CC=C(C=C2)CC3C(=O)NC(=O)S3,loss of weight,CID000004856,"3-[hydroxy-(pyridin-2-ylamino)methylidene]-2-methyl-1,1-dioxo-1lambda6,2-benzothiazin-4-one",CN1C(=C(NC2=CC=CC=N2)O)C(=O)C3=CC=CC=C3S1(=O)=O
CID000004829,Pioglitazone,CCC1=CN=C(C=C1)CCOC2=CC=C(C=C2)CC3C(=O)NC(=O)S3,cholecystitis,CID000005544,Mycolog,CC12CC(C3(C(C1CC(C2(C(=O)CO)O)O)CCC4=CC(=O)C=CC43C)F)O
CID000004829,Pioglitazone,CCC1=CN=C(C=C1)CCOC2=CC=C(C=C2)CC3C(=O)NC(=O)S3,nasopharyngitis,CID000008953,sodium;hydrogen carbonate,C(=O)(O)[O-].[Na+]
CID000004829,Pioglitazone,CCC1=CN=C(C=C1)CCOC2=CC=C(C=C2)CC3C(=O)NC(=O)S3,apoplexy,CID000005253,sotalol,CC(C)NCC(C1=CC=C(C=C1)NS(=O)(=O)C)O
CID000004829,Pioglitazone,CCC1=CN=C(C=C1)CCOC2=CC=C(C=C2)CC3C(=O)NC(=O)S3,gastric inflammation,CID000005245,Risedronic acid,C1=CC(=CN=C1)CC(O)(P(=O)(O)O)P(=O)(O)O
CID000004829,Pioglitazone,CCC1=CN=C(C=C1)CCOC2=CC=C(C=C2)CC3C(=O)NC(=O)S3,loss of weight,CID000152945,Dutasteride?,CC12CCC3C(C1CCC2C(=O)NC4=C(C=CC(=C4)C(F)(F)F)C(F)(F)F)CCC5C3(C=CC(=O)N5)C
CID000004829,Pioglitazone,CCC1=CN=C(C=C1)CCOC2=CC=C(C=C2)CC3C(=O)NC(=O)S3,Adenopathy,CID000077999,rosiglitazone,CN(CCOC1=CC=C(C=C1)CC2C(=O)NC(=O)S2)C3=CC=CC=N3
CID000004829,Pioglitazone,CCC1=CN=C(C=C1)CCOC2=CC=C(C=C2)CC3C(=O)NC(=O)S3,thrombocytopenia,CID000005978,vincristine,CCC1(CC2CC(C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)C78CCN9C7C(C=CC9)(C(C(C8N6C=O)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O
CID000004829,Pioglitazone,CCC1=CN=C(C=C1)CCOC2=CC=C(C=C2)CC3C(=O)NC(=O)S3,erythema,CID000005650,N-pentanoyl-N-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-L-valine,CCCCC(=O)N(CC1=CC=C(C=C1)C2=CC=CC=C2C3=NNN=N3)C(C(C)C)C(=O)O
CID000004829,Pioglitazone,CCC1=CN=C(C=C1)CCOC2=CC=C(C=C2)CC3C(=O)NC(=O)S3,erythema,CID000005073,risperidone,CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F
CID000004829,Pioglitazone,CCC1=CN=C(C=C1)CCOC2=CC=C(C=C2)CC3C(=O)NC(=O)S3,Adenopathy,CID000004889,Pravastatin Impurity A,CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC(CC(CC(=O)O)O)O)O
CID000004829,Pioglitazone,CCC1=CN=C(C=C1)CCOC2=CC=C(C=C2)CC3C(=O)NC(=O)S3,cholecystitis,CID000038904,Carboplatinum,C1CC(C1)(C(=O)O)C(=O)O.N.N.[Pt]
CID000004829,Pioglitazone,CCC1=CN=C(C=C1)CCOC2=CC=C(C=C2)CC3C(=O)NC(=O)S3,Anorexia,CID005481350,Tenofovir disoproxil,CC(C)OC(=O)OCOP(=O)(COC(C)CN1C=NC2=C(N=CN=C21)N)OCOC(=O)OC(C)C
CID000004829,Pioglitazone,CCC1=CN=C(C=C1)CCOC2=CC=C(C=C2)CC3C(=O)NC(=O)S3,disseminated lupus erythematosus,CID000016231,AMILORIDE,C1(=C(N=C(C(=N1)Cl)N)N)C(=O)N=C(N)N
CID000004829,Pioglitazone,CCC1=CN=C(C=C1)CCOC2=CC=C(C=C2)CC3C(=O)NC(=O)S3,High blood pressure,CID000087177,"D-Fructose, 4-O-alpha-D-glucopyranosyl-",C(C1C(C(C(C(O1)OC(C(CO)O)C(C(=O)CO)O)O)O)O)O
CID000004829,Pioglitazone,CCC1=CN=C(C=C1)CCOC2=CC=C(C=C2)CC3C(=O)NC(=O)S3,increased white blood cell count,CID000163742,SCHEMBL1650579,COC1C(C(C(C(O1)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)COS(=O)(=O)O)OC4C(C(C(C(O4)C(=O)O)OC5C(C(C(C(O5)COS(=O)(=O)O)O)O)NS(=O)(=O)O)O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O)NS(=O)(=O)O
CID000004829,Pioglitazone,CCC1=CN=C(C=C1)CCOC2=CC=C(C=C2)CC3C(=O)NC(=O)S3,cholecystitis,CID005311297,SCHEMBL1133011,CC(C)(C1=CC=CC=C1CCC(C2=CC=CC(=C2)C=CC3=NC4=C(C=CC(=C4)Cl)C=C3)S)O
CID000004829,Pioglitazone,CCC1=CN=C(C=C1)CCOC2=CC=C(C=C2)CC3C(=O)NC(=O)S3,loss of weight,CID000065999,Telmisartan,CCCC1=NC2=C(N1CC3=CC=C(C=C3)C4=CC=CC=C4C(=O)O)C=C(C=C2C)C5=NC6=CC=CC=C6N5C
CID000004829,Pioglitazone,CCC1=CN=C(C=C1)CCOC2=CC=C(C=C2)CC3C(=O)NC(=O)S3,cholecystitis,CID000005732,zolpidem,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C
CID000004829,Pioglitazone,CCC1=CN=C(C=C1)CCOC2=CC=C(C=C2)CC3C(=O)NC(=O)S3,loss of weight,CID005311048,SCHEMBL11440306,C(N)(N)(Cl)Cl
CID000004829,Pioglitazone,CCC1=CN=C(C=C1)CCOC2=CC=C(C=C2)CC3C(=O)NC(=O)S3,dysarthria,CID000005077,105601-20-5,CCN(C)C(=O)OC1=CC=CC(=C1)C(C)N(C)C
CID000004829,Pioglitazone,CCC1=CN=C(C=C1)CCOC2=CC=C(C=C2)CC3C(=O)NC(=O)S3,aching muscles,CID000005076,162990-01-4,CC(C)C1=NC(=CS1)CN(C)C(=O)NC(C(C)C)C(=O)NC(CC2=CC=CC=C2)CC(C(CC3=CC=CC=C3)NC(=O)OCC4=CN=CS4)O
CID000004829,Pioglitazone,CCC1=CN=C(C=C1)CCOC2=CC=C(C=C2)CC3C(=O)NC(=O)S3,loss of weight,CID000005478,racemic-Timolol,CC(C)(C)NCC(COC1=NSN=C1N2CCOCC2)O
CID000004829,Pioglitazone,CCC1=CN=C(C=C1)CCOC2=CC=C(C=C2)CC3C(=O)NC(=O)S3,asthma,CID000005152,Salmeterol,C1=CC=C(C=C1)CCCCOCCCCCCNCC(C2=CC(=C(C=C2)O)CO)O
CID000004829,Pioglitazone,CCC1=CN=C(C=C1)CCOC2=CC=C(C=C2)CC3C(=O)NC(=O)S3,abnormal ECG,CID000124087,Desloratadine,C1CC2=C(C=CC(=C2)Cl)C(=C3CCNCC3)C4=C1C=CC=N4
CID000004829,Pioglitazone,CCC1=CN=C(C=C1)CCOC2=CC=C(C=C2)CC3C(=O)NC(=O)S3,apoplexy,CID000160051,Colesevelam,CCCCCCCCCCNCC=C.C[N+](C)(C)CCCCCCNCC=C.C=CCN.C1C(O1)CCl.Cl.[Cl-]
CID000004829,Pioglitazone,CCC1=CN=C(C=C1)CCOC2=CC=C(C=C2)CC3C(=O)NC(=O)S3,defaecation urgency,CID000125017,Desvenlafaxine,CN(C)CC(C1=CC=C(C=C1)O)C2(CCCCC2)O
CID000004829,Pioglitazone,CCC1=CN=C(C=C1)CCOC2=CC=C(C=C2)CC3C(=O)NC(=O)S3,erythema,CID000110635,Tadalafil,CN1CC(=O)N2C(C1=O)CC3=C(C2C4=CC5=C(C=C4)OCO5)NC6=CC=CC=C36
CID000004829,Pioglitazone,CCC1=CN=C(C=C1)CCOC2=CC=C(C=C2)CC3C(=O)NC(=O)S3,cholecystitis,CID000667490,6-Mercaptopurine,C1=NC2=C(N1)C(=S)N=CN2
CID000004829,Pioglitazone,CCC1=CN=C(C=C1)CCOC2=CC=C(C=C2)CC3C(=O)NC(=O)S3,bradycardia,CID005493444,Aliskiren,CC(C)C(CC1=CC(=C(C=C1)OC)OCCCOC)CC(C(CC(C(C)C)C(=O)NCC(C)(C)C(=O)N)O)N
CID000004829,Pioglitazone,CCC1=CN=C(C=C1)CCOC2=CC=C(C=C2)CC3C(=O)NC(=O)S3,abdominal pain upper,CID000004885,104617-86-9,CCCNC1CCC2=C(C1)SC(=N2)N
CID000004829,Pioglitazone,CCC1=CN=C(C=C1)CCOC2=CC=C(C=C2)CC3C(=O)NC(=O)S3,cholecystitis,CID006398525,,C(C1C(C(C(C(O1)OC2(C(C(C(O2)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)COS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.[Al].[Al].[Al].[Al].[Al].[Al].[Al].[Al].[Al]
CID000004829,Pioglitazone,CCC1=CN=C(C=C1)CCOC2=CC=C(C=C2)CC3C(=O)NC(=O)S3,gastric inflammation,CID000004900,Fernisone,CC12CC(=O)C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C
CID000004829,Pioglitazone,CCC1=CN=C(C=C1)CCOC2=CC=C(C=C2)CC3C(=O)NC(=O)S3,apoplexy,CID000004909,primidone,CCC1(C(=O)NCNC1=O)C2=CC=CC=C2
CID000004829,Pioglitazone,CCC1=CN=C(C=C1)CCOC2=CC=C(C=C2)CC3C(=O)NC(=O)S3,loss of weight,CID000060852,Ibandronic Acid,CCCCCN(C)CCC(O)(P(=O)(O)O)P(=O)(O)O
CID000004829,Pioglitazone,CCC1=CN=C(C=C1)CCOC2=CC=C(C=C2)CC3C(=O)NC(=O)S3,edema,CID000060854,Ziprasidone,C1CN(CCN1CCC2=C(C=C3C(=C2)CC(=O)N3)Cl)C4=NSC5=CC=CC=C54
CID000004829,Pioglitazone,CCC1=CN=C(C=C1)CCOC2=CC=C(C=C2)CC3C(=O)NC(=O)S3,Adenopathy,CID000054454,simvastatin,CCC(C)(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C
CID000004829,Pioglitazone,CCC1=CN=C(C=C1)CCOC2=CC=C(C=C2)CC3C(=O)NC(=O)S3,abnormal ECG,CID003468412,SCHEMBL1176571,CC1C=CC=CCCC=CC=CC=CC=CC(CC(C(C(CC(=O)CC(C(CCC(CC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)C(=O)O)O)OC2C(C(C(C(O2)C)O)N)O
CID000004829,Pioglitazone,CCC1=CN=C(C=C1)CCOC2=CC=C(C=C2)CC3C(=O)NC(=O)S3,loss of weight,CID000005394,temozolomide,CN1C(=O)N2C=NC(=C2N=N1)C(=O)N
CID000004829,Pioglitazone,CCC1=CN=C(C=C1)CCOC2=CC=C(C=C2)CC3C(=O)NC(=O)S3,gastric inflammation,CID000005391,temazepam,CN1C2=C(C=C(C=C2)Cl)C(=NC(C1=O)O)C3=CC=CC=C3
CID000004829,Pioglitazone,CCC1=CN=C(C=C1)CCOC2=CC=C(C=C2)CC3C(=O)NC(=O)S3,Adenopathy,CID000170361,Varenicline,C1C2CNCC1C3=CC4=NC=CN=C4C=C23
CID000004829,Pioglitazone,CCC1=CN=C(C=C1)CCOC2=CC=C(C=C2)CC3C(=O)NC(=O)S3,weight gain,CID000005719,zaleplon,CCN(C1=CC=CC(=C1)C2=CC=NC3=C(C=NN23)C#N)C(=O)C
CID000004829,Pioglitazone,CCC1=CN=C(C=C1)CCOC2=CC=C(C=C2)CC3C(=O)NC(=O)S3,bradycardia,CID000071329,Dofetilide,CN(CCC1=CC=C(C=C1)NS(=O)(=O)C)CCOC2=CC=C(C=C2)NS(=O)(=O)C
CID000004829,Pioglitazone,CCC1=CN=C(C=C1)CCOC2=CC=C(C=C2)CC3C(=O)NC(=O)S3,loss of weight,CID000019090,megestrol,CC1=CC2C(CCC3(C2CCC3(C(=O)C)O)C)C4(C1=CC(=O)CC4)C
CID000004829,Pioglitazone,CCC1=CN=C(C=C1)CCOC2=CC=C(C=C2)CC3C(=O)NC(=O)S3,belching,CID000004911,probenecid,CCCN(CCC)S(=O)(=O)C1=CC=C(C=C1)C(=O)O
CID000004829,Pioglitazone,CCC1=CN=C(C=C1)CCOC2=CC=C(C=C2)CC3C(=O)NC(=O)S3,cholecystitis,CID000062924,"S-(fluoromethyl) (6S,9R,10S,11S,13S,14S,16R,17R)-6,9-difluoro-11,17-dihydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthrene-17-carbothioate",CC1CC2C3CC(C4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)SCF)O)C)O)F)C)F
CID000004829,Pioglitazone,CCC1=CN=C(C=C1)CCOC2=CC=C(C=C2)CC3C(=O)NC(=O)S3,Adenopathy,CID005381226,"[(7S,9E,11S,12R,13S,14R,15R,16R,17S,18S,19E,21Z,26E)-2,15,17,29-tetrahydroxy-11-methoxy-3,7,12,14,16,18,22-heptamethyl-26-[[(4-methylpiperazin-1-yl)amino]methylidene]-6,23,27-trioxo-8,30-dioxa-24-azatetracyclo[23.3.1.14,7.05,28]triaconta-1(28),2,4,9,19,21,25(29)-heptaen-13-yl] acetate",CC1C=CC=C(C(=O)NC2=C(C3=C(C4=C(C(=C3O)C)OC(C4=O)(OC=CC(C(C(C(C(C(C1O)C)O)C)OC(=O)C)C)OC)C)C(=O)C2=CNN5CCN(CC5)C)O)C
CID000004829,Pioglitazone,CCC1=CN=C(C=C1)CCOC2=CC=C(C=C2)CC3C(=O)NC(=O)S3,cholecystitis,CID000004927,promethazine,CC(CN1C2=CC=CC=C2SC3=CC=CC=C31)N(C)C
CID000004829,Pioglitazone,CCC1=CN=C(C=C1)CCOC2=CC=C(C=C2)CC3C(=O)NC(=O)S3,dysarthria,CID000004920,"1-acetyl-9a,11a-dimethyl-1H,2H,3H,3aH,3bH,4H,5H,7H,8H,9H,9aH,9bH,10H,11H,11aH-cyclopenta[a]phenanthren-7-one",CC(=O)C1CCC2C1(CCC3C2CCC4=CC(=O)CCC34C)C
CID000004829,Pioglitazone,CCC1=CN=C(C=C1)CCOC2=CC=C(C=C2)CC3C(=O)NC(=O)S3,gastric inflammation,CID000005523,Ultram,CN(C)CC1CCCCC1(C2=CC(=CC=C2)OC)O
CID000004829,Pioglitazone,CCC1=CN=C(C=C1)CCOC2=CC=C(C=C2)CC3C(=O)NC(=O)S3,abnormal EEG,CID000005645,"3,7-Dihydroxycholan-24-oic acid",CC(CCC(=O)O)C1CCC2C1(CCC3C2C(CC4C3(CCC(C4)O)C)O)C
CID000004829,Pioglitazone,CCC1=CN=C(C=C1)CCOC2=CC=C(C=C2)CC3C(=O)NC(=O)S3,dysarthria,CID000005487,tizanidine,C1CN=C(N1)NC2=C(C=CC3=NSN=C32)Cl
CID000004829,Pioglitazone,CCC1=CN=C(C=C1)CCOC2=CC=C(C=C2)CC3C(=O)NC(=O)S3,cholecystitis,CID000027991,DESMOPRESSIN,C1CC(N(C1)C(=O)C2CSSCCC(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N2)CC(=O)N)CCC(=O)N)CC3=CC=CC=C3)CC4=CC=C(C=C4)O)C(=O)NC(CCCN=C(N)N)C(=O)NCC(=O)N
CID000004829,Pioglitazone,CCC1=CN=C(C=C1)CCOC2=CC=C(C=C2)CC3C(=O)NC(=O)S3,Back Ache,CID000004894,"11,17,21-Trihydroxypregna-1,4-diene-3,20-dione",CC12CC(C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C)O
CID000004829,Pioglitazone,CCC1=CN=C(C=C1)CCOC2=CC=C(C=C2)CC3C(=O)NC(=O)S3,bulging,CID000444013,GADOVERSETAMIDE,COCCNC(=O)CN(CCN(CCN(CC(=O)NCCOC)CC(=O)[O-])CC(=O)[O-])CC(=O)[O-].[Gd+3]
CID000004829,Pioglitazone,CCC1=CN=C(C=C1)CCOC2=CC=C(C=C2)CC3C(=O)NC(=O)S3,loss of weight,CID000010631,medroxyprogesterone,CC1CC2C(CCC3(C2CCC3(C(=O)C)O)C)C4(C1=CC(=O)CC4)C
CID000004829,Pioglitazone,CCC1=CN=C(C=C1)CCOC2=CC=C(C=C2)CC3C(=O)NC(=O)S3,apoplexy,CID000060865,(E)-Olopatadine,CN(C)CCC=C1C2=CC=CC=C2COC3=C1C=C(C=C3)CC(=O)O
CID000004829,Pioglitazone,CCC1=CN=C(C=C1)CCOC2=CC=C(C=C2)CC3C(=O)NC(=O)S3,nocturia,CID000005195,Deprenyl,CC(CC1=CC=CC=C1)N(C)CC#C
CID000002474,bupivacaine,CCCCN1CCCCC1C(=O)NC2=C(C=CC=C2C)C,icterus,CID000003763,isoflurane,C(C(F)(F)F)(OC(F)F)Cl
CID000002474,bupivacaine,CCCCN1CCCCC1C(=O)NC2=C(C=CC=C2C)C,erythema,CID000003676,lidocaine,CCN(CC)CC(=O)NC1=C(C=CC=C1C)C
CID000002474,bupivacaine,CCCCN1CCCCC1C(=O)NC2=C(C=CC=C2C)C,drug toxicity NOS,CID000051263,ALFENTANIL,CCC(=O)N(C1=CC=CC=C1)C2(CCN(CC2)CCN3C(=O)N(N=N3)CC)COC
CID000002474,bupivacaine,CCCCN1CCCCC1C(=O)NC2=C(C=CC=C2C)C,acute pancreatitis,CID000039765,Vecuronium,CC(=O)OC1CC2CCC3C(C2(CC1N4CCCCC4)C)CCC5(C3CC(C5OC(=O)C)[N+]6(CCCCC6)C)C
CID000002474,bupivacaine,CCCCN1CCCCC1C(=O)NC2=C(C=CC=C2C)C,subarachnoid haemorrhage,CID000002803,clonidine,C1CN=C(N1)NC2=C(C=CC=C2Cl)Cl
CID000002474,bupivacaine,CCCCN1CCCCC1C(=O)NC2=C(C=CC=C2C)C,neumonia,CID000008953,sodium;hydrogen carbonate,C(=O)(O)[O-].[Na+]
CID000002474,bupivacaine,CCCCN1CCCCC1C(=O)NC2=C(C=CC=C2C)C,Bacteraemia,CID000003440,furosemide,C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl
CID000002474,bupivacaine,CCCCN1CCCCC1C(=O)NC2=C(C=CC=C2C)C,thrombocytopenia,CID000003075,"2-[3-acetyloxy-2-(4-methoxyphenyl)-4-oxo-2,3-dihydro-1,5-benzothiazepin-5-yl]ethyl-dimethylazanium",CC(=O)OC1C(SC2=CC=CC=C2N(C1=O)CC[NH+](C)C)C3=CC=C(C=C3)OC
CID000002474,bupivacaine,CCCCN1CCCCC1C(=O)NC2=C(C=CC=C2C)C,heart rate increased,CID000003890,TRANS (15S)-LATANOPROST,CC(C)OC(=O)CCCC=CCC1C(CC(C1CCC(CCC2=CC=CC=C2)O)O)O
CID000002474,bupivacaine,CCCCN1CCCCC1C(=O)NC2=C(C=CC=C2C)C,Back Ache,CID000004927,promethazine,CC(CN1C2=CC=CC=C2SC3=CC=CC=C31)N(C)C
CID000002474,bupivacaine,CCCCN1CCCCC1C(=O)NC2=C(C=CC=C2C)C,alopecia,CID000005544,Mycolog,CC12CC(C3(C(C1CC(C2(C(=O)CO)O)O)CCC4=CC(=O)C=CC43C)F)O
CID000002474,bupivacaine,CCCCN1CCCCC1C(=O)NC2=C(C=CC=C2C)C,Dyspnea exertional,CID000004510,nitroglycerin,C(C(CO[N+](=O)[O-])O[N+](=O)[O-])O[N+](=O)[O-]
CID000002474,bupivacaine,CCCCN1CCCCC1C(=O)NC2=C(C=CC=C2C)C,Arrhythmia,CID000002541,candesartan,CCOC1=NC2=CC=CC(=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5)C(=O)O
CID000002474,bupivacaine,CCCCN1CCCCC1C(=O)NC2=C(C=CC=C2C)C,thrombocytopenia,CID000004140,Isomethergine,CCC(CO)NC(=O)C1CN(C2CC3=CNC4=CC=CC(=C34)C2=C1)C
CID000002474,bupivacaine,CCCCN1CCCCC1C(=O)NC2=C(C=CC=C2C)C,muscle weakness,CID000004425,"4a,9-dihydroxy-3-prop-2-enyl-2,4,5,6,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinolin-7-one",C=CCN1CCC23C4C(=O)CCC2(C1CC5=C3C(=C(C=C5)O)O4)O
CID000002474,bupivacaine,CCCCN1CCCCC1C(=O)NC2=C(C=CC=C2C)C,Bleeding,CID000003325,famotidine,C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N
CID000002474,bupivacaine,CCCCN1CCCCC1C(=O)NC2=C(C=CC=C2C)C,glaucoma,CID000004894,"11,17,21-Trihydroxypregna-1,4-diene-3,20-dione",CC12CC(C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C)O
CID000002474,bupivacaine,CCCCN1CCCCC1C(=O)NC2=C(C=CC=C2C)C,Extrasystoles Ventricular,CID000054454,simvastatin,CCC(C)(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C
CID000002474,bupivacaine,CCCCN1CCCCC1C(=O)NC2=C(C=CC=C2C)C,pleural pain,CID000004138,55-40-3,CC(CC1=CC(=C(C=C1)O)O)(C(=O)O)N
CID000002474,bupivacaine,CCCCN1CCCCC1C(=O)NC2=C(C=CC=C2C)C,constipated,CID000004679,pantoprazole,COC1=C(C(=NC=C1)CS(=O)C2=NC3=C(N2)C=C(C=C3)OC(F)F)OC
CID000002474,bupivacaine,CCCCN1CCCCC1C(=O)NC2=C(C=CC=C2C)C,Paraesthesia,CID000003658,hydroxyzine,C1CN(CCN1CCOCCO)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl
CID000002474,bupivacaine,CCCCN1CCCCC1C(=O)NC2=C(C=CC=C2C)C,Dyspnea exertional,CID000005771,Oxytocin acetate salt hydrate,CCC(C)C1C(=O)NC(C(=O)NC(C(=O)NC(CSSCC(C(=O)NC(C(=O)N1)CC2=CC=C(C=C2)O)N)C(=O)N3CCCC3C(=O)NC(CC(C)C)C(=O)NCC(=O)N)CC(=O)N)CCC(=O)N
CID000002474,bupivacaine,CCCCN1CCCCC1C(=O)NC2=C(C=CC=C2C)C,confusion,CID000005650,N-pentanoyl-N-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-L-valine,CCCCC(=O)N(CC1=CC=C(C=C1)C2=CC=CC=C2C3=NNN=N3)C(C(C)C)C(=O)O
CID000002474,bupivacaine,CCCCN1CCCCC1C(=O)NC2=C(C=CC=C2C)C,neuropathy,CID000005478,racemic-Timolol,CC(C)(C)NCC(COC1=NSN=C1N2CCOCC2)O
CID000002474,bupivacaine,CCCCN1CCCCC1C(=O)NC2=C(C=CC=C2C)C,erythema,CID000003345,fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3
CID000002474,bupivacaine,CCCCN1CCCCC1C(=O)NC2=C(C=CC=C2C)C,erythema,CID000002658,3-(carbamoyloxymethyl)-7-[[2-(furan-2-yl)-2-methoxyiminoacetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate,CON=C(C1=CC=CO1)C(=O)NC2C3N(C2=O)C(=C(CS3)COC(=O)N)C(=O)[O-]
CID000002474,bupivacaine,CCCCN1CCCCC1C(=O)NC2=C(C=CC=C2C)C,loss of weight,CID000004691,"3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine",C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4
CID000002474,bupivacaine,CCCCN1CCCCC1C(=O)NC2=C(C=CC=C2C)C,anaphylactic reaction,CID000002656,"7-[[2-(2-amino-1,3-thiazol-4-yl)-2-methoxyiminoacetyl]amino]-3-[(2-methyl-6-oxido-5-oxo-1,2,4-triazin-3-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CN1C(=NC(=O)C(=N1)[O-])SCC2=C(N3C(C(C3=O)NC(=O)C(=NOC)C4=CSC(=N4)N)SC2)C(=O)[O-]
CID000002474,bupivacaine,CCCCN1CCCCC1C(=O)NC2=C(C=CC=C2C)C,loss of weight,CID000005732,zolpidem,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C
CID000002474,bupivacaine,CCCCN1CCCCC1C(=O)NC2=C(C=CC=C2C)C,dysaesthesia,CID000004616,oxazepam,C1=CC=C(C=C1)C2=NC(C(=O)NC3=C2C=C(C=C3)Cl)O
CID000002474,bupivacaine,CCCCN1CCCCC1C(=O)NC2=C(C=CC=C2C)C,loss of weight,CID000002662,celecoxib,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F
CID000002474,bupivacaine,CCCCN1CCCCC1C(=O)NC2=C(C=CC=C2C)C,Back Ache,CID000003883,lansoprazole,CC1=C(C=CN=C1CS(=O)C2=NC3=CC=CC=C3N2)OCC(F)(F)F
CID000002474,bupivacaine,CCCCN1CCCCC1C(=O)NC2=C(C=CC=C2C)C,respiratory failure,CID000003661,L-Hyoscyamine,CN1C2CCC1CC(C2)OC(=O)C(CO)C3=CC=CC=C3
CID000002474,bupivacaine,CCCCN1CCCCC1C(=O)NC2=C(C=CC=C2C)C,edema,CID000004173,metronidazole,CC1=NC=C(N1CCO)[N+](=O)[O-]
CID000002474,bupivacaine,CCCCN1CCCCC1C(=O)NC2=C(C=CC=C2C)C,dysaesthesia,CID000002771,citalopram,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F
CID000002474,bupivacaine,CCCCN1CCCCC1C(=O)NC2=C(C=CC=C2C)C,Paraesthesia,CID000004900,Fernisone,CC12CC(=O)C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C
CID000002474,bupivacaine,CCCCN1CCCCC1C(=O)NC2=C(C=CC=C2C)C,cholelithiasis,CID000003937,N~2~-(1-carboxy-3-phenylpropyl)lysylproline,C1CC(N(C1)C(=O)C(CCCCN)NC(CCC2=CC=CC=C2)C(=O)O)C(=O)O
CID000002474,bupivacaine,CCCCN1CCCCC1C(=O)NC2=C(C=CC=C2C)C,drug toxicity NOS,CID000003958,lorazepam,C1=CC=C(C(=C1)C2=NC(C(=O)NC3=C2C=C(C=C3)Cl)O)Cl
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,cholecystitis,CID000005544,Mycolog,CC12CC(C3(C(C1CC(C2(C(=O)CO)O)O)CCC4=CC(=O)C=CC43C)F)O
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,gastric inflammation,CID000002732,chlorthalidone,C1=CC=C2C(=C1)C(=O)NC2(C3=CC(=C(C=C3)Cl)S(=O)(=O)N)O
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,loss of weight,CID000002733,chlorzoxazone,C1=CC2=C(C=C1Cl)NC(=O)O2
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,myelodysplasia,CID000036339,Etomidate,CCOC(=O)C1=CN=CN1C(C)C2=CC=CC=C2
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,adenomyosis,CID000003062,Lanicor,CC1C(C(CC(O1)OC2C(OC(CC2O)OC3C(OC(CC3O)OC4CCC5(C(C4)CCC6C5CC(C7(C6(CCC7C8=CC(=O)OC8)O)C)O)C)C)C)O)O
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,methaemoglobinaemia,CID000004927,promethazine,CC(CN1C2=CC=CC=C2SC3=CC=CC=C31)N(C)C
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,adenomyosis,CID000004920,"1-acetyl-9a,11a-dimethyl-1H,2H,3H,3aH,3bH,4H,5H,7H,8H,9H,9aH,9bH,10H,11H,11aH-cyclopenta[a]phenanthren-7-one",CC(=O)C1CCC2C1(CCC3C2CCC4=CC(=O)CCC34C)C
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,adenomyosis,CID000002088,ALENDRONIC ACID,C(CC(O)(P(=O)(O)O)P(=O)(O)O)CN
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,Acidosis,CID000001971,914348-29-1,C1CC1NC2=C3C(=NC(=N2)N)N(C=N3)C4CC(C=C4)CO
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,Adenopathy,CID000003148,dolasetron,C1C2CC3CC(CC1N3CC2=O)OC(=O)C4=CNC5=CC=CC=C54
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,weight gain,CID000002951,dantrolene(1-),C1C(=NC(=O)N1N=CC2=CC=C(O2)C3=CC=C(C=C3)[N+](=O)[O-])[O-]
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,Adenopathy,CID000057469,IMIQUIMOD,CC(C)CN1C=NC2=C1C3=CC=CC=C3N=C2N
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,eruption,CID000004536,Minovlar,CC12CCC3C(C1CCC2(C#C)O)CCC4=CC(=O)CCC34
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,Adenopathy,CID000005376,(E/Z)-Tamoxifen,CCC(=C(C1=CC=CC=C1)C2=CC=C(C=C2)OCCN(C)C)C3=CC=CC=C3
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,cholecystitis,CID000001117,sulfate,[O-]S(=O)(=O)[O-]
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,adenomyosis,CID000124087,Desloratadine,C1CC2=C(C=CC(=C2)Cl)C(=C3CCNCC3)C4=C1C=CC=N4
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,gastric inflammation,CID000003410,formoterol,CC(CC1=CC=C(C=C1)OC)NCC(C2=CC(=C(C=C2)O)NC=O)O
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,apoplexy,CID000048175,"[(6S,9R,16S,17R)-17-(2-chloroacetyl)-6,9-difluoro-11-hydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl] propanoate",CCC(=O)OC1(C(CC2C1(CC(C3(C2CC(C4=CC(=O)C=CC43C)F)F)O)C)C)C(=O)CCl
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,gastric inflammation,CID006447131,Pimecrolimus,CCC1C=C(CC(CC(C2C(CC(C(O2)(C(=O)C(=O)N3CCCCC3C(=O)OC(C(C(CC1=O)O)C)C(=CC4CCC(C(C4)OC)Cl)C)O)C)OC)OC)C)C
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,cholecystitis,CID000001065,9-epi-Quinine,COC1=CC2=C(C=CN=C2C=C1)C(C3CC4CCN3CC4C=C)O
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,Adenopathy,CID000003516,guaifenesin,COC1=CC=CC=C1OCC(CO)O
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,gastric inflammation,CID000003890,TRANS (15S)-LATANOPROST,CC(C)OC(=O)CCCC=CCC1C(CC(C1CCC(CCC2=CC=CC=C2)O)O)O
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,gastric inflammation,CID000002662,celecoxib,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,cholecystitis,CID003468412,SCHEMBL1176571,CC1C=CC=CCCC=CC=CC=CC=CC(CC(C(C(CC(=O)CC(C(CCC(CC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)C(=O)O)O)OC2C(C(C(C(O2)C)O)N)O
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,cholecystitis,CID000003780,"D-Glucitol, 1,4:3,6-dianhydro-, 2,5-dinitrate",C1C(C2C(O1)C(CO2)O[N+](=O)[O-])O[N+](=O)[O-]
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,cholecystitis,CID000002550,1-(2-methyl-3-sulfanylpropanoyl)pyrrolidine-2-carboxylic acid,CC(CS)C(=O)N1CCCC1C(=O)O
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,Back Ache,CID000002551,Carbamylcholine,C[N+](C)(C)CCOC(=O)N
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,cholecystitis,CID000060852,Ibandronic Acid,CCCCCN(C)CCC(O)(P(=O)(O)O)P(=O)(O)O
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,cholecystitis,CID000060854,Ziprasidone,C1CN(CCN1CCC2=C(C=C3C(=C2)CC(=O)N3)Cl)C4=NSC5=CC=CC=C54
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,abnormal ECG,CID000002375,bicalutamide,CC(CS(=O)(=O)C1=CC=C(C=C1)F)(C(=O)NC2=CC(=C(C=C2)C#N)C(F)(F)F)O
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,subarachnoid haemorrhage,CID000004195,midodrine,COC1=CC(=C(C=C1)OC)C(CNC(=O)CN)O
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,ear infection,CID000087177,"D-Fructose, 4-O-alpha-D-glucopyranosyl-",C(C1C(C(C(C(O1)OC(C(CO)O)C(C(=O)CO)O)O)O)O)O
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,Acne,CID000003676,lidocaine,CCN(CC)CC(=O)NC1=C(C=CC=C1C)C
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,cholecystitis,CID000004543,nortriptyline,CNCCC=C1C2=CC=CC=C2CCC3=CC=CC=C31
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,Adenopathy,CID000004542,norgestrel,CCC12CCC3C(C1CCC2(C#C)O)CCC4=CC(=O)CCC34
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,weight gain,CID000003827,ketotifen,CN1CCC(=C2C3=C(C(=O)CC4=CC=CC=C42)SC=C3)CC1
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,failure to thrive,CID000005878,OXANDROLONE,CC12CCC3C(C1CCC2(C)O)CCC4C3(COC(=O)C4)C
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,dysarthria,CID004659568,"2-cyano-3-(3,4-dihydroxy-5-nitrophenyl)-N,N-diethylprop-2-enamide",CCN(CC)C(=O)C(=CC1=CC(=C(C(=C1)O)O)[N+](=O)[O-])C#N
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,cholecystectomies,CID000005245,Risedronic acid,C1=CC(=CN=C1)CC(O)(P(=O)(O)O)P(=O)(O)O
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,Adenopathy,CID005311297,SCHEMBL1133011,CC(C)(C1=CC=CC=C1CCC(C2=CC=CC(=C2)C=CC3=NC4=C(C=CC(=C4)Cl)C=C3)S)O
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,abnormal ECG,CID000147912,DSSTox_GSID_49066,CCC(C(C)O)N1C(=O)N(C=N1)C2=CC=C(C=C2)N3CCN(CC3)C4=CC=C(C=C4)OCC5CC(OC5)(CN6C=NC=N6)C7=C(C=C(C=C7)F)F
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,gastric inflammation,CID000002806,90055-48-4,COC(=O)C(C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,Adenopathy,CID000002803,clonidine,C1CN=C(N1)NC2=C(C=CC=C2Cl)Cl
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,Nail disorder,CID000160051,Colesevelam,CCCCCCCCCCNCC=C.C[N+](C)(C)CCCCCCNCC=C.C=CCN.C1C(O1)CCl.Cl.[Cl-]
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,thrombocytopenia,CID000004425,"4a,9-dihydroxy-3-prop-2-enyl-2,4,5,6,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinolin-7-one",C=CCN1CCC23C4C(=O)CCC2(C1CC5=C3C(=C(C=C5)O)O4)O
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,meningitides,CID000005771,Oxytocin acetate salt hydrate,CCC(C)C1C(=O)NC(C(=O)NC(C(=O)NC(CSSCC(C(=O)NC(C(=O)N1)CC2=CC=C(C=C2)O)N)C(=O)N3CCCC3C(=O)NC(CC(C)C)C(=O)NCC(=O)N)CC(=O)N)CCC(=O)N
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,gastric inflammation,CID000005487,tizanidine,C1CN=C(N1)NC2=C(C=CC3=NSN=C32)Cl
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,thrombocytopenia,CID000005486,(R)-Tirofiban,CCCCS(=O)(=O)NC(CC1=CC=C(C=C1)OCCCCC2CCNCC2)C(=O)O
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,food allergy,CID000002656,"7-[[2-(2-amino-1,3-thiazol-4-yl)-2-methoxyiminoacetyl]amino]-3-[(2-methyl-6-oxido-5-oxo-1,2,4-triazin-3-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CN1C(=NC(=O)C(=N1)[O-])SCC2=C(N3C(C(C3=O)NC(=O)C(=NOC)C4=CSC(=N4)N)SC2)C(=O)[O-]
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,Adenopathy,CID000002658,3-(carbamoyloxymethyl)-7-[[2-(furan-2-yl)-2-methoxyiminoacetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate,CON=C(C1=CC=CO1)C(=O)NC2C3N(C2=O)C(=C(CS3)COC(=O)N)C(=O)[O-]
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,gastric inflammation,CID000005523,Ultram,CN(C)CC1CCCCC1(C2=CC(=CC=C2)OC)O
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,gastric inflammation,CID000002713,55-56-1,C1=CC(=CC=C1NC(=NC(=NCCCCCCN=C(N)N=C(N)NC2=CC=C(C=C2)Cl)N)N)Cl
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,elevated cholesterol,CID000003043,9-[5-(hydroxymethyl)oxolan-2-yl]-3H-purin-6-one,C1CC(OC1CO)N2C=NC3=C2NC=NC3=O
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,ear infection,CID000003042,dicyclomine,CCN(CC)CCOC(=O)C1(CCCCC1)C2CCCCC2
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,cholecystitis,CID000004909,primidone,CCC1(C(=O)NCNC1=O)C2=CC=CC=C2
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,cholecystitis,CID000004900,Fernisone,CC12CC(=O)C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,phlebothrombosis,CID000002725,chlorpheniramine,CN(C)CCC(C1=CC=C(C=C1)Cl)C2=CC=CC=N2
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,gastric inflammation,CID000004044,mefenamic acid,CC1=C(C(=CC=C1)NC2=CC=CC=C2C(=O)O)C
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,cholecystitis,CID000002524,32222-06-3,CC(CCCC(C)(C)O)C1CCC2C1(CCCC2=CC=C3CC(CC(C3=C)O)O)C
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,Adenopathy,CID000004201,minoxidil,C1CCN(CC1)C2=NC(=N)N(C(=C2)N)O
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,Acne,CID000004205,mirtazapine,CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,gastric inflammation,CID000012536,638-94-8,CC1(OC2CC3C4CCC5=CC(=O)C=CC5(C4C(CC3(C2(O1)C(=O)CO)C)O)C)C
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,dysarthria,CID000002978,16849-50-6,CCCCCC1=CC(=C2C3C=C(CCC3C(OC2=C1)(C)C)C)O
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,cholecystitis,CID000004510,nitroglycerin,C(C(CO[N+](=O)[O-])O[N+](=O)[O-])O[N+](=O)[O-]
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,acute pancreatitis,CID005311082,"2-[(1R,4S,10S,13S,19S)-19-[4-(diaminomethylideneamino)butyl]-10-(1H-indol-3-ylmethyl)-3,9,12,15,18,21,27-heptaoxo-24,25-dithia-2,8,11,14,17,20-hexazatricyclo[18.6.1.04,8]heptacosan-13-yl]acetic acid",C1CC2C(=O)NC3CSSCCC(=O)N(C3=O)C(C(=O)NCC(=O)NC(C(=O)NC(C(=O)N2C1)CC4=CNC5=CC=CC=C54)CC(=O)O)CCCCN=C(N)N
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,Acne,CID000005391,temazepam,CN1C2=C(C=C(C=C2)Cl)C(=NC(C1=O)O)C3=CC=CC=C3
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,myelodysplasia,CID000005394,temozolomide,CN1C(=O)N2C=NC(=C2N=N1)C(=O)N
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,gastric inflammation,CID000003325,famotidine,C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,cholecystitis,CID000005152,Salmeterol,C1=CC=C(C=C1)CCCCOCCCCCCNCC(C2=CC(=C(C=C2)O)CO)O
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,excessive thirst,CID000004497,nimodipine,CC1=C(C(C(=C(N1)C)C(=O)OC(C)C)C2=CC(=CC=C2)[N+](=O)[O-])C(=O)OCCOC
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,gastroenteritis viral,CID000667490,6-Mercaptopurine,C1=NC2=C(N1)C(=S)N=CN2
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,hepatic neoplasia,CID000002405,BISOPROLOL,CC(C)NCC(COC1=CC=C(C=C1)COCCOC(C)C)O
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,increased white blood cell count,CID005493444,Aliskiren,CC(C)C(CC1=CC(=C(C=C1)OC)OCCCOC)CC(C(CC(C(C)C)C(=O)NCC(C)(C)C(=O)N)O)N
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,cholecystectomies,CID000002265,azathioprine,CN1C=NC(=C1SC2=NC=NC3=C2NC=N3)[N+](=O)[O-]
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,erythema,CID000002266,azelaic acid,C(CCCC(=O)O)CCCC(=O)O
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,cholecystitis,CID000005645,"3,7-Dihydroxycholan-24-oic acid",CC(CCC(=O)O)C1CCC2C1(CCC3C2C(CC4C3(CCC(C4)O)C)O)C
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,drug toxicity NOS,CID000003763,isoflurane,C(C(F)(F)F)(OC(F)F)Cl
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,apoplexy,CID000057537,92206-54-7,CCCN(CCC1=CC=CS1)C2CCC3=C(C2)C=CC=C3O
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,apoplexy,CID000002609,Lilly 99638,C1C(=C(N2C(S1)C(C2=O)NC(=O)C(C3=CC=CC=C3)N)C(=O)O)Cl
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,gastric inflammation,CID000004601,orphenadrine,CC1=CC=CC=C1C(C2=CC=CC=C2)OCCN(C)C
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,thyroid cancer,CID000152945,Dutasteride?,CC12CCC3C(C1CCC2C(=O)NC4=C(C=CC(=C4)C(F)(F)F)C(F)(F)F)CCC5C3(C=CC(=O)N5)C
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,drug withdrawal,CID000010631,medroxyprogesterone,CC1CC2C(CCC3(C2CCC3(C(=O)C)O)C)C4(C1=CC(=O)CC4)C
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,drug toxicity NOS,CID000002720,chlorothiazide,C1=C2C(=CC(=C1Cl)S(=O)(=O)N)S(=O)(=O)N=CN2
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,Adenopathy,CID006398525,,C(C1C(C(C(C(O1)OC2(C(C(C(O2)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)COS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.[Al].[Al].[Al].[Al].[Al].[Al].[Al].[Al].[Al]
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,abnormal ECG,CID000071616,Voriconazole,CC(C1=NC=NC=C1F)C(CN2C=NC=N2)(C3=C(C=C(C=C3)F)F)O
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,apoplexy,CID000002099,alosetron,CC1=C(N=CN1)CN2CCC3=C(C2=O)C4=CC=CC=C4N3C
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,ear infection,CID000004236,modafinil,C1=CC=C(C=C1)C(C2=CC=CC=C2)S(=O)CC(=O)N
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,Adenopathy,CID000060787,sequinavir,CC(C)(C)NC(=O)C1CC2CCCCC2CN1CC(C(CC3=CC=CC=C3)NC(=O)C(CC(=O)N)NC(=O)C4=NC5=CC=CC=C5C=C4)O
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,cholecystitis,CID000003937,N~2~-(1-carboxy-3-phenylpropyl)lysylproline,C1CC(N(C1)C(=O)C(CCCCN)NC(CCC2=CC=CC=C2)C(=O)O)C(=O)O
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,cholecystitis,CID000003154,120280-13-9,CCNC1CC(S(=O)(=O)C2=C1C=C(S2)S(=O)(=O)N)C
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,loss of weight,CID000002949,MLS003115428,CC12CCC3C(C1CCC2(C#C)O)CCC4=CC5=C(CC34C)C=NO5
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,gastric inflammation,CID000038904,Carboplatinum,C1CC(C1)(C(=O)O)C(=O)O.N.N.[Pt]
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,erythema,CID000001690,Doxorubicin (Adriamycin) HCl,CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)[NH3+])O
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,blood sodium decreased,CID000002578,carmustine,C(CCl)NC(=O)N(CCCl)N=O
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,gastric inflammation,CID000060164,ADAPALENE,COC1=C(C=C(C=C1)C2=CC3=C(C=C2)C=C(C=C3)C(=O)O)C45CC6CC(C4)CC(C6)C5
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,myelodysplasia,CID000003405,2-[[4-[(2-amino-4-oxo-1H-pteridin-6-yl)methylamino]benzoyl]amino]pentanedioic acid,C1=CC(=CC=C1C(=O)NC(CCC(=O)O)C(=O)O)NCC2=CN=C3C(=N2)C(=O)N=C(N3)N
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,Adenopathy,CID000002435,brimonidine,C1CN=C(N1)NC2=C(C3=NC=CN=C3C=C2)Br
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,loss of weight,CID000004178,Mexiletine,CC1=C(C(=CC=C1)C)OCC(C)N
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,gastric inflammation,CID000004614,oxaprozin,C1=CC=C(C=C1)C2=C(OC(=N2)CCC(=O)O)C3=CC=CC=C3
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,weight gain,CID000115237,Paliperidone,CC1=C(C(=O)N2CCCC(C2=N1)O)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,loss of weight,CID000001986,acetazolamide,CC(=O)NC1=NN=C(S1)S(=O)(=O)N
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,cholecystitis,CID000001983,acetaminophen,CC(=O)NC1=CC=C(C=C1)O
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,back injury,CID000004856,"3-[hydroxy-(pyridin-2-ylamino)methylidene]-2-methyl-1,1-dioxo-1lambda6,2-benzothiazin-4-one",CN1C(=C(NC2=CC=CC=N2)O)C(=O)C3=CC=CC=C3S1(=O)=O
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,angiitis,CID000004440,naratriptan,CNS(=O)(=O)CCC1=CC2=C(C=C1)NC=C2C3CCN(CC3)C
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,drug withdrawal,CID000110635,Tadalafil,CN1CC(=O)N2C(C1=O)CC3=C(C2C4=CC5=C(C=C4)OCO5)NC6=CC=CC=C36
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,bursitis,CID000003305,Etidronic acid,CC(O)(P(=O)(O)O)P(=O)(O)O
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,thrombocytopenia,CID004479097,"cobalt;[5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] 1-[3-[2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2,7,12,17-tetrahydro-1H-corrin-21-id-3-yl]propanoylamino]propan-2-yl phosphate;hydrate",CC1=CC2=C(C=C1C)N(C=N2)C3C(C(C(O3)CO)OP(=O)([O-])OC(C)CNC(=O)CCC4(C(C5C6(C(C(C(=N6)C(=C7C(C(C(=N7)C=C8C(C(C(=N8)C(=C4[N-]5)C)CCC(=O)N)(C)C)CCC(=O)N)(C)CC(=O)N)C)CCC(=O)N)(C)CC(=O)N)C)CC(=O)N)C)O.O.[Co]
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,adenomyosis,CID000003883,lansoprazole,CC1=C(C=CN=C1CS(=O)C2=NC3=CC=CC=C3N2)OCC(F)(F)F
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,Back Ache,CID000005719,zaleplon,CCN(C1=CC=CC(=C1)C2=CC=NC3=C(C=NN23)C#N)C(=O)C
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,erythema,CID000060754,Gadodiamide hydrate,CNC(=O)CN(CCN(CCN(CC(=O)NC)CC(=O)[O-])CC(=O)[O-])CC(=O)[O-].O.[Gd+3]
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,bulging,CID000444013,GADOVERSETAMIDE,COCCNC(=O)CN(CCN(CCN(CC(=O)NCCOC)CC(=O)[O-])CC(=O)[O-])CC(=O)[O-].[Gd+3]
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,Sinus headache,CID000002676,"7-[4-(4-fluorophenyl)-5-(methoxymethyl)-2,6-di(propan-2-yl)pyridin-3-yl]-3,5-dihydroxyhept-6-enoic acid",CC(C)C1=C(C(=C(C(=N1)C(C)C)COC)C2=CC=C(C=C2)F)C=CC(CC(CC(=O)O)O)O
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,Adenopathy,CID000005076,162990-01-4,CC(C)C1=NC(=CS1)CN(C)C(=O)NC(C(C)C)C(=O)NC(CC2=CC=CC=C2)CC(C(CC3=CC=CC=C3)NC(=O)OCC4=CN=CS4)O
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,drug toxicity NOS,CID000005077,105601-20-5,CCN(C)C(=O)OC1=CC=CC(=C1)C(C)N(C)C
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,cholecystitis,CID000005073,risperidone,CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,allergic dermatitis,CID000004064,meprobamate,CCCC(C)(COC(=O)N)COC(=O)N
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,angiitis,CID005381226,"[(7S,9E,11S,12R,13S,14R,15R,16R,17S,18S,19E,21Z,26E)-2,15,17,29-tetrahydroxy-11-methoxy-3,7,12,14,16,18,22-heptamethyl-26-[[(4-methylpiperazin-1-yl)amino]methylidene]-6,23,27-trioxo-8,30-dioxa-24-azatetracyclo[23.3.1.14,7.05,28]triaconta-1(28),2,4,9,19,21,25(29)-heptaen-13-yl] acetate",CC1C=CC=C(C(=O)NC2=C(C3=C(C4=C(C(=C3O)C)OC(C4=O)(OC=CC(C(C(C(C(C(C1O)C)O)C)OC(=O)C)C)OC)C)C(=O)C2=CNN5CCN(CC5)C)O)C
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,myelodysplasia,CID000002541,candesartan,CCOC1=NC2=CC=CC(=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5)C(=O)O
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,adenomyosis,CID000004889,Pravastatin Impurity A,CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC(CC(CC(=O)O)O)O)O
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,gastric inflammation,CID000004885,104617-86-9,CCCNC1CCC2=C(C1)SC(=N2)N
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,dysarthria,CID000060865,(E)-Olopatadine,CN(C)CCC=C1C2=CC=CC=C2COC3=C1C=C(C=C3)CC(=O)O
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,loss of weight,CID000004748,perphenazine,C1CN(CCN1CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)Cl)CCO
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,gastric inflammation,CID000004745,SCHEMBL7711911,CCCN1CC(CC2C1CC3=CNC4=CC=CC2=C34)CSC
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,cholecystitis,CID000003961,losartan,CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)CO)Cl
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,cholecystitis,CID000003962,79952-43-5,CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,cholecystitis,CID000002369,betaxolol,CC(C)NCC(COC1=CC=C(C=C1)CCOCC2CC2)O
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,bursitis,CID000077992,Frovatriptan,CNC1CCC2=C(C1)C3=C(N2)C=CC(=C3)C(=O)N
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,Adenopathy,CID000077999,rosiglitazone,CN(CCOC1=CC=C(C=C1)CC2C(=O)NC(=O)S2)C3=CC=CC=N3
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,erythema,CID000005584,trimipramine,CC(CN1C2=CC=CC=C2CCC3=CC=CC=C31)CN(C)C
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,eruption,CID000004189,miconazole,C1=CC(=C(C=C1Cl)Cl)COC(CN2C=CN=C2)C3=C(C=C(C=C3)Cl)Cl
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,cholecystitis,CID000002284,baclofen,C1=CC(=CC=C1C(CC(=O)O)CN)Cl
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,gastric inflammation,CID000002130,amantadine,C1C2CC3CC1CC(C2)(C3)N
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,gastric inflammation,CID000003661,L-Hyoscyamine,CN1C2CCC1CC(C2)OC(=O)C(CO)C3=CC=CC=C3
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,loss of weight,CID000003278,ETHACRYNIC ACID,CCC(=C)C(=O)C1=C(C(=C(C=C1)OCC(=O)O)Cl)Cl
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,gastric inflammation,CID000002891,"cobalt(2+);[5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] 1-[3-[2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2,7,12,17-tetrahydro-1H-corrin-21-id-3-yl]propanoylamino]propan-2-yl hydrogen phosphate;cyanide",CC1=CC2=C(C=C1C)N(C=N2)C3C(C(C(O3)CO)OP(=O)(O)OC(C)CNC(=O)CCC4(C(C5C6(C(C(C(=N6)C(=C7C(C(C(=N7)C=C8C(C(C(=N8)C(=C4[N-]5)C)CCC(=O)N)(C)C)CCC(=O)N)(C)CC(=O)N)C)CCC(=O)N)(C)CC(=O)N)C)CC(=O)N)C)O.[C-]#N.[Co+2]
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,agitated,CID000122316,1875-50-9,C#CCNC1CCC2=CC=CC=C12
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,Adenopathy,CID000005478,racemic-Timolol,CC(C)(C)NCC(COC1=NSN=C1N2CCOCC2)O
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,Adenopathy,CID000002462,51372-29-3,CCCC1OC2CC3C4CCC5=CC(=O)C=CC5(C4C(CC3(C2(O1)C(=O)CO)C)O)C
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,cholecystectomies,CID000170361,Varenicline,C1C2CNCC1C3=CC4=NC=CN=C4C=C23
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,erythema,CID000003333,felodipine,CCOC(=O)C1=C(NC(=C(C1C2=C(C(=CC=C2)Cl)Cl)C(=O)OC)C)C
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,cholecystitis,CID000004107,methocarbamol,COC1=CC=CC=C1OCC(COC(=O)N)O
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,Acne,CID000003339,fenofibrate,CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C2=CC=C(C=C2)Cl
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,gastric inflammation,CID000004666,7-Epi Paclitaxel,CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,erythema,CID000009052,2-hydroxy-3-[1-(4-nitrophenyl)-3-oxobutyl]chromen-4-one,CC(=O)CC(C1=CC=C(C=C1)[N+](=O)[O-])C2=C(OC3=CC=CC=C3C2=O)O
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,cholecystitis,CID000002818,"3-chloro-6-(4-methylpiperazin-1-yl)-5H-benzo[b][1,4]benzodiazepine",CN1CCN(CC1)C2=C3C=CC=CC3=NC4=C(N2)C=C(C=C4)Cl
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,dysarthria,CID000003741,ioversol,C(CO)N(C1=C(C(=C(C(=C1I)C(=O)NCC(CO)O)I)C(=O)NCC(CO)O)I)C(=O)CO
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,gastric inflammation,CID000003749,irbesartan,CCCCC1=NC2(CCCC2)C(=O)N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,drug toxicity NOS,CID005481350,Tenofovir disoproxil,CC(C)OC(=O)OCOP(=O)(COC(C)CN1C=NC2=C(N=CN=C21)N)OCOC(=O)OC(C)C
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,Adenopathy,CID000003075,"2-[3-acetyloxy-2-(4-methoxyphenyl)-4-oxo-2,3-dihydro-1,5-benzothiazepin-5-yl]ethyl-dimethylazanium",CC(=O)OC1C(SC2=CC=CC=C2N(C1=O)CC[NH+](C)C)C3=CC=C(C=C3)OC
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,gastric inflammation,CID000004585,"2-methyl-4-(4-methylpiperazin-1-yl)-5H-thieno[3,2-c][1,5]benzodiazepine",CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,myelodysplasia,CID000004054,memantine,CC12CC3CC(C1)(CC(C3)(C2)N)C
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,cholecystitis,CID000004170,metolazone,CC1NC2=CC(=C(C=C2C(=O)N1C3=CC=CC=C3C)S(=O)(=O)N)Cl
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,cholecystitis,CID000003958,lorazepam,C1=CC=C(C(=C1)C2=NC(C(=O)NC3=C2C=C(C=C3)Cl)O)Cl
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,cholecystitis,CID000003954,loperamide(1+),CN(C)C(=O)C(CC[NH+]1CCC(CC1)(C2=CC=C(C=C2)Cl)O)(C3=CC=CC=C3)C4=CC=CC=C4
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,Sinus headache,CID000125017,Desvenlafaxine,CN(C)CC(C1=CC=C(C=C1)O)C2(CCCCC2)O
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,erythema,CID000003249,50-14-6,CC(C)C(C)C=CC(C)C1CCC2C1(CCCC2=CC=C3CC(CCC3=C)O)C
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,erythema,CID000003869,labetalol,CC(CCC1=CC=CC=C1)NCC(C2=CC(=C(C=C2)O)C(=O)N)O
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,hepatic neoplasia,CID000060184,"2'-epi-Perindopril, (2'R)-",CCCC(C(=O)OCC)NC(C)C(=O)N1C2CCCCC2CC1C(=O)O
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,gastric inflammation,CID000003463,gemfibrozil,CC1=CC(=C(C=C1)C)OCCCC(C)(C)C(=O)O
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,cholecystitis,CID000004158,methylphenidate,COC(=O)C(C1CCCCN1)C2=CC=CC=C2
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,agitated,CID000005095,ropinirole,CCCN(CCC)CCC1=C2CC(=O)NC2=CC=C1
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,methaemoglobinaemia,CID000002022,2-amino-9-(2-hydroxyethoxymethyl)-3H-purin-6-one,C1=NC2=C(N1COCCO)NC(=NC2=O)N
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,Arrhythmia,CID000004463,nevirapine,CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,alopecia,CID000027686,CHEMBL4088679,C1=CC2=C(C(=C1)OCC(COC3=CC4=C(C=C3)OC(=CC4=O)C(=O)O)O)C(=O)C=C(O2)C(=O)O
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,methaemoglobinaemia,CID000005978,vincristine,CCC1(CC2CC(C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)C78CCN9C7C(C=CC9)(C(C(C8N6C=O)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,Dyspnea exertional,CID000004616,oxazepam,C1=CC=C(C=C1)C2=NC(C(=O)NC3=C2C=C(C=C3)Cl)O
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,nasopharyngitis,CID000001071,9-cis retinol,CC1=C(C(CCC1)(C)C)C=CC(=CC=CC(=CCO)C)C
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,adenomyosis,CID000003440,furosemide,C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,right heart failure,CID000039765,Vecuronium,CC(=O)OC1CC2CCC3C(C2(CC1N4CCCCC4)C)CCC5(C3CC(C5OC(=O)C)[N+]6(CCCCC6)C)C
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,Adenopathy,CID000005732,zolpidem,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,erythema,CID000004138,55-40-3,CC(CC1=CC(=C(C=C1)O)O)(C(=O)O)N
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,gastric inflammation,CID000005195,Deprenyl,CC(CC1=CC=CC=C1)N(C)CC#C
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,gastric inflammation,CID000004691,"3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine",C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,cholecystitis,CID000008953,sodium;hydrogen carbonate,C(=O)(O)[O-].[Na+]
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,Adenopathy,CID000002153,theophylline,CN1C2=C(C(=O)N(C1=O)C)NC=N2
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,metabolic encephalopathy,CID005311048,SCHEMBL11440306,C(N)(N)(Cl)Cl
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,erythema,CID000072938,Gemifloxacin,CON=C1CN(CC1CN)C2=C(C=C3C(=O)C(=CN(C3=N2)C4CC4)C(=O)O)F
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,erythema,CID000005352,38194-50-2,CC1=C(C2=C(C1=CC3=CC=C(C=C3)S(=O)C)C=CC(=C2)F)CC(=O)O
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,cholecystitis,CID000005358,sumatriptan,CNS(=O)(=O)CC1=CC2=C(C=C1)NC=C2CCN(C)C
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,subarachnoid haemorrhage,CID000002349,Cillin,CC1(C(N2C(S1)C(C2=O)NC(=O)CC3=CC=CC=C3)C(=O)O)C
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,cholecystitis,CID000065999,Telmisartan,CCCC1=NC2=C(N1CC3=CC=C(C=C3)C4=CC=CC=C4C(=O)O)C=C(C=C2C)C5=NC6=CC=CC=C6N5C
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,Adenopathy,CID000019090,megestrol,CC1=CC2C(CCC3(C2CCC3(C(=O)C)O)C)C4(C1=CC(=O)CC4)C
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,right heart failure,CID000003310,33419-42-0,CC1OCC2C(O1)C(C(C(O2)OC3C4COC(=O)C4C(C5=CC6=C(C=C35)OCO6)C7=CC(=C(C(=C7)OC)O)OC)O)O
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,erythema,CID000005253,sotalol,CC(C)NCC(C1=CC=C(C=C1)NS(=O)(=O)C)O
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,apoplexy,CID000163742,SCHEMBL1650579,COC1C(C(C(C(O1)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)COS(=O)(=O)O)OC4C(C(C(C(O4)C(=O)O)OC5C(C(C(C(O5)COS(=O)(=O)O)O)O)NS(=O)(=O)O)O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O)NS(=O)(=O)O
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,adenomyosis,CID000054454,simvastatin,CCC(C)(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,Adenopathy,CID000071329,Dofetilide,CN(CCC1=CC=C(C=C1)NS(=O)(=O)C)CCOC2=CC=C(C=C2)NS(=O)(=O)C
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,cholecystitis,CID000016231,AMILORIDE,C1(=C(N=C(C(=N1)Cl)N)N)C(=O)N=C(N)N
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,High blood pressure,CID000002646,Cefprozil (E)-isomer,CC=CC1=C(N2C(C(C2=O)NC(=O)C(C3=CC=C(C=C3)O)N)SC1)C(=O)O
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,cholecystitis,CID000005512,124936-74-9,CC1=CC(=C(C=C1)O)C(CCN(C(C)C)C(C)C)C2=CC=CC=C2
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,eruption,CID000005515,hycamptamine hydrochloride hydrate,CCC1(C2=C(COC1=O)C(=O)N3CC4=CC5=C(C=CC(=C5CN(C)C)O)N=C4C3=C2)O
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,apoplexy,CID000003059,diflunisal,C1=CC(=C(C=C1C2=C(C=C(C=C2)F)F)C(=O)O)O
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,angiitis,CID000004911,probenecid,CCCN(CCC)S(=O)(=O)C1=CC=C(C=C1)C(=O)O
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,right heart failure,CID000004075,5-Aminosalicylic acid,C1=CC(=C(C=C1N)C(=O)O)O
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,Bone Fracture Spontaneous,CID000004894,"11,17,21-Trihydroxypregna-1,4-diene-3,20-dione",CC12CC(C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C)O
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,elevated cholesterol,CID000004211,mitotane,C1=CC=C(C(=C1)C(C2=CC=C(C=C2)Cl)C(Cl)Cl)Cl
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,confusion,CID000003198,econazole,C1=CC(=CC=C1COC(CN2C=CN=C2)C3=C(C=C(C=C3)Cl)Cl)Cl
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,hydronephrosis,CID000074989,ATOVAQUONE,C1CC(CCC1C2=CC=C(C=C2)Cl)C3=C(C4=CC=CC=C4C(=O)C3=O)O
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,ear ache,CID000002907,cyclophosphamide,C1CNP(=O)(OC1)N(CCCl)CCCl
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,Adenopathy,CID000003658,hydroxyzine,C1CN(CCN1CCOCCO)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,cholecystitis,CID000002771,citalopram,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,apoplexy,CID000003261,estazolam,C1C2=NN=CN2C3=C(C=C(C=C3)Cl)C(=N1)C4=CC=CC=C4
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,gastric inflammation,CID000004819,"2(3H)-Furanone, 3-ethyldihydro-4-[(1-methyl-1H-imidazol-5-yl)methyl]-, (3S-cis)-",CCC1C(COC1=O)CC2=CN=CN2C
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,erythema,CID000004736,Talwin,CC1C2CC3=C(C1(CCN2CC=C(C)C)C)C=C(C=C3)O
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,methaemoglobinaemia,CID000027991,DESMOPRESSIN,C1CC(N(C1)C(=O)C2CSSCCC(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N2)CC(=O)N)CCC(=O)N)CC3=CC=CC=C3)CC4=CC=C(C=C4)O)C(=O)NC(CCCN=C(N)N)C(=O)NCC(=O)N
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,thyroid cancer,CID000040976,CHEMBL430483,CCC12CC(=C)C3C(C1CCC2(C#C)O)CCC4=CC(=O)CCC34
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,colitis ischemic,CID000003449,Epigalanthamin,CN1CCC23C=CC(CC2OC4=C(C=CC(=C34)C1)OC)O
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,cholecystitis,CID000004173,metronidazole,CC1=NC=C(N1CCO)[N+](=O)[O-]
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,Adenopathy,CID000004679,pantoprazole,COC1=C(C(=NC=C1)CS(=O)C2=NC3=C(N2)C=C(C=C3)OC(F)F)OC
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,Acne,CID000005650,N-pentanoyl-N-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-L-valine,CCCCC(=O)N(CC1=CC=C(C=C1)C2=CC=CC=C2C3=NNN=N3)C(C(C)C)C(=O)O
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,apoplexy,CID000003750,"4,11-diethyl-4-hydroxy-3,14-dioxo-3,4,12,14-tetrahydro-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinolin-9-yl 1,4'-bipiperidine-1'-carboxylate",CCC1=C2CN3C(=CC4=C(C3=O)COC(=O)C4(CC)O)C2=NC5=C1C=C(C=C5)OC(=O)N6CCC(CC6)N7CCCCC7
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,Morphea,CID000062924,"S-(fluoromethyl) (6S,9R,10S,11S,13S,14S,16R,17R)-6,9-difluoro-11,17-dihydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthrene-17-carbothioate",CC1CC2C3CC(C4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)SCF)O)C)O)F)C)F
CID000000853,DL-Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,adenomyosis,CID000003345,fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3
CID005311297,SCHEMBL1133011,CC(C)(C1=CC=CC=C1CCC(C2=CC=CC(=C2)C=CC3=NC4=C(C=CC(=C4)Cl)C=C3)S)O,neumonia,CID005481350,Tenofovir disoproxil,CC(C)OC(=O)OCOP(=O)(COC(C)CN1C=NC2=C(N=CN=C21)N)OCOC(=O)OC(C)C
CID005311297,SCHEMBL1133011,CC(C)(C1=CC=CC=C1CCC(C2=CC=CC(=C2)C=CC3=NC4=C(C=CC(=C4)Cl)C=C3)S)O,thrombocytopenia,CID005381226,"[(7S,9E,11S,12R,13S,14R,15R,16R,17S,18S,19E,21Z,26E)-2,15,17,29-tetrahydroxy-11-methoxy-3,7,12,14,16,18,22-heptamethyl-26-[[(4-methylpiperazin-1-yl)amino]methylidene]-6,23,27-trioxo-8,30-dioxa-24-azatetracyclo[23.3.1.14,7.05,28]triaconta-1(28),2,4,9,19,21,25(29)-heptaen-13-yl] acetate",CC1C=CC=C(C(=O)NC2=C(C3=C(C4=C(C(=C3O)C)OC(C4=O)(OC=CC(C(C(C(C(C(C1O)C)O)C)OC(=O)C)C)OC)C)C(=O)C2=CNN5CCN(CC5)C)O)C
CID005311297,SCHEMBL1133011,CC(C)(C1=CC=CC=C1CCC(C2=CC=CC(=C2)C=CC3=NC4=C(C=CC(=C4)Cl)C=C3)S)O,apoplexy,CID006447131,Pimecrolimus,CCC1C=C(CC(CC(C2C(CC(C(O2)(C(=O)C(=O)N3CCCCC3C(=O)OC(C(C(CC1=O)O)C)C(=CC4CCC(C(C4)OC)Cl)C)O)C)OC)OC)C)C
CID005311297,SCHEMBL1133011,CC(C)(C1=CC=CC=C1CCC(C2=CC=CC(=C2)C=CC3=NC4=C(C=CC(=C4)Cl)C=C3)S)O,erythema,CID005493444,Aliskiren,CC(C)C(CC1=CC(=C(C=C1)OC)OCCCOC)CC(C(CC(C(C)C)C(=O)NCC(C)(C)C(=O)N)O)N
CID005311297,SCHEMBL1133011,CC(C)(C1=CC=CC=C1CCC(C2=CC=CC(=C2)C=CC3=NC4=C(C=CC(=C4)Cl)C=C3)S)O,gastric inflammation,CID006398525,,C(C1C(C(C(C(O1)OC2(C(C(C(O2)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)COS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.[Al].[Al].[Al].[Al].[Al].[Al].[Al].[Al].[Al]
CID000002551,Carbamylcholine,C[N+](C)(C)CCOC(=O)N,Back Ache,CID000003075,"2-[3-acetyloxy-2-(4-methoxyphenyl)-4-oxo-2,3-dihydro-1,5-benzothiazepin-5-yl]ethyl-dimethylazanium",CC(=O)OC1C(SC2=CC=CC=C2N(C1=O)CC[NH+](C)C)C3=CC=C(C=C3)OC
CID000003962,79952-43-5,CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C,gastric inflammation,CID000004927,promethazine,CC(CN1C2=CC=CC=C2SC3=CC=CC=C31)N(C)C
CID000003962,79952-43-5,CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C,erythema,CID000054454,simvastatin,CCC(C)(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C
CID000003962,79952-43-5,CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C,apoplexy,CID005311048,SCHEMBL11440306,C(N)(N)(Cl)Cl
CID000003962,79952-43-5,CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C,apoplexy,CID000004158,methylphenidate,COC(=O)C(C1CCCCN1)C2=CC=CC=C2
CID000003962,79952-43-5,CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C,eczema,CID000152945,Dutasteride?,CC12CCC3C(C1CCC2C(=O)NC4=C(C=CC(=C4)C(F)(F)F)C(F)(F)F)CCC5C3(C=CC(=O)N5)C
CID000003962,79952-43-5,CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C,abnormal ECG,CID000004054,memantine,CC12CC3CC(C1)(CC(C3)(C2)N)C
CID000003962,79952-43-5,CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C,Bleeding,CID000057537,92206-54-7,CCCN(CCC1=CC=CS1)C2CCC3=C(C2)C=CC=C3O
CID000003962,79952-43-5,CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C,apoplexy,CID006398525,,C(C1C(C(C(C(O1)OC2(C(C(C(O2)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)COS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.[Al].[Al].[Al].[Al].[Al].[Al].[Al].[Al].[Al]
CID000003962,79952-43-5,CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C,abnormal ECG,CID000005512,124936-74-9,CC1=CC(=C(C=C1)O)C(CCN(C(C)C)C(C)C)C2=CC=CC=C2
CID000003962,79952-43-5,CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C,Hypoventilation,CID000004745,SCHEMBL7711911,CCCN1CC(CC2C1CC3=CNC4=CC=CC2=C34)CSC
CID000003962,79952-43-5,CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C,Sinus headache,CID000004205,mirtazapine,CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4
CID000003962,79952-43-5,CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C,nephrotic syndrome,CID000004201,minoxidil,C1CCN(CC1)C2=NC(=N)N(C(=C2)N)O
CID000003962,79952-43-5,CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C,Sinus headache,CID000110635,Tadalafil,CN1CC(=O)N2C(C1=O)CC3=C(C2C4=CC5=C(C=C4)OCO5)NC6=CC=CC=C36
CID000003962,79952-43-5,CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C,erythema,CID000005152,Salmeterol,C1=CC=C(C=C1)CCCCOCCCCCCNCC(C2=CC(=C(C=C2)O)CO)O
CID000003962,79952-43-5,CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C,erythema,CID000004666,7-Epi Paclitaxel,CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C
CID000003962,79952-43-5,CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C,weight gain,CID000005358,sumatriptan,CNS(=O)(=O)CC1=CC2=C(C=C1)NC=C2CCN(C)C
CID000003962,79952-43-5,CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C,hyperalimentation,CID004659568,"2-cyano-3-(3,4-dihydroxy-5-nitrophenyl)-N,N-diethylprop-2-enamide",CCN(CC)C(=O)C(=CC1=CC(=C(C(=C1)O)O)[N+](=O)[O-])C#N
CID000003962,79952-43-5,CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C,cholecystitis,CID000004900,Fernisone,CC12CC(=O)C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C
CID000003962,79952-43-5,CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C,gastric inflammation,CID000004909,primidone,CCC1(C(=O)NCNC1=O)C2=CC=CC=C2
CID000003962,79952-43-5,CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C,deglutition disorder,CID000057469,IMIQUIMOD,CC(C)CN1C=NC2=C1C3=CC=CC=C3N=C2N
CID000003962,79952-43-5,CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C,apoplexy,CID000004616,oxazepam,C1=CC=C(C=C1)C2=NC(C(=O)NC3=C2C=C(C=C3)Cl)O
CID000003962,79952-43-5,CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C,apoplexy,CID000004236,modafinil,C1=CC=C(C=C1)C(C2=CC=CC=C2)S(=O)CC(=O)N
CID000003962,79952-43-5,CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C,gastric inflammation,CID000004585,"2-methyl-4-(4-methylpiperazin-1-yl)-5H-thieno[3,2-c][1,5]benzodiazepine",CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C
CID000003962,79952-43-5,CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C,haemorrhage intracranial,CID000004614,oxaprozin,C1=CC=C(C=C1)C2=C(OC(=N2)CCC(=O)O)C3=CC=CC=C3
CID000003962,79952-43-5,CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C,neumonia,CID000004075,5-Aminosalicylic acid,C1=CC(=C(C=C1N)C(=O)O)O
CID000003962,79952-43-5,CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C,nasopharyngitis,CID000016231,AMILORIDE,C1(=C(N=C(C(=N1)Cl)N)N)C(=O)N=C(N)N
CID000003962,79952-43-5,CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C,Adenopathy,CID000005732,zolpidem,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C
CID000003962,79952-43-5,CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C,gastric inflammation,CID000004691,"3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine",C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4
CID000003962,79952-43-5,CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C,gastric inflammation,CID000005073,risperidone,CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F
CID000003962,79952-43-5,CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C,erythema,CID000004856,"3-[hydroxy-(pyridin-2-ylamino)methylidene]-2-methyl-1,1-dioxo-1lambda6,2-benzothiazin-4-one",CN1C(=C(NC2=CC=CC=N2)O)C(=O)C3=CC=CC=C3S1(=O)=O
CID000003962,79952-43-5,CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C,gastric inflammation,CID000060852,Ibandronic Acid,CCCCCN(C)CCC(O)(P(=O)(O)O)P(=O)(O)O
CID000003962,79952-43-5,CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C,apoplexy,CID000124087,Desloratadine,C1CC2=C(C=CC(=C2)Cl)C(=C3CCNCC3)C4=C1C=CC=N4
CID000003962,79952-43-5,CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C,Adenopathy,CID000005650,N-pentanoyl-N-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-L-valine,CCCCC(=O)N(CC1=CC=C(C=C1)C2=CC=CC=C2C3=NNN=N3)C(C(C)C)C(=O)O
CID000003962,79952-43-5,CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C,abnormal ECG,CID000071329,Dofetilide,CN(CCC1=CC=C(C=C1)NS(=O)(=O)C)CCOC2=CC=C(C=C2)NS(=O)(=O)C
CID000003962,79952-43-5,CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C,gastric inflammation,CID000005376,(E/Z)-Tamoxifen,CCC(=C(C1=CC=CC=C1)C2=CC=C(C=C2)OCCN(C)C)C3=CC=CC=C3
CID000003962,79952-43-5,CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C,cholecystitis,CID000010631,medroxyprogesterone,CC1CC2C(CCC3(C2CCC3(C(=O)C)O)C)C4(C1=CC(=O)CC4)C
CID000003962,79952-43-5,CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C,cholecystectomies,CID000170361,Varenicline,C1C2CNCC1C3=CC4=NC=CN=C4C=C23
CID000003962,79952-43-5,CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C,erythema,CID000004885,104617-86-9,CCCNC1CCC2=C(C1)SC(=N2)N
CID000003962,79952-43-5,CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C,cholecystitis,CID000004889,Pravastatin Impurity A,CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC(CC(CC(=O)O)O)O)O
CID000003962,79952-43-5,CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C,dizziness,CID000087177,"D-Fructose, 4-O-alpha-D-glucopyranosyl-",C(C1C(C(C(C(O1)OC(C(CO)O)C(C(=O)CO)O)O)O)O)O
CID000003962,79952-43-5,CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C,dizziness,CID000004911,probenecid,CCCN(CCC)S(=O)(=O)C1=CC=C(C=C1)C(=O)O
CID000003962,79952-43-5,CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C,cholecystitis,CID000005245,Risedronic acid,C1=CC(=CN=C1)CC(O)(P(=O)(O)O)P(=O)(O)O
CID000003962,79952-43-5,CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C,cholecystitis,CID000004679,pantoprazole,COC1=C(C(=NC=C1)CS(=O)C2=NC3=C(N2)C=C(C=C3)OC(F)F)OC
CID000003962,79952-43-5,CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C,cellulitis,CID000008953,sodium;hydrogen carbonate,C(=O)(O)[O-].[Na+]
CID000003962,79952-43-5,CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C,weight gain,CID000005095,ropinirole,CCCN(CCC)CCC1=C2CC(=O)NC2=CC=C1
CID000003962,79952-43-5,CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C,cholecystitis,CID000005544,Mycolog,CC12CC(C3(C(C1CC(C2(C(=O)CO)O)O)CCC4=CC(=O)C=CC43C)F)O
CID000003962,79952-43-5,CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C,abnormal ECG,CID000005253,sotalol,CC(C)NCC(C1=CC=C(C=C1)NS(=O)(=O)C)O
CID000003962,79952-43-5,CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C,Adenopathy,CID000062924,"S-(fluoromethyl) (6S,9R,10S,11S,13S,14S,16R,17R)-6,9-difluoro-11,17-dihydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthrene-17-carbothioate",CC1CC2C3CC(C4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)SCF)O)C)O)F)C)F
CID000003962,79952-43-5,CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C,Back Ache,CID000005978,vincristine,CCC1(CC2CC(C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)C78CCN9C7C(C=CC9)(C(C(C8N6C=O)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O
CID000003962,79952-43-5,CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C,gout,CID000005352,38194-50-2,CC1=C(C2=C(C1=CC3=CC=C(C=C3)S(=O)C)C=CC(=C2)F)CC(=O)O
CID000003962,79952-43-5,CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C,thrombocytopenia,CID000005077,105601-20-5,CCN(C)C(=O)OC1=CC=CC(=C1)C(C)N(C)C
CID000003962,79952-43-5,CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C,loss of weight,CID000019090,megestrol,CC1=CC2C(CCC3(C2CCC3(C(=O)C)O)C)C4(C1=CC(=O)CC4)C
CID000003962,79952-43-5,CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C,hyperglycaemia,CID000004189,miconazole,C1=CC(=C(C=C1Cl)Cl)COC(CN2C=CN=C2)C3=C(C=C(C=C3)Cl)Cl
CID000003962,79952-43-5,CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C,cholecystitis,CID000004543,nortriptyline,CNCCC=C1C2=CC=CC=C2CCC3=CC=CC=C31
CID000003962,79952-43-5,CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C,abnormal ECG,CID000038904,Carboplatinum,C1CC(C1)(C(=O)O)C(=O)O.N.N.[Pt]
CID000003962,79952-43-5,CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C,edema,CID006447131,Pimecrolimus,CCC1C=C(CC(CC(C2C(CC(C(O2)(C(=O)C(=O)N3CCCCC3C(=O)OC(C(C(CC1=O)O)C)C(=CC4CCC(C(C4)OC)Cl)C)O)C)OC)OC)C)C
CID000003962,79952-43-5,CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C,Bleeding,CID000005394,temozolomide,CN1C(=O)N2C=NC(=C2N=N1)C(=O)N
CID000003962,79952-43-5,CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C,rhinorrhea,CID000005391,temazepam,CN1C2=C(C=C(C=C2)Cl)C(=NC(C1=O)O)C3=CC=CC=C3
CID000003962,79952-43-5,CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C,loss of weight,CID000060865,(E)-Olopatadine,CN(C)CCC=C1C2=CC=CC=C2COC3=C1C=C(C=C3)CC(=O)O
CID000003962,79952-43-5,CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C,eruption,CID000004173,metronidazole,CC1=NC=C(N1CCO)[N+](=O)[O-]
CID000003962,79952-43-5,CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C,cholecystitis,CID000004170,metolazone,CC1NC2=CC(=C(C=C2C(=O)N1C3=CC=CC=C3C)S(=O)(=O)N)Cl
CID000003962,79952-43-5,CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C,rhinorrhea,CID000065999,Telmisartan,CCCC1=NC2=C(N1CC3=CC=C(C=C3)C4=CC=CC=C4C(=O)O)C=C(C=C2C)C5=NC6=CC=CC=C6N5C
CID000003962,79952-43-5,CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C,apoplexy,CID000060854,Ziprasidone,C1CN(CCN1CCC2=C(C=C3C(=C2)CC(=O)N3)Cl)C4=NSC5=CC=CC=C54
CID000003962,79952-43-5,CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C,gastric inflammation,CID000005487,tizanidine,C1CN=C(N1)NC2=C(C=CC3=NSN=C32)Cl
CID000003962,79952-43-5,CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C,upper gastrointestinal bleeding,CID000005478,racemic-Timolol,CC(C)(C)NCC(COC1=NSN=C1N2CCOCC2)O
CID000003962,79952-43-5,CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C,dysarthria,CID000005523,Ultram,CN(C)CC1CCCCC1(C2=CC(=CC=C2)OC)O
CID000003962,79952-43-5,CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C,erythema,CID000004894,"11,17,21-Trihydroxypregna-1,4-diene-3,20-dione",CC12CC(C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C)O
CID000003962,79952-43-5,CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C,hepatic neoplasia,CID000077999,rosiglitazone,CN(CCOC1=CC=C(C=C1)CC2C(=O)NC(=O)S2)C3=CC=CC=N3
CID000003962,79952-43-5,CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C,cholecystitis,CID000004510,nitroglycerin,C(C(CO[N+](=O)[O-])O[N+](=O)[O-])O[N+](=O)[O-]
CID000003962,79952-43-5,CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C,dysarthria,CID003468412,SCHEMBL1176571,CC1C=CC=CCCC=CC=CC=CC=CC(CC(C(C(CC(=O)CC(C(CCC(CC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)C(=O)O)O)OC2C(C(C(C(O2)C)O)N)O
CID000003962,79952-43-5,CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C,erythema,CID000004107,methocarbamol,COC1=CC=CC=C1OCC(COC(=O)N)O
CID000005253,sotalol,CC(C)NCC(C1=CC=C(C=C1)NS(=O)(=O)C)O,Ovarian Cyst,CID000077999,rosiglitazone,CN(CCOC1=CC=C(C=C1)CC2C(=O)NC(=O)S2)C3=CC=CC=N3
CID000005253,sotalol,CC(C)NCC(C1=CC=C(C=C1)NS(=O)(=O)C)O,Cystitis Interstitial,CID000054454,simvastatin,CCC(C)(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C
CID000005253,sotalol,CC(C)NCC(C1=CC=C(C=C1)NS(=O)(=O)C)O,apoplexy,CID000005391,temazepam,CN1C2=C(C=C(C=C2)Cl)C(=NC(C1=O)O)C3=CC=CC=C3
CID000005253,sotalol,CC(C)NCC(C1=CC=C(C=C1)NS(=O)(=O)C)O,colitis,CID000065999,Telmisartan,CCCC1=NC2=C(N1CC3=CC=C(C=C3)C4=CC=CC=C4C(=O)O)C=C(C=C2C)C5=NC6=CC=CC=C6N5C
CID000005253,sotalol,CC(C)NCC(C1=CC=C(C=C1)NS(=O)(=O)C)O,dry skin,CID000060852,Ibandronic Acid,CCCCCN(C)CCC(O)(P(=O)(O)O)P(=O)(O)O
CID000005253,sotalol,CC(C)NCC(C1=CC=C(C=C1)NS(=O)(=O)C)O,apoplexy,CID000005732,zolpidem,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C
CID000005253,sotalol,CC(C)NCC(C1=CC=C(C=C1)NS(=O)(=O)C)O,apoplexy,CID000060184,"2'-epi-Perindopril, (2'R)-",CCCC(C(=O)OCC)NC(C)C(=O)N1C2CCCCC2CC1C(=O)O
CID000005253,sotalol,CC(C)NCC(C1=CC=C(C=C1)NS(=O)(=O)C)O,apoplexy,CID000005512,124936-74-9,CC1=CC(=C(C=C1)O)C(CCN(C(C)C)C(C)C)C2=CC=CC=C2
CID000005253,sotalol,CC(C)NCC(C1=CC=C(C=C1)NS(=O)(=O)C)O,bradycardia,CID000071329,Dofetilide,CN(CCC1=CC=C(C=C1)NS(=O)(=O)C)CCOC2=CC=C(C=C2)NS(=O)(=O)C
CID000005253,sotalol,CC(C)NCC(C1=CC=C(C=C1)NS(=O)(=O)C)O,thrombocytopenia,CID000152945,Dutasteride?,CC12CCC3C(C1CCC2C(=O)NC4=C(C=CC(=C4)C(F)(F)F)C(F)(F)F)CCC5C3(C=CC(=O)N5)C
CID000005253,sotalol,CC(C)NCC(C1=CC=C(C=C1)NS(=O)(=O)C)O,gastric inflammation,CID000005650,N-pentanoyl-N-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-L-valine,CCCCC(=O)N(CC1=CC=C(C=C1)C2=CC=CC=C2C3=NNN=N3)C(C(C)C)C(=O)O
CID000005253,sotalol,CC(C)NCC(C1=CC=C(C=C1)NS(=O)(=O)C)O,abnormal ECG,CID000038904,Carboplatinum,C1CC(C1)(C(=O)O)C(=O)O.N.N.[Pt]
CID000005253,sotalol,CC(C)NCC(C1=CC=C(C=C1)NS(=O)(=O)C)O,Hepatitis A,CID005493444,Aliskiren,CC(C)C(CC1=CC(=C(C=C1)OC)OCCCOC)CC(C(CC(C(C)C)C(=O)NCC(C)(C)C(=O)N)O)N
CID000005253,sotalol,CC(C)NCC(C1=CC=C(C=C1)NS(=O)(=O)C)O,gastric inflammation,CID005311048,SCHEMBL11440306,C(N)(N)(Cl)Cl
CID000005253,sotalol,CC(C)NCC(C1=CC=C(C=C1)NS(=O)(=O)C)O,loss of weight,CID000019090,megestrol,CC1=CC2C(CCC3(C2CCC3(C(=O)C)O)C)C4(C1=CC(=O)CC4)C
CID000005253,sotalol,CC(C)NCC(C1=CC=C(C=C1)NS(=O)(=O)C)O,apoplexy,CID000062924,"S-(fluoromethyl) (6S,9R,10S,11S,13S,14S,16R,17R)-6,9-difluoro-11,17-dihydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthrene-17-carbothioate",CC1CC2C3CC(C4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)SCF)O)C)O)F)C)F
CID000005253,sotalol,CC(C)NCC(C1=CC=C(C=C1)NS(=O)(=O)C)O,psoriasis,CID000009052,2-hydroxy-3-[1-(4-nitrophenyl)-3-oxobutyl]chromen-4-one,CC(=O)CC(C1=CC=C(C=C1)[N+](=O)[O-])C2=C(OC3=CC=CC=C3C2=O)O
CID000004616,oxazepam,C1=CC=C(C=C1)C2=NC(C(=O)NC3=C2C=C(C=C3)Cl)O,drug toxicity NOS,CID000009052,2-hydroxy-3-[1-(4-nitrophenyl)-3-oxobutyl]chromen-4-one,CC(=O)CC(C1=CC=C(C=C1)[N+](=O)[O-])C2=C(OC3=CC=CC=C3C2=O)O
CID000004616,oxazepam,C1=CC=C(C=C1)C2=NC(C(=O)NC3=C2C=C(C=C3)Cl)O,apoplexy,CID000005245,Risedronic acid,C1=CC(=CN=C1)CC(O)(P(=O)(O)O)P(=O)(O)O
CID000004616,oxazepam,C1=CC=C(C=C1)C2=NC(C(=O)NC3=C2C=C(C=C3)Cl)O,apoplexy,CID000060854,Ziprasidone,C1CN(CCN1CCC2=C(C=C3C(=C2)CC(=O)N3)Cl)C4=NSC5=CC=CC=C54
CID000004616,oxazepam,C1=CC=C(C=C1)C2=NC(C(=O)NC3=C2C=C(C=C3)Cl)O,cerebral vascular disorder,CID000005523,Ultram,CN(C)CC1CCCCC1(C2=CC(=CC=C2)OC)O
CID000004616,oxazepam,C1=CC=C(C=C1)C2=NC(C(=O)NC3=C2C=C(C=C3)Cl)O,gastric inflammation,CID000062924,"S-(fluoromethyl) (6S,9R,10S,11S,13S,14S,16R,17R)-6,9-difluoro-11,17-dihydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthrene-17-carbothioate",CC1CC2C3CC(C4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)SCF)O)C)O)F)C)F
CID000004616,oxazepam,C1=CC=C(C=C1)C2=NC(C(=O)NC3=C2C=C(C=C3)Cl)O,loss of weight,CID000005487,tizanidine,C1CN=C(N1)NC2=C(C=CC3=NSN=C32)Cl
CID000004616,oxazepam,C1=CC=C(C=C1)C2=NC(C(=O)NC3=C2C=C(C=C3)Cl)O,increased white blood cell count,CID000005077,105601-20-5,CCN(C)C(=O)OC1=CC=CC(=C1)C(C)N(C)C
CID000004616,oxazepam,C1=CC=C(C=C1)C2=NC(C(=O)NC3=C2C=C(C=C3)Cl)O,arteriosclerotic heart disease,CID000005076,162990-01-4,CC(C)C1=NC(=CS1)CN(C)C(=O)NC(C(C)C)C(=O)NC(CC2=CC=CC=C2)CC(C(CC3=CC=CC=C3)NC(=O)OCC4=CN=CS4)O
CID000004616,oxazepam,C1=CC=C(C=C1)C2=NC(C(=O)NC3=C2C=C(C=C3)Cl)O,drug toxicity NOS,CID000004927,promethazine,CC(CN1C2=CC=CC=C2SC3=CC=CC=C31)N(C)C
CID000004616,oxazepam,C1=CC=C(C=C1)C2=NC(C(=O)NC3=C2C=C(C=C3)Cl)O,haemorrhage rectum,CID000004894,"11,17,21-Trihydroxypregna-1,4-diene-3,20-dione",CC12CC(C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C)O
CID000004616,oxazepam,C1=CC=C(C=C1)C2=NC(C(=O)NC3=C2C=C(C=C3)Cl)O,loss of weight,CID005481350,Tenofovir disoproxil,CC(C)OC(=O)OCOP(=O)(COC(C)CN1C=NC2=C(N=CN=C21)N)OCOC(=O)OC(C)C
CID000004616,oxazepam,C1=CC=C(C=C1)C2=NC(C(=O)NC3=C2C=C(C=C3)Cl)O,loss of weight,CID000010631,medroxyprogesterone,CC1CC2C(CCC3(C2CCC3(C(=O)C)O)C)C4(C1=CC(=O)CC4)C
CID000004616,oxazepam,C1=CC=C(C=C1)C2=NC(C(=O)NC3=C2C=C(C=C3)Cl)O,allergic dermatitis,CID000005376,(E/Z)-Tamoxifen,CCC(=C(C1=CC=CC=C1)C2=CC=C(C=C2)OCCN(C)C)C3=CC=CC=C3
CID000004616,oxazepam,C1=CC=C(C=C1)C2=NC(C(=O)NC3=C2C=C(C=C3)Cl)O,Back Ache,CID000004691,"3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine",C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4
CID000004616,oxazepam,C1=CC=C(C=C1)C2=NC(C(=O)NC3=C2C=C(C=C3)Cl)O,loss of weight,CID000008953,sodium;hydrogen carbonate,C(=O)(O)[O-].[Na+]
CID000004616,oxazepam,C1=CC=C(C=C1)C2=NC(C(=O)NC3=C2C=C(C=C3)Cl)O,anaphylactic reaction,CID000039765,Vecuronium,CC(=O)OC1CC2CCC3C(C2(CC1N4CCCCC4)C)CCC5(C3CC(C5OC(=O)C)[N+]6(CCCCC6)C)C
CID000004616,oxazepam,C1=CC=C(C=C1)C2=NC(C(=O)NC3=C2C=C(C=C3)Cl)O,excessive thirst,CID000054454,simvastatin,CCC(C)(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C
CID000004616,oxazepam,C1=CC=C(C=C1)C2=NC(C(=O)NC3=C2C=C(C=C3)Cl)O,bladder retention,CID000005584,trimipramine,CC(CN1C2=CC=CC=C2CCC3=CC=CC=C31)CN(C)C
CID000004616,oxazepam,C1=CC=C(C=C1)C2=NC(C(=O)NC3=C2C=C(C=C3)Cl)O,loss of weight,CID005311048,SCHEMBL11440306,C(N)(N)(Cl)Cl
CID000004616,oxazepam,C1=CC=C(C=C1)C2=NC(C(=O)NC3=C2C=C(C=C3)Cl)O,agoraphobia,CID000004745,SCHEMBL7711911,CCCN1CC(CC2C1CC3=CNC4=CC=CC2=C34)CSC
CID000004616,oxazepam,C1=CC=C(C=C1)C2=NC(C(=O)NC3=C2C=C(C=C3)Cl)O,Infection Urinary Tract,CID000005512,124936-74-9,CC1=CC(=C(C=C1)O)C(CCN(C(C)C)C(C)C)C2=CC=CC=C2
CID000004616,oxazepam,C1=CC=C(C=C1)C2=NC(C(=O)NC3=C2C=C(C=C3)Cl)O,atelectasis,CID000038904,Carboplatinum,C1CC(C1)(C(=O)O)C(=O)O.N.N.[Pt]
CID000004616,oxazepam,C1=CC=C(C=C1)C2=NC(C(=O)NC3=C2C=C(C=C3)Cl)O,deglutition disorder,CID000004909,primidone,CCC1(C(=O)NCNC1=O)C2=CC=CC=C2
CID000004616,oxazepam,C1=CC=C(C=C1)C2=NC(C(=O)NC3=C2C=C(C=C3)Cl)O,Hepatic failure,CID000004856,"3-[hydroxy-(pyridin-2-ylamino)methylidene]-2-methyl-1,1-dioxo-1lambda6,2-benzothiazin-4-one",CN1C(=C(NC2=CC=CC=N2)O)C(=O)C3=CC=CC=C3S1(=O)=O
CID000004616,oxazepam,C1=CC=C(C=C1)C2=NC(C(=O)NC3=C2C=C(C=C3)Cl)O,Scleroderma,CID000060184,"2'-epi-Perindopril, (2'R)-",CCCC(C(=O)OCC)NC(C)C(=O)N1C2CCCCC2CC1C(=O)O
CID000004616,oxazepam,C1=CC=C(C=C1)C2=NC(C(=O)NC3=C2C=C(C=C3)Cl)O,Excess potassium,CID000004889,Pravastatin Impurity A,CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC(CC(CC(=O)O)O)O)O
CID000004616,oxazepam,C1=CC=C(C=C1)C2=NC(C(=O)NC3=C2C=C(C=C3)Cl)O,eruption,CID004659568,"2-cyano-3-(3,4-dihydroxy-5-nitrophenyl)-N,N-diethylprop-2-enamide",CCN(CC)C(=O)C(=CC1=CC(=C(C(=C1)O)O)[N+](=O)[O-])C#N
CID000004616,oxazepam,C1=CC=C(C=C1)C2=NC(C(=O)NC3=C2C=C(C=C3)Cl)O,apoplexy,CID000087177,"D-Fructose, 4-O-alpha-D-glucopyranosyl-",C(C1C(C(C(C(O1)OC(C(CO)O)C(C(=O)CO)O)O)O)O)O
CID000004616,oxazepam,C1=CC=C(C=C1)C2=NC(C(=O)NC3=C2C=C(C=C3)Cl)O,Back Ache,CID000005650,N-pentanoyl-N-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-L-valine,CCCCC(=O)N(CC1=CC=C(C=C1)C2=CC=CC=C2C3=NNN=N3)C(C(C)C)C(=O)O
CID000004616,oxazepam,C1=CC=C(C=C1)C2=NC(C(=O)NC3=C2C=C(C=C3)Cl)O,Back Ache,CID000124087,Desloratadine,C1CC2=C(C=CC(=C2)Cl)C(=C3CCNCC3)C4=C1C=CC=N4
CID000004616,oxazepam,C1=CC=C(C=C1)C2=NC(C(=O)NC3=C2C=C(C=C3)Cl)O,gastric inflammation,CID000005073,risperidone,CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F
CID000004616,oxazepam,C1=CC=C(C=C1)C2=NC(C(=O)NC3=C2C=C(C=C3)Cl)O,loss of weight,CID003468412,SCHEMBL1176571,CC1C=CC=CCCC=CC=CC=CC=CC(CC(C(C(CC(=O)CC(C(CCC(CC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)C(=O)O)O)OC2C(C(C(C(O2)C)O)N)O
CID000004616,oxazepam,C1=CC=C(C=C1)C2=NC(C(=O)NC3=C2C=C(C=C3)Cl)O,loss of weight,CID006398525,,C(C1C(C(C(C(O1)OC2(C(C(C(O2)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)COS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.[Al].[Al].[Al].[Al].[Al].[Al].[Al].[Al].[Al]
CID000004616,oxazepam,C1=CC=C(C=C1)C2=NC(C(=O)NC3=C2C=C(C=C3)Cl)O,insulin dependent diabetes mellitus,CID000077999,rosiglitazone,CN(CCOC1=CC=C(C=C1)CC2C(=O)NC(=O)S2)C3=CC=CC=N3
CID000004616,oxazepam,C1=CC=C(C=C1)C2=NC(C(=O)NC3=C2C=C(C=C3)Cl)O,loss of weight,CID000005152,Salmeterol,C1=CC=C(C=C1)CCCCOCCCCCCNCC(C2=CC(=C(C=C2)O)CO)O
CID000004616,oxazepam,C1=CC=C(C=C1)C2=NC(C(=O)NC3=C2C=C(C=C3)Cl)O,apoplexy,CID000170361,Varenicline,C1C2CNCC1C3=CC4=NC=CN=C4C=C23
CID000004616,oxazepam,C1=CC=C(C=C1)C2=NC(C(=O)NC3=C2C=C(C=C3)Cl)O,drug toxicity NOS,CID000065999,Telmisartan,CCCC1=NC2=C(N1CC3=CC=C(C=C3)C4=CC=CC=C4C(=O)O)C=C(C=C2C)C5=NC6=CC=CC=C6N5C
CID000004616,oxazepam,C1=CC=C(C=C1)C2=NC(C(=O)NC3=C2C=C(C=C3)Cl)O,cellulitis,CID000004666,7-Epi Paclitaxel,CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C
CID000004616,oxazepam,C1=CC=C(C=C1)C2=NC(C(=O)NC3=C2C=C(C=C3)Cl)O,confusion,CID000005978,vincristine,CCC1(CC2CC(C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)C78CCN9C7C(C=CC9)(C(C(C8N6C=O)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O
CID000004616,oxazepam,C1=CC=C(C=C1)C2=NC(C(=O)NC3=C2C=C(C=C3)Cl)O,deglutition disorder,CID000019090,megestrol,CC1=CC2C(CCC3(C2CCC3(C(=O)C)O)C)C4(C1=CC(=O)CC4)C
CID000004616,oxazepam,C1=CC=C(C=C1)C2=NC(C(=O)NC3=C2C=C(C=C3)Cl)O,gastric inflammation,CID000004900,Fernisone,CC12CC(=O)C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C
CID000004616,oxazepam,C1=CC=C(C=C1)C2=NC(C(=O)NC3=C2C=C(C=C3)Cl)O,gastric inflammation,CID000004679,pantoprazole,COC1=C(C(=NC=C1)CS(=O)C2=NC3=C(N2)C=C(C=C3)OC(F)F)OC
CID000004616,oxazepam,C1=CC=C(C=C1)C2=NC(C(=O)NC3=C2C=C(C=C3)Cl)O,encephalitis viral,CID000005394,temozolomide,CN1C(=O)N2C=NC(=C2N=N1)C(=O)N
CID000004616,oxazepam,C1=CC=C(C=C1)C2=NC(C(=O)NC3=C2C=C(C=C3)Cl)O,Back Ache,CID000005391,temazepam,CN1C2=C(C=C(C=C2)Cl)C(=NC(C1=O)O)C3=CC=CC=C3
CID000004616,oxazepam,C1=CC=C(C=C1)C2=NC(C(=O)NC3=C2C=C(C=C3)Cl)O,hepatic neoplasia,CID000005732,zolpidem,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C
CID000124087,Desloratadine,C1CC2=C(C=CC(=C2)Cl)C(=C3CCNCC3)C4=C1C=CC=N4,heart rate increased,CID000160051,Colesevelam,CCCCCCCCCCNCC=C.C[N+](C)(C)CCCCCCNCC=C.C=CCN.C1C(O1)CCl.Cl.[Cl-]
CID000124087,Desloratadine,C1CC2=C(C=CC(=C2)Cl)C(=C3CCNCC3)C4=C1C=CC=N4,loss of weight,CID006447131,Pimecrolimus,CCC1C=C(CC(CC(C2C(CC(C(O2)(C(=O)C(=O)N3CCCCC3C(=O)OC(C(C(CC1=O)O)C)C(=CC4CCC(C(C4)OC)Cl)C)O)C)OC)OC)C)C
CID000124087,Desloratadine,C1CC2=C(C=CC(=C2)Cl)C(=C3CCNCC3)C4=C1C=CC=N4,loss of weight,CID006398525,,C(C1C(C(C(C(O1)OC2(C(C(C(O2)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)COS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.[Al].[Al].[Al].[Al].[Al].[Al].[Al].[Al].[Al]
CID000124087,Desloratadine,C1CC2=C(C=CC(=C2)Cl)C(=C3CCNCC3)C4=C1C=CC=N4,loss of weight,CID000170361,Varenicline,C1C2CNCC1C3=CC4=NC=CN=C4C=C23
CID000124087,Desloratadine,C1CC2=C(C=CC(=C2)Cl)C(=C3CCNCC3)C4=C1C=CC=N4,hepatitis,CID005481350,Tenofovir disoproxil,CC(C)OC(=O)OCOP(=O)(COC(C)CN1C=NC2=C(N=CN=C21)N)OCOC(=O)OC(C)C
CID000124087,Desloratadine,C1CC2=C(C=CC(=C2)Cl)C(=C3CCNCC3)C4=C1C=CC=N4,gastric inflammation,CID003468412,SCHEMBL1176571,CC1C=CC=CCCC=CC=CC=CC=CC(CC(C(C(CC(=O)CC(C(CCC(CC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)C(=O)O)O)OC2C(C(C(C(O2)C)O)N)O
CID000124087,Desloratadine,C1CC2=C(C=CC(=C2)Cl)C(=C3CCNCC3)C4=C1C=CC=N4,dizziness,CID000152945,Dutasteride?,CC12CCC3C(C1CCC2C(=O)NC4=C(C=CC(=C4)C(F)(F)F)C(F)(F)F)CCC5C3(C=CC(=O)N5)C
CID000002995,desipramine,CNCCCN1C2=CC=CC=C2CCC3=CC=CC=C31,gastric inflammation,CID000003440,furosemide,C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl
CID000002995,desipramine,CNCCCN1C2=CC=CC=C2CCC3=CC=CC=C31,erythema,CID000005732,zolpidem,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C
CID000002995,desipramine,CNCCCN1C2=CC=CC=C2CCC3=CC=CC=C31,primary biliary cirrhosis,CID000005645,"3,7-Dihydroxycholan-24-oic acid",CC(CCC(=O)O)C1CCC2C1(CCC3C2C(CC4C3(CCC(C4)O)C)O)C
CID000002995,desipramine,CNCCCN1C2=CC=CC=C2CCC3=CC=CC=C31,erythema,CID000003961,losartan,CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)CO)Cl
CID000002995,desipramine,CNCCCN1C2=CC=CC=C2CCC3=CC=CC=C31,abnormal ECG,CID000003958,lorazepam,C1=CC=C(C(=C1)C2=NC(C(=O)NC3=C2C=C(C=C3)Cl)O)Cl
CID000002995,desipramine,CNCCCN1C2=CC=CC=C2CCC3=CC=CC=C31,abnormal ECG,CID000004585,"2-methyl-4-(4-methylpiperazin-1-yl)-5H-thieno[3,2-c][1,5]benzodiazepine",CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C
CID000002995,desipramine,CNCCCN1C2=CC=CC=C2CCC3=CC=CC=C31,elevated cholesterol,CID000054454,simvastatin,CCC(C)(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C
CID000002658,3-(carbamoyloxymethyl)-7-[[2-(furan-2-yl)-2-methoxyiminoacetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate,CON=C(C1=CC=CO1)C(=O)NC2C3N(C2=O)C(=C(CS3)COC(=O)N)C(=O)[O-],erythema,CID000004889,Pravastatin Impurity A,CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC(CC(CC(=O)O)O)O)O
CID000002658,3-(carbamoyloxymethyl)-7-[[2-(furan-2-yl)-2-methoxyiminoacetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate,CON=C(C1=CC=CO1)C(=O)NC2C3N(C2=O)C(=C(CS3)COC(=O)N)C(=O)[O-],apoplexy,CID000005245,Risedronic acid,C1=CC(=CN=C1)CC(O)(P(=O)(O)O)P(=O)(O)O
CID000002658,3-(carbamoyloxymethyl)-7-[[2-(furan-2-yl)-2-methoxyiminoacetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate,CON=C(C1=CC=CO1)C(=O)NC2C3N(C2=O)C(=C(CS3)COC(=O)N)C(=O)[O-],gastric inflammation,CID000003062,Lanicor,CC1C(C(CC(O1)OC2C(OC(CC2O)OC3C(OC(CC3O)OC4CCC5(C(C4)CCC6C5CC(C7(C6(CCC7C8=CC(=O)OC8)O)C)O)C)C)C)O)O
CID000002658,3-(carbamoyloxymethyl)-7-[[2-(furan-2-yl)-2-methoxyiminoacetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate,CON=C(C1=CC=CO1)C(=O)NC2C3N(C2=O)C(=C(CS3)COC(=O)N)C(=O)[O-],bursitis,CID000004885,104617-86-9,CCCNC1CCC2=C(C1)SC(=N2)N
CID000002658,3-(carbamoyloxymethyl)-7-[[2-(furan-2-yl)-2-methoxyiminoacetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate,CON=C(C1=CC=CO1)C(=O)NC2C3N(C2=O)C(=C(CS3)COC(=O)N)C(=O)[O-],increased white blood cell count,CID000060854,Ziprasidone,C1CN(CCN1CCC2=C(C=C3C(=C2)CC(=O)N3)Cl)C4=NSC5=CC=CC=C54
CID000002658,3-(carbamoyloxymethyl)-7-[[2-(furan-2-yl)-2-methoxyiminoacetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate,CON=C(C1=CC=CO1)C(=O)NC2C3N(C2=O)C(=C(CS3)COC(=O)N)C(=O)[O-],erythema,CID000005544,Mycolog,CC12CC(C3(C(C1CC(C2(C(=O)CO)O)O)CCC4=CC(=O)C=CC43C)F)O
CID000002658,3-(carbamoyloxymethyl)-7-[[2-(furan-2-yl)-2-methoxyiminoacetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate,CON=C(C1=CC=CO1)C(=O)NC2C3N(C2=O)C(=C(CS3)COC(=O)N)C(=O)[O-],eruption,CID000163742,SCHEMBL1650579,COC1C(C(C(C(O1)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)COS(=O)(=O)O)OC4C(C(C(C(O4)C(=O)O)OC5C(C(C(C(O5)COS(=O)(=O)O)O)O)NS(=O)(=O)O)O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O)NS(=O)(=O)O
CID000002658,3-(carbamoyloxymethyl)-7-[[2-(furan-2-yl)-2-methoxyiminoacetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate,CON=C(C1=CC=CO1)C(=O)NC2C3N(C2=O)C(=C(CS3)COC(=O)N)C(=O)[O-],erythema,CID000002907,cyclophosphamide,C1CNP(=O)(OC1)N(CCCl)CCCl
CID000002658,3-(carbamoyloxymethyl)-7-[[2-(furan-2-yl)-2-methoxyiminoacetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate,CON=C(C1=CC=CO1)C(=O)NC2C3N(C2=O)C(=C(CS3)COC(=O)N)C(=O)[O-],Adenopathy,CID000003749,irbesartan,CCCCC1=NC2(CCCC2)C(=O)N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5
CID000002658,3-(carbamoyloxymethyl)-7-[[2-(furan-2-yl)-2-methoxyiminoacetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate,CON=C(C1=CC=CO1)C(=O)NC2C3N(C2=O)C(=C(CS3)COC(=O)N)C(=O)[O-],gastric inflammation,CID000004856,"3-[hydroxy-(pyridin-2-ylamino)methylidene]-2-methyl-1,1-dioxo-1lambda6,2-benzothiazin-4-one",CN1C(=C(NC2=CC=CC=N2)O)C(=O)C3=CC=CC=C3S1(=O)=O
CID000002658,3-(carbamoyloxymethyl)-7-[[2-(furan-2-yl)-2-methoxyiminoacetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate,CON=C(C1=CC=CO1)C(=O)NC2C3N(C2=O)C(=C(CS3)COC(=O)N)C(=O)[O-],ear infection,CID000667490,6-Mercaptopurine,C1=NC2=C(N1)C(=S)N=CN2
CID000002658,3-(carbamoyloxymethyl)-7-[[2-(furan-2-yl)-2-methoxyiminoacetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate,CON=C(C1=CC=CO1)C(=O)NC2C3N(C2=O)C(=C(CS3)COC(=O)N)C(=O)[O-],heart rate increased,CID000003661,L-Hyoscyamine,CN1C2CCC1CC(C2)OC(=O)C(CO)C3=CC=CC=C3
CID000002658,3-(carbamoyloxymethyl)-7-[[2-(furan-2-yl)-2-methoxyiminoacetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate,CON=C(C1=CC=CO1)C(=O)NC2C3N(C2=O)C(=C(CS3)COC(=O)N)C(=O)[O-],acute kidney failure,CID000038904,Carboplatinum,C1CC(C1)(C(=O)O)C(=O)O.N.N.[Pt]
CID000002658,3-(carbamoyloxymethyl)-7-[[2-(furan-2-yl)-2-methoxyiminoacetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate,CON=C(C1=CC=CO1)C(=O)NC2C3N(C2=O)C(=C(CS3)COC(=O)N)C(=O)[O-],increased white blood cell count,CID000170361,Varenicline,C1C2CNCC1C3=CC4=NC=CN=C4C=C23
CID000002658,3-(carbamoyloxymethyl)-7-[[2-(furan-2-yl)-2-methoxyiminoacetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate,CON=C(C1=CC=CO1)C(=O)NC2C3N(C2=O)C(=C(CS3)COC(=O)N)C(=O)[O-],elevated cholesterol,CID000003310,33419-42-0,CC1OCC2C(O1)C(C(C(O2)OC3C4COC(=O)C4C(C5=CC6=C(C=C35)OCO6)C7=CC(=C(C(=C7)OC)O)OC)O)O
CID000002658,3-(carbamoyloxymethyl)-7-[[2-(furan-2-yl)-2-methoxyiminoacetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate,CON=C(C1=CC=CO1)C(=O)NC2C3N(C2=O)C(=C(CS3)COC(=O)N)C(=O)[O-],cholecystitis,CID000004679,pantoprazole,COC1=C(C(=NC=C1)CS(=O)C2=NC3=C(N2)C=C(C=C3)OC(F)F)OC
CID000002658,3-(carbamoyloxymethyl)-7-[[2-(furan-2-yl)-2-methoxyiminoacetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate,CON=C(C1=CC=CO1)C(=O)NC2C3N(C2=O)C(=C(CS3)COC(=O)N)C(=O)[O-],enlarged liver,CID000004075,5-Aminosalicylic acid,C1=CC(=C(C=C1N)C(=O)O)O
CID000002658,3-(carbamoyloxymethyl)-7-[[2-(furan-2-yl)-2-methoxyiminoacetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate,CON=C(C1=CC=CO1)C(=O)NC2C3N(C2=O)C(=C(CS3)COC(=O)N)C(=O)[O-],loss of weight,CID000005512,124936-74-9,CC1=CC(=C(C=C1)O)C(CCN(C(C)C)C(C)C)C2=CC=CC=C2
CID000002658,3-(carbamoyloxymethyl)-7-[[2-(furan-2-yl)-2-methoxyiminoacetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate,CON=C(C1=CC=CO1)C(=O)NC2C3N(C2=O)C(=C(CS3)COC(=O)N)C(=O)[O-],angiitis,CID000004542,norgestrel,CCC12CCC3C(C1CCC2(C#C)O)CCC4=CC(=O)CCC34
CID000002658,3-(carbamoyloxymethyl)-7-[[2-(furan-2-yl)-2-methoxyiminoacetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate,CON=C(C1=CC=CO1)C(=O)NC2C3N(C2=O)C(=C(CS3)COC(=O)N)C(=O)[O-],erythema,CID000005650,N-pentanoyl-N-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-L-valine,CCCCC(=O)N(CC1=CC=C(C=C1)C2=CC=CC=C2C3=NNN=N3)C(C(C)C)C(=O)O
CID000002658,3-(carbamoyloxymethyl)-7-[[2-(furan-2-yl)-2-methoxyiminoacetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate,CON=C(C1=CC=CO1)C(=O)NC2C3N(C2=O)C(=C(CS3)COC(=O)N)C(=O)[O-],cholecystitis,CID000004927,promethazine,CC(CN1C2=CC=CC=C2SC3=CC=CC=C31)N(C)C
CID000002658,3-(carbamoyloxymethyl)-7-[[2-(furan-2-yl)-2-methoxyiminoacetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate,CON=C(C1=CC=CO1)C(=O)NC2C3N(C2=O)C(=C(CS3)COC(=O)N)C(=O)[O-],gastric inflammation,CID000003463,gemfibrozil,CC1=CC(=C(C=C1)C)OCCCC(C)(C)C(=O)O
CID000002658,3-(carbamoyloxymethyl)-7-[[2-(furan-2-yl)-2-methoxyiminoacetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate,CON=C(C1=CC=CO1)C(=O)NC2C3N(C2=O)C(=C(CS3)COC(=O)N)C(=O)[O-],angiitis,CID000010631,medroxyprogesterone,CC1CC2C(CCC3(C2CCC3(C(=O)C)O)C)C4(C1=CC(=O)CC4)C
CID000002658,3-(carbamoyloxymethyl)-7-[[2-(furan-2-yl)-2-methoxyiminoacetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate,CON=C(C1=CC=CO1)C(=O)NC2C3N(C2=O)C(=C(CS3)COC(=O)N)C(=O)[O-],apoplexy,CID000077999,rosiglitazone,CN(CCOC1=CC=C(C=C1)CC2C(=O)NC(=O)S2)C3=CC=CC=N3
CID000002658,3-(carbamoyloxymethyl)-7-[[2-(furan-2-yl)-2-methoxyiminoacetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate,CON=C(C1=CC=CO1)C(=O)NC2C3N(C2=O)C(=C(CS3)COC(=O)N)C(=O)[O-],cholecystitis,CID000004900,Fernisone,CC12CC(=O)C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C
CID000002658,3-(carbamoyloxymethyl)-7-[[2-(furan-2-yl)-2-methoxyiminoacetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate,CON=C(C1=CC=CO1)C(=O)NC2C3N(C2=O)C(=C(CS3)COC(=O)N)C(=O)[O-],gastric inflammation,CID006398525,,C(C1C(C(C(C(O1)OC2(C(C(C(O2)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)COS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.[Al].[Al].[Al].[Al].[Al].[Al].[Al].[Al].[Al]
CID000002658,3-(carbamoyloxymethyl)-7-[[2-(furan-2-yl)-2-methoxyiminoacetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate,CON=C(C1=CC=CO1)C(=O)NC2C3N(C2=O)C(=C(CS3)COC(=O)N)C(=O)[O-],dysarthria,CID000003869,labetalol,CC(CCC1=CC=CC=C1)NCC(C2=CC(=C(C=C2)O)C(=O)N)O
CID000002658,3-(carbamoyloxymethyl)-7-[[2-(furan-2-yl)-2-methoxyiminoacetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate,CON=C(C1=CC=CO1)C(=O)NC2C3N(C2=O)C(=C(CS3)COC(=O)N)C(=O)[O-],hepatitis,CID000003763,isoflurane,C(C(F)(F)F)(OC(F)F)Cl
CID000002658,3-(carbamoyloxymethyl)-7-[[2-(furan-2-yl)-2-methoxyiminoacetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate,CON=C(C1=CC=CO1)C(=O)NC2C3N(C2=O)C(=C(CS3)COC(=O)N)C(=O)[O-],loss of weight,CID000003954,loperamide(1+),CN(C)C(=O)C(CC[NH+]1CCC(CC1)(C2=CC=C(C=C2)Cl)O)(C3=CC=CC=C3)C4=CC=CC=C4
CID000002658,3-(carbamoyloxymethyl)-7-[[2-(furan-2-yl)-2-methoxyiminoacetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate,CON=C(C1=CC=CO1)C(=O)NC2C3N(C2=O)C(=C(CS3)COC(=O)N)C(=O)[O-],cholecystitis,CID000003958,lorazepam,C1=CC=C(C(=C1)C2=NC(C(=O)NC3=C2C=C(C=C3)Cl)O)Cl
CID000002658,3-(carbamoyloxymethyl)-7-[[2-(furan-2-yl)-2-methoxyiminoacetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate,CON=C(C1=CC=CO1)C(=O)NC2C3N(C2=O)C(=C(CS3)COC(=O)N)C(=O)[O-],thrombocytopenia,CID000074989,ATOVAQUONE,C1CC(CCC1C2=CC=C(C=C2)Cl)C3=C(C4=CC=CC=C4C(=O)C3=O)O
CID000002658,3-(carbamoyloxymethyl)-7-[[2-(furan-2-yl)-2-methoxyiminoacetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate,CON=C(C1=CC=CO1)C(=O)NC2C3N(C2=O)C(=C(CS3)COC(=O)N)C(=O)[O-],bursitis,CID000005095,ropinirole,CCCN(CCC)CCC1=C2CC(=O)NC2=CC=C1
CID000002658,3-(carbamoyloxymethyl)-7-[[2-(furan-2-yl)-2-methoxyiminoacetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate,CON=C(C1=CC=CO1)C(=O)NC2C3N(C2=O)C(=C(CS3)COC(=O)N)C(=O)[O-],drug toxicity NOS,CID000004158,methylphenidate,COC(=O)C(C1CCCCN1)C2=CC=CC=C2
CID000002658,3-(carbamoyloxymethyl)-7-[[2-(furan-2-yl)-2-methoxyiminoacetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate,CON=C(C1=CC=CO1)C(=O)NC2C3N(C2=O)C(=C(CS3)COC(=O)N)C(=O)[O-],gastric inflammation,CID000004510,nitroglycerin,C(C(CO[N+](=O)[O-])O[N+](=O)[O-])O[N+](=O)[O-]
CID000002658,3-(carbamoyloxymethyl)-7-[[2-(furan-2-yl)-2-methoxyiminoacetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate,CON=C(C1=CC=CO1)C(=O)NC2C3N(C2=O)C(=C(CS3)COC(=O)N)C(=O)[O-],gastric inflammation,CID000003339,fenofibrate,CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C2=CC=C(C=C2)Cl
CID000002658,3-(carbamoyloxymethyl)-7-[[2-(furan-2-yl)-2-methoxyiminoacetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate,CON=C(C1=CC=CO1)C(=O)NC2C3N(C2=O)C(=C(CS3)COC(=O)N)C(=O)[O-],gastric inflammation,CID000003333,felodipine,CCOC(=O)C1=C(NC(=C(C1C2=C(C(=CC=C2)Cl)Cl)C(=O)OC)C)C
CID000002658,3-(carbamoyloxymethyl)-7-[[2-(furan-2-yl)-2-methoxyiminoacetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate,CON=C(C1=CC=CO1)C(=O)NC2C3N(C2=O)C(=C(CS3)COC(=O)N)C(=O)[O-],cholecystitis,CID000002818,"3-chloro-6-(4-methylpiperazin-1-yl)-5H-benzo[b][1,4]benzodiazepine",CN1CCN(CC1)C2=C3C=CC=CC3=NC4=C(N2)C=C(C=C4)Cl
CID000002658,3-(carbamoyloxymethyl)-7-[[2-(furan-2-yl)-2-methoxyiminoacetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate,CON=C(C1=CC=CO1)C(=O)NC2C3N(C2=O)C(=C(CS3)COC(=O)N)C(=O)[O-],haemorrhage intracranial,CID000036339,Etomidate,CCOC(=O)C1=CN=CN1C(C)C2=CC=CC=C2
CID000002658,3-(carbamoyloxymethyl)-7-[[2-(furan-2-yl)-2-methoxyiminoacetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate,CON=C(C1=CC=CO1)C(=O)NC2C3N(C2=O)C(=C(CS3)COC(=O)N)C(=O)[O-],loss of weight,CID000004614,oxaprozin,C1=CC=C(C=C1)C2=C(OC(=N2)CCC(=O)O)C3=CC=CC=C3
CID000002658,3-(carbamoyloxymethyl)-7-[[2-(furan-2-yl)-2-methoxyiminoacetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate,CON=C(C1=CC=CO1)C(=O)NC2C3N(C2=O)C(=C(CS3)COC(=O)N)C(=O)[O-],gastric inflammation,CID000003075,"2-[3-acetyloxy-2-(4-methoxyphenyl)-4-oxo-2,3-dihydro-1,5-benzothiazepin-5-yl]ethyl-dimethylazanium",CC(=O)OC1C(SC2=CC=CC=C2N(C1=O)CC[NH+](C)C)C3=CC=C(C=C3)OC
CID000002658,3-(carbamoyloxymethyl)-7-[[2-(furan-2-yl)-2-methoxyiminoacetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate,CON=C(C1=CC=CO1)C(=O)NC2C3N(C2=O)C(=C(CS3)COC(=O)N)C(=O)[O-],cholecystitis,CID000004691,"3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine",C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4
CID000002658,3-(carbamoyloxymethyl)-7-[[2-(furan-2-yl)-2-methoxyiminoacetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate,CON=C(C1=CC=CO1)C(=O)NC2C3N(C2=O)C(=C(CS3)COC(=O)N)C(=O)[O-],Adenopathy,CID000003961,losartan,CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)CO)Cl
CID000002658,3-(carbamoyloxymethyl)-7-[[2-(furan-2-yl)-2-methoxyiminoacetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate,CON=C(C1=CC=CO1)C(=O)NC2C3N(C2=O)C(=C(CS3)COC(=O)N)C(=O)[O-],bursitis,CID000002891,"cobalt(2+);[5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] 1-[3-[2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2,7,12,17-tetrahydro-1H-corrin-21-id-3-yl]propanoylamino]propan-2-yl hydrogen phosphate;cyanide",CC1=CC2=C(C=C1C)N(C=N2)C3C(C(C(O3)CO)OP(=O)(O)OC(C)CNC(=O)CCC4(C(C5C6(C(C(C(=N6)C(=C7C(C(C(=N7)C=C8C(C(C(=N8)C(=C4[N-]5)C)CCC(=O)N)(C)C)CCC(=O)N)(C)CC(=O)N)C)CCC(=O)N)(C)CC(=O)N)C)CC(=O)N)C)O.[C-]#N.[Co+2]
CID000002658,3-(carbamoyloxymethyl)-7-[[2-(furan-2-yl)-2-methoxyiminoacetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate,CON=C(C1=CC=CO1)C(=O)NC2C3N(C2=O)C(=C(CS3)COC(=O)N)C(=O)[O-],confusion,CID005381226,"[(7S,9E,11S,12R,13S,14R,15R,16R,17S,18S,19E,21Z,26E)-2,15,17,29-tetrahydroxy-11-methoxy-3,7,12,14,16,18,22-heptamethyl-26-[[(4-methylpiperazin-1-yl)amino]methylidene]-6,23,27-trioxo-8,30-dioxa-24-azatetracyclo[23.3.1.14,7.05,28]triaconta-1(28),2,4,9,19,21,25(29)-heptaen-13-yl] acetate",CC1C=CC=C(C(=O)NC2=C(C3=C(C4=C(C(=C3O)C)OC(C4=O)(OC=CC(C(C(C(C(C(C1O)C)O)C)OC(=O)C)C)OC)C)C(=O)C2=CNN5CCN(CC5)C)O)C
CID000002658,3-(carbamoyloxymethyl)-7-[[2-(furan-2-yl)-2-methoxyiminoacetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate,CON=C(C1=CC=CO1)C(=O)NC2C3N(C2=O)C(=C(CS3)COC(=O)N)C(=O)[O-],erythema,CID000004107,methocarbamol,COC1=CC=CC=C1OCC(COC(=O)N)O
CID000002658,3-(carbamoyloxymethyl)-7-[[2-(furan-2-yl)-2-methoxyiminoacetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate,CON=C(C1=CC=CO1)C(=O)NC2C3N(C2=O)C(=C(CS3)COC(=O)N)C(=O)[O-],corneal degeneration,CID000005478,racemic-Timolol,CC(C)(C)NCC(COC1=NSN=C1N2CCOCC2)O
CID000002658,3-(carbamoyloxymethyl)-7-[[2-(furan-2-yl)-2-methoxyiminoacetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate,CON=C(C1=CC=CO1)C(=O)NC2C3N(C2=O)C(=C(CS3)COC(=O)N)C(=O)[O-],Sinus headache,CID000003676,lidocaine,CCN(CC)CC(=O)NC1=C(C=CC=C1C)C
CID000002658,3-(carbamoyloxymethyl)-7-[[2-(furan-2-yl)-2-methoxyiminoacetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate,CON=C(C1=CC=CO1)C(=O)NC2C3N(C2=O)C(=C(CS3)COC(=O)N)C(=O)[O-],cholecystitis,CID000003883,lansoprazole,CC1=C(C=CN=C1CS(=O)C2=NC3=CC=CC=C3N2)OCC(F)(F)F
CID000002658,3-(carbamoyloxymethyl)-7-[[2-(furan-2-yl)-2-methoxyiminoacetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate,CON=C(C1=CC=CO1)C(=O)NC2C3N(C2=O)C(=C(CS3)COC(=O)N)C(=O)[O-],thrombocytopenia,CID000060184,"2'-epi-Perindopril, (2'R)-",CCCC(C(=O)OCC)NC(C)C(=O)N1C2CCCCC2CC1C(=O)O
CID000002658,3-(carbamoyloxymethyl)-7-[[2-(furan-2-yl)-2-methoxyiminoacetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate,CON=C(C1=CC=CO1)C(=O)NC2C3N(C2=O)C(=C(CS3)COC(=O)N)C(=O)[O-],arterial pressure NOS increased,CID000005584,trimipramine,CC(CN1C2=CC=CC=C2CCC3=CC=CC=C31)CN(C)C
CID000002658,3-(carbamoyloxymethyl)-7-[[2-(furan-2-yl)-2-methoxyiminoacetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate,CON=C(C1=CC=CO1)C(=O)NC2C3N(C2=O)C(=C(CS3)COC(=O)N)C(=O)[O-],gastric inflammation,CID000003405,2-[[4-[(2-amino-4-oxo-1H-pteridin-6-yl)methylamino]benzoyl]amino]pentanedioic acid,C1=CC(=CC=C1C(=O)NC(CCC(=O)O)C(=O)O)NCC2=CN=C3C(=N2)C(=O)N=C(N3)N
CID000002658,3-(carbamoyloxymethyl)-7-[[2-(furan-2-yl)-2-methoxyiminoacetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate,CON=C(C1=CC=CO1)C(=O)NC2C3N(C2=O)C(=C(CS3)COC(=O)N)C(=O)[O-],confusion,CID000004666,7-Epi Paclitaxel,CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C
CID000002658,3-(carbamoyloxymethyl)-7-[[2-(furan-2-yl)-2-methoxyiminoacetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate,CON=C(C1=CC=CO1)C(=O)NC2C3N(C2=O)C(=C(CS3)COC(=O)N)C(=O)[O-],gastric inflammation,CID000005732,zolpidem,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C
CID000002658,3-(carbamoyloxymethyl)-7-[[2-(furan-2-yl)-2-methoxyiminoacetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate,CON=C(C1=CC=CO1)C(=O)NC2C3N(C2=O)C(=C(CS3)COC(=O)N)C(=O)[O-],constipated,CID000005073,risperidone,CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F
CID000002658,3-(carbamoyloxymethyl)-7-[[2-(furan-2-yl)-2-methoxyiminoacetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate,CON=C(C1=CC=CO1)C(=O)NC2C3N(C2=O)C(=C(CS3)COC(=O)N)C(=O)[O-],adenitis,CID000005076,162990-01-4,CC(C)C1=NC(=CS1)CN(C)C(=O)NC(C(C)C)C(=O)NC(CC2=CC=CC=C2)CC(C(CC3=CC=CC=C3)NC(=O)OCC4=CN=CS4)O
CID000002658,3-(carbamoyloxymethyl)-7-[[2-(furan-2-yl)-2-methoxyiminoacetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate,CON=C(C1=CC=CO1)C(=O)NC2C3N(C2=O)C(=C(CS3)COC(=O)N)C(=O)[O-],bursitis,CID000004920,"1-acetyl-9a,11a-dimethyl-1H,2H,3H,3aH,3bH,4H,5H,7H,8H,9H,9aH,9bH,10H,11H,11aH-cyclopenta[a]phenanthren-7-one",CC(=O)C1CCC2C1(CCC3C2CCC4=CC(=O)CCC34C)C
CID000002658,3-(carbamoyloxymethyl)-7-[[2-(furan-2-yl)-2-methoxyiminoacetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate,CON=C(C1=CC=CO1)C(=O)NC2C3N(C2=O)C(=C(CS3)COC(=O)N)C(=O)[O-],rotator cuff syndrome,CID000004236,modafinil,C1=CC=C(C=C1)C(C2=CC=CC=C2)S(=O)CC(=O)N
CID000002658,3-(carbamoyloxymethyl)-7-[[2-(furan-2-yl)-2-methoxyiminoacetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate,CON=C(C1=CC=CO1)C(=O)NC2C3N(C2=O)C(=C(CS3)COC(=O)N)C(=O)[O-],cholecystitis,CID000003937,N~2~-(1-carboxy-3-phenylpropyl)lysylproline,C1CC(N(C1)C(=O)C(CCCCN)NC(CCC2=CC=CC=C2)C(=O)O)C(=O)O
CID000002658,3-(carbamoyloxymethyl)-7-[[2-(furan-2-yl)-2-methoxyiminoacetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate,CON=C(C1=CC=CO1)C(=O)NC2C3N(C2=O)C(=C(CS3)COC(=O)N)C(=O)[O-],gastric inflammation,CID000002662,celecoxib,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F
CID000002658,3-(carbamoyloxymethyl)-7-[[2-(furan-2-yl)-2-methoxyiminoacetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate,CON=C(C1=CC=CO1)C(=O)NC2C3N(C2=O)C(=C(CS3)COC(=O)N)C(=O)[O-],cholecystitis,CID000004173,metronidazole,CC1=NC=C(N1CCO)[N+](=O)[O-]
CID000002658,3-(carbamoyloxymethyl)-7-[[2-(furan-2-yl)-2-methoxyiminoacetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate,CON=C(C1=CC=CO1)C(=O)NC2C3N(C2=O)C(=C(CS3)COC(=O)N)C(=O)[O-],Dyspnea exertional,CID000003780,"D-Glucitol, 1,4:3,6-dianhydro-, 2,5-dinitrate",C1C(C2C(O1)C(CO2)O[N+](=O)[O-])O[N+](=O)[O-]
CID000002658,3-(carbamoyloxymethyl)-7-[[2-(furan-2-yl)-2-methoxyiminoacetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate,CON=C(C1=CC=CO1)C(=O)NC2C3N(C2=O)C(=C(CS3)COC(=O)N)C(=O)[O-],gastric inflammation,CID000004894,"11,17,21-Trihydroxypregna-1,4-diene-3,20-dione",CC12CC(C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C)O
CID000002658,3-(carbamoyloxymethyl)-7-[[2-(furan-2-yl)-2-methoxyiminoacetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate,CON=C(C1=CC=CO1)C(=O)NC2C3N(C2=O)C(=C(CS3)COC(=O)N)C(=O)[O-],gastric inflammation,CID000087177,"D-Fructose, 4-O-alpha-D-glucopyranosyl-",C(C1C(C(C(C(O1)OC(C(CO)O)C(C(=O)CO)O)O)O)O)O
CID000002658,3-(carbamoyloxymethyl)-7-[[2-(furan-2-yl)-2-methoxyiminoacetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate,CON=C(C1=CC=CO1)C(=O)NC2C3N(C2=O)C(=C(CS3)COC(=O)N)C(=O)[O-],Bleeding,CID000004463,nevirapine,CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4
CID000002658,3-(carbamoyloxymethyl)-7-[[2-(furan-2-yl)-2-methoxyiminoacetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate,CON=C(C1=CC=CO1)C(=O)NC2C3N(C2=O)C(=C(CS3)COC(=O)N)C(=O)[O-],cholecystitis,CID000004585,"2-methyl-4-(4-methylpiperazin-1-yl)-5H-thieno[3,2-c][1,5]benzodiazepine",CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C
CID000002658,3-(carbamoyloxymethyl)-7-[[2-(furan-2-yl)-2-methoxyiminoacetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate,CON=C(C1=CC=CO1)C(=O)NC2C3N(C2=O)C(=C(CS3)COC(=O)N)C(=O)[O-],gastric inflammation,CID000060865,(E)-Olopatadine,CN(C)CCC=C1C2=CC=CC=C2COC3=C1C=C(C=C3)CC(=O)O
CID000002658,3-(carbamoyloxymethyl)-7-[[2-(furan-2-yl)-2-methoxyiminoacetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate,CON=C(C1=CC=CO1)C(=O)NC2C3N(C2=O)C(=C(CS3)COC(=O)N)C(=O)[O-],gastric inflammation,CID000008953,sodium;hydrogen carbonate,C(=O)(O)[O-].[Na+]
CID000002658,3-(carbamoyloxymethyl)-7-[[2-(furan-2-yl)-2-methoxyiminoacetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate,CON=C(C1=CC=CO1)C(=O)NC2C3N(C2=O)C(=C(CS3)COC(=O)N)C(=O)[O-],cholecystitis,CID000004205,mirtazapine,CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4
CID000002658,3-(carbamoyloxymethyl)-7-[[2-(furan-2-yl)-2-methoxyiminoacetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate,CON=C(C1=CC=CO1)C(=O)NC2C3N(C2=O)C(=C(CS3)COC(=O)N)C(=O)[O-],rotator cuff syndrome,CID000005152,Salmeterol,C1=CC=C(C=C1)CCCCOCCCCCCNCC(C2=CC(=C(C=C2)O)CO)O
CID000002658,3-(carbamoyloxymethyl)-7-[[2-(furan-2-yl)-2-methoxyiminoacetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate,CON=C(C1=CC=CO1)C(=O)NC2C3N(C2=O)C(=C(CS3)COC(=O)N)C(=O)[O-],gastric inflammation,CID000003658,hydroxyzine,C1CN(CCN1CCOCCO)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl
CID000002658,3-(carbamoyloxymethyl)-7-[[2-(furan-2-yl)-2-methoxyiminoacetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate,CON=C(C1=CC=CO1)C(=O)NC2C3N(C2=O)C(=C(CS3)COC(=O)N)C(=O)[O-],portal hypertension,CID000027686,CHEMBL4088679,C1=CC2=C(C(=C1)OCC(COC3=CC4=C(C=C3)OC(=CC4=O)C(=O)O)O)C(=O)C=C(O2)C(=O)O
CID000002658,3-(carbamoyloxymethyl)-7-[[2-(furan-2-yl)-2-methoxyiminoacetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate,CON=C(C1=CC=CO1)C(=O)NC2C3N(C2=O)C(=C(CS3)COC(=O)N)C(=O)[O-],bursitis,CID000003325,famotidine,C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N
CID000002658,3-(carbamoyloxymethyl)-7-[[2-(furan-2-yl)-2-methoxyiminoacetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate,CON=C(C1=CC=CO1)C(=O)NC2C3N(C2=O)C(=C(CS3)COC(=O)N)C(=O)[O-],gastric inflammation,CID000002803,clonidine,C1CN=C(N1)NC2=C(C=CC=C2Cl)Cl
CID000002658,3-(carbamoyloxymethyl)-7-[[2-(furan-2-yl)-2-methoxyiminoacetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate,CON=C(C1=CC=CO1)C(=O)NC2C3N(C2=O)C(=C(CS3)COC(=O)N)C(=O)[O-],gastric inflammation,CID000002806,90055-48-4,COC(=O)C(C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3
CID000002658,3-(carbamoyloxymethyl)-7-[[2-(furan-2-yl)-2-methoxyiminoacetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate,CON=C(C1=CC=CO1)C(=O)NC2C3N(C2=O)C(=C(CS3)COC(=O)N)C(=O)[O-],cholecystitis,CID000002771,citalopram,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F
CID000002658,3-(carbamoyloxymethyl)-7-[[2-(furan-2-yl)-2-methoxyiminoacetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate,CON=C(C1=CC=CO1)C(=O)NC2C3N(C2=O)C(=C(CS3)COC(=O)N)C(=O)[O-],bursitis,CID000004601,orphenadrine,CC1=CC=CC=C1C(C2=CC=CC=C2)OCCN(C)C
CID000002658,3-(carbamoyloxymethyl)-7-[[2-(furan-2-yl)-2-methoxyiminoacetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate,CON=C(C1=CC=CO1)C(=O)NC2C3N(C2=O)C(=C(CS3)COC(=O)N)C(=O)[O-],bursitis,CID000005719,zaleplon,CCN(C1=CC=CC(=C1)C2=CC=NC3=C(C=NN23)C#N)C(=O)C
CID000002658,3-(carbamoyloxymethyl)-7-[[2-(furan-2-yl)-2-methoxyiminoacetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate,CON=C(C1=CC=CO1)C(=O)NC2C3N(C2=O)C(=C(CS3)COC(=O)N)C(=O)[O-],cholecystitis,CID000005523,Ultram,CN(C)CC1CCCCC1(C2=CC(=CC=C2)OC)O
CID000002658,3-(carbamoyloxymethyl)-7-[[2-(furan-2-yl)-2-methoxyiminoacetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate,CON=C(C1=CC=CO1)C(=O)NC2C3N(C2=O)C(=C(CS3)COC(=O)N)C(=O)[O-],gastric inflammation,CID000054454,simvastatin,CCC(C)(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C
CID000002658,3-(carbamoyloxymethyl)-7-[[2-(furan-2-yl)-2-methoxyiminoacetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate,CON=C(C1=CC=CO1)C(=O)NC2C3N(C2=O)C(=C(CS3)COC(=O)N)C(=O)[O-],erythema,CID000005978,vincristine,CCC1(CC2CC(C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)C78CCN9C7C(C=CC9)(C(C(C8N6C=O)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O
CID000002658,3-(carbamoyloxymethyl)-7-[[2-(furan-2-yl)-2-methoxyiminoacetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate,CON=C(C1=CC=CO1)C(=O)NC2C3N(C2=O)C(=C(CS3)COC(=O)N)C(=O)[O-],gastric inflammation,CID000003516,guaifenesin,COC1=CC=CC=C1OCC(CO)O
CID000002658,3-(carbamoyloxymethyl)-7-[[2-(furan-2-yl)-2-methoxyiminoacetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate,CON=C(C1=CC=CO1)C(=O)NC2C3N(C2=O)C(=C(CS3)COC(=O)N)C(=O)[O-],Amnesia,CID000051263,ALFENTANIL,CCC(=O)N(C1=CC=CC=C1)C2(CCN(CC2)CCN3C(=O)N(N=N3)CC)COC
CID000002658,3-(carbamoyloxymethyl)-7-[[2-(furan-2-yl)-2-methoxyiminoacetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate,CON=C(C1=CC=CO1)C(=O)NC2C3N(C2=O)C(=C(CS3)COC(=O)N)C(=O)[O-],cholecystitis,CID000005391,temazepam,CN1C2=C(C=C(C=C2)Cl)C(=NC(C1=O)O)C3=CC=CC=C3
CID000002658,3-(carbamoyloxymethyl)-7-[[2-(furan-2-yl)-2-methoxyiminoacetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate,CON=C(C1=CC=CO1)C(=O)NC2C3N(C2=O)C(=C(CS3)COC(=O)N)C(=O)[O-],loss of weight,CID000003890,TRANS (15S)-LATANOPROST,CC(C)OC(=O)CCCC=CCC1C(CC(C1CCC(CCC2=CC=CC=C2)O)O)O
CID000002658,3-(carbamoyloxymethyl)-7-[[2-(furan-2-yl)-2-methoxyiminoacetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate,CON=C(C1=CC=CO1)C(=O)NC2C3N(C2=O)C(=C(CS3)COC(=O)N)C(=O)[O-],hepatitis,CID000003410,formoterol,CC(CC1=CC=C(C=C1)OC)NCC(C2=CC(=C(C=C2)O)NC=O)O
CID000002658,3-(carbamoyloxymethyl)-7-[[2-(furan-2-yl)-2-methoxyiminoacetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate,CON=C(C1=CC=CO1)C(=O)NC2C3N(C2=O)C(=C(CS3)COC(=O)N)C(=O)[O-],apoplexy,CID000110635,Tadalafil,CN1CC(=O)N2C(C1=O)CC3=C(C2C4=CC5=C(C=C4)OCO5)NC6=CC=CC=C36
CID000002658,3-(carbamoyloxymethyl)-7-[[2-(furan-2-yl)-2-methoxyiminoacetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate,CON=C(C1=CC=CO1)C(=O)NC2C3N(C2=O)C(=C(CS3)COC(=O)N)C(=O)[O-],cholecystitis,CID000062924,"S-(fluoromethyl) (6S,9R,10S,11S,13S,14S,16R,17R)-6,9-difluoro-11,17-dihydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthrene-17-carbothioate",CC1CC2C3CC(C4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)SCF)O)C)O)F)C)F
CID000002658,3-(carbamoyloxymethyl)-7-[[2-(furan-2-yl)-2-methoxyiminoacetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate,CON=C(C1=CC=CO1)C(=O)NC2C3N(C2=O)C(=C(CS3)COC(=O)N)C(=O)[O-],lung infiltration,CID000071616,Voriconazole,CC(C1=NC=NC=C1F)C(CN2C=NC=N2)(C3=C(C=C(C=C3)F)F)O
CID000002658,3-(carbamoyloxymethyl)-7-[[2-(furan-2-yl)-2-methoxyiminoacetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate,CON=C(C1=CC=CO1)C(=O)NC2C3N(C2=O)C(=C(CS3)COC(=O)N)C(=O)[O-],erythema,CID003468412,SCHEMBL1176571,CC1C=CC=CCCC=CC=CC=CC=CC(CC(C(C(CC(=O)CC(C(CCC(CC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)C(=O)O)O)OC2C(C(C(C(O2)C)O)N)O
CID000002658,3-(carbamoyloxymethyl)-7-[[2-(furan-2-yl)-2-methoxyiminoacetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate,CON=C(C1=CC=CO1)C(=O)NC2C3N(C2=O)C(=C(CS3)COC(=O)N)C(=O)[O-],ADH inappropriate,CID000002951,dantrolene(1-),C1C(=NC(=O)N1N=CC2=CC=C(O2)C3=CC=C(C=C3)[N+](=O)[O-])[O-]
CID000002658,3-(carbamoyloxymethyl)-7-[[2-(furan-2-yl)-2-methoxyiminoacetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate,CON=C(C1=CC=CO1)C(=O)NC2C3N(C2=O)C(=C(CS3)COC(=O)N)C(=O)[O-],erythema,CID000003928,Lincomycine,CCCC1CC(N(C1)C)C(=O)NC(C2C(C(C(C(O2)SC)O)O)O)C(C)O
CID000002658,3-(carbamoyloxymethyl)-7-[[2-(furan-2-yl)-2-methoxyiminoacetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate,CON=C(C1=CC=CO1)C(=O)NC2C3N(C2=O)C(=C(CS3)COC(=O)N)C(=O)[O-],Bleeding,CID000039765,Vecuronium,CC(=O)OC1CC2CCC3C(C2(CC1N4CCCCC4)C)CCC5(C3CC(C5OC(=O)C)[N+]6(CCCCC6)C)C
CID000002658,3-(carbamoyloxymethyl)-7-[[2-(furan-2-yl)-2-methoxyiminoacetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate,CON=C(C1=CC=CO1)C(=O)NC2C3N(C2=O)C(=C(CS3)COC(=O)N)C(=O)[O-],Drug hypersensitivity,CID005311048,SCHEMBL11440306,C(N)(N)(Cl)Cl
CID000002658,3-(carbamoyloxymethyl)-7-[[2-(furan-2-yl)-2-methoxyiminoacetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate,CON=C(C1=CC=CO1)C(=O)NC2C3N(C2=O)C(=C(CS3)COC(=O)N)C(=O)[O-],gastric inflammation,CID000003440,furosemide,C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl
CID000002658,3-(carbamoyloxymethyl)-7-[[2-(furan-2-yl)-2-methoxyiminoacetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate,CON=C(C1=CC=CO1)C(=O)NC2C3N(C2=O)C(=C(CS3)COC(=O)N)C(=O)[O-],dermatitides,CID000160051,Colesevelam,CCCCCCCCCCNCC=C.C[N+](C)(C)CCCCCCNCC=C.C=CCN.C1C(O1)CCl.Cl.[Cl-]
CID000002658,3-(carbamoyloxymethyl)-7-[[2-(furan-2-yl)-2-methoxyiminoacetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate,CON=C(C1=CC=CO1)C(=O)NC2C3N(C2=O)C(=C(CS3)COC(=O)N)C(=O)[O-],Bleeding,CID000005771,Oxytocin acetate salt hydrate,CCC(C)C1C(=O)NC(C(=O)NC(C(=O)NC(CSSCC(C(=O)NC(C(=O)N1)CC2=CC=C(C=C2)O)N)C(=O)N3CCCC3C(=O)NC(CC(C)C)C(=O)NCC(=O)N)CC(=O)N)CCC(=O)N
CID000002658,3-(carbamoyloxymethyl)-7-[[2-(furan-2-yl)-2-methoxyiminoacetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate,CON=C(C1=CC=CO1)C(=O)NC2C3N(C2=O)C(=C(CS3)COC(=O)N)C(=O)[O-],gastric inflammation,CID000003345,fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3
CID000003154,120280-13-9,CCNC1CC(S(=O)(=O)C2=C1C=C(S2)S(=O)(=O)N)C,apoplexy,CID000003883,lansoprazole,CC1=C(C=CN=C1CS(=O)C2=NC3=CC=CC=C3N2)OCC(F)(F)F
CID000003154,120280-13-9,CCNC1CC(S(=O)(=O)C2=C1C=C(S2)S(=O)(=O)N)C,gout,CID000004894,"11,17,21-Trihydroxypregna-1,4-diene-3,20-dione",CC12CC(C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C)O
CID000003154,120280-13-9,CCNC1CC(S(=O)(=O)C2=C1C=C(S2)S(=O)(=O)N)C,erythema,CID000004585,"2-methyl-4-(4-methylpiperazin-1-yl)-5H-thieno[3,2-c][1,5]benzodiazepine",CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C
CID000003154,120280-13-9,CCNC1CC(S(=O)(=O)C2=C1C=C(S2)S(=O)(=O)N)C,colitis ischemic,CID000003937,N~2~-(1-carboxy-3-phenylpropyl)lysylproline,C1CC(N(C1)C(=O)C(CCCCN)NC(CCC2=CC=CC=C2)C(=O)O)C(=O)O
CID000003154,120280-13-9,CCNC1CC(S(=O)(=O)C2=C1C=C(S2)S(=O)(=O)N)C,apoplexy,CID000005512,124936-74-9,CC1=CC(=C(C=C1)O)C(CCN(C(C)C)C(C)C)C2=CC=CC=C2
CID000003154,120280-13-9,CCNC1CC(S(=O)(=O)C2=C1C=C(S2)S(=O)(=O)N)C,apoplexy,CID000004819,"2(3H)-Furanone, 3-ethyldihydro-4-[(1-methyl-1H-imidazol-5-yl)methyl]-, (3S-cis)-",CCC1C(COC1=O)CC2=CN=CN2C
CID000003154,120280-13-9,CCNC1CC(S(=O)(=O)C2=C1C=C(S2)S(=O)(=O)N)C,failure to thrive,CID000004205,mirtazapine,CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4
CID000003154,120280-13-9,CCNC1CC(S(=O)(=O)C2=C1C=C(S2)S(=O)(=O)N)C,gout,CID000004510,nitroglycerin,C(C(CO[N+](=O)[O-])O[N+](=O)[O-])O[N+](=O)[O-]
CID000003154,120280-13-9,CCNC1CC(S(=O)(=O)C2=C1C=C(S2)S(=O)(=O)N)C,weight gain,CID000019090,megestrol,CC1=CC2C(CCC3(C2CCC3(C(=O)C)O)C)C4(C1=CC(=O)CC4)C
CID000003154,120280-13-9,CCNC1CC(S(=O)(=O)C2=C1C=C(S2)S(=O)(=O)N)C,Adenopathy,CID000004679,pantoprazole,COC1=C(C(=NC=C1)CS(=O)C2=NC3=C(N2)C=C(C=C3)OC(F)F)OC
CID000003154,120280-13-9,CCNC1CC(S(=O)(=O)C2=C1C=C(S2)S(=O)(=O)N)C,glaucoma,CID000005544,Mycolog,CC12CC(C3(C(C1CC(C2(C(=O)CO)O)O)CCC4=CC(=O)C=CC43C)F)O
CID000003154,120280-13-9,CCNC1CC(S(=O)(=O)C2=C1C=C(S2)S(=O)(=O)N)C,Adenopathy,CID000003958,lorazepam,C1=CC=C(C(=C1)C2=NC(C(=O)NC3=C2C=C(C=C3)Cl)O)Cl
CID000003154,120280-13-9,CCNC1CC(S(=O)(=O)C2=C1C=C(S2)S(=O)(=O)N)C,Adenopathy,CID000077999,rosiglitazone,CN(CCOC1=CC=C(C=C1)CC2C(=O)NC(=O)S2)C3=CC=CC=N3
CID000003154,120280-13-9,CCNC1CC(S(=O)(=O)C2=C1C=C(S2)S(=O)(=O)N)C,apoplexy,CID000005732,zolpidem,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C
CID000003154,120280-13-9,CCNC1CC(S(=O)(=O)C2=C1C=C(S2)S(=O)(=O)N)C,thrombocytopenia,CID000003676,lidocaine,CCN(CC)CC(=O)NC1=C(C=CC=C1C)C
CID000003154,120280-13-9,CCNC1CC(S(=O)(=O)C2=C1C=C(S2)S(=O)(=O)N)C,loss of weight,CID000003339,fenofibrate,CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C2=CC=C(C=C2)Cl
CID000003154,120280-13-9,CCNC1CC(S(=O)(=O)C2=C1C=C(S2)S(=O)(=O)N)C,haemorrhage rectum,CID000003333,felodipine,CCOC(=O)C1=C(NC(=C(C1C2=C(C(=CC=C2)Cl)Cl)C(=O)OC)C)C
CID000003154,120280-13-9,CCNC1CC(S(=O)(=O)C2=C1C=C(S2)S(=O)(=O)N)C,haematoma,CID000004927,promethazine,CC(CN1C2=CC=CC=C2SC3=CC=CC=C31)N(C)C
CID000003154,120280-13-9,CCNC1CC(S(=O)(=O)C2=C1C=C(S2)S(=O)(=O)N)C,gastric inflammation,CID000003890,TRANS (15S)-LATANOPROST,CC(C)OC(=O)CCCC=CCC1C(CC(C1CCC(CCC2=CC=CC=C2)O)O)O
CID000003154,120280-13-9,CCNC1CC(S(=O)(=O)C2=C1C=C(S2)S(=O)(=O)N)C,gastric inflammation,CID000004889,Pravastatin Impurity A,CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC(CC(CC(=O)O)O)O)O
CID000003154,120280-13-9,CCNC1CC(S(=O)(=O)C2=C1C=C(S2)S(=O)(=O)N)C,abnormal ECG,CID000003345,fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3
CID000003154,120280-13-9,CCNC1CC(S(=O)(=O)C2=C1C=C(S2)S(=O)(=O)N)C,thrombocytopenia,CID000003658,hydroxyzine,C1CN(CCN1CCOCCO)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl
CID000003154,120280-13-9,CCNC1CC(S(=O)(=O)C2=C1C=C(S2)S(=O)(=O)N)C,apoplexy,CID000004691,"3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine",C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4
CID000003154,120280-13-9,CCNC1CC(S(=O)(=O)C2=C1C=C(S2)S(=O)(=O)N)C,aspiration pneumonia,CID000004054,memantine,CC12CC3CC(C1)(CC(C3)(C2)N)C
CID000003154,120280-13-9,CCNC1CC(S(=O)(=O)C2=C1C=C(S2)S(=O)(=O)N)C,apoplexy,CID000005073,risperidone,CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F
CID000003154,120280-13-9,CCNC1CC(S(=O)(=O)C2=C1C=C(S2)S(=O)(=O)N)C,Difficulty breathing,CID003468412,SCHEMBL1176571,CC1C=CC=CCCC=CC=CC=CC=CC(CC(C(C(CC(=O)CC(C(CCC(CC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)C(=O)O)O)OC2C(C(C(C(O2)C)O)N)O
CID000003154,120280-13-9,CCNC1CC(S(=O)(=O)C2=C1C=C(S2)S(=O)(=O)N)C,dry skin,CID000060852,Ibandronic Acid,CCCCCN(C)CCC(O)(P(=O)(O)O)P(=O)(O)O
CID000003154,120280-13-9,CCNC1CC(S(=O)(=O)C2=C1C=C(S2)S(=O)(=O)N)C,gastric inflammation,CID000005478,racemic-Timolol,CC(C)(C)NCC(COC1=NSN=C1N2CCOCC2)O
CID000003154,120280-13-9,CCNC1CC(S(=O)(=O)C2=C1C=C(S2)S(=O)(=O)N)C,thrombocytopenia,CID000038904,Carboplatinum,C1CC(C1)(C(=O)O)C(=O)O.N.N.[Pt]
CID000003154,120280-13-9,CCNC1CC(S(=O)(=O)C2=C1C=C(S2)S(=O)(=O)N)C,ear ache,CID000003440,furosemide,C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl
CID000003154,120280-13-9,CCNC1CC(S(=O)(=O)C2=C1C=C(S2)S(=O)(=O)N)C,loss of weight,CID000003449,Epigalanthamin,CN1CCC23C=CC(CC2OC4=C(C=CC(=C34)C1)OC)O
CID000003154,120280-13-9,CCNC1CC(S(=O)(=O)C2=C1C=C(S2)S(=O)(=O)N)C,cholecystitis,CID000054454,simvastatin,CCC(C)(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C
CID000003154,120280-13-9,CCNC1CC(S(=O)(=O)C2=C1C=C(S2)S(=O)(=O)N)C,deglutition disorder,CID000005095,ropinirole,CCCN(CCC)CCC1=C2CC(=O)NC2=CC=C1
CID000003154,120280-13-9,CCNC1CC(S(=O)(=O)C2=C1C=C(S2)S(=O)(=O)N)C,Adenopathy,CID000004666,7-Epi Paclitaxel,CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C
CID000003154,120280-13-9,CCNC1CC(S(=O)(=O)C2=C1C=C(S2)S(=O)(=O)N)C,increased white blood cell count,CID000003325,famotidine,C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N
CID000003154,120280-13-9,CCNC1CC(S(=O)(=O)C2=C1C=C(S2)S(=O)(=O)N)C,Adenopathy,CID000003405,2-[[4-[(2-amino-4-oxo-1H-pteridin-6-yl)methylamino]benzoyl]amino]pentanedioic acid,C1=CC(=CC=C1C(=O)NC(CCC(=O)O)C(=O)O)NCC2=CN=C3C(=N2)C(=O)N=C(N3)N
CID000003154,120280-13-9,CCNC1CC(S(=O)(=O)C2=C1C=C(S2)S(=O)(=O)N)C,loss of weight,CID000170361,Varenicline,C1C2CNCC1C3=CC4=NC=CN=C4C=C23
CID000003154,120280-13-9,CCNC1CC(S(=O)(=O)C2=C1C=C(S2)S(=O)(=O)N)C,gastric inflammation,CID000004900,Fernisone,CC12CC(=O)C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C
CID000003154,120280-13-9,CCNC1CC(S(=O)(=O)C2=C1C=C(S2)S(=O)(=O)N)C,respiratory alkalosis,CID000062924,"S-(fluoromethyl) (6S,9R,10S,11S,13S,14S,16R,17R)-6,9-difluoro-11,17-dihydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthrene-17-carbothioate",CC1CC2C3CC(C4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)SCF)O)C)O)F)C)F
CID000003154,120280-13-9,CCNC1CC(S(=O)(=O)C2=C1C=C(S2)S(=O)(=O)N)C,leucocytosis,CID000005391,temazepam,CN1C2=C(C=C(C=C2)Cl)C(=NC(C1=O)O)C3=CC=CC=C3
CID000003154,120280-13-9,CCNC1CC(S(=O)(=O)C2=C1C=C(S2)S(=O)(=O)N)C,Adenopathy,CID000087177,"D-Fructose, 4-O-alpha-D-glucopyranosyl-",C(C1C(C(C(C(O1)OC(C(CO)O)C(C(=O)CO)O)O)O)O)O
CID000003154,120280-13-9,CCNC1CC(S(=O)(=O)C2=C1C=C(S2)S(=O)(=O)N)C,apoplexy,CID000003749,irbesartan,CCCCC1=NC2(CCCC2)C(=O)N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5
CID000003154,120280-13-9,CCNC1CC(S(=O)(=O)C2=C1C=C(S2)S(=O)(=O)N)C,eruption,CID000003954,loperamide(1+),CN(C)C(=O)C(CC[NH+]1CCC(CC1)(C2=CC=C(C=C2)Cl)O)(C3=CC=CC=C3)C4=CC=CC=C4
CID000003154,120280-13-9,CCNC1CC(S(=O)(=O)C2=C1C=C(S2)S(=O)(=O)N)C,glaucoma,CID000071329,Dofetilide,CN(CCC1=CC=C(C=C1)NS(=O)(=O)C)CCOC2=CC=C(C=C2)NS(=O)(=O)C
CID000003154,120280-13-9,CCNC1CC(S(=O)(=O)C2=C1C=C(S2)S(=O)(=O)N)C,glaucoma,CID000065999,Telmisartan,CCCC1=NC2=C(N1CC3=CC=C(C=C3)C4=CC=CC=C4C(=O)O)C=C(C=C2C)C5=NC6=CC=CC=C6N5C
CID000003154,120280-13-9,CCNC1CC(S(=O)(=O)C2=C1C=C(S2)S(=O)(=O)N)C,Bleeding,CID000003661,L-Hyoscyamine,CN1C2CCC1CC(C2)OC(=O)C(CO)C3=CC=CC=C3
CID000003154,120280-13-9,CCNC1CC(S(=O)(=O)C2=C1C=C(S2)S(=O)(=O)N)C,allergic dermatitis,CID000005245,Risedronic acid,C1=CC(=CN=C1)CC(O)(P(=O)(O)O)P(=O)(O)O
CID000003154,120280-13-9,CCNC1CC(S(=O)(=O)C2=C1C=C(S2)S(=O)(=O)N)C,glaucoma,CID000152945,Dutasteride?,CC12CCC3C(C1CCC2C(=O)NC4=C(C=CC(=C4)C(F)(F)F)C(F)(F)F)CCC5C3(C=CC(=O)N5)C
CID000003154,120280-13-9,CCNC1CC(S(=O)(=O)C2=C1C=C(S2)S(=O)(=O)N)C,gastric inflammation,CID000003961,losartan,CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)CO)Cl
CID000003154,120280-13-9,CCNC1CC(S(=O)(=O)C2=C1C=C(S2)S(=O)(=O)N)C,constipated,CID000005523,Ultram,CN(C)CC1CCCCC1(C2=CC(=CC=C2)OC)O
CID000003154,120280-13-9,CCNC1CC(S(=O)(=O)C2=C1C=C(S2)S(=O)(=O)N)C,angiitis,CID000005650,N-pentanoyl-N-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-L-valine,CCCCC(=O)N(CC1=CC=C(C=C1)C2=CC=CC=C2C3=NNN=N3)C(C(C)C)C(=O)O
CID000072938,Gemifloxacin,CON=C1CN(CC1CN)C2=C(C=C3C(=O)C(=CN(C3=N2)C4CC4)C(=O)O)F,diarrhea,CID000077999,rosiglitazone,CN(CCOC1=CC=C(C=C1)CC2C(=O)NC(=O)S2)C3=CC=CC=N3
CID000004885,104617-86-9,CCCNC1CCC2=C(C1)SC(=N2)N,nasopharyngitis,CID000004920,"1-acetyl-9a,11a-dimethyl-1H,2H,3H,3aH,3bH,4H,5H,7H,8H,9H,9aH,9bH,10H,11H,11aH-cyclopenta[a]phenanthren-7-one",CC(=O)C1CCC2C1(CCC3C2CCC4=CC(=O)CCC34C)C
CID000004885,104617-86-9,CCCNC1CCC2=C(C1)SC(=N2)N,neuropathy,CID000005645,"3,7-Dihydroxycholan-24-oic acid",CC(CCC(=O)O)C1CCC2C1(CCC3C2C(CC4C3(CCC(C4)O)C)O)C
CID000004885,104617-86-9,CCCNC1CCC2=C(C1)SC(=N2)N,loss of weight,CID000170361,Varenicline,C1C2CNCC1C3=CC4=NC=CN=C4C=C23
CID000004885,104617-86-9,CCCNC1CCC2=C(C1)SC(=N2)N,subarachnoid haemorrhage,CID000005719,zaleplon,CCN(C1=CC=CC(=C1)C2=CC=NC3=C(C=NN23)C#N)C(=O)C
CID000004885,104617-86-9,CCCNC1CCC2=C(C1)SC(=N2)N,gastric inflammation,CID000087177,"D-Fructose, 4-O-alpha-D-glucopyranosyl-",C(C1C(C(C(C(O1)OC(C(CO)O)C(C(=O)CO)O)O)O)O)O
CID000004885,104617-86-9,CCCNC1CCC2=C(C1)SC(=N2)N,Back Ache,CID000005391,temazepam,CN1C2=C(C=C(C=C2)Cl)C(=NC(C1=O)O)C3=CC=CC=C3
CID000004885,104617-86-9,CCCNC1CCC2=C(C1)SC(=N2)N,gout,CID000065999,Telmisartan,CCCC1=NC2=C(N1CC3=CC=C(C=C3)C4=CC=CC=C4C(=O)O)C=C(C=C2C)C5=NC6=CC=CC=C6N5C
CID000004885,104617-86-9,CCCNC1CCC2=C(C1)SC(=N2)N,weight gain,CID000122316,1875-50-9,C#CCNC1CCC2=CC=CC=C12
CID000004885,104617-86-9,CCCNC1CCC2=C(C1)SC(=N2)N,loss of weight,CID000005152,Salmeterol,C1=CC=C(C=C1)CCCCOCCCCCCNCC(C2=CC(=C(C=C2)O)CO)O
CID000004885,104617-86-9,CCCNC1CCC2=C(C1)SC(=N2)N,dysarthria,CID000005487,tizanidine,C1CN=C(N1)NC2=C(C=CC3=NSN=C32)Cl
CID000004885,104617-86-9,CCCNC1CCC2=C(C1)SC(=N2)N,fracture nonunion,CID000062924,"S-(fluoromethyl) (6S,9R,10S,11S,13S,14S,16R,17R)-6,9-difluoro-11,17-dihydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthrene-17-carbothioate",CC1CC2C3CC(C4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)SCF)O)C)O)F)C)F
CID000004885,104617-86-9,CCCNC1CCC2=C(C1)SC(=N2)N,weight gain,CID003468412,SCHEMBL1176571,CC1C=CC=CCCC=CC=CC=CC=CC(CC(C(C(CC(=O)CC(C(CCC(CC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)C(=O)O)O)OC2C(C(C(C(O2)C)O)N)O
CID000004885,104617-86-9,CCCNC1CCC2=C(C1)SC(=N2)N,gastric inflammation,CID000004900,Fernisone,CC12CC(=O)C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C
CID000004885,104617-86-9,CCCNC1CCC2=C(C1)SC(=N2)N,Adenopathy,CID000054454,simvastatin,CCC(C)(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C
CID000004885,104617-86-9,CCCNC1CCC2=C(C1)SC(=N2)N,gastric inflammation,CID000005245,Risedronic acid,C1=CC(=CN=C1)CC(O)(P(=O)(O)O)P(=O)(O)O
CID000004885,104617-86-9,CCCNC1CCC2=C(C1)SC(=N2)N,deglutition disorder,CID005311048,SCHEMBL11440306,C(N)(N)(Cl)Cl
CID000004885,104617-86-9,CCCNC1CCC2=C(C1)SC(=N2)N,apoplexy,CID000057537,92206-54-7,CCCN(CCC1=CC=CS1)C2CCC3=C(C2)C=CC=C3O
CID000004885,104617-86-9,CCCNC1CCC2=C(C1)SC(=N2)N,Back Ache,CID004659568,"2-cyano-3-(3,4-dihydroxy-5-nitrophenyl)-N,N-diethylprop-2-enamide",CCN(CC)C(=O)C(=CC1=CC(=C(C(=C1)O)O)[N+](=O)[O-])C#N
CID000004885,104617-86-9,CCCNC1CCC2=C(C1)SC(=N2)N,deglutition disorder,CID000005070,riluzole,C1=CC2=C(C=C1OC(F)(F)F)SC(=N2)N
CID000004885,104617-86-9,CCCNC1CCC2=C(C1)SC(=N2)N,gastric inflammation,CID000010631,medroxyprogesterone,CC1CC2C(CCC3(C2CCC3(C(=O)C)O)C)C4(C1=CC(=O)CC4)C
CID000004885,104617-86-9,CCCNC1CCC2=C(C1)SC(=N2)N,deglutition disorder,CID000152945,Dutasteride?,CC12CCC3C(C1CCC2C(=O)NC4=C(C=CC(=C4)C(F)(F)F)C(F)(F)F)CCC5C3(C=CC(=O)N5)C
CID000004885,104617-86-9,CCCNC1CCC2=C(C1)SC(=N2)N,erythema,CID000005095,ropinirole,CCCN(CCC)CCC1=C2CC(=O)NC2=CC=C1
CID000004885,104617-86-9,CCCNC1CCC2=C(C1)SC(=N2)N,enlarged spleen,CID000077999,rosiglitazone,CN(CCOC1=CC=C(C=C1)CC2C(=O)NC(=O)S2)C3=CC=CC=N3
CID000004885,104617-86-9,CCCNC1CCC2=C(C1)SC(=N2)N,subarachnoid haemorrhage,CID000005073,risperidone,CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F
CID000004885,104617-86-9,CCCNC1CCC2=C(C1)SC(=N2)N,Incontinence,CID000005077,105601-20-5,CCN(C)C(=O)OC1=CC=CC(=C1)C(C)N(C)C
CID000004885,104617-86-9,CCCNC1CCC2=C(C1)SC(=N2)N,hyperhidrosis,CID000160051,Colesevelam,CCCCCCCCCCNCC=C.C[N+](C)(C)CCCCCCNCC=C.C=CCN.C1C(O1)CCl.Cl.[Cl-]
CID000004885,104617-86-9,CCCNC1CCC2=C(C1)SC(=N2)N,thrombocytopenia,CID000038904,Carboplatinum,C1CC(C1)(C(=O)O)C(=O)O.N.N.[Pt]
CID000004885,104617-86-9,CCCNC1CCC2=C(C1)SC(=N2)N,right heart failure,CID000005732,zolpidem,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C
CID000004885,104617-86-9,CCCNC1CCC2=C(C1)SC(=N2)N,angiitis,CID000060852,Ibandronic Acid,CCCCCN(C)CCC(O)(P(=O)(O)O)P(=O)(O)O
CID000004885,104617-86-9,CCCNC1CCC2=C(C1)SC(=N2)N,loss of weight,CID000060854,Ziprasidone,C1CN(CCN1CCC2=C(C=C3C(=C2)CC(=O)N3)Cl)C4=NSC5=CC=CC=C54
CID000004885,104617-86-9,CCCNC1CCC2=C(C1)SC(=N2)N,angiitis,CID000005544,Mycolog,CC12CC(C3(C(C1CC(C2(C(=O)CO)O)O)CCC4=CC(=O)C=CC43C)F)O
CID000004885,104617-86-9,CCCNC1CCC2=C(C1)SC(=N2)N,weight gain,CID000004927,promethazine,CC(CN1C2=CC=CC=C2SC3=CC=CC=C31)N(C)C
CID000004885,104617-86-9,CCCNC1CCC2=C(C1)SC(=N2)N,loss of weight,CID000005195,Deprenyl,CC(CC1=CC=CC=C1)N(C)CC#C
CID000004885,104617-86-9,CCCNC1CCC2=C(C1)SC(=N2)N,Dyspnea exertional,CID000005523,Ultram,CN(C)CC1CCCCC1(C2=CC(=CC=C2)OC)O
CID000004885,104617-86-9,CCCNC1CCC2=C(C1)SC(=N2)N,cholecystitis,CID000005512,124936-74-9,CC1=CC(=C(C=C1)O)C(CCN(C(C)C)C(C)C)C2=CC=CC=C2
CID000004885,104617-86-9,CCCNC1CCC2=C(C1)SC(=N2)N,angiitis,CID000005358,sumatriptan,CNS(=O)(=O)CC1=CC2=C(C=C1)NC=C2CCN(C)C
CID000004885,104617-86-9,CCCNC1CCC2=C(C1)SC(=N2)N,edema,CID000004894,"11,17,21-Trihydroxypregna-1,4-diene-3,20-dione",CC12CC(C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C)O
CID000004885,104617-86-9,CCCNC1CCC2=C(C1)SC(=N2)N,loss of weight,CID000110635,Tadalafil,CN1CC(=O)N2C(C1=O)CC3=C(C2C4=CC5=C(C=C4)OCO5)NC6=CC=CC=C36
CID000004885,104617-86-9,CCCNC1CCC2=C(C1)SC(=N2)N,gastric inflammation,CID000005650,N-pentanoyl-N-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-L-valine,CCCCC(=O)N(CC1=CC=C(C=C1)C2=CC=CC=C2C3=NNN=N3)C(C(C)C)C(=O)O
CID000004885,104617-86-9,CCCNC1CCC2=C(C1)SC(=N2)N,loss of weight,CID000004909,primidone,CCC1(C(=O)NCNC1=O)C2=CC=CC=C2
CID000004885,104617-86-9,CCCNC1CCC2=C(C1)SC(=N2)N,thrombocytopenia,CID000005376,(E/Z)-Tamoxifen,CCC(=C(C1=CC=CC=C1)C2=CC=C(C=C2)OCCN(C)C)C3=CC=CC=C3
CID000004885,104617-86-9,CCCNC1CCC2=C(C1)SC(=N2)N,nasopharyngitis,CID000004889,Pravastatin Impurity A,CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC(CC(CC(=O)O)O)O)O
CID000004885,104617-86-9,CCCNC1CCC2=C(C1)SC(=N2)N,Adenopathy,CID006398525,,C(C1C(C(C(C(O1)OC2(C(C(C(O2)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)COS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.[Al].[Al].[Al].[Al].[Al].[Al].[Al].[Al].[Al]
CID000002435,brimonidine,C1CN=C(N1)NC2=C(C3=NC=CN=C3C=C2)Br,drug toxicity NOS,CID000003661,L-Hyoscyamine,CN1C2CCC1CC(C2)OC(=O)C(CO)C3=CC=CC=C3
CID000002435,brimonidine,C1CN=C(N1)NC2=C(C3=NC=CN=C3C=C2)Br,Infection Upper Respiratory,CID000004679,pantoprazole,COC1=C(C(=NC=C1)CS(=O)C2=NC3=C(N2)C=C(C=C3)OC(F)F)OC
CID000002435,brimonidine,C1CN=C(N1)NC2=C(C3=NC=CN=C3C=C2)Br,gastric inflammation,CID003468412,SCHEMBL1176571,CC1C=CC=CCCC=CC=CC=CC=CC(CC(C(C(CC(=O)CC(C(CCC(CC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)C(=O)O)O)OC2C(C(C(C(O2)C)O)N)O
CID000002435,brimonidine,C1CN=C(N1)NC2=C(C3=NC=CN=C3C=C2)Br,apoplexy,CID000002732,chlorthalidone,C1=CC=C2C(=C1)C(=O)NC2(C3=CC(=C(C=C3)Cl)S(=O)(=O)N)O
CID000002435,brimonidine,C1CN=C(N1)NC2=C(C3=NC=CN=C3C=C2)Br,apoplexy,CID000003463,gemfibrozil,CC1=CC(=C(C=C1)C)OCCCC(C)(C)C(=O)O
CID000002435,brimonidine,C1CN=C(N1)NC2=C(C3=NC=CN=C3C=C2)Br,glaucoma,CID000060852,Ibandronic Acid,CCCCCN(C)CCC(O)(P(=O)(O)O)P(=O)(O)O
CID000002435,brimonidine,C1CN=C(N1)NC2=C(C3=NC=CN=C3C=C2)Br,apoplexy,CID000060854,Ziprasidone,C1CN(CCN1CCC2=C(C=C3C(=C2)CC(=O)N3)Cl)C4=NSC5=CC=CC=C54
CID000002435,brimonidine,C1CN=C(N1)NC2=C(C3=NC=CN=C3C=C2)Br,erythema,CID000062924,"S-(fluoromethyl) (6S,9R,10S,11S,13S,14S,16R,17R)-6,9-difluoro-11,17-dihydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthrene-17-carbothioate",CC1CC2C3CC(C4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)SCF)O)C)O)F)C)F
CID000002435,brimonidine,C1CN=C(N1)NC2=C(C3=NC=CN=C3C=C2)Br,apoplexy,CID000005487,tizanidine,C1CN=C(N1)NC2=C(C=CC3=NSN=C32)Cl
CID000002435,brimonidine,C1CN=C(N1)NC2=C(C3=NC=CN=C3C=C2)Br,rotator cuff syndrome,CID000003780,"D-Glucitol, 1,4:3,6-dianhydro-, 2,5-dinitrate",C1C(C2C(O1)C(CO2)O[N+](=O)[O-])O[N+](=O)[O-]
CID000002435,brimonidine,C1CN=C(N1)NC2=C(C3=NC=CN=C3C=C2)Br,gastric inflammation,CID000038904,Carboplatinum,C1CC(C1)(C(=O)O)C(=O)O.N.N.[Pt]
CID000002435,brimonidine,C1CN=C(N1)NC2=C(C3=NC=CN=C3C=C2)Br,glaucoma,CID000002541,candesartan,CCOC1=NC2=CC=CC(=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5)C(=O)O
CID000002435,brimonidine,C1CN=C(N1)NC2=C(C3=NC=CN=C3C=C2)Br,Decreased Libido,CID000004920,"1-acetyl-9a,11a-dimethyl-1H,2H,3H,3aH,3bH,4H,5H,7H,8H,9H,9aH,9bH,10H,11H,11aH-cyclopenta[a]phenanthren-7-one",CC(=O)C1CCC2C1(CCC3C2CCC4=CC(=O)CCC34C)C
CID000002435,brimonidine,C1CN=C(N1)NC2=C(C3=NC=CN=C3C=C2)Br,apoplexy,CID000004927,promethazine,CC(CN1C2=CC=CC=C2SC3=CC=CC=C31)N(C)C
CID000002435,brimonidine,C1CN=C(N1)NC2=C(C3=NC=CN=C3C=C2)Br,Adenopathy,CID000077999,rosiglitazone,CN(CCOC1=CC=C(C=C1)CC2C(=O)NC(=O)S2)C3=CC=CC=N3
CID000002435,brimonidine,C1CN=C(N1)NC2=C(C3=NC=CN=C3C=C2)Br,apoplexy,CID000004691,"3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine",C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4
CID000002435,brimonidine,C1CN=C(N1)NC2=C(C3=NC=CN=C3C=C2)Br,insulin dependent diabetes mellitus,CID000003325,famotidine,C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N
CID000002435,brimonidine,C1CN=C(N1)NC2=C(C3=NC=CN=C3C=C2)Br,loss of weight,CID000004889,Pravastatin Impurity A,CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC(CC(CC(=O)O)O)O)O
CID000002435,brimonidine,C1CN=C(N1)NC2=C(C3=NC=CN=C3C=C2)Br,Adenopathy,CID000003405,2-[[4-[(2-amino-4-oxo-1H-pteridin-6-yl)methylamino]benzoyl]amino]pentanedioic acid,C1=CC(=CC=C1C(=O)NC(CCC(=O)O)C(=O)O)NCC2=CN=C3C(=N2)C(=O)N=C(N3)N
CID000002435,brimonidine,C1CN=C(N1)NC2=C(C3=NC=CN=C3C=C2)Br,glaucoma,CID000005358,sumatriptan,CNS(=O)(=O)CC1=CC2=C(C=C1)NC=C2CCN(C)C
CID000002435,brimonidine,C1CN=C(N1)NC2=C(C3=NC=CN=C3C=C2)Br,loss of weight,CID000003883,lansoprazole,CC1=C(C=CN=C1CS(=O)C2=NC3=CC=CC=C3N2)OCC(F)(F)F
CID000002435,brimonidine,C1CN=C(N1)NC2=C(C3=NC=CN=C3C=C2)Br,dysarthria,CID000004054,memantine,CC12CC3CC(C1)(CC(C3)(C2)N)C
CID000002435,brimonidine,C1CN=C(N1)NC2=C(C3=NC=CN=C3C=C2)Br,weight gain,CID000002524,32222-06-3,CC(CCCC(C)(C)O)C1CCC2C1(CCCC2=CC=C3CC(CC(C3=C)O)O)C
CID000002435,brimonidine,C1CN=C(N1)NC2=C(C3=NC=CN=C3C=C2)Br,Adenopathy,CID000087177,"D-Fructose, 4-O-alpha-D-glucopyranosyl-",C(C1C(C(C(C(O1)OC(C(CO)O)C(C(=O)CO)O)O)O)O)O
CID000002435,brimonidine,C1CN=C(N1)NC2=C(C3=NC=CN=C3C=C2)Br,gout,CID000005523,Ultram,CN(C)CC1CCCCC1(C2=CC(=CC=C2)OC)O
CID000002435,brimonidine,C1CN=C(N1)NC2=C(C3=NC=CN=C3C=C2)Br,constipated,CID000005095,ropinirole,CCCN(CCC)CCC1=C2CC(=O)NC2=CC=C1
CID000002435,brimonidine,C1CN=C(N1)NC2=C(C3=NC=CN=C3C=C2)Br,apoplexy,CID000003658,hydroxyzine,C1CN(CCN1CCOCCO)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl
CID000002435,brimonidine,C1CN=C(N1)NC2=C(C3=NC=CN=C3C=C2)Br,eruption,CID000002891,"cobalt(2+);[5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] 1-[3-[2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2,7,12,17-tetrahydro-1H-corrin-21-id-3-yl]propanoylamino]propan-2-yl hydrogen phosphate;cyanide",CC1=CC2=C(C=C1C)N(C=N2)C3C(C(C(O3)CO)OP(=O)(O)OC(C)CNC(=O)CCC4(C(C5C6(C(C(C(=N6)C(=C7C(C(C(=N7)C=C8C(C(C(=N8)C(=C4[N-]5)C)CCC(=O)N)(C)C)CCC(=O)N)(C)CC(=O)N)C)CCC(=O)N)(C)CC(=O)N)C)CC(=O)N)C)O.[C-]#N.[Co+2]
CID000002435,brimonidine,C1CN=C(N1)NC2=C(C3=NC=CN=C3C=C2)Br,Multiple Myeloma,CID000003410,formoterol,CC(CC1=CC=C(C=C1)OC)NCC(C2=CC(=C(C=C2)O)NC=O)O
CID000002435,brimonidine,C1CN=C(N1)NC2=C(C3=NC=CN=C3C=C2)Br,angiitis,CID000005650,N-pentanoyl-N-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-L-valine,CCCCC(=O)N(CC1=CC=C(C=C1)C2=CC=CC=C2C3=NNN=N3)C(C(C)C)C(=O)O
CID000002435,brimonidine,C1CN=C(N1)NC2=C(C3=NC=CN=C3C=C2)Br,apoplexy,CID006398525,,C(C1C(C(C(C(O1)OC2(C(C(C(O2)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)COS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.[Al].[Al].[Al].[Al].[Al].[Al].[Al].[Al].[Al]
CID000002435,brimonidine,C1CN=C(N1)NC2=C(C3=NC=CN=C3C=C2)Br,gastric inflammation,CID000003075,"2-[3-acetyloxy-2-(4-methoxyphenyl)-4-oxo-2,3-dihydro-1,5-benzothiazepin-5-yl]ethyl-dimethylazanium",CC(=O)OC1C(SC2=CC=CC=C2N(C1=O)CC[NH+](C)C)C3=CC=C(C=C3)OC
CID000002435,brimonidine,C1CN=C(N1)NC2=C(C3=NC=CN=C3C=C2)Br,apoplexy,CID000004543,nortriptyline,CNCCC=C1C2=CC=CC=C2CCC3=CC=CC=C31
CID000002435,brimonidine,C1CN=C(N1)NC2=C(C3=NC=CN=C3C=C2)Br,gastric inflammation,CID000005512,124936-74-9,CC1=CC(=C(C=C1)O)C(CCN(C(C)C)C(C)C)C2=CC=CC=C2
CID000002435,brimonidine,C1CN=C(N1)NC2=C(C3=NC=CN=C3C=C2)Br,abdominal pain upper,CID000004856,"3-[hydroxy-(pyridin-2-ylamino)methylidene]-2-methyl-1,1-dioxo-1lambda6,2-benzothiazin-4-one",CN1C(=C(NC2=CC=CC=N2)O)C(=O)C3=CC=CC=C3S1(=O)=O
CID000002435,brimonidine,C1CN=C(N1)NC2=C(C3=NC=CN=C3C=C2)Br,loss of weight,CID000003345,fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3
CID000002435,brimonidine,C1CN=C(N1)NC2=C(C3=NC=CN=C3C=C2)Br,erythema,CID000002771,citalopram,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F
CID000002435,brimonidine,C1CN=C(N1)NC2=C(C3=NC=CN=C3C=C2)Br,gastric inflammation,CID000004900,Fernisone,CC12CC(=O)C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C
CID000002435,brimonidine,C1CN=C(N1)NC2=C(C3=NC=CN=C3C=C2)Br,loss of weight,CID000005544,Mycolog,CC12CC(C3(C(C1CC(C2(C(=O)CO)O)O)CCC4=CC(=O)C=CC43C)F)O
CID000002435,brimonidine,C1CN=C(N1)NC2=C(C3=NC=CN=C3C=C2)Br,cellulitis,CID000003749,irbesartan,CCCCC1=NC2(CCCC2)C(=O)N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5
CID000002435,brimonidine,C1CN=C(N1)NC2=C(C3=NC=CN=C3C=C2)Br,insulin dependent diabetes mellitus,CID000004170,metolazone,CC1NC2=CC(=C(C=C2C(=O)N1C3=CC=CC=C3C)S(=O)(=O)N)Cl
CID000002435,brimonidine,C1CN=C(N1)NC2=C(C3=NC=CN=C3C=C2)Br,apoplexy,CID000005073,risperidone,CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F
CID000002435,brimonidine,C1CN=C(N1)NC2=C(C3=NC=CN=C3C=C2)Br,neumonia,CID000005077,105601-20-5,CCN(C)C(=O)OC1=CC=CC(=C1)C(C)N(C)C
CID000002435,brimonidine,C1CN=C(N1)NC2=C(C3=NC=CN=C3C=C2)Br,panic attack,CID000003954,loperamide(1+),CN(C)C(=O)C(CC[NH+]1CCC(CC1)(C2=CC=C(C=C2)Cl)O)(C3=CC=CC=C3)C4=CC=CC=C4
CID000002435,brimonidine,C1CN=C(N1)NC2=C(C3=NC=CN=C3C=C2)Br,Adenopathy,CID000003958,lorazepam,C1=CC=C(C(=C1)C2=NC(C(=O)NC3=C2C=C(C=C3)Cl)O)Cl
CID000002435,brimonidine,C1CN=C(N1)NC2=C(C3=NC=CN=C3C=C2)Br,malnourished,CID000004510,nitroglycerin,C(C(CO[N+](=O)[O-])O[N+](=O)[O-])O[N+](=O)[O-]
CID000002435,brimonidine,C1CN=C(N1)NC2=C(C3=NC=CN=C3C=C2)Br,apoplexy,CID000004819,"2(3H)-Furanone, 3-ethyldihydro-4-[(1-methyl-1H-imidazol-5-yl)methyl]-, (3S-cis)-",CCC1C(COC1=O)CC2=CN=CN2C
CID000002435,brimonidine,C1CN=C(N1)NC2=C(C3=NC=CN=C3C=C2)Br,insulin dependent diabetes mellitus,CID000003333,felodipine,CCOC(=O)C1=C(NC(=C(C1C2=C(C(=CC=C2)Cl)Cl)C(=O)OC)C)C
CID000002435,brimonidine,C1CN=C(N1)NC2=C(C3=NC=CN=C3C=C2)Br,apoplexy,CID000003339,fenofibrate,CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C2=CC=C(C=C2)Cl
CID000002435,brimonidine,C1CN=C(N1)NC2=C(C3=NC=CN=C3C=C2)Br,gastric inflammation,CID000005245,Risedronic acid,C1=CC(=CN=C1)CC(O)(P(=O)(O)O)P(=O)(O)O
CID000002435,brimonidine,C1CN=C(N1)NC2=C(C3=NC=CN=C3C=C2)Br,gastric inflammation,CID000004894,"11,17,21-Trihydroxypregna-1,4-diene-3,20-dione",CC12CC(C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C)O
CID000002435,brimonidine,C1CN=C(N1)NC2=C(C3=NC=CN=C3C=C2)Br,Pain,CID000003676,lidocaine,CCN(CC)CC(=O)NC1=C(C=CC=C1C)C
CID000002435,brimonidine,C1CN=C(N1)NC2=C(C3=NC=CN=C3C=C2)Br,Adenopathy,CID000004666,7-Epi Paclitaxel,CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C
CID000002435,brimonidine,C1CN=C(N1)NC2=C(C3=NC=CN=C3C=C2)Br,apoplexy,CID000002462,51372-29-3,CCCC1OC2CC3C4CCC5=CC(=O)C=CC5(C4C(CC3(C2(O1)C(=O)CO)C)O)C
CID000002435,brimonidine,C1CN=C(N1)NC2=C(C3=NC=CN=C3C=C2)Br,esophageal spasm,CID000002662,celecoxib,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F
CID000002435,brimonidine,C1CN=C(N1)NC2=C(C3=NC=CN=C3C=C2)Br,drug toxicity NOS,CID000005478,racemic-Timolol,CC(C)(C)NCC(COC1=NSN=C1N2CCOCC2)O
CID000002435,brimonidine,C1CN=C(N1)NC2=C(C3=NC=CN=C3C=C2)Br,Adenopathy,CID000002656,"7-[[2-(2-amino-1,3-thiazol-4-yl)-2-methoxyiminoacetyl]amino]-3-[(2-methyl-6-oxido-5-oxo-1,2,4-triazin-3-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CN1C(=NC(=O)C(=N1)[O-])SCC2=C(N3C(C(C3=O)NC(=O)C(=NOC)C4=CSC(=N4)N)SC2)C(=O)[O-]
CID000002435,brimonidine,C1CN=C(N1)NC2=C(C3=NC=CN=C3C=C2)Br,apoplexy,CID000005732,zolpidem,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C
CID000002435,brimonidine,C1CN=C(N1)NC2=C(C3=NC=CN=C3C=C2)Br,ocular hypertension,CID000002550,1-(2-methyl-3-sulfanylpropanoyl)pyrrolidine-2-carboxylic acid,CC(CS)C(=O)N1CCCC1C(=O)O
CID000002435,brimonidine,C1CN=C(N1)NC2=C(C3=NC=CN=C3C=C2)Br,erythema,CID000003890,TRANS (15S)-LATANOPROST,CC(C)OC(=O)CCCC=CCC1C(CC(C1CCC(CCC2=CC=CC=C2)O)O)O
CID000002435,brimonidine,C1CN=C(N1)NC2=C(C3=NC=CN=C3C=C2)Br,gastric inflammation,CID000003440,furosemide,C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl
CID000002435,brimonidine,C1CN=C(N1)NC2=C(C3=NC=CN=C3C=C2)Br,Adenopathy,CID000003937,N~2~-(1-carboxy-3-phenylpropyl)lysylproline,C1CC(N(C1)C(=O)C(CCCCN)NC(CCC2=CC=CC=C2)C(=O)O)C(=O)O
CID000002435,brimonidine,C1CN=C(N1)NC2=C(C3=NC=CN=C3C=C2)Br,dizziness,CID000071329,Dofetilide,CN(CCC1=CC=C(C=C1)NS(=O)(=O)C)CCOC2=CC=C(C=C2)NS(=O)(=O)C
CID000002435,brimonidine,C1CN=C(N1)NC2=C(C3=NC=CN=C3C=C2)Br,gastric inflammation,CID000005391,temazepam,CN1C2=C(C=C(C=C2)Cl)C(=NC(C1=O)O)C3=CC=CC=C3
CID000002435,brimonidine,C1CN=C(N1)NC2=C(C3=NC=CN=C3C=C2)Br,insulin dependent diabetes mellitus,CID000003062,Lanicor,CC1C(C(CC(O1)OC2C(OC(CC2O)OC3C(OC(CC3O)OC4CCC5(C(C4)CCC6C5CC(C7(C6(CCC7C8=CC(=O)OC8)O)C)O)C)C)C)O)O
CID000002435,brimonidine,C1CN=C(N1)NC2=C(C3=NC=CN=C3C=C2)Br,constipated,CID000170361,Varenicline,C1C2CNCC1C3=CC4=NC=CN=C4C=C23
CID000002435,brimonidine,C1CN=C(N1)NC2=C(C3=NC=CN=C3C=C2)Br,pulmonary arrest,CID000065999,Telmisartan,CCCC1=NC2=C(N1CC3=CC=C(C=C3)C4=CC=CC=C4C(=O)O)C=C(C=C2C)C5=NC6=CC=CC=C6N5C
CID000002435,brimonidine,C1CN=C(N1)NC2=C(C3=NC=CN=C3C=C2)Br,Adenopathy,CID000054454,simvastatin,CCC(C)(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C
CID000002435,brimonidine,C1CN=C(N1)NC2=C(C3=NC=CN=C3C=C2)Br,atelectasis,CID000005152,Salmeterol,C1=CC=C(C=C1)CCCCOCCCCCCNCC(C2=CC(=C(C=C2)O)CO)O
CID000002435,brimonidine,C1CN=C(N1)NC2=C(C3=NC=CN=C3C=C2)Br,apoplexy,CID000003961,losartan,CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)CO)Cl
CID000002435,brimonidine,C1CN=C(N1)NC2=C(C3=NC=CN=C3C=C2)Br,apoplexy,CID000003516,guaifenesin,COC1=CC=CC=C1OCC(CO)O
CID000002435,brimonidine,C1CN=C(N1)NC2=C(C3=NC=CN=C3C=C2)Br,Infection Upper Respiratory,CID000004205,mirtazapine,CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4
CID000002435,brimonidine,C1CN=C(N1)NC2=C(C3=NC=CN=C3C=C2)Br,thrombocytopenia,CID000152945,Dutasteride?,CC12CCC3C(C1CCC2C(=O)NC4=C(C=CC(=C4)C(F)(F)F)C(F)(F)F)CCC5C3(C=CC(=O)N5)C
CID000002435,brimonidine,C1CN=C(N1)NC2=C(C3=NC=CN=C3C=C2)Br,apoplexy,CID000004585,"2-methyl-4-(4-methylpiperazin-1-yl)-5H-thieno[3,2-c][1,5]benzodiazepine",CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C
CID000002435,brimonidine,C1CN=C(N1)NC2=C(C3=NC=CN=C3C=C2)Br,apoplexy,CID000002803,clonidine,C1CN=C(N1)NC2=C(C=CC=C2Cl)Cl
CID000002435,brimonidine,C1CN=C(N1)NC2=C(C3=NC=CN=C3C=C2)Br,Diplopia,CID000002806,90055-48-4,COC(=O)C(C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3
CID000003249,50-14-6,CC(C)C(C)C=CC(C)C1CCC2C1(CCCC2=CC=C3CC(CCC3=C)O)C,cardiac murmur,CID000003305,Etidronic acid,CC(O)(P(=O)(O)O)P(=O)(O)O
CID000003249,50-14-6,CC(C)C(C)C=CC(C)C1CCC2C1(CCCC2=CC=C3CC(CCC3=C)O)C,erythema,CID000005487,tizanidine,C1CN=C(N1)NC2=C(C=CC3=NSN=C32)Cl
CID000003249,50-14-6,CC(C)C(C)C=CC(C)C1CCC2C1(CCCC2=CC=C3CC(CCC3=C)O)C,Pain,CID000003410,formoterol,CC(CC1=CC=C(C=C1)OC)NCC(C2=CC(=C(C=C2)O)NC=O)O
CID000003249,50-14-6,CC(C)C(C)C=CC(C)C1CCC2C1(CCCC2=CC=C3CC(CCC3=C)O)C,eruption,CID000010631,medroxyprogesterone,CC1CC2C(CCC3(C2CCC3(C(=O)C)O)C)C4(C1=CC(=O)CC4)C
CID000003249,50-14-6,CC(C)C(C)C=CC(C)C1CCC2C1(CCCC2=CC=C3CC(CCC3=C)O)C,loss of weight,CID000003516,guaifenesin,COC1=CC=CC=C1OCC(CO)O
CID000003249,50-14-6,CC(C)C(C)C=CC(C)C1CCC2C1(CCCC2=CC=C3CC(CCC3=C)O)C,angiitis,CID000005245,Risedronic acid,C1=CC(=CN=C1)CC(O)(P(=O)(O)O)P(=O)(O)O
CID000003249,50-14-6,CC(C)C(C)C=CC(C)C1CCC2C1(CCCC2=CC=C3CC(CCC3=C)O)C,muscle inflammation,CID000003463,gemfibrozil,CC1=CC(=C(C=C1)C)OCCCC(C)(C)C(=O)O
CID000003249,50-14-6,CC(C)C(C)C=CC(C)C1CCC2C1(CCCC2=CC=C3CC(CCC3=C)O)C,rectal prolapse,CID000004900,Fernisone,CC12CC(=O)C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C
CID000003249,50-14-6,CC(C)C(C)C=CC(C)C1CCC2C1(CCCC2=CC=C3CC(CCC3=C)O)C,elevated erythrocyte sedimentation rate,CID000003325,famotidine,C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N
CID000003249,50-14-6,CC(C)C(C)C=CC(C)C1CCC2C1(CCCC2=CC=C3CC(CCC3=C)O)C,gastric inflammation,CID000004679,pantoprazole,COC1=C(C(=NC=C1)CS(=O)C2=NC3=C(N2)C=C(C=C3)OC(F)F)OC
CID000003249,50-14-6,CC(C)C(C)C=CC(C)C1CCC2C1(CCCC2=CC=C3CC(CCC3=C)O)C,gastric inflammation,CID000004585,"2-methyl-4-(4-methylpiperazin-1-yl)-5H-thieno[3,2-c][1,5]benzodiazepine",CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C
CID000003249,50-14-6,CC(C)C(C)C=CC(C)C1CCC2C1(CCCC2=CC=C3CC(CCC3=C)O)C,angiitis,CID000005391,temazepam,CN1C2=C(C=C(C=C2)Cl)C(=NC(C1=O)O)C3=CC=CC=C3
CID000003249,50-14-6,CC(C)C(C)C=CC(C)C1CCC2C1(CCCC2=CC=C3CC(CCC3=C)O)C,apoplexy,CID000003749,irbesartan,CCCCC1=NC2(CCCC2)C(=O)N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5
CID000003249,50-14-6,CC(C)C(C)C=CC(C)C1CCC2C1(CCCC2=CC=C3CC(CCC3=C)O)C,loss of weight,CID000003883,lansoprazole,CC1=C(C=CN=C1CS(=O)C2=NC3=CC=CC=C3N2)OCC(F)(F)F
CID000003249,50-14-6,CC(C)C(C)C=CC(C)C1CCC2C1(CCCC2=CC=C3CC(CCC3=C)O)C,Back Ache,CID000065999,Telmisartan,CCCC1=NC2=C(N1CC3=CC=C(C=C3)C4=CC=CC=C4C(=O)O)C=C(C=C2C)C5=NC6=CC=CC=C6N5C
CID000003249,50-14-6,CC(C)C(C)C=CC(C)C1CCC2C1(CCCC2=CC=C3CC(CCC3=C)O)C,cholecystitis,CID000003405,2-[[4-[(2-amino-4-oxo-1H-pteridin-6-yl)methylamino]benzoyl]amino]pentanedioic acid,C1=CC(=CC=C1C(=O)NC(CCC(=O)O)C(=O)O)NCC2=CN=C3C(=N2)C(=O)N=C(N3)N
CID000003249,50-14-6,CC(C)C(C)C=CC(C)C1CCC2C1(CCCC2=CC=C3CC(CCC3=C)O)C,eruption,CID000054454,simvastatin,CCC(C)(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C
CID000003249,50-14-6,CC(C)C(C)C=CC(C)C1CCC2C1(CCCC2=CC=C3CC(CCC3=C)O)C,erythema,CID000060852,Ibandronic Acid,CCCCCN(C)CCC(O)(P(=O)(O)O)P(=O)(O)O
CID000003249,50-14-6,CC(C)C(C)C=CC(C)C1CCC2C1(CCCC2=CC=C3CC(CCC3=C)O)C,trigeminal neuralgia,CID000003345,fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3
CID000003249,50-14-6,CC(C)C(C)C=CC(C)C1CCC2C1(CCCC2=CC=C3CC(CCC3=C)O)C,eruption,CID000004691,"3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine",C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4
CID000003249,50-14-6,CC(C)C(C)C=CC(C)C1CCC2C1(CCCC2=CC=C3CC(CCC3=C)O)C,increased white blood cell count,CID000003954,loperamide(1+),CN(C)C(=O)C(CC[NH+]1CCC(CC1)(C2=CC=C(C=C2)Cl)O)(C3=CC=CC=C3)C4=CC=CC=C4
CID000003249,50-14-6,CC(C)C(C)C=CC(C)C1CCC2C1(CCCC2=CC=C3CC(CCC3=C)O)C,angiitis,CID000003958,lorazepam,C1=CC=C(C(=C1)C2=NC(C(=O)NC3=C2C=C(C=C3)Cl)O)Cl
CID000003249,50-14-6,CC(C)C(C)C=CC(C)C1CCC2C1(CCCC2=CC=C3CC(CCC3=C)O)C,eruption,CID000004075,5-Aminosalicylic acid,C1=CC(=C(C=C1N)C(=O)O)O
CID000003249,50-14-6,CC(C)C(C)C=CC(C)C1CCC2C1(CCCC2=CC=C3CC(CCC3=C)O)C,heart rate increased,CID000004927,promethazine,CC(CN1C2=CC=CC=C2SC3=CC=CC=C31)N(C)C
CID000003249,50-14-6,CC(C)C(C)C=CC(C)C1CCC2C1(CCCC2=CC=C3CC(CCC3=C)O)C,rectal prolapse,CID000004189,miconazole,C1=CC(=C(C=C1Cl)Cl)COC(CN2C=CN=C2)C3=C(C=C(C=C3)Cl)Cl
CID000003249,50-14-6,CC(C)C(C)C=CC(C)C1CCC2C1(CCCC2=CC=C3CC(CCC3=C)O)C,Bleeding,CID000004201,minoxidil,C1CCN(CC1)C2=NC(=N)N(C(=C2)N)O
CID000003249,50-14-6,CC(C)C(C)C=CC(C)C1CCC2C1(CCCC2=CC=C3CC(CCC3=C)O)C,erythema,CID000005650,N-pentanoyl-N-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-L-valine,CCCCC(=O)N(CC1=CC=C(C=C1)C2=CC=CC=C2C3=NNN=N3)C(C(C)C)C(=O)O
CID000003249,50-14-6,CC(C)C(C)C=CC(C)C1CCC2C1(CCCC2=CC=C3CC(CCC3=C)O)C,gastric inflammation,CID000008953,sodium;hydrogen carbonate,C(=O)(O)[O-].[Na+]
CID000003249,50-14-6,CC(C)C(C)C=CC(C)C1CCC2C1(CCCC2=CC=C3CC(CCC3=C)O)C,asthenia,CID000667490,6-Mercaptopurine,C1=NC2=C(N1)C(=S)N=CN2
CID000003249,50-14-6,CC(C)C(C)C=CC(C)C1CCC2C1(CCCC2=CC=C3CC(CCC3=C)O)C,gastric inflammation,CID006398525,,C(C1C(C(C(C(O1)OC2(C(C(C(O2)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)COS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.[Al].[Al].[Al].[Al].[Al].[Al].[Al].[Al].[Al]
CID000003249,50-14-6,CC(C)C(C)C=CC(C)C1CCC2C1(CCCC2=CC=C3CC(CCC3=C)O)C,loss of weight,CID000087177,"D-Fructose, 4-O-alpha-D-glucopyranosyl-",C(C1C(C(C(C(O1)OC(C(CO)O)C(C(=O)CO)O)O)O)O)O
CID000003249,50-14-6,CC(C)C(C)C=CC(C)C1CCC2C1(CCCC2=CC=C3CC(CCC3=C)O)C,Arrhythmia,CID000004107,methocarbamol,COC1=CC=CC=C1OCC(COC(=O)N)O
CID000003249,50-14-6,CC(C)C(C)C=CC(C)C1CCC2C1(CCCC2=CC=C3CC(CCC3=C)O)C,confusion,CID000005523,Ultram,CN(C)CC1CCCCC1(C2=CC(=CC=C2)OC)O
CID000003249,50-14-6,CC(C)C(C)C=CC(C)C1CCC2C1(CCCC2=CC=C3CC(CCC3=C)O)C,nasopharyngitis,CID000004889,Pravastatin Impurity A,CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC(CC(CC(=O)O)O)O)O
CID000003249,50-14-6,CC(C)C(C)C=CC(C)C1CCC2C1(CCCC2=CC=C3CC(CCC3=C)O)C,drug toxicity NOS,CID000003333,felodipine,CCOC(=O)C1=C(NC(=C(C1C2=C(C(=CC=C2)Cl)Cl)C(=O)OC)C)C
CID000003249,50-14-6,CC(C)C(C)C=CC(C)C1CCC2C1(CCCC2=CC=C3CC(CCC3=C)O)C,loss of weight,CID000003339,fenofibrate,CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C2=CC=C(C=C2)Cl
CID000003249,50-14-6,CC(C)C(C)C=CC(C)C1CCC2C1(CCCC2=CC=C3CC(CCC3=C)O)C,Infection Urinary Tract,CID000005512,124936-74-9,CC1=CC(=C(C=C1)O)C(CCN(C(C)C)C(C)C)C2=CC=CC=C2
CID000003249,50-14-6,CC(C)C(C)C=CC(C)C1CCC2C1(CCCC2=CC=C3CC(CCC3=C)O)C,trigeminal neuralgia,CID000004543,nortriptyline,CNCCC=C1C2=CC=CC=C2CCC3=CC=CC=C31
CID000003249,50-14-6,CC(C)C(C)C=CC(C)C1CCC2C1(CCCC2=CC=C3CC(CCC3=C)O)C,allergic dermatitis,CID000003961,losartan,CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)CO)Cl
CID000003249,50-14-6,CC(C)C(C)C=CC(C)C1CCC2C1(CCCC2=CC=C3CC(CCC3=C)O)C,loss of weight,CID000077999,rosiglitazone,CN(CCOC1=CC=C(C=C1)CC2C(=O)NC(=O)S2)C3=CC=CC=N3
CID000003249,50-14-6,CC(C)C(C)C=CC(C)C1CCC2C1(CCCC2=CC=C3CC(CCC3=C)O)C,angiitis,CID000003937,N~2~-(1-carboxy-3-phenylpropyl)lysylproline,C1CC(N(C1)C(=O)C(CCCCN)NC(CCC2=CC=CC=C2)C(=O)O)C(=O)O
CID000003249,50-14-6,CC(C)C(C)C=CC(C)C1CCC2C1(CCCC2=CC=C3CC(CCC3=C)O)C,confusion,CID000170361,Varenicline,C1C2CNCC1C3=CC4=NC=CN=C4C=C23
CID000003249,50-14-6,CC(C)C(C)C=CC(C)C1CCC2C1(CCCC2=CC=C3CC(CCC3=C)O)C,cardiac murmur,CID000003780,"D-Glucitol, 1,4:3,6-dianhydro-, 2,5-dinitrate",C1C(C2C(O1)C(CO2)O[N+](=O)[O-])O[N+](=O)[O-]
CID000003249,50-14-6,CC(C)C(C)C=CC(C)C1CCC2C1(CCCC2=CC=C3CC(CCC3=C)O)C,back injury,CID000005732,zolpidem,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C
CID000003249,50-14-6,CC(C)C(C)C=CC(C)C1CCC2C1(CCCC2=CC=C3CC(CCC3=C)O)C,loss of weight,CID000062924,"S-(fluoromethyl) (6S,9R,10S,11S,13S,14S,16R,17R)-6,9-difluoro-11,17-dihydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthrene-17-carbothioate",CC1CC2C3CC(C4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)SCF)O)C)O)F)C)F
CID000003249,50-14-6,CC(C)C(C)C=CC(C)C1CCC2C1(CCCC2=CC=C3CC(CCC3=C)O)C,nasopharyngitis,CID000004510,nitroglycerin,C(C(CO[N+](=O)[O-])O[N+](=O)[O-])O[N+](=O)[O-]
CID000003249,50-14-6,CC(C)C(C)C=CC(C)C1CCC2C1(CCCC2=CC=C3CC(CCC3=C)O)C,tetany,CID000004170,metolazone,CC1NC2=CC(=C(C=C2C(=O)N1C3=CC=CC=C3C)S(=O)(=O)N)Cl
CID000003249,50-14-6,CC(C)C(C)C=CC(C)C1CCC2C1(CCCC2=CC=C3CC(CCC3=C)O)C,increased white blood cell count,CID000003676,lidocaine,CCN(CC)CC(=O)NC1=C(C=CC=C1C)C
CID000003249,50-14-6,CC(C)C(C)C=CC(C)C1CCC2C1(CCCC2=CC=C3CC(CCC3=C)O)C,body temperature increased,CID000005645,"3,7-Dihydroxycholan-24-oic acid",CC(CCC(=O)O)C1CCC2C1(CCC3C2C(CC4C3(CCC(C4)O)C)O)C
CID000003249,50-14-6,CC(C)C(C)C=CC(C)C1CCC2C1(CCCC2=CC=C3CC(CCC3=C)O)C,constipated,CID000004205,mirtazapine,CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4
CID000003249,50-14-6,CC(C)C(C)C=CC(C)C1CCC2C1(CCCC2=CC=C3CC(CCC3=C)O)C,faecal incontinence,CID000003890,TRANS (15S)-LATANOPROST,CC(C)OC(=O)CCCC=CCC1C(CC(C1CCC(CCC2=CC=CC=C2)O)O)O
CID000003249,50-14-6,CC(C)C(C)C=CC(C)C1CCC2C1(CCCC2=CC=C3CC(CCC3=C)O)C,cholecystitis,CID000003440,furosemide,C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl
CID000003249,50-14-6,CC(C)C(C)C=CC(C)C1CCC2C1(CCCC2=CC=C3CC(CCC3=C)O)C,gastric inflammation,CID000004894,"11,17,21-Trihydroxypregna-1,4-diene-3,20-dione",CC12CC(C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C)O
CID000003249,50-14-6,CC(C)C(C)C=CC(C)C1CCC2C1(CCCC2=CC=C3CC(CCC3=C)O)C,loss of weight,CID000005544,Mycolog,CC12CC(C3(C(C1CC(C2(C(=O)CO)O)O)CCC4=CC(=O)C=CC43C)F)O
CID000003249,50-14-6,CC(C)C(C)C=CC(C)C1CCC2C1(CCCC2=CC=C3CC(CCC3=C)O)C,apoplexy,CID000005073,risperidone,CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F
CID000004463,nevirapine,CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4,deglutition disorder,CID000065027,N-[3-[(1R)-1-[(2R)-6-hydroxy-4-oxo-2-(2-phenylethyl)-2-propyl-3H-pyran-5-yl]propyl]phenyl]-5-(trifluoromethyl)pyridine-2-sulfonamide,CCCC1(CC(=O)C(=C(O1)O)C(CC)C2=CC(=CC=C2)NS(=O)(=O)C3=NC=C(C=C3)C(F)(F)F)CCC4=CC=CC=C4
CID000004463,nevirapine,CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4,Bone Fracture Spontaneous,CID000060787,sequinavir,CC(C)(C)NC(=O)C1CC2CCCCC2CN1CC(C(CC3=CC=CC=C3)NC(=O)C(CC(=O)N)NC(=O)C4=NC5=CC=CC=C5C=C4)O
CID000004463,nevirapine,CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4,apoplexy,CID000005732,zolpidem,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C
CID000004463,nevirapine,CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4,eruption,CID005381226,"[(7S,9E,11S,12R,13S,14R,15R,16R,17S,18S,19E,21Z,26E)-2,15,17,29-tetrahydroxy-11-methoxy-3,7,12,14,16,18,22-heptamethyl-26-[[(4-methylpiperazin-1-yl)amino]methylidene]-6,23,27-trioxo-8,30-dioxa-24-azatetracyclo[23.3.1.14,7.05,28]triaconta-1(28),2,4,9,19,21,25(29)-heptaen-13-yl] acetate",CC1C=CC=C(C(=O)NC2=C(C3=C(C4=C(C(=C3O)C)OC(C4=O)(OC=CC(C(C(C(C(C(C1O)C)O)C)OC(=O)C)C)OC)C)C(=O)C2=CNN5CCN(CC5)C)O)C
CID000004463,nevirapine,CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4,loss of weight,CID006398525,,C(C1C(C(C(C(O1)OC2(C(C(C(O2)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)COS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.[Al].[Al].[Al].[Al].[Al].[Al].[Al].[Al].[Al]
CID000004463,nevirapine,CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4,confusion,CID000004909,primidone,CCC1(C(=O)NCNC1=O)C2=CC=CC=C2
CID000004463,nevirapine,CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4,abnormal ECG,CID000054454,simvastatin,CCC(C)(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C
CID000004463,nevirapine,CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4,Adenopathy,CID000131536,Fosamprenavir,CC(C)CN(CC(C(CC1=CC=CC=C1)NC(=O)OC2CCOC2)OP(=O)(O)O)S(=O)(=O)C3=CC=C(C=C3)N
CID000004463,nevirapine,CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4,apoplexy,CID000004691,"3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine",C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4
CID000004463,nevirapine,CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4,gallbladder cancer,CID000005095,ropinirole,CCCN(CCC)CCC1=C2CC(=O)NC2=CC=C1
CID000004463,nevirapine,CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4,allergic dermatitis,CID000004894,"11,17,21-Trihydroxypregna-1,4-diene-3,20-dione",CC12CC(C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C)O
CID000004463,nevirapine,CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4,drug toxicity NOS,CID000077999,rosiglitazone,CN(CCOC1=CC=C(C=C1)CC2C(=O)NC(=O)S2)C3=CC=CC=N3
CID000004463,nevirapine,CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4,icterus,CID000004543,nortriptyline,CNCCC=C1C2=CC=CC=C2CCC3=CC=CC=C31
CID000004463,nevirapine,CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4,apoplexy,CID000004585,"2-methyl-4-(4-methylpiperazin-1-yl)-5H-thieno[3,2-c][1,5]benzodiazepine",CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C
CID000004463,nevirapine,CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4,pulmonary hypertension,CID000004927,promethazine,CC(CN1C2=CC=CC=C2SC3=CC=CC=C31)N(C)C
CID000004463,nevirapine,CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4,Pain,CID000004900,Fernisone,CC12CC(=O)C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C
CID000004463,nevirapine,CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4,elevated cholesterol,CID000062924,"S-(fluoromethyl) (6S,9R,10S,11S,13S,14S,16R,17R)-6,9-difluoro-11,17-dihydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthrene-17-carbothioate",CC1CC2C3CC(C4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)SCF)O)C)O)F)C)F
CID000004463,nevirapine,CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4,Dyspnea exertional,CID000005076,162990-01-4,CC(C)C1=NC(=CS1)CN(C)C(=O)NC(C(C)C)C(=O)NC(CC2=CC=CC=C2)CC(C(CC3=CC=CC=C3)NC(=O)OCC4=CN=CS4)O
CID000004463,nevirapine,CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4,apoplexy,CID000004679,pantoprazole,COC1=C(C(=NC=C1)CS(=O)C2=NC3=C(N2)C=C(C=C3)OC(F)F)OC
CID000004463,nevirapine,CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4,thrombocytopenia,CID000019090,megestrol,CC1=CC2C(CCC3(C2CCC3(C(=O)C)O)C)C4(C1=CC(=O)CC4)C
CID000004463,nevirapine,CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4,herpes zoster,CID000170361,Varenicline,C1C2CNCC1C3=CC4=NC=CN=C4C=C23
CID000004463,nevirapine,CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4,pulmonary hypertension,CID000152945,Dutasteride?,CC12CCC3C(C1CCC2C(=O)NC4=C(C=CC(=C4)C(F)(F)F)C(F)(F)F)CCC5C3(C=CC(=O)N5)C
CID000004463,nevirapine,CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4,Adenopathy,CID000004889,Pravastatin Impurity A,CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC(CC(CC(=O)O)O)O)O
CID000004463,nevirapine,CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4,cholecystitis,CID005481350,Tenofovir disoproxil,CC(C)OC(=O)OCOP(=O)(COC(C)CN1C=NC2=C(N=CN=C21)N)OCOC(=O)OC(C)C
CID000004463,nevirapine,CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4,nasopharyngitis,CID000005391,temazepam,CN1C2=C(C=C(C=C2)Cl)C(=NC(C1=O)O)C3=CC=CC=C3
CID000004463,nevirapine,CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4,apoplexy,CID000005073,risperidone,CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F
CID000054454,simvastatin,CCC(C)(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C,gastric inflammation,CID000060184,"2'-epi-Perindopril, (2'R)-",CCCC(C(=O)OCC)NC(C)C(=O)N1C2CCCCC2CC1C(=O)O
CID000054454,simvastatin,CCC(C)(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C,dysarthria,CID004479097,"cobalt;[5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] 1-[3-[2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2,7,12,17-tetrahydro-1H-corrin-21-id-3-yl]propanoylamino]propan-2-yl phosphate;hydrate",CC1=CC2=C(C=C1C)N(C=N2)C3C(C(C(O3)CO)OP(=O)([O-])OC(C)CNC(=O)CCC4(C(C5C6(C(C(C(=N6)C(=C7C(C(C(=N7)C=C8C(C(C(=N8)C(=C4[N-]5)C)CCC(=O)N)(C)C)CCC(=O)N)(C)CC(=O)N)C)CCC(=O)N)(C)CC(=O)N)C)CC(=O)N)C)O.O.[Co]
CID000054454,simvastatin,CCC(C)(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C,Adenopathy,CID000170361,Varenicline,C1C2CNCC1C3=CC4=NC=CN=C4C=C23
CID000054454,simvastatin,CCC(C)(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C,back injury,CID000060852,Ibandronic Acid,CCCCCN(C)CCC(O)(P(=O)(O)O)P(=O)(O)O
CID000054454,simvastatin,CCC(C)(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C,agitated,CID000060854,Ziprasidone,C1CN(CCN1CCC2=C(C=C3C(=C2)CC(=O)N3)Cl)C4=NSC5=CC=CC=C54
CID000054454,simvastatin,CCC(C)(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C,atelectasis,CID000110635,Tadalafil,CN1CC(=O)N2C(C1=O)CC3=C(C2C4=CC5=C(C=C4)OCO5)NC6=CC=CC=C36
CID000054454,simvastatin,CCC(C)(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C,cholecystitis,CID000077999,rosiglitazone,CN(CCOC1=CC=C(C=C1)CC2C(=O)NC(=O)S2)C3=CC=CC=N3
CID000054454,simvastatin,CCC(C)(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C,ADVERSE DRUG EFFECT,CID000667490,6-Mercaptopurine,C1=NC2=C(N1)C(=S)N=CN2
CID000054454,simvastatin,CCC(C)(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C,cerebellar ataxia,CID003468412,SCHEMBL1176571,CC1C=CC=CCCC=CC=CC=CC=CC(CC(C(C(CC(=O)CC(C(CCC(CC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)C(=O)O)O)OC2C(C(C(C(O2)C)O)N)O
CID000054454,simvastatin,CCC(C)(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C,loss of weight,CID005493444,Aliskiren,CC(C)C(CC1=CC(=C(C=C1)OC)OCCCOC)CC(C(CC(C(C)C)C(=O)NCC(C)(C)C(=O)N)O)N
CID000054454,simvastatin,CCC(C)(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C,erythema,CID005311082,"2-[(1R,4S,10S,13S,19S)-19-[4-(diaminomethylideneamino)butyl]-10-(1H-indol-3-ylmethyl)-3,9,12,15,18,21,27-heptaoxo-24,25-dithia-2,8,11,14,17,20-hexazatricyclo[18.6.1.04,8]heptacosan-13-yl]acetic acid",C1CC2C(=O)NC3CSSCCC(=O)N(C3=O)C(C(=O)NCC(=O)NC(C(=O)NC(C(=O)N2C1)CC4=CNC5=CC=CC=C54)CC(=O)O)CCCCN=C(N)N
CID000054454,simvastatin,CCC(C)(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C,erythema,CID006447131,Pimecrolimus,CCC1C=C(CC(CC(C2C(CC(C(O2)(C(=O)C(=O)N3CCCCC3C(=O)OC(C(C(CC1=O)O)C)C(=CC4CCC(C(C4)OC)Cl)C)O)C)OC)OC)C)C
CID000054454,simvastatin,CCC(C)(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C,abnormal EEG,CID000152945,Dutasteride?,CC12CCC3C(C1CCC2C(=O)NC4=C(C=CC(=C4)C(F)(F)F)C(F)(F)F)CCC5C3(C=CC(=O)N5)C
CID000054454,simvastatin,CCC(C)(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C,Acne,CID000062924,"S-(fluoromethyl) (6S,9R,10S,11S,13S,14S,16R,17R)-6,9-difluoro-11,17-dihydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthrene-17-carbothioate",CC1CC2C3CC(C4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)SCF)O)C)O)F)C)F
CID000054454,simvastatin,CCC(C)(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C,dry skin,CID000060754,Gadodiamide hydrate,CNC(=O)CN(CCN(CCN(CC(=O)NC)CC(=O)[O-])CC(=O)[O-])CC(=O)[O-].O.[Gd+3]
CID000054454,simvastatin,CCC(C)(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C,gastric inflammation,CID000057469,IMIQUIMOD,CC(C)CN1C=NC2=C1C3=CC=CC=C3N=C2N
CID000054454,simvastatin,CCC(C)(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C,Adenopathy,CID000065999,Telmisartan,CCCC1=NC2=C(N1CC3=CC=C(C=C3)C4=CC=CC=C4C(=O)O)C=C(C=C2C)C5=NC6=CC=CC=C6N5C
CID000054454,simvastatin,CCC(C)(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C,Back Ache,CID000160051,Colesevelam,CCCCCCCCCCNCC=C.C[N+](C)(C)CCCCCCNCC=C.C=CCN.C1C(O1)CCl.Cl.[Cl-]
CID000054454,simvastatin,CCC(C)(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C,atelectasis,CID005481350,Tenofovir disoproxil,CC(C)OC(=O)OCOP(=O)(COC(C)CN1C=NC2=C(N=CN=C21)N)OCOC(=O)OC(C)C
CID000054454,simvastatin,CCC(C)(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C,myelodysplasia,CID006398525,,C(C1C(C(C(C(O1)OC2(C(C(C(O2)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)COS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.[Al].[Al].[Al].[Al].[Al].[Al].[Al].[Al].[Al]
CID000054454,simvastatin,CCC(C)(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C,loss of weight,CID000071616,Voriconazole,CC(C1=NC=NC=C1F)C(CN2C=NC=N2)(C3=C(C=C(C=C3)F)F)O
CID000054454,simvastatin,CCC(C)(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C,loss of weight,CID004659568,"2-cyano-3-(3,4-dihydroxy-5-nitrophenyl)-N,N-diethylprop-2-enamide",CCN(CC)C(=O)C(=CC1=CC(=C(C(=C1)O)O)[N+](=O)[O-])C#N
CID000054454,simvastatin,CCC(C)(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C,hematoma subdural,CID000444013,GADOVERSETAMIDE,COCCNC(=O)CN(CCN(CCN(CC(=O)NCCOC)CC(=O)[O-])CC(=O)[O-])CC(=O)[O-].[Gd+3]
CID000054454,simvastatin,CCC(C)(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C,gastric inflammation,CID000163742,SCHEMBL1650579,COC1C(C(C(C(O1)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)COS(=O)(=O)O)OC4C(C(C(C(O4)C(=O)O)OC5C(C(C(C(O5)COS(=O)(=O)O)O)O)NS(=O)(=O)O)O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O)NS(=O)(=O)O
CID000054454,simvastatin,CCC(C)(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C,weight gain,CID000115237,Paliperidone,CC1=C(C(=O)N2CCCC(C2=N1)O)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F
CID000054454,simvastatin,CCC(C)(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C,Adenopathy,CID000087177,"D-Fructose, 4-O-alpha-D-glucopyranosyl-",C(C1C(C(C(C(O1)OC(C(CO)O)C(C(=O)CO)O)O)O)O)O
CID000054454,simvastatin,CCC(C)(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C,angiitis,CID005381226,"[(7S,9E,11S,12R,13S,14R,15R,16R,17S,18S,19E,21Z,26E)-2,15,17,29-tetrahydroxy-11-methoxy-3,7,12,14,16,18,22-heptamethyl-26-[[(4-methylpiperazin-1-yl)amino]methylidene]-6,23,27-trioxo-8,30-dioxa-24-azatetracyclo[23.3.1.14,7.05,28]triaconta-1(28),2,4,9,19,21,25(29)-heptaen-13-yl] acetate",CC1C=CC=C(C(=O)NC2=C(C3=C(C4=C(C(=C3O)C)OC(C4=O)(OC=CC(C(C(C(C(C(C1O)C)O)C)OC(=O)C)C)OC)C)C(=O)C2=CNN5CCN(CC5)C)O)C
CID000054454,simvastatin,CCC(C)(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C,back injury,CID000125017,Desvenlafaxine,CN(C)CC(C1=CC=C(C=C1)O)C2(CCCCC2)O
CID000054454,simvastatin,CCC(C)(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C,loss of weight,CID000057537,92206-54-7,CCCN(CCC1=CC=CS1)C2CCC3=C(C2)C=CC=C3O
CID000054454,simvastatin,CCC(C)(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C,loss of weight,CID000071329,Dofetilide,CN(CCC1=CC=C(C=C1)NS(=O)(=O)C)CCOC2=CC=C(C=C2)NS(=O)(=O)C
CID000054454,simvastatin,CCC(C)(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C,angina,CID000122316,1875-50-9,C#CCNC1CCC2=CC=CC=C12
CID000054454,simvastatin,CCC(C)(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C,abnormal ECG,CID000147912,DSSTox_GSID_49066,CCC(C(C)O)N1C(=O)N(C=N1)C2=CC=C(C=C2)N3CCN(CC3)C4=CC=C(C=C4)OCC5CC(OC5)(CN6C=NC=N6)C7=C(C=C(C=C7)F)F
CID000054454,simvastatin,CCC(C)(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C,back injury,CID000060865,(E)-Olopatadine,CN(C)CCC=C1C2=CC=CC=C2COC3=C1C=C(C=C3)CC(=O)O
CID000054454,simvastatin,CCC(C)(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C,Adenopathy,CID005311048,SCHEMBL11440306,C(N)(N)(Cl)Cl
CID000065999,Telmisartan,CCCC1=NC2=C(N1CC3=CC=C(C=C3)C4=CC=CC=C4C(=O)O)C=C(C=C2C)C5=NC6=CC=CC=C6N5C,abnormal ECG,CID000110635,Tadalafil,CN1CC(=O)N2C(C1=O)CC3=C(C2C4=CC5=C(C=C4)OCO5)NC6=CC=CC=C36
CID000065999,Telmisartan,CCCC1=NC2=C(N1CC3=CC=C(C=C3)C4=CC=CC=C4C(=O)O)C=C(C=C2C)C5=NC6=CC=CC=C6N5C,Arrhythmia,CID000071329,Dofetilide,CN(CCC1=CC=C(C=C1)NS(=O)(=O)C)CCOC2=CC=C(C=C2)NS(=O)(=O)C
CID000065999,Telmisartan,CCCC1=NC2=C(N1CC3=CC=C(C=C3)C4=CC=CC=C4C(=O)O)C=C(C=C2C)C5=NC6=CC=CC=C6N5C,loss of weight,CID000087177,"D-Fructose, 4-O-alpha-D-glucopyranosyl-",C(C1C(C(C(C(O1)OC(C(CO)O)C(C(=O)CO)O)O)O)O)O
CID000065999,Telmisartan,CCCC1=NC2=C(N1CC3=CC=C(C=C3)C4=CC=CC=C4C(=O)O)C=C(C=C2C)C5=NC6=CC=CC=C6N5C,acute kidney failure,CID000152945,Dutasteride?,CC12CCC3C(C1CCC2C(=O)NC4=C(C=CC(=C4)C(F)(F)F)C(F)(F)F)CCC5C3(C=CC(=O)N5)C
CID000065999,Telmisartan,CCCC1=NC2=C(N1CC3=CC=C(C=C3)C4=CC=CC=C4C(=O)O)C=C(C=C2C)C5=NC6=CC=CC=C6N5C,High blood pressure,CID003468412,SCHEMBL1176571,CC1C=CC=CCCC=CC=CC=CC=CC(CC(C(C(CC(=O)CC(C(CCC(CC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)C(=O)O)O)OC2C(C(C(C(O2)C)O)N)O
CID000065999,Telmisartan,CCCC1=NC2=C(N1CC3=CC=C(C=C3)C4=CC=CC=C4C(=O)O)C=C(C=C2C)C5=NC6=CC=CC=C6N5C,nausea,CID000125017,Desvenlafaxine,CN(C)CC(C1=CC=C(C=C1)O)C2(CCCCC2)O
CID000065999,Telmisartan,CCCC1=NC2=C(N1CC3=CC=C(C=C3)C4=CC=CC=C4C(=O)O)C=C(C=C2C)C5=NC6=CC=CC=C6N5C,abnormal ECG,CID000163742,SCHEMBL1650579,COC1C(C(C(C(O1)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)COS(=O)(=O)O)OC4C(C(C(C(O4)C(=O)O)OC5C(C(C(C(O5)COS(=O)(=O)O)O)O)NS(=O)(=O)O)O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O)NS(=O)(=O)O
CID000065999,Telmisartan,CCCC1=NC2=C(N1CC3=CC=C(C=C3)C4=CC=CC=C4C(=O)O)C=C(C=C2C)C5=NC6=CC=CC=C6N5C,Sinus headache,CID000077999,rosiglitazone,CN(CCOC1=CC=C(C=C1)CC2C(=O)NC(=O)S2)C3=CC=CC=N3
CID000065999,Telmisartan,CCCC1=NC2=C(N1CC3=CC=C(C=C3)C4=CC=CC=C4C(=O)O)C=C(C=C2C)C5=NC6=CC=CC=C6N5C,atelectasis,CID005311048,SCHEMBL11440306,C(N)(N)(Cl)Cl
CID000065999,Telmisartan,CCCC1=NC2=C(N1CC3=CC=C(C=C3)C4=CC=CC=C4C(=O)O)C=C(C=C2C)C5=NC6=CC=CC=C6N5C,loss of weight,CID000170361,Varenicline,C1C2CNCC1C3=CC4=NC=CN=C4C=C23
CID000065999,Telmisartan,CCCC1=NC2=C(N1CC3=CC=C(C=C3)C4=CC=CC=C4C(=O)O)C=C(C=C2C)C5=NC6=CC=CC=C6N5C,apoplexy,CID005493444,Aliskiren,CC(C)C(CC1=CC(=C(C=C1)OC)OCCCOC)CC(C(CC(C(C)C)C(=O)NCC(C)(C)C(=O)N)O)N
CID000065999,Telmisartan,CCCC1=NC2=C(N1CC3=CC=C(C=C3)C4=CC=CC=C4C(=O)O)C=C(C=C2C)C5=NC6=CC=CC=C6N5C,neumonia,CID000160051,Colesevelam,CCCCCCCCCCNCC=C.C[N+](C)(C)CCCCCCNCC=C.C=CCN.C1C(O1)CCl.Cl.[Cl-]
CID000065999,Telmisartan,CCCC1=NC2=C(N1CC3=CC=C(C=C3)C4=CC=CC=C4C(=O)O)C=C(C=C2C)C5=NC6=CC=CC=C6N5C,acute brain syndrome,CID000071616,Voriconazole,CC(C1=NC=NC=C1F)C(CN2C=NC=N2)(C3=C(C=C(C=C3)F)F)O
CID000065999,Telmisartan,CCCC1=NC2=C(N1CC3=CC=C(C=C3)C4=CC=CC=C4C(=O)O)C=C(C=C2C)C5=NC6=CC=CC=C6N5C,atelectasis,CID006398525,,C(C1C(C(C(C(O1)OC2(C(C(C(O2)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)COS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.[Al].[Al].[Al].[Al].[Al].[Al].[Al].[Al].[Al]
CID000005076,162990-01-4,CC(C)C1=NC(=CS1)CN(C)C(=O)NC(C(C)C)C(=O)NC(CC2=CC=CC=C2)CC(C(CC3=CC=CC=C3)NC(=O)OCC4=CN=CS4)O,ADVERSE DRUG EFFECT,CID000071616,Voriconazole,CC(C1=NC=NC=C1F)C(CN2C=NC=N2)(C3=C(C=C(C=C3)F)F)O
CID000005076,162990-01-4,CC(C)C1=NC(=CS1)CN(C)C(=O)NC(C(C)C)C(=O)NC(CC2=CC=CC=C2)CC(C(CC3=CC=CC=C3)NC(=O)OCC4=CN=CS4)O,acute pancreatitis,CID000074989,ATOVAQUONE,C1CC(CCC1C2=CC=C(C=C2)Cl)C3=C(C4=CC=CC=C4C(=O)C3=O)O
CID000005076,162990-01-4,CC(C)C1=NC(=CS1)CN(C)C(=O)NC(C(C)C)C(=O)NC(CC2=CC=CC=C2)CC(C(CC3=CC=CC=C3)NC(=O)OCC4=CN=CS4)O,Arrhythmia,CID000005245,Risedronic acid,C1=CC(=CN=C1)CC(O)(P(=O)(O)O)P(=O)(O)O
CID000005076,162990-01-4,CC(C)C1=NC(=CS1)CN(C)C(=O)NC(C(C)C)C(=O)NC(CC2=CC=CC=C2)CC(C(CC3=CC=CC=C3)NC(=O)OCC4=CN=CS4)O,loss of weight,CID003468412,SCHEMBL1176571,CC1C=CC=CCCC=CC=CC=CC=CC(CC(C(C(CC(=O)CC(C(CCC(CC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)C(=O)O)O)OC2C(C(C(C(O2)C)O)N)O
CID000005076,162990-01-4,CC(C)C1=NC(=CS1)CN(C)C(=O)NC(C(C)C)C(=O)NC(CC2=CC=CC=C2)CC(C(CC3=CC=CC=C3)NC(=O)OCC4=CN=CS4)O,haemorrhage intracranial,CID000005152,Salmeterol,C1=CC=C(C=C1)CCCCOCCCCCCNCC(C2=CC(=C(C=C2)O)CO)O
CID000005076,162990-01-4,CC(C)C1=NC(=CS1)CN(C)C(=O)NC(C(C)C)C(=O)NC(CC2=CC=CC=C2)CC(C(CC3=CC=CC=C3)NC(=O)OCC4=CN=CS4)O,Acidosis,CID000077999,rosiglitazone,CN(CCOC1=CC=C(C=C1)CC2C(=O)NC(=O)S2)C3=CC=CC=N3
CID000005076,162990-01-4,CC(C)C1=NC(=CS1)CN(C)C(=O)NC(C(C)C)C(=O)NC(CC2=CC=CC=C2)CC(C(CC3=CC=CC=C3)NC(=O)OCC4=CN=CS4)O,loss of weight,CID000005523,Ultram,CN(C)CC1CCCCC1(C2=CC(=CC=C2)OC)O
CID000005076,162990-01-4,CC(C)C1=NC(=CS1)CN(C)C(=O)NC(C(C)C)C(=O)NC(CC2=CC=CC=C2)CC(C(CC3=CC=CC=C3)NC(=O)OCC4=CN=CS4)O,nasopharyngitis,CID000005391,temazepam,CN1C2=C(C=C(C=C2)Cl)C(=NC(C1=O)O)C3=CC=CC=C3
CID000005076,162990-01-4,CC(C)C1=NC(=CS1)CN(C)C(=O)NC(C(C)C)C(=O)NC(CC2=CC=CC=C2)CC(C(CC3=CC=CC=C3)NC(=O)OCC4=CN=CS4)O,drug toxicity NOS,CID000008953,sodium;hydrogen carbonate,C(=O)(O)[O-].[Na+]
CID000005076,162990-01-4,CC(C)C1=NC(=CS1)CN(C)C(=O)NC(C(C)C)C(=O)NC(CC2=CC=CC=C2)CC(C(CC3=CC=CC=C3)NC(=O)OCC4=CN=CS4)O,cholecystitis,CID000005732,zolpidem,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C
CID000005076,162990-01-4,CC(C)C1=NC(=CS1)CN(C)C(=O)NC(C(C)C)C(=O)NC(CC2=CC=CC=C2)CC(C(CC3=CC=CC=C3)NC(=O)OCC4=CN=CS4)O,hepatitis,CID000060854,Ziprasidone,C1CN(CCN1CCC2=C(C=C3C(=C2)CC(=O)N3)Cl)C4=NSC5=CC=CC=C54
CID000005076,162990-01-4,CC(C)C1=NC(=CS1)CN(C)C(=O)NC(C(C)C)C(=O)NC(CC2=CC=CC=C2)CC(C(CC3=CC=CC=C3)NC(=O)OCC4=CN=CS4)O,Bleeding,CID000010631,medroxyprogesterone,CC1CC2C(CCC3(C2CCC3(C(=O)C)O)C)C4(C1=CC(=O)CC4)C
CID000005076,162990-01-4,CC(C)C1=NC(=CS1)CN(C)C(=O)NC(C(C)C)C(=O)NC(CC2=CC=CC=C2)CC(C(CC3=CC=CC=C3)NC(=O)OCC4=CN=CS4)O,elevated cholesterol,CID000005978,vincristine,CCC1(CC2CC(C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)C78CCN9C7C(C=CC9)(C(C(C8N6C=O)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O
CID000005076,162990-01-4,CC(C)C1=NC(=CS1)CN(C)C(=O)NC(C(C)C)C(=O)NC(CC2=CC=CC=C2)CC(C(CC3=CC=CC=C3)NC(=O)OCC4=CN=CS4)O,drug toxicity NOS,CID005311048,SCHEMBL11440306,C(N)(N)(Cl)Cl
CID000005076,162990-01-4,CC(C)C1=NC(=CS1)CN(C)C(=O)NC(C(C)C)C(=O)NC(CC2=CC=CC=C2)CC(C(CC3=CC=CC=C3)NC(=O)OCC4=CN=CS4)O,cholecystitis,CID000060787,sequinavir,CC(C)(C)NC(=O)C1CC2CCCCC2CN1CC(C(CC3=CC=CC=C3)NC(=O)C(CC(=O)N)NC(=O)C4=NC5=CC=CC=C5C=C4)O
CID000005076,162990-01-4,CC(C)C1=NC(=CS1)CN(C)C(=O)NC(C(C)C)C(=O)NC(CC2=CC=CC=C2)CC(C(CC3=CC=CC=C3)NC(=O)OCC4=CN=CS4)O,cholecystitis,CID000110635,Tadalafil,CN1CC(=O)N2C(C1=O)CC3=C(C2C4=CC5=C(C=C4)OCO5)NC6=CC=CC=C36
CID000005076,162990-01-4,CC(C)C1=NC(=CS1)CN(C)C(=O)NC(C(C)C)C(=O)NC(CC2=CC=CC=C2)CC(C(CC3=CC=CC=C3)NC(=O)OCC4=CN=CS4)O,loss of weight,CID000019090,megestrol,CC1=CC2C(CCC3(C2CCC3(C(=O)C)O)C)C4(C1=CC(=O)CC4)C
CID000005076,162990-01-4,CC(C)C1=NC(=CS1)CN(C)C(=O)NC(C(C)C)C(=O)NC(CC2=CC=CC=C2)CC(C(CC3=CC=CC=C3)NC(=O)OCC4=CN=CS4)O,night blindness,CID000170361,Varenicline,C1C2CNCC1C3=CC4=NC=CN=C4C=C23
CID000005076,162990-01-4,CC(C)C1=NC(=CS1)CN(C)C(=O)NC(C(C)C)C(=O)NC(CC2=CC=CC=C2)CC(C(CC3=CC=CC=C3)NC(=O)OCC4=CN=CS4)O,cholelithiasis,CID000005771,Oxytocin acetate salt hydrate,CCC(C)C1C(=O)NC(C(=O)NC(C(=O)NC(CSSCC(C(=O)NC(C(=O)N1)CC2=CC=C(C=C2)O)N)C(=O)N3CCCC3C(=O)NC(CC(C)C)C(=O)NCC(=O)N)CC(=O)N)CCC(=O)N
CID000005076,162990-01-4,CC(C)C1=NC(=CS1)CN(C)C(=O)NC(C(C)C)C(=O)NC(CC2=CC=CC=C2)CC(C(CC3=CC=CC=C3)NC(=O)OCC4=CN=CS4)O,Adenopathy,CID000062924,"S-(fluoromethyl) (6S,9R,10S,11S,13S,14S,16R,17R)-6,9-difluoro-11,17-dihydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthrene-17-carbothioate",CC1CC2C3CC(C4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)SCF)O)C)O)F)C)F
CID000005076,162990-01-4,CC(C)C1=NC(=CS1)CN(C)C(=O)NC(C(C)C)C(=O)NC(CC2=CC=CC=C2)CC(C(CC3=CC=CC=C3)NC(=O)OCC4=CN=CS4)O,erythema,CID000038904,Carboplatinum,C1CC(C1)(C(=O)O)C(=O)O.N.N.[Pt]
CID000005076,162990-01-4,CC(C)C1=NC(=CS1)CN(C)C(=O)NC(C(C)C)C(=O)NC(CC2=CC=CC=C2)CC(C(CC3=CC=CC=C3)NC(=O)OCC4=CN=CS4)O,bulging,CID000005512,124936-74-9,CC1=CC(=C(C=C1)O)C(CCN(C(C)C)C(C)C)C2=CC=CC=C2
CID000005076,162990-01-4,CC(C)C1=NC(=CS1)CN(C)C(=O)NC(C(C)C)C(=O)NC(CC2=CC=CC=C2)CC(C(CC3=CC=CC=C3)NC(=O)OCC4=CN=CS4)O,loss of weight,CID000005878,OXANDROLONE,CC12CCC3C(C1CCC2(C)O)CCC4C3(COC(=O)C4)C
CID000005076,162990-01-4,CC(C)C1=NC(=CS1)CN(C)C(=O)NC(C(C)C)C(=O)NC(CC2=CC=CC=C2)CC(C(CC3=CC=CC=C3)NC(=O)OCC4=CN=CS4)O,apoplexy,CID000005650,N-pentanoyl-N-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-L-valine,CCCCC(=O)N(CC1=CC=C(C=C1)C2=CC=CC=C2C3=NNN=N3)C(C(C)C)C(=O)O
CID000005076,162990-01-4,CC(C)C1=NC(=CS1)CN(C)C(=O)NC(C(C)C)C(=O)NC(CC2=CC=CC=C2)CC(C(CC3=CC=CC=C3)NC(=O)OCC4=CN=CS4)O,nephrosclerosis,CID000027686,CHEMBL4088679,C1=CC2=C(C(=C1)OCC(COC3=CC4=C(C=C3)OC(=CC4=O)C(=O)O)O)C(=O)C=C(O2)C(=O)O
CID000005076,162990-01-4,CC(C)C1=NC(=CS1)CN(C)C(=O)NC(C(C)C)C(=O)NC(CC2=CC=CC=C2)CC(C(CC3=CC=CC=C3)NC(=O)OCC4=CN=CS4)O,gallbladder cancer,CID000005095,ropinirole,CCCN(CCC)CCC1=C2CC(=O)NC2=CC=C1
CID000005076,162990-01-4,CC(C)C1=NC(=CS1)CN(C)C(=O)NC(C(C)C)C(=O)NC(CC2=CC=CC=C2)CC(C(CC3=CC=CC=C3)NC(=O)OCC4=CN=CS4)O,eruption,CID000060865,(E)-Olopatadine,CN(C)CCC=C1C2=CC=CC=C2COC3=C1C=C(C=C3)CC(=O)O
CID000005076,162990-01-4,CC(C)C1=NC(=CS1)CN(C)C(=O)NC(C(C)C)C(=O)NC(CC2=CC=CC=C2)CC(C(CC3=CC=CC=C3)NC(=O)OCC4=CN=CS4)O,loss of weight,CID005381226,"[(7S,9E,11S,12R,13S,14R,15R,16R,17S,18S,19E,21Z,26E)-2,15,17,29-tetrahydroxy-11-methoxy-3,7,12,14,16,18,22-heptamethyl-26-[[(4-methylpiperazin-1-yl)amino]methylidene]-6,23,27-trioxo-8,30-dioxa-24-azatetracyclo[23.3.1.14,7.05,28]triaconta-1(28),2,4,9,19,21,25(29)-heptaen-13-yl] acetate",CC1C=CC=C(C(=O)NC2=C(C3=C(C4=C(C(=C3O)C)OC(C4=O)(OC=CC(C(C(C(C(C(C1O)C)O)C)OC(=O)C)C)OC)C)C(=O)C2=CNN5CCN(CC5)C)O)C
CID000005076,162990-01-4,CC(C)C1=NC(=CS1)CN(C)C(=O)NC(C(C)C)C(=O)NC(CC2=CC=CC=C2)CC(C(CC3=CC=CC=C3)NC(=O)OCC4=CN=CS4)O,thrombocytopenia,CID000005544,Mycolog,CC12CC(C3(C(C1CC(C2(C(=O)CO)O)O)CCC4=CC(=O)C=CC43C)F)O
CID000005076,162990-01-4,CC(C)C1=NC(=CS1)CN(C)C(=O)NC(C(C)C)C(=O)NC(CC2=CC=CC=C2)CC(C(CC3=CC=CC=C3)NC(=O)OCC4=CN=CS4)O,gout,CID000005358,sumatriptan,CNS(=O)(=O)CC1=CC2=C(C=C1)NC=C2CCN(C)C
CID000005076,162990-01-4,CC(C)C1=NC(=CS1)CN(C)C(=O)NC(C(C)C)C(=O)NC(CC2=CC=CC=C2)CC(C(CC3=CC=CC=C3)NC(=O)OCC4=CN=CS4)O,cerebral vascular disorder,CID000147912,DSSTox_GSID_49066,CCC(C(C)O)N1C(=O)N(C=N1)C2=CC=C(C=C2)N3CCN(CC3)C4=CC=C(C=C4)OCC5CC(OC5)(CN6C=NC=N6)C7=C(C=C(C=C7)F)F
CID000005076,162990-01-4,CC(C)C1=NC(=CS1)CN(C)C(=O)NC(C(C)C)C(=O)NC(CC2=CC=CC=C2)CC(C(CC3=CC=CC=C3)NC(=O)OCC4=CN=CS4)O,enlarged liver,CID000057469,IMIQUIMOD,CC(C)CN1C=NC2=C1C3=CC=CC=C3N=C2N
CID000005076,162990-01-4,CC(C)C1=NC(=CS1)CN(C)C(=O)NC(C(C)C)C(=O)NC(CC2=CC=CC=C2)CC(C(CC3=CC=CC=C3)NC(=O)OCC4=CN=CS4)O,Adenopathy,CID000131536,Fosamprenavir,CC(C)CN(CC(C(CC1=CC=CC=C1)NC(=O)OC2CCOC2)OP(=O)(O)O)S(=O)(=O)C3=CC=C(C=C3)N
CID000005076,162990-01-4,CC(C)C1=NC(=CS1)CN(C)C(=O)NC(C(C)C)C(=O)NC(CC2=CC=CC=C2)CC(C(CC3=CC=CC=C3)NC(=O)OCC4=CN=CS4)O,enlarged liver,CID000060184,"2'-epi-Perindopril, (2'R)-",CCCC(C(=O)OCC)NC(C)C(=O)N1C2CCCCC2CC1C(=O)O
CID000005076,162990-01-4,CC(C)C1=NC(=CS1)CN(C)C(=O)NC(C(C)C)C(=O)NC(CC2=CC=CC=C2)CC(C(CC3=CC=CC=C3)NC(=O)OCC4=CN=CS4)O,pulmonary hypertension,CID000152945,Dutasteride?,CC12CCC3C(C1CCC2C(=O)NC4=C(C=CC(=C4)C(F)(F)F)C(F)(F)F)CCC5C3(C=CC(=O)N5)C
CID000005076,162990-01-4,CC(C)C1=NC(=CS1)CN(C)C(=O)NC(C(C)C)C(=O)NC(CC2=CC=CC=C2)CC(C(CC3=CC=CC=C3)NC(=O)OCC4=CN=CS4)O,gastric inflammation,CID000065027,N-[3-[(1R)-1-[(2R)-6-hydroxy-4-oxo-2-(2-phenylethyl)-2-propyl-3H-pyran-5-yl]propyl]phenyl]-5-(trifluoromethyl)pyridine-2-sulfonamide,CCCC1(CC(=O)C(=C(O1)O)C(CC)C2=CC(=CC=C2)NS(=O)(=O)C3=NC=C(C=C3)C(F)(F)F)CCC4=CC=CC=C4
CID000005076,162990-01-4,CC(C)C1=NC(=CS1)CN(C)C(=O)NC(C(C)C)C(=O)NC(CC2=CC=CC=C2)CC(C(CC3=CC=CC=C3)NC(=O)OCC4=CN=CS4)O,acute pancreatitis,CID000005645,"3,7-Dihydroxycholan-24-oic acid",CC(CCC(=O)O)C1CCC2C1(CCC3C2C(CC4C3(CCC(C4)O)C)O)C
CID000005076,162990-01-4,CC(C)C1=NC(=CS1)CN(C)C(=O)NC(C(C)C)C(=O)NC(CC2=CC=CC=C2)CC(C(CC3=CC=CC=C3)NC(=O)OCC4=CN=CS4)O,gastric inflammation,CID005481350,Tenofovir disoproxil,CC(C)OC(=O)OCOP(=O)(COC(C)CN1C=NC2=C(N=CN=C21)N)OCOC(=O)OC(C)C
CID000005076,162990-01-4,CC(C)C1=NC(=CS1)CN(C)C(=O)NC(C(C)C)C(=O)NC(CC2=CC=CC=C2)CC(C(CC3=CC=CC=C3)NC(=O)OCC4=CN=CS4)O,loss of weight,CID000087177,"D-Fructose, 4-O-alpha-D-glucopyranosyl-",C(C1C(C(C(C(O1)OC(C(CO)O)C(C(=O)CO)O)O)O)O)O
CID000003958,lorazepam,C1=CC=C(C(=C1)C2=NC(C(=O)NC3=C2C=C(C=C3)Cl)O)Cl,dizziness,CID000027686,CHEMBL4088679,C1=CC2=C(C(=C1)OCC(COC3=CC4=C(C=C3)OC(=CC4=O)C(=O)O)O)C(=O)C=C(O2)C(=O)O
CID000003958,lorazepam,C1=CC=C(C(=C1)C2=NC(C(=O)NC3=C2C=C(C=C3)Cl)O)Cl,failure to thrive,CID000163742,SCHEMBL1650579,COC1C(C(C(C(O1)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)COS(=O)(=O)O)OC4C(C(C(C(O4)C(=O)O)OC5C(C(C(C(O5)COS(=O)(=O)O)O)O)NS(=O)(=O)O)O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O)NS(=O)(=O)O
CID000003958,lorazepam,C1=CC=C(C(=C1)C2=NC(C(=O)NC3=C2C=C(C=C3)Cl)O)Cl,cholecystitis,CID000005512,124936-74-9,CC1=CC(=C(C=C1)O)C(CCN(C(C)C)C(C)C)C2=CC=CC=C2
CID000003958,lorazepam,C1=CC=C(C(=C1)C2=NC(C(=O)NC3=C2C=C(C=C3)Cl)O)Cl,enlarged liver,CID000131536,Fosamprenavir,CC(C)CN(CC(C(CC1=CC=CC=C1)NC(=O)OC2CCOC2)OP(=O)(O)O)S(=O)(=O)C3=CC=C(C=C3)N
CID000003958,lorazepam,C1=CC=C(C(=C1)C2=NC(C(=O)NC3=C2C=C(C=C3)Cl)O)Cl,dysarthria,CID000115237,Paliperidone,CC1=C(C(=O)N2CCCC(C2=N1)O)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F
CID000003958,lorazepam,C1=CC=C(C(=C1)C2=NC(C(=O)NC3=C2C=C(C=C3)Cl)O)Cl,Back Ache,CID005311082,"2-[(1R,4S,10S,13S,19S)-19-[4-(diaminomethylideneamino)butyl]-10-(1H-indol-3-ylmethyl)-3,9,12,15,18,21,27-heptaoxo-24,25-dithia-2,8,11,14,17,20-hexazatricyclo[18.6.1.04,8]heptacosan-13-yl]acetic acid",C1CC2C(=O)NC3CSSCCC(=O)N(C3=O)C(C(=O)NCC(=O)NC(C(=O)NC(C(=O)N2C1)CC4=CNC5=CC=CC=C54)CC(=O)O)CCCCN=C(N)N
CID000003958,lorazepam,C1=CC=C(C(=C1)C2=NC(C(=O)NC3=C2C=C(C=C3)Cl)O)Cl,hypermagnesemia,CID000119182,Clofarabine,C1=NC2=C(N=C(N=C2N1C3C(C(C(O3)CO)O)F)Cl)N
CID000003958,lorazepam,C1=CC=C(C(=C1)C2=NC(C(=O)NC3=C2C=C(C=C3)Cl)O)Cl,apoplexy,CID000004138,55-40-3,CC(CC1=CC(=C(C=C1)O)O)(C(=O)O)N
CID000003958,lorazepam,C1=CC=C(C(=C1)C2=NC(C(=O)NC3=C2C=C(C=C3)Cl)O)Cl,cholecystitis,CID000060854,Ziprasidone,C1CN(CCN1CCC2=C(C=C3C(=C2)CC(=O)N3)Cl)C4=NSC5=CC=CC=C54
CID000003958,lorazepam,C1=CC=C(C(=C1)C2=NC(C(=O)NC3=C2C=C(C=C3)Cl)O)Cl,cholecystectomies,CID000060852,Ibandronic Acid,CCCCCN(C)CCC(O)(P(=O)(O)O)P(=O)(O)O
CID000003958,lorazepam,C1=CC=C(C(=C1)C2=NC(C(=O)NC3=C2C=C(C=C3)Cl)O)Cl,gastric inflammation,CID000004691,"3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine",C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4
CID000003958,lorazepam,C1=CC=C(C(=C1)C2=NC(C(=O)NC3=C2C=C(C=C3)Cl)O)Cl,gastric inflammation,CID006398525,,C(C1C(C(C(C(O1)OC2(C(C(C(O2)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)COS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.[Al].[Al].[Al].[Al].[Al].[Al].[Al].[Al].[Al]
CID000003958,lorazepam,C1=CC=C(C(=C1)C2=NC(C(=O)NC3=C2C=C(C=C3)Cl)O)Cl,back injury,CID000170361,Varenicline,C1C2CNCC1C3=CC4=NC=CN=C4C=C23
CID000003958,lorazepam,C1=CC=C(C(=C1)C2=NC(C(=O)NC3=C2C=C(C=C3)Cl)O)Cl,gastric inflammation,CID000004909,primidone,CCC1(C(=O)NCNC1=O)C2=CC=CC=C2
CID000003958,lorazepam,C1=CC=C(C(=C1)C2=NC(C(=O)NC3=C2C=C(C=C3)Cl)O)Cl,atelectasis,CID000039765,Vecuronium,CC(=O)OC1CC2CCC3C(C2(CC1N4CCCCC4)C)CCC5(C3CC(C5OC(=O)C)[N+]6(CCCCC6)C)C
CID000003958,lorazepam,C1=CC=C(C(=C1)C2=NC(C(=O)NC3=C2C=C(C=C3)Cl)O)Cl,gastric inflammation,CID000004679,pantoprazole,COC1=C(C(=NC=C1)CS(=O)C2=NC3=C(N2)C=C(C=C3)OC(F)F)OC
CID000003958,lorazepam,C1=CC=C(C(=C1)C2=NC(C(=O)NC3=C2C=C(C=C3)Cl)O)Cl,atelectasis,CID000036339,Etomidate,CCOC(=O)C1=CN=CN1C(C)C2=CC=CC=C2
CID000003958,lorazepam,C1=CC=C(C(=C1)C2=NC(C(=O)NC3=C2C=C(C=C3)Cl)O)Cl,methaemoglobinaemia,CID000004856,"3-[hydroxy-(pyridin-2-ylamino)methylidene]-2-methyl-1,1-dioxo-1lambda6,2-benzothiazin-4-one",CN1C(=C(NC2=CC=CC=N2)O)C(=O)C3=CC=CC=C3S1(=O)=O
CID000003958,lorazepam,C1=CC=C(C(=C1)C2=NC(C(=O)NC3=C2C=C(C=C3)Cl)O)Cl,cholecystitis,CID000004585,"2-methyl-4-(4-methylpiperazin-1-yl)-5H-thieno[3,2-c][1,5]benzodiazepine",CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C
CID000003958,lorazepam,C1=CC=C(C(=C1)C2=NC(C(=O)NC3=C2C=C(C=C3)Cl)O)Cl,weight gain,CID000125017,Desvenlafaxine,CN(C)CC(C1=CC=C(C=C1)O)C2(CCCCC2)O
CID000003958,lorazepam,C1=CC=C(C(=C1)C2=NC(C(=O)NC3=C2C=C(C=C3)Cl)O)Cl,cholecystitis,CID000004739,53910-25-1,C1C(C(OC1N2C=NC3=C2NC=NCC3O)CO)O
CID000003958,lorazepam,C1=CC=C(C(=C1)C2=NC(C(=O)NC3=C2C=C(C=C3)Cl)O)Cl,loss of weight,CID000004736,Talwin,CC1C2CC3=C(C1(CCN2CC=C(C)C)C)C=C(C=C3)O
CID000003958,lorazepam,C1=CC=C(C(=C1)C2=NC(C(=O)NC3=C2C=C(C=C3)Cl)O)Cl,gastric inflammation,CID000005732,zolpidem,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C
CID000003958,lorazepam,C1=CC=C(C(=C1)C2=NC(C(=O)NC3=C2C=C(C=C3)Cl)O)Cl,Adenopathy,CID000008953,sodium;hydrogen carbonate,C(=O)(O)[O-].[Na+]
CID000003958,lorazepam,C1=CC=C(C(=C1)C2=NC(C(=O)NC3=C2C=C(C=C3)Cl)O)Cl,erythema,CID000005650,N-pentanoyl-N-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-L-valine,CCCCC(=O)N(CC1=CC=C(C=C1)C2=CC=CC=C2C3=NNN=N3)C(C(C)C)C(=O)O
CID000003958,lorazepam,C1=CC=C(C(=C1)C2=NC(C(=O)NC3=C2C=C(C=C3)Cl)O)Cl,Adenopathy,CID000038904,Carboplatinum,C1CC(C1)(C(=O)O)C(=O)O.N.N.[Pt]
CID000003958,lorazepam,C1=CC=C(C(=C1)C2=NC(C(=O)NC3=C2C=C(C=C3)Cl)O)Cl,Adenopathy,CID000004900,Fernisone,CC12CC(=O)C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C
CID000003958,lorazepam,C1=CC=C(C(=C1)C2=NC(C(=O)NC3=C2C=C(C=C3)Cl)O)Cl,gastric inflammation,CID000005195,Deprenyl,CC(CC1=CC=CC=C1)N(C)CC#C
CID000003958,lorazepam,C1=CC=C(C(=C1)C2=NC(C(=O)NC3=C2C=C(C=C3)Cl)O)Cl,gastric inflammation,CID000005376,(E/Z)-Tamoxifen,CCC(=C(C1=CC=CC=C1)C2=CC=C(C=C2)OCCN(C)C)C3=CC=CC=C3
CID000003958,lorazepam,C1=CC=C(C(=C1)C2=NC(C(=O)NC3=C2C=C(C=C3)Cl)O)Cl,thrombocytopenia,CID000036811,dobutamine,CC(CCC1=CC=C(C=C1)O)NCCC2=CC(=C(C=C2)O)O
CID000003958,lorazepam,C1=CC=C(C(=C1)C2=NC(C(=O)NC3=C2C=C(C=C3)Cl)O)Cl,drug withdrawal,CID000110635,Tadalafil,CN1CC(=O)N2C(C1=O)CC3=C(C2C4=CC5=C(C=C4)OCO5)NC6=CC=CC=C36
CID000003958,lorazepam,C1=CC=C(C(=C1)C2=NC(C(=O)NC3=C2C=C(C=C3)Cl)O)Cl,angiitis,CID000160051,Colesevelam,CCCCCCCCCCNCC=C.C[N+](C)(C)CCCCCCNCC=C.C=CCN.C1C(O1)CCl.Cl.[Cl-]
CID000003958,lorazepam,C1=CC=C(C(=C1)C2=NC(C(=O)NC3=C2C=C(C=C3)Cl)O)Cl,Adenopathy,CID000077999,rosiglitazone,CN(CCOC1=CC=C(C=C1)CC2C(=O)NC(=O)S2)C3=CC=CC=N3
CID000003958,lorazepam,C1=CC=C(C(=C1)C2=NC(C(=O)NC3=C2C=C(C=C3)Cl)O)Cl,agitated,CID000005095,ropinirole,CCCN(CCC)CCC1=C2CC(=O)NC2=CC=C1
CID000003958,lorazepam,C1=CC=C(C(=C1)C2=NC(C(=O)NC3=C2C=C(C=C3)Cl)O)Cl,Adenopathy,CID000004054,memantine,CC12CC3CC(C1)(CC(C3)(C2)N)C
CID000003958,lorazepam,C1=CC=C(C(=C1)C2=NC(C(=O)NC3=C2C=C(C=C3)Cl)O)Cl,gastric inflammation,CID000087177,"D-Fructose, 4-O-alpha-D-glucopyranosyl-",C(C1C(C(C(C(O1)OC(C(CO)O)C(C(=O)CO)O)O)O)O)O
CID000003958,lorazepam,C1=CC=C(C(=C1)C2=NC(C(=O)NC3=C2C=C(C=C3)Cl)O)Cl,loss of weight,CID000071616,Voriconazole,CC(C1=NC=NC=C1F)C(CN2C=NC=N2)(C3=C(C=C(C=C3)F)F)O
CID000003958,lorazepam,C1=CC=C(C(=C1)C2=NC(C(=O)NC3=C2C=C(C=C3)Cl)O)Cl,Adenopathy,CID000019090,megestrol,CC1=CC2C(CCC3(C2CCC3(C(=O)C)O)C)C4(C1=CC(=O)CC4)C
CID000003958,lorazepam,C1=CC=C(C(=C1)C2=NC(C(=O)NC3=C2C=C(C=C3)Cl)O)Cl,gastric inflammation,CID000005391,temazepam,CN1C2=C(C=C(C=C2)Cl)C(=NC(C1=O)O)C3=CC=CC=C3
CID000003958,lorazepam,C1=CC=C(C(=C1)C2=NC(C(=O)NC3=C2C=C(C=C3)Cl)O)Cl,gastric inflammation,CID000005394,temozolomide,CN1C(=O)N2C=NC(=C2N=N1)C(=O)N
CID000003958,lorazepam,C1=CC=C(C(=C1)C2=NC(C(=O)NC3=C2C=C(C=C3)Cl)O)Cl,apoplexy,CID000004440,naratriptan,CNS(=O)(=O)CCC1=CC2=C(C=C1)NC=C2C3CCN(CC3)C
CID000003958,lorazepam,C1=CC=C(C(=C1)C2=NC(C(=O)NC3=C2C=C(C=C3)Cl)O)Cl,angiitis,CID000005478,racemic-Timolol,CC(C)(C)NCC(COC1=NSN=C1N2CCOCC2)O
CID000003958,lorazepam,C1=CC=C(C(=C1)C2=NC(C(=O)NC3=C2C=C(C=C3)Cl)O)Cl,cholecystitis,CID000004158,methylphenidate,COC(=O)C(C1CCCCN1)C2=CC=CC=C2
CID000003958,lorazepam,C1=CC=C(C(=C1)C2=NC(C(=O)NC3=C2C=C(C=C3)Cl)O)Cl,gastric inflammation,CID000060865,(E)-Olopatadine,CN(C)CCC=C1C2=CC=CC=C2COC3=C1C=C(C=C3)CC(=O)O
CID000003958,lorazepam,C1=CC=C(C(=C1)C2=NC(C(=O)NC3=C2C=C(C=C3)Cl)O)Cl,drug toxicity NOS,CID004479097,"cobalt;[5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] 1-[3-[2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2,7,12,17-tetrahydro-1H-corrin-21-id-3-yl]propanoylamino]propan-2-yl phosphate;hydrate",CC1=CC2=C(C=C1C)N(C=N2)C3C(C(C(O3)CO)OP(=O)([O-])OC(C)CNC(=O)CCC4(C(C5C6(C(C(C(=N6)C(=C7C(C(C(=N7)C=C8C(C(C(=N8)C(=C4[N-]5)C)CCC(=O)N)(C)C)CCC(=O)N)(C)CC(=O)N)C)CCC(=O)N)(C)CC(=O)N)C)CC(=O)N)C)O.O.[Co]
CID000003958,lorazepam,C1=CC=C(C(=C1)C2=NC(C(=O)NC3=C2C=C(C=C3)Cl)O)Cl,abnormal EEG,CID000004064,meprobamate,CCCC(C)(COC(=O)N)COC(=O)N
CID000003958,lorazepam,C1=CC=C(C(=C1)C2=NC(C(=O)NC3=C2C=C(C=C3)Cl)O)Cl,nasopharyngitis,CID005481350,Tenofovir disoproxil,CC(C)OC(=O)OCOP(=O)(COC(C)CN1C=NC2=C(N=CN=C21)N)OCOC(=O)OC(C)C
CID000003958,lorazepam,C1=CC=C(C(=C1)C2=NC(C(=O)NC3=C2C=C(C=C3)Cl)O)Cl,Small intestinal obstruction,CID000147912,DSSTox_GSID_49066,CCC(C(C)O)N1C(=O)N(C=N1)C2=CC=C(C=C2)N3CCN(CC3)C4=CC=C(C=C4)OCC5CC(OC5)(CN6C=NC=N6)C7=C(C=C(C=C7)F)F
CID000003958,lorazepam,C1=CC=C(C(=C1)C2=NC(C(=O)NC3=C2C=C(C=C3)Cl)O)Cl,cholecystitis,CID000667490,6-Mercaptopurine,C1=NC2=C(N1)C(=S)N=CN2
CID000003958,lorazepam,C1=CC=C(C(=C1)C2=NC(C(=O)NC3=C2C=C(C=C3)Cl)O)Cl,gastric inflammation,CID000004614,oxaprozin,C1=CC=C(C=C1)C2=C(OC(=N2)CCC(=O)O)C3=CC=CC=C3
CID000003958,lorazepam,C1=CC=C(C(=C1)C2=NC(C(=O)NC3=C2C=C(C=C3)Cl)O)Cl,Acne,CID000005544,Mycolog,CC12CC(C3(C(C1CC(C2(C(=O)CO)O)O)CCC4=CC(=O)C=CC43C)F)O
CID000003958,lorazepam,C1=CC=C(C(=C1)C2=NC(C(=O)NC3=C2C=C(C=C3)Cl)O)Cl,apoplexy,CID000004189,miconazole,C1=CC(=C(C=C1Cl)Cl)COC(CN2C=CN=C2)C3=C(C=C(C=C3)Cl)Cl
CID000003958,lorazepam,C1=CC=C(C(=C1)C2=NC(C(=O)NC3=C2C=C(C=C3)Cl)O)Cl,Penile pain,CID000004236,modafinil,C1=CC=C(C=C1)C(C2=CC=CC=C2)S(=O)CC(=O)N
CID000003958,lorazepam,C1=CC=C(C(=C1)C2=NC(C(=O)NC3=C2C=C(C=C3)Cl)O)Cl,cholecystitis,CID000005245,Risedronic acid,C1=CC(=CN=C1)CC(O)(P(=O)(O)O)P(=O)(O)O
CID000003958,lorazepam,C1=CC=C(C(=C1)C2=NC(C(=O)NC3=C2C=C(C=C3)Cl)O)Cl,apoplexy,CID006447131,Pimecrolimus,CCC1C=C(CC(CC(C2C(CC(C(O2)(C(=O)C(=O)N3CCCCC3C(=O)OC(C(C(CC1=O)O)C)C(=CC4CCC(C(C4)OC)Cl)C)O)C)OC)OC)C)C
CID000003958,lorazepam,C1=CC=C(C(=C1)C2=NC(C(=O)NC3=C2C=C(C=C3)Cl)O)Cl,Back Ache,CID000004920,"1-acetyl-9a,11a-dimethyl-1H,2H,3H,3aH,3bH,4H,5H,7H,8H,9H,9aH,9bH,10H,11H,11aH-cyclopenta[a]phenanthren-7-one",CC(=O)C1CCC2C1(CCC3C2CCC4=CC(=O)CCC34C)C
CID000003958,lorazepam,C1=CC=C(C(=C1)C2=NC(C(=O)NC3=C2C=C(C=C3)Cl)O)Cl,cholecystitis,CID000004927,promethazine,CC(CN1C2=CC=CC=C2SC3=CC=CC=C31)N(C)C
CID000003958,lorazepam,C1=CC=C(C(=C1)C2=NC(C(=O)NC3=C2C=C(C=C3)Cl)O)Cl,gastric inflammation,CID000004510,nitroglycerin,C(C(CO[N+](=O)[O-])O[N+](=O)[O-])O[N+](=O)[O-]
CID000003958,lorazepam,C1=CC=C(C(=C1)C2=NC(C(=O)NC3=C2C=C(C=C3)Cl)O)Cl,apoplexy,CID000009052,2-hydroxy-3-[1-(4-nitrophenyl)-3-oxobutyl]chromen-4-one,CC(=O)CC(C1=CC=C(C=C1)[N+](=O)[O-])C2=C(OC3=CC=CC=C3C2=O)O
CID000003958,lorazepam,C1=CC=C(C(=C1)C2=NC(C(=O)NC3=C2C=C(C=C3)Cl)O)Cl,gastric inflammation,CID000003961,losartan,CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)CO)Cl
CID000003958,lorazepam,C1=CC=C(C(=C1)C2=NC(C(=O)NC3=C2C=C(C=C3)Cl)O)Cl,cholecystitis,CID000004666,7-Epi Paclitaxel,CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C
CID000003958,lorazepam,C1=CC=C(C(=C1)C2=NC(C(=O)NC3=C2C=C(C=C3)Cl)O)Cl,gastric inflammation,CID000005073,risperidone,CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F
CID000003958,lorazepam,C1=CC=C(C(=C1)C2=NC(C(=O)NC3=C2C=C(C=C3)Cl)O)Cl,abnormal ECG,CID000005077,105601-20-5,CCN(C)C(=O)OC1=CC=CC(=C1)C(C)N(C)C
CID000003958,lorazepam,C1=CC=C(C(=C1)C2=NC(C(=O)NC3=C2C=C(C=C3)Cl)O)Cl,Pain,CID000122316,1875-50-9,C#CCNC1CCC2=CC=CC=C12
CID000003958,lorazepam,C1=CC=C(C(=C1)C2=NC(C(=O)NC3=C2C=C(C=C3)Cl)O)Cl,neumonia,CID000005878,OXANDROLONE,CC12CCC3C(C1CCC2(C)O)CCC4C3(COC(=O)C4)C
CID000003958,lorazepam,C1=CC=C(C(=C1)C2=NC(C(=O)NC3=C2C=C(C=C3)Cl)O)Cl,Abdominal hernia,CID000004201,minoxidil,C1CCN(CC1)C2=NC(=N)N(C(=C2)N)O
CID000003958,lorazepam,C1=CC=C(C(=C1)C2=NC(C(=O)NC3=C2C=C(C=C3)Cl)O)Cl,cholecystitis,CID000004205,mirtazapine,CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4
CID000003958,lorazepam,C1=CC=C(C(=C1)C2=NC(C(=O)NC3=C2C=C(C=C3)Cl)O)Cl,gastric inflammation,CID005311048,SCHEMBL11440306,C(N)(N)(Cl)Cl
CID000003958,lorazepam,C1=CC=C(C(=C1)C2=NC(C(=O)NC3=C2C=C(C=C3)Cl)O)Cl,cholecystitis,CID000004748,perphenazine,C1CN(CCN1CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)Cl)CCO
CID000003958,lorazepam,C1=CC=C(C(=C1)C2=NC(C(=O)NC3=C2C=C(C=C3)Cl)O)Cl,Hepatic failure,CID000051263,ALFENTANIL,CCC(=O)N(C1=CC=CC=C1)C2(CCN(CC2)CCN3C(=O)N(N=N3)CC)COC
CID000003958,lorazepam,C1=CC=C(C(=C1)C2=NC(C(=O)NC3=C2C=C(C=C3)Cl)O)Cl,cholecystitis,CID000004173,metronidazole,CC1=NC=C(N1CCO)[N+](=O)[O-]
CID000003958,lorazepam,C1=CC=C(C(=C1)C2=NC(C(=O)NC3=C2C=C(C=C3)Cl)O)Cl,eruption,CID000057537,92206-54-7,CCCN(CCC1=CC=CS1)C2CCC3=C(C2)C=CC=C3O
CID000003958,lorazepam,C1=CC=C(C(=C1)C2=NC(C(=O)NC3=C2C=C(C=C3)Cl)O)Cl,angiitis,CID000004542,norgestrel,CCC12CCC3C(C1CCC2(C#C)O)CCC4=CC(=O)CCC34
CID000003958,lorazepam,C1=CC=C(C(=C1)C2=NC(C(=O)NC3=C2C=C(C=C3)Cl)O)Cl,cholecystitis,CID000004543,nortriptyline,CNCCC=C1C2=CC=CC=C2CCC3=CC=CC=C31
CID000003958,lorazepam,C1=CC=C(C(=C1)C2=NC(C(=O)NC3=C2C=C(C=C3)Cl)O)Cl,cholecystitis,CID000004170,metolazone,CC1NC2=CC(=C(C=C2C(=O)N1C3=CC=CC=C3C)S(=O)(=O)N)Cl
CID000003958,lorazepam,C1=CC=C(C(=C1)C2=NC(C(=O)NC3=C2C=C(C=C3)Cl)O)Cl,apoplexy,CID000004178,Mexiletine,CC1=C(C(=CC=C1)C)OCC(C)N
CID000003958,lorazepam,C1=CC=C(C(=C1)C2=NC(C(=O)NC3=C2C=C(C=C3)Cl)O)Cl,loss of weight,CID000012536,638-94-8,CC1(OC2CC3C4CCC5=CC(=O)C=CC5(C4C(CC3(C2(O1)C(=O)CO)C)O)C)C
CID000003958,lorazepam,C1=CC=C(C(=C1)C2=NC(C(=O)NC3=C2C=C(C=C3)Cl)O)Cl,erythema,CID000004894,"11,17,21-Trihydroxypregna-1,4-diene-3,20-dione",CC12CC(C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C)O
CID000003958,lorazepam,C1=CC=C(C(=C1)C2=NC(C(=O)NC3=C2C=C(C=C3)Cl)O)Cl,loss of weight,CID000004046,mefloquine,C1CCNC(C1)C(C2=CC(=NC3=C2C=CC=C3C(F)(F)F)C(F)(F)F)O
CID000003958,lorazepam,C1=CC=C(C(=C1)C2=NC(C(=O)NC3=C2C=C(C=C3)Cl)O)Cl,gastric inflammation,CID000004044,mefenamic acid,CC1=C(C(=CC=C1)NC2=CC=CC=C2C(=O)O)C
CID000003958,lorazepam,C1=CC=C(C(=C1)C2=NC(C(=O)NC3=C2C=C(C=C3)Cl)O)Cl,cholecystitis,CID000005523,Ultram,CN(C)CC1CCCCC1(C2=CC(=CC=C2)OC)O
CID000003958,lorazepam,C1=CC=C(C(=C1)C2=NC(C(=O)NC3=C2C=C(C=C3)Cl)O)Cl,weight gain,CID000016231,AMILORIDE,C1(=C(N=C(C(=N1)Cl)N)N)C(=O)N=C(N)N
CID000003958,lorazepam,C1=CC=C(C(=C1)C2=NC(C(=O)NC3=C2C=C(C=C3)Cl)O)Cl,gastric inflammation,CID000060787,sequinavir,CC(C)(C)NC(=O)C1CC2CCCCC2CN1CC(C(CC3=CC=CC=C3)NC(=O)C(CC(=O)N)NC(=O)C4=NC5=CC=CC=C5C=C4)O
CID000003958,lorazepam,C1=CC=C(C(=C1)C2=NC(C(=O)NC3=C2C=C(C=C3)Cl)O)Cl,loss of weight,CID000152945,Dutasteride?,CC12CCC3C(C1CCC2C(=O)NC4=C(C=CC(=C4)C(F)(F)F)C(F)(F)F)CCC5C3(C=CC(=O)N5)C
CID000003958,lorazepam,C1=CC=C(C(=C1)C2=NC(C(=O)NC3=C2C=C(C=C3)Cl)O)Cl,cholecystitis,CID000027991,DESMOPRESSIN,C1CC(N(C1)C(=O)C2CSSCCC(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N2)CC(=O)N)CCC(=O)N)CC3=CC=CC=C3)CC4=CC=C(C=C4)O)C(=O)NC(CCCN=C(N)N)C(=O)NCC(=O)N
CID000003958,lorazepam,C1=CC=C(C(=C1)C2=NC(C(=O)NC3=C2C=C(C=C3)Cl)O)Cl,cholecystitis,CID000005152,Salmeterol,C1=CC=C(C=C1)CCCCOCCCCCCNCC(C2=CC(=C(C=C2)O)CO)O
CID000003958,lorazepam,C1=CC=C(C(=C1)C2=NC(C(=O)NC3=C2C=C(C=C3)Cl)O)Cl,gastric inflammation,CID000005487,tizanidine,C1CN=C(N1)NC2=C(C=CC3=NSN=C32)Cl
CID000003958,lorazepam,C1=CC=C(C(=C1)C2=NC(C(=O)NC3=C2C=C(C=C3)Cl)O)Cl,gastric inflammation,CID000005978,vincristine,CCC1(CC2CC(C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)C78CCN9C7C(C=CC9)(C(C(C8N6C=O)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O
CID000003958,lorazepam,C1=CC=C(C(=C1)C2=NC(C(=O)NC3=C2C=C(C=C3)Cl)O)Cl,gastric inflammation,CID000005719,zaleplon,CCN(C1=CC=CC(=C1)C2=CC=NC3=C(C=NN23)C#N)C(=O)C
CID000003958,lorazepam,C1=CC=C(C(=C1)C2=NC(C(=O)NC3=C2C=C(C=C3)Cl)O)Cl,rhinorrhea,CID000004536,Minovlar,CC12CCC3C(C1CCC2(C#C)O)CCC4=CC(=O)CCC34
CID000003958,lorazepam,C1=CC=C(C(=C1)C2=NC(C(=O)NC3=C2C=C(C=C3)Cl)O)Cl,Dyspnea exertional,CID000004601,orphenadrine,CC1=CC=CC=C1C(C2=CC=CC=C2)OCCN(C)C
CID000003958,lorazepam,C1=CC=C(C(=C1)C2=NC(C(=O)NC3=C2C=C(C=C3)Cl)O)Cl,cholecystitis,CID000005358,sumatriptan,CNS(=O)(=O)CC1=CC2=C(C=C1)NC=C2CCN(C)C
CID000003958,lorazepam,C1=CC=C(C(=C1)C2=NC(C(=O)NC3=C2C=C(C=C3)Cl)O)Cl,weight gain,CID000004195,midodrine,COC1=CC(=C(C=C1)OC)C(CNC(=O)CN)O
CID000003958,lorazepam,C1=CC=C(C(=C1)C2=NC(C(=O)NC3=C2C=C(C=C3)Cl)O)Cl,apoplexy,CID000005352,38194-50-2,CC1=C(C2=C(C1=CC3=CC=C(C=C3)S(=O)C)C=CC(=C2)F)CC(=O)O
CID000003958,lorazepam,C1=CC=C(C(=C1)C2=NC(C(=O)NC3=C2C=C(C=C3)Cl)O)Cl,back injury,CID000010631,medroxyprogesterone,CC1CC2C(CCC3(C2CCC3(C(=O)C)O)C)C4(C1=CC(=O)CC4)C
CID000003958,lorazepam,C1=CC=C(C(=C1)C2=NC(C(=O)NC3=C2C=C(C=C3)Cl)O)Cl,cholecystitis,CID000005645,"3,7-Dihydroxycholan-24-oic acid",CC(CCC(=O)O)C1CCC2C1(CCC3C2C(CC4C3(CCC(C4)O)C)O)C
CID000003958,lorazepam,C1=CC=C(C(=C1)C2=NC(C(=O)NC3=C2C=C(C=C3)Cl)O)Cl,cholecystitis,CID003468412,SCHEMBL1176571,CC1C=CC=CCCC=CC=CC=CC=CC(CC(C(C(CC(=O)CC(C(CCC(CC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)C(=O)O)O)OC2C(C(C(C(O2)C)O)N)O
CID000003958,lorazepam,C1=CC=C(C(=C1)C2=NC(C(=O)NC3=C2C=C(C=C3)Cl)O)Cl,angiitis,CID000005771,Oxytocin acetate salt hydrate,CCC(C)C1C(=O)NC(C(=O)NC(C(=O)NC(CSSCC(C(=O)NC(C(=O)N1)CC2=CC=C(C=C2)O)N)C(=O)N3CCCC3C(=O)NC(CC(C)C)C(=O)NCC(=O)N)CC(=O)N)CCC(=O)N
CID000003958,lorazepam,C1=CC=C(C(=C1)C2=NC(C(=O)NC3=C2C=C(C=C3)Cl)O)Cl,Back Ache,CID000004745,SCHEMBL7711911,CCCN1CC(CC2C1CC3=CNC4=CC=CC2=C34)CSC
CID000003958,lorazepam,C1=CC=C(C(=C1)C2=NC(C(=O)NC3=C2C=C(C=C3)Cl)O)Cl,apoplexy,CID005381226,"[(7S,9E,11S,12R,13S,14R,15R,16R,17S,18S,19E,21Z,26E)-2,15,17,29-tetrahydroxy-11-methoxy-3,7,12,14,16,18,22-heptamethyl-26-[[(4-methylpiperazin-1-yl)amino]methylidene]-6,23,27-trioxo-8,30-dioxa-24-azatetracyclo[23.3.1.14,7.05,28]triaconta-1(28),2,4,9,19,21,25(29)-heptaen-13-yl] acetate",CC1C=CC=C(C(=O)NC2=C(C3=C(C4=C(C(=C3O)C)OC(C4=O)(OC=CC(C(C(C(C(C(C1O)C)O)C)OC(=O)C)C)OC)C)C(=O)C2=CNN5CCN(CC5)C)O)C
CID000003958,lorazepam,C1=CC=C(C(=C1)C2=NC(C(=O)NC3=C2C=C(C=C3)Cl)O)Cl,neumonia,CID000005584,trimipramine,CC(CN1C2=CC=CC=C2CCC3=CC=CC=C31)CN(C)C
CID000003958,lorazepam,C1=CC=C(C(=C1)C2=NC(C(=O)NC3=C2C=C(C=C3)Cl)O)Cl,hypermagnesemia,CID000074989,ATOVAQUONE,C1CC(CCC1C2=CC=C(C=C2)Cl)C3=C(C4=CC=CC=C4C(=O)C3=O)O
CID000003958,lorazepam,C1=CC=C(C(=C1)C2=NC(C(=O)NC3=C2C=C(C=C3)Cl)O)Cl,gastric inflammation,CID000004107,methocarbamol,COC1=CC=CC=C1OCC(COC(=O)N)O
CID000003958,lorazepam,C1=CC=C(C(=C1)C2=NC(C(=O)NC3=C2C=C(C=C3)Cl)O)Cl,gastric inflammation,CID000504578,"(2S,3S,4R,5R,6R)-5-amino-6-[(2R,3S,4R,5S)-5-[(1R,2S,3R,6R)-3-amino-6-[(1S,2R,3R,4R,5R)-2-amino-5-(aminomethyl)-3,4-dihydroxycyclohexyl]oxy-2-hydroxycyclohexyl]oxy-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl]oxy-2-(aminomethyl)oxane-3,4-diol",C1CC(C(C(C1N)O)OC2C(C(C(O2)CO)OC3C(C(C(C(O3)CN)O)O)N)O)OC4CC(C(C(C4N)O)O)CN
CID000003958,lorazepam,C1=CC=C(C(=C1)C2=NC(C(=O)NC3=C2C=C(C=C3)Cl)O)Cl,apoplexy,CID000048175,"[(6S,9R,16S,17R)-17-(2-chloroacetyl)-6,9-difluoro-11-hydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl] propanoate",CCC(=O)OC1(C(CC2C1(CC(C3(C2CC(C4=CC(=O)C=CC43C)F)F)O)C)C)C(=O)CCl
CID000003958,lorazepam,C1=CC=C(C(=C1)C2=NC(C(=O)NC3=C2C=C(C=C3)Cl)O)Cl,cholecystitis,CID000062924,"S-(fluoromethyl) (6S,9R,10S,11S,13S,14S,16R,17R)-6,9-difluoro-11,17-dihydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthrene-17-carbothioate",CC1CC2C3CC(C4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)SCF)O)C)O)F)C)F
CID000003958,lorazepam,C1=CC=C(C(=C1)C2=NC(C(=O)NC3=C2C=C(C=C3)Cl)O)Cl,gastric inflammation,CID000004819,"2(3H)-Furanone, 3-ethyldihydro-4-[(1-methyl-1H-imidazol-5-yl)methyl]-, (3S-cis)-",CCC1C(COC1=O)CC2=CN=CN2C
CID000003958,lorazepam,C1=CC=C(C(=C1)C2=NC(C(=O)NC3=C2C=C(C=C3)Cl)O)Cl,Back Ache,CID005493444,Aliskiren,CC(C)C(CC1=CC(=C(C=C1)OC)OCCCOC)CC(C(CC(C(C)C)C(=O)NCC(C)(C)C(=O)N)O)N
CID000003958,lorazepam,C1=CC=C(C(=C1)C2=NC(C(=O)NC3=C2C=C(C=C3)Cl)O)Cl,drug toxicity NOS,CID000004451,CHEMBL365442,CC1=C(C=CC=C1O)C(=O)NC(CSC2=CC=CC=C2)C(CN3CC4CCCCC4CC3C(=O)NC(C)(C)C)O
CID000003958,lorazepam,C1=CC=C(C(=C1)C2=NC(C(=O)NC3=C2C=C(C=C3)Cl)O)Cl,apoplexy,CID000071329,Dofetilide,CN(CCC1=CC=C(C=C1)NS(=O)(=O)C)CCOC2=CC=C(C=C2)NS(=O)(=O)C
CID000003958,lorazepam,C1=CC=C(C(=C1)C2=NC(C(=O)NC3=C2C=C(C=C3)Cl)O)Cl,bulging,CID000060754,Gadodiamide hydrate,CNC(=O)CN(CCN(CCN(CC(=O)NC)CC(=O)[O-])CC(=O)[O-])CC(=O)[O-].O.[Gd+3]
CID000003958,lorazepam,C1=CC=C(C(=C1)C2=NC(C(=O)NC3=C2C=C(C=C3)Cl)O)Cl,apoplexy,CID000060184,"2'-epi-Perindopril, (2'R)-",CCCC(C(=O)OCC)NC(C)C(=O)N1C2CCCCC2CC1C(=O)O
CID000003958,lorazepam,C1=CC=C(C(=C1)C2=NC(C(=O)NC3=C2C=C(C=C3)Cl)O)Cl,cholecystitis,CID000004425,"4a,9-dihydroxy-3-prop-2-enyl-2,4,5,6,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinolin-7-one",C=CCN1CCC23C4C(=O)CCC2(C1CC5=C3C(=C(C=C5)O)O4)O
CID000003958,lorazepam,C1=CC=C(C(=C1)C2=NC(C(=O)NC3=C2C=C(C=C3)Cl)O)Cl,cholecystitis,CID000004889,Pravastatin Impurity A,CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC(CC(CC(=O)O)O)O)O
CID000003958,lorazepam,C1=CC=C(C(=C1)C2=NC(C(=O)NC3=C2C=C(C=C3)Cl)O)Cl,erythema,CID000004075,5-Aminosalicylic acid,C1=CC(=C(C=C1N)C(=O)O)O
CID000087177,"D-Fructose, 4-O-alpha-D-glucopyranosyl-",C(C1C(C(C(C(O1)OC(C(CO)O)C(C(=O)CO)O)O)O)O)O,gastric inflammation,CID006398525,,C(C1C(C(C(C(O1)OC2(C(C(C(O2)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)COS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.[Al].[Al].[Al].[Al].[Al].[Al].[Al].[Al].[Al]
CID000087177,"D-Fructose, 4-O-alpha-D-glucopyranosyl-",C(C1C(C(C(C(O1)OC(C(CO)O)C(C(=O)CO)O)O)O)O)O,gastric inflammation,CID005311048,SCHEMBL11440306,C(N)(N)(Cl)Cl
CID000087177,"D-Fructose, 4-O-alpha-D-glucopyranosyl-",C(C1C(C(C(C(O1)OC(C(CO)O)C(C(=O)CO)O)O)O)O)O,angiitis,CID005381226,"[(7S,9E,11S,12R,13S,14R,15R,16R,17S,18S,19E,21Z,26E)-2,15,17,29-tetrahydroxy-11-methoxy-3,7,12,14,16,18,22-heptamethyl-26-[[(4-methylpiperazin-1-yl)amino]methylidene]-6,23,27-trioxo-8,30-dioxa-24-azatetracyclo[23.3.1.14,7.05,28]triaconta-1(28),2,4,9,19,21,25(29)-heptaen-13-yl] acetate",CC1C=CC=C(C(=O)NC2=C(C3=C(C4=C(C(=C3O)C)OC(C4=O)(OC=CC(C(C(C(C(C(C1O)C)O)C)OC(=O)C)C)OC)C)C(=O)C2=CNN5CCN(CC5)C)O)C
CID000087177,"D-Fructose, 4-O-alpha-D-glucopyranosyl-",C(C1C(C(C(C(O1)OC(C(CO)O)C(C(=O)CO)O)O)O)O)O,apoplexy,CID005481350,Tenofovir disoproxil,CC(C)OC(=O)OCOP(=O)(COC(C)CN1C=NC2=C(N=CN=C21)N)OCOC(=O)OC(C)C
CID000087177,"D-Fructose, 4-O-alpha-D-glucopyranosyl-",C(C1C(C(C(C(O1)OC(C(CO)O)C(C(=O)CO)O)O)O)O)O,Adenopathy,CID000163742,SCHEMBL1650579,COC1C(C(C(C(O1)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)COS(=O)(=O)O)OC4C(C(C(C(O4)C(=O)O)OC5C(C(C(C(O5)COS(=O)(=O)O)O)O)NS(=O)(=O)O)O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O)NS(=O)(=O)O
CID000087177,"D-Fructose, 4-O-alpha-D-glucopyranosyl-",C(C1C(C(C(C(O1)OC(C(CO)O)C(C(=O)CO)O)O)O)O)O,weight gain,CID000170361,Varenicline,C1C2CNCC1C3=CC4=NC=CN=C4C=C23
CID000087177,"D-Fructose, 4-O-alpha-D-glucopyranosyl-",C(C1C(C(C(C(O1)OC(C(CO)O)C(C(=O)CO)O)O)O)O)O,erythema,CID003468412,SCHEMBL1176571,CC1C=CC=CCCC=CC=CC=CC=CC(CC(C(C(CC(=O)CC(C(CCC(CC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)C(=O)O)O)OC2C(C(C(C(O2)C)O)N)O
CID000087177,"D-Fructose, 4-O-alpha-D-glucopyranosyl-",C(C1C(C(C(C(O1)OC(C(CO)O)C(C(=O)CO)O)O)O)O)O,gout,CID000110635,Tadalafil,CN1CC(=O)N2C(C1=O)CC3=C(C2C4=CC5=C(C=C4)OCO5)NC6=CC=CC=C36
CID000087177,"D-Fructose, 4-O-alpha-D-glucopyranosyl-",C(C1C(C(C(C(O1)OC(C(CO)O)C(C(=O)CO)O)O)O)O)O,aphasia,CID000152945,Dutasteride?,CC12CCC3C(C1CCC2C(=O)NC4=C(C=CC(=C4)C(F)(F)F)C(F)(F)F)CCC5C3(C=CC(=O)N5)C
CID000087177,"D-Fructose, 4-O-alpha-D-glucopyranosyl-",C(C1C(C(C(C(O1)OC(C(CO)O)C(C(=O)CO)O)O)O)O)O,hyperalimentation,CID000504578,"(2S,3S,4R,5R,6R)-5-amino-6-[(2R,3S,4R,5S)-5-[(1R,2S,3R,6R)-3-amino-6-[(1S,2R,3R,4R,5R)-2-amino-5-(aminomethyl)-3,4-dihydroxycyclohexyl]oxy-2-hydroxycyclohexyl]oxy-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl]oxy-2-(aminomethyl)oxane-3,4-diol",C1CC(C(C(C1N)O)OC2C(C(C(O2)CO)OC3C(C(C(C(O3)CN)O)O)N)O)OC4CC(C(C(C4N)O)O)CN
CID000087177,"D-Fructose, 4-O-alpha-D-glucopyranosyl-",C(C1C(C(C(C(O1)OC(C(CO)O)C(C(=O)CO)O)O)O)O)O,dizziness,CID000160051,Colesevelam,CCCCCCCCCCNCC=C.C[N+](C)(C)CCCCCCNCC=C.C=CCN.C1C(O1)CCl.Cl.[Cl-]
CID000005878,OXANDROLONE,CC12CCC3C(C1CCC2(C)O)CCC4C3(COC(=O)C4)C,loss of weight,CID005481350,Tenofovir disoproxil,CC(C)OC(=O)OCOP(=O)(COC(C)CN1C=NC2=C(N=CN=C21)N)OCOC(=O)OC(C)C
CID000005878,OXANDROLONE,CC12CCC3C(C1CCC2(C)O)CCC4C3(COC(=O)C4)C,nasopharyngitis,CID000060787,sequinavir,CC(C)(C)NC(=O)C1CC2CCCCC2CN1CC(C(CC3=CC=CC=C3)NC(=O)C(CC(=O)N)NC(=O)C4=NC5=CC=CC=C5C=C4)O
CID000005878,OXANDROLONE,CC12CCC3C(C1CCC2(C)O)CCC4C3(COC(=O)C4)C,thrombocytopenia,CID000074989,ATOVAQUONE,C1CC(CCC1C2=CC=C(C=C2)Cl)C3=C(C4=CC=CC=C4C(=O)C3=O)O
CID000005878,OXANDROLONE,CC12CCC3C(C1CCC2(C)O)CCC4C3(COC(=O)C4)C,erythema,CID000038904,Carboplatinum,C1CC(C1)(C(=O)O)C(=O)O.N.N.[Pt]
CID000005878,OXANDROLONE,CC12CCC3C(C1CCC2(C)O)CCC4C3(COC(=O)C4)C,cellulitis,CID000077999,rosiglitazone,CN(CCOC1=CC=C(C=C1)CC2C(=O)NC(=O)S2)C3=CC=CC=N3
CID000005878,OXANDROLONE,CC12CCC3C(C1CCC2(C)O)CCC4C3(COC(=O)C4)C,loss of weight,CID000019090,megestrol,CC1=CC2C(CCC3(C2CCC3(C(=O)C)O)C)C4(C1=CC(=O)CC4)C
CID000005878,OXANDROLONE,CC12CCC3C(C1CCC2(C)O)CCC4C3(COC(=O)C4)C,atelectasis,CID000062924,"S-(fluoromethyl) (6S,9R,10S,11S,13S,14S,16R,17R)-6,9-difluoro-11,17-dihydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthrene-17-carbothioate",CC1CC2C3CC(C4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)SCF)O)C)O)F)C)F
CID000005878,OXANDROLONE,CC12CCC3C(C1CCC2(C)O)CCC4C3(COC(=O)C4)C,constipated,CID000110635,Tadalafil,CN1CC(=O)N2C(C1=O)CC3=C(C2C4=CC5=C(C=C4)OCO5)NC6=CC=CC=C36
CID000003463,gemfibrozil,CC1=CC(=C(C=C1)C)OCCCC(C)(C)C(=O)O,Dyspnea exertional,CID000005391,temazepam,CN1C2=C(C=C(C=C2)Cl)C(=NC(C1=O)O)C3=CC=CC=C3
CID000003463,gemfibrozil,CC1=CC(=C(C=C1)C)OCCCC(C)(C)C(=O)O,Back Ache,CID000005732,zolpidem,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C
CID000003463,gemfibrozil,CC1=CC(=C(C=C1)C)OCCCC(C)(C)C(=O)O,erythema,CID000004666,7-Epi Paclitaxel,CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C
CID000003463,gemfibrozil,CC1=CC(=C(C=C1)C)OCCCC(C)(C)C(=O)O,bladder retention,CID000004585,"2-methyl-4-(4-methylpiperazin-1-yl)-5H-thieno[3,2-c][1,5]benzodiazepine",CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C
CID000003463,gemfibrozil,CC1=CC(=C(C=C1)C)OCCCC(C)(C)C(=O)O,gastric inflammation,CID000152945,Dutasteride?,CC12CCC3C(C1CCC2C(=O)NC4=C(C=CC(=C4)C(F)(F)F)C(F)(F)F)CCC5C3(C=CC(=O)N5)C
CID000003463,gemfibrozil,CC1=CC(=C(C=C1)C)OCCCC(C)(C)C(=O)O,Dyspnea exertional,CID000004170,metolazone,CC1NC2=CC(=C(C=C2C(=O)N1C3=CC=CC=C3C)S(=O)(=O)N)Cl
CID000003463,gemfibrozil,CC1=CC(=C(C=C1)C)OCCCC(C)(C)C(=O)O,gastric inflammation,CID000004510,nitroglycerin,C(C(CO[N+](=O)[O-])O[N+](=O)[O-])O[N+](=O)[O-]
CID000003463,gemfibrozil,CC1=CC(=C(C=C1)C)OCCCC(C)(C)C(=O)O,apoplexy,CID000005073,risperidone,CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F
CID000003463,gemfibrozil,CC1=CC(=C(C=C1)C)OCCCC(C)(C)C(=O)O,ear infection,CID000004691,"3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine",C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4
CID000003463,gemfibrozil,CC1=CC(=C(C=C1)C)OCCCC(C)(C)C(=O)O,cholecystitis,CID000004107,methocarbamol,COC1=CC=CC=C1OCC(COC(=O)N)O
CID000003463,gemfibrozil,CC1=CC(=C(C=C1)C)OCCCC(C)(C)C(=O)O,nasopharyngitis,CID005481350,Tenofovir disoproxil,CC(C)OC(=O)OCOP(=O)(COC(C)CN1C=NC2=C(N=CN=C21)N)OCOC(=O)OC(C)C
CID000003463,gemfibrozil,CC1=CC(=C(C=C1)C)OCCCC(C)(C)C(=O)O,Back Ache,CID000004889,Pravastatin Impurity A,CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC(CC(CC(=O)O)O)O)O
CID000003463,gemfibrozil,CC1=CC(=C(C=C1)C)OCCCC(C)(C)C(=O)O,polymyalgia rheumatica,CID000003961,losartan,CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)CO)Cl
CID000003463,gemfibrozil,CC1=CC(=C(C=C1)C)OCCCC(C)(C)C(=O)O,angiitis,CID000005245,Risedronic acid,C1=CC(=CN=C1)CC(O)(P(=O)(O)O)P(=O)(O)O
CID000003463,gemfibrozil,CC1=CC(=C(C=C1)C)OCCCC(C)(C)C(=O)O,cholecystitis,CID000062924,"S-(fluoromethyl) (6S,9R,10S,11S,13S,14S,16R,17R)-6,9-difluoro-11,17-dihydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthrene-17-carbothioate",CC1CC2C3CC(C4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)SCF)O)C)O)F)C)F
CID000003463,gemfibrozil,CC1=CC(=C(C=C1)C)OCCCC(C)(C)C(=O)O,apoplexy,CID000005512,124936-74-9,CC1=CC(=C(C=C1)O)C(CCN(C(C)C)C(C)C)C2=CC=CC=C2
CID000003463,gemfibrozil,CC1=CC(=C(C=C1)C)OCCCC(C)(C)C(=O)O,fracture nonunion,CID000004900,Fernisone,CC12CC(=O)C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C
CID000003463,gemfibrozil,CC1=CC(=C(C=C1)C)OCCCC(C)(C)C(=O)O,gastric inflammation,CID000005650,N-pentanoyl-N-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-L-valine,CCCCC(=O)N(CC1=CC=C(C=C1)C2=CC=CC=C2C3=NNN=N3)C(C(C)C)C(=O)O
CID000003463,gemfibrozil,CC1=CC(=C(C=C1)C)OCCCC(C)(C)C(=O)O,dysarthria,CID000004205,mirtazapine,CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4
CID000003463,gemfibrozil,CC1=CC(=C(C=C1)C)OCCCC(C)(C)C(=O)O,gastric inflammation,CID000004679,pantoprazole,COC1=C(C(=NC=C1)CS(=O)C2=NC3=C(N2)C=C(C=C3)OC(F)F)OC
CID000003463,gemfibrozil,CC1=CC(=C(C=C1)C)OCCCC(C)(C)C(=O)O,apoplexy,CID000060854,Ziprasidone,C1CN(CCN1CCC2=C(C=C3C(=C2)CC(=O)N3)Cl)C4=NSC5=CC=CC=C54
CID000003463,gemfibrozil,CC1=CC(=C(C=C1)C)OCCCC(C)(C)C(=O)O,erythema,CID000003749,irbesartan,CCCCC1=NC2(CCCC2)C(=O)N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5
CID000003463,gemfibrozil,CC1=CC(=C(C=C1)C)OCCCC(C)(C)C(=O)O,loss of weight,CID000005095,ropinirole,CCCN(CCC)CCC1=C2CC(=O)NC2=CC=C1
CID000003463,gemfibrozil,CC1=CC(=C(C=C1)C)OCCCC(C)(C)C(=O)O,Adenopathy,CID000005152,Salmeterol,C1=CC=C(C=C1)CCCCOCCCCCCNCC(C2=CC(=C(C=C2)O)CO)O
CID000003463,gemfibrozil,CC1=CC(=C(C=C1)C)OCCCC(C)(C)C(=O)O,Dyspnea exertional,CID000005544,Mycolog,CC12CC(C3(C(C1CC(C2(C(=O)CO)O)O)CCC4=CC(=O)C=CC43C)F)O
CID000003463,gemfibrozil,CC1=CC(=C(C=C1)C)OCCCC(C)(C)C(=O)O,insulin dependent diabetes mellitus,CID000003516,guaifenesin,COC1=CC=CC=C1OCC(CO)O
CID000003463,gemfibrozil,CC1=CC(=C(C=C1)C)OCCCC(C)(C)C(=O)O,abnormal ECG,CID000170361,Varenicline,C1C2CNCC1C3=CC4=NC=CN=C4C=C23
CID000003463,gemfibrozil,CC1=CC(=C(C=C1)C)OCCCC(C)(C)C(=O)O,loss of weight,CID000003937,N~2~-(1-carboxy-3-phenylpropyl)lysylproline,C1CC(N(C1)C(=O)C(CCCCN)NC(CCC2=CC=CC=C2)C(=O)O)C(=O)O
CID000003463,gemfibrozil,CC1=CC(=C(C=C1)C)OCCCC(C)(C)C(=O)O,rotator cuff syndrome,CID000160051,Colesevelam,CCCCCCCCCCNCC=C.C[N+](C)(C)CCCCCCNCC=C.C=CCN.C1C(O1)CCl.Cl.[Cl-]
CID000003463,gemfibrozil,CC1=CC(=C(C=C1)C)OCCCC(C)(C)C(=O)O,abdominal pain upper,CID000004543,nortriptyline,CNCCC=C1C2=CC=CC=C2CCC3=CC=CC=C31
CID000003463,gemfibrozil,CC1=CC(=C(C=C1)C)OCCCC(C)(C)C(=O)O,Dyspnea exertional,CID000003883,lansoprazole,CC1=C(C=CN=C1CS(=O)C2=NC3=CC=CC=C3N2)OCC(F)(F)F
CID000003463,gemfibrozil,CC1=CC(=C(C=C1)C)OCCCC(C)(C)C(=O)O,gastric inflammation,CID000004927,promethazine,CC(CN1C2=CC=CC=C2SC3=CC=CC=C31)N(C)C
CID000003463,gemfibrozil,CC1=CC(=C(C=C1)C)OCCCC(C)(C)C(=O)O,haemorrhage rectum,CID000003658,hydroxyzine,C1CN(CCN1CCOCCO)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl
CID000003463,gemfibrozil,CC1=CC(=C(C=C1)C)OCCCC(C)(C)C(=O)O,Sinus headache,CID000003954,loperamide(1+),CN(C)C(=O)C(CC[NH+]1CCC(CC1)(C2=CC=C(C=C2)Cl)O)(C3=CC=CC=C3)C4=CC=CC=C4
CID000003463,gemfibrozil,CC1=CC(=C(C=C1)C)OCCCC(C)(C)C(=O)O,gastric inflammation,CID000005523,Ultram,CN(C)CC1CCCCC1(C2=CC(=CC=C2)OC)O
CID000003463,gemfibrozil,CC1=CC(=C(C=C1)C)OCCCC(C)(C)C(=O)O,loss of weight,CID000077999,rosiglitazone,CN(CCOC1=CC=C(C=C1)CC2C(=O)NC(=O)S2)C3=CC=CC=N3
CID000003463,gemfibrozil,CC1=CC(=C(C=C1)C)OCCCC(C)(C)C(=O)O,erythema,CID000038904,Carboplatinum,C1CC(C1)(C(=O)O)C(=O)O.N.N.[Pt]
CID000003463,gemfibrozil,CC1=CC(=C(C=C1)C)OCCCC(C)(C)C(=O)O,insulin dependent diabetes mellitus,CID000003780,"D-Glucitol, 1,4:3,6-dianhydro-, 2,5-dinitrate",C1C(C2C(O1)C(CO2)O[N+](=O)[O-])O[N+](=O)[O-]
CID000003463,gemfibrozil,CC1=CC(=C(C=C1)C)OCCCC(C)(C)C(=O)O,body temperature increased,CID000003890,TRANS (15S)-LATANOPROST,CC(C)OC(=O)CCCC=CCC1C(CC(C1CCC(CCC2=CC=CC=C2)O)O)O
CID000001690,Doxorubicin (Adriamycin) HCl,CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)[NH3+])O,gastric inflammation,CID000003405,2-[[4-[(2-amino-4-oxo-1H-pteridin-6-yl)methylamino]benzoyl]amino]pentanedioic acid,C1=CC(=CC=C1C(=O)NC(CCC(=O)O)C(=O)O)NCC2=CN=C3C(=N2)C(=O)N=C(N3)N
CID000001690,Doxorubicin (Adriamycin) HCl,CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)[NH3+])O,atelectasis,CID000004158,methylphenidate,COC(=O)C(C1CCCCN1)C2=CC=CC=C2
CID000001690,Doxorubicin (Adriamycin) HCl,CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)[NH3+])O,loss of weight,CID000002656,"7-[[2-(2-amino-1,3-thiazol-4-yl)-2-methoxyiminoacetyl]amino]-3-[(2-methyl-6-oxido-5-oxo-1,2,4-triazin-3-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CN1C(=NC(=O)C(=N1)[O-])SCC2=C(N3C(C(C3=O)NC(=O)C(=NOC)C4=CSC(=N4)N)SC2)C(=O)[O-]
CID000001690,Doxorubicin (Adriamycin) HCl,CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)[NH3+])O,weight gain,CID000005358,sumatriptan,CNS(=O)(=O)CC1=CC2=C(C=C1)NC=C2CCN(C)C
CID000001690,Doxorubicin (Adriamycin) HCl,CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)[NH3+])O,bursitis,CID000002375,bicalutamide,CC(CS(=O)(=O)C1=CC=C(C=C1)F)(C(=O)NC2=CC(=C(C=C2)C#N)C(F)(F)F)O
CID000001690,Doxorubicin (Adriamycin) HCl,CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)[NH3+])O,folate deficiency,CID005481350,Tenofovir disoproxil,CC(C)OC(=O)OCOP(=O)(COC(C)CN1C=NC2=C(N=CN=C21)N)OCOC(=O)OC(C)C
CID000001690,Doxorubicin (Adriamycin) HCl,CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)[NH3+])O,weight gain,CID000008953,sodium;hydrogen carbonate,C(=O)(O)[O-].[Na+]
CID000001690,Doxorubicin (Adriamycin) HCl,CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)[NH3+])O,erythema,CID000003883,lansoprazole,CC1=C(C=CN=C1CS(=O)C2=NC3=CC=CC=C3N2)OCC(F)(F)F
CID000001690,Doxorubicin (Adriamycin) HCl,CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)[NH3+])O,atypical mycobacterial infection,CID005381226,"[(7S,9E,11S,12R,13S,14R,15R,16R,17S,18S,19E,21Z,26E)-2,15,17,29-tetrahydroxy-11-methoxy-3,7,12,14,16,18,22-heptamethyl-26-[[(4-methylpiperazin-1-yl)amino]methylidene]-6,23,27-trioxo-8,30-dioxa-24-azatetracyclo[23.3.1.14,7.05,28]triaconta-1(28),2,4,9,19,21,25(29)-heptaen-13-yl] acetate",CC1C=CC=C(C(=O)NC2=C(C3=C(C4=C(C(=C3O)C)OC(C4=O)(OC=CC(C(C(C(C(C(C1O)C)O)C)OC(=O)C)C)OC)C)C(=O)C2=CNN5CCN(CC5)C)O)C
CID000001690,Doxorubicin (Adriamycin) HCl,CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)[NH3+])O,myelodysplasia,CID000003310,33419-42-0,CC1OCC2C(O1)C(C(C(O2)OC3C4COC(=O)C4C(C5=CC6=C(C=C35)OCO6)C7=CC(=C(C(=C7)OC)O)OC)O)O
CID000001690,Doxorubicin (Adriamycin) HCl,CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)[NH3+])O,loss of weight,CID000002524,32222-06-3,CC(CCCC(C)(C)O)C1CCC2C1(CCCC2=CC=C3CC(CC(C3=C)O)O)C
CID000001690,Doxorubicin (Adriamycin) HCl,CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)[NH3+])O,apoplexy,CID000003075,"2-[3-acetyloxy-2-(4-methoxyphenyl)-4-oxo-2,3-dihydro-1,5-benzothiazepin-5-yl]ethyl-dimethylazanium",CC(=O)OC1C(SC2=CC=CC=C2N(C1=O)CC[NH+](C)C)C3=CC=C(C=C3)OC
CID000001690,Doxorubicin (Adriamycin) HCl,CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)[NH3+])O,emesis,CID000060852,Ibandronic Acid,CCCCCN(C)CCC(O)(P(=O)(O)O)P(=O)(O)O
CID000001690,Doxorubicin (Adriamycin) HCl,CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)[NH3+])O,cholecystitis,CID000019090,megestrol,CC1=CC2C(CCC3(C2CCC3(C(=O)C)O)C)C4(C1=CC(=O)CC4)C
CID000001690,Doxorubicin (Adriamycin) HCl,CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)[NH3+])O,thrombocytopenia,CID000002725,chlorpheniramine,CN(C)CCC(C1=CC=C(C=C1)Cl)C2=CC=CC=N2
CID000001690,Doxorubicin (Adriamycin) HCl,CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)[NH3+])O,Adenopathy,CID000005732,zolpidem,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C
CID000001690,Doxorubicin (Adriamycin) HCl,CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)[NH3+])O,loss of weight,CID000004543,nortriptyline,CNCCC=C1C2=CC=CC=C2CCC3=CC=CC=C31
CID000001690,Doxorubicin (Adriamycin) HCl,CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)[NH3+])O,eruption,CID000002265,azathioprine,CN1C=NC(=C1SC2=NC=NC3=C2NC=N3)[N+](=O)[O-]
CID000001690,Doxorubicin (Adriamycin) HCl,CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)[NH3+])O,enlarged liver,CID000005645,"3,7-Dihydroxycholan-24-oic acid",CC(CCC(=O)O)C1CCC2C1(CCC3C2C(CC4C3(CCC(C4)O)C)O)C
CID000001690,Doxorubicin (Adriamycin) HCl,CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)[NH3+])O,gastric inflammation,CID000003345,fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3
CID000001690,Doxorubicin (Adriamycin) HCl,CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)[NH3+])O,angiitis,CID000002578,carmustine,C(CCl)NC(=O)N(CCCl)N=O
CID000001690,Doxorubicin (Adriamycin) HCl,CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)[NH3+])O,angiitis,CID000060184,"2'-epi-Perindopril, (2'R)-",CCCC(C(=O)OCC)NC(C)C(=O)N1C2CCCCC2CC1C(=O)O
CID000001690,Doxorubicin (Adriamycin) HCl,CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)[NH3+])O,Adenopathy,CID000002771,citalopram,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F
CID000001690,Doxorubicin (Adriamycin) HCl,CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)[NH3+])O,Back Ache,CID000004205,mirtazapine,CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4
CID000001690,Doxorubicin (Adriamycin) HCl,CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)[NH3+])O,loss of weight,CID000004201,minoxidil,C1CCN(CC1)C2=NC(=N)N(C(=C2)N)O
CID000001690,Doxorubicin (Adriamycin) HCl,CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)[NH3+])O,cellulitis,CID000027686,CHEMBL4088679,C1=CC2=C(C(=C1)OCC(COC3=CC4=C(C=C3)OC(=CC4=O)C(=O)O)O)C(=O)C=C(O2)C(=O)O
CID000001690,Doxorubicin (Adriamycin) HCl,CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)[NH3+])O,bursitis,CID000077999,rosiglitazone,CN(CCOC1=CC=C(C=C1)CC2C(=O)NC(=O)S2)C3=CC=CC=N3
CID000001690,Doxorubicin (Adriamycin) HCl,CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)[NH3+])O,eruption,CID000003749,irbesartan,CCCCC1=NC2(CCCC2)C(=O)N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5
CID000001690,Doxorubicin (Adriamycin) HCl,CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)[NH3+])O,proctalgia,CID000004173,metronidazole,CC1=NC=C(N1CCO)[N+](=O)[O-]
CID000001690,Doxorubicin (Adriamycin) HCl,CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)[NH3+])O,gastric inflammation,CID000003954,loperamide(1+),CN(C)C(=O)C(CC[NH+]1CCC(CC1)(C2=CC=C(C=C2)Cl)O)(C3=CC=CC=C3)C4=CC=CC=C4
CID000001690,Doxorubicin (Adriamycin) HCl,CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)[NH3+])O,drug toxicity NOS,CID000005073,risperidone,CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F
CID000001690,Doxorubicin (Adriamycin) HCl,CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)[NH3+])O,loss of weight,CID000003043,9-[5-(hydroxymethyl)oxolan-2-yl]-3H-purin-6-one,C1CC(OC1CO)N2C=NC3=C2NC=NC3=O
CID000001690,Doxorubicin (Adriamycin) HCl,CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)[NH3+])O,thrombocytopenia,CID000003042,dicyclomine,CCN(CC)CCOC(=O)C1(CCCCC1)C2CCCCC2
CID000001690,Doxorubicin (Adriamycin) HCl,CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)[NH3+])O,Adenopathy,CID000002803,clonidine,C1CN=C(N1)NC2=C(C=CC=C2Cl)Cl
CID000001690,Doxorubicin (Adriamycin) HCl,CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)[NH3+])O,cholecystectomies,CID000002806,90055-48-4,COC(=O)C(C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3
CID000001690,Doxorubicin (Adriamycin) HCl,CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)[NH3+])O,cellulitis,CID006398525,,C(C1C(C(C(C(O1)OC2(C(C(C(O2)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)COS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.[Al].[Al].[Al].[Al].[Al].[Al].[Al].[Al].[Al]
CID000001690,Doxorubicin (Adriamycin) HCl,CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)[NH3+])O,allergic dermatitis,CID000004510,nitroglycerin,C(C(CO[N+](=O)[O-])O[N+](=O)[O-])O[N+](=O)[O-]
CID000001690,Doxorubicin (Adriamycin) HCl,CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)[NH3+])O,Bleeding,CID000147912,DSSTox_GSID_49066,CCC(C(C)O)N1C(=O)N(C=N1)C2=CC=C(C=C2)N3CCN(CC3)C4=CC=C(C=C4)OCC5CC(OC5)(CN6C=NC=N6)C7=C(C=C(C=C7)F)F
CID000001690,Doxorubicin (Adriamycin) HCl,CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)[NH3+])O,angina,CID000003333,felodipine,CCOC(=O)C1=C(NC(=C(C1C2=C(C(=CC=C2)Cl)Cl)C(=O)OC)C)C
CID000001690,Doxorubicin (Adriamycin) HCl,CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)[NH3+])O,deep vein thromboses,CID000003339,fenofibrate,CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C2=CC=C(C=C2)Cl
CID000001690,Doxorubicin (Adriamycin) HCl,CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)[NH3+])O,cholecystitis,CID000004819,"2(3H)-Furanone, 3-ethyldihydro-4-[(1-methyl-1H-imidazol-5-yl)methyl]-, (3S-cis)-",CCC1C(COC1=O)CC2=CN=CN2C
CID000001690,Doxorubicin (Adriamycin) HCl,CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)[NH3+])O,icterus,CID000131536,Fosamprenavir,CC(C)CN(CC(C(CC1=CC=CC=C1)NC(=O)OC2CCOC2)OP(=O)(O)O)S(=O)(=O)C3=CC=C(C=C3)N
CID000001690,Doxorubicin (Adriamycin) HCl,CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)[NH3+])O,weight gain,CID000005245,Risedronic acid,C1=CC(=CN=C1)CC(O)(P(=O)(O)O)P(=O)(O)O
CID000001690,Doxorubicin (Adriamycin) HCl,CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)[NH3+])O,Back Ache,CID000001983,acetaminophen,CC(=O)NC1=CC=C(C=C1)O
CID000001690,Doxorubicin (Adriamycin) HCl,CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)[NH3+])O,myelodysplasia,CID000004894,"11,17,21-Trihydroxypregna-1,4-diene-3,20-dione",CC12CC(C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C)O
CID000001690,Doxorubicin (Adriamycin) HCl,CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)[NH3+])O,eruption,CID000003676,lidocaine,CCN(CC)CC(=O)NC1=C(C=CC=C1C)C
CID000001690,Doxorubicin (Adriamycin) HCl,CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)[NH3+])O,gastric inflammation,CID000004666,7-Epi Paclitaxel,CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C
CID000001690,Doxorubicin (Adriamycin) HCl,CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)[NH3+])O,atelectasis,CID000002462,51372-29-3,CCCC1OC2CC3C4CCC5=CC(=O)C=CC5(C4C(CC3(C2(O1)C(=O)CO)C)O)C
CID000001690,Doxorubicin (Adriamycin) HCl,CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)[NH3+])O,gastric inflammation,CID000002662,celecoxib,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F
CID000001690,Doxorubicin (Adriamycin) HCl,CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)[NH3+])O,myelodysplasia,CID000038904,Carboplatinum,C1CC(C1)(C(=O)O)C(=O)O.N.N.[Pt]
CID000001690,Doxorubicin (Adriamycin) HCl,CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)[NH3+])O,abnormal ECG,CID000002978,16849-50-6,CCCCCC1=CC(=C2C3C=C(CCC3C(OC2=C1)(C)C)C)O
CID000001690,Doxorubicin (Adriamycin) HCl,CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)[NH3+])O,abnormal ECG,CID000002550,1-(2-methyl-3-sulfanylpropanoyl)pyrrolidine-2-carboxylic acid,CC(CS)C(=O)N1CCCC1C(=O)O
CID000001690,Doxorubicin (Adriamycin) HCl,CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)[NH3+])O,colitis,CID000152945,Dutasteride?,CC12CCC3C(C1CCC2C(=O)NC4=C(C=CC(=C4)C(F)(F)F)C(F)(F)F)CCC5C3(C=CC(=O)N5)C
CID000001690,Doxorubicin (Adriamycin) HCl,CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)[NH3+])O,gastric inflammation,CID000002713,55-56-1,C1=CC(=CC=C1NC(=NC(=NCCCCCCN=C(N)N=C(N)NC2=CC=C(C=C2)Cl)N)N)Cl
CID000001690,Doxorubicin (Adriamycin) HCl,CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)[NH3+])O,erythema,CID000003440,furosemide,C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl
CID000001690,Doxorubicin (Adriamycin) HCl,CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)[NH3+])O,loss of weight,CID000001971,914348-29-1,C1CC1NC2=C3C(=NC(=N2)N)N(C=N3)C4CC(C=C4)CO
CID000001690,Doxorubicin (Adriamycin) HCl,CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)[NH3+])O,erythema,CID000010631,medroxyprogesterone,CC1CC2C(CCC3(C2CCC3(C(=O)C)O)C)C4(C1=CC(=O)CC4)C
CID000001690,Doxorubicin (Adriamycin) HCl,CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)[NH3+])O,Adenopathy,CID000002088,ALENDRONIC ACID,C(CC(O)(P(=O)(O)O)P(=O)(O)O)CN
CID000001690,Doxorubicin (Adriamycin) HCl,CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)[NH3+])O,gastric inflammation,CID000003937,N~2~-(1-carboxy-3-phenylpropyl)lysylproline,C1CC(N(C1)C(=O)C(CCCCN)NC(CCC2=CC=CC=C2)C(=O)O)C(=O)O
CID000001690,Doxorubicin (Adriamycin) HCl,CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)[NH3+])O,elevated cholesterol,CID000060787,sequinavir,CC(C)(C)NC(=O)C1CC2CCCCC2CN1CC(C(CC3=CC=CC=C3)NC(=O)C(CC(=O)N)NC(=O)C4=NC5=CC=CC=C5C=C4)O
CID000001690,Doxorubicin (Adriamycin) HCl,CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)[NH3+])O,Adenopathy,CID000005394,temozolomide,CN1C(=O)N2C=NC(=C2N=N1)C(=O)N
CID000001690,Doxorubicin (Adriamycin) HCl,CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)[NH3+])O,Adenopathy,CID000005391,temazepam,CN1C2=C(C=C(C=C2)Cl)C(=NC(C1=O)O)C3=CC=CC=C3
CID000001690,Doxorubicin (Adriamycin) HCl,CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)[NH3+])O,erythema,CID000062924,"S-(fluoromethyl) (6S,9R,10S,11S,13S,14S,16R,17R)-6,9-difluoro-11,17-dihydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthrene-17-carbothioate",CC1CC2C3CC(C4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)SCF)O)C)O)F)C)F
CID000001690,Doxorubicin (Adriamycin) HCl,CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)[NH3+])O,myelodysplasia,CID000003062,Lanicor,CC1C(C(CC(O1)OC2C(OC(CC2O)OC3C(OC(CC3O)OC4CCC5(C(C4)CCC6C5CC(C7(C6(CCC7C8=CC(=O)OC8)O)C)O)C)C)C)O)O
CID000001690,Doxorubicin (Adriamycin) HCl,CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)[NH3+])O,myelodysplasia,CID005311048,SCHEMBL11440306,C(N)(N)(Cl)Cl
CID000001690,Doxorubicin (Adriamycin) HCl,CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)[NH3+])O,gastric inflammation,CID000002907,cyclophosphamide,C1CNP(=O)(OC1)N(CCCl)CCCl
CID000001690,Doxorubicin (Adriamycin) HCl,CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)[NH3+])O,gastric inflammation,CID000004691,"3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine",C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4
CID000001690,Doxorubicin (Adriamycin) HCl,CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)[NH3+])O,hepatic neoplasia,CID000003148,dolasetron,C1C2CC3CC(CC1N3CC2=O)OC(=O)C4=CNC5=CC=CC=C54
CID000001690,Doxorubicin (Adriamycin) HCl,CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)[NH3+])O,thrombocytopenia,CID000004211,mitotane,C1=CC=C(C(=C1)C(C2=CC=C(C=C2)Cl)C(Cl)Cl)Cl
CID000001690,Doxorubicin (Adriamycin) HCl,CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)[NH3+])O,Adenopathy,CID000003414,phosphonatoformate,C(=O)([O-])P(=O)([O-])[O-]
CID000001690,Doxorubicin (Adriamycin) HCl,CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)[NH3+])O,cholecystectomies,CID000005978,vincristine,CCC1(CC2CC(C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)C78CCN9C7C(C=CC9)(C(C(C8N6C=O)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O
CID000001690,Doxorubicin (Adriamycin) HCl,CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)[NH3+])O,apoplexy,CID000002405,BISOPROLOL,CC(C)NCC(COC1=CC=C(C=C1)COCCOC(C)C)O
CID000001690,Doxorubicin (Adriamycin) HCl,CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)[NH3+])O,apoplexy,CID000003750,"4,11-diethyl-4-hydroxy-3,14-dioxo-3,4,12,14-tetrahydro-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinolin-9-yl 1,4'-bipiperidine-1'-carboxylate",CCC1=C2CN3C(=CC4=C(C3=O)COC(=O)C4(CC)O)C2=NC5=C1C=C(C=C5)OC(=O)N6CCC(CC6)N7CCCCC7
CID000001690,Doxorubicin (Adriamycin) HCl,CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)[NH3+])O,myelodysplasia,CID000004900,Fernisone,CC12CC(=O)C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C
CID000001690,Doxorubicin (Adriamycin) HCl,CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)[NH3+])O,loss of weight,CID000005523,Ultram,CN(C)CC1CCCCC1(C2=CC(=CC=C2)OC)O
CID000001690,Doxorubicin (Adriamycin) HCl,CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)[NH3+])O,myelodysplasia,CID000003961,losartan,CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)CO)Cl
CID000001690,Doxorubicin (Adriamycin) HCl,CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)[NH3+])O,drug toxicity NOS,CID000002818,"3-chloro-6-(4-methylpiperazin-1-yl)-5H-benzo[b][1,4]benzodiazepine",CN1CCN(CC1)C2=C3C=CC=CC3=NC4=C(N2)C=C(C=C4)Cl
CID000001690,Doxorubicin (Adriamycin) HCl,CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)[NH3+])O,thrombocytopenia,CID000003890,TRANS (15S)-LATANOPROST,CC(C)OC(=O)CCCC=CCC1C(CC(C1CCC(CCC2=CC=CC=C2)O)O)O
CID000001690,Doxorubicin (Adriamycin) HCl,CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)[NH3+])O,Adenopathy,CID000003305,Etidronic acid,CC(O)(P(=O)(O)O)P(=O)(O)O
CID000001690,Doxorubicin (Adriamycin) HCl,CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)[NH3+])O,loss of weight,CID000002891,"cobalt(2+);[5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] 1-[3-[2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2,7,12,17-tetrahydro-1H-corrin-21-id-3-yl]propanoylamino]propan-2-yl hydrogen phosphate;cyanide",CC1=CC2=C(C=C1C)N(C=N2)C3C(C(C(O3)CO)OP(=O)(O)OC(C)CNC(=O)CCC4(C(C5C6(C(C(C(=N6)C(=C7C(C(C(=N7)C=C8C(C(C(=N8)C(=C4[N-]5)C)CCC(=O)N)(C)C)CCC(=O)N)(C)CC(=O)N)C)CCC(=O)N)(C)CC(=O)N)C)CC(=O)N)C)O.[C-]#N.[Co+2]
CID000001690,Doxorubicin (Adriamycin) HCl,CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)[NH3+])O,Excoriation,CID000060754,Gadodiamide hydrate,CNC(=O)CN(CCN(CCN(CC(=O)NC)CC(=O)[O-])CC(=O)[O-])CC(=O)[O-].O.[Gd+3]
CID000001690,Doxorubicin (Adriamycin) HCl,CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)[NH3+])O,Back Ache,CID000004585,"2-methyl-4-(4-methylpiperazin-1-yl)-5H-thieno[3,2-c][1,5]benzodiazepine",CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C
CID000001690,Doxorubicin (Adriamycin) HCl,CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)[NH3+])O,gastric inflammation,CID000004679,pantoprazole,COC1=C(C(=NC=C1)CS(=O)C2=NC3=C(N2)C=C(C=C3)OC(F)F)OC
CID000001690,Doxorubicin (Adriamycin) HCl,CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)[NH3+])O,apoplexy,CID003468412,SCHEMBL1176571,CC1C=CC=CCCC=CC=CC=CC=CC(CC(C(C(CC(=O)CC(C(CCC(CC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)C(=O)O)O)OC2C(C(C(C(O2)C)O)N)O
CID000001690,Doxorubicin (Adriamycin) HCl,CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)[NH3+])O,icterus,CID000002478,busulfan,CS(=O)(=O)OCCCCOS(=O)(=O)C
CID000001690,Doxorubicin (Adriamycin) HCl,CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)[NH3+])O,gastric inflammation,CID000005376,(E/Z)-Tamoxifen,CCC(=C(C1=CC=CC=C1)C2=CC=C(C=C2)OCCN(C)C)C3=CC=CC=C3
CID000001690,Doxorubicin (Adriamycin) HCl,CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)[NH3+])O,allergic dermatitis,CID000005512,124936-74-9,CC1=CC(=C(C=C1)O)C(CCN(C(C)C)C(C)C)C2=CC=CC=C2
CID000001690,Doxorubicin (Adriamycin) HCl,CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)[NH3+])O,apoplexy,CID000170361,Varenicline,C1C2CNCC1C3=CC4=NC=CN=C4C=C23
CID000001690,Doxorubicin (Adriamycin) HCl,CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)[NH3+])O,loss of weight,CID000005152,Salmeterol,C1=CC=C(C=C1)CCCCOCCCCCCNCC(C2=CC(=C(C=C2)O)CO)O
CID000001690,Doxorubicin (Adriamycin) HCl,CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)[NH3+])O,gastric inflammation,CID000002022,2-amino-9-(2-hydroxyethoxymethyl)-3H-purin-6-one,C1=NC2=C(N1COCCO)NC(=NC2=O)N
CID000001690,Doxorubicin (Adriamycin) HCl,CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)[NH3+])O,Adenopathy,CID000667490,6-Mercaptopurine,C1=NC2=C(N1)C(=S)N=CN2
CID000001690,Doxorubicin (Adriamycin) HCl,CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)[NH3+])O,allergic dermatitis,CID000163742,SCHEMBL1650579,COC1C(C(C(C(O1)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)COS(=O)(=O)O)OC4C(C(C(C(O4)C(=O)O)OC5C(C(C(C(O5)COS(=O)(=O)O)O)O)NS(=O)(=O)O)O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O)NS(=O)(=O)O
CID000001690,Doxorubicin (Adriamycin) HCl,CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)[NH3+])O,body temperature increased,CID000074989,ATOVAQUONE,C1CC(CCC1C2=CC=C(C=C2)Cl)C3=C(C4=CC=CC=C4C(=O)C3=O)O
CID000001690,Doxorubicin (Adriamycin) HCl,CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)[NH3+])O,constipated,CID000002541,candesartan,CCOC1=NC2=CC=CC(=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5)C(=O)O
CID000001690,Doxorubicin (Adriamycin) HCl,CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)[NH3+])O,deglutition disorder,CID000004189,miconazole,C1=CC(=C(C=C1Cl)Cl)COC(CN2C=CN=C2)C3=C(C=C(C=C3)Cl)Cl
CID000001690,Doxorubicin (Adriamycin) HCl,CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)[NH3+])O,Back Ache,CID000005544,Mycolog,CC12CC(C3(C(C1CC(C2(C(=O)CO)O)O)CCC4=CC(=O)C=CC43C)F)O
CID000001690,Doxorubicin (Adriamycin) HCl,CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)[NH3+])O,lung infiltration,CID000071616,Voriconazole,CC(C1=NC=NC=C1F)C(CN2C=NC=N2)(C3=C(C=C(C=C3)F)F)O
CID000001690,Doxorubicin (Adriamycin) HCl,CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)[NH3+])O,apoplexy,CID000004927,promethazine,CC(CN1C2=CC=CC=C2SC3=CC=CC=C31)N(C)C
CID000001690,Doxorubicin (Adriamycin) HCl,CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)[NH3+])O,gastric inflammation,CID000003325,famotidine,C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N
CID000001690,Doxorubicin (Adriamycin) HCl,CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)[NH3+])O,dysarthria,CID000002284,baclofen,C1=CC(=CC=C1C(CC(=O)O)CN)Cl
CID000001690,Doxorubicin (Adriamycin) HCl,CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)[NH3+])O,thrombocytopenia,CID000005478,racemic-Timolol,CC(C)(C)NCC(COC1=NSN=C1N2CCOCC2)O
CID000001690,Doxorubicin (Adriamycin) HCl,CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)[NH3+])O,Adenopathy,CID000005650,N-pentanoyl-N-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-L-valine,CCCCC(=O)N(CC1=CC=C(C=C1)C2=CC=CC=C2C3=NNN=N3)C(C(C)C)C(=O)O
CID000001690,Doxorubicin (Adriamycin) HCl,CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)[NH3+])O,Paraesthesia,CID000004889,Pravastatin Impurity A,CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC(CC(CC(=O)O)O)O)O
CID000002673,Cefradin,CC1=C(N2C(C(C2=O)NC(=O)C(C3=CCC=CC3)N)SC1)C(=O)O,sepsis,CID000003062,Lanicor,CC1C(C(CC(O1)OC2C(OC(CC2O)OC3C(OC(CC3O)OC4CCC5(C(C4)CCC6C5CC(C7(C6(CCC7C8=CC(=O)OC8)O)C)O)C)C)C)O)O
CID000060164,ADAPALENE,COC1=C(C=C(C=C1)C2=CC3=C(C=C2)C=C(C=C3)C(=O)O)C45CC6CC(C4)CC(C6)C5,gastric inflammation,CID006447131,Pimecrolimus,CCC1C=C(CC(CC(C2C(CC(C(O2)(C(=O)C(=O)N3CCCCC3C(=O)OC(C(C(CC1=O)O)C)C(=CC4CCC(C(C4)OC)Cl)C)O)C)OC)OC)C)C
CID000002818,"3-chloro-6-(4-methylpiperazin-1-yl)-5H-benzo[b][1,4]benzodiazepine",CN1CCN(CC1)C2=C3C=CC=CC3=NC4=C(N2)C=C(C=C4)Cl,erythema,CID000003658,hydroxyzine,C1CN(CCN1CCOCCO)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl
CID000002818,"3-chloro-6-(4-methylpiperazin-1-yl)-5H-benzo[b][1,4]benzodiazepine",CN1CCN(CC1)C2=C3C=CC=CC3=NC4=C(N2)C=C(C=C4)Cl,aspiration pneumonia,CID000003449,Epigalanthamin,CN1CCC23C=CC(CC2OC4=C(C=CC(=C34)C1)OC)O
CID000002818,"3-chloro-6-(4-methylpiperazin-1-yl)-5H-benzo[b][1,4]benzodiazepine",CN1CCN(CC1)C2=C3C=CC=CC3=NC4=C(N2)C=C(C=C4)Cl,gastric inflammation,CID000003440,furosemide,C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl
CID000002818,"3-chloro-6-(4-methylpiperazin-1-yl)-5H-benzo[b][1,4]benzodiazepine",CN1CCN(CC1)C2=C3C=CC=CC3=NC4=C(N2)C=C(C=C4)Cl,dysarthria,CID000010631,medroxyprogesterone,CC1CC2C(CCC3(C2CCC3(C(=O)C)O)C)C4(C1=CC(=O)CC4)C
CID000002818,"3-chloro-6-(4-methylpiperazin-1-yl)-5H-benzo[b][1,4]benzodiazepine",CN1CCN(CC1)C2=C3C=CC=CC3=NC4=C(N2)C=C(C=C4)Cl,thrombocytopenia,CID000005152,Salmeterol,C1=CC=C(C=C1)CCCCOCCCCCCNCC(C2=CC(=C(C=C2)O)CO)O
CID000002818,"3-chloro-6-(4-methylpiperazin-1-yl)-5H-benzo[b][1,4]benzodiazepine",CN1CCN(CC1)C2=C3C=CC=CC3=NC4=C(N2)C=C(C=C4)Cl,loss of weight,CID000019090,megestrol,CC1=CC2C(CCC3(C2CCC3(C(=O)C)O)C)C4(C1=CC(=O)CC4)C
CID000002818,"3-chloro-6-(4-methylpiperazin-1-yl)-5H-benzo[b][1,4]benzodiazepine",CN1CCN(CC1)C2=C3C=CC=CC3=NC4=C(N2)C=C(C=C4)Cl,Enuresis,CID000004075,5-Aminosalicylic acid,C1=CC(=C(C=C1N)C(=O)O)O
CID000002818,"3-chloro-6-(4-methylpiperazin-1-yl)-5H-benzo[b][1,4]benzodiazepine",CN1CCN(CC1)C2=C3C=CC=CC3=NC4=C(N2)C=C(C=C4)Cl,ear infection,CID000004894,"11,17,21-Trihydroxypregna-1,4-diene-3,20-dione",CC12CC(C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C)O
CID000002818,"3-chloro-6-(4-methylpiperazin-1-yl)-5H-benzo[b][1,4]benzodiazepine",CN1CCN(CC1)C2=C3C=CC=CC3=NC4=C(N2)C=C(C=C4)Cl,drug toxicity NOS,CID000003749,irbesartan,CCCCC1=NC2(CCCC2)C(=O)N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5
CID000002818,"3-chloro-6-(4-methylpiperazin-1-yl)-5H-benzo[b][1,4]benzodiazepine",CN1CCN(CC1)C2=C3C=CC=CC3=NC4=C(N2)C=C(C=C4)Cl,right heart failure,CID000004585,"2-methyl-4-(4-methylpiperazin-1-yl)-5H-thieno[3,2-c][1,5]benzodiazepine",CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C
CID000002818,"3-chloro-6-(4-methylpiperazin-1-yl)-5H-benzo[b][1,4]benzodiazepine",CN1CCN(CC1)C2=C3C=CC=CC3=NC4=C(N2)C=C(C=C4)Cl,weight gain,CID000005391,temazepam,CN1C2=C(C=C(C=C2)Cl)C(=NC(C1=O)O)C3=CC=CC=C3
CID000002818,"3-chloro-6-(4-methylpiperazin-1-yl)-5H-benzo[b][1,4]benzodiazepine",CN1CCN(CC1)C2=C3C=CC=CC3=NC4=C(N2)C=C(C=C4)Cl,abnormal ECG,CID000003333,felodipine,CCOC(=O)C1=C(NC(=C(C1C2=C(C(=CC=C2)Cl)Cl)C(=O)OC)C)C
CID000002818,"3-chloro-6-(4-methylpiperazin-1-yl)-5H-benzo[b][1,4]benzodiazepine",CN1CCN(CC1)C2=C3C=CC=CC3=NC4=C(N2)C=C(C=C4)Cl,thrombocytopenia,CID000038904,Carboplatinum,C1CC(C1)(C(=O)O)C(=O)O.N.N.[Pt]
CID000002818,"3-chloro-6-(4-methylpiperazin-1-yl)-5H-benzo[b][1,4]benzodiazepine",CN1CCN(CC1)C2=C3C=CC=CC3=NC4=C(N2)C=C(C=C4)Cl,Alcoholic intoxication,CID000003890,TRANS (15S)-LATANOPROST,CC(C)OC(=O)CCCC=CCC1C(CC(C1CCC(CCC2=CC=CC=C2)O)O)O
CID000002818,"3-chloro-6-(4-methylpiperazin-1-yl)-5H-benzo[b][1,4]benzodiazepine",CN1CCN(CC1)C2=C3C=CC=CC3=NC4=C(N2)C=C(C=C4)Cl,bleeding Vaginal,CID000170361,Varenicline,C1C2CNCC1C3=CC4=NC=CN=C4C=C23
CID000002818,"3-chloro-6-(4-methylpiperazin-1-yl)-5H-benzo[b][1,4]benzodiazepine",CN1CCN(CC1)C2=C3C=CC=CC3=NC4=C(N2)C=C(C=C4)Cl,agitated,CID000115237,Paliperidone,CC1=C(C(=O)N2CCCC(C2=N1)O)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F
CID000002818,"3-chloro-6-(4-methylpiperazin-1-yl)-5H-benzo[b][1,4]benzodiazepine",CN1CCN(CC1)C2=C3C=CC=CC3=NC4=C(N2)C=C(C=C4)Cl,apoplexy,CID000003075,"2-[3-acetyloxy-2-(4-methoxyphenyl)-4-oxo-2,3-dihydro-1,5-benzothiazepin-5-yl]ethyl-dimethylazanium",CC(=O)OC1C(SC2=CC=CC=C2N(C1=O)CC[NH+](C)C)C3=CC=C(C=C3)OC
CID000002818,"3-chloro-6-(4-methylpiperazin-1-yl)-5H-benzo[b][1,4]benzodiazepine",CN1CCN(CC1)C2=C3C=CC=CC3=NC4=C(N2)C=C(C=C4)Cl,neumonia,CID000002951,dantrolene(1-),C1C(=NC(=O)N1N=CC2=CC=C(O2)C3=CC=C(C=C3)[N+](=O)[O-])[O-]
CID000002818,"3-chloro-6-(4-methylpiperazin-1-yl)-5H-benzo[b][1,4]benzodiazepine",CN1CCN(CC1)C2=C3C=CC=CC3=NC4=C(N2)C=C(C=C4)Cl,loss of weight,CID000008953,sodium;hydrogen carbonate,C(=O)(O)[O-].[Na+]
CID000002818,"3-chloro-6-(4-methylpiperazin-1-yl)-5H-benzo[b][1,4]benzodiazepine",CN1CCN(CC1)C2=C3C=CC=CC3=NC4=C(N2)C=C(C=C4)Cl,apoplexy,CID000004205,mirtazapine,CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4
CID000002818,"3-chloro-6-(4-methylpiperazin-1-yl)-5H-benzo[b][1,4]benzodiazepine",CN1CCN(CC1)C2=C3C=CC=CC3=NC4=C(N2)C=C(C=C4)Cl,dysarthria,CID000003961,losartan,CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)CO)Cl
CID000002818,"3-chloro-6-(4-methylpiperazin-1-yl)-5H-benzo[b][1,4]benzodiazepine",CN1CCN(CC1)C2=C3C=CC=CC3=NC4=C(N2)C=C(C=C4)Cl,neumonia,CID003468412,SCHEMBL1176571,CC1C=CC=CCCC=CC=CC=CC=CC(CC(C(C(CC(=O)CC(C(CCC(CC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)C(=O)O)O)OC2C(C(C(C(O2)C)O)N)O
CID000002818,"3-chloro-6-(4-methylpiperazin-1-yl)-5H-benzo[b][1,4]benzodiazepine",CN1CCN(CC1)C2=C3C=CC=CC3=NC4=C(N2)C=C(C=C4)Cl,enlarged liver,CID000005544,Mycolog,CC12CC(C3(C(C1CC(C2(C(=O)CO)O)O)CCC4=CC(=O)C=CC43C)F)O
CID000002818,"3-chloro-6-(4-methylpiperazin-1-yl)-5H-benzo[b][1,4]benzodiazepine",CN1CCN(CC1)C2=C3C=CC=CC3=NC4=C(N2)C=C(C=C4)Cl,bradycardia,CID000005245,Risedronic acid,C1=CC(=CN=C1)CC(O)(P(=O)(O)O)P(=O)(O)O
CID000002818,"3-chloro-6-(4-methylpiperazin-1-yl)-5H-benzo[b][1,4]benzodiazepine",CN1CCN(CC1)C2=C3C=CC=CC3=NC4=C(N2)C=C(C=C4)Cl,apoplexy,CID000003345,fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3
CID000002818,"3-chloro-6-(4-methylpiperazin-1-yl)-5H-benzo[b][1,4]benzodiazepine",CN1CCN(CC1)C2=C3C=CC=CC3=NC4=C(N2)C=C(C=C4)Cl,convulsion,CID000005719,zaleplon,CCN(C1=CC=CC(=C1)C2=CC=NC3=C(C=NN23)C#N)C(=O)C
CID000002818,"3-chloro-6-(4-methylpiperazin-1-yl)-5H-benzo[b][1,4]benzodiazepine",CN1CCN(CC1)C2=C3C=CC=CC3=NC4=C(N2)C=C(C=C4)Cl,thrombocytopenia,CID000002907,cyclophosphamide,C1CNP(=O)(OC1)N(CCCl)CCCl
CID000002818,"3-chloro-6-(4-methylpiperazin-1-yl)-5H-benzo[b][1,4]benzodiazepine",CN1CCN(CC1)C2=C3C=CC=CC3=NC4=C(N2)C=C(C=C4)Cl,gastric inflammation,CID000005512,124936-74-9,CC1=CC(=C(C=C1)O)C(CCN(C(C)C)C(C)C)C2=CC=CC=C2
CID000002818,"3-chloro-6-(4-methylpiperazin-1-yl)-5H-benzo[b][1,4]benzodiazepine",CN1CCN(CC1)C2=C3C=CC=CC3=NC4=C(N2)C=C(C=C4)Cl,colitis ischemic,CID000003937,N~2~-(1-carboxy-3-phenylpropyl)lysylproline,C1CC(N(C1)C(=O)C(CCCCN)NC(CCC2=CC=CC=C2)C(=O)O)C(=O)O
CID000002818,"3-chloro-6-(4-methylpiperazin-1-yl)-5H-benzo[b][1,4]benzodiazepine",CN1CCN(CC1)C2=C3C=CC=CC3=NC4=C(N2)C=C(C=C4)Cl,abnormal EEG,CID000003405,2-[[4-[(2-amino-4-oxo-1H-pteridin-6-yl)methylamino]benzoyl]amino]pentanedioic acid,C1=CC(=CC=C1C(=O)NC(CCC(=O)O)C(=O)O)NCC2=CN=C3C(=N2)C(=O)N=C(N3)N
CID000002818,"3-chloro-6-(4-methylpiperazin-1-yl)-5H-benzo[b][1,4]benzodiazepine",CN1CCN(CC1)C2=C3C=CC=CC3=NC4=C(N2)C=C(C=C4)Cl,apoplexy,CID000077999,rosiglitazone,CN(CCOC1=CC=C(C=C1)CC2C(=O)NC(=O)S2)C3=CC=CC=N3
CID000002818,"3-chloro-6-(4-methylpiperazin-1-yl)-5H-benzo[b][1,4]benzodiazepine",CN1CCN(CC1)C2=C3C=CC=CC3=NC4=C(N2)C=C(C=C4)Cl,drug toxicity NOS,CID000003310,33419-42-0,CC1OCC2C(O1)C(C(C(O2)OC3C4COC(=O)C4C(C5=CC6=C(C=C35)OCO6)C7=CC(=C(C(=C7)OC)O)OC)O)O
CID000002818,"3-chloro-6-(4-methylpiperazin-1-yl)-5H-benzo[b][1,4]benzodiazepine",CN1CCN(CC1)C2=C3C=CC=CC3=NC4=C(N2)C=C(C=C4)Cl,cholecystectomies,CID000060854,Ziprasidone,C1CN(CCN1CCC2=C(C=C3C(=C2)CC(=O)N3)Cl)C4=NSC5=CC=CC=C54
CID000002818,"3-chloro-6-(4-methylpiperazin-1-yl)-5H-benzo[b][1,4]benzodiazepine",CN1CCN(CC1)C2=C3C=CC=CC3=NC4=C(N2)C=C(C=C4)Cl,loss of weight,CID000062924,"S-(fluoromethyl) (6S,9R,10S,11S,13S,14S,16R,17R)-6,9-difluoro-11,17-dihydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthrene-17-carbothioate",CC1CC2C3CC(C4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)SCF)O)C)O)F)C)F
CID000002818,"3-chloro-6-(4-methylpiperazin-1-yl)-5H-benzo[b][1,4]benzodiazepine",CN1CCN(CC1)C2=C3C=CC=CC3=NC4=C(N2)C=C(C=C4)Cl,thrombocytopenia,CID006398525,,C(C1C(C(C(C(O1)OC2(C(C(C(O2)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)COS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.[Al].[Al].[Al].[Al].[Al].[Al].[Al].[Al].[Al]
CID000002818,"3-chloro-6-(4-methylpiperazin-1-yl)-5H-benzo[b][1,4]benzodiazepine",CN1CCN(CC1)C2=C3C=CC=CC3=NC4=C(N2)C=C(C=C4)Cl,neumonia,CID000004889,Pravastatin Impurity A,CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC(CC(CC(=O)O)O)O)O
CID000002818,"3-chloro-6-(4-methylpiperazin-1-yl)-5H-benzo[b][1,4]benzodiazepine",CN1CCN(CC1)C2=C3C=CC=CC3=NC4=C(N2)C=C(C=C4)Cl,neuropathy,CID000004666,7-Epi Paclitaxel,CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C
CID000002818,"3-chloro-6-(4-methylpiperazin-1-yl)-5H-benzo[b][1,4]benzodiazepine",CN1CCN(CC1)C2=C3C=CC=CC3=NC4=C(N2)C=C(C=C4)Cl,abnormal ECG,CID000004510,nitroglycerin,C(C(CO[N+](=O)[O-])O[N+](=O)[O-])O[N+](=O)[O-]
CID000002818,"3-chloro-6-(4-methylpiperazin-1-yl)-5H-benzo[b][1,4]benzodiazepine",CN1CCN(CC1)C2=C3C=CC=CC3=NC4=C(N2)C=C(C=C4)Cl,apoplexy,CID000003325,famotidine,C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N
CID000002818,"3-chloro-6-(4-methylpiperazin-1-yl)-5H-benzo[b][1,4]benzodiazepine",CN1CCN(CC1)C2=C3C=CC=CC3=NC4=C(N2)C=C(C=C4)Cl,insulin dependent diabetes mellitus,CID000003339,fenofibrate,CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C2=CC=C(C=C2)Cl
CID000002818,"3-chloro-6-(4-methylpiperazin-1-yl)-5H-benzo[b][1,4]benzodiazepine",CN1CCN(CC1)C2=C3C=CC=CC3=NC4=C(N2)C=C(C=C4)Cl,cholecystitis,CID000005073,risperidone,CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F
CID000002818,"3-chloro-6-(4-methylpiperazin-1-yl)-5H-benzo[b][1,4]benzodiazepine",CN1CCN(CC1)C2=C3C=CC=CC3=NC4=C(N2)C=C(C=C4)Cl,abnormal ECG,CID000004927,promethazine,CC(CN1C2=CC=CC=C2SC3=CC=CC=C31)N(C)C
CID000002818,"3-chloro-6-(4-methylpiperazin-1-yl)-5H-benzo[b][1,4]benzodiazepine",CN1CCN(CC1)C2=C3C=CC=CC3=NC4=C(N2)C=C(C=C4)Cl,excessive thirst,CID000004691,"3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine",C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4
CID000002818,"3-chloro-6-(4-methylpiperazin-1-yl)-5H-benzo[b][1,4]benzodiazepine",CN1CCN(CC1)C2=C3C=CC=CC3=NC4=C(N2)C=C(C=C4)Cl,cholecystitis,CID000004173,metronidazole,CC1=NC=C(N1CCO)[N+](=O)[O-]
CID000002818,"3-chloro-6-(4-methylpiperazin-1-yl)-5H-benzo[b][1,4]benzodiazepine",CN1CCN(CC1)C2=C3C=CC=CC3=NC4=C(N2)C=C(C=C4)Cl,gastric inflammation,CID000005732,zolpidem,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C
CID000002818,"3-chloro-6-(4-methylpiperazin-1-yl)-5H-benzo[b][1,4]benzodiazepine",CN1CCN(CC1)C2=C3C=CC=CC3=NC4=C(N2)C=C(C=C4)Cl,dysarthria,CID000004236,modafinil,C1=CC=C(C=C1)C(C2=CC=CC=C2)S(=O)CC(=O)N
CID000002818,"3-chloro-6-(4-methylpiperazin-1-yl)-5H-benzo[b][1,4]benzodiazepine",CN1CCN(CC1)C2=C3C=CC=CC3=NC4=C(N2)C=C(C=C4)Cl,ear infection,CID000003954,loperamide(1+),CN(C)C(=O)C(CC[NH+]1CCC(CC1)(C2=CC=C(C=C2)Cl)O)(C3=CC=CC=C3)C4=CC=CC=C4
CID000002818,"3-chloro-6-(4-methylpiperazin-1-yl)-5H-benzo[b][1,4]benzodiazepine",CN1CCN(CC1)C2=C3C=CC=CC3=NC4=C(N2)C=C(C=C4)Cl,loss of weight,CID000004543,nortriptyline,CNCCC=C1C2=CC=CC=C2CCC3=CC=CC=C31
CID000002818,"3-chloro-6-(4-methylpiperazin-1-yl)-5H-benzo[b][1,4]benzodiazepine",CN1CCN(CC1)C2=C3C=CC=CC3=NC4=C(N2)C=C(C=C4)Cl,gastric inflammation,CID000004856,"3-[hydroxy-(pyridin-2-ylamino)methylidene]-2-methyl-1,1-dioxo-1lambda6,2-benzothiazin-4-one",CN1C(=C(NC2=CC=CC=N2)O)C(=O)C3=CC=CC=C3S1(=O)=O
CID000002818,"3-chloro-6-(4-methylpiperazin-1-yl)-5H-benzo[b][1,4]benzodiazepine",CN1CCN(CC1)C2=C3C=CC=CC3=NC4=C(N2)C=C(C=C4)Cl,insulin dependent diabetes mellitus,CID000004748,perphenazine,C1CN(CCN1CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)Cl)CCO
CID000002818,"3-chloro-6-(4-methylpiperazin-1-yl)-5H-benzo[b][1,4]benzodiazepine",CN1CCN(CC1)C2=C3C=CC=CC3=NC4=C(N2)C=C(C=C4)Cl,atelectasis,CID000004745,SCHEMBL7711911,CCCN1CC(CC2C1CC3=CNC4=CC=CC2=C34)CSC
CID000002818,"3-chloro-6-(4-methylpiperazin-1-yl)-5H-benzo[b][1,4]benzodiazepine",CN1CCN(CC1)C2=C3C=CC=CC3=NC4=C(N2)C=C(C=C4)Cl,neumonia,CID000003516,guaifenesin,COC1=CC=CC=C1OCC(CO)O
CID000002818,"3-chloro-6-(4-methylpiperazin-1-yl)-5H-benzo[b][1,4]benzodiazepine",CN1CCN(CC1)C2=C3C=CC=CC3=NC4=C(N2)C=C(C=C4)Cl,weight gain,CID000005095,ropinirole,CCCN(CCC)CCC1=C2CC(=O)NC2=CC=C1
CID000002818,"3-chloro-6-(4-methylpiperazin-1-yl)-5H-benzo[b][1,4]benzodiazepine",CN1CCN(CC1)C2=C3C=CC=CC3=NC4=C(N2)C=C(C=C4)Cl,loss of weight,CID000004158,methylphenidate,COC(=O)C(C1CCCCN1)C2=CC=CC=C2
CID000002818,"3-chloro-6-(4-methylpiperazin-1-yl)-5H-benzo[b][1,4]benzodiazepine",CN1CCN(CC1)C2=C3C=CC=CC3=NC4=C(N2)C=C(C=C4)Cl,deglutition disorder,CID000003780,"D-Glucitol, 1,4:3,6-dianhydro-, 2,5-dinitrate",C1C(C2C(O1)C(CO2)O[N+](=O)[O-])O[N+](=O)[O-]
CID000002818,"3-chloro-6-(4-methylpiperazin-1-yl)-5H-benzo[b][1,4]benzodiazepine",CN1CCN(CC1)C2=C3C=CC=CC3=NC4=C(N2)C=C(C=C4)Cl,increased white blood cell count,CID000002891,"cobalt(2+);[5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] 1-[3-[2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2,7,12,17-tetrahydro-1H-corrin-21-id-3-yl]propanoylamino]propan-2-yl hydrogen phosphate;cyanide",CC1=CC2=C(C=C1C)N(C=N2)C3C(C(C(O3)CO)OP(=O)(O)OC(C)CNC(=O)CCC4(C(C5C6(C(C(C(=N6)C(=C7C(C(C(=N7)C=C8C(C(C(=N8)C(=C4[N-]5)C)CCC(=O)N)(C)C)CCC(=O)N)(C)CC(=O)N)C)CCC(=O)N)(C)CC(=O)N)C)CC(=O)N)C)O.[C-]#N.[Co+2]
CID000002818,"3-chloro-6-(4-methylpiperazin-1-yl)-5H-benzo[b][1,4]benzodiazepine",CN1CCN(CC1)C2=C3C=CC=CC3=NC4=C(N2)C=C(C=C4)Cl,increased white blood cell count,CID000004054,memantine,CC12CC3CC(C1)(CC(C3)(C2)N)C
CID000002818,"3-chloro-6-(4-methylpiperazin-1-yl)-5H-benzo[b][1,4]benzodiazepine",CN1CCN(CC1)C2=C3C=CC=CC3=NC4=C(N2)C=C(C=C4)Cl,gastric inflammation,CID000004679,pantoprazole,COC1=C(C(=NC=C1)CS(=O)C2=NC3=C(N2)C=C(C=C3)OC(F)F)OC
CID000002818,"3-chloro-6-(4-methylpiperazin-1-yl)-5H-benzo[b][1,4]benzodiazepine",CN1CCN(CC1)C2=C3C=CC=CC3=NC4=C(N2)C=C(C=C4)Cl,dysarthria,CID000003661,L-Hyoscyamine,CN1C2CCC1CC(C2)OC(=O)C(CO)C3=CC=CC=C3
CID000002818,"3-chloro-6-(4-methylpiperazin-1-yl)-5H-benzo[b][1,4]benzodiazepine",CN1CCN(CC1)C2=C3C=CC=CC3=NC4=C(N2)C=C(C=C4)Cl,drug toxicity NOS,CID005311048,SCHEMBL11440306,C(N)(N)(Cl)Cl
CID000002818,"3-chloro-6-(4-methylpiperazin-1-yl)-5H-benzo[b][1,4]benzodiazepine",CN1CCN(CC1)C2=C3C=CC=CC3=NC4=C(N2)C=C(C=C4)Cl,hyperglycaemia,CID000027991,DESMOPRESSIN,C1CC(N(C1)C(=O)C2CSSCCC(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N2)CC(=O)N)CCC(=O)N)CC3=CC=CC=C3)CC4=CC=C(C=C4)O)C(=O)NC(CCCN=C(N)N)C(=O)NCC(=O)N
CID000002818,"3-chloro-6-(4-methylpiperazin-1-yl)-5H-benzo[b][1,4]benzodiazepine",CN1CCN(CC1)C2=C3C=CC=CC3=NC4=C(N2)C=C(C=C4)Cl,increased white blood cell count,CID000004909,primidone,CCC1(C(=O)NCNC1=O)C2=CC=CC=C2
CID000002818,"3-chloro-6-(4-methylpiperazin-1-yl)-5H-benzo[b][1,4]benzodiazepine",CN1CCN(CC1)C2=C3C=CC=CC3=NC4=C(N2)C=C(C=C4)Cl,apoplexy,CID000004900,Fernisone,CC12CC(=O)C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C
CID000002818,"3-chloro-6-(4-methylpiperazin-1-yl)-5H-benzo[b][1,4]benzodiazepine",CN1CCN(CC1)C2=C3C=CC=CC3=NC4=C(N2)C=C(C=C4)Cl,drug toxicity NOS,CID000005978,vincristine,CCC1(CC2CC(C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)C78CCN9C7C(C=CC9)(C(C(C8N6C=O)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O
CID000002818,"3-chloro-6-(4-methylpiperazin-1-yl)-5H-benzo[b][1,4]benzodiazepine",CN1CCN(CC1)C2=C3C=CC=CC3=NC4=C(N2)C=C(C=C4)Cl,agitated,CID000005077,105601-20-5,CCN(C)C(=O)OC1=CC=CC(=C1)C(C)N(C)C
CID000002818,"3-chloro-6-(4-methylpiperazin-1-yl)-5H-benzo[b][1,4]benzodiazepine",CN1CCN(CC1)C2=C3C=CC=CC3=NC4=C(N2)C=C(C=C4)Cl,gastric inflammation,CID000060184,"2'-epi-Perindopril, (2'R)-",CCCC(C(=O)OCC)NC(C)C(=O)N1C2CCCCC2CC1C(=O)O
CID000002818,"3-chloro-6-(4-methylpiperazin-1-yl)-5H-benzo[b][1,4]benzodiazepine",CN1CCN(CC1)C2=C3C=CC=CC3=NC4=C(N2)C=C(C=C4)Cl,empyema,CID000003883,lansoprazole,CC1=C(C=CN=C1CS(=O)C2=NC3=CC=CC=C3N2)OCC(F)(F)F
CID000002818,"3-chloro-6-(4-methylpiperazin-1-yl)-5H-benzo[b][1,4]benzodiazepine",CN1CCN(CC1)C2=C3C=CC=CC3=NC4=C(N2)C=C(C=C4)Cl,apoplexy,CID000003062,Lanicor,CC1C(C(CC(O1)OC2C(OC(CC2O)OC3C(OC(CC3O)OC4CCC5(C(C4)CCC6C5CC(C7(C6(CCC7C8=CC(=O)OC8)O)C)O)C)C)C)O)O
CID000002818,"3-chloro-6-(4-methylpiperazin-1-yl)-5H-benzo[b][1,4]benzodiazepine",CN1CCN(CC1)C2=C3C=CC=CC3=NC4=C(N2)C=C(C=C4)Cl,heart attack,CID000002949,MLS003115428,CC12CCC3C(C1CCC2(C#C)O)CCC4=CC5=C(CC34C)C=NO5
CID000002818,"3-chloro-6-(4-methylpiperazin-1-yl)-5H-benzo[b][1,4]benzodiazepine",CN1CCN(CC1)C2=C3C=CC=CC3=NC4=C(N2)C=C(C=C4)Cl,agitated,CID000005650,N-pentanoyl-N-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-L-valine,CCCCC(=O)N(CC1=CC=C(C=C1)C2=CC=CC=C2C3=NNN=N3)C(C(C)C)C(=O)O
CID000002818,"3-chloro-6-(4-methylpiperazin-1-yl)-5H-benzo[b][1,4]benzodiazepine",CN1CCN(CC1)C2=C3C=CC=CC3=NC4=C(N2)C=C(C=C4)Cl,faecal incontinence,CID000005376,(E/Z)-Tamoxifen,CCC(=C(C1=CC=CC=C1)C2=CC=C(C=C2)OCCN(C)C)C3=CC=CC=C3
CID000002818,"3-chloro-6-(4-methylpiperazin-1-yl)-5H-benzo[b][1,4]benzodiazepine",CN1CCN(CC1)C2=C3C=CC=CC3=NC4=C(N2)C=C(C=C4)Cl,anaphylactic reaction,CID000110635,Tadalafil,CN1CC(=O)N2C(C1=O)CC3=C(C2C4=CC5=C(C=C4)OCO5)NC6=CC=CC=C36
CID000004054,memantine,CC12CC3CC(C1)(CC(C3)(C2)N)C,Adenopathy,CID000060865,(E)-Olopatadine,CN(C)CCC=C1C2=CC=CC=C2COC3=C1C=C(C=C3)CC(=O)O
CID000004054,memantine,CC12CC3CC(C1)(CC(C3)(C2)N)C,erythema,CID000004170,metolazone,CC1NC2=CC(=C(C=C2C(=O)N1C3=CC=CC=C3C)S(=O)(=O)N)Cl
CID000004054,memantine,CC12CC3CC(C1)(CC(C3)(C2)N)C,muscle weakness,CID000019090,megestrol,CC1=CC2C(CCC3(C2CCC3(C(=O)C)O)C)C4(C1=CC(=O)CC4)C
CID000004054,memantine,CC12CC3CC(C1)(CC(C3)(C2)N)C,abnormal ECG,CID000005391,temazepam,CN1C2=C(C=C(C=C2)Cl)C(=NC(C1=O)O)C3=CC=CC=C3
CID000004054,memantine,CC12CC3CC(C1)(CC(C3)(C2)N)C,thrombocytopenia,CID000005394,temozolomide,CN1C(=O)N2C=NC(=C2N=N1)C(=O)N
CID000004054,memantine,CC12CC3CC(C1)(CC(C3)(C2)N)C,loss of weight,CID000062924,"S-(fluoromethyl) (6S,9R,10S,11S,13S,14S,16R,17R)-6,9-difluoro-11,17-dihydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthrene-17-carbothioate",CC1CC2C3CC(C4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)SCF)O)C)O)F)C)F
CID000004054,memantine,CC12CC3CC(C1)(CC(C3)(C2)N)C,nausea,CID000005358,sumatriptan,CNS(=O)(=O)CC1=CC2=C(C=C1)NC=C2CCN(C)C
CID000004054,memantine,CC12CC3CC(C1)(CC(C3)(C2)N)C,apoplexy,CID000004585,"2-methyl-4-(4-methylpiperazin-1-yl)-5H-thieno[3,2-c][1,5]benzodiazepine",CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C
CID000004054,memantine,CC12CC3CC(C1)(CC(C3)(C2)N)C,loss of weight,CID000160051,Colesevelam,CCCCCCCCCCNCC=C.C[N+](C)(C)CCCCCCNCC=C.C=CCN.C1C(O1)CCl.Cl.[Cl-]
CID000004054,memantine,CC12CC3CC(C1)(CC(C3)(C2)N)C,constipated,CID006398525,,C(C1C(C(C(C(O1)OC2(C(C(C(O2)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)COS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.[Al].[Al].[Al].[Al].[Al].[Al].[Al].[Al].[Al]
CID000004054,memantine,CC12CC3CC(C1)(CC(C3)(C2)N)C,loss of weight,CID000004510,nitroglycerin,C(C(CO[N+](=O)[O-])O[N+](=O)[O-])O[N+](=O)[O-]
CID000004054,memantine,CC12CC3CC(C1)(CC(C3)(C2)N)C,deglutition disorder,CID000152945,Dutasteride?,CC12CCC3C(C1CCC2C(=O)NC4=C(C=CC(=C4)C(F)(F)F)C(F)(F)F)CCC5C3(C=CC(=O)N5)C
CID000004054,memantine,CC12CC3CC(C1)(CC(C3)(C2)N)C,loss of weight,CID000060854,Ziprasidone,C1CN(CCN1CCC2=C(C=C3C(=C2)CC(=O)N3)Cl)C4=NSC5=CC=CC=C54
CID000004054,memantine,CC12CC3CC(C1)(CC(C3)(C2)N)C,joint swelling,CID000060852,Ibandronic Acid,CCCCCN(C)CCC(O)(P(=O)(O)O)P(=O)(O)O
CID000004054,memantine,CC12CC3CC(C1)(CC(C3)(C2)N)C,cerebral vascular disorder,CID000004819,"2(3H)-Furanone, 3-ethyldihydro-4-[(1-methyl-1H-imidazol-5-yl)methyl]-, (3S-cis)-",CCC1C(COC1=O)CC2=CN=CN2C
CID000004054,memantine,CC12CC3CC(C1)(CC(C3)(C2)N)C,apoplexy,CID000004889,Pravastatin Impurity A,CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC(CC(CC(=O)O)O)O)O
CID000004054,memantine,CC12CC3CC(C1)(CC(C3)(C2)N)C,dry skin,CID000005376,(E/Z)-Tamoxifen,CCC(=C(C1=CC=CC=C1)C2=CC=C(C=C2)OCCN(C)C)C3=CC=CC=C3
CID000004054,memantine,CC12CC3CC(C1)(CC(C3)(C2)N)C,glaucoma,CID000004543,nortriptyline,CNCCC=C1C2=CC=CC=C2CCC3=CC=CC=C31
CID000004054,memantine,CC12CC3CC(C1)(CC(C3)(C2)N)C,apoplexy,CID000077999,rosiglitazone,CN(CCOC1=CC=C(C=C1)CC2C(=O)NC(=O)S2)C3=CC=CC=N3
CID000004054,memantine,CC12CC3CC(C1)(CC(C3)(C2)N)C,cholecystitis,CID000004679,pantoprazole,COC1=C(C(=NC=C1)CS(=O)C2=NC3=C(N2)C=C(C=C3)OC(F)F)OC
CID000004054,memantine,CC12CC3CC(C1)(CC(C3)(C2)N)C,abnormal ECG,CID000005650,N-pentanoyl-N-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-L-valine,CCCCC(=O)N(CC1=CC=C(C=C1)C2=CC=CC=C2C3=NNN=N3)C(C(C)C)C(=O)O
CID000004054,memantine,CC12CC3CC(C1)(CC(C3)(C2)N)C,erythema,CID000004900,Fernisone,CC12CC(=O)C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C
CID000004054,memantine,CC12CC3CC(C1)(CC(C3)(C2)N)C,apoplexy,CID000005095,ropinirole,CCCN(CCC)CCC1=C2CC(=O)NC2=CC=C1
CID000004054,memantine,CC12CC3CC(C1)(CC(C3)(C2)N)C,ecchymoses,CID000163742,SCHEMBL1650579,COC1C(C(C(C(O1)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)COS(=O)(=O)O)OC4C(C(C(C(O4)C(=O)O)OC5C(C(C(C(O5)COS(=O)(=O)O)O)O)NS(=O)(=O)O)O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O)NS(=O)(=O)O
CID000004054,memantine,CC12CC3CC(C1)(CC(C3)(C2)N)C,elevated cholesterol,CID000005478,racemic-Timolol,CC(C)(C)NCC(COC1=NSN=C1N2CCOCC2)O
CID000004054,memantine,CC12CC3CC(C1)(CC(C3)(C2)N)C,apoplexy,CID000170361,Varenicline,C1C2CNCC1C3=CC4=NC=CN=C4C=C23
CID000004054,memantine,CC12CC3CC(C1)(CC(C3)(C2)N)C,angiitis,CID000004158,methylphenidate,COC(=O)C(C1CCCCN1)C2=CC=CC=C2
CID000004054,memantine,CC12CC3CC(C1)(CC(C3)(C2)N)C,dysarthria,CID000004691,"3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine",C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4
CID000004054,memantine,CC12CC3CC(C1)(CC(C3)(C2)N)C,Adenopathy,CID000004236,modafinil,C1=CC=C(C=C1)C(C2=CC=CC=C2)S(=O)CC(=O)N
CID000004054,memantine,CC12CC3CC(C1)(CC(C3)(C2)N)C,abnormal ECG,CID000005512,124936-74-9,CC1=CC(=C(C=C1)O)C(CCN(C(C)C)C(C)C)C2=CC=CC=C2
CID000004054,memantine,CC12CC3CC(C1)(CC(C3)(C2)N)C,loss of weight,CID000004927,promethazine,CC(CN1C2=CC=CC=C2SC3=CC=CC=C31)N(C)C
CID000004054,memantine,CC12CC3CC(C1)(CC(C3)(C2)N)C,weight gain,CID000122316,1875-50-9,C#CCNC1CCC2=CC=CC=C12
CID000004054,memantine,CC12CC3CC(C1)(CC(C3)(C2)N)C,apoplexy,CID000005245,Risedronic acid,C1=CC(=CN=C1)CC(O)(P(=O)(O)O)P(=O)(O)O
CID000004054,memantine,CC12CC3CC(C1)(CC(C3)(C2)N)C,thrombocytopenia,CID000057537,92206-54-7,CCCN(CCC1=CC=CS1)C2CCC3=C(C2)C=CC=C3O
CID000004054,memantine,CC12CC3CC(C1)(CC(C3)(C2)N)C,abnormal EEG,CID000005073,risperidone,CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F
CID000004054,memantine,CC12CC3CC(C1)(CC(C3)(C2)N)C,atelectasis,CID000005077,105601-20-5,CCN(C)C(=O)OC1=CC=CC(=C1)C(C)N(C)C
CID000004054,memantine,CC12CC3CC(C1)(CC(C3)(C2)N)C,Atrioventricular block first degree,CID000004205,mirtazapine,CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4
CID000004054,memantine,CC12CC3CC(C1)(CC(C3)(C2)N)C,loss of weight,CID000004909,primidone,CCC1(C(=O)NCNC1=O)C2=CC=CC=C2
CID000004054,memantine,CC12CC3CC(C1)(CC(C3)(C2)N)C,Acne,CID000005732,zolpidem,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C
CID000004054,memantine,CC12CC3CC(C1)(CC(C3)(C2)N)C,drug toxicity NOS,CID000004173,metronidazole,CC1=NC=C(N1CCO)[N+](=O)[O-]
CID000004054,memantine,CC12CC3CC(C1)(CC(C3)(C2)N)C,drug toxicity NOS,CID003468412,SCHEMBL1176571,CC1C=CC=CCCC=CC=CC=CC=CC(CC(C(C(CC(=O)CC(C(CCC(CC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)C(=O)O)O)OC2C(C(C(C(O2)C)O)N)O
CID000004054,memantine,CC12CC3CC(C1)(CC(C3)(C2)N)C,dysarthria,CID000005544,Mycolog,CC12CC(C3(C(C1CC(C2(C(=O)CO)O)O)CCC4=CC(=O)C=CC43C)F)O
CID000004054,memantine,CC12CC3CC(C1)(CC(C3)(C2)N)C,Adenopathy,CID000005523,Ultram,CN(C)CC1CCCCC1(C2=CC(=CC=C2)OC)O
CID000004054,memantine,CC12CC3CC(C1)(CC(C3)(C2)N)C,loss of weight,CID000005152,Salmeterol,C1=CC=C(C=C1)CCCCOCCCCCCNCC(C2=CC(=C(C=C2)O)CO)O
CID000004054,memantine,CC12CC3CC(C1)(CC(C3)(C2)N)C,apoplexy,CID000005487,tizanidine,C1CN=C(N1)NC2=C(C=CC3=NSN=C32)Cl
CID000077999,rosiglitazone,CN(CCOC1=CC=C(C=C1)CC2C(=O)NC(=O)S2)C3=CC=CC=N3,loss of weight,CID003468412,SCHEMBL1176571,CC1C=CC=CCCC=CC=CC=CC=CC(CC(C(C(CC(=O)CC(C(CCC(CC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)C(=O)O)O)OC2C(C(C(C(O2)C)O)N)O
CID000077999,rosiglitazone,CN(CCOC1=CC=C(C=C1)CC2C(=O)NC(=O)S2)C3=CC=CC=N3,loss of weight,CID000170361,Varenicline,C1C2CNCC1C3=CC4=NC=CN=C4C=C23
CID000077999,rosiglitazone,CN(CCOC1=CC=C(C=C1)CC2C(=O)NC(=O)S2)C3=CC=CC=N3,arteriosclerotic heart disease,CID005311082,"2-[(1R,4S,10S,13S,19S)-19-[4-(diaminomethylideneamino)butyl]-10-(1H-indol-3-ylmethyl)-3,9,12,15,18,21,27-heptaoxo-24,25-dithia-2,8,11,14,17,20-hexazatricyclo[18.6.1.04,8]heptacosan-13-yl]acetic acid",C1CC2C(=O)NC3CSSCCC(=O)N(C3=O)C(C(=O)NCC(=O)NC(C(=O)NC(C(=O)N2C1)CC4=CNC5=CC=CC=C54)CC(=O)O)CCCCN=C(N)N
CID000077999,rosiglitazone,CN(CCOC1=CC=C(C=C1)CC2C(=O)NC(=O)S2)C3=CC=CC=N3,hyperglycaemia,CID000163742,SCHEMBL1650579,COC1C(C(C(C(O1)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)COS(=O)(=O)O)OC4C(C(C(C(O4)C(=O)O)OC5C(C(C(C(O5)COS(=O)(=O)O)O)O)NS(=O)(=O)O)O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O)NS(=O)(=O)O
CID000077999,rosiglitazone,CN(CCOC1=CC=C(C=C1)CC2C(=O)NC(=O)S2)C3=CC=CC=N3,gastric inflammation,CID006398525,,C(C1C(C(C(C(O1)OC2(C(C(C(O2)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)COS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.[Al].[Al].[Al].[Al].[Al].[Al].[Al].[Al].[Al]
CID000077999,rosiglitazone,CN(CCOC1=CC=C(C=C1)CC2C(=O)NC(=O)S2)C3=CC=CC=N3,constipated,CID005311048,SCHEMBL11440306,C(N)(N)(Cl)Cl
CID000077999,rosiglitazone,CN(CCOC1=CC=C(C=C1)CC2C(=O)NC(=O)S2)C3=CC=CC=N3,loss of weight,CID000667490,6-Mercaptopurine,C1=NC2=C(N1)C(=S)N=CN2
CID000077999,rosiglitazone,CN(CCOC1=CC=C(C=C1)CC2C(=O)NC(=O)S2)C3=CC=CC=N3,dysarthria,CID000110635,Tadalafil,CN1CC(=O)N2C(C1=O)CC3=C(C2C4=CC5=C(C=C4)OCO5)NC6=CC=CC=C36
CID000077999,rosiglitazone,CN(CCOC1=CC=C(C=C1)CC2C(=O)NC(=O)S2)C3=CC=CC=N3,loss of weight,CID000152945,Dutasteride?,CC12CCC3C(C1CCC2C(=O)NC4=C(C=CC(=C4)C(F)(F)F)C(F)(F)F)CCC5C3(C=CC(=O)N5)C
CID000077999,rosiglitazone,CN(CCOC1=CC=C(C=C1)CC2C(=O)NC(=O)S2)C3=CC=CC=N3,High blood pressure,CID000160051,Colesevelam,CCCCCCCCCCNCC=C.C[N+](C)(C)CCCCCCNCC=C.C=CCN.C1C(O1)CCl.Cl.[Cl-]
CID000004107,methocarbamol,COC1=CC=CC=C1OCC(COC(=O)N)O,deglutition disorder,CID000004894,"11,17,21-Trihydroxypregna-1,4-diene-3,20-dione",CC12CC(C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C)O
CID000004107,methocarbamol,COC1=CC=CC=C1OCC(COC(=O)N)O,elevated cholesterol,CID000110635,Tadalafil,CN1CC(=O)N2C(C1=O)CC3=C(C2C4=CC5=C(C=C4)OCO5)NC6=CC=CC=C36
CID000004107,methocarbamol,COC1=CC=CC=C1OCC(COC(=O)N)O,back injury,CID000004510,nitroglycerin,C(C(CO[N+](=O)[O-])O[N+](=O)[O-])O[N+](=O)[O-]
CID000004107,methocarbamol,COC1=CC=CC=C1OCC(COC(=O)N)O,angiitis,CID000004236,modafinil,C1=CC=C(C=C1)C(C2=CC=CC=C2)S(=O)CC(=O)N
CID000004107,methocarbamol,COC1=CC=CC=C1OCC(COC(=O)N)O,back injury,CID000005544,Mycolog,CC12CC(C3(C(C1CC(C2(C(=O)CO)O)O)CCC4=CC(=O)C=CC43C)F)O
CID000004107,methocarbamol,COC1=CC=CC=C1OCC(COC(=O)N)O,Adenopathy,CID000005732,zolpidem,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C
CID000004107,methocarbamol,COC1=CC=CC=C1OCC(COC(=O)N)O,apoplexy,CID000005245,Risedronic acid,C1=CC(=CN=C1)CC(O)(P(=O)(O)O)P(=O)(O)O
CID000004107,methocarbamol,COC1=CC=CC=C1OCC(COC(=O)N)O,gastric inflammation,CID000005391,temazepam,CN1C2=C(C=C(C=C2)Cl)C(=NC(C1=O)O)C3=CC=CC=C3
CID000004107,methocarbamol,COC1=CC=CC=C1OCC(COC(=O)N)O,apoplexy,CID000005719,zaleplon,CCN(C1=CC=CC(=C1)C2=CC=NC3=C(C=NN23)C#N)C(=O)C
CID000004107,methocarbamol,COC1=CC=CC=C1OCC(COC(=O)N)O,nasopharyngitis,CID000060865,(E)-Olopatadine,CN(C)CCC=C1C2=CC=CC=C2COC3=C1C=C(C=C3)CC(=O)O
CID000004107,methocarbamol,COC1=CC=CC=C1OCC(COC(=O)N)O,cholecystitis,CID000062924,"S-(fluoromethyl) (6S,9R,10S,11S,13S,14S,16R,17R)-6,9-difluoro-11,17-dihydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthrene-17-carbothioate",CC1CC2C3CC(C4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)SCF)O)C)O)F)C)F
CID000004107,methocarbamol,COC1=CC=CC=C1OCC(COC(=O)N)O,gastric inflammation,CID000005487,tizanidine,C1CN=C(N1)NC2=C(C=CC3=NSN=C32)Cl
CID000004107,methocarbamol,COC1=CC=CC=C1OCC(COC(=O)N)O,Adenopathy,CID000004900,Fernisone,CC12CC(=O)C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C
CID000004107,methocarbamol,COC1=CC=CC=C1OCC(COC(=O)N)O,gastric inflammation,CID000004679,pantoprazole,COC1=C(C(=NC=C1)CS(=O)C2=NC3=C(N2)C=C(C=C3)OC(F)F)OC
CID000004107,methocarbamol,COC1=CC=CC=C1OCC(COC(=O)N)O,gastric inflammation,CID000004585,"2-methyl-4-(4-methylpiperazin-1-yl)-5H-thieno[3,2-c][1,5]benzodiazepine",CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C
CID000004107,methocarbamol,COC1=CC=CC=C1OCC(COC(=O)N)O,apoplexy,CID000004736,Talwin,CC1C2CC3=C(C1(CCN2CC=C(C)C)C)C=C(C=C3)O
CID000004107,methocarbamol,COC1=CC=CC=C1OCC(COC(=O)N)O,Adenopathy,CID000004205,mirtazapine,CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4
CID000004107,methocarbamol,COC1=CC=CC=C1OCC(COC(=O)N)O,gastric inflammation,CID005381226,"[(7S,9E,11S,12R,13S,14R,15R,16R,17S,18S,19E,21Z,26E)-2,15,17,29-tetrahydroxy-11-methoxy-3,7,12,14,16,18,22-heptamethyl-26-[[(4-methylpiperazin-1-yl)amino]methylidene]-6,23,27-trioxo-8,30-dioxa-24-azatetracyclo[23.3.1.14,7.05,28]triaconta-1(28),2,4,9,19,21,25(29)-heptaen-13-yl] acetate",CC1C=CC=C(C(=O)NC2=C(C3=C(C4=C(C(=C3O)C)OC(C4=O)(OC=CC(C(C(C(C(C(C1O)C)O)C)OC(=O)C)C)OC)C)C(=O)C2=CNN5CCN(CC5)C)O)C
CID000004107,methocarbamol,COC1=CC=CC=C1OCC(COC(=O)N)O,loss of weight,CID006398525,,C(C1C(C(C(C(O1)OC2(C(C(C(O2)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)COS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.[Al].[Al].[Al].[Al].[Al].[Al].[Al].[Al].[Al]
CID000004107,methocarbamol,COC1=CC=CC=C1OCC(COC(=O)N)O,back injury,CID000170361,Varenicline,C1C2CNCC1C3=CC4=NC=CN=C4C=C23
CID000004107,methocarbamol,COC1=CC=CC=C1OCC(COC(=O)N)O,Adenopathy,CID000004856,"3-[hydroxy-(pyridin-2-ylamino)methylidene]-2-methyl-1,1-dioxo-1lambda6,2-benzothiazin-4-one",CN1C(=C(NC2=CC=CC=N2)O)C(=O)C3=CC=CC=C3S1(=O)=O
CID000004107,methocarbamol,COC1=CC=CC=C1OCC(COC(=O)N)O,gastric inflammation,CID000005073,risperidone,CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F
CID000004107,methocarbamol,COC1=CC=CC=C1OCC(COC(=O)N)O,gastric inflammation,CID000004614,oxaprozin,C1=CC=C(C=C1)C2=C(OC(=N2)CCC(=O)O)C3=CC=CC=C3
CID000004107,methocarbamol,COC1=CC=CC=C1OCC(COC(=O)N)O,Adenopathy,CID000004927,promethazine,CC(CN1C2=CC=CC=C2SC3=CC=CC=C31)N(C)C
CID000004107,methocarbamol,COC1=CC=CC=C1OCC(COC(=O)N)O,Dyspnea exertional,CID000004889,Pravastatin Impurity A,CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC(CC(CC(=O)O)O)O)O
CID000004107,methocarbamol,COC1=CC=CC=C1OCC(COC(=O)N)O,Adenopathy,CID000005152,Salmeterol,C1=CC=C(C=C1)CCCCOCCCCCCNCC(C2=CC(=C(C=C2)O)CO)O
CID000004107,methocarbamol,COC1=CC=CC=C1OCC(COC(=O)N)O,contact dermatitis,CID000005195,Deprenyl,CC(CC1=CC=CC=C1)N(C)CC#C
CID000004107,methocarbamol,COC1=CC=CC=C1OCC(COC(=O)N)O,gastric inflammation,CID000005352,38194-50-2,CC1=C(C2=C(C1=CC3=CC=C(C=C3)S(=O)C)C=CC(=C2)F)CC(=O)O
CID000004107,methocarbamol,COC1=CC=CC=C1OCC(COC(=O)N)O,atelectasis,CID000005095,ropinirole,CCCN(CCC)CCC1=C2CC(=O)NC2=CC=C1
CID000004107,methocarbamol,COC1=CC=CC=C1OCC(COC(=O)N)O,weight gain,CID000060854,Ziprasidone,C1CN(CCN1CCC2=C(C=C3C(=C2)CC(=O)N3)Cl)C4=NSC5=CC=CC=C54
CID000004107,methocarbamol,COC1=CC=CC=C1OCC(COC(=O)N)O,fracture nonunion,CID000005650,N-pentanoyl-N-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-L-valine,CCCCC(=O)N(CC1=CC=C(C=C1)C2=CC=CC=C2C3=NNN=N3)C(C(C)C)C(=O)O
CID000004107,methocarbamol,COC1=CC=CC=C1OCC(COC(=O)N)O,Pain,CID000019090,megestrol,CC1=CC2C(CCC3(C2CCC3(C(=O)C)O)C)C4(C1=CC(=O)CC4)C
CID000004107,methocarbamol,COC1=CC=CC=C1OCC(COC(=O)N)O,gastric inflammation,CID000005523,Ultram,CN(C)CC1CCCCC1(C2=CC(=CC=C2)OC)O
CID000004107,methocarbamol,COC1=CC=CC=C1OCC(COC(=O)N)O,agitated,CID000005358,sumatriptan,CNS(=O)(=O)CC1=CC2=C(C=C1)NC=C2CCN(C)C
CID000004107,methocarbamol,COC1=CC=CC=C1OCC(COC(=O)N)O,gastric inflammation,CID000004691,"3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine",C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4
CID000004107,methocarbamol,COC1=CC=CC=C1OCC(COC(=O)N)O,elevated cholesterol,CID000010631,medroxyprogesterone,CC1CC2C(CCC3(C2CCC3(C(=O)C)O)C)C4(C1=CC(=O)CC4)C
CID000004107,methocarbamol,COC1=CC=CC=C1OCC(COC(=O)N)O,drug toxicity NOS,CID000004170,metolazone,CC1NC2=CC(=C(C=C2C(=O)N1C3=CC=CC=C3C)S(=O)(=O)N)Cl
CID000004107,methocarbamol,COC1=CC=CC=C1OCC(COC(=O)N)O,gastric inflammation,CID000004173,metronidazole,CC1=NC=C(N1CCO)[N+](=O)[O-]
CID000004107,methocarbamol,COC1=CC=CC=C1OCC(COC(=O)N)O,Adenopathy,CID000005512,124936-74-9,CC1=CC(=C(C=C1)O)C(CCN(C(C)C)C(C)C)C2=CC=CC=C2
CID000004107,methocarbamol,COC1=CC=CC=C1OCC(COC(=O)N)O,fracture nonunion,CID000004158,methylphenidate,COC(=O)C(C1CCCCN1)C2=CC=CC=C2
CID000004107,methocarbamol,COC1=CC=CC=C1OCC(COC(=O)N)O,gastric inflammation,CID000004543,nortriptyline,CNCCC=C1C2=CC=CC=C2CCC3=CC=CC=C31
CID000004107,methocarbamol,COC1=CC=CC=C1OCC(COC(=O)N)O,enlarged liver,CID006447131,Pimecrolimus,CCC1C=C(CC(CC(C2C(CC(C(O2)(C(=O)C(=O)N3CCCCC3C(=O)OC(C(C(CC1=O)O)C)C(=CC4CCC(C(C4)OC)Cl)C)O)C)OC)OC)C)C
CID000004107,methocarbamol,COC1=CC=CC=C1OCC(COC(=O)N)O,Adenopathy,CID003468412,SCHEMBL1176571,CC1C=CC=CCCC=CC=CC=CC=CC(CC(C(C(CC(=O)CC(C(CCC(CC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)C(=O)O)O)OC2C(C(C(C(O2)C)O)N)O
CID000005391,temazepam,CN1C2=C(C=C(C=C2)Cl)C(=NC(C1=O)O)C3=CC=CC=C3,constipated,CID000005584,trimipramine,CC(CN1C2=CC=CC=C2CCC3=CC=CC=C31)CN(C)C
CID000005391,temazepam,CN1C2=C(C=C(C=C2)Cl)C(=NC(C1=O)O)C3=CC=CC=C3,gastric inflammation,CID000005732,zolpidem,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C
CID000005391,temazepam,CN1C2=C(C=C(C=C2)Cl)C(=NC(C1=O)O)C3=CC=CC=C3,constipated,CID000115237,Paliperidone,CC1=C(C(=O)N2CCCC(C2=N1)O)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F
CID000005391,temazepam,CN1C2=C(C=C(C=C2)Cl)C(=NC(C1=O)O)C3=CC=CC=C3,erythema,CID000038904,Carboplatinum,C1CC(C1)(C(=O)O)C(=O)O.N.N.[Pt]
CID000005391,temazepam,CN1C2=C(C=C(C=C2)Cl)C(=NC(C1=O)O)C3=CC=CC=C3,methaemoglobinaemia,CID000005487,tizanidine,C1CN=C(N1)NC2=C(C=CC3=NSN=C32)Cl
CID000005391,temazepam,CN1C2=C(C=C(C=C2)Cl)C(=NC(C1=O)O)C3=CC=CC=C3,nasopharyngitis,CID000071329,Dofetilide,CN(CCC1=CC=C(C=C1)NS(=O)(=O)C)CCOC2=CC=C(C=C2)NS(=O)(=O)C
CID000005391,temazepam,CN1C2=C(C=C(C=C2)Cl)C(=NC(C1=O)O)C3=CC=CC=C3,hypermagnesemia,CID000008953,sodium;hydrogen carbonate,C(=O)(O)[O-].[Na+]
CID000005391,temazepam,CN1C2=C(C=C(C=C2)Cl)C(=NC(C1=O)O)C3=CC=CC=C3,abnormal ECG,CID000060787,sequinavir,CC(C)(C)NC(=O)C1CC2CCCCC2CN1CC(C(CC3=CC=CC=C3)NC(=O)C(CC(=O)N)NC(=O)C4=NC5=CC=CC=C5C=C4)O
CID000005391,temazepam,CN1C2=C(C=C(C=C2)Cl)C(=NC(C1=O)O)C3=CC=CC=C3,deglutition disorder,CID006447131,Pimecrolimus,CCC1C=C(CC(CC(C2C(CC(C(O2)(C(=O)C(=O)N3CCCCC3C(=O)OC(C(C(CC1=O)O)C)C(=CC4CCC(C(C4)OC)Cl)C)O)C)OC)OC)C)C
CID000005391,temazepam,CN1C2=C(C=C(C=C2)Cl)C(=NC(C1=O)O)C3=CC=CC=C3,anaemia,CID000074989,ATOVAQUONE,C1CC(CCC1C2=CC=C(C=C2)Cl)C3=C(C4=CC=CC=C4C(=O)C3=O)O
CID000005391,temazepam,CN1C2=C(C=C(C=C2)Cl)C(=NC(C1=O)O)C3=CC=CC=C3,arteriosclerotic heart disease,CID000057469,IMIQUIMOD,CC(C)CN1C=NC2=C1C3=CC=CC=C3N=C2N
CID000005391,temazepam,CN1C2=C(C=C(C=C2)Cl)C(=NC(C1=O)O)C3=CC=CC=C3,loss of weight,CID000005394,temozolomide,CN1C(=O)N2C=NC(=C2N=N1)C(=O)N
CID000005391,temazepam,CN1C2=C(C=C(C=C2)Cl)C(=NC(C1=O)O)C3=CC=CC=C3,atelectasis,CID000152945,Dutasteride?,CC12CCC3C(C1CCC2C(=O)NC4=C(C=CC(=C4)C(F)(F)F)C(F)(F)F)CCC5C3(C=CC(=O)N5)C
CID000005391,temazepam,CN1C2=C(C=C(C=C2)Cl)C(=NC(C1=O)O)C3=CC=CC=C3,gastric inflammation,CID000060184,"2'-epi-Perindopril, (2'R)-",CCCC(C(=O)OCC)NC(C)C(=O)N1C2CCCCC2CC1C(=O)O
CID000005391,temazepam,CN1C2=C(C=C(C=C2)Cl)C(=NC(C1=O)O)C3=CC=CC=C3,Adenopathy,CID000005978,vincristine,CCC1(CC2CC(C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)C78CCN9C7C(C=CC9)(C(C(C8N6C=O)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O
CID000005391,temazepam,CN1C2=C(C=C(C=C2)Cl)C(=NC(C1=O)O)C3=CC=CC=C3,gastric inflammation,CID003468412,SCHEMBL1176571,CC1C=CC=CCCC=CC=CC=CC=CC(CC(C(C(CC(=O)CC(C(CCC(CC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)C(=O)O)O)OC2C(C(C(C(O2)C)O)N)O
CID000005391,temazepam,CN1C2=C(C=C(C=C2)Cl)C(=NC(C1=O)O)C3=CC=CC=C3,gout,CID000060852,Ibandronic Acid,CCCCCN(C)CCC(O)(P(=O)(O)O)P(=O)(O)O
CID000005391,temazepam,CN1C2=C(C=C(C=C2)Cl)C(=NC(C1=O)O)C3=CC=CC=C3,cholecystitis,CID000005523,Ultram,CN(C)CC1CCCCC1(C2=CC(=CC=C2)OC)O
CID000005391,temazepam,CN1C2=C(C=C(C=C2)Cl)C(=NC(C1=O)O)C3=CC=CC=C3,Bone marrow fibrosis,CID000005650,N-pentanoyl-N-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-L-valine,CCCCC(=O)N(CC1=CC=C(C=C1)C2=CC=CC=C2C3=NNN=N3)C(C(C)C)C(=O)O
CID000005391,temazepam,CN1C2=C(C=C(C=C2)Cl)C(=NC(C1=O)O)C3=CC=CC=C3,thrombocytopenia,CID000163742,SCHEMBL1650579,COC1C(C(C(C(O1)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)COS(=O)(=O)O)OC4C(C(C(C(O4)C(=O)O)OC5C(C(C(C(O5)COS(=O)(=O)O)O)O)NS(=O)(=O)O)O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O)NS(=O)(=O)O
CID000005391,temazepam,CN1C2=C(C=C(C=C2)Cl)C(=NC(C1=O)O)C3=CC=CC=C3,myelodysplasia,CID006398525,,C(C1C(C(C(C(O1)OC2(C(C(C(O2)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)COS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.[Al].[Al].[Al].[Al].[Al].[Al].[Al].[Al].[Al]
CID000005391,temazepam,CN1C2=C(C=C(C=C2)Cl)C(=NC(C1=O)O)C3=CC=CC=C3,cholecystitis,CID000010631,medroxyprogesterone,CC1CC2C(CCC3(C2CCC3(C(=O)C)O)C)C4(C1=CC(=O)CC4)C
CID000005391,temazepam,CN1C2=C(C=C(C=C2)Cl)C(=NC(C1=O)O)C3=CC=CC=C3,apoplexy,CID000110635,Tadalafil,CN1CC(=O)N2C(C1=O)CC3=C(C2C4=CC5=C(C=C4)OCO5)NC6=CC=CC=C36
CID000005391,temazepam,CN1C2=C(C=C(C=C2)Cl)C(=NC(C1=O)O)C3=CC=CC=C3,cholecystitis,CID000019090,megestrol,CC1=CC2C(CCC3(C2CCC3(C(=O)C)O)C)C4(C1=CC(=O)CC4)C
CID000005391,temazepam,CN1C2=C(C=C(C=C2)Cl)C(=NC(C1=O)O)C3=CC=CC=C3,nausea,CID000657298,propylthiouracil,CCCC1=CC(=O)NC(=S)N1
CID000005391,temazepam,CN1C2=C(C=C(C=C2)Cl)C(=NC(C1=O)O)C3=CC=CC=C3,gastric inflammation,CID000005512,124936-74-9,CC1=CC(=C(C=C1)O)C(CCN(C(C)C)C(C)C)C2=CC=CC=C2
CID000005391,temazepam,CN1C2=C(C=C(C=C2)Cl)C(=NC(C1=O)O)C3=CC=CC=C3,back injury,CID000005719,zaleplon,CCN(C1=CC=CC(=C1)C2=CC=NC3=C(C=NN23)C#N)C(=O)C
CID000005391,temazepam,CN1C2=C(C=C(C=C2)Cl)C(=NC(C1=O)O)C3=CC=CC=C3,nausea,CID005381226,"[(7S,9E,11S,12R,13S,14R,15R,16R,17S,18S,19E,21Z,26E)-2,15,17,29-tetrahydroxy-11-methoxy-3,7,12,14,16,18,22-heptamethyl-26-[[(4-methylpiperazin-1-yl)amino]methylidene]-6,23,27-trioxo-8,30-dioxa-24-azatetracyclo[23.3.1.14,7.05,28]triaconta-1(28),2,4,9,19,21,25(29)-heptaen-13-yl] acetate",CC1C=CC=C(C(=O)NC2=C(C3=C(C4=C(C(=C3O)C)OC(C4=O)(OC=CC(C(C(C(C(C(C1O)C)O)C)OC(=O)C)C)OC)C)C(=O)C2=CNN5CCN(CC5)C)O)C
CID000005391,temazepam,CN1C2=C(C=C(C=C2)Cl)C(=NC(C1=O)O)C3=CC=CC=C3,atelectasis,CID000036339,Etomidate,CCOC(=O)C1=CN=CN1C(C)C2=CC=CC=C2
CID000005391,temazepam,CN1C2=C(C=C(C=C2)Cl)C(=NC(C1=O)O)C3=CC=CC=C3,enlarged liver,CID000005645,"3,7-Dihydroxycholan-24-oic acid",CC(CCC(=O)O)C1CCC2C1(CCC3C2C(CC4C3(CCC(C4)O)C)O)C
CID000005391,temazepam,CN1C2=C(C=C(C=C2)Cl)C(=NC(C1=O)O)C3=CC=CC=C3,Adenopathy,CID000170361,Varenicline,C1C2CNCC1C3=CC4=NC=CN=C4C=C23
CID000005391,temazepam,CN1C2=C(C=C(C=C2)Cl)C(=NC(C1=O)O)C3=CC=CC=C3,drug toxicity NOS,CID000667490,6-Mercaptopurine,C1=NC2=C(N1)C(=S)N=CN2
CID000005391,temazepam,CN1C2=C(C=C(C=C2)Cl)C(=NC(C1=O)O)C3=CC=CC=C3,cholecystitis,CID000060854,Ziprasidone,C1CN(CCN1CCC2=C(C=C3C(=C2)CC(=O)N3)Cl)C4=NSC5=CC=CC=C54
CID000005391,temazepam,CN1C2=C(C=C(C=C2)Cl)C(=NC(C1=O)O)C3=CC=CC=C3,methaemoglobinaemia,CID005311048,SCHEMBL11440306,C(N)(N)(Cl)Cl
CID000005391,temazepam,CN1C2=C(C=C(C=C2)Cl)C(=NC(C1=O)O)C3=CC=CC=C3,cholecystitis,CID000062924,"S-(fluoromethyl) (6S,9R,10S,11S,13S,14S,16R,17R)-6,9-difluoro-11,17-dihydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthrene-17-carbothioate",CC1CC2C3CC(C4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)SCF)O)C)O)F)C)F
CID000005391,temazepam,CN1C2=C(C=C(C=C2)Cl)C(=NC(C1=O)O)C3=CC=CC=C3,gastric inflammation,CID000005544,Mycolog,CC12CC(C3(C(C1CC(C2(C(=O)CO)O)O)CCC4=CC(=O)C=CC43C)F)O
CID000005391,temazepam,CN1C2=C(C=C(C=C2)Cl)C(=NC(C1=O)O)C3=CC=CC=C3,constipated,CID000125017,Desvenlafaxine,CN(C)CC(C1=CC=C(C=C1)O)C2(CCCCC2)O
CID000005391,temazepam,CN1C2=C(C=C(C=C2)Cl)C(=NC(C1=O)O)C3=CC=CC=C3,loss of weight,CID000005478,racemic-Timolol,CC(C)(C)NCC(COC1=NSN=C1N2CCOCC2)O
CID000005391,temazepam,CN1C2=C(C=C(C=C2)Cl)C(=NC(C1=O)O)C3=CC=CC=C3,Anxiety,CID000122316,1875-50-9,C#CCNC1CCC2=CC=CC=C12
CID000005391,temazepam,CN1C2=C(C=C(C=C2)Cl)C(=NC(C1=O)O)C3=CC=CC=C3,thrombocytopenia,CID005311082,"2-[(1R,4S,10S,13S,19S)-19-[4-(diaminomethylideneamino)butyl]-10-(1H-indol-3-ylmethyl)-3,9,12,15,18,21,27-heptaoxo-24,25-dithia-2,8,11,14,17,20-hexazatricyclo[18.6.1.04,8]heptacosan-13-yl]acetic acid",C1CC2C(=O)NC3CSSCCC(=O)N(C3=O)C(C(=O)NCC(=O)NC(C(=O)NC(C(=O)N2C1)CC4=CNC5=CC=CC=C54)CC(=O)O)CCCCN=C(N)N
CID000005391,temazepam,CN1C2=C(C=C(C=C2)Cl)C(=NC(C1=O)O)C3=CC=CC=C3,erythema,CID000060865,(E)-Olopatadine,CN(C)CCC=C1C2=CC=CC=C2COC3=C1C=C(C=C3)CC(=O)O
CID000657298,propylthiouracil,CCCC1=CC(=O)NC(=S)N1,diarrhea,CID005311048,SCHEMBL11440306,C(N)(N)(Cl)Cl
CID000657298,propylthiouracil,CCCC1=CC(=O)NC(=S)N1,diarrhea,CID003468412,SCHEMBL1176571,CC1C=CC=CCCC=CC=CC=CC=CC(CC(C(C(CC(=O)CC(C(CCC(CC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)C(=O)O)O)OC2C(C(C(C(O2)C)O)N)O
CID000010631,medroxyprogesterone,CC1CC2C(CCC3(C2CCC3(C(=O)C)O)C)C4(C1=CC(=O)CC4)C,atelectasis,CID000667490,6-Mercaptopurine,C1=NC2=C(N1)C(=S)N=CN2
CID000010631,medroxyprogesterone,CC1CC2C(CCC3(C2CCC3(C(=O)C)O)C)C4(C1=CC(=O)CC4)C,loss of weight,CID005311048,SCHEMBL11440306,C(N)(N)(Cl)Cl
CID000010631,medroxyprogesterone,CC1CC2C(CCC3(C2CCC3(C(=O)C)O)C)C4(C1=CC(=O)CC4)C,Infection Urinary Tract,CID000016231,AMILORIDE,C1(=C(N=C(C(=N1)Cl)N)N)C(=O)N=C(N)N
CID000010631,medroxyprogesterone,CC1CC2C(CCC3(C2CCC3(C(=O)C)O)C)C4(C1=CC(=O)CC4)C,gastric inflammation,CID000019090,megestrol,CC1=CC2C(CCC3(C2CCC3(C(=O)C)O)C)C4(C1=CC(=O)CC4)C
CID000010631,medroxyprogesterone,CC1CC2C(CCC3(C2CCC3(C(=O)C)O)C)C4(C1=CC(=O)CC4)C,bleeding Vaginal,CID000038904,Carboplatinum,C1CC(C1)(C(=O)O)C(=O)O.N.N.[Pt]
CID000010631,medroxyprogesterone,CC1CC2C(CCC3(C2CCC3(C(=O)C)O)C)C4(C1=CC(=O)CC4)C,galactorrhea,CID000115237,Paliperidone,CC1=C(C(=O)N2CCCC(C2=N1)O)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F
CID000010631,medroxyprogesterone,CC1CC2C(CCC3(C2CCC3(C(=O)C)O)C)C4(C1=CC(=O)CC4)C,gastric inflammation,CID000060852,Ibandronic Acid,CCCCCN(C)CCC(O)(P(=O)(O)O)P(=O)(O)O
CID000010631,medroxyprogesterone,CC1CC2C(CCC3(C2CCC3(C(=O)C)O)C)C4(C1=CC(=O)CC4)C,Back Ache,CID000060854,Ziprasidone,C1CN(CCN1CCC2=C(C=C3C(=C2)CC(=O)N3)Cl)C4=NSC5=CC=CC=C54
CID000010631,medroxyprogesterone,CC1CC2C(CCC3(C2CCC3(C(=O)C)O)C)C4(C1=CC(=O)CC4)C,ear infection,CID003468412,SCHEMBL1176571,CC1C=CC=CCCC=CC=CC=CC=CC(CC(C(C(CC(=O)CC(C(CCC(CC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)C(=O)O)O)OC2C(C(C(C(O2)C)O)N)O
CID000010631,medroxyprogesterone,CC1CC2C(CCC3(C2CCC3(C(=O)C)O)C)C4(C1=CC(=O)CC4)C,back injury,CID000170361,Varenicline,C1C2CNCC1C3=CC4=NC=CN=C4C=C23
CID000010631,medroxyprogesterone,CC1CC2C(CCC3(C2CCC3(C(=O)C)O)C)C4(C1=CC(=O)CC4)C,Dyspnea exertional,CID000062924,"S-(fluoromethyl) (6S,9R,10S,11S,13S,14S,16R,17R)-6,9-difluoro-11,17-dihydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthrene-17-carbothioate",CC1CC2C3CC(C4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)SCF)O)C)O)F)C)F
CID000010631,medroxyprogesterone,CC1CC2C(CCC3(C2CCC3(C(=O)C)O)C)C4(C1=CC(=O)CC4)C,gastric inflammation,CID006398525,,C(C1C(C(C(C(O1)OC2(C(C(C(O2)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)COS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.[Al].[Al].[Al].[Al].[Al].[Al].[Al].[Al].[Al]
CID000004736,Talwin,CC1C2CC3=C(C1(CCN2CC=C(C)C)C)C=C(C=C3)O,apoplexy,CID000004927,promethazine,CC(CN1C2=CC=CC=C2SC3=CC=CC=C31)N(C)C
CID000004736,Talwin,CC1C2CC3=C(C1(CCN2CC=C(C)C)C)C=C(C=C3)O,apoplexy,CID000005358,sumatriptan,CNS(=O)(=O)CC1=CC2=C(C=C1)NC=C2CCN(C)C
CID000004736,Talwin,CC1C2CC3=C(C1(CCN2CC=C(C)C)C)C=C(C=C3)O,apoplexy,CID000004900,Fernisone,CC12CC(=O)C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C
CID000004736,Talwin,CC1C2CC3=C(C1(CCN2CC=C(C)C)C)C=C(C=C3)O,loss of weight,CID000005732,zolpidem,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C
CID000004736,Talwin,CC1C2CC3=C(C1(CCN2CC=C(C)C)C)C=C(C=C3)O,weight gain,CID000005487,tizanidine,C1CN=C(N1)NC2=C(C=CC3=NSN=C32)Cl
CID000004736,Talwin,CC1C2CC3=C(C1(CCN2CC=C(C)C)C)C=C(C=C3)O,loss of weight,CID000005523,Ultram,CN(C)CC1CCCCC1(C2=CC(=CC=C2)OC)O
CID000005523,Ultram,CN(C)CC1CCCCC1(C2=CC(=CC=C2)OC)O,abnormal ECG,CID000019090,megestrol,CC1=CC2C(CCC3(C2CCC3(C(=O)C)O)C)C4(C1=CC(=O)CC4)C
CID000005523,Ultram,CN(C)CC1CCCCC1(C2=CC(=CC=C2)OC)O,gastric inflammation,CID000005544,Mycolog,CC12CC(C3(C(C1CC(C2(C(=O)CO)O)O)CCC4=CC(=O)C=CC43C)F)O
CID000005523,Ultram,CN(C)CC1CCCCC1(C2=CC(=CC=C2)OC)O,gastric inflammation,CID006398525,,C(C1C(C(C(C(O1)OC2(C(C(C(O2)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)COS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.[Al].[Al].[Al].[Al].[Al].[Al].[Al].[Al].[Al]
CID000005523,Ultram,CN(C)CC1CCCCC1(C2=CC(=CC=C2)OC)O,gastric inflammation,CID000038904,Carboplatinum,C1CC(C1)(C(=O)O)C(=O)O.N.N.[Pt]
CID000005523,Ultram,CN(C)CC1CCCCC1(C2=CC(=CC=C2)OC)O,cholecystitis,CID000005732,zolpidem,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C
CID000005523,Ultram,CN(C)CC1CCCCC1(C2=CC(=CC=C2)OC)O,cholecystitis,CID000005650,N-pentanoyl-N-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-L-valine,CCCCC(=O)N(CC1=CC=C(C=C1)C2=CC=CC=C2C3=NNN=N3)C(C(C)C)C(=O)O
CID000005523,Ultram,CN(C)CC1CCCCC1(C2=CC(=CC=C2)OC)O,adenomyosis,CID000062924,"S-(fluoromethyl) (6S,9R,10S,11S,13S,14S,16R,17R)-6,9-difluoro-11,17-dihydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthrene-17-carbothioate",CC1CC2C3CC(C4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)SCF)O)C)O)F)C)F
CID000005523,Ultram,CN(C)CC1CCCCC1(C2=CC(=CC=C2)OC)O,dizziness,CID000027686,CHEMBL4088679,C1=CC2=C(C(=C1)OCC(COC3=CC4=C(C=C3)OC(=CC4=O)C(=O)O)O)C(=O)C=C(O2)C(=O)O
CID000005523,Ultram,CN(C)CC1CCCCC1(C2=CC(=CC=C2)OC)O,cellulitis,CID000074989,ATOVAQUONE,C1CC(CCC1C2=CC=C(C=C2)Cl)C3=C(C4=CC=CC=C4C(=O)C3=O)O
CID000005523,Ultram,CN(C)CC1CCCCC1(C2=CC(=CC=C2)OC)O,abnormal ECG,CID005311048,SCHEMBL11440306,C(N)(N)(Cl)Cl
CID000005523,Ultram,CN(C)CC1CCCCC1(C2=CC(=CC=C2)OC)O,Adenopathy,CID000060865,(E)-Olopatadine,CN(C)CCC=C1C2=CC=CC=C2COC3=C1C=C(C=C3)CC(=O)O
CID000005523,Ultram,CN(C)CC1CCCCC1(C2=CC(=CC=C2)OC)O,enlarged liver,CID000160051,Colesevelam,CCCCCCCCCCNCC=C.C[N+](C)(C)CCCCCCNCC=C.C=CCN.C1C(O1)CCl.Cl.[Cl-]
CID000005523,Ultram,CN(C)CC1CCCCC1(C2=CC(=CC=C2)OC)O,allergic dermatitis,CID000060852,Ibandronic Acid,CCCCCN(C)CCC(O)(P(=O)(O)O)P(=O)(O)O
CID000005523,Ultram,CN(C)CC1CCCCC1(C2=CC(=CC=C2)OC)O,Adenopathy,CID003468412,SCHEMBL1176571,CC1C=CC=CCCC=CC=CC=CC=CC(CC(C(C(CC(=O)CC(C(CCC(CC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)C(=O)O)O)OC2C(C(C(C(O2)C)O)N)O
CID000005523,Ultram,CN(C)CC1CCCCC1(C2=CC(=CC=C2)OC)O,enlarged liver,CID000016231,AMILORIDE,C1(=C(N=C(C(=N1)Cl)N)N)C(=O)N=C(N)N
CID000005523,Ultram,CN(C)CC1CCCCC1(C2=CC(=CC=C2)OC)O,angiitis,CID000110635,Tadalafil,CN1CC(=O)N2C(C1=O)CC3=C(C2C4=CC5=C(C=C4)OCO5)NC6=CC=CC=C36
CID000005523,Ultram,CN(C)CC1CCCCC1(C2=CC(=CC=C2)OC)O,loss of weight,CID000170361,Varenicline,C1C2CNCC1C3=CC4=NC=CN=C4C=C23
CID000005523,Ultram,CN(C)CC1CCCCC1(C2=CC(=CC=C2)OC)O,dizziness,CID000012536,638-94-8,CC1(OC2CC3C4CCC5=CC(=O)C=CC5(C4C(CC3(C2(O1)C(=O)CO)C)O)C)C
CID000005523,Ultram,CN(C)CC1CCCCC1(C2=CC(=CC=C2)OC)O,erythema,CID000005719,zaleplon,CCN(C1=CC=CC(=C1)C2=CC=NC3=C(C=NN23)C#N)C(=O)C
CID000005523,Ultram,CN(C)CC1CCCCC1(C2=CC(=CC=C2)OC)O,deglutition disorder,CID000152945,Dutasteride?,CC12CCC3C(C1CCC2C(=O)NC4=C(C=CC(=C4)C(F)(F)F)C(F)(F)F)CCC5C3(C=CC(=O)N5)C
CID000005523,Ultram,CN(C)CC1CCCCC1(C2=CC(=CC=C2)OC)O,loss of weight,CID000005978,vincristine,CCC1(CC2CC(C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)C78CCN9C7C(C=CC9)(C(C(C8N6C=O)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O
CID000005523,Ultram,CN(C)CC1CCCCC1(C2=CC(=CC=C2)OC)O,weight gain,CID000005645,"3,7-Dihydroxycholan-24-oic acid",CC(CCC(=O)O)C1CCC2C1(CCC3C2C(CC4C3(CCC(C4)O)C)O)C
CID000005523,Ultram,CN(C)CC1CCCCC1(C2=CC(=CC=C2)OC)O,erythema,CID000060854,Ziprasidone,C1CN(CCN1CCC2=C(C=C3C(=C2)CC(=O)N3)Cl)C4=NSC5=CC=CC=C54
CID000057469,IMIQUIMOD,CC(C)CN1C=NC2=C1C3=CC=CC=C3N=C2N,eruption,CID000062924,"S-(fluoromethyl) (6S,9R,10S,11S,13S,14S,16R,17R)-6,9-difluoro-11,17-dihydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthrene-17-carbothioate",CC1CC2C3CC(C4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)SCF)O)C)O)F)C)F
CID000000119,4-aminobutyric acid,C(CC(=O)O)CN,herpes simplex,CID000005645,"3,7-Dihydroxycholan-24-oic acid",CC(CCC(=O)O)C1CCC2C1(CCC3C2C(CC4C3(CCC(C4)O)C)O)C
CID000000119,4-aminobutyric acid,C(CC(=O)O)CN,erythema,CID000003440,furosemide,C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl
CID000000119,4-aminobutyric acid,C(CC(=O)O)CN,High blood pressure,CID000001117,sulfate,[O-]S(=O)(=O)[O-]
CID000000119,4-aminobutyric acid,C(CC(=O)O)CN,gastric inflammation,CID000003883,lansoprazole,CC1=C(C=CN=C1CS(=O)C2=NC3=CC=CC=C3N2)OCC(F)(F)F
CID000000119,4-aminobutyric acid,C(CC(=O)O)CN,abnormal EEG,CID000001983,acetaminophen,CC(=O)NC1=CC=C(C=C1)O
CID000000119,4-aminobutyric acid,C(CC(=O)O)CN,angiitis,CID000002907,cyclophosphamide,C1CNP(=O)(OC1)N(CCCl)CCCl
CID000000119,4-aminobutyric acid,C(CC(=O)O)CN,erythema,CID000039765,Vecuronium,CC(=O)OC1CC2CCC3C(C2(CC1N4CCCCC4)C)CCC5(C3CC(C5OC(=O)C)[N+]6(CCCCC6)C)C
CID000000119,4-aminobutyric acid,C(CC(=O)O)CN,atelectasis,CID000004679,pantoprazole,COC1=C(C(=NC=C1)CS(=O)C2=NC3=C(N2)C=C(C=C3)OC(F)F)OC
CID000000119,4-aminobutyric acid,C(CC(=O)O)CN,eruption,CID000004900,Fernisone,CC12CC(=O)C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C
CID000000119,4-aminobutyric acid,C(CC(=O)O)CN,angiitis,CID000002265,azathioprine,CN1C=NC(=C1SC2=NC=NC3=C2NC=N3)[N+](=O)[O-]
CID000000119,4-aminobutyric acid,C(CC(=O)O)CN,deglutition disorder,CID000002656,"7-[[2-(2-amino-1,3-thiazol-4-yl)-2-methoxyiminoacetyl]amino]-3-[(2-methyl-6-oxido-5-oxo-1,2,4-triazin-3-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CN1C(=NC(=O)C(=N1)[O-])SCC2=C(N3C(C(C3=O)NC(=O)C(=NOC)C4=CSC(=N4)N)SC2)C(=O)[O-]
CID000000119,4-aminobutyric acid,C(CC(=O)O)CN,angiitis,CID000003405,2-[[4-[(2-amino-4-oxo-1H-pteridin-6-yl)methylamino]benzoyl]amino]pentanedioic acid,C1=CC(=CC=C1C(=O)NC(CCC(=O)O)C(=O)O)NCC2=CN=C3C(=N2)C(=O)N=C(N3)N
CID000000119,4-aminobutyric acid,C(CC(=O)O)CN,confusion,CID000008953,sodium;hydrogen carbonate,C(=O)(O)[O-].[Na+]
CID000000119,4-aminobutyric acid,C(CC(=O)O)CN,angiitis,CID000002022,2-amino-9-(2-hydroxyethoxymethyl)-3H-purin-6-one,C1=NC2=C(N1COCCO)NC(=NC2=O)N
CID000000119,4-aminobutyric acid,C(CC(=O)O)CN,hypermagnesemia,CID000003325,famotidine,C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N
CID000000119,4-aminobutyric acid,C(CC(=O)O)CN,abnormal EEG,CID000004173,metronidazole,CC1=NC=C(N1CCO)[N+](=O)[O-]
CID000000119,4-aminobutyric acid,C(CC(=O)O)CN,bacterial vaginitis,CID000002771,citalopram,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F
CID000000119,4-aminobutyric acid,C(CC(=O)O)CN,angiitis,CID000004894,"11,17,21-Trihydroxypregna-1,4-diene-3,20-dione",CC12CC(C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C)O
CID000002130,amantadine,C1C2CC3CC1CC(C2)(C3)N,neuropathy,CID000003780,"D-Glucitol, 1,4:3,6-dianhydro-, 2,5-dinitrate",C1C(C2C(O1)C(CO2)O[N+](=O)[O-])O[N+](=O)[O-]
CID000002130,amantadine,C1C2CC3CC1CC(C2)(C3)N,gastric inflammation,CID000004745,SCHEMBL7711911,CCCN1CC(CC2C1CC3=CNC4=CC=CC2=C34)CSC
CID000002130,amantadine,C1C2CC3CC1CC(C2)(C3)N,gastric inflammation,CID000003325,famotidine,C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N
CID000002130,amantadine,C1C2CC3CC1CC(C2)(C3)N,angiitis,CID000002662,celecoxib,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F
CID000002130,amantadine,C1C2CC3CC1CC(C2)(C3)N,apoplexy,CID000004691,"3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine",C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4
CID000002130,amantadine,C1C2CC3CC1CC(C2)(C3)N,angiitis,CID000003405,2-[[4-[(2-amino-4-oxo-1H-pteridin-6-yl)methylamino]benzoyl]amino]pentanedioic acid,C1=CC(=CC=C1C(=O)NC(CCC(=O)O)C(=O)O)NCC2=CN=C3C(=N2)C(=O)N=C(N3)N
CID000002130,amantadine,C1C2CC3CC1CC(C2)(C3)N,back injury,CID000004158,methylphenidate,COC(=O)C(C1CCCCN1)C2=CC=CC=C2
CID000002130,amantadine,C1C2CC3CC1CC(C2)(C3)N,subarachnoid haemorrhage,CID000002656,"7-[[2-(2-amino-1,3-thiazol-4-yl)-2-methoxyiminoacetyl]amino]-3-[(2-methyl-6-oxido-5-oxo-1,2,4-triazin-3-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CN1C(=NC(=O)C(=N1)[O-])SCC2=C(N3C(C(C3=O)NC(=O)C(=NOC)C4=CSC(=N4)N)SC2)C(=O)[O-]
CID000002130,amantadine,C1C2CC3CC1CC(C2)(C3)N,back injury,CID000003883,lansoprazole,CC1=C(C=CN=C1CS(=O)C2=NC3=CC=CC=C3N2)OCC(F)(F)F
CID000002130,amantadine,C1C2CC3CC1CC(C2)(C3)N,Arrhythmia,CID000003062,Lanicor,CC1C(C(CC(O1)OC2C(OC(CC2O)OC3C(OC(CC3O)OC4CCC5(C(C4)CCC6C5CC(C7(C6(CCC7C8=CC(=O)OC8)O)C)O)C)C)C)O)O
CID000002130,amantadine,C1C2CC3CC1CC(C2)(C3)N,aortic regurgitation,CID000002891,"cobalt(2+);[5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] 1-[3-[2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2,7,12,17-tetrahydro-1H-corrin-21-id-3-yl]propanoylamino]propan-2-yl hydrogen phosphate;cyanide",CC1=CC2=C(C=C1C)N(C=N2)C3C(C(C(O3)CO)OP(=O)(O)OC(C)CNC(=O)CCC4(C(C5C6(C(C(C(=N6)C(=C7C(C(C(=N7)C=C8C(C(C(=N8)C(=C4[N-]5)C)CCC(=O)N)(C)C)CCC(=O)N)(C)CC(=O)N)C)CCC(=O)N)(C)CC(=O)N)C)CC(=O)N)C)O.[C-]#N.[Co+2]
CID000002130,amantadine,C1C2CC3CC1CC(C2)(C3)N,High blood pressure,CID000005195,Deprenyl,CC(CC1=CC=CC=C1)N(C)CC#C
CID000002130,amantadine,C1C2CC3CC1CC(C2)(C3)N,angiitis,CID000004900,Fernisone,CC12CC(=O)C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C
CID000002130,amantadine,C1C2CC3CC1CC(C2)(C3)N,weight gain,CID000005650,N-pentanoyl-N-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-L-valine,CCCCC(=O)N(CC1=CC=C(C=C1)C2=CC=CC=C2C3=NNN=N3)C(C(C)C)C(=O)O
CID000002130,amantadine,C1C2CC3CC1CC(C2)(C3)N,dysarthria,CID000005095,ropinirole,CCCN(CCC)CCC1=C2CC(=O)NC2=CC=C1
CID000002130,amantadine,C1C2CC3CC1CC(C2)(C3)N,aspiration pneumonia,CID000002524,32222-06-3,CC(CCCC(C)(C)O)C1CCC2C1(CCCC2=CC=C3CC(CC(C3=C)O)O)C
CID000002130,amantadine,C1C2CC3CC1CC(C2)(C3)N,angiitis,CID000003345,fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3
CID000002130,amantadine,C1C2CC3CC1CC(C2)(C3)N,cholecystitis,CID000002771,citalopram,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F
CID000002130,amantadine,C1C2CC3CC1CC(C2)(C3)N,arterial pressure NOS decreased,CID000004178,Mexiletine,CC1=C(C(=CC=C1)C)OCC(C)N
CID000002130,amantadine,C1C2CC3CC1CC(C2)(C3)N,loss of weight,CID000004543,nortriptyline,CNCCC=C1C2=CC=CC=C2CCC3=CC=CC=C31
CID000002130,amantadine,C1C2CC3CC1CC(C2)(C3)N,angiitis,CID000005512,124936-74-9,CC1=CC(=C(C=C1)O)C(CCN(C(C)C)C(C)C)C2=CC=CC=C2
CID000002130,amantadine,C1C2CC3CC1CC(C2)(C3)N,cholecystitis,CID000002806,90055-48-4,COC(=O)C(C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3
CID000002130,amantadine,C1C2CC3CC1CC(C2)(C3)N,increased white blood cell count,CID000005073,risperidone,CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F
CID000002130,amantadine,C1C2CC3CC1CC(C2)(C3)N,angiitis,CID000005077,105601-20-5,CCN(C)C(=O)OC1=CC=CC(=C1)C(C)N(C)C
CID000002130,amantadine,C1C2CC3CC1CC(C2)(C3)N,chondrocalcinosis pyrophosphate,CID000004889,Pravastatin Impurity A,CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC(CC(CC(=O)O)O)O)O
CID000002130,amantadine,C1C2CC3CC1CC(C2)(C3)N,neumonia,CID000005487,tizanidine,C1CN=C(N1)NC2=C(C=CC3=NSN=C32)Cl
CID000002130,amantadine,C1C2CC3CC1CC(C2)(C3)N,cholecystitis,CID000004236,modafinil,C1=CC=C(C=C1)C(C2=CC=CC=C2)S(=O)CC(=O)N
CID000002130,amantadine,C1C2CC3CC1CC(C2)(C3)N,apoplexy,CID000002284,baclofen,C1=CC(=CC=C1C(CC(=O)O)CN)Cl
CID000002130,amantadine,C1C2CC3CC1CC(C2)(C3)N,periodontitis,CID000005245,Risedronic acid,C1=CC(=CN=C1)CC(O)(P(=O)(O)O)P(=O)(O)O
CID000002130,amantadine,C1C2CC3CC1CC(C2)(C3)N,angiitis,CID000005732,zolpidem,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C
CID000002130,amantadine,C1C2CC3CC1CC(C2)(C3)N,loss of weight,CID000003676,lidocaine,CCN(CC)CC(=O)NC1=C(C=CC=C1C)C
CID000002130,amantadine,C1C2CC3CC1CC(C2)(C3)N,angiitis,CID000002462,51372-29-3,CCCC1OC2CC3C4CCC5=CC(=O)C=CC5(C4C(CC3(C2(O1)C(=O)CO)C)O)C
CID000002130,amantadine,C1C2CC3CC1CC(C2)(C3)N,subarachnoid haemorrhage,CID000005645,"3,7-Dihydroxycholan-24-oic acid",CC(CCC(=O)O)C1CCC2C1(CCC3C2C(CC4C3(CCC(C4)O)C)O)C
CID000002130,amantadine,C1C2CC3CC1CC(C2)(C3)N,Pain,CID000003440,furosemide,C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl
CID000002130,amantadine,C1C2CC3CC1CC(C2)(C3)N,amentia,CID000003961,losartan,CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)CO)Cl
CID000002130,amantadine,C1C2CC3CC1CC(C2)(C3)N,cholecystitis,CID000005152,Salmeterol,C1=CC=C(C=C1)CCCCOCCCCCCNCC(C2=CC(=C(C=C2)O)CO)O
CID000002130,amantadine,C1C2CC3CC1CC(C2)(C3)N,back injury,CID000003516,guaifenesin,COC1=CC=CC=C1OCC(CO)O
CID000002130,amantadine,C1C2CC3CC1CC(C2)(C3)N,angiitis,CID000004679,pantoprazole,COC1=C(C(=NC=C1)CS(=O)C2=NC3=C(N2)C=C(C=C3)OC(F)F)OC
CID000002130,amantadine,C1C2CC3CC1CC(C2)(C3)N,loss of weight,CID000003075,"2-[3-acetyloxy-2-(4-methoxyphenyl)-4-oxo-2,3-dihydro-1,5-benzothiazepin-5-yl]ethyl-dimethylazanium",CC(=O)OC1C(SC2=CC=CC=C2N(C1=O)CC[NH+](C)C)C3=CC=C(C=C3)OC
CID000002130,amantadine,C1C2CC3CC1CC(C2)(C3)N,cholecystitis,CID000004585,"2-methyl-4-(4-methylpiperazin-1-yl)-5H-thieno[3,2-c][1,5]benzodiazepine",CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C
CID000002130,amantadine,C1C2CC3CC1CC(C2)(C3)N,cholecystitis,CID000004894,"11,17,21-Trihydroxypregna-1,4-diene-3,20-dione",CC12CC(C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C)O
CID000002130,amantadine,C1C2CC3CC1CC(C2)(C3)N,thrombocytopenia,CID000060854,Ziprasidone,C1CN(CCN1CCC2=C(C=C3C(=C2)CC(=O)N3)Cl)C4=NSC5=CC=CC=C54
CID000002130,amantadine,C1C2CC3CC1CC(C2)(C3)N,angiitis,CID000062924,"S-(fluoromethyl) (6S,9R,10S,11S,13S,14S,16R,17R)-6,9-difluoro-11,17-dihydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthrene-17-carbothioate",CC1CC2C3CC(C4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)SCF)O)C)O)F)C)F
CID000002265,azathioprine,CN1C=NC(=C1SC2=NC=NC3=C2NC=N3)[N+](=O)[O-],apoplexy,CID000003937,N~2~-(1-carboxy-3-phenylpropyl)lysylproline,C1CC(N(C1)C(=O)C(CCCCN)NC(CCC2=CC=CC=C2)C(=O)O)C(=O)O
CID000002265,azathioprine,CN1C=NC(=C1SC2=NC=NC3=C2NC=N3)[N+](=O)[O-],Adenopathy,CID000004691,"3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine",C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4
CID000002265,azathioprine,CN1C=NC(=C1SC2=NC=NC3=C2NC=N3)[N+](=O)[O-],Adenopathy,CID000003961,losartan,CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)CO)Cl
CID000002265,azathioprine,CN1C=NC(=C1SC2=NC=NC3=C2NC=N3)[N+](=O)[O-],cholecystitis,CID000003883,lansoprazole,CC1=C(C=CN=C1CS(=O)C2=NC3=CC=CC=C3N2)OCC(F)(F)F
CID000002265,azathioprine,CN1C=NC(=C1SC2=NC=NC3=C2NC=N3)[N+](=O)[O-],Adenopathy,CID000002771,citalopram,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F
CID000002265,azathioprine,CN1C=NC(=C1SC2=NC=NC3=C2NC=N3)[N+](=O)[O-],angiitis,CID000003440,furosemide,C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl
CID000002265,azathioprine,CN1C=NC(=C1SC2=NC=NC3=C2NC=N3)[N+](=O)[O-],loss of weight,CID000005152,Salmeterol,C1=CC=C(C=C1)CCCCOCCCCCCNCC(C2=CC(=C(C=C2)O)CO)O
CID000002265,azathioprine,CN1C=NC(=C1SC2=NC=NC3=C2NC=N3)[N+](=O)[O-],apoplexy,CID000003339,fenofibrate,CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C2=CC=C(C=C2)Cl
CID000002265,azathioprine,CN1C=NC(=C1SC2=NC=NC3=C2NC=N3)[N+](=O)[O-],angiitis,CID006398525,,C(C1C(C(C(C(O1)OC2(C(C(C(O2)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)COS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.[Al].[Al].[Al].[Al].[Al].[Al].[Al].[Al].[Al]
CID000002265,azathioprine,CN1C=NC(=C1SC2=NC=NC3=C2NC=N3)[N+](=O)[O-],loss of weight,CID000003749,irbesartan,CCCCC1=NC2(CCCC2)C(=O)N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5
CID000002265,azathioprine,CN1C=NC(=C1SC2=NC=NC3=C2NC=N3)[N+](=O)[O-],Adenopathy,CID000004075,5-Aminosalicylic acid,C1=CC(=C(C=C1N)C(=O)O)O
CID000002265,azathioprine,CN1C=NC(=C1SC2=NC=NC3=C2NC=N3)[N+](=O)[O-],loss of weight,CID000004510,nitroglycerin,C(C(CO[N+](=O)[O-])O[N+](=O)[O-])O[N+](=O)[O-]
CID000002265,azathioprine,CN1C=NC(=C1SC2=NC=NC3=C2NC=N3)[N+](=O)[O-],drug toxicity NOS,CID000005645,"3,7-Dihydroxycholan-24-oic acid",CC(CCC(=O)O)C1CCC2C1(CCC3C2C(CC4C3(CCC(C4)O)C)O)C
CID000002265,azathioprine,CN1C=NC(=C1SC2=NC=NC3=C2NC=N3)[N+](=O)[O-],excessive thirst,CID000667490,6-Mercaptopurine,C1=NC2=C(N1)C(=S)N=CN2
CID000002265,azathioprine,CN1C=NC(=C1SC2=NC=NC3=C2NC=N3)[N+](=O)[O-],gastric inflammation,CID000004585,"2-methyl-4-(4-methylpiperazin-1-yl)-5H-thieno[3,2-c][1,5]benzodiazepine",CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C
CID000002265,azathioprine,CN1C=NC(=C1SC2=NC=NC3=C2NC=N3)[N+](=O)[O-],erythema,CID000002662,celecoxib,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F
CID000002265,azathioprine,CN1C=NC(=C1SC2=NC=NC3=C2NC=N3)[N+](=O)[O-],gastric inflammation,CID000005732,zolpidem,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C
CID000002265,azathioprine,CN1C=NC(=C1SC2=NC=NC3=C2NC=N3)[N+](=O)[O-],gastric inflammation,CID000004173,metronidazole,CC1=NC=C(N1CCO)[N+](=O)[O-]
CID000002265,azathioprine,CN1C=NC(=C1SC2=NC=NC3=C2NC=N3)[N+](=O)[O-],Back Ache,CID000005245,Risedronic acid,C1=CC(=CN=C1)CC(O)(P(=O)(O)O)P(=O)(O)O
CID000002265,azathioprine,CN1C=NC(=C1SC2=NC=NC3=C2NC=N3)[N+](=O)[O-],Dyspnea exertional,CID000062924,"S-(fluoromethyl) (6S,9R,10S,11S,13S,14S,16R,17R)-6,9-difluoro-11,17-dihydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthrene-17-carbothioate",CC1CC2C3CC(C4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)SCF)O)C)O)F)C)F
CID000002265,azathioprine,CN1C=NC(=C1SC2=NC=NC3=C2NC=N3)[N+](=O)[O-],Adenopathy,CID000003890,TRANS (15S)-LATANOPROST,CC(C)OC(=O)CCCC=CCC1C(CC(C1CCC(CCC2=CC=CC=C2)O)O)O
CID000002265,azathioprine,CN1C=NC(=C1SC2=NC=NC3=C2NC=N3)[N+](=O)[O-],myelodysplasia,CID000003062,Lanicor,CC1C(C(CC(O1)OC2C(OC(CC2O)OC3C(OC(CC3O)OC4CCC5(C(C4)CCC6C5CC(C7(C6(CCC7C8=CC(=O)OC8)O)C)O)C)C)C)O)O
CID000002265,6-(3-methyl-5-nitroimidazol-4-yl)sulfanyl-7H-purine,CN1C=NC(=C1SC2=NC=NC3=C2NC=N3)[N+](=O)[O-],loss of weight,CID000003954,loperamide(1+),CN(C)C(=O)C(CC[NH+]1CCC(CC1)(C2=CC=C(C=C2)Cl)O)(C3=CC=CC=C3)C4=CC=CC=C4
CID000002265,azathioprine,CN1C=NC(=C1SC2=NC=NC3=C2NC=N3)[N+](=O)[O-],cholecystitis,CID000004927,promethazine,CC(CN1C2=CC=CC=C2SC3=CC=CC=C31)N(C)C
CID000002265,azathioprine,CN1C=NC(=C1SC2=NC=NC3=C2NC=N3)[N+](=O)[O-],cholecystitis,CID000005544,Mycolog,CC12CC(C3(C(C1CC(C2(C(=O)CO)O)O)CCC4=CC(=O)C=CC43C)F)O
CID000002265,azathioprine,CN1C=NC(=C1SC2=NC=NC3=C2NC=N3)[N+](=O)[O-],weight gain,CID000004236,modafinil,C1=CC=C(C=C1)C(C2=CC=CC=C2)S(=O)CC(=O)N
CID000002265,azathioprine,CN1C=NC(=C1SC2=NC=NC3=C2NC=N3)[N+](=O)[O-],loss of weight,CID000002550,1-(2-methyl-3-sulfanylpropanoyl)pyrrolidine-2-carboxylic acid,CC(CS)C(=O)N1CCCC1C(=O)O
CID000002265,azathioprine,CN1C=NC(=C1SC2=NC=NC3=C2NC=N3)[N+](=O)[O-],loss of weight,CID000004894,"11,17,21-Trihydroxypregna-1,4-diene-3,20-dione",CC12CC(C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C)O
CID000002265,azathioprine,CN1C=NC(=C1SC2=NC=NC3=C2NC=N3)[N+](=O)[O-],gastric inflammation,CID000003345,fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3
CID000002265,azathioprine,CN1C=NC(=C1SC2=NC=NC3=C2NC=N3)[N+](=O)[O-],paranoia,CID000004205,mirtazapine,CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4
CID000002265,azathioprine,CN1C=NC(=C1SC2=NC=NC3=C2NC=N3)[N+](=O)[O-],dysarthria,CID000003658,hydroxyzine,C1CN(CCN1CCOCCO)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl
CID000002265,azathioprine,CN1C=NC(=C1SC2=NC=NC3=C2NC=N3)[N+](=O)[O-],Adenopathy,CID000003405,2-[[4-[(2-amino-4-oxo-1H-pteridin-6-yl)methylamino]benzoyl]amino]pentanedioic acid,C1=CC(=CC=C1C(=O)NC(CCC(=O)O)C(=O)O)NCC2=CN=C3C(=N2)C(=O)N=C(N3)N
CID000002265,azathioprine,CN1C=NC(=C1SC2=NC=NC3=C2NC=N3)[N+](=O)[O-],loss of weight,CID000002462,51372-29-3,CCCC1OC2CC3C4CCC5=CC(=O)C=CC5(C4C(CC3(C2(O1)C(=O)CO)C)O)C
CID000002265,azathioprine,CN1C=NC(=C1SC2=NC=NC3=C2NC=N3)[N+](=O)[O-],angiitis,CID000003676,lidocaine,CCN(CC)CC(=O)NC1=C(C=CC=C1C)C
CID000002265,azathioprine,CN1C=NC(=C1SC2=NC=NC3=C2NC=N3)[N+](=O)[O-],loss of weight,CID000002405,BISOPROLOL,CC(C)NCC(COC1=CC=C(C=C1)COCCOC(C)C)O
CID000002265,azathioprine,CN1C=NC(=C1SC2=NC=NC3=C2NC=N3)[N+](=O)[O-],angiitis,CID000002907,cyclophosphamide,C1CNP(=O)(OC1)N(CCCl)CCCl
CID000002265,azathioprine,CN1C=NC(=C1SC2=NC=NC3=C2NC=N3)[N+](=O)[O-],gastric inflammation,CID000003325,famotidine,C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N
CID000002265,azathioprine,CN1C=NC(=C1SC2=NC=NC3=C2NC=N3)[N+](=O)[O-],gout,CID000002541,candesartan,CCOC1=NC2=CC=CC(=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5)C(=O)O
CID000002265,azathioprine,CN1C=NC(=C1SC2=NC=NC3=C2NC=N3)[N+](=O)[O-],cholecystitis,CID000004900,Fernisone,CC12CC(=O)C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C
CID000002265,azathioprine,CN1C=NC(=C1SC2=NC=NC3=C2NC=N3)[N+](=O)[O-],scotoma,CID000002803,clonidine,C1CN=C(N1)NC2=C(C=CC=C2Cl)Cl
CID000002265,azathioprine,CN1C=NC(=C1SC2=NC=NC3=C2NC=N3)[N+](=O)[O-],right heart failure,CID000008953,sodium;hydrogen carbonate,C(=O)(O)[O-].[Na+]
CID000002265,azathioprine,CN1C=NC(=C1SC2=NC=NC3=C2NC=N3)[N+](=O)[O-],angiitis,CID000002284,baclofen,C1=CC(=CC=C1C(CC(=O)O)CN)Cl
CID000002265,azathioprine,CN1C=NC(=C1SC2=NC=NC3=C2NC=N3)[N+](=O)[O-],gastric inflammation,CID000004543,nortriptyline,CNCCC=C1C2=CC=CC=C2CCC3=CC=CC=C31
CID000002265,azathioprine,CN1C=NC(=C1SC2=NC=NC3=C2NC=N3)[N+](=O)[O-],gastroenteritis viral,CID003468412,SCHEMBL1176571,CC1C=CC=CCCC=CC=CC=CC=CC(CC(C(C(CC(=O)CC(C(CCC(CC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)C(=O)O)O)OC2C(C(C(C(O2)C)O)N)O
CID000002265,azathioprine,CN1C=NC(=C1SC2=NC=NC3=C2NC=N3)[N+](=O)[O-],Dyspnea exertional,CID000002806,90055-48-4,COC(=O)C(C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3
CID000002265,azathioprine,CN1C=NC(=C1SC2=NC=NC3=C2NC=N3)[N+](=O)[O-],loss of weight,CID000005650,N-pentanoyl-N-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-L-valine,CCCCC(=O)N(CC1=CC=C(C=C1)C2=CC=CC=C2C3=NNN=N3)C(C(C)C)C(=O)O
CID000002265,azathioprine,CN1C=NC(=C1SC2=NC=NC3=C2NC=N3)[N+](=O)[O-],angiitis,CID000002524,32222-06-3,CC(CCCC(C)(C)O)C1CCC2C1(CCCC2=CC=C3CC(CC(C3=C)O)O)C
CID000002265,azathioprine,CN1C=NC(=C1SC2=NC=NC3=C2NC=N3)[N+](=O)[O-],myelodysplasia,CID000003075,"2-[3-acetyloxy-2-(4-methoxyphenyl)-4-oxo-2,3-dihydro-1,5-benzothiazepin-5-yl]ethyl-dimethylazanium",CC(=O)OC1C(SC2=CC=CC=C2N(C1=O)CC[NH+](C)C)C3=CC=C(C=C3)OC
CID000002265,azathioprine,CN1C=NC(=C1SC2=NC=NC3=C2NC=N3)[N+](=O)[O-],myelodysplasia,CID000002891,"cobalt(2+);[5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] 1-[3-[2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2,7,12,17-tetrahydro-1H-corrin-21-id-3-yl]propanoylamino]propan-2-yl hydrogen phosphate;cyanide",CC1=CC2=C(C=C1C)N(C=N2)C3C(C(C(O3)CO)OP(=O)(O)OC(C)CNC(=O)CCC4(C(C5C6(C(C(C(=N6)C(=C7C(C(C(=N7)C=C8C(C(C(=N8)C(=C4[N-]5)C)CCC(=O)N)(C)C)CCC(=O)N)(C)CC(=O)N)C)CCC(=O)N)(C)CC(=O)N)C)CC(=O)N)C)O.[C-]#N.[Co+2]
CID000002265,azathioprine,CN1C=NC(=C1SC2=NC=NC3=C2NC=N3)[N+](=O)[O-],gastric inflammation,CID000004679,pantoprazole,COC1=C(C(=NC=C1)CS(=O)C2=NC3=C(N2)C=C(C=C3)OC(F)F)OC
CID000002265,azathioprine,CN1C=NC(=C1SC2=NC=NC3=C2NC=N3)[N+](=O)[O-],Pain,CID000004889,Pravastatin Impurity A,CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC(CC(CC(=O)O)O)O)O
CID000002662,celecoxib,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,constipated,CID000004044,mefenamic acid,CC1=C(C(=CC=C1)NC2=CC=CC=C2C(=O)O)C
CID000002662,celecoxib,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,Adenopathy,CID000004236,modafinil,C1=CC=C(C=C1)C(C2=CC=CC=C2)S(=O)CC(=O)N
CID000002662,celecoxib,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,Pain,CID000004748,perphenazine,C1CN(CCN1CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)Cl)CCO
CID000002662,celecoxib,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,apoplexy,CID000004745,SCHEMBL7711911,CCCN1CC(CC2C1CC3=CNC4=CC=CC2=C34)CSC
CID000002662,celecoxib,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,edema,CID000016231,AMILORIDE,C1(=C(N=C(C(=N1)Cl)N)N)C(=O)N=C(N)N
CID000002662,celecoxib,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,Back Ache,CID000003261,estazolam,C1C2=NN=CN2C3=C(C=C(C=C3)Cl)C(=N1)C4=CC=CC=C4
CID000002662,celecoxib,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,erythema,CID000005478,racemic-Timolol,CC(C)(C)NCC(COC1=NSN=C1N2CCOCC2)O
CID000002662,celecoxib,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,gastric inflammation,CID000005732,zolpidem,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C
CID000002662,celecoxib,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,gastric inflammation,CID000003325,famotidine,C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N
CID000002662,celecoxib,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,Back Ache,CID000060854,Ziprasidone,C1CN(CCN1CCC2=C(C=C3C(=C2)CC(=O)N3)Cl)C4=NSC5=CC=CC=C54
CID000002662,celecoxib,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,gastric inflammation,CID000060852,Ibandronic Acid,CCCCCN(C)CCC(O)(P(=O)(O)O)P(=O)(O)O
CID000002662,celecoxib,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,erythema,CID000004666,7-Epi Paclitaxel,CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C
CID000002662,celecoxib,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,abnormal ECG,CID000163742,SCHEMBL1650579,COC1C(C(C(C(O1)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)COS(=O)(=O)O)OC4C(C(C(C(O4)C(=O)O)OC5C(C(C(C(O5)COS(=O)(=O)O)O)O)NS(=O)(=O)O)O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O)NS(=O)(=O)O
CID000002662,celecoxib,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,cholecystitis,CID000003345,fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3
CID000002662,celecoxib,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,gastric inflammation,CID000004585,"2-methyl-4-(4-methylpiperazin-1-yl)-5H-thieno[3,2-c][1,5]benzodiazepine",CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C
CID000002662,celecoxib,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,gastric inflammation,CID006398525,,C(C1C(C(C(C(O1)OC2(C(C(C(O2)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)COS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.[Al].[Al].[Al].[Al].[Al].[Al].[Al].[Al].[Al]
CID000002662,celecoxib,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,cholecystitis,CID000003405,2-[[4-[(2-amino-4-oxo-1H-pteridin-6-yl)methylamino]benzoyl]amino]pentanedioic acid,C1=CC(=CC=C1C(=O)NC(CCC(=O)O)C(=O)O)NCC2=CN=C3C(=N2)C(=O)N=C(N3)N
CID000002662,celecoxib,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,gastric inflammation,CID000004173,metronidazole,CC1=NC=C(N1CCO)[N+](=O)[O-]
CID000002662,celecoxib,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,cholecystitis,CID000005073,risperidone,CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F
CID000002662,celecoxib,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,abnormal ECG,CID000005077,105601-20-5,CCN(C)C(=O)OC1=CC=CC(=C1)C(C)N(C)C
CID000002662,celecoxib,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,allergic dermatitis,CID000003043,9-[5-(hydroxymethyl)oxolan-2-yl]-3H-purin-6-one,C1CC(OC1CO)N2C=NC3=C2NC=NC3=O
CID000002662,celecoxib,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,gastric inflammation,CID000003148,dolasetron,C1C2CC3CC(CC1N3CC2=O)OC(=O)C4=CNC5=CC=CC=C54
CID000002662,celecoxib,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,elevated cholesterol,CID000002713,55-56-1,C1=CC(=CC=C1NC(=NC(=NCCCCCCN=C(N)N=C(N)NC2=CC=C(C=C2)Cl)N)N)Cl
CID000002662,celecoxib,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,Adenopathy,CID005311048,SCHEMBL11440306,C(N)(N)(Cl)Cl
CID000002662,celecoxib,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,gastric inflammation,CID000004691,"3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine",C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4
CID000002662,celecoxib,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,Bleeding,CID000060787,sequinavir,CC(C)(C)NC(=O)C1CC2CCCCC2CN1CC(C(CC3=CC=CC=C3)NC(=O)C(CC(=O)N)NC(=O)C4=NC5=CC=CC=C5C=C4)O
CID000002662,celecoxib,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,gastric inflammation,CID000003449,Epigalanthamin,CN1CCC23C=CC(CC2OC4=C(C=CC(=C34)C1)OC)O
CID000002662,celecoxib,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,gastric inflammation,CID000003440,furosemide,C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl
CID000002662,celecoxib,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,loss of weight,CID000110635,Tadalafil,CN1CC(=O)N2C(C1=O)CC3=C(C2C4=CC5=C(C=C4)OCO5)NC6=CC=CC=C36
CID000002662,celecoxib,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,loss of weight,CID000004189,miconazole,C1=CC(=C(C=C1Cl)Cl)COC(CN2C=CN=C2)C3=C(C=C(C=C3)Cl)Cl
CID000002662,celecoxib,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,Adenopathy,CID000004614,oxaprozin,C1=CC=C(C=C1)C2=C(OC(=N2)CCC(=O)O)C3=CC=CC=C3
CID000002662,celecoxib,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,cholecystitis,CID000019090,megestrol,CC1=CC2C(CCC3(C2CCC3(C(=O)C)O)C)C4(C1=CC(=O)CC4)C
CID000002662,celecoxib,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,nasopharyngitis,CID000071329,Dofetilide,CN(CCC1=CC=C(C=C1)NS(=O)(=O)C)CCOC2=CC=C(C=C2)NS(=O)(=O)C
CID000002662,celecoxib,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,angiitis,CID000160051,Colesevelam,CCCCCCCCCCNCC=C.C[N+](C)(C)CCCCCCNCC=C.C=CCN.C1C(O1)CCl.Cl.[Cl-]
CID000002662,celecoxib,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,cholecystitis,CID000003658,hydroxyzine,C1CN(CCN1CCOCCO)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl
CID000002662,celecoxib,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,erythema,CID000170361,Varenicline,C1C2CNCC1C3=CC4=NC=CN=C4C=C23
CID000002662,celecoxib,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,ear ache,CID000003075,"2-[3-acetyloxy-2-(4-methoxyphenyl)-4-oxo-2,3-dihydro-1,5-benzothiazepin-5-yl]ethyl-dimethylazanium",CC(=O)OC1C(SC2=CC=CC=C2N(C1=O)CC[NH+](C)C)C3=CC=C(C=C3)OC
CID000002662,celecoxib,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,gastric inflammation,CID000002806,90055-48-4,COC(=O)C(C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3
CID000002662,celecoxib,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,cholecystitis,CID000004889,Pravastatin Impurity A,CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC(CC(CC(=O)O)O)O)O
CID000002662,celecoxib,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,angiitis,CID000008953,sodium;hydrogen carbonate,C(=O)(O)[O-].[Na+]
CID000002662,celecoxib,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,Bacteraemia,CID000003750,"4,11-diethyl-4-hydroxy-3,14-dioxo-3,4,12,14-tetrahydro-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinolin-9-yl 1,4'-bipiperidine-1'-carboxylate",CCC1=C2CN3C(=CC4=C(C3=O)COC(=O)C4(CC)O)C2=NC5=C1C=C(C=C5)OC(=O)N6CCC(CC6)N7CCCCC7
CID000002662,celecoxib,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,cholecystitis,CID000005245,Risedronic acid,C1=CC(=CN=C1)CC(O)(P(=O)(O)O)P(=O)(O)O
CID000002662,celecoxib,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,Adenopathy,CID000062924,"S-(fluoromethyl) (6S,9R,10S,11S,13S,14S,16R,17R)-6,9-difluoro-11,17-dihydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthrene-17-carbothioate",CC1CC2C3CC(C4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)SCF)O)C)O)F)C)F
CID000002662,celecoxib,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,emesis,CID000003410,formoterol,CC(CC1=CC=C(C=C1)OC)NCC(C2=CC(=C(C=C2)O)NC=O)O
CID000002662,celecoxib,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,erythema,CID000002978,16849-50-6,CCCCCC1=CC(=C2C3C=C(CCC3C(OC2=C1)(C)C)C)O
CID000002662,celecoxib,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,erythema,CID000005512,124936-74-9,CC1=CC(=C(C=C1)O)C(CCN(C(C)C)C(C)C)C2=CC=CC=C2
CID000002662,celecoxib,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,cholecystitis,CID000002803,clonidine,C1CN=C(N1)NC2=C(C=CC=C2Cl)Cl
CID000002662,celecoxib,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,back injury,CID000004158,methylphenidate,COC(=O)C(C1CCCCN1)C2=CC=CC=C2
CID000002662,celecoxib,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,Adenopathy,CID000003516,guaifenesin,COC1=CC=CC=C1OCC(CO)O
CID000002662,celecoxib,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,Adenopathy,CID000038904,Carboplatinum,C1CC(C1)(C(=O)O)C(=O)O.N.N.[Pt]
CID000002662,celecoxib,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,glaucoma,CID000003706,SCHEMBL1176257,CC(C)(C)NC(=O)C1CN(CCN1CC(CC(CC2=CC=CC=C2)C(=O)NC3C(CC4=CC=CC=C34)O)O)CC5=CN=CC=C5
CID000002662,celecoxib,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,ear ache,CID000002771,citalopram,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F
CID000002662,celecoxib,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,cholecystitis,CID000005650,N-pentanoyl-N-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-L-valine,CCCCC(=O)N(CC1=CC=C(C=C1)C2=CC=CC=C2C3=NNN=N3)C(C(C)C)C(=O)O
CID000002662,celecoxib,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,cholecystitis,CID000027686,CHEMBL4088679,C1=CC2=C(C(=C1)OCC(COC3=CC4=C(C=C3)OC(=CC4=O)C(=O)O)O)C(=O)C=C(O2)C(=O)O
CID000002662,celecoxib,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,gout,CID000003827,ketotifen,CN1CCC(=C2C3=C(C(=O)CC4=CC=CC=C42)SC=C3)CC1
CID000002662,celecoxib,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,gastric inflammation,CID000003780,"D-Glucitol, 1,4:3,6-dianhydro-, 2,5-dinitrate",C1C(C2C(O1)C(CO2)O[N+](=O)[O-])O[N+](=O)[O-]
CID000002662,celecoxib,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,erythema,CID000005095,ropinirole,CCCN(CCC)CCC1=C2CC(=O)NC2=CC=C1
CID000002662,celecoxib,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,gastric inflammation,CID000004205,mirtazapine,CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4
CID000002662,celecoxib,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,myelodysplasia,CID000060865,(E)-Olopatadine,CN(C)CCC=C1C2=CC=CC=C2COC3=C1C=C(C=C3)CC(=O)O
CID000002662,celecoxib,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,gastric inflammation,CID000004679,pantoprazole,COC1=C(C(=NC=C1)CS(=O)C2=NC3=C(N2)C=C(C=C3)OC(F)F)OC
CID000002662,celecoxib,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,loss of weight,CID000048175,"[(6S,9R,16S,17R)-17-(2-chloroacetyl)-6,9-difluoro-11-hydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl] propanoate",CCC(=O)OC1(C(CC2C1(CC(C3(C2CC(C4=CC(=O)C=CC43C)F)F)O)C)C)C(=O)CCl
CID000002662,celecoxib,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,asthma,CID005493444,Aliskiren,CC(C)C(CC1=CC(=C(C=C1)OC)OCCCOC)CC(C(CC(C(C)C)C(=O)NCC(C)(C)C(=O)N)O)N
CID000002662,celecoxib,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,loss of weight,CID000005394,temozolomide,CN1C(=O)N2C=NC(=C2N=N1)C(=O)N
CID000002662,celecoxib,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,Back Ache,CID000667490,6-Mercaptopurine,C1=NC2=C(N1)C(=S)N=CN2
CID000002662,celecoxib,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,cholecystitis,CID000003676,lidocaine,CCN(CC)CC(=O)NC1=C(C=CC=C1C)C
CID000002662,celecoxib,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,cholecystitis,CID000005544,Mycolog,CC12CC(C3(C(C1CC(C2(C(=O)CO)O)O)CCC4=CC(=O)C=CC43C)F)O
CID000002662,celecoxib,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,loss of weight,CID000003059,diflunisal,C1=CC(=C(C=C1C2=C(C=C(C=C2)F)F)C(=O)O)O
CID000002662,celecoxib,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,insulin dependent diabetes mellitus,CID000012536,638-94-8,CC1(OC2CC3C4CCC5=CC(=O)C=CC5(C4C(CC3(C2(O1)C(=O)CO)C)O)C)C
CID000002662,celecoxib,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,gastric inflammation,CID000003890,TRANS (15S)-LATANOPROST,CC(C)OC(=O)CCCC=CCC1C(CC(C1CCC(CCC2=CC=CC=C2)O)O)O
CID000002662,celecoxib,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,sick sinus syndrome,CID000005352,38194-50-2,CC1=C(C2=C(C1=CC3=CC=C(C=C3)S(=O)C)C=CC(=C2)F)CC(=O)O
CID000002662,celecoxib,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,cholecystitis,CID000005358,sumatriptan,CNS(=O)(=O)CC1=CC2=C(C=C1)NC=C2CCN(C)C
CID000002662,celecoxib,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,rotator cuff syndrome,CID000004911,probenecid,CCCN(CCC)S(=O)(=O)C1=CC=C(C=C1)C(=O)O
CID000002662,celecoxib,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,thrombocytopenia,CID000071616,Voriconazole,CC(C1=NC=NC=C1F)C(CN2C=NC=N2)(C3=C(C=C(C=C3)F)F)O
CID000002662,celecoxib,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,heart rate increased,CID000125017,Desvenlafaxine,CN(C)CC(C1=CC=C(C=C1)O)C2(CCCCC2)O
CID000002662,celecoxib,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,agitated,CID000004819,"2(3H)-Furanone, 3-ethyldihydro-4-[(1-methyl-1H-imidazol-5-yl)methyl]-, (3S-cis)-",CCC1C(COC1=O)CC2=CN=CN2C
CID000002662,celecoxib,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,loss of weight,CID000004138,55-40-3,CC(CC1=CC(=C(C=C1)O)O)(C(=O)O)N
CID000002662,celecoxib,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,gastric inflammation,CID000003937,N~2~-(1-carboxy-3-phenylpropyl)lysylproline,C1CC(N(C1)C(=O)C(CCCCN)NC(CCC2=CC=CC=C2)C(=O)O)C(=O)O
CID000002662,celecoxib,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,back injury,CID000003062,Lanicor,CC1C(C(CC(O1)OC2C(OC(CC2O)OC3C(OC(CC3O)OC4CCC5(C(C4)CCC6C5CC(C7(C6(CCC7C8=CC(=O)OC8)O)C)O)C)C)C)O)O
CID000002662,celecoxib,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,colitis ischemic,CID000003305,Etidronic acid,CC(O)(P(=O)(O)O)P(=O)(O)O
CID000002662,celecoxib,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,gastric inflammation,CID000004543,nortriptyline,CNCCC=C1C2=CC=CC=C2CCC3=CC=CC=C31
CID000002662,celecoxib,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,cholecystitis,CID000004170,metolazone,CC1NC2=CC(=C(C=C2C(=O)N1C3=CC=CC=C3C)S(=O)(=O)N)Cl
CID000002662,celecoxib,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,cholecystectomies,CID000004894,"11,17,21-Trihydroxypregna-1,4-diene-3,20-dione",CC12CC(C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C)O
CID000002662,celecoxib,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,gastric inflammation,CID000005487,tizanidine,C1CN=C(N1)NC2=C(C=CC3=NSN=C32)Cl
CID000002662,celecoxib,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,Adenopathy,CID000003883,lansoprazole,CC1=C(C=CN=C1CS(=O)C2=NC3=CC=CC=C3N2)OCC(F)(F)F
CID000002662,celecoxib,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,gastric inflammation,CID000004075,5-Aminosalicylic acid,C1=CC(=C(C=C1N)C(=O)O)O
CID000002662,celecoxib,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,gastric inflammation,CID000002891,"cobalt(2+);[5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] 1-[3-[2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2,7,12,17-tetrahydro-1H-corrin-21-id-3-yl]propanoylamino]propan-2-yl hydrogen phosphate;cyanide",CC1=CC2=C(C=C1C)N(C=N2)C3C(C(C(O3)CO)OP(=O)(O)OC(C)CNC(=O)CCC4(C(C5C6(C(C(C(=N6)C(=C7C(C(C(=N7)C=C8C(C(C(=N8)C(=C4[N-]5)C)CCC(=O)N)(C)C)CCC(=O)N)(C)CC(=O)N)C)CCC(=O)N)(C)CC(=O)N)C)CC(=O)N)C)O.[C-]#N.[Co+2]
CID000002662,celecoxib,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,Adenopathy,CID000004920,"1-acetyl-9a,11a-dimethyl-1H,2H,3H,3aH,3bH,4H,5H,7H,8H,9H,9aH,9bH,10H,11H,11aH-cyclopenta[a]phenanthren-7-one",CC(=O)C1CCC2C1(CCC3C2CCC4=CC(=O)CCC34C)C
CID000002662,celecoxib,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,cholecystitis,CID000004927,promethazine,CC(CN1C2=CC=CC=C2SC3=CC=CC=C31)N(C)C
CID000002662,celecoxib,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,gastric inflammation,CID000131536,Fosamprenavir,CC(C)CN(CC(C(CC1=CC=CC=C1)NC(=O)OC2CCOC2)OP(=O)(O)O)S(=O)(=O)C3=CC=C(C=C3)N
CID000002662,celecoxib,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,Adenopathy,CID000004856,"3-[hydroxy-(pyridin-2-ylamino)methylidene]-2-methyl-1,1-dioxo-1lambda6,2-benzothiazin-4-one",CN1C(=C(NC2=CC=CC=N2)O)C(=O)C3=CC=CC=C3S1(=O)=O
CID000002662,celecoxib,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,Adenopathy,CID000005376,(E/Z)-Tamoxifen,CCC(=C(C1=CC=CC=C1)C2=CC=C(C=C2)OCCN(C)C)C3=CC=CC=C3
CID000002662,celecoxib,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,weight gain,CID006447131,Pimecrolimus,CCC1C=C(CC(CC(C2C(CC(C(O2)(C(=O)C(=O)N3CCCCC3C(=O)OC(C(C(CC1=O)O)C)C(=CC4CCC(C(C4)OC)Cl)C)O)C)OC)OC)C)C
CID000002662,celecoxib,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,loss of weight,CID000060184,"2'-epi-Perindopril, (2'R)-",CCCC(C(=O)OCC)NC(C)C(=O)N1C2CCCCC2CC1C(=O)O
CID000002662,celecoxib,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,gastric inflammation,CID000003961,losartan,CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)CO)Cl
CID000002662,celecoxib,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,cholecystitis,CID000003339,fenofibrate,CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C2=CC=C(C=C2)Cl
CID000002662,celecoxib,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,cholecystitis,CID000003333,felodipine,CCOC(=O)C1=C(NC(=C(C1C2=C(C(=CC=C2)Cl)Cl)C(=O)OC)C)C
CID000002662,celecoxib,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,defaecation urgency,CID000152945,Dutasteride?,CC12CCC3C(C1CCC2C(=O)NC4=C(C=CC(=C4)C(F)(F)F)C(F)(F)F)CCC5C3(C=CC(=O)N5)C
CID000002662,celecoxib,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,gastric inflammation,CID000004510,nitroglycerin,C(C(CO[N+](=O)[O-])O[N+](=O)[O-])O[N+](=O)[O-]
CID000002662,celecoxib,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,High blood pressure,CID000005645,"3,7-Dihydroxycholan-24-oic acid",CC(CCC(=O)O)C1CCC2C1(CCC3C2C(CC4C3(CCC(C4)O)C)O)C
CID000002662,celecoxib,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,gastroenteritis viral,CID009571074,"(6R)-7-[[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-methoxyiminoacetyl]amino]-3-[(Z)-2-(4-methyl-1,3-thiazol-5-yl)ethenyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid",CC1=C(SC=N1)C=CC2=C(N3C(C(C3=O)NC(=O)C(=NOC)C4=CSC(=N4)N)SC2)C(=O)O
CID000002662,celecoxib,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,bipolar disorder,CID000004440,naratriptan,CNS(=O)(=O)CCC1=CC2=C(C=C1)NC=C2C3CCN(CC3)C
CID000002662,celecoxib,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,Back Ache,CID000004601,orphenadrine,CC1=CC=CC=C1C(C2=CC=CC=C2)OCCN(C)C
CID000002662,celecoxib,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,Adenopathy,CID000003954,loperamide(1+),CN(C)C(=O)C(CC[NH+]1CCC(CC1)(C2=CC=C(C=C2)Cl)O)(C3=CC=CC=C3)C4=CC=CC=C4
CID000002662,celecoxib,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,allergic dermatitis,CID000004195,midodrine,COC1=CC(=C(C=C1)OC)C(CNC(=O)CN)O
CID000002662,celecoxib,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,bulging,CID000057537,92206-54-7,CCCN(CCC1=CC=CS1)C2CCC3=C(C2)C=CC=C3O
CID000002662,celecoxib,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,loss of weight,CID000003661,L-Hyoscyamine,CN1C2CCC1CC(C2)OC(=O)C(CO)C3=CC=CC=C3
CID000002662,celecoxib,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,erythema,CID000005719,zaleplon,CCN(C1=CC=CC(=C1)C2=CC=NC3=C(C=NN23)C#N)C(=O)C
CID000002662,celecoxib,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,loss of weight,CID000003042,dicyclomine,CCN(CC)CCOC(=O)C1(CCCCC1)C2CCCCC2
CID000002662,celecoxib,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,colitis,CID000074989,ATOVAQUONE,C1CC(CCC1C2=CC=C(C=C2)Cl)C3=C(C4=CC=CC=C4C(=O)C3=O)O
CID000002662,celecoxib,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,apoplexy,CID000002732,chlorthalidone,C1=CC=C2C(=C1)C(=O)NC2(C3=CC(=C(C=C3)Cl)S(=O)(=O)N)O
CID000002662,celecoxib,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,chondrocalcinosis pyrophosphate,CID000009052,2-hydroxy-3-[1-(4-nitrophenyl)-3-oxobutyl]chromen-4-one,CC(=O)CC(C1=CC=C(C=C1)[N+](=O)[O-])C2=C(OC3=CC=CC=C3C2=O)O
CID000002662,celecoxib,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,gastric inflammation,CID000003749,irbesartan,CCCCC1=NC2(CCCC2)C(=O)N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5
CID000002662,celecoxib,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,loss of weight,CID000004909,primidone,CCC1(C(=O)NCNC1=O)C2=CC=CC=C2
CID000002662,celecoxib,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,gastric inflammation,CID000004900,Fernisone,CC12CC(=O)C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C
CID000002662,celecoxib,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,Adenopathy,CID003468412,SCHEMBL1176571,CC1C=CC=CCCC=CC=CC=CC=CC(CC(C(C(CC(=O)CC(C(CCC(CC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)C(=O)O)O)OC2C(C(C(C(O2)C)O)N)O
CID000002662,celecoxib,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,gastric inflammation,CID000005978,vincristine,CCC1(CC2CC(C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)C78CCN9C7C(C=CC9)(C(C(C8N6C=O)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O
CID000002662,celecoxib,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,dizziness,CID000004201,minoxidil,C1CCN(CC1)C2=NC(=N)N(C(=C2)N)O
CID000002662,celecoxib,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,cholecystitis,CID000005152,Salmeterol,C1=CC=C(C=C1)CCCCOCCCCCCNCC(C2=CC(=C(C=C2)O)CO)O
CID000002662,celecoxib,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,Back Ache,CID000003869,labetalol,CC(CCC1=CC=CC=C1)NCC(C2=CC(=C(C=C2)O)C(=O)N)O
CID000002662,celecoxib,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,gastric inflammation,CID000002907,cyclophosphamide,C1CNP(=O)(OC1)N(CCCl)CCCl
CID000002662,celecoxib,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,rotator cuff syndrome,CID000002676,"7-[4-(4-fluorophenyl)-5-(methoxymethyl)-2,6-di(propan-2-yl)pyridin-3-yl]-3,5-dihydroxyhept-6-enoic acid",CC(C)C1=C(C(=C(C(=N1)C(C)C)COC)C2=CC=C(C=C2)F)C=CC(CC(CC(=O)O)O)O
CID000002662,celecoxib,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,peritonitis,CID000005584,trimipramine,CC(CN1C2=CC=CC=C2CCC3=CC=CC=C31)CN(C)C
CID000002662,celecoxib,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,drug toxicity NOS,CID004479097,"cobalt;[5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] 1-[3-[2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2,7,12,17-tetrahydro-1H-corrin-21-id-3-yl]propanoylamino]propan-2-yl phosphate;hydrate",CC1=CC2=C(C=C1C)N(C=N2)C3C(C(C(O3)CO)OP(=O)([O-])OC(C)CNC(=O)CCC4(C(C5C6(C(C(C(=N6)C(=C7C(C(C(=N7)C=C8C(C(C(=N8)C(=C4[N-]5)C)CCC(=O)N)(C)C)CCC(=O)N)(C)CC(=O)N)C)CCC(=O)N)(C)CC(=O)N)C)CC(=O)N)C)O.O.[Co]
CID000002662,celecoxib,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,loss of weight,CID000004536,Minovlar,CC12CCC3C(C1CCC2(C#C)O)CCC4=CC(=O)CCC34
CID000002662,celecoxib,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,gastric inflammation,CID000003310,33419-42-0,CC1OCC2C(O1)C(C(C(O2)OC3C4COC(=O)C4C(C5=CC6=C(C=C35)OCO6)C7=CC(=C(C(=C7)OC)O)OC)O)O
CID000005195,Deprenyl,CC(CC1=CC=CC=C1)N(C)CC#C,loss of weight,CID000062924,"S-(fluoromethyl) (6S,9R,10S,11S,13S,14S,16R,17R)-6,9-difluoro-11,17-dihydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthrene-17-carbothioate",CC1CC2C3CC(C4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)SCF)O)C)O)F)C)F
CID000005195,Deprenyl,CC(CC1=CC=CC=C1)N(C)CC#C,loss of weight,CID000005732,zolpidem,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C
CID000005195,Deprenyl,CC(CC1=CC=CC=C1)N(C)CC#C,Pleural Effusion,CID000005650,N-pentanoyl-N-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-L-valine,CCCCC(=O)N(CC1=CC=C(C=C1)C2=CC=CC=C2C3=NNN=N3)C(C(C)C)C(=O)O
CID000005195,Deprenyl,CC(CC1=CC=CC=C1)N(C)CC#C,panic attack,CID000060854,Ziprasidone,C1CN(CCN1CCC2=C(C=C3C(=C2)CC(=O)N3)Cl)C4=NSC5=CC=CC=C54
CID000005195,Deprenyl,CC(CC1=CC=CC=C1)N(C)CC#C,nervous tension,CID000057537,92206-54-7,CCCN(CCC1=CC=CS1)C2CCC3=C(C2)C=CC=C3O
CID000002978,16849-50-6,CCCCCC1=CC(=C2C3C=C(CCC3C(OC2=C1)(C)C)C)O,malnourished,CID000004205,mirtazapine,CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4
CID000002978,16849-50-6,CCCCCC1=CC(=C2C3C=C(CCC3C(OC2=C1)(C)C)C)O,weight gain,CID000003339,fenofibrate,CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C2=CC=C(C=C2)Cl
CID000002978,16849-50-6,CCCCCC1=CC(=C2C3C=C(CCC3C(OC2=C1)(C)C)C)O,failure to thrive,CID000038904,Carboplatinum,C1CC(C1)(C(=O)O)C(=O)O.N.N.[Pt]
CID000002978,16849-50-6,CCCCCC1=CC(=C2C3C=C(CCC3C(OC2=C1)(C)C)C)O,atelectasis,CID000003750,"4,11-diethyl-4-hydroxy-3,14-dioxo-3,4,12,14-tetrahydro-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinolin-9-yl 1,4'-bipiperidine-1'-carboxylate",CCC1=C2CN3C(=CC4=C(C3=O)COC(=O)C4(CC)O)C2=NC5=C1C=C(C=C5)OC(=O)N6CCC(CC6)N7CCCCC7
CID000002978,16849-50-6,CCCCCC1=CC(=C2C3C=C(CCC3C(OC2=C1)(C)C)C)O,rhinorrhea,CID000003516,guaifenesin,COC1=CC=CC=C1OCC(CO)O
CID000002978,16849-50-6,CCCCCC1=CC(=C2C3C=C(CCC3C(OC2=C1)(C)C)C)O,edema,CID000019090,megestrol,CC1=CC2C(CCC3(C2CCC3(C(=O)C)O)C)C4(C1=CC(=O)CC4)C
CID000002978,16849-50-6,CCCCCC1=CC(=C2C3C=C(CCC3C(OC2=C1)(C)C)C)O,loss of weight,CID000003658,hydroxyzine,C1CN(CCN1CCOCCO)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl
CID000002978,16849-50-6,CCCCCC1=CC(=C2C3C=C(CCC3C(OC2=C1)(C)C)C)O,duodenitis,CID000004911,probenecid,CCCN(CCC)S(=O)(=O)C1=CC=C(C=C1)C(=O)O
CID000002978,16849-50-6,CCCCCC1=CC(=C2C3C=C(CCC3C(OC2=C1)(C)C)C)O,loss of weight,CID000004900,Fernisone,CC12CC(=O)C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C
CID000002978,16849-50-6,CCCCCC1=CC(=C2C3C=C(CCC3C(OC2=C1)(C)C)C)O,loss of weight,CID000003062,Lanicor,CC1C(C(CC(O1)OC2C(OC(CC2O)OC3C(OC(CC3O)OC4CCC5(C(C4)CCC6C5CC(C7(C6(CCC7C8=CC(=O)OC8)O)C)O)C)C)C)O)O
CID000002978,16849-50-6,CCCCCC1=CC(=C2C3C=C(CCC3C(OC2=C1)(C)C)C)O,thrombocytopenia,CID000003661,L-Hyoscyamine,CN1C2CCC1CC(C2)OC(=O)C(CO)C3=CC=CC=C3
CID000002978,16849-50-6,CCCCCC1=CC(=C2C3C=C(CCC3C(OC2=C1)(C)C)C)O,loss of weight,CID000005152,Salmeterol,C1=CC=C(C=C1)CCCCOCCCCCCNCC(C2=CC(=C(C=C2)O)CO)O
CID000002978,16849-50-6,CCCCCC1=CC(=C2C3C=C(CCC3C(OC2=C1)(C)C)C)O,atelectasis,CID000004510,nitroglycerin,C(C(CO[N+](=O)[O-])O[N+](=O)[O-])O[N+](=O)[O-]
CID000002978,16849-50-6,CCCCCC1=CC(=C2C3C=C(CCC3C(OC2=C1)(C)C)C)O,ADVERSE DRUG EFFECT,CID000003883,lansoprazole,CC1=C(C=CN=C1CS(=O)C2=NC3=CC=CC=C3N2)OCC(F)(F)F
CID000002978,16849-50-6,CCCCCC1=CC(=C2C3C=C(CCC3C(OC2=C1)(C)C)C)O,loss of weight,CID000003148,dolasetron,C1C2CC3CC(CC1N3CC2=O)OC(=O)C4=CNC5=CC=CC=C54
CID000002978,16849-50-6,CCCCCC1=CC(=C2C3C=C(CCC3C(OC2=C1)(C)C)C)O,Back Ache,CID000004666,7-Epi Paclitaxel,CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C
CID000002978,16849-50-6,CCCCCC1=CC(=C2C3C=C(CCC3C(OC2=C1)(C)C)C)O,apoplexy,CID005311048,SCHEMBL11440306,C(N)(N)(Cl)Cl
CID000002978,16849-50-6,CCCCCC1=CC(=C2C3C=C(CCC3C(OC2=C1)(C)C)C)O,sick sinus syndrome,CID000003405,2-[[4-[(2-amino-4-oxo-1H-pteridin-6-yl)methylamino]benzoyl]amino]pentanedioic acid,C1=CC(=CC=C1C(=O)NC(CCC(=O)O)C(=O)O)NCC2=CN=C3C(=N2)C(=O)N=C(N3)N
CID000002978,16849-50-6,CCCCCC1=CC(=C2C3C=C(CCC3C(OC2=C1)(C)C)C)O,loss of weight,CID000003954,loperamide(1+),CN(C)C(=O)C(CC[NH+]1CCC(CC1)(C2=CC=C(C=C2)Cl)O)(C3=CC=CC=C3)C4=CC=CC=C4
CID000002978,16849-50-6,CCCCCC1=CC(=C2C3C=C(CCC3C(OC2=C1)(C)C)C)O,heart rate increased,CID000065027,N-[3-[(1R)-1-[(2R)-6-hydroxy-4-oxo-2-(2-phenylethyl)-2-propyl-3H-pyran-5-yl]propyl]phenyl]-5-(trifluoromethyl)pyridine-2-sulfonamide,CCCC1(CC(=O)C(=C(O1)O)C(CC)C2=CC(=CC=C2)NS(=O)(=O)C3=NC=C(C=C3)C(F)(F)F)CCC4=CC=CC=C4
CID000002978,16849-50-6,CCCCCC1=CC(=C2C3C=C(CCC3C(OC2=C1)(C)C)C)O,dysarthria,CID000004927,promethazine,CC(CN1C2=CC=CC=C2SC3=CC=CC=C31)N(C)C
CID000002978,16849-50-6,CCCCCC1=CC(=C2C3C=C(CCC3C(OC2=C1)(C)C)C)O,loss of weight,CID000005650,N-pentanoyl-N-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-L-valine,CCCCC(=O)N(CC1=CC=C(C=C1)C2=CC=CC=C2C3=NNN=N3)C(C(C)C)C(=O)O
CID000002978,16849-50-6,CCCCCC1=CC(=C2C3C=C(CCC3C(OC2=C1)(C)C)C)O,Bladder inflammation,CID000074989,ATOVAQUONE,C1CC(CCC1C2=CC=C(C=C2)Cl)C3=C(C4=CC=CC=C4C(=O)C3=O)O
CID000002978,16849-50-6,CCCCCC1=CC(=C2C3C=C(CCC3C(OC2=C1)(C)C)C)O,aspiration pneumonia,CID000004889,Pravastatin Impurity A,CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC(CC(CC(=O)O)O)O)O
CID000002978,16849-50-6,CCCCCC1=CC(=C2C3C=C(CCC3C(OC2=C1)(C)C)C)O,erythema,CID000003325,famotidine,C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N
CID000002978,16849-50-6,CCCCCC1=CC(=C2C3C=C(CCC3C(OC2=C1)(C)C)C)O,methaemoglobinaemia,CID000004679,pantoprazole,COC1=C(C(=NC=C1)CS(=O)C2=NC3=C(N2)C=C(C=C3)OC(F)F)OC
CID000002978,16849-50-6,CCCCCC1=CC(=C2C3C=C(CCC3C(OC2=C1)(C)C)C)O,arteriosclerotic heart disease,CID000004585,"2-methyl-4-(4-methylpiperazin-1-yl)-5H-thieno[3,2-c][1,5]benzodiazepine",CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C
CID000002978,16849-50-6,CCCCCC1=CC(=C2C3C=C(CCC3C(OC2=C1)(C)C)C)O,Diplopia,CID000004158,methylphenidate,COC(=O)C(C1CCCCN1)C2=CC=CC=C2
CID000002978,16849-50-6,CCCCCC1=CC(=C2C3C=C(CCC3C(OC2=C1)(C)C)C)O,methaemoglobinaemia,CID000003937,N~2~-(1-carboxy-3-phenylpropyl)lysylproline,C1CC(N(C1)C(=O)C(CCCCN)NC(CCC2=CC=CC=C2)C(=O)O)C(=O)O
CID000002978,16849-50-6,CCCCCC1=CC(=C2C3C=C(CCC3C(OC2=C1)(C)C)C)O,thrombocytopenia,CID000152945,Dutasteride?,CC12CCC3C(C1CCC2C(=O)NC4=C(C=CC(=C4)C(F)(F)F)C(F)(F)F)CCC5C3(C=CC(=O)N5)C
CID000002978,16849-50-6,CCCCCC1=CC(=C2C3C=C(CCC3C(OC2=C1)(C)C)C)O,allergic dermatitis,CID000003310,33419-42-0,CC1OCC2C(O1)C(C(C(O2)OC3C4COC(=O)C4C(C5=CC6=C(C=C35)OCO6)C7=CC(=C(C(=C7)OC)O)OC)O)O
CID000002978,16849-50-6,CCCCCC1=CC(=C2C3C=C(CCC3C(OC2=C1)(C)C)C)O,bulging,CID000004451,CHEMBL365442,CC1=C(C=CC=C1O)C(=O)NC(CSC2=CC=CC=C2)C(CN3CC4CCCCC4CC3C(=O)NC(C)(C)C)O
CID000002978,16849-50-6,CCCCCC1=CC(=C2C3C=C(CCC3C(OC2=C1)(C)C)C)O,elevated cholesterol,CID000062924,"S-(fluoromethyl) (6S,9R,10S,11S,13S,14S,16R,17R)-6,9-difluoro-11,17-dihydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthrene-17-carbothioate",CC1CC2C3CC(C4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)SCF)O)C)O)F)C)F
CID000002978,16849-50-6,CCCCCC1=CC(=C2C3C=C(CCC3C(OC2=C1)(C)C)C)O,loss of weight,CID000005544,Mycolog,CC12CC(C3(C(C1CC(C2(C(=O)CO)O)O)CCC4=CC(=O)C=CC43C)F)O
CID000002978,16849-50-6,CCCCCC1=CC(=C2C3C=C(CCC3C(OC2=C1)(C)C)C)O,Adenopathy,CID000005732,zolpidem,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C
CID000002978,16849-50-6,CCCCCC1=CC(=C2C3C=C(CCC3C(OC2=C1)(C)C)C)O,loss of weight,CID000005978,vincristine,CCC1(CC2CC(C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)C78CCN9C7C(C=CC9)(C(C(C8N6C=O)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O
CID000002978,16849-50-6,CCCCCC1=CC(=C2C3C=C(CCC3C(OC2=C1)(C)C)C)O,loss of weight,CID000003961,losartan,CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)CO)Cl
CID000002978,16849-50-6,CCCCCC1=CC(=C2C3C=C(CCC3C(OC2=C1)(C)C)C)O,rhinorrhea,CID000003075,"2-[3-acetyloxy-2-(4-methoxyphenyl)-4-oxo-2,3-dihydro-1,5-benzothiazepin-5-yl]ethyl-dimethylazanium",CC(=O)OC1C(SC2=CC=CC=C2N(C1=O)CC[NH+](C)C)C3=CC=C(C=C3)OC
CID000002978,16849-50-6,CCCCCC1=CC(=C2C3C=C(CCC3C(OC2=C1)(C)C)C)O,Embolism pulmonary,CID000003676,lidocaine,CCN(CC)CC(=O)NC1=C(C=CC=C1C)C
CID000002978,16849-50-6,CCCCCC1=CC(=C2C3C=C(CCC3C(OC2=C1)(C)C)C)O,Back Ache,CID000003345,fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3
CID000002978,16849-50-6,CCCCCC1=CC(=C2C3C=C(CCC3C(OC2=C1)(C)C)C)O,Pain,CID000004691,"3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine",C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4
CID000002978,16849-50-6,CCCCCC1=CC(=C2C3C=C(CCC3C(OC2=C1)(C)C)C)O,methaemoglobinaemia,CID000003440,furosemide,C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl
CID000002978,16849-50-6,CCCCCC1=CC(=C2C3C=C(CCC3C(OC2=C1)(C)C)C)O,atelectasis,CID000004173,metronidazole,CC1=NC=C(N1CCO)[N+](=O)[O-]
CID000002978,16849-50-6,CCCCCC1=CC(=C2C3C=C(CCC3C(OC2=C1)(C)C)C)O,apoplexy,CID000004236,modafinil,C1=CC=C(C=C1)C(C2=CC=CC=C2)S(=O)CC(=O)N
CID000002978,16849-50-6,CCCCCC1=CC(=C2C3C=C(CCC3C(OC2=C1)(C)C)C)O,loss of weight,CID000005073,risperidone,CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F
CID000002978,16849-50-6,CCCCCC1=CC(=C2C3C=C(CCC3C(OC2=C1)(C)C)C)O,Amnesia,CID000003043,9-[5-(hydroxymethyl)oxolan-2-yl]-3H-purin-6-one,C1CC(OC1CO)N2C=NC3=C2NC=NC3=O
CID000002978,16849-50-6,CCCCCC1=CC(=C2C3C=C(CCC3C(OC2=C1)(C)C)C)O,loss of weight,CID003468412,SCHEMBL1176571,CC1C=CC=CCCC=CC=CC=CC=CC(CC(C(C(CC(=O)CC(C(CCC(CC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)C(=O)O)O)OC2C(C(C(C(O2)C)O)N)O
CID000003043,9-[5-(hydroxymethyl)oxolan-2-yl]-3H-purin-6-one,C1CC(OC1CO)N2C=NC3=C2NC=NC3=O,gastric inflammation,CID000004044,mefenamic acid,CC1=C(C(=CC=C1)NC2=CC=CC=C2C(=O)O)C
CID000003043,9-[5-(hydroxymethyl)oxolan-2-yl]-3H-purin-6-one,C1CC(OC1CO)N2C=NC3=C2NC=NC3=O,neumonia,CID000005645,"3,7-Dihydroxycholan-24-oic acid",CC(CCC(=O)O)C1CCC2C1(CCC3C2C(CC4C3(CCC(C4)O)C)O)C
CID000003043,9-[5-(hydroxymethyl)oxolan-2-yl]-3H-purin-6-one,C1CC(OC1CO)N2C=NC3=C2NC=NC3=O,drug toxicity NOS,CID000005978,vincristine,CCC1(CC2CC(C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)C78CCN9C7C(C=CC9)(C(C(C8N6C=O)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O
CID000003043,9-[5-(hydroxymethyl)oxolan-2-yl]-3H-purin-6-one,C1CC(OC1CO)N2C=NC3=C2NC=NC3=O,Dyspnea exertional,CID000003325,famotidine,C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N
CID000003043,9-[5-(hydroxymethyl)oxolan-2-yl]-3H-purin-6-one,C1CC(OC1CO)N2C=NC3=C2NC=NC3=O,eruption,CID000004679,pantoprazole,COC1=C(C(=NC=C1)CS(=O)C2=NC3=C(N2)C=C(C=C3)OC(F)F)OC
CID000003043,9-[5-(hydroxymethyl)oxolan-2-yl]-3H-purin-6-one,C1CC(OC1CO)N2C=NC3=C2NC=NC3=O,loss of weight,CID000003345,fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3
CID000003043,9-[5-(hydroxymethyl)oxolan-2-yl]-3H-purin-6-one,C1CC(OC1CO)N2C=NC3=C2NC=NC3=O,loss of weight,CID000004158,methylphenidate,COC(=O)C(C1CCCCN1)C2=CC=CC=C2
CID000003043,9-[5-(hydroxymethyl)oxolan-2-yl]-3H-purin-6-one,C1CC(OC1CO)N2C=NC3=C2NC=NC3=O,deglutition disorder,CID000110635,Tadalafil,CN1CC(=O)N2C(C1=O)CC3=C(C2C4=CC5=C(C=C4)OCO5)NC6=CC=CC=C36
CID000003043,9-[5-(hydroxymethyl)oxolan-2-yl]-3H-purin-6-one,C1CC(OC1CO)N2C=NC3=C2NC=NC3=O,Adenopathy,CID000003405,2-[[4-[(2-amino-4-oxo-1H-pteridin-6-yl)methylamino]benzoyl]amino]pentanedioic acid,C1=CC(=CC=C1C(=O)NC(CCC(=O)O)C(=O)O)NCC2=CN=C3C(=N2)C(=O)N=C(N3)N
CID000003043,9-[5-(hydroxymethyl)oxolan-2-yl]-3H-purin-6-one,C1CC(OC1CO)N2C=NC3=C2NC=NC3=O,Chronic Kidney Disease,CID000008953,sodium;hydrogen carbonate,C(=O)(O)[O-].[Na+]
CID000003043,9-[5-(hydroxymethyl)oxolan-2-yl]-3H-purin-6-one,C1CC(OC1CO)N2C=NC3=C2NC=NC3=O,apoplexy,CID000004585,"2-methyl-4-(4-methylpiperazin-1-yl)-5H-thieno[3,2-c][1,5]benzodiazepine",CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C
CID000003043,9-[5-(hydroxymethyl)oxolan-2-yl]-3H-purin-6-one,C1CC(OC1CO)N2C=NC3=C2NC=NC3=O,insulin dependent diabetes mellitus,CID000003937,N~2~-(1-carboxy-3-phenylpropyl)lysylproline,C1CC(N(C1)C(=O)C(CCCCN)NC(CCC2=CC=CC=C2)C(=O)O)C(=O)O
CID000003043,9-[5-(hydroxymethyl)oxolan-2-yl]-3H-purin-6-one,C1CC(OC1CO)N2C=NC3=C2NC=NC3=O,Adenopathy,CID000003676,lidocaine,CCN(CC)CC(=O)NC1=C(C=CC=C1C)C
CID000003043,9-[5-(hydroxymethyl)oxolan-2-yl]-3H-purin-6-one,C1CC(OC1CO)N2C=NC3=C2NC=NC3=O,angiitis,CID000004900,Fernisone,CC12CC(=O)C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C
CID000003043,9-[5-(hydroxymethyl)oxolan-2-yl]-3H-purin-6-one,C1CC(OC1CO)N2C=NC3=C2NC=NC3=O,myocarditis,CID000003961,losartan,CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)CO)Cl
CID000003043,9-[5-(hydroxymethyl)oxolan-2-yl]-3H-purin-6-one,C1CC(OC1CO)N2C=NC3=C2NC=NC3=O,loss of weight,CID000074989,ATOVAQUONE,C1CC(CCC1C2=CC=C(C=C2)Cl)C3=C(C4=CC=CC=C4C(=O)C3=O)O
CID000003043,9-[5-(hydroxymethyl)oxolan-2-yl]-3H-purin-6-one,C1CC(OC1CO)N2C=NC3=C2NC=NC3=O,abdominal pain upper,CID000003440,furosemide,C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl
CID000003043,9-[5-(hydroxymethyl)oxolan-2-yl]-3H-purin-6-one,C1CC(OC1CO)N2C=NC3=C2NC=NC3=O,cholecystectomies,CID000004451,CHEMBL365442,CC1=C(C=CC=C1O)C(=O)NC(CSC2=CC=CC=C2)C(CN3CC4CCCCC4CC3C(=O)NC(C)(C)C)O
CID000003043,9-[5-(hydroxymethyl)oxolan-2-yl]-3H-purin-6-one,C1CC(OC1CO)N2C=NC3=C2NC=NC3=O,cholecystectomies,CID000004173,metronidazole,CC1=NC=C(N1CCO)[N+](=O)[O-]
CID000003043,9-[5-(hydroxymethyl)oxolan-2-yl]-3H-purin-6-one,C1CC(OC1CO)N2C=NC3=C2NC=NC3=O,dysarthria,CID000062924,"S-(fluoromethyl) (6S,9R,10S,11S,13S,14S,16R,17R)-6,9-difluoro-11,17-dihydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthrene-17-carbothioate",CC1CC2C3CC(C4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)SCF)O)C)O)F)C)F
CID000003043,9-[5-(hydroxymethyl)oxolan-2-yl]-3H-purin-6-one,C1CC(OC1CO)N2C=NC3=C2NC=NC3=O,Neutropenia,CID000003414,phosphonatoformate,C(=O)([O-])P(=O)([O-])[O-]
CID000003043,9-[5-(hydroxymethyl)oxolan-2-yl]-3H-purin-6-one,C1CC(OC1CO)N2C=NC3=C2NC=NC3=O,insulin dependent diabetes mellitus,CID000003339,fenofibrate,CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C2=CC=C(C=C2)Cl
CID000003043,9-[5-(hydroxymethyl)oxolan-2-yl]-3H-purin-6-one,C1CC(OC1CO)N2C=NC3=C2NC=NC3=O,cardiovascular collapse,CID000003410,formoterol,CC(CC1=CC=C(C=C1)OC)NCC(C2=CC(=C(C=C2)O)NC=O)O
CID000003043,9-[5-(hydroxymethyl)oxolan-2-yl]-3H-purin-6-one,C1CC(OC1CO)N2C=NC3=C2NC=NC3=O,cholecystitis,CID000004691,"3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine",C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4
CID000003043,9-[5-(hydroxymethyl)oxolan-2-yl]-3H-purin-6-one,C1CC(OC1CO)N2C=NC3=C2NC=NC3=O,cholecystitis,CID000003658,hydroxyzine,C1CN(CCN1CCOCCO)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl
CID000003043,9-[5-(hydroxymethyl)oxolan-2-yl]-3H-purin-6-one,C1CC(OC1CO)N2C=NC3=C2NC=NC3=O,abnormal ECG,CID000004927,promethazine,CC(CN1C2=CC=CC=C2SC3=CC=CC=C31)N(C)C
CID000003043,9-[5-(hydroxymethyl)oxolan-2-yl]-3H-purin-6-one,C1CC(OC1CO)N2C=NC3=C2NC=NC3=O,abdominal pain upper,CID000131536,Fosamprenavir,CC(C)CN(CC(C(CC1=CC=CC=C1)NC(=O)OC2CCOC2)OP(=O)(O)O)S(=O)(=O)C3=CC=C(C=C3)N
CID000003043,9-[5-(hydroxymethyl)oxolan-2-yl]-3H-purin-6-one,C1CC(OC1CO)N2C=NC3=C2NC=NC3=O,cholecystitis,CID000004889,Pravastatin Impurity A,CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC(CC(CC(=O)O)O)O)O
CID000003043,9-[5-(hydroxymethyl)oxolan-2-yl]-3H-purin-6-one,C1CC(OC1CO)N2C=NC3=C2NC=NC3=O,cholecystitis,CID000065027,N-[3-[(1R)-1-[(2R)-6-hydroxy-4-oxo-2-(2-phenylethyl)-2-propyl-3H-pyran-5-yl]propyl]phenyl]-5-(trifluoromethyl)pyridine-2-sulfonamide,CCCC1(CC(=O)C(=C(O1)O)C(CC)C2=CC(=CC=C2)NS(=O)(=O)C3=NC=C(C=C3)C(F)(F)F)CCC4=CC=CC=C4
CID000003043,9-[5-(hydroxymethyl)oxolan-2-yl]-3H-purin-6-one,C1CC(OC1CO)N2C=NC3=C2NC=NC3=O,Hepatic failure,CID000005650,N-pentanoyl-N-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-L-valine,CCCCC(=O)N(CC1=CC=C(C=C1)C2=CC=CC=C2C3=NNN=N3)C(C(C)C)C(=O)O
CID000003043,9-[5-(hydroxymethyl)oxolan-2-yl]-3H-purin-6-one,C1CC(OC1CO)N2C=NC3=C2NC=NC3=O,High blood pressure,CID006398525,,C(C1C(C(C(C(O1)OC2(C(C(C(O2)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)COS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.[Al].[Al].[Al].[Al].[Al].[Al].[Al].[Al].[Al]
CID000003043,9-[5-(hydroxymethyl)oxolan-2-yl]-3H-purin-6-one,C1CC(OC1CO)N2C=NC3=C2NC=NC3=O,abnormal ECG,CID000004543,nortriptyline,CNCCC=C1C2=CC=CC=C2CCC3=CC=CC=C31
CID000003043,9-[5-(hydroxymethyl)oxolan-2-yl]-3H-purin-6-one,C1CC(OC1CO)N2C=NC3=C2NC=NC3=O,deglutition disorder,CID000038904,Carboplatinum,C1CC(C1)(C(=O)O)C(=O)O.N.N.[Pt]
CID000003043,9-[5-(hydroxymethyl)oxolan-2-yl]-3H-purin-6-one,C1CC(OC1CO)N2C=NC3=C2NC=NC3=O,loss of weight,CID000003198,econazole,C1=CC(=CC=C1COC(CN2C=CN=C2)C3=C(C=C(C=C3)Cl)Cl)Cl
CID000003043,9-[5-(hydroxymethyl)oxolan-2-yl]-3H-purin-6-one,C1CC(OC1CO)N2C=NC3=C2NC=NC3=O,body temperature increased,CID000004666,7-Epi Paclitaxel,CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C
CID000003043,9-[5-(hydroxymethyl)oxolan-2-yl]-3H-purin-6-one,C1CC(OC1CO)N2C=NC3=C2NC=NC3=O,cholecystectomies,CID000003706,SCHEMBL1176257,CC(C)(C)NC(=O)C1CN(CCN1CC(CC(CC2=CC=CC=C2)C(=O)NC3C(CC4=CC=CC=C34)O)O)CC5=CN=CC=C5
CID000003043,9-[5-(hydroxymethyl)oxolan-2-yl]-3H-purin-6-one,C1CC(OC1CO)N2C=NC3=C2NC=NC3=O,apoplexy,CID000005073,risperidone,CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F
CID000003043,9-[5-(hydroxymethyl)oxolan-2-yl]-3H-purin-6-one,C1CC(OC1CO)N2C=NC3=C2NC=NC3=O,neumonia,CID000003261,estazolam,C1C2=NN=CN2C3=C(C=C(C=C3)Cl)C(=N1)C4=CC=CC=C4
CID000003043,9-[5-(hydroxymethyl)oxolan-2-yl]-3H-purin-6-one,C1CC(OC1CO)N2C=NC3=C2NC=NC3=O,Bacteraemia,CID000003062,Lanicor,CC1C(C(CC(O1)OC2C(OC(CC2O)OC3C(OC(CC3O)OC4CCC5(C(C4)CCC6C5CC(C7(C6(CCC7C8=CC(=O)OC8)O)C)O)C)C)C)O)O
CID000003043,9-[5-(hydroxymethyl)oxolan-2-yl]-3H-purin-6-one,C1CC(OC1CO)N2C=NC3=C2NC=NC3=O,gastric inflammation,CID000060787,sequinavir,CC(C)(C)NC(=O)C1CC2CCCCC2CN1CC(C(CC3=CC=CC=C3)NC(=O)C(CC(=O)N)NC(=O)C4=NC5=CC=CC=C5C=C4)O
CID000003043,9-[5-(hydroxymethyl)oxolan-2-yl]-3H-purin-6-one,C1CC(OC1CO)N2C=NC3=C2NC=NC3=O,thrombocytopenia,CID000005544,Mycolog,CC12CC(C3(C(C1CC(C2(C(=O)CO)O)O)CCC4=CC(=O)C=CC43C)F)O
CID000003043,9-[5-(hydroxymethyl)oxolan-2-yl]-3H-purin-6-one,C1CC(OC1CO)N2C=NC3=C2NC=NC3=O,Adenopathy,CID000003883,lansoprazole,CC1=C(C=CN=C1CS(=O)C2=NC3=CC=CC=C3N2)OCC(F)(F)F
CID000003043,9-[5-(hydroxymethyl)oxolan-2-yl]-3H-purin-6-one,C1CC(OC1CO)N2C=NC3=C2NC=NC3=O,sleep disorder,CID000170361,Varenicline,C1C2CNCC1C3=CC4=NC=CN=C4C=C23
CID000003043,9-[5-(hydroxymethyl)oxolan-2-yl]-3H-purin-6-one,C1CC(OC1CO)N2C=NC3=C2NC=NC3=O,dysarthria,CID000004205,mirtazapine,CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4
CID000003043,9-[5-(hydroxymethyl)oxolan-2-yl]-3H-purin-6-one,C1CC(OC1CO)N2C=NC3=C2NC=NC3=O,erythema,CID000071616,Voriconazole,CC(C1=NC=NC=C1F)C(CN2C=NC=N2)(C3=C(C=C(C=C3)F)F)O
CID000003043,9-[5-(hydroxymethyl)oxolan-2-yl]-3H-purin-6-one,C1CC(OC1CO)N2C=NC3=C2NC=NC3=O,cholecystitis,CID000005732,zolpidem,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C
CID000003043,9-[5-(hydroxymethyl)oxolan-2-yl]-3H-purin-6-one,C1CC(OC1CO)N2C=NC3=C2NC=NC3=O,loss of weight,CID000019090,megestrol,CC1=CC2C(CCC3(C2CCC3(C(=O)C)O)C)C4(C1=CC(=O)CC4)C
CID000003043,9-[5-(hydroxymethyl)oxolan-2-yl]-3H-purin-6-one,C1CC(OC1CO)N2C=NC3=C2NC=NC3=O,Adenopathy,CID000004894,"11,17,21-Trihydroxypregna-1,4-diene-3,20-dione",CC12CC(C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C)O
CID000003043,9-[5-(hydroxymethyl)oxolan-2-yl]-3H-purin-6-one,C1CC(OC1CO)N2C=NC3=C2NC=NC3=O,gastric inflammation,CID000003954,loperamide(1+),CN(C)C(=O)C(CC[NH+]1CCC(CC1)(C2=CC=C(C=C2)Cl)O)(C3=CC=CC=C3)C4=CC=CC=C4
CID000003750,"4,11-diethyl-4-hydroxy-3,14-dioxo-3,4,12,14-tetrahydro-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinolin-9-yl 1,4'-bipiperidine-1'-carboxylate",CCC1=C2CN3C(=CC4=C(C3=O)COC(=O)C4(CC)O)C2=NC5=C1C=C(C=C5)OC(=O)N6CCC(CC6)N7CCCCC7,abdominal pain upper,CID000004666,7-Epi Paclitaxel,CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C
CID000003750,"4,11-diethyl-4-hydroxy-3,14-dioxo-3,4,12,14-tetrahydro-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinolin-9-yl 1,4'-bipiperidine-1'-carboxylate",CCC1=C2CN3C(=CC4=C(C3=O)COC(=O)C4(CC)O)C2=NC5=C1C=C(C=C5)OC(=O)N6CCC(CC6)N7CCCCC7,Dyspnea exertional,CID000004679,pantoprazole,COC1=C(C(=NC=C1)CS(=O)C2=NC3=C(N2)C=C(C=C3)OC(F)F)OC
CID000003750,"4,11-diethyl-4-hydroxy-3,14-dioxo-3,4,12,14-tetrahydro-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinolin-9-yl 1,4'-bipiperidine-1'-carboxylate",CCC1=C2CN3C(=CC4=C(C3=O)COC(=O)C4(CC)O)C2=NC5=C1C=C(C=C5)OC(=O)N6CCC(CC6)N7CCCCC7,apoplexy,CID000004691,"3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine",C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4
CID000003750,"4,11-diethyl-4-hydroxy-3,14-dioxo-3,4,12,14-tetrahydro-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinolin-9-yl 1,4'-bipiperidine-1'-carboxylate",CCC1=C2CN3C(=CC4=C(C3=O)COC(=O)C4(CC)O)C2=NC5=C1C=C(C=C5)OC(=O)N6CCC(CC6)N7CCCCC7,apoplexy,CID000062924,"S-(fluoromethyl) (6S,9R,10S,11S,13S,14S,16R,17R)-6,9-difluoro-11,17-dihydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthrene-17-carbothioate",CC1CC2C3CC(C4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)SCF)O)C)O)F)C)F
CID000003750,"4,11-diethyl-4-hydroxy-3,14-dioxo-3,4,12,14-tetrahydro-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinolin-9-yl 1,4'-bipiperidine-1'-carboxylate",CCC1=C2CN3C(=CC4=C(C3=O)COC(=O)C4(CC)O)C2=NC5=C1C=C(C=C5)OC(=O)N6CCC(CC6)N7CCCCC7,glossodynia,CID000004585,"2-methyl-4-(4-methylpiperazin-1-yl)-5H-thieno[3,2-c][1,5]benzodiazepine",CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C
CID000003750,"4,11-diethyl-4-hydroxy-3,14-dioxo-3,4,12,14-tetrahydro-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinolin-9-yl 1,4'-bipiperidine-1'-carboxylate",CCC1=C2CN3C(=CC4=C(C3=O)COC(=O)C4(CC)O)C2=NC5=C1C=C(C=C5)OC(=O)N6CCC(CC6)N7CCCCC7,drug toxicity NOS,CID000003937,N~2~-(1-carboxy-3-phenylpropyl)lysylproline,C1CC(N(C1)C(=O)C(CCCCN)NC(CCC2=CC=CC=C2)C(=O)O)C(=O)O
CID000003750,"4,11-diethyl-4-hydroxy-3,14-dioxo-3,4,12,14-tetrahydro-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinolin-9-yl 1,4'-bipiperidine-1'-carboxylate",CCC1=C2CN3C(=CC4=C(C3=O)COC(=O)C4(CC)O)C2=NC5=C1C=C(C=C5)OC(=O)N6CCC(CC6)N7CCCCC7,insulin dependent diabetes mellitus,CID000004889,Pravastatin Impurity A,CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC(CC(CC(=O)O)O)O)O
CID000003750,"4,11-diethyl-4-hydroxy-3,14-dioxo-3,4,12,14-tetrahydro-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinolin-9-yl 1,4'-bipiperidine-1'-carboxylate",CCC1=C2CN3C(=CC4=C(C3=O)COC(=O)C4(CC)O)C2=NC5=C1C=C(C=C5)OC(=O)N6CCC(CC6)N7CCCCC7,Extrasystoles Ventricular,CID000003954,loperamide(1+),CN(C)C(=O)C(CC[NH+]1CCC(CC1)(C2=CC=C(C=C2)Cl)O)(C3=CC=CC=C3)C4=CC=CC=C4
CID000003750,"4,11-diethyl-4-hydroxy-3,14-dioxo-3,4,12,14-tetrahydro-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinolin-9-yl 1,4'-bipiperidine-1'-carboxylate",CCC1=C2CN3C(=CC4=C(C3=O)COC(=O)C4(CC)O)C2=NC5=C1C=C(C=C5)OC(=O)N6CCC(CC6)N7CCCCC7,increased white blood cell count,CID006398525,,C(C1C(C(C(C(O1)OC2(C(C(C(O2)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)COS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.[Al].[Al].[Al].[Al].[Al].[Al].[Al].[Al].[Al]
CID000003750,"4,11-diethyl-4-hydroxy-3,14-dioxo-3,4,12,14-tetrahydro-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinolin-9-yl 1,4'-bipiperidine-1'-carboxylate",CCC1=C2CN3C(=CC4=C(C3=O)COC(=O)C4(CC)O)C2=NC5=C1C=C(C=C5)OC(=O)N6CCC(CC6)N7CCCCC7,thrombocytopenia,CID003468412,SCHEMBL1176571,CC1C=CC=CCCC=CC=CC=CC=CC(CC(C(C(CC(=O)CC(C(CCC(CC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)C(=O)O)O)OC2C(C(C(C(O2)C)O)N)O
CID000003750,"4,11-diethyl-4-hydroxy-3,14-dioxo-3,4,12,14-tetrahydro-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinolin-9-yl 1,4'-bipiperidine-1'-carboxylate",CCC1=C2CN3C(=CC4=C(C3=O)COC(=O)C4(CC)O)C2=NC5=C1C=C(C=C5)OC(=O)N6CCC(CC6)N7CCCCC7,Acne,CID000003883,lansoprazole,CC1=C(C=CN=C1CS(=O)C2=NC3=CC=CC=C3N2)OCC(F)(F)F
CID000003750,"4,11-diethyl-4-hydroxy-3,14-dioxo-3,4,12,14-tetrahydro-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinolin-9-yl 1,4'-bipiperidine-1'-carboxylate",CCC1=C2CN3C(=CC4=C(C3=O)COC(=O)C4(CC)O)C2=NC5=C1C=C(C=C5)OC(=O)N6CCC(CC6)N7CCCCC7,erythema,CID000005394,temozolomide,CN1C(=O)N2C=NC(=C2N=N1)C(=O)N
CID000003750,"4,11-diethyl-4-hydroxy-3,14-dioxo-3,4,12,14-tetrahydro-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinolin-9-yl 1,4'-bipiperidine-1'-carboxylate",CCC1=C2CN3C(=CC4=C(C3=O)COC(=O)C4(CC)O)C2=NC5=C1C=C(C=C5)OC(=O)N6CCC(CC6)N7CCCCC7,thrombocytopenia,CID000005645,"3,7-Dihydroxycholan-24-oic acid",CC(CCC(=O)O)C1CCC2C1(CCC3C2C(CC4C3(CCC(C4)O)C)O)C
CID000003750,"4,11-diethyl-4-hydroxy-3,14-dioxo-3,4,12,14-tetrahydro-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinolin-9-yl 1,4'-bipiperidine-1'-carboxylate",CCC1=C2CN3C(=CC4=C(C3=O)COC(=O)C4(CC)O)C2=NC5=C1C=C(C=C5)OC(=O)N6CCC(CC6)N7CCCCC7,deglutition disorder,CID000004510,nitroglycerin,C(C(CO[N+](=O)[O-])O[N+](=O)[O-])O[N+](=O)[O-]
CID000003750,"4,11-diethyl-4-hydroxy-3,14-dioxo-3,4,12,14-tetrahydro-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinolin-9-yl 1,4'-bipiperidine-1'-carboxylate",CCC1=C2CN3C(=CC4=C(C3=O)COC(=O)C4(CC)O)C2=NC5=C1C=C(C=C5)OC(=O)N6CCC(CC6)N7CCCCC7,insulin dependent diabetes mellitus,CID000003961,losartan,CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)CO)Cl
CID000003750,"4,11-diethyl-4-hydroxy-3,14-dioxo-3,4,12,14-tetrahydro-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinolin-9-yl 1,4'-bipiperidine-1'-carboxylate",CCC1=C2CN3C(=CC4=C(C3=O)COC(=O)C4(CC)O)C2=NC5=C1C=C(C=C5)OC(=O)N6CCC(CC6)N7CCCCC7,apoplexy,CID000005152,Salmeterol,C1=CC=C(C=C1)CCCCOCCCCCCNCC(C2=CC(=C(C=C2)O)CO)O
CID000003750,"4,11-diethyl-4-hydroxy-3,14-dioxo-3,4,12,14-tetrahydro-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinolin-9-yl 1,4'-bipiperidine-1'-carboxylate",CCC1=C2CN3C(=CC4=C(C3=O)COC(=O)C4(CC)O)C2=NC5=C1C=C(C=C5)OC(=O)N6CCC(CC6)N7CCCCC7,cellulitis,CID000004205,mirtazapine,CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4
CID000003750,"4,11-diethyl-4-hydroxy-3,14-dioxo-3,4,12,14-tetrahydro-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinolin-9-yl 1,4'-bipiperidine-1'-carboxylate",CCC1=C2CN3C(=CC4=C(C3=O)COC(=O)C4(CC)O)C2=NC5=C1C=C(C=C5)OC(=O)N6CCC(CC6)N7CCCCC7,apoplexy,CID000005732,zolpidem,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C
CID000003750,"4,11-diethyl-4-hydroxy-3,14-dioxo-3,4,12,14-tetrahydro-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinolin-9-yl 1,4'-bipiperidine-1'-carboxylate",CCC1=C2CN3C(=CC4=C(C3=O)COC(=O)C4(CC)O)C2=NC5=C1C=C(C=C5)OC(=O)N6CCC(CC6)N7CCCCC7,gastric inflammation,CID000038904,Carboplatinum,C1CC(C1)(C(=O)O)C(=O)O.N.N.[Pt]
CID000003750,"4,11-diethyl-4-hydroxy-3,14-dioxo-3,4,12,14-tetrahydro-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinolin-9-yl 1,4'-bipiperidine-1'-carboxylate",CCC1=C2CN3C(=CC4=C(C3=O)COC(=O)C4(CC)O)C2=NC5=C1C=C(C=C5)OC(=O)N6CCC(CC6)N7CCCCC7,weight gain,CID000005650,N-pentanoyl-N-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-L-valine,CCCCC(=O)N(CC1=CC=C(C=C1)C2=CC=CC=C2C3=NNN=N3)C(C(C)C)C(=O)O
CID000003750,"4,11-diethyl-4-hydroxy-3,14-dioxo-3,4,12,14-tetrahydro-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinolin-9-yl 1,4'-bipiperidine-1'-carboxylate",CCC1=C2CN3C(=CC4=C(C3=O)COC(=O)C4(CC)O)C2=NC5=C1C=C(C=C5)OC(=O)N6CCC(CC6)N7CCCCC7,abnormal EEG,CID000005978,vincristine,CCC1(CC2CC(C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)C78CCN9C7C(C=CC9)(C(C(C8N6C=O)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O
CID000003750,"4,11-diethyl-4-hydroxy-3,14-dioxo-3,4,12,14-tetrahydro-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinolin-9-yl 1,4'-bipiperidine-1'-carboxylate",CCC1=C2CN3C(=CC4=C(C3=O)COC(=O)C4(CC)O)C2=NC5=C1C=C(C=C5)OC(=O)N6CCC(CC6)N7CCCCC7,apoplexy,CID000004900,Fernisone,CC12CC(=O)C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C
CID000003750,"4,11-diethyl-4-hydroxy-3,14-dioxo-3,4,12,14-tetrahydro-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinolin-9-yl 1,4'-bipiperidine-1'-carboxylate",CCC1=C2CN3C(=CC4=C(C3=O)COC(=O)C4(CC)O)C2=NC5=C1C=C(C=C5)OC(=O)N6CCC(CC6)N7CCCCC7,Neutropenia,CID000005515,hycamptamine hydrochloride hydrate,CCC1(C2=C(COC1=O)C(=O)N3CC4=CC5=C(C=CC(=C5CN(C)C)O)N=C4C3=C2)O
CID000003750,"4,11-diethyl-4-hydroxy-3,14-dioxo-3,4,12,14-tetrahydro-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinolin-9-yl 1,4'-bipiperidine-1'-carboxylate",CCC1=C2CN3C(=CC4=C(C3=O)COC(=O)C4(CC)O)C2=NC5=C1C=C(C=C5)OC(=O)N6CCC(CC6)N7CCCCC7,Excess potassium,CID000019090,megestrol,CC1=CC2C(CCC3(C2CCC3(C(=O)C)O)C)C4(C1=CC(=O)CC4)C
CID000003750,"4,11-diethyl-4-hydroxy-3,14-dioxo-3,4,12,14-tetrahydro-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinolin-9-yl 1,4'-bipiperidine-1'-carboxylate",CCC1=C2CN3C(=CC4=C(C3=O)COC(=O)C4(CC)O)C2=NC5=C1C=C(C=C5)OC(=O)N6CCC(CC6)N7CCCCC7,mouth ulcer,CID000005544,Mycolog,CC12CC(C3(C(C1CC(C2(C(=O)CO)O)O)CCC4=CC(=O)C=CC43C)F)O
CID000003750,"4,11-diethyl-4-hydroxy-3,14-dioxo-3,4,12,14-tetrahydro-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinolin-9-yl 1,4'-bipiperidine-1'-carboxylate",CCC1=C2CN3C(=CC4=C(C3=O)COC(=O)C4(CC)O)C2=NC5=C1C=C(C=C5)OC(=O)N6CCC(CC6)N7CCCCC7,increased white blood cell count,CID000004927,promethazine,CC(CN1C2=CC=CC=C2SC3=CC=CC=C31)N(C)C
CID000003750,"4,11-diethyl-4-hydroxy-3,14-dioxo-3,4,12,14-tetrahydro-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinolin-9-yl 1,4'-bipiperidine-1'-carboxylate",CCC1=C2CN3C(=CC4=C(C3=O)COC(=O)C4(CC)O)C2=NC5=C1C=C(C=C5)OC(=O)N6CCC(CC6)N7CCCCC7,right heart failure,CID000004894,"11,17,21-Trihydroxypregna-1,4-diene-3,20-dione",CC12CC(C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C)O
CID000003750,"4,11-diethyl-4-hydroxy-3,14-dioxo-3,4,12,14-tetrahydro-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinolin-9-yl 1,4'-bipiperidine-1'-carboxylate",CCC1=C2CN3C(=CC4=C(C3=O)COC(=O)C4(CC)O)C2=NC5=C1C=C(C=C5)OC(=O)N6CCC(CC6)N7CCCCC7,haemorrhoids,CID000004236,modafinil,C1=CC=C(C=C1)C(C2=CC=CC=C2)S(=O)CC(=O)N
CID000003750,"4,11-diethyl-4-hydroxy-3,14-dioxo-3,4,12,14-tetrahydro-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinolin-9-yl 1,4'-bipiperidine-1'-carboxylate",CCC1=C2CN3C(=CC4=C(C3=O)COC(=O)C4(CC)O)C2=NC5=C1C=C(C=C5)OC(=O)N6CCC(CC6)N7CCCCC7,gastric inflammation,CID005311048,SCHEMBL11440306,C(N)(N)(Cl)Cl
CID000003750,"4,11-diethyl-4-hydroxy-3,14-dioxo-3,4,12,14-tetrahydro-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinolin-9-yl 1,4'-bipiperidine-1'-carboxylate",CCC1=C2CN3C(=CC4=C(C3=O)COC(=O)C4(CC)O)C2=NC5=C1C=C(C=C5)OC(=O)N6CCC(CC6)N7CCCCC7,lung infiltration,CID000005512,124936-74-9,CC1=CC(=C(C=C1)O)C(CCN(C(C)C)C(C)C)C2=CC=CC=C2
CID000003750,"4,11-diethyl-4-hydroxy-3,14-dioxo-3,4,12,14-tetrahydro-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinolin-9-yl 1,4'-bipiperidine-1'-carboxylate",CCC1=C2CN3C(=CC4=C(C3=O)COC(=O)C4(CC)O)C2=NC5=C1C=C(C=C5)OC(=O)N6CCC(CC6)N7CCCCC7,loss of weight,CID000004173,metronidazole,CC1=NC=C(N1CCO)[N+](=O)[O-]
CID005311048,SCHEMBL11440306,C(N)(N)(Cl)Cl,cholecystitis,CID006398525,,C(C1C(C(C(C(O1)OC2(C(C(C(O2)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)COS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.[Al].[Al].[Al].[Al].[Al].[Al].[Al].[Al].[Al]
CID000038904,Carboplatinum,C1CC(C1)(C(=O)O)C(=O)O.N.N.[Pt],gastroenteritis viral,CID000062924,"S-(fluoromethyl) (6S,9R,10S,11S,13S,14S,16R,17R)-6,9-difluoro-11,17-dihydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthrene-17-carbothioate",CC1CC2C3CC(C4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)SCF)O)C)O)F)C)F
CID000038904,Carboplatinum,C1CC(C1)(C(=O)O)C(=O)O.N.N.[Pt],eruption,CID000060184,"2'-epi-Perindopril, (2'R)-",CCCC(C(=O)OCC)NC(C)C(=O)N1C2CCCCC2CC1C(=O)O
CID000038904,Carboplatinum,C1CC(C1)(C(=O)O)C(=O)O.N.N.[Pt],paronychia,CID006398525,,C(C1C(C(C(C(O1)OC2(C(C(C(O2)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)COS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.[Al].[Al].[Al].[Al].[Al].[Al].[Al].[Al].[Al]
CID000038904,Carboplatinum,C1CC(C1)(C(=O)O)C(=O)O.N.N.[Pt],thrombocytopenia,CID000163742,SCHEMBL1650579,COC1C(C(C(C(O1)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)COS(=O)(=O)O)OC4C(C(C(C(O4)C(=O)O)OC5C(C(C(C(O5)COS(=O)(=O)O)O)O)NS(=O)(=O)O)O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O)NS(=O)(=O)O
CID000038904,Carboplatinum,C1CC(C1)(C(=O)O)C(=O)O.N.N.[Pt],loss of weight,CID000152945,Dutasteride?,CC12CCC3C(C1CCC2C(=O)NC4=C(C=CC(=C4)C(F)(F)F)C(F)(F)F)CCC5C3(C=CC(=O)N5)C
CID000038904,Carboplatinum,C1CC(C1)(C(=O)O)C(=O)O.N.N.[Pt],loss of weight,CID003468412,SCHEMBL1176571,CC1C=CC=CCCC=CC=CC=CC=CC(CC(C(C(CC(=O)CC(C(CCC(CC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)C(=O)O)O)OC2C(C(C(C(O2)C)O)N)O
CID000038904,Carboplatinum,C1CC(C1)(C(=O)O)C(=O)O.N.N.[Pt],deglutition disorder,CID000060787,sequinavir,CC(C)(C)NC(=O)C1CC2CCCCC2CN1CC(C(CC3=CC=CC=C3)NC(=O)C(CC(=O)N)NC(=O)C4=NC5=CC=CC=C5C=C4)O
CID000038904,Carboplatinum,C1CC(C1)(C(=O)O)C(=O)O.N.N.[Pt],Arrhythmia,CID000170361,Varenicline,C1C2CNCC1C3=CC4=NC=CN=C4C=C23
CID000002578,carmustine,C(CCl)NC(=O)N(CCCl)N=O,Small intestinal obstruction,CID000003075,"2-[3-acetyloxy-2-(4-methoxyphenyl)-4-oxo-2,3-dihydro-1,5-benzothiazepin-5-yl]ethyl-dimethylazanium",CC(=O)OC1C(SC2=CC=CC=C2N(C1=O)CC[NH+](C)C)C3=CC=C(C=C3)OC
CID000002578,carmustine,C(CCl)NC(=O)N(CCCl)N=O,Adenopathy,CID000004894,"11,17,21-Trihydroxypregna-1,4-diene-3,20-dione",CC12CC(C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C)O
CID000002578,carmustine,C(CCl)NC(=O)N(CCCl)N=O,cholelithiasis,CID000004205,mirtazapine,CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4
CID000002578,carmustine,C(CCl)NC(=O)N(CCCl)N=O,thrombocytopenia,CID000005376,(E/Z)-Tamoxifen,CCC(=C(C1=CC=CC=C1)C2=CC=C(C=C2)OCCN(C)C)C3=CC=CC=C3
CID000002578,carmustine,C(CCl)NC(=O)N(CCCl)N=O,eruption,CID000003325,famotidine,C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N
CID000002578,carmustine,C(CCl)NC(=O)N(CCCl)N=O,deglutition disorder,CID000004691,"3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine",C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4
CID000002578,carmustine,C(CCl)NC(=O)N(CCCl)N=O,loss of weight,CID000002656,"7-[[2-(2-amino-1,3-thiazol-4-yl)-2-methoxyiminoacetyl]amino]-3-[(2-methyl-6-oxido-5-oxo-1,2,4-triazin-3-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CN1C(=NC(=O)C(=N1)[O-])SCC2=C(N3C(C(C3=O)NC(=O)C(=NOC)C4=CSC(=N4)N)SC2)C(=O)[O-]
CID000002578,carmustine,C(CCl)NC(=O)N(CCCl)N=O,confusion,CID000003883,lansoprazole,CC1=C(C=CN=C1CS(=O)C2=NC3=CC=CC=C3N2)OCC(F)(F)F
CID000002578,carmustine,C(CCl)NC(=O)N(CCCl)N=O,gastric inflammation,CID000003310,33419-42-0,CC1OCC2C(O1)C(C(C(O2)OC3C4COC(=O)C4C(C5=CC6=C(C=C35)OCO6)C7=CC(=C(C(=C7)OC)O)OC)O)O
CID000002578,carmustine,C(CCl)NC(=O)N(CCCl)N=O,eruption,CID000071616,Voriconazole,CC(C1=NC=NC=C1F)C(CN2C=NC=N2)(C3=C(C=C(C=C3)F)F)O
CID000002578,carmustine,C(CCl)NC(=O)N(CCCl)N=O,drug toxicity NOS,CID000147912,DSSTox_GSID_49066,CCC(C(C)O)N1C(=O)N(C=N1)C2=CC=C(C=C2)N3CCN(CC3)C4=CC=C(C=C4)OCC5CC(OC5)(CN6C=NC=N6)C7=C(C=C(C=C7)F)F
CID000002578,carmustine,C(CCl)NC(=O)N(CCCl)N=O,angiitis,CID000005978,vincristine,CCC1(CC2CC(C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)C78CCN9C7C(C=CC9)(C(C(C8N6C=O)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O
CID000002578,carmustine,C(CCl)NC(=O)N(CCCl)N=O,myelodysplasia,CID000004900,Fernisone,CC12CC(=O)C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C
CID000002578,carmustine,C(CCl)NC(=O)N(CCCl)N=O,Bacteraemia,CID000003345,fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3
CID000002578,carmustine,C(CCl)NC(=O)N(CCCl)N=O,Bacteraemia,CID000003954,loperamide(1+),CN(C)C(=O)C(CC[NH+]1CCC(CC1)(C2=CC=C(C=C2)Cl)O)(C3=CC=CC=C3)C4=CC=CC=C4
CID000002578,carmustine,C(CCl)NC(=O)N(CCCl)N=O,gastroenteritis viral,CID000002771,citalopram,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F
CID000002578,carmustine,C(CCl)NC(=O)N(CCCl)N=O,atelectasis,CID000003405,2-[[4-[(2-amino-4-oxo-1H-pteridin-6-yl)methylamino]benzoyl]amino]pentanedioic acid,C1=CC(=CC=C1C(=O)NC(CCC(=O)O)C(=O)O)NCC2=CN=C3C(=N2)C(=O)N=C(N3)N
CID000002578,carmustine,C(CCl)NC(=O)N(CCCl)N=O,Bacteraemia,CID000004173,metronidazole,CC1=NC=C(N1CCO)[N+](=O)[O-]
CID000002578,carmustine,C(CCl)NC(=O)N(CCCl)N=O,thrombocytopenia,CID000004666,7-Epi Paclitaxel,CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C
CID000002578,carmustine,C(CCl)NC(=O)N(CCCl)N=O,angiitis,CID000060184,"2'-epi-Perindopril, (2'R)-",CCCC(C(=O)OCC)NC(C)C(=O)N1C2CCCCC2CC1C(=O)O
CID000002578,carmustine,C(CCl)NC(=O)N(CCCl)N=O,increased white blood cell count,CID000005073,risperidone,CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F
CID000002578,carmustine,C(CCl)NC(=O)N(CCCl)N=O,erythema,CID000003937,N~2~-(1-carboxy-3-phenylpropyl)lysylproline,C1CC(N(C1)C(=O)C(CCCCN)NC(CCC2=CC=CC=C2)C(=O)O)C(=O)O
CID000002578,carmustine,C(CCl)NC(=O)N(CCCl)N=O,aspiration pneumonia,CID000005732,zolpidem,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C
CID000002578,carmustine,C(CCl)NC(=O)N(CCCl)N=O,abnormal ECG,CID000003440,furosemide,C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl
CID000002578,carmustine,C(CCl)NC(=O)N(CCCl)N=O,angiitis,CID000002907,cyclophosphamide,C1CNP(=O)(OC1)N(CCCl)CCCl
CID000002578,carmustine,C(CCl)NC(=O)N(CCCl)N=O,respiratory alkalosis,CID000005394,temozolomide,CN1C(=O)N2C=NC(=C2N=N1)C(=O)N
CID000002578,carmustine,C(CCl)NC(=O)N(CCCl)N=O,Sinus headache,CID000004679,pantoprazole,COC1=C(C(=NC=C1)CS(=O)C2=NC3=C(N2)C=C(C=C3)OC(F)F)OC
CID000005077,105601-20-5,CCN(C)C(=O)OC1=CC=CC(=C1)C(C)N(C)C,deglutition disorder,CID000005095,ropinirole,CCCN(CCC)CCC1=C2CC(=O)NC2=CC=C1
CID000005077,105601-20-5,CCN(C)C(=O)OC1=CC=CC(=C1)C(C)N(C)C,loss of weight,CID000122316,1875-50-9,C#CCNC1CCC2=CC=CC=C12
CID000005077,105601-20-5,CCN(C)C(=O)OC1=CC=CC(=C1)C(C)N(C)C,elevated cholesterol,CID000005478,racemic-Timolol,CC(C)(C)NCC(COC1=NSN=C1N2CCOCC2)O
CID000005077,105601-20-5,CCN(C)C(=O)OC1=CC=CC(=C1)C(C)N(C)C,apoplexy,CID000005732,zolpidem,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C
CID000005077,105601-20-5,CCN(C)C(=O)OC1=CC=CC(=C1)C(C)N(C)C,hyperglycaemia,CID000057537,92206-54-7,CCCN(CCC1=CC=CS1)C2CCC3=C(C2)C=CC=C3O
CID000005077,105601-20-5,CCN(C)C(=O)OC1=CC=CC(=C1)C(C)N(C)C,loss of weight,CID000005650,N-pentanoyl-N-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-L-valine,CCCCC(=O)N(CC1=CC=C(C=C1)C2=CC=CC=C2C3=NNN=N3)C(C(C)C)C(=O)O
CID000005077,105601-20-5,CCN(C)C(=O)OC1=CC=CC(=C1)C(C)N(C)C,abnormal ECG,CID000005512,124936-74-9,CC1=CC(=C(C=C1)O)C(CCN(C(C)C)C(C)C)C2=CC=CC=C2
CID000005077,105601-20-5,CCN(C)C(=O)OC1=CC=CC(=C1)C(C)N(C)C,apoplexy,CID000060852,Ibandronic Acid,CCCCCN(C)CCC(O)(P(=O)(O)O)P(=O)(O)O
CID000005077,105601-20-5,CCN(C)C(=O)OC1=CC=CC(=C1)C(C)N(C)C,loss of weight,CID000060854,Ziprasidone,C1CN(CCN1CCC2=C(C=C3C(=C2)CC(=O)N3)Cl)C4=NSC5=CC=CC=C54
CID000005077,105601-20-5,CCN(C)C(=O)OC1=CC=CC(=C1)C(C)N(C)C,agitated,CID000062924,"S-(fluoromethyl) (6S,9R,10S,11S,13S,14S,16R,17R)-6,9-difluoro-11,17-dihydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthrene-17-carbothioate",CC1CC2C3CC(C4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)SCF)O)C)O)F)C)F
CID000005077,105601-20-5,CCN(C)C(=O)OC1=CC=CC(=C1)C(C)N(C)C,muscle weakness,CID000152945,Dutasteride?,CC12CCC3C(C1CCC2C(=O)NC4=C(C=CC(=C4)C(F)(F)F)C(F)(F)F)CCC5C3(C=CC(=O)N5)C
CID000005077,105601-20-5,CCN(C)C(=O)OC1=CC=CC(=C1)C(C)N(C)C,apoplexy,CID000005245,Risedronic acid,C1=CC(=CN=C1)CC(O)(P(=O)(O)O)P(=O)(O)O
CID000005077,105601-20-5,CCN(C)C(=O)OC1=CC=CC(=C1)C(C)N(C)C,apoplexy,CID000019090,megestrol,CC1=CC2C(CCC3(C2CCC3(C(=O)C)O)C)C4(C1=CC(=O)CC4)C
CID000008953,sodium;hydrogen carbonate,C(=O)(O)[O-].[Na+],heart attack,CID000051263,ALFENTANIL,CCC(=O)N(C1=CC=CC=C1)C2(CCN(CC2)CCN3C(=O)N(N=N3)CC)COC
CID000008953,sodium;hydrogen carbonate,C(=O)(O)[O-].[Na+],acute pancreatitis,CID000071616,Voriconazole,CC(C1=NC=NC=C1F)C(CN2C=NC=N2)(C3=C(C=C(C=C3)F)F)O
CID000008953,sodium;hydrogen carbonate,C(=O)(O)[O-].[Na+],allergic dermatitis,CID000060754,Gadodiamide hydrate,CNC(=O)CN(CCN(CCN(CC(=O)NC)CC(=O)[O-])CC(=O)[O-])CC(=O)[O-].O.[Gd+3]
CID000008953,sodium;hydrogen carbonate,C(=O)(O)[O-].[Na+],atelectasis,CID000062924,"S-(fluoromethyl) (6S,9R,10S,11S,13S,14S,16R,17R)-6,9-difluoro-11,17-dihydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthrene-17-carbothioate",CC1CC2C3CC(C4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)SCF)O)C)O)F)C)F
CID000008953,sodium;hydrogen carbonate,C(=O)(O)[O-].[Na+],nasopharyngitis,CID000039765,Vecuronium,CC(=O)OC1CC2CCC3C(C2(CC1N4CCCCC4)C)CCC5(C3CC(C5OC(=O)C)[N+]6(CCCCC6)C)C
CID000008953,sodium;hydrogen carbonate,C(=O)(O)[O-].[Na+],Excoriation,CID000667490,6-Mercaptopurine,C1=NC2=C(N1)C(=S)N=CN2
CID000008953,sodium;hydrogen carbonate,C(=O)(O)[O-].[Na+],gastric inflammation,CID000019090,megestrol,CC1=CC2C(CCC3(C2CCC3(C(=O)C)O)C)C4(C1=CC(=O)CC4)C
CID000008953,sodium;hydrogen carbonate,C(=O)(O)[O-].[Na+],abnormal ECG,CID003468412,SCHEMBL1176571,CC1C=CC=CCCC=CC=CC=CC=CC(CC(C(C(CC(=O)CC(C(CCC(CC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)C(=O)O)O)OC2C(C(C(C(O2)C)O)N)O
CID000008953,sodium;hydrogen carbonate,C(=O)(O)[O-].[Na+],itch,CID000147912,DSSTox_GSID_49066,CCC(C(C)O)N1C(=O)N(C=N1)C2=CC=C(C=C2)N3CCN(CC3)C4=CC=C(C=C4)OCC5CC(OC5)(CN6C=NC=N6)C7=C(C=C(C=C7)F)F
CID000008953,sodium;hydrogen carbonate,C(=O)(O)[O-].[Na+],gastric inflammation,CID000036339,Etomidate,CCOC(=O)C1=CN=CN1C(C)C2=CC=CC=C2
CID000008953,sodium;hydrogen carbonate,C(=O)(O)[O-].[Na+],deglutition disorder,CID000036811,dobutamine,CC(CCC1=CC=C(C=C1)O)NCCC2=CC(=C(C=C2)O)O
CID000008953,sodium;hydrogen carbonate,C(=O)(O)[O-].[Na+],Pain,CID000074989,ATOVAQUONE,C1CC(CCC1C2=CC=C(C=C2)Cl)C3=C(C4=CC=CC=C4C(=O)C3=O)O
CID000008953,sodium;hydrogen carbonate,C(=O)(O)[O-].[Na+],Back Ache,CID006398525,,C(C1C(C(C(C(O1)OC2(C(C(C(O2)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)COS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.[Al].[Al].[Al].[Al].[Al].[Al].[Al].[Al].[Al]
CID000004064,meprobamate,CCCC(C)(COC(=O)N)COC(=O)N,gastroenteritis,CID000004585,"2-methyl-4-(4-methylpiperazin-1-yl)-5H-thieno[3,2-c][1,5]benzodiazepine",CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C
CID000004064,meprobamate,CCCC(C)(COC(=O)N)COC(=O)N,atelectasis,CID000004927,promethazine,CC(CN1C2=CC=CC=C2SC3=CC=CC=C31)N(C)C
CID000004064,meprobamate,CCCC(C)(COC(=O)N)COC(=O)N,abnormal ECG,CID000004205,mirtazapine,CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4
CID000004064,meprobamate,CCCC(C)(COC(=O)N)COC(=O)N,apoplexy,CID000004691,"3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine",C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4
CID000004064,meprobamate,CCCC(C)(COC(=O)N)COC(=O)N,road traffic accident,CID000005732,zolpidem,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C
CID000004064,meprobamate,CCCC(C)(COC(=O)N)COC(=O)N,abnormal EEG,CID000004900,Fernisone,CC12CC(=O)C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C
CID000004064,meprobamate,CCCC(C)(COC(=O)N)COC(=O)N,icterus,CID000005073,risperidone,CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F
CID000002720,chlorothiazide,C1=C2C(=CC(=C1Cl)S(=O)(=O)N)S(=O)(=O)N=CN2,dysarthria,CID000003062,Lanicor,CC1C(C(CC(O1)OC2C(OC(CC2O)OC3C(OC(CC3O)OC4CCC5(C(C4)CCC6C5CC(C7(C6(CCC7C8=CC(=O)OC8)O)C)O)C)C)C)O)O
CID000002720,chlorothiazide,C1=C2C(=CC(=C1Cl)S(=O)(=O)N)S(=O)(=O)N=CN2,atelectasis,CID003468412,SCHEMBL1176571,CC1C=CC=CCCC=CC=CC=CC=CC(CC(C(C(CC(=O)CC(C(CCC(CC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)C(=O)O)O)OC2C(C(C(C(O2)C)O)N)O
CID000002720,chlorothiazide,C1=C2C(=CC(=C1Cl)S(=O)(=O)N)S(=O)(=O)N=CN2,diaphragmatic hernia,CID000004691,"3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine",C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4
CID000002720,chlorothiazide,C1=C2C(=CC(=C1Cl)S(=O)(=O)N)S(=O)(=O)N=CN2,drug toxicity NOS,CID000003440,furosemide,C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl
CID000002720,chlorothiazide,C1=C2C(=CC(=C1Cl)S(=O)(=O)N)S(=O)(=O)N=CN2,brain neoplasm,CID000005771,Oxytocin acetate salt hydrate,CCC(C)C1C(=O)NC(C(=O)NC(C(=O)NC(CSSCC(C(=O)NC(C(=O)N1)CC2=CC=C(C=C2)O)N)C(=O)N3CCCC3C(=O)NC(CC(C)C)C(=O)NCC(=O)N)CC(=O)N)CCC(=O)N
CID000002720,chlorothiazide,C1=C2C(=CC(=C1Cl)S(=O)(=O)N)S(=O)(=O)N=CN2,diaphragmatic hernia,CID000003325,famotidine,C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N
CID000002720,chlorothiazide,C1=C2C(=CC(=C1Cl)S(=O)(=O)N)S(=O)(=O)N=CN2,cellulitis,CID000004900,Fernisone,CC12CC(=O)C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C
CID000002720,chlorothiazide,C1=C2C(=CC(=C1Cl)S(=O)(=O)N)S(=O)(=O)N=CN2,loss of weight,CID000003075,"2-[3-acetyloxy-2-(4-methoxyphenyl)-4-oxo-2,3-dihydro-1,5-benzothiazepin-5-yl]ethyl-dimethylazanium",CC(=O)OC1C(SC2=CC=CC=C2N(C1=O)CC[NH+](C)C)C3=CC=C(C=C3)OC
CID000002720,chlorothiazide,C1=C2C(=CC(=C1Cl)S(=O)(=O)N)S(=O)(=O)N=CN2,gastric inflammation,CID000003345,fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3
CID000002720,chlorothiazide,C1=C2C(=CC(=C1Cl)S(=O)(=O)N)S(=O)(=O)N=CN2,loss of weight,CID000004173,metronidazole,CC1=NC=C(N1CCO)[N+](=O)[O-]
CID000002720,chlorothiazide,C1=C2C(=CC(=C1Cl)S(=O)(=O)N)S(=O)(=O)N=CN2,Bladder inflammation,CID000062924,"S-(fluoromethyl) (6S,9R,10S,11S,13S,14S,16R,17R)-6,9-difluoro-11,17-dihydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthrene-17-carbothioate",CC1CC2C3CC(C4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)SCF)O)C)O)F)C)F
CID000002720,chlorothiazide,C1=C2C(=CC(=C1Cl)S(=O)(=O)N)S(=O)(=O)N=CN2,diaphragmatic hernia,CID000003883,lansoprazole,CC1=C(C=CN=C1CS(=O)C2=NC3=CC=CC=C3N2)OCC(F)(F)F
CID000002720,chlorothiazide,C1=C2C(=CC(=C1Cl)S(=O)(=O)N)S(=O)(=O)N=CN2,elevated cholesterol,CID000003937,N~2~-(1-carboxy-3-phenylpropyl)lysylproline,C1CC(N(C1)C(=O)C(CCCCN)NC(CCC2=CC=CC=C2)C(=O)O)C(=O)O
CID000002720,chlorothiazide,C1=C2C(=CC(=C1Cl)S(=O)(=O)N)S(=O)(=O)N=CN2,Pleural Effusion,CID000003405,2-[[4-[(2-amino-4-oxo-1H-pteridin-6-yl)methylamino]benzoyl]amino]pentanedioic acid,C1=CC(=CC=C1C(=O)NC(CCC(=O)O)C(=O)O)NCC2=CN=C3C(=N2)C(=O)N=C(N3)N
CID000002720,chlorothiazide,C1=C2C(=CC(=C1Cl)S(=O)(=O)N)S(=O)(=O)N=CN2,apoplexy,CID000004585,"2-methyl-4-(4-methylpiperazin-1-yl)-5H-thieno[3,2-c][1,5]benzodiazepine",CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C
CID000002720,chlorothiazide,C1=C2C(=CC(=C1Cl)S(=O)(=O)N)S(=O)(=O)N=CN2,apoplexy,CID000002771,citalopram,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F
CID000002720,chlorothiazide,C1=C2C(=CC(=C1Cl)S(=O)(=O)N)S(=O)(=O)N=CN2,thrombocytopenia,CID000004679,pantoprazole,COC1=C(C(=NC=C1)CS(=O)C2=NC3=C(N2)C=C(C=C3)OC(F)F)OC
CID000002153,theophylline,CN1C2=C(C(=O)N(C1=O)C)NC=N2,cholecystitis,CID000005650,N-pentanoyl-N-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-L-valine,CCCCC(=O)N(CC1=CC=C(C=C1)C2=CC=CC=C2C3=NNN=N3)C(C(C)C)C(=O)O
CID000002153,theophylline,CN1C2=C(C(=O)N(C1=O)C)NC=N2,cholecystitis,CID000005487,tizanidine,C1CN=C(N1)NC2=C(C=CC3=NSN=C32)Cl
CID000002153,theophylline,CN1C2=C(C(=O)N(C1=O)C)NC=N2,cholecystitis,CID000002462,51372-29-3,CCCC1OC2CC3C4CCC5=CC(=O)C=CC5(C4C(CC3(C2(O1)C(=O)CO)C)O)C
CID000002153,theophylline,CN1C2=C(C(=O)N(C1=O)C)NC=N2,abnormal ECG,CID000005245,Risedronic acid,C1=CC(=CN=C1)CC(O)(P(=O)(O)O)P(=O)(O)O
CID000002153,theophylline,CN1C2=C(C(=O)N(C1=O)C)NC=N2,atelectasis,CID000002656,"7-[[2-(2-amino-1,3-thiazol-4-yl)-2-methoxyiminoacetyl]amino]-3-[(2-methyl-6-oxido-5-oxo-1,2,4-triazin-3-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CN1C(=NC(=O)C(=N1)[O-])SCC2=C(N3C(C(C3=O)NC(=O)C(=NOC)C4=CSC(=N4)N)SC2)C(=O)[O-]
CID000002153,theophylline,CN1C2=C(C(=O)N(C1=O)C)NC=N2,gout,CID000004894,"11,17,21-Trihydroxypregna-1,4-diene-3,20-dione",CC12CC(C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C)O
CID000002153,theophylline,CN1C2=C(C(=O)N(C1=O)C)NC=N2,apoplexy,CID000003405,2-[[4-[(2-amino-4-oxo-1H-pteridin-6-yl)methylamino]benzoyl]amino]pentanedioic acid,C1=CC(=CC=C1C(=O)NC(CCC(=O)O)C(=O)O)NCC2=CN=C3C(=N2)C(=O)N=C(N3)N
CID000002153,theophylline,CN1C2=C(C(=O)N(C1=O)C)NC=N2,loss of weight,CID000003676,lidocaine,CCN(CC)CC(=O)NC1=C(C=CC=C1C)C
CID000002153,theophylline,CN1C2=C(C(=O)N(C1=O)C)NC=N2,apoplexy,CID000005358,sumatriptan,CNS(=O)(=O)CC1=CC2=C(C=C1)NC=C2CCN(C)C
CID000002153,theophylline,CN1C2=C(C(=O)N(C1=O)C)NC=N2,respiratory alkalosis,CID000003780,"D-Glucitol, 1,4:3,6-dianhydro-, 2,5-dinitrate",C1C(C2C(O1)C(CO2)O[N+](=O)[O-])O[N+](=O)[O-]
CID000002153,theophylline,CN1C2=C(C(=O)N(C1=O)C)NC=N2,apoplexy,CID000003333,felodipine,CCOC(=O)C1=C(NC(=C(C1C2=C(C(=CC=C2)Cl)Cl)C(=O)OC)C)C
CID000002153,theophylline,CN1C2=C(C(=O)N(C1=O)C)NC=N2,gastric inflammation,CID000003339,fenofibrate,CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C2=CC=C(C=C2)Cl
CID000002153,theophylline,CN1C2=C(C(=O)N(C1=O)C)NC=N2,apoplexy,CID000002806,90055-48-4,COC(=O)C(C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3
CID000002153,theophylline,CN1C2=C(C(=O)N(C1=O)C)NC=N2,apoplexy,CID000002803,clonidine,C1CN=C(N1)NC2=C(C=CC=C2Cl)Cl
CID000002153,theophylline,CN1C2=C(C(=O)N(C1=O)C)NC=N2,gastric inflammation,CID000002405,BISOPROLOL,CC(C)NCC(COC1=CC=C(C=C1)COCCOC(C)C)O
CID000002153,theophylline,CN1C2=C(C(=O)N(C1=O)C)NC=N2,myelodysplasia,CID000004889,Pravastatin Impurity A,CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC(CC(CC(=O)O)O)O)O
CID000002153,theophylline,CN1C2=C(C(=O)N(C1=O)C)NC=N2,cholecystitis,CID000004927,promethazine,CC(CN1C2=CC=CC=C2SC3=CC=CC=C31)N(C)C
CID000002153,theophylline,CN1C2=C(C(=O)N(C1=O)C)NC=N2,gastric inflammation,CID000002771,citalopram,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F
CID000002153,theophylline,CN1C2=C(C(=O)N(C1=O)C)NC=N2,gastric inflammation,CID000003345,fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3
CID000002153,theophylline,CN1C2=C(C(=O)N(C1=O)C)NC=N2,apoplexy,CID000003890,TRANS (15S)-LATANOPROST,CC(C)OC(=O)CCCC=CCC1C(CC(C1CCC(CCC2=CC=CC=C2)O)O)O
CID000002153,theophylline,CN1C2=C(C(=O)N(C1=O)C)NC=N2,hypochloraemia,CID000005073,risperidone,CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F
CID000002153,theophylline,CN1C2=C(C(=O)N(C1=O)C)NC=N2,cholecystitis,CID000002541,candesartan,CCOC1=NC2=CC=CC(=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5)C(=O)O
CID000002153,theophylline,CN1C2=C(C(=O)N(C1=O)C)NC=N2,gastric inflammation,CID000003516,guaifenesin,COC1=CC=CC=C1OCC(CO)O
CID000002153,theophylline,CN1C2=C(C(=O)N(C1=O)C)NC=N2,cholecystitis,CID000005732,zolpidem,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C
CID000002153,theophylline,CN1C2=C(C(=O)N(C1=O)C)NC=N2,allergic dermatitis,CID000003410,formoterol,CC(CC1=CC=C(C=C1)OC)NCC(C2=CC(=C(C=C2)O)NC=O)O
CID000002153,theophylline,CN1C2=C(C(=O)N(C1=O)C)NC=N2,malnourished,CID000003062,Lanicor,CC1C(C(CC(O1)OC2C(OC(CC2O)OC3C(OC(CC3O)OC4CCC5(C(C4)CCC6C5CC(C7(C6(CCC7C8=CC(=O)OC8)O)C)O)C)C)C)O)O
CID000002153,theophylline,CN1C2=C(C(=O)N(C1=O)C)NC=N2,gastric inflammation,CID000005512,124936-74-9,CC1=CC(=C(C=C1)O)C(CCN(C(C)C)C(C)C)C2=CC=CC=C2
CID000002153,theophylline,CN1C2=C(C(=O)N(C1=O)C)NC=N2,back injury,CID000003325,famotidine,C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N
CID000002153,theophylline,CN1C2=C(C(=O)N(C1=O)C)NC=N2,eruption,CID000003827,ketotifen,CN1CCC(=C2C3=C(C(=O)CC4=CC=CC=C42)SC=C3)CC1
CID000002153,theophylline,CN1C2=C(C(=O)N(C1=O)C)NC=N2,cholecystitis,CID000004691,"3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine",C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4
CID000002153,theophylline,CN1C2=C(C(=O)N(C1=O)C)NC=N2,respiratory alkalosis,CID000004679,pantoprazole,COC1=C(C(=NC=C1)CS(=O)C2=NC3=C(N2)C=C(C=C3)OC(F)F)OC
CID000002153,theophylline,CN1C2=C(C(=O)N(C1=O)C)NC=N2,stridor,CID000003440,furosemide,C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl
CID000002153,theophylline,CN1C2=C(C(=O)N(C1=O)C)NC=N2,apoplexy,CID000005152,Salmeterol,C1=CC=C(C=C1)CCCCOCCCCCCNCC(C2=CC(=C(C=C2)O)CO)O
CID000002153,theophylline,CN1C2=C(C(=O)N(C1=O)C)NC=N2,gastric inflammation,CID000005544,Mycolog,CC12CC(C3(C(C1CC(C2(C(=O)CO)O)O)CCC4=CC(=O)C=CC43C)F)O
CID000002153,theophylline,CN1C2=C(C(=O)N(C1=O)C)NC=N2,angiitis,CID000002550,1-(2-methyl-3-sulfanylpropanoyl)pyrrolidine-2-carboxylic acid,CC(CS)C(=O)N1CCCC1C(=O)O
CID000002153,theophylline,CN1C2=C(C(=O)N(C1=O)C)NC=N2,erythema,CID000027686,CHEMBL4088679,C1=CC2=C(C(=C1)OCC(COC3=CC4=C(C=C3)OC(=CC4=O)C(=O)O)O)C(=O)C=C(O2)C(=O)O
CID000002153,theophylline,CN1C2=C(C(=O)N(C1=O)C)NC=N2,apoplexy,CID000004205,mirtazapine,CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4
CID000002153,theophylline,CN1C2=C(C(=O)N(C1=O)C)NC=N2,cholecystitis,CID000003961,losartan,CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)CO)Cl
CID000002153,theophylline,CN1C2=C(C(=O)N(C1=O)C)NC=N2,abnormal ECG,CID000004170,metolazone,CC1NC2=CC(=C(C=C2C(=O)N1C3=CC=CC=C3C)S(=O)(=O)N)Cl
CID000002153,theophylline,CN1C2=C(C(=O)N(C1=O)C)NC=N2,erythema,CID000004900,Fernisone,CC12CC(=O)C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C
CID000002153,theophylline,CN1C2=C(C(=O)N(C1=O)C)NC=N2,apoplexy,CID000003075,"2-[3-acetyloxy-2-(4-methoxyphenyl)-4-oxo-2,3-dihydro-1,5-benzothiazepin-5-yl]ethyl-dimethylazanium",CC(=O)OC1C(SC2=CC=CC=C2N(C1=O)CC[NH+](C)C)C3=CC=C(C=C3)OC
CID000002153,theophylline,CN1C2=C(C(=O)N(C1=O)C)NC=N2,ear infection,CID000004510,nitroglycerin,C(C(CO[N+](=O)[O-])O[N+](=O)[O-])O[N+](=O)[O-]
CID000002153,theophylline,CN1C2=C(C(=O)N(C1=O)C)NC=N2,eosinophilic pneumonia,CID000062924,"S-(fluoromethyl) (6S,9R,10S,11S,13S,14S,16R,17R)-6,9-difluoro-11,17-dihydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthrene-17-carbothioate",CC1CC2C3CC(C4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)SCF)O)C)O)F)C)F
CID000002153,theophylline,CN1C2=C(C(=O)N(C1=O)C)NC=N2,back injury,CID000003883,lansoprazole,CC1=C(C=CN=C1CS(=O)C2=NC3=CC=CC=C3N2)OCC(F)(F)F
CID000002153,theophylline,CN1C2=C(C(=O)N(C1=O)C)NC=N2,Adenopathy,CID000003658,hydroxyzine,C1CN(CCN1CCOCCO)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl
CID000002153,theophylline,CN1C2=C(C(=O)N(C1=O)C)NC=N2,eruption,CID000004666,7-Epi Paclitaxel,CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C
CID000002153,theophylline,CN1C2=C(C(=O)N(C1=O)C)NC=N2,cholecystitis,CID000003937,N~2~-(1-carboxy-3-phenylpropyl)lysylproline,C1CC(N(C1)C(=O)C(CCCCN)NC(CCC2=CC=CC=C2)C(=O)O)C(=O)O
CID000002153,theophylline,CN1C2=C(C(=O)N(C1=O)C)NC=N2,erythema,CID000004173,metronidazole,CC1=NC=C(N1CCO)[N+](=O)[O-]
CID000002153,theophylline,CN1C2=C(C(=O)N(C1=O)C)NC=N2,apoplexy,CID000003749,irbesartan,CCCCC1=NC2(CCCC2)C(=O)N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5
CID000002153,theophylline,CN1C2=C(C(=O)N(C1=O)C)NC=N2,gastric inflammation,CID000170361,Varenicline,C1C2CNCC1C3=CC4=NC=CN=C4C=C23
CID000002153,theophylline,CN1C2=C(C(=O)N(C1=O)C)NC=N2,cholecystitis,CID000004585,"2-methyl-4-(4-methylpiperazin-1-yl)-5H-thieno[3,2-c][1,5]benzodiazepine",CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C
CID000003345,fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,atelectasis,CID000152945,Dutasteride?,CC12CCC3C(C1CCC2C(=O)NC4=C(C=CC(=C4)C(F)(F)F)C(F)(F)F)CCC5C3(C=CC(=O)N5)C
CID000003345,fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,chest pain,CID000004542,norgestrel,CCC12CCC3C(C1CCC2(C#C)O)CCC4=CC(=O)CCC34
CID000003345,fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,methaemoglobinaemia,CID000004543,nortriptyline,CNCCC=C1C2=CC=CC=C2CCC3=CC=CC=C31
CID000003345,fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,periodontitis,CID000004819,"2(3H)-Furanone, 3-ethyldihydro-4-[(1-methyl-1H-imidazol-5-yl)methyl]-, (3S-cis)-",CCC1C(COC1=O)CC2=CN=CN2C
CID000003345,fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,gastric inflammation,CID000005650,N-pentanoyl-N-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-L-valine,CCCCC(=O)N(CC1=CC=C(C=C1)C2=CC=CC=C2C3=NNN=N3)C(C(C)C)C(=O)O
CID000003345,fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,apoplexy,CID000003780,"D-Glucitol, 1,4:3,6-dianhydro-, 2,5-dinitrate",C1C(C2C(O1)C(CO2)O[N+](=O)[O-])O[N+](=O)[O-]
CID000003345,fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,Adenopathy,CID000005245,Risedronic acid,C1=CC(=CN=C1)CC(O)(P(=O)(O)O)P(=O)(O)O
CID000003345,fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,cholecystitis,CID000003954,loperamide(1+),CN(C)C(=O)C(CC[NH+]1CCC(CC1)(C2=CC=C(C=C2)Cl)O)(C3=CC=CC=C3)C4=CC=CC=C4
CID000003345,fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,myelodysplasia,CID000004425,"4a,9-dihydroxy-3-prop-2-enyl-2,4,5,6,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinolin-7-one",C=CCN1CCC23C4C(=O)CCC2(C1CC5=C3C(=C(C=C5)O)O4)O
CID000003345,fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,gastric inflammation,CID000005376,(E/Z)-Tamoxifen,CCC(=C(C1=CC=CC=C1)C2=CC=C(C=C2)OCCN(C)C)C3=CC=CC=C3
CID000003345,fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,cholecystitis,CID000027991,DESMOPRESSIN,C1CC(N(C1)C(=O)C2CSSCCC(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N2)CC(=O)N)CCC(=O)N)CC3=CC=CC=C3)CC4=CC=C(C=C4)O)C(=O)NC(CCCN=C(N)N)C(=O)NCC(=O)N
CID000003345,fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,drug toxicity NOS,CID000051263,ALFENTANIL,CCC(=O)N(C1=CC=CC=C1)C2(CCN(CC2)CCN3C(=O)N(N=N3)CC)COC
CID000003345,fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,loss of weight,CID000004920,"1-acetyl-9a,11a-dimethyl-1H,2H,3H,3aH,3bH,4H,5H,7H,8H,9H,9aH,9bH,10H,11H,11aH-cyclopenta[a]phenanthren-7-one",CC(=O)C1CCC2C1(CCC3C2CCC4=CC(=O)CCC34C)C
CID000003345,fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,Adenopathy,CID000036339,Etomidate,CCOC(=O)C1=CN=CN1C(C)C2=CC=CC=C2
CID000003345,fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,abnormal EEG,CID000060612,levomedetomidine,CC1=C(C(=CC=C1)C(C)C2=CN=CN2)C
CID000003345,fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,angiitis,CID000071616,Voriconazole,CC(C1=NC=NC=C1F)C(CN2C=NC=N2)(C3=C(C=C(C=C3)F)F)O
CID000003345,fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,methaemoglobinaemia,CID000005487,tizanidine,C1CN=C(N1)NC2=C(C=CC3=NSN=C32)Cl
CID000003345,fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,gastric inflammation,CID000062924,"S-(fluoromethyl) (6S,9R,10S,11S,13S,14S,16R,17R)-6,9-difluoro-11,17-dihydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthrene-17-carbothioate",CC1CC2C3CC(C4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)SCF)O)C)O)F)C)F
CID000003345,fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,rhinorrhea,CID000004536,Minovlar,CC12CCC3C(C1CCC2(C#C)O)CCC4=CC(=O)CCC34
CID000003345,fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,Adenopathy,CID000147912,DSSTox_GSID_49066,CCC(C(C)O)N1C(=O)N(C=N1)C2=CC=C(C=C2)N3CCN(CC3)C4=CC=C(C=C4)OCC5CC(OC5)(CN6C=NC=N6)C7=C(C=C(C=C7)F)F
CID000003345,fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,methaemoglobinaemia,CID000003883,lansoprazole,CC1=C(C=CN=C1CS(=O)C2=NC3=CC=CC=C3N2)OCC(F)(F)F
CID000003345,fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,Adenopathy,CID000005719,zaleplon,CCN(C1=CC=CC(=C1)C2=CC=NC3=C(C=NN23)C#N)C(=O)C
CID000003345,fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,Adenopathy,CID000004601,orphenadrine,CC1=CC=CC=C1C(C2=CC=CC=C2)OCCN(C)C
CID000003345,fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,heart rate increased,CID000003562,halothane,C(C(F)(F)F)(Cl)Br
CID000003345,fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,atelectasis,CID005493444,Aliskiren,CC(C)C(CC1=CC(=C(C=C1)OC)OCCCOC)CC(C(CC(C(C)C)C(=O)NCC(C)(C)C(=O)N)O)N
CID000003345,fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,cholecystitis,CID000003961,losartan,CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)CO)Cl
CID000003345,fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,gastric inflammation,CID006398525,,C(C1C(C(C(C(O1)OC2(C(C(C(O2)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)COS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.[Al].[Al].[Al].[Al].[Al].[Al].[Al].[Al].[Al]
CID000003345,fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,cholecystitis,CID000005152,Salmeterol,C1=CC=C(C=C1)CCCCOCCCCCCNCC(C2=CC(=C(C=C2)O)CO)O
CID000003345,fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,myelodysplasia,CID000004894,"11,17,21-Trihydroxypregna-1,4-diene-3,20-dione",CC12CC(C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C)O
CID000003345,fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,Lyell,CID000003734,Bracco 15000,CC(C(=O)NC1=C(C(=C(C(=C1I)C(=O)NC(CO)CO)I)C(=O)NC(CO)CO)I)O
CID000003345,fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,atelectasis,CID000004911,probenecid,CCCN(CCC)S(=O)(=O)C1=CC=C(C=C1)C(=O)O
CID000003345,fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,gastric inflammation,CID000003405,2-[[4-[(2-amino-4-oxo-1H-pteridin-6-yl)methylamino]benzoyl]amino]pentanedioic acid,C1=CC(=CC=C1C(=O)NC(CCC(=O)O)C(=O)O)NCC2=CN=C3C(=N2)C(=O)N=C(N3)N
CID000003345,fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,myelodysplasia,CID000004510,nitroglycerin,C(C(CO[N+](=O)[O-])O[N+](=O)[O-])O[N+](=O)[O-]
CID000003345,fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,drug toxicity NOS,CID000004440,naratriptan,CNS(=O)(=O)CCC1=CC2=C(C=C1)NC=C2C3CCN(CC3)C
CID000003345,fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,rhinorrhea,CID000060865,(E)-Olopatadine,CN(C)CCC=C1C2=CC=CC=C2COC3=C1C=C(C=C3)CC(=O)O
CID000003345,fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,cholecystitis,CID000005732,zolpidem,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C
CID000003345,fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,gastric inflammation,CID000003937,N~2~-(1-carboxy-3-phenylpropyl)lysylproline,C1CC(N(C1)C(=O)C(CCCCN)NC(CCC2=CC=CC=C2)C(=O)O)C(=O)O
CID000003345,fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,gastric inflammation,CID000004158,methylphenidate,COC(=O)C(C1CCCCN1)C2=CC=CC=C2
CID000003345,fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,abnormal ECG,CID000039765,Vecuronium,CC(=O)OC1CC2CCC3C(C2(CC1N4CCCCC4)C)CCC5(C3CC(C5OC(=O)C)[N+]6(CCCCC6)C)C
CID000003345,fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,bulging,CID000071329,Dofetilide,CN(CCC1=CC=C(C=C1)NS(=O)(=O)C)CCOC2=CC=C(C=C2)NS(=O)(=O)C
CID000003345,fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,gastric inflammation,CID000004075,5-Aminosalicylic acid,C1=CC(=C(C=C1N)C(=O)O)O
CID000003345,fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,cholecystitis,CID000005544,Mycolog,CC12CC(C3(C(C1CC(C2(C(=O)CO)O)O)CCC4=CC(=O)C=CC43C)F)O
CID000003345,fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,back injury,CID000005095,ropinirole,CCCN(CCC)CCC1=C2CC(=O)NC2=CC=C1
CID000003345,fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,apoplexy,CID000005352,38194-50-2,CC1=C(C2=C(C1=CC3=CC=C(C=C3)S(=O)C)C=CC(=C2)F)CC(=O)O
CID000003345,fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,cholecystitis,CID000005358,sumatriptan,CNS(=O)(=O)CC1=CC2=C(C=C1)NC=C2CCN(C)C
CID000003345,fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,apoplexy,CID000004138,55-40-3,CC(CC1=CC(=C(C=C1)O)O)(C(=O)O)N
CID000003345,fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,heart rate increased,CID000027686,CHEMBL4088679,C1=CC2=C(C(=C1)OCC(COC3=CC4=C(C=C3)OC(=CC4=O)C(=O)O)O)C(=O)C=C(O2)C(=O)O
CID000003345,fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,muscle disorder,CID000004497,nimodipine,CC1=C(C(C(=C(N1)C)C(=O)OC(C)C)C2=CC(=CC=C2)[N+](=O)[O-])C(=O)OCCOC
CID000003345,fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,als,CID000005070,riluzole,C1=CC2=C(C=C1OC(F)(F)F)SC(=N2)N
CID000003345,fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,Acute Respiratory Distress Syndrome,CID000163742,SCHEMBL1650579,COC1C(C(C(C(O1)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)COS(=O)(=O)O)OC4C(C(C(C(O4)C(=O)O)OC5C(C(C(C(O5)COS(=O)(=O)O)O)O)NS(=O)(=O)O)O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O)NS(=O)(=O)O
CID000003345,fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,gastric inflammation,CID000003516,guaifenesin,COC1=CC=CC=C1OCC(CO)O
CID000003345,fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,muscle paresis,CID000005515,hycamptamine hydrochloride hydrate,CCC1(C2=C(COC1=O)C(=O)N3CC4=CC5=C(C=CC(=C5CN(C)C)O)N=C4C3=C2)O
CID000003345,fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,glossodynia,CID000115237,Paliperidone,CC1=C(C(=O)N2CCCC(C2=N1)O)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F
CID000003345,fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,nervous tension,CID000125017,Desvenlafaxine,CN(C)CC(C1=CC=C(C=C1)O)C2(CCCCC2)O
CID000003345,fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,gastric inflammation,CID000003658,hydroxyzine,C1CN(CCN1CCOCCO)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl
CID000003345,fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,Acne,CID000004585,"2-methyl-4-(4-methylpiperazin-1-yl)-5H-thieno[3,2-c][1,5]benzodiazepine",CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C
CID000003345,fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,cholecystitis,CID000005512,124936-74-9,CC1=CC(=C(C=C1)O)C(CCN(C(C)C)C(C)C)C2=CC=CC=C2
CID000003345,fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,erythema,CID000003890,TRANS (15S)-LATANOPROST,CC(C)OC(=O)CCCC=CCC1C(CC(C1CCC(CCC2=CC=CC=C2)O)O)O
CID000003345,fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,cholecystitis,CID000005073,risperidone,CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F
CID000003345,fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,loss of weight,CID000160051,Colesevelam,CCCCCCCCCCNCC=C.C[N+](C)(C)CCCCCCNCC=C.C=CCN.C1C(O1)CCl.Cl.[Cl-]
CID000003345,fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,methaemoglobinaemia,CID000004679,pantoprazole,COC1=C(C(=NC=C1)CS(=O)C2=NC3=C(N2)C=C(C=C3)OC(F)F)OC
CID000003345,fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,hypermagnesemia,CID000036811,dobutamine,CC(CCC1=CC=C(C=C1)O)NCCC2=CC(=C(C=C2)O)O
CID000003345,fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,atelectasis,CID005311082,"2-[(1R,4S,10S,13S,19S)-19-[4-(diaminomethylideneamino)butyl]-10-(1H-indol-3-ylmethyl)-3,9,12,15,18,21,27-heptaoxo-24,25-dithia-2,8,11,14,17,20-hexazatricyclo[18.6.1.04,8]heptacosan-13-yl]acetic acid",C1CC2C(=O)NC3CSSCCC(=O)N(C3=O)C(C(=O)NCC(=O)NC(C(=O)NC(C(=O)N2C1)CC4=CNC5=CC=CC=C54)CC(=O)O)CCCCN=C(N)N
CID000003345,fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,methaemoglobinaemia,CID000004889,Pravastatin Impurity A,CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC(CC(CC(=O)O)O)O)O
CID000003345,fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,cholecystitis,CID000003676,lidocaine,CCN(CC)CC(=O)NC1=C(C=CC=C1C)C
CID000003345,fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,Adenopathy,CID000003440,furosemide,C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl
CID000003345,fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,abnormal EEG,CID000003410,formoterol,CC(CC1=CC=C(C=C1)OC)NCC(C2=CC(=C(C=C2)O)NC=O)O
CID000003345,fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,dysarthria,CID000060852,Ibandronic Acid,CCCCCN(C)CCC(O)(P(=O)(O)O)P(=O)(O)O
CID000003345,fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,atelectasis,CID000060184,"2'-epi-Perindopril, (2'R)-",CCCC(C(=O)OCC)NC(C)C(=O)N1C2CCCCC2CC1C(=O)O
CID000003345,fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,Abnormal Gait,CID000057537,92206-54-7,CCCN(CCC1=CC=CS1)C2CCC3=C(C2)C=CC=C3O
CID000003345,fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,cholecystitis,CID000004927,promethazine,CC(CN1C2=CC=CC=C2SC3=CC=CC=C31)N(C)C
CID000003345,fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,right heart failure,CID000009052,2-hydroxy-3-[1-(4-nitrophenyl)-3-oxobutyl]chromen-4-one,CC(=O)CC(C1=CC=C(C=C1)[N+](=O)[O-])C2=C(OC3=CC=CC=C3C2=O)O
CID000003345,fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,cholecystitis,CID003468412,SCHEMBL1176571,CC1C=CC=CCCC=CC=CC=CC=CC(CC(C(C(CC(=O)CC(C(CCC(CC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)C(=O)O)O)OC2C(C(C(C(O2)C)O)N)O
CID000003345,fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,cholecystitis,CID000005645,"3,7-Dihydroxycholan-24-oic acid",CC(CCC(=O)O)C1CCC2C1(CCC3C2C(CC4C3(CCC(C4)O)C)O)C
CID000003345,fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,erythema,CID000004856,"3-[hydroxy-(pyridin-2-ylamino)methylidene]-2-methyl-1,1-dioxo-1lambda6,2-benzothiazin-4-one",CN1C(=C(NC2=CC=CC=N2)O)C(=O)C3=CC=CC=C3S1(=O)=O
CID000003345,fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,apoplexy,CID000004189,miconazole,C1=CC(=C(C=C1Cl)Cl)COC(CN2C=CN=C2)C3=C(C=C(C=C3)Cl)Cl
CID000003345,fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,cholecystectomies,CID000004236,modafinil,C1=CC=C(C=C1)C(C2=CC=CC=C2)S(=O)CC(=O)N
CID000003345,fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,loss of weight,CID000005478,racemic-Timolol,CC(C)(C)NCC(COC1=NSN=C1N2CCOCC2)O
CID000003345,fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,constipated,CID000003449,Epigalanthamin,CN1CCC23C=CC(CC2OC4=C(C=CC(=C34)C1)OC)O
CID000003345,fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,cholecystitis,CID000019090,megestrol,CC1=CC2C(CCC3(C2CCC3(C(=O)C)O)C)C4(C1=CC(=O)CC4)C
CID000003345,fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,methaemoglobinaemia,CID000004691,"3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine",C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4
CID000003345,fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,Dyspnea exertional,CID000005771,Oxytocin acetate salt hydrate,CCC(C)C1C(=O)NC(C(=O)NC(C(=O)NC(CSSCC(C(=O)NC(C(=O)N1)CC2=CC=C(C=C2)O)N)C(=O)N3CCCC3C(=O)NC(CC(C)C)C(=O)NCC(=O)N)CC(=O)N)CCC(=O)N
CID000003345,fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,weight gain,CID000004614,oxaprozin,C1=CC=C(C=C1)C2=C(OC(=N2)CCC(=O)O)C3=CC=CC=C3
CID000003345,fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,drug withdrawal,CID000060854,Ziprasidone,C1CN(CCN1CCC2=C(C=C3C(=C2)CC(=O)N3)Cl)C4=NSC5=CC=CC=C54
CID000003345,fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,acute pancreatitis,CID000074989,ATOVAQUONE,C1CC(CCC1C2=CC=C(C=C2)Cl)C3=C(C4=CC=CC=C4C(=O)C3=O)O
CID000003345,fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,cholecystitis,CID000004205,mirtazapine,CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4
CID000003345,fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,Adenopathy,CID000004201,minoxidil,C1CCN(CC1)C2=NC(=N)N(C(=C2)N)O
CID000003345,fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,abnormal EEG,CID000003763,isoflurane,C(C(F)(F)F)(OC(F)F)Cl
CID000003345,fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,drug toxicity NOS,CID000131536,Fosamprenavir,CC(C)CN(CC(C(CC1=CC=CC=C1)NC(=O)OC2CCOC2)OP(=O)(O)O)S(=O)(=O)C3=CC=C(C=C3)N
CID000003345,fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,cholecystitis,CID000667490,6-Mercaptopurine,C1=NC2=C(N1)C(=S)N=CN2
CID000003345,fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,septic shock,CID000060754,Gadodiamide hydrate,CNC(=O)CN(CCN(CCN(CC(=O)NC)CC(=O)[O-])CC(=O)[O-])CC(=O)[O-].O.[Gd+3]
CID000003345,fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,gastric inflammation,CID000004173,metronidazole,CC1=NC=C(N1CCO)[N+](=O)[O-]
CID000003345,fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,cholecystitis,CID000004170,metolazone,CC1NC2=CC(=C(C=C2C(=O)N1C3=CC=CC=C3C)S(=O)(=O)N)Cl
CID000003345,fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,edema,CID000004178,Mexiletine,CC1=C(C(=CC=C1)C)OCC(C)N
CID000003345,fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,Back Ache,CID000003749,irbesartan,CCCCC1=NC2(CCCC2)C(=O)N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5
CID000003345,fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,gastric inflammation,CID000004900,Fernisone,CC12CC(=O)C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C
CID000003345,fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,gastric inflammation,CID000004909,primidone,CCC1(C(=O)NCNC1=O)C2=CC=CC=C2
CID000003345,fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,erythema,CID000003661,L-Hyoscyamine,CN1C2CCC1CC(C2)OC(=O)C(CO)C3=CC=CC=C3
CID000003345,fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,erythema,CID000005394,temozolomide,CN1C(=O)N2C=NC(=C2N=N1)C(=O)N
CID000003345,fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,drug toxicity NOS,CID000016231,AMILORIDE,C1(=C(N=C(C(=N1)Cl)N)N)C(=O)N=C(N)N
CID000003345,fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,gastric inflammation,CID000005978,vincristine,CCC1(CC2CC(C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)C78CCN9C7C(C=CC9)(C(C(C8N6C=O)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O
CID000003345,fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,cholecystitis,CID000004666,7-Epi Paclitaxel,CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C
CID000003345,fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,enlarged liver,CID000004044,mefenamic acid,CC1=C(C(=CC=C1)NC2=CC=CC=C2C(=O)O)C
CID000003345,fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,loss of weight,CID000110635,Tadalafil,CN1CC(=O)N2C(C1=O)CC3=C(C2C4=CC5=C(C=C4)OCO5)NC6=CC=CC=C36
CID000003345,fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,gastric inflammation,CID000012536,638-94-8,CC1(OC2CC3C4CCC5=CC(=O)C=CC5(C4C(CC3(C2(O1)C(=O)CO)C)O)C)C
CID000003345,fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,back injury,CID000003869,labetalol,CC(CCC1=CC=CC=C1)NCC(C2=CC(=C(C=C2)O)C(=O)N)O
CID000003345,fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,Acute Respiratory Distress Syndrome,CID000504578,"(2S,3S,4R,5R,6R)-5-amino-6-[(2R,3S,4R,5S)-5-[(1R,2S,3R,6R)-3-amino-6-[(1S,2R,3R,4R,5R)-2-amino-5-(aminomethyl)-3,4-dihydroxycyclohexyl]oxy-2-hydroxycyclohexyl]oxy-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl]oxy-2-(aminomethyl)oxane-3,4-diol",C1CC(C(C(C1N)O)OC2C(C(C(O2)CO)OC3C(C(C(C(O3)CN)O)O)N)O)OC4CC(C(C(C4N)O)O)CN
CID000003345,fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,loss of weight,CID000004748,perphenazine,C1CN(CCN1CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)Cl)CCO
CID000003345,fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,Adenopathy,CID000170361,Varenicline,C1C2CNCC1C3=CC4=NC=CN=C4C=C23
CID000004497,nimodipine,CC1=C(C(C(=C(N1)C)C(=O)OC(C)C)C2=CC(=CC=C2)[N+](=O)[O-])C(=O)OCCOC,subarachnoid haemorrhage,CID000004679,pantoprazole,COC1=C(C(=NC=C1)CS(=O)C2=NC3=C(N2)C=C(C=C3)OC(F)F)OC
CID000004542,norgestrel,CCC12CCC3C(C1CCC2(C#C)O)CCC4=CC(=O)CCC34,erythema,CID000005732,zolpidem,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C
CID000004542,norgestrel,CCC12CCC3C(C1CCC2(C#C)O)CCC4=CC(=O)CCC34,weight gain,CID000004920,"1-acetyl-9a,11a-dimethyl-1H,2H,3H,3aH,3bH,4H,5H,7H,8H,9H,9aH,9bH,10H,11H,11aH-cyclopenta[a]phenanthren-7-one",CC(=O)C1CCC2C1(CCC3C2CCC4=CC(=O)CCC34C)C
CID000004542,norgestrel,CCC12CCC3C(C1CCC2(C#C)O)CCC4=CC(=O)CCC34,loss of weight,CID000004585,"2-methyl-4-(4-methylpiperazin-1-yl)-5H-thieno[3,2-c][1,5]benzodiazepine",CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C
CID000004542,norgestrel,CCC12CCC3C(C1CCC2(C#C)O)CCC4=CC(=O)CCC34,alopecia,CID000005512,124936-74-9,CC1=CC(=C(C=C1)O)C(CCN(C(C)C)C(C)C)C2=CC=CC=C2
CID000004542,norgestrel,CCC12CCC3C(C1CCC2(C#C)O)CCC4=CC(=O)CCC34,weight gain,CID000062924,"S-(fluoromethyl) (6S,9R,10S,11S,13S,14S,16R,17R)-6,9-difluoro-11,17-dihydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthrene-17-carbothioate",CC1CC2C3CC(C4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)SCF)O)C)O)F)C)F
CID000004542,norgestrel,CCC12CCC3C(C1CCC2(C#C)O)CCC4=CC(=O)CCC34,bleeding Vaginal,CID000005650,N-pentanoyl-N-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-L-valine,CCCCC(=O)N(CC1=CC=C(C=C1)C2=CC=CC=C2C3=NNN=N3)C(C(C)C)C(=O)O
CID000004542,norgestrel,CCC12CCC3C(C1CCC2(C#C)O)CCC4=CC(=O)CCC34,thrombocytopenia,CID000004900,Fernisone,CC12CC(=O)C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C
CID000004542,norgestrel,CCC12CCC3C(C1CCC2(C#C)O)CCC4=CC(=O)CCC34,High blood pressure,CID000005544,Mycolog,CC12CC(C3(C(C1CC(C2(C(=O)CO)O)O)CCC4=CC(=O)C=CC43C)F)O
CID000004542,norgestrel,CCC12CCC3C(C1CCC2(C#C)O)CCC4=CC(=O)CCC34,abortion spontaneous,CID000170361,Varenicline,C1C2CNCC1C3=CC4=NC=CN=C4C=C23
CID000004542,norgestrel,CCC12CCC3C(C1CCC2(C#C)O)CCC4=CC(=O)CCC34,apoplexy,CID000005376,(E/Z)-Tamoxifen,CCC(=C(C1=CC=CC=C1)C2=CC=C(C=C2)OCCN(C)C)C3=CC=CC=C3
CID000004542,norgestrel,CCC12CCC3C(C1CCC2(C#C)O)CCC4=CC(=O)CCC34,loss of weight,CID000004679,pantoprazole,COC1=C(C(=NC=C1)CS(=O)C2=NC3=C(N2)C=C(C=C3)OC(F)F)OC
CID000004542,norgestrel,CCC12CCC3C(C1CCC2(C#C)O)CCC4=CC(=O)CCC34,gastric inflammation,CID000004691,"3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine",C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4
CID000004542,norgestrel,CCC12CCC3C(C1CCC2(C#C)O)CCC4=CC(=O)CCC34,irregular menstrual cycle,CID000005358,sumatriptan,CNS(=O)(=O)CC1=CC2=C(C=C1)NC=C2CCN(C)C
CID000051263,ALFENTANIL,CCC(=O)N(C1=CC=CC=C1)C2(CCN(CC2)CCN3C(=O)N(N=N3)CC)COC,increased white blood cell count,CID003468412,SCHEMBL1176571,CC1C=CC=CCCC=CC=CC=CC=CC(CC(C(C(CC(=O)CC(C(CCC(CC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)C(=O)O)O)OC2C(C(C(C(O2)C)O)N)O
CID000051263,ALFENTANIL,CCC(=O)N(C1=CC=CC=C1)C2(CCN(CC2)CCN3C(=O)N(N=N3)CC)COC,increased white blood cell count,CID006398525,,C(C1C(C(C(C(O1)OC2(C(C(C(O2)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)COS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.[Al].[Al].[Al].[Al].[Al].[Al].[Al].[Al].[Al]
CID000003261,estazolam,C1C2=NN=CN2C3=C(C=C(C=C3)Cl)C(=N1)C4=CC=CC=C4,insulin dependent diabetes mellitus,CID000004173,metronidazole,CC1=NC=C(N1CCO)[N+](=O)[O-]
CID000003261,estazolam,C1C2=NN=CN2C3=C(C=C(C=C3)Cl)C(=N1)C4=CC=CC=C4,neumonia,CID000004044,mefenamic acid,CC1=C(C(=CC=C1)NC2=CC=CC=C2C(=O)O)C
CID000003261,estazolam,C1C2=NN=CN2C3=C(C=C(C=C3)Cl)C(=N1)C4=CC=CC=C4,apoplexy,CID000004691,"3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine",C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4
CID000003261,estazolam,C1C2=NN=CN2C3=C(C=C(C=C3)Cl)C(=N1)C4=CC=CC=C4,dysarthria,CID000005073,risperidone,CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F
CID000003261,estazolam,C1C2=NN=CN2C3=C(C=C(C=C3)Cl)C(=N1)C4=CC=CC=C4,loss of weight,CID000004889,Pravastatin Impurity A,CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC(CC(CC(=O)O)O)O)O
CID000003261,estazolam,C1C2=NN=CN2C3=C(C=C(C=C3)Cl)C(=N1)C4=CC=CC=C4,insulin dependent diabetes mellitus,CID000003325,famotidine,C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N
CID000003261,estazolam,C1C2=NN=CN2C3=C(C=C(C=C3)Cl)C(=N1)C4=CC=CC=C4,loss of weight,CID000004679,pantoprazole,COC1=C(C(=NC=C1)CS(=O)C2=NC3=C(N2)C=C(C=C3)OC(F)F)OC
CID000003261,estazolam,C1C2=NN=CN2C3=C(C=C(C=C3)Cl)C(=N1)C4=CC=CC=C4,right heart failure,CID000004585,"2-methyl-4-(4-methylpiperazin-1-yl)-5H-thieno[3,2-c][1,5]benzodiazepine",CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C
CID000003261,estazolam,C1C2=NN=CN2C3=C(C=C(C=C3)Cl)C(=N1)C4=CC=CC=C4,increased white blood cell count,CID000004158,methylphenidate,COC(=O)C(C1CCCCN1)C2=CC=CC=C2
CID000003261,estazolam,C1C2=NN=CN2C3=C(C=C(C=C3)Cl)C(=N1)C4=CC=CC=C4,Adenopathy,CID000005732,zolpidem,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C
CID000003261,estazolam,C1C2=NN=CN2C3=C(C=C(C=C3)Cl)C(=N1)C4=CC=CC=C4,Adenopathy,CID000003440,furosemide,C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl
CID000003261,estazolam,C1C2=NN=CN2C3=C(C=C(C=C3)Cl)C(=N1)C4=CC=CC=C4,insulin dependent diabetes mellitus,CID000003937,N~2~-(1-carboxy-3-phenylpropyl)lysylproline,C1CC(N(C1)C(=O)C(CCCCN)NC(CCC2=CC=CC=C2)C(=O)O)C(=O)O
CID000003261,estazolam,C1C2=NN=CN2C3=C(C=C(C=C3)Cl)C(=N1)C4=CC=CC=C4,loss of weight,CID000003883,lansoprazole,CC1=C(C=CN=C1CS(=O)C2=NC3=CC=CC=C3N2)OCC(F)(F)F
CID000003261,estazolam,C1C2=NN=CN2C3=C(C=C(C=C3)Cl)C(=N1)C4=CC=CC=C4,apoplexy,CID000005650,N-pentanoyl-N-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-L-valine,CCCCC(=O)N(CC1=CC=C(C=C1)C2=CC=CC=C2C3=NNN=N3)C(C(C)C)C(=O)O
CID000003261,estazolam,C1C2=NN=CN2C3=C(C=C(C=C3)Cl)C(=N1)C4=CC=CC=C4,loss of weight,CID003468412,SCHEMBL1176571,CC1C=CC=CCCC=CC=CC=CC=CC(CC(C(C(CC(=O)CC(C(CCC(CC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)C(=O)O)O)OC2C(C(C(C(O2)C)O)N)O
CID000003261,estazolam,C1C2=NN=CN2C3=C(C=C(C=C3)Cl)C(=N1)C4=CC=CC=C4,loss of weight,CID000004927,promethazine,CC(CN1C2=CC=CC=C2SC3=CC=CC=C31)N(C)C
CID000003261,estazolam,C1C2=NN=CN2C3=C(C=C(C=C3)Cl)C(=N1)C4=CC=CC=C4,nasopharyngitis,CID000003954,loperamide(1+),CN(C)C(=O)C(CC[NH+]1CCC(CC1)(C2=CC=C(C=C2)Cl)O)(C3=CC=CC=C3)C4=CC=CC=C4
CID000003261,estazolam,C1C2=NN=CN2C3=C(C=C(C=C3)Cl)C(=N1)C4=CC=CC=C4,apoplexy,CID000005512,124936-74-9,CC1=CC(=C(C=C1)O)C(CCN(C(C)C)C(C)C)C2=CC=CC=C2
CID000003261,estazolam,C1C2=NN=CN2C3=C(C=C(C=C3)Cl)C(=N1)C4=CC=CC=C4,loss of weight,CID000005487,tizanidine,C1CN=C(N1)NC2=C(C=CC3=NSN=C32)Cl
CID000003261,estazolam,C1C2=NN=CN2C3=C(C=C(C=C3)Cl)C(=N1)C4=CC=CC=C4,apoplexy,CID000004900,Fernisone,CC12CC(=O)C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C
CID000003261,estazolam,C1C2=NN=CN2C3=C(C=C(C=C3)Cl)C(=N1)C4=CC=CC=C4,cachectic,CID000115237,Paliperidone,CC1=C(C(=O)N2CCCC(C2=N1)O)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F
CID000003261,estazolam,C1C2=NN=CN2C3=C(C=C(C=C3)Cl)C(=N1)C4=CC=CC=C4,insulin dependent diabetes mellitus,CID000004510,nitroglycerin,C(C(CO[N+](=O)[O-])O[N+](=O)[O-])O[N+](=O)[O-]
CID000003261,estazolam,C1C2=NN=CN2C3=C(C=C(C=C3)Cl)C(=N1)C4=CC=CC=C4,loss of weight,CID000005152,Salmeterol,C1=CC=C(C=C1)CCCCOCCCCCCNCC(C2=CC(=C(C=C2)O)CO)O
CID000003261,estazolam,C1C2=NN=CN2C3=C(C=C(C=C3)Cl)C(=N1)C4=CC=CC=C4,loss of weight,CID000062924,"S-(fluoromethyl) (6S,9R,10S,11S,13S,14S,16R,17R)-6,9-difluoro-11,17-dihydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthrene-17-carbothioate",CC1CC2C3CC(C4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)SCF)O)C)O)F)C)F
CID000003261,estazolam,C1C2=NN=CN2C3=C(C=C(C=C3)Cl)C(=N1)C4=CC=CC=C4,High blood pressure,CID000005645,"3,7-Dihydroxycholan-24-oic acid",CC(CCC(=O)O)C1CCC2C1(CCC3C2C(CC4C3(CCC(C4)O)C)O)C
CID000003261,estazolam,C1C2=NN=CN2C3=C(C=C(C=C3)Cl)C(=N1)C4=CC=CC=C4,apoplexy,CID000003405,2-[[4-[(2-amino-4-oxo-1H-pteridin-6-yl)methylamino]benzoyl]amino]pentanedioic acid,C1=CC(=CC=C1C(=O)NC(CCC(=O)O)C(=O)O)NCC2=CN=C3C(=N2)C(=O)N=C(N3)N
CID000003261,estazolam,C1C2=NN=CN2C3=C(C=C(C=C3)Cl)C(=N1)C4=CC=CC=C4,cataract,CID000060787,sequinavir,CC(C)(C)NC(=O)C1CC2CCCCC2CN1CC(C(CC3=CC=CC=C3)NC(=O)C(CC(=O)N)NC(=O)C4=NC5=CC=CC=C5C=C4)O
CID000152945,Dutasteride?,CC12CCC3C(C1CCC2C(=O)NC4=C(C=CC(=C4)C(F)(F)F)C(F)(F)F)CCC5C3(C=CC(=O)N5)C,dizziness,CID005493444,Aliskiren,CC(C)C(CC1=CC(=C(C=C1)OC)OCCCOC)CC(C(CC(C(C)C)C(=O)NCC(C)(C)C(=O)N)O)N
CID000152945,Dutasteride?,CC12CCC3C(C1CCC2C(=O)NC4=C(C=CC(=C4)C(F)(F)F)C(F)(F)F)CCC5C3(C=CC(=O)N5)C,bulging,CID006398525,,C(C1C(C(C(C(O1)OC2(C(C(C(O2)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)COS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.[Al].[Al].[Al].[Al].[Al].[Al].[Al].[Al].[Al]
CID000152945,Dutasteride?,CC12CCC3C(C1CCC2C(=O)NC4=C(C=CC(=C4)C(F)(F)F)C(F)(F)F)CCC5C3(C=CC(=O)N5)C,Bacteraemia,CID000160051,Colesevelam,CCCCCCCCCCNCC=C.C[N+](C)(C)CCCCCCNCC=C.C=CCN.C1C(O1)CCl.Cl.[Cl-]
CID000152945,Dutasteride?,CC12CCC3C(C1CCC2C(=O)NC4=C(C=CC(=C4)C(F)(F)F)C(F)(F)F)CCC5C3(C=CC(=O)N5)C,heart rate increased,CID003468412,SCHEMBL1176571,CC1C=CC=CCCC=CC=CC=CC=CC(CC(C(C(CC(=O)CC(C(CCC(CC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)C(=O)O)O)OC2C(C(C(C(O2)C)O)N)O
CID000152945,Dutasteride?,CC12CCC3C(C1CCC2C(=O)NC4=C(C=CC(=C4)C(F)(F)F)C(F)(F)F)CCC5C3(C=CC(=O)N5)C,weight gain,CID000170361,Varenicline,C1C2CNCC1C3=CC4=NC=CN=C4C=C23
CID000002803,clonidine,C1CN=C(N1)NC2=C(C=CC=C2Cl)Cl,loss of weight,CID000170361,Varenicline,C1C2CNCC1C3=CC4=NC=CN=C4C=C23
CID000002803,clonidine,C1CN=C(N1)NC2=C(C=CC=C2Cl)Cl,cholecystitis,CID000005152,Salmeterol,C1=CC=C(C=C1)CCCCOCCCCCCNCC(C2=CC(=C(C=C2)O)CO)O
CID000002803,clonidine,C1CN=C(N1)NC2=C(C=CC=C2Cl)Cl,cholecystitis,CID000004205,mirtazapine,CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4
CID000002803,clonidine,C1CN=C(N1)NC2=C(C=CC=C2Cl)Cl,gastric inflammation,CID000004201,minoxidil,C1CCN(CC1)C2=NC(=N)N(C(=C2)N)O
CID000002803,clonidine,C1CN=C(N1)NC2=C(C=CC=C2Cl)Cl,Adenopathy,CID000003062,Lanicor,CC1C(C(CC(O1)OC2C(OC(CC2O)OC3C(OC(CC3O)OC4CCC5(C(C4)CCC6C5CC(C7(C6(CCC7C8=CC(=O)OC8)O)C)O)C)C)C)O)O
CID000002803,clonidine,C1CN=C(N1)NC2=C(C=CC=C2Cl)Cl,erythema,CID000002891,"cobalt(2+);[5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] 1-[3-[2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2,7,12,17-tetrahydro-1H-corrin-21-id-3-yl]propanoylamino]propan-2-yl hydrogen phosphate;cyanide",CC1=CC2=C(C=C1C)N(C=N2)C3C(C(C(O3)CO)OP(=O)(O)OC(C)CNC(=O)CCC4(C(C5C6(C(C(C(=N6)C(=C7C(C(C(=N7)C=C8C(C(C(=N8)C(=C4[N-]5)C)CCC(=O)N)(C)C)CCC(=O)N)(C)CC(=O)N)C)CCC(=O)N)(C)CC(=O)N)C)CC(=O)N)C)O.[C-]#N.[Co+2]
CID000002803,clonidine,C1CN=C(N1)NC2=C(C=CC=C2Cl)Cl,sunburn,CID000115237,Paliperidone,CC1=C(C(=O)N2CCCC(C2=N1)O)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F
CID000002803,clonidine,C1CN=C(N1)NC2=C(C=CC=C2Cl)Cl,back injury,CID000003869,labetalol,CC(CCC1=CC=CC=C1)NCC(C2=CC(=C(C=C2)O)C(=O)N)O
CID000002803,clonidine,C1CN=C(N1)NC2=C(C=CC=C2Cl)Cl,gastric inflammation,CID000005487,tizanidine,C1CN=C(N1)NC2=C(C=CC3=NSN=C32)Cl
CID000002803,clonidine,C1CN=C(N1)NC2=C(C=CC=C2Cl)Cl,cholecystitis,CID000005732,zolpidem,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C
CID000002803,clonidine,C1CN=C(N1)NC2=C(C=CC=C2Cl)Cl,cholecystitis,CID000003883,lansoprazole,CC1=C(C=CN=C1CS(=O)C2=NC3=CC=CC=C3N2)OCC(F)(F)F
CID000002803,clonidine,C1CN=C(N1)NC2=C(C=CC=C2Cl)Cl,weight gain,CID000071329,Dofetilide,CN(CCC1=CC=C(C=C1)NS(=O)(=O)C)CCOC2=CC=C(C=C2)NS(=O)(=O)C
CID000002803,clonidine,C1CN=C(N1)NC2=C(C=CC=C2Cl)Cl,apoplexy,CID000004543,nortriptyline,CNCCC=C1C2=CC=CC=C2CCC3=CC=CC=C31
CID000002803,clonidine,C1CN=C(N1)NC2=C(C=CC=C2Cl)Cl,apoplexy,CID000004666,7-Epi Paclitaxel,CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C
CID000002803,clonidine,C1CN=C(N1)NC2=C(C=CC=C2Cl)Cl,gastric inflammation,CID000060854,Ziprasidone,C1CN(CCN1CCC2=C(C=C3C(=C2)CC(=O)N3)Cl)C4=NSC5=CC=CC=C54
CID000002803,clonidine,C1CN=C(N1)NC2=C(C=CC=C2Cl)Cl,eruption,CID000060852,Ibandronic Acid,CCCCCN(C)CCC(O)(P(=O)(O)O)P(=O)(O)O
CID000002803,clonidine,C1CN=C(N1)NC2=C(C=CC=C2Cl)Cl,gout,CID000160051,Colesevelam,CCCCCCCCCCNCC=C.C[N+](C)(C)CCCCCCNCC=C.C=CCN.C1C(O1)CCl.Cl.[Cl-]
CID000002803,clonidine,C1CN=C(N1)NC2=C(C=CC=C2Cl)Cl,Back Ache,CID000060184,"2'-epi-Perindopril, (2'R)-",CCCC(C(=O)OCC)NC(C)C(=O)N1C2CCCCC2CC1C(=O)O
CID000002803,clonidine,C1CN=C(N1)NC2=C(C=CC=C2Cl)Cl,Back Ache,CID005311082,"2-[(1R,4S,10S,13S,19S)-19-[4-(diaminomethylideneamino)butyl]-10-(1H-indol-3-ylmethyl)-3,9,12,15,18,21,27-heptaoxo-24,25-dithia-2,8,11,14,17,20-hexazatricyclo[18.6.1.04,8]heptacosan-13-yl]acetic acid",C1CC2C(=O)NC3CSSCCC(=O)N(C3=O)C(C(=O)NCC(=O)NC(C(=O)NC(C(=O)N2C1)CC4=CNC5=CC=CC=C54)CC(=O)O)CCCCN=C(N)N
CID000002803,clonidine,C1CN=C(N1)NC2=C(C=CC=C2Cl)Cl,Adenopathy,CID000005245,Risedronic acid,C1=CC(=CN=C1)CC(O)(P(=O)(O)O)P(=O)(O)O
CID000002803,clonidine,C1CN=C(N1)NC2=C(C=CC=C2Cl)Cl,gastric inflammation,CID000003780,"D-Glucitol, 1,4:3,6-dianhydro-, 2,5-dinitrate",C1C(C2C(O1)C(CO2)O[N+](=O)[O-])O[N+](=O)[O-]
CID000002803,clonidine,C1CN=C(N1)NC2=C(C=CC=C2Cl)Cl,gastric inflammation,CID000003661,L-Hyoscyamine,CN1C2CCC1CC(C2)OC(=O)C(CO)C3=CC=CC=C3
CID000002803,clonidine,C1CN=C(N1)NC2=C(C=CC=C2Cl)Cl,apoplexy,CID000005478,racemic-Timolol,CC(C)(C)NCC(COC1=NSN=C1N2CCOCC2)O
CID000002803,clonidine,C1CN=C(N1)NC2=C(C=CC=C2Cl)Cl,apoplexy,CID000019090,megestrol,CC1=CC2C(CCC3(C2CCC3(C(=O)C)O)C)C4(C1=CC(=O)CC4)C
CID000002803,clonidine,C1CN=C(N1)NC2=C(C=CC=C2Cl)Cl,cholecystitis,CID000005544,Mycolog,CC12CC(C3(C(C1CC(C2(C(=O)CO)O)O)CCC4=CC(=O)C=CC43C)F)O
CID000002803,clonidine,C1CN=C(N1)NC2=C(C=CC=C2Cl)Cl,bursitis,CID000060865,(E)-Olopatadine,CN(C)CCC=C1C2=CC=CC=C2COC3=C1C=C(C=C3)CC(=O)O
CID000002803,clonidine,C1CN=C(N1)NC2=C(C=CC=C2Cl)Cl,allergic dermatitis,CID000125017,Desvenlafaxine,CN(C)CC(C1=CC=C(C=C1)O)C2(CCCCC2)O
CID000002803,clonidine,C1CN=C(N1)NC2=C(C=CC=C2Cl)Cl,cholecystitis,CID000003042,dicyclomine,CCN(CC)CCOC(=O)C1(CCCCC1)C2CCCCC2
CID000002803,clonidine,C1CN=C(N1)NC2=C(C=CC=C2Cl)Cl,Acne,CID000005073,risperidone,CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F
CID000002803,clonidine,C1CN=C(N1)NC2=C(C=CC=C2Cl)Cl,loss of weight,CID000003516,guaifenesin,COC1=CC=CC=C1OCC(CO)O
CID000002803,clonidine,C1CN=C(N1)NC2=C(C=CC=C2Cl)Cl,gastric inflammation,CID000004889,Pravastatin Impurity A,CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC(CC(CC(=O)O)O)O)O
CID000002803,clonidine,C1CN=C(N1)NC2=C(C=CC=C2Cl)Cl,erythema,CID000003658,hydroxyzine,C1CN(CCN1CCOCCO)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl
CID000002803,clonidine,C1CN=C(N1)NC2=C(C=CC=C2Cl)Cl,cholecystitis,CID000004927,promethazine,CC(CN1C2=CC=CC=C2SC3=CC=CC=C31)N(C)C
CID000002803,clonidine,C1CN=C(N1)NC2=C(C=CC=C2Cl)Cl,dysarthria,CID000004920,"1-acetyl-9a,11a-dimethyl-1H,2H,3H,3aH,3bH,4H,5H,7H,8H,9H,9aH,9bH,10H,11H,11aH-cyclopenta[a]phenanthren-7-one",CC(=O)C1CCC2C1(CCC3C2CCC4=CC(=O)CCC34C)C
CID000002803,clonidine,C1CN=C(N1)NC2=C(C=CC=C2Cl)Cl,Dyspnea exertional,CID000005650,N-pentanoyl-N-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-L-valine,CCCCC(=O)N(CC1=CC=C(C=C1)C2=CC=CC=C2C3=NNN=N3)C(C(C)C)C(=O)O
CID000002803,clonidine,C1CN=C(N1)NC2=C(C=CC=C2Cl)Cl,loss of weight,CID000003410,formoterol,CC(CC1=CC=C(C=C1)OC)NCC(C2=CC(=C(C=C2)O)NC=O)O
CID000002803,clonidine,C1CN=C(N1)NC2=C(C=CC=C2Cl)Cl,gastric inflammation,CID000002806,90055-48-4,COC(=O)C(C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3
CID000002803,clonidine,C1CN=C(N1)NC2=C(C=CC=C2Cl)Cl,apoplexy,CID000004236,modafinil,C1=CC=C(C=C1)C(C2=CC=CC=C2)S(=O)CC(=O)N
CID000002803,clonidine,C1CN=C(N1)NC2=C(C=CC=C2Cl)Cl,back injury,CID000003075,"2-[3-acetyloxy-2-(4-methoxyphenyl)-4-oxo-2,3-dihydro-1,5-benzothiazepin-5-yl]ethyl-dimethylazanium",CC(=O)OC1C(SC2=CC=CC=C2N(C1=O)CC[NH+](C)C)C3=CC=C(C=C3)OC
CID000002803,clonidine,C1CN=C(N1)NC2=C(C=CC=C2Cl)Cl,eruption,CID000004856,"3-[hydroxy-(pyridin-2-ylamino)methylidene]-2-methyl-1,1-dioxo-1lambda6,2-benzothiazin-4-one",CN1C(=C(NC2=CC=CC=N2)O)C(=O)C3=CC=CC=C3S1(=O)=O
CID000002803,clonidine,C1CN=C(N1)NC2=C(C=CC=C2Cl)Cl,cholecystitis,CID000005512,124936-74-9,CC1=CC(=C(C=C1)O)C(CCN(C(C)C)C(C)C)C2=CC=CC=C2
CID000002803,clonidine,C1CN=C(N1)NC2=C(C=CC=C2Cl)Cl,erythema,CID000003890,TRANS (15S)-LATANOPROST,CC(C)OC(=O)CCCC=CCC1C(CC(C1CCC(CCC2=CC=CC=C2)O)O)O
CID000002803,clonidine,C1CN=C(N1)NC2=C(C=CC=C2Cl)Cl,aspiration pneumonia,CID000003763,isoflurane,C(C(F)(F)F)(OC(F)F)Cl
CID000002803,clonidine,C1CN=C(N1)NC2=C(C=CC=C2Cl)Cl,cholecystitis,CID000004170,metolazone,CC1NC2=CC(=C(C=C2C(=O)N1C3=CC=CC=C3C)S(=O)(=O)N)Cl
CID000002803,clonidine,C1CN=C(N1)NC2=C(C=CC=C2Cl)Cl,cholecystitis,CID000004173,metronidazole,CC1=NC=C(N1CCO)[N+](=O)[O-]
CID000002803,clonidine,C1CN=C(N1)NC2=C(C=CC=C2Cl)Cl,gastric inflammation,CID000003333,felodipine,CCOC(=O)C1=C(NC(=C(C1C2=C(C(=CC=C2)Cl)Cl)C(=O)OC)C)C
CID000002803,clonidine,C1CN=C(N1)NC2=C(C=CC=C2Cl)Cl,Dyspnea exertional,CID000003339,fenofibrate,CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C2=CC=C(C=C2)Cl
CID000002803,clonidine,C1CN=C(N1)NC2=C(C=CC=C2Cl)Cl,abnormal EEG,CID000003449,Epigalanthamin,CN1CCC23C=CC(CC2OC4=C(C=CC(=C34)C1)OC)O
CID000002803,clonidine,C1CN=C(N1)NC2=C(C=CC=C2Cl)Cl,angiitis,CID000005352,38194-50-2,CC1=C(C2=C(C1=CC3=CC=C(C=C3)S(=O)C)C=CC(=C2)F)CC(=O)O
CID000002803,clonidine,C1CN=C(N1)NC2=C(C=CC=C2Cl)Cl,cholecystitis,CID000005358,sumatriptan,CNS(=O)(=O)CC1=CC2=C(C=C1)NC=C2CCN(C)C
CID000002803,clonidine,C1CN=C(N1)NC2=C(C=CC=C2Cl)Cl,Pain,CID000071616,Voriconazole,CC(C1=NC=NC=C1F)C(CN2C=NC=N2)(C3=C(C=C(C=C3)F)F)O
CID000002803,clonidine,C1CN=C(N1)NC2=C(C=CC=C2Cl)Cl,gastric inflammation,CID000003961,losartan,CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)CO)Cl
CID000002803,clonidine,C1CN=C(N1)NC2=C(C=CC=C2Cl)Cl,loss of weight,CID000004614,oxaprozin,C1=CC=C(C=C1)C2=C(OC(=N2)CCC(=O)O)C3=CC=CC=C3
CID000002803,clonidine,C1CN=C(N1)NC2=C(C=CC=C2Cl)Cl,gastric inflammation,CID000005376,(E/Z)-Tamoxifen,CCC(=C(C1=CC=CC=C1)C2=CC=C(C=C2)OCCN(C)C)C3=CC=CC=C3
CID000002803,clonidine,C1CN=C(N1)NC2=C(C=CC=C2Cl)Cl,loss of weight,CID000005095,ropinirole,CCCN(CCC)CCC1=C2CC(=O)NC2=CC=C1
CID000002803,clonidine,C1CN=C(N1)NC2=C(C=CC=C2Cl)Cl,cholecystitis,CID000003676,lidocaine,CCN(CC)CC(=O)NC1=C(C=CC=C1C)C
CID000002803,clonidine,C1CN=C(N1)NC2=C(C=CC=C2Cl)Cl,cholecystitis,CID000004691,"3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine",C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4
CID000002803,clonidine,C1CN=C(N1)NC2=C(C=CC=C2Cl)Cl,apoplexy,CID000004909,primidone,CCC1(C(=O)NCNC1=O)C2=CC=CC=C2
CID000002803,clonidine,C1CN=C(N1)NC2=C(C=CC=C2Cl)Cl,cholecystitis,CID000004900,Fernisone,CC12CC(=O)C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C
CID000002803,clonidine,C1CN=C(N1)NC2=C(C=CC=C2Cl)Cl,cholecystitis,CID000027991,DESMOPRESSIN,C1CC(N(C1)C(=O)C2CSSCCC(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N2)CC(=O)N)CCC(=O)N)CC3=CC=CC=C3)CC4=CC=C(C=C4)O)C(=O)NC(CCCN=C(N)N)C(=O)NCC(=O)N
CID000002803,clonidine,C1CN=C(N1)NC2=C(C=CC=C2Cl)Cl,apoplexy,CID000005978,vincristine,CCC1(CC2CC(C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)C78CCN9C7C(C=CC9)(C(C(C8N6C=O)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O
CID000002803,clonidine,C1CN=C(N1)NC2=C(C=CC=C2Cl)Cl,cholecystitis,CID000062924,"S-(fluoromethyl) (6S,9R,10S,11S,13S,14S,16R,17R)-6,9-difluoro-11,17-dihydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthrene-17-carbothioate",CC1CC2C3CC(C4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)SCF)O)C)O)F)C)F
CID000002803,clonidine,C1CN=C(N1)NC2=C(C=CC=C2Cl)Cl,Acne,CID000004585,"2-methyl-4-(4-methylpiperazin-1-yl)-5H-thieno[3,2-c][1,5]benzodiazepine",CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C
CID000002803,clonidine,C1CN=C(N1)NC2=C(C=CC=C2Cl)Cl,gastric inflammation,CID000003937,N~2~-(1-carboxy-3-phenylpropyl)lysylproline,C1CC(N(C1)C(=O)C(CCCCN)NC(CCC2=CC=CC=C2)C(=O)O)C(=O)O
CID000002803,clonidine,C1CN=C(N1)NC2=C(C=CC=C2Cl)Cl,cholecystitis,CID000003749,irbesartan,CCCCC1=NC2(CCCC2)C(=O)N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5
CID000002803,clonidine,C1CN=C(N1)NC2=C(C=CC=C2Cl)Cl,insulin dependent diabetes mellitus,CID000002907,cyclophosphamide,C1CNP(=O)(OC1)N(CCCl)CCCl
CID000002803,clonidine,C1CN=C(N1)NC2=C(C=CC=C2Cl)Cl,gastric inflammation,CID000004158,methylphenidate,COC(=O)C(C1CCCCN1)C2=CC=CC=C2
CID000002803,clonidine,C1CN=C(N1)NC2=C(C=CC=C2Cl)Cl,insulin dependent diabetes mellitus,CID000003310,33419-42-0,CC1OCC2C(O1)C(C(C(O2)OC3C4COC(=O)C4C(C5=CC6=C(C=C35)OCO6)C7=CC(=C(C(=C7)OC)O)OC)O)O
CID000002803,clonidine,C1CN=C(N1)NC2=C(C=CC=C2Cl)Cl,apoplexy,CID000004748,perphenazine,C1CN(CCN1CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)Cl)CCO
CID000002803,clonidine,C1CN=C(N1)NC2=C(C=CC=C2Cl)Cl,cholecystitis,CID000004679,pantoprazole,COC1=C(C(=NC=C1)CS(=O)C2=NC3=C(N2)C=C(C=C3)OC(F)F)OC
CID000002803,clonidine,C1CN=C(N1)NC2=C(C=CC=C2Cl)Cl,apoplexy,CID000005719,zaleplon,CCN(C1=CC=CC(=C1)C2=CC=NC3=C(C=NN23)C#N)C(=O)C
CID000002803,clonidine,C1CN=C(N1)NC2=C(C=CC=C2Cl)Cl,aspiration pneumonia,CID000036339,Etomidate,CCOC(=O)C1=CN=CN1C(C)C2=CC=CC=C2
CID000002803,clonidine,C1CN=C(N1)NC2=C(C=CC=C2Cl)Cl,apoplexy,CID000004189,miconazole,C1=CC(=C(C=C1Cl)Cl)COC(CN2C=CN=C2)C3=C(C=C(C=C3)Cl)Cl
CID000002803,clonidine,C1CN=C(N1)NC2=C(C=CC=C2Cl)Cl,gastric inflammation,CID000003325,famotidine,C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N
CID000002803,clonidine,C1CN=C(N1)NC2=C(C=CC=C2Cl)Cl,bulging,CID000060754,Gadodiamide hydrate,CNC(=O)CN(CCN(CCN(CC(=O)NC)CC(=O)[O-])CC(=O)[O-])CC(=O)[O-].O.[Gd+3]
CID000002803,clonidine,C1CN=C(N1)NC2=C(C=CC=C2Cl)Cl,gastric inflammation,CID000003440,furosemide,C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl
CID000002803,clonidine,C1CN=C(N1)NC2=C(C=CC=C2Cl)Cl,abnormal ECG,CID005493444,Aliskiren,CC(C)C(CC1=CC(=C(C=C1)OC)OCCCOC)CC(C(CC(C(C)C)C(=O)NCC(C)(C)C(=O)N)O)N
CID000002803,clonidine,C1CN=C(N1)NC2=C(C=CC=C2Cl)Cl,thrombocytopenia,CID000163742,SCHEMBL1650579,COC1C(C(C(C(O1)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)COS(=O)(=O)O)OC4C(C(C(C(O4)C(=O)O)OC5C(C(C(C(O5)COS(=O)(=O)O)O)O)NS(=O)(=O)O)O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O)NS(=O)(=O)O
CID000002803,clonidine,C1CN=C(N1)NC2=C(C=CC=C2Cl)Cl,elevated cholesterol,CID000110635,Tadalafil,CN1CC(=O)N2C(C1=O)CC3=C(C2C4=CC5=C(C=C4)OCO5)NC6=CC=CC=C36
CID000002803,clonidine,C1CN=C(N1)NC2=C(C=CC=C2Cl)Cl,loss of weight,CID000004075,5-Aminosalicylic acid,C1=CC(=C(C=C1N)C(=O)O)O
CID000002803,clonidine,C1CN=C(N1)NC2=C(C=CC=C2Cl)Cl,joint stiffness,CID000003954,loperamide(1+),CN(C)C(=O)C(CC[NH+]1CCC(CC1)(C2=CC=C(C=C2)Cl)O)(C3=CC=CC=C3)C4=CC=CC=C4
CID000002803,clonidine,C1CN=C(N1)NC2=C(C=CC=C2Cl)Cl,gastric inflammation,CID003468412,SCHEMBL1176571,CC1C=CC=CCCC=CC=CC=CC=CC(CC(C(C(CC(=O)CC(C(CCC(CC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)C(=O)O)O)OC2C(C(C(C(O2)C)O)N)O
CID000002803,clonidine,C1CN=C(N1)NC2=C(C=CC=C2Cl)Cl,drug toxicity NOS,CID000004894,"11,17,21-Trihydroxypregna-1,4-diene-3,20-dione",CC12CC(C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C)O
CID000002803,clonidine,C1CN=C(N1)NC2=C(C=CC=C2Cl)Cl,gastric inflammation,CID000003405,2-[[4-[(2-amino-4-oxo-1H-pteridin-6-yl)methylamino]benzoyl]amino]pentanedioic acid,C1=CC(=CC=C1C(=O)NC(CCC(=O)O)C(=O)O)NCC2=CN=C3C(=N2)C(=O)N=C(N3)N
CID000002803,clonidine,C1CN=C(N1)NC2=C(C=CC=C2Cl)Cl,apoplexy,CID000004138,55-40-3,CC(CC1=CC(=C(C=C1)O)O)(C(=O)O)N
CID000002803,clonidine,C1CN=C(N1)NC2=C(C=CC=C2Cl)Cl,gastric inflammation,CID000004911,probenecid,CCCN(CCC)S(=O)(=O)C1=CC=C(C=C1)C(=O)O
CID000002803,clonidine,C1CN=C(N1)NC2=C(C=CC=C2Cl)Cl,Adenopathy,CID000003148,dolasetron,C1C2CC3CC(CC1N3CC2=O)OC(=O)C4=CNC5=CC=CC=C54
CID000002803,clonidine,C1CN=C(N1)NC2=C(C=CC=C2Cl)Cl,gastric inflammation,CID006398525,,C(C1C(C(C(C(O1)OC2(C(C(C(O2)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)COS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.[Al].[Al].[Al].[Al].[Al].[Al].[Al].[Al].[Al]
CID000002803,clonidine,C1CN=C(N1)NC2=C(C=CC=C2Cl)Cl,allergic dermatitis,CID000005645,"3,7-Dihydroxycholan-24-oic acid",CC(CCC(=O)O)C1CCC2C1(CCC3C2C(CC4C3(CCC(C4)O)C)O)C
CID000002803,clonidine,C1CN=C(N1)NC2=C(C=CC=C2Cl)Cl,gastric inflammation,CID000004510,nitroglycerin,C(C(CO[N+](=O)[O-])O[N+](=O)[O-])O[N+](=O)[O-]
CID000004044,mefenamic acid,CC1=C(C(=CC=C1)NC2=CC=CC=C2C(=O)O)C,neumonia,CID000005645,"3,7-Dihydroxycholan-24-oic acid",CC(CCC(=O)O)C1CCC2C1(CCC3C2C(CC4C3(CCC(C4)O)C)O)C
CID000004044,mefenamic acid,CC1=C(C(=CC=C1)NC2=CC=CC=C2C(=O)O)C,erythema,CID000004691,"3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine",C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4
CID000004044,mefenamic acid,CC1=C(C(=CC=C1)NC2=CC=CC=C2C(=O)O)C,gastric inflammation,CID006447131,Pimecrolimus,CCC1C=C(CC(CC(C2C(CC(C(O2)(C(=O)C(=O)N3CCCCC3C(=O)OC(C(C(CC1=O)O)C)C(=CC4CCC(C(C4)OC)Cl)C)O)C)OC)OC)C)C
CID000004044,mefenamic acid,CC1=C(C(=CC=C1)NC2=CC=CC=C2C(=O)O)C,gastric inflammation,CID000060787,sequinavir,CC(C)(C)NC(=O)C1CC2CCCCC2CN1CC(C(CC3=CC=CC=C3)NC(=O)C(CC(=O)N)NC(=O)C4=NC5=CC=CC=C5C=C4)O
CID000004044,mefenamic acid,CC1=C(C(=CC=C1)NC2=CC=CC=C2C(=O)O)C,acute pancreatitis,CID000004894,"11,17,21-Trihydroxypregna-1,4-diene-3,20-dione",CC12CC(C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C)O
CID000004044,mefenamic acid,CC1=C(C(=CC=C1)NC2=CC=CC=C2C(=O)O)C,gastric inflammation,CID000004679,pantoprazole,COC1=C(C(=NC=C1)CS(=O)C2=NC3=C(N2)C=C(C=C3)OC(F)F)OC
CID000004044,mefenamic acid,CC1=C(C(=CC=C1)NC2=CC=CC=C2C(=O)O)C,Back Ache,CID000004889,Pravastatin Impurity A,CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC(CC(CC(=O)O)O)O)O
CID000004044,mefenamic acid,CC1=C(C(=CC=C1)NC2=CC=CC=C2C(=O)O)C,erythema,CID000004173,metronidazole,CC1=NC=C(N1CCO)[N+](=O)[O-]
CID000005376,(E/Z)-Tamoxifen,CCC(=C(C1=CC=CC=C1)C2=CC=C(C=C2)OCCN(C)C)C3=CC=CC=C3,loss of weight,CID000060852,Ibandronic Acid,CCCCCN(C)CCC(O)(P(=O)(O)O)P(=O)(O)O
CID000005376,(E/Z)-Tamoxifen,CCC(=C(C1=CC=CC=C1)C2=CC=C(C=C2)OCCN(C)C)C3=CC=CC=C3,respiratory failure,CID003468412,SCHEMBL1176571,CC1C=CC=CCCC=CC=CC=CC=CC(CC(C(C(CC(=O)CC(C(CCC(CC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)C(=O)O)O)OC2C(C(C(C(O2)C)O)N)O
CID000005376,(E/Z)-Tamoxifen,CCC(=C(C1=CC=CC=C1)C2=CC=C(C=C2)OCCN(C)C)C3=CC=CC=C3,Ovarian cancer,CID000005544,Mycolog,CC12CC(C3(C(C1CC(C2(C(=O)CO)O)O)CCC4=CC(=O)C=CC43C)F)O
CID000005376,(E/Z)-Tamoxifen,CCC(=C(C1=CC=CC=C1)C2=CC=C(C=C2)OCCN(C)C)C3=CC=CC=C3,dry skin,CID000005478,racemic-Timolol,CC(C)(C)NCC(COC1=NSN=C1N2CCOCC2)O
CID000005376,(E/Z)-Tamoxifen,CCC(=C(C1=CC=CC=C1)C2=CC=C(C=C2)OCCN(C)C)C3=CC=CC=C3,loss of weight,CID000005584,trimipramine,CC(CN1C2=CC=CC=C2CCC3=CC=CC=C31)CN(C)C
CID000005376,(E/Z)-Tamoxifen,CCC(=C(C1=CC=CC=C1)C2=CC=C(C=C2)OCCN(C)C)C3=CC=CC=C3,apoplexy,CID006398525,,C(C1C(C(C(C(O1)OC2(C(C(C(O2)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)COS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.[Al].[Al].[Al].[Al].[Al].[Al].[Al].[Al].[Al]
CID000005376,(E/Z)-Tamoxifen,CCC(=C(C1=CC=CC=C1)C2=CC=C(C=C2)OCCN(C)C)C3=CC=CC=C3,gastric inflammation,CID000005732,zolpidem,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C
CID000005376,(E/Z)-Tamoxifen,CCC(=C(C1=CC=CC=C1)C2=CC=C(C=C2)OCCN(C)C)C3=CC=CC=C3,confusion,CID000170361,Varenicline,C1C2CNCC1C3=CC4=NC=CN=C4C=C23
CID000005376,(E/Z)-Tamoxifen,CCC(=C(C1=CC=CC=C1)C2=CC=C(C=C2)OCCN(C)C)C3=CC=CC=C3,Sinus headache,CID000062924,"S-(fluoromethyl) (6S,9R,10S,11S,13S,14S,16R,17R)-6,9-difluoro-11,17-dihydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthrene-17-carbothioate",CC1CC2C3CC(C4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)SCF)O)C)O)F)C)F
CID000005376,(E/Z)-Tamoxifen,CCC(=C(C1=CC=CC=C1)C2=CC=C(C=C2)OCCN(C)C)C3=CC=CC=C3,thrombocytopenia,CID000005978,vincristine,CCC1(CC2CC(C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)C78CCN9C7C(C=CC9)(C(C(C8N6C=O)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O
CID000005376,(E/Z)-Tamoxifen,CCC(=C(C1=CC=CC=C1)C2=CC=C(C=C2)OCCN(C)C)C3=CC=CC=C3,elevated cholesterol,CID000005394,temozolomide,CN1C(=O)N2C=NC(=C2N=N1)C(=O)N
CID000005376,(E/Z)-Tamoxifen,CCC(=C(C1=CC=CC=C1)C2=CC=C(C=C2)OCCN(C)C)C3=CC=CC=C3,weight gain,CID000005645,"3,7-Dihydroxycholan-24-oic acid",CC(CCC(=O)O)C1CCC2C1(CCC3C2C(CC4C3(CCC(C4)O)C)O)C
CID000005376,(E/Z)-Tamoxifen,CCC(=C(C1=CC=CC=C1)C2=CC=C(C=C2)OCCN(C)C)C3=CC=CC=C3,breast neoplasm,CID000005512,124936-74-9,CC1=CC(=C(C=C1)O)C(CCN(C(C)C)C(C)C)C2=CC=CC=C2
CID000005376,(E/Z)-Tamoxifen,CCC(=C(C1=CC=CC=C1)C2=CC=C(C=C2)OCCN(C)C)C3=CC=CC=C3,erythema,CID000060184,"2'-epi-Perindopril, (2'R)-",CCCC(C(=O)OCC)NC(C)C(=O)N1C2CCCCC2CC1C(=O)O
CID000005376,(E/Z)-Tamoxifen,CCC(=C(C1=CC=CC=C1)C2=CC=C(C=C2)OCCN(C)C)C3=CC=CC=C3,loss of weight,CID000005650,N-pentanoyl-N-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-L-valine,CCCCC(=O)N(CC1=CC=C(C=C1)C2=CC=CC=C2C3=NNN=N3)C(C(C)C)C(=O)O
CID000005376,(E/Z)-Tamoxifen,CCC(=C(C1=CC=CC=C1)C2=CC=C(C=C2)OCCN(C)C)C3=CC=CC=C3,loss of weight,CID000019090,megestrol,CC1=CC2C(CCC3(C2CCC3(C(=O)C)O)C)C4(C1=CC(=O)CC4)C
CID000004543,nortriptyline,CNCCC=C1C2=CC=CC=C2CCC3=CC=CC=C31,apoplexy,CID000005245,Risedronic acid,C1=CC(=CN=C1)CC(O)(P(=O)(O)O)P(=O)(O)O
CID000004543,nortriptyline,CNCCC=C1C2=CC=CC=C2CCC3=CC=CC=C31,apoplexy,CID000005650,N-pentanoyl-N-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-L-valine,CCCCC(=O)N(CC1=CC=C(C=C1)C2=CC=CC=C2C3=NNN=N3)C(C(C)C)C(=O)O
CID000004543,nortriptyline,CNCCC=C1C2=CC=CC=C2CCC3=CC=CC=C31,gastric inflammation,CID000004679,pantoprazole,COC1=C(C(=NC=C1)CS(=O)C2=NC3=C(N2)C=C(C=C3)OC(F)F)OC
CID000004543,nortriptyline,CNCCC=C1C2=CC=CC=C2CCC3=CC=CC=C31,agitated,CID000160051,Colesevelam,CCCCCCCCCCNCC=C.C[N+](C)(C)CCCCCCNCC=C.C=CCN.C1C(O1)CCl.Cl.[Cl-]
CID000004543,nortriptyline,CNCCC=C1C2=CC=CC=C2CCC3=CC=CC=C31,thrombocytopenia,CID000110635,Tadalafil,CN1CC(=O)N2C(C1=O)CC3=C(C2C4=CC5=C(C=C4)OCO5)NC6=CC=CC=C36
CID000004543,nortriptyline,CNCCC=C1C2=CC=CC=C2CCC3=CC=CC=C31,gastric inflammation,CID000012536,638-94-8,CC1(OC2CC3C4CCC5=CC(=O)C=CC5(C4C(CC3(C2(O1)C(=O)CO)C)O)C)C
CID000004543,nortriptyline,CNCCC=C1C2=CC=CC=C2CCC3=CC=CC=C31,agitated,CID000005073,risperidone,CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F
CID000004543,nortriptyline,CNCCC=C1C2=CC=CC=C2CCC3=CC=CC=C31,methaemoglobinaemia,CID000004900,Fernisone,CC12CC(=O)C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C
CID000004543,nortriptyline,CNCCC=C1C2=CC=CC=C2CCC3=CC=CC=C31,loss of weight,CID000170361,Varenicline,C1C2CNCC1C3=CC4=NC=CN=C4C=C23
CID000004543,nortriptyline,CNCCC=C1C2=CC=CC=C2CCC3=CC=CC=C31,myelodysplasia,CID000004894,"11,17,21-Trihydroxypregna-1,4-diene-3,20-dione",CC12CC(C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C)O
CID000004543,nortriptyline,CNCCC=C1C2=CC=CC=C2CCC3=CC=CC=C31,icterus,CID000060787,sequinavir,CC(C)(C)NC(=O)C1CC2CCCCC2CN1CC(C(CC3=CC=CC=C3)NC(=O)C(CC(=O)N)NC(=O)C4=NC5=CC=CC=C5C=C4)O
CID000004543,nortriptyline,CNCCC=C1C2=CC=CC=C2CCC3=CC=CC=C31,back injury,CID006398525,,C(C1C(C(C(C(O1)OC2(C(C(C(O2)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)COS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.[Al].[Al].[Al].[Al].[Al].[Al].[Al].[Al].[Al]
CID000004543,nortriptyline,CNCCC=C1C2=CC=CC=C2CCC3=CC=CC=C31,gastric inflammation,CID000004614,oxaprozin,C1=CC=C(C=C1)C2=C(OC(=N2)CCC(=O)O)C3=CC=CC=C3
CID000004543,nortriptyline,CNCCC=C1C2=CC=CC=C2CCC3=CC=CC=C31,erythema,CID000005732,zolpidem,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C
CID000004543,nortriptyline,CNCCC=C1C2=CC=CC=C2CCC3=CC=CC=C31,dry skin,CID000005152,Salmeterol,C1=CC=C(C=C1)CCCCOCCCCCCNCC(C2=CC(=C(C=C2)O)CO)O
CID000004543,nortriptyline,CNCCC=C1C2=CC=CC=C2CCC3=CC=CC=C31,apoplexy,CID000005645,"3,7-Dihydroxycholan-24-oic acid",CC(CCC(=O)O)C1CCC2C1(CCC3C2C(CC4C3(CCC(C4)O)C)O)C
CID000004543,nortriptyline,CNCCC=C1C2=CC=CC=C2CCC3=CC=CC=C31,insulin dependent diabetes mellitus,CID000005487,tizanidine,C1CN=C(N1)NC2=C(C=CC3=NSN=C32)Cl
CID000004543,nortriptyline,CNCCC=C1C2=CC=CC=C2CCC3=CC=CC=C31,heart rate increased,CID000077992,Frovatriptan,CNC1CCC2=C(C1)C3=C(N2)C=CC(=C3)C(=O)N
CID000004543,nortriptyline,CNCCC=C1C2=CC=CC=C2CCC3=CC=CC=C31,gastric inflammation,CID000004927,promethazine,CC(CN1C2=CC=CC=C2SC3=CC=CC=C31)N(C)C
CID000004543,nortriptyline,CNCCC=C1C2=CC=CC=C2CCC3=CC=CC=C31,loss of weight,CID000004920,"1-acetyl-9a,11a-dimethyl-1H,2H,3H,3aH,3bH,4H,5H,7H,8H,9H,9aH,9bH,10H,11H,11aH-cyclopenta[a]phenanthren-7-one",CC(=O)C1CCC2C1(CCC3C2CCC4=CC(=O)CCC34C)C
CID000004543,nortriptyline,CNCCC=C1C2=CC=CC=C2CCC3=CC=CC=C31,Adenopathy,CID000005719,zaleplon,CCN(C1=CC=CC(=C1)C2=CC=NC3=C(C=NN23)C#N)C(=O)C
CID000004543,nortriptyline,CNCCC=C1C2=CC=CC=C2CCC3=CC=CC=C31,gastric inflammation,CID000004856,"3-[hydroxy-(pyridin-2-ylamino)methylidene]-2-methyl-1,1-dioxo-1lambda6,2-benzothiazin-4-one",CN1C(=C(NC2=CC=CC=N2)O)C(=O)C3=CC=CC=C3S1(=O)=O
CID000004543,nortriptyline,CNCCC=C1C2=CC=CC=C2CCC3=CC=CC=C31,apoplexy,CID000005512,124936-74-9,CC1=CC(=C(C=C1)O)C(CCN(C(C)C)C(C)C)C2=CC=CC=C2
CID000004543,nortriptyline,CNCCC=C1C2=CC=CC=C2CCC3=CC=CC=C31,agitated,CID000004666,7-Epi Paclitaxel,CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C
CID000004543,nortriptyline,CNCCC=C1C2=CC=CC=C2CCC3=CC=CC=C31,gastric inflammation,CID000004889,Pravastatin Impurity A,CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC(CC(CC(=O)O)O)O)O
CID000004543,nortriptyline,CNCCC=C1C2=CC=CC=C2CCC3=CC=CC=C31,dizziness,CID000019090,megestrol,CC1=CC2C(CCC3(C2CCC3(C(=O)C)O)C)C4(C1=CC(=O)CC4)C
CID000004543,nortriptyline,CNCCC=C1C2=CC=CC=C2CCC3=CC=CC=C31,gastric inflammation,CID000005358,sumatriptan,CNS(=O)(=O)CC1=CC2=C(C=C1)NC=C2CCN(C)C
CID000004543,nortriptyline,CNCCC=C1C2=CC=CC=C2CCC3=CC=CC=C31,loss of weight,CID000005352,38194-50-2,CC1=C(C2=C(C1=CC3=CC=C(C=C3)S(=O)C)C=CC(=C2)F)CC(=O)O
CID000004543,nortriptyline,CNCCC=C1C2=CC=CC=C2CCC3=CC=CC=C31,erythema,CID000005544,Mycolog,CC12CC(C3(C(C1CC(C2(C(=O)CO)O)O)CCC4=CC(=O)C=CC43C)F)O
CID000004543,nortriptyline,CNCCC=C1C2=CC=CC=C2CCC3=CC=CC=C31,apoplexy,CID003468412,SCHEMBL1176571,CC1C=CC=CCCC=CC=CC=CC=CC(CC(C(C(CC(=O)CC(C(CCC(CC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)C(=O)O)O)OC2C(C(C(C(O2)C)O)N)O
CID000004543,nortriptyline,CNCCC=C1C2=CC=CC=C2CCC3=CC=CC=C31,insulin dependent diabetes mellitus,CID000004748,perphenazine,C1CN(CCN1CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)Cl)CCO
CID000004543,nortriptyline,CNCCC=C1C2=CC=CC=C2CCC3=CC=CC=C31,erythema,CID000062924,"S-(fluoromethyl) (6S,9R,10S,11S,13S,14S,16R,17R)-6,9-difluoro-11,17-dihydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthrene-17-carbothioate",CC1CC2C3CC(C4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)SCF)O)C)O)F)C)F
CID000004543,nortriptyline,CNCCC=C1C2=CC=CC=C2CCC3=CC=CC=C31,apoplexy,CID000060854,Ziprasidone,C1CN(CCN1CCC2=C(C=C3C(=C2)CC(=O)N3)Cl)C4=NSC5=CC=CC=C54
CID000004543,nortriptyline,CNCCC=C1C2=CC=CC=C2CCC3=CC=CC=C31,loss of weight,CID000060852,Ibandronic Acid,CCCCCN(C)CCC(O)(P(=O)(O)O)P(=O)(O)O
CID000004543,nortriptyline,CNCCC=C1C2=CC=CC=C2CCC3=CC=CC=C31,gastric inflammation,CID000004585,"2-methyl-4-(4-methylpiperazin-1-yl)-5H-thieno[3,2-c][1,5]benzodiazepine",CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C
CID000004543,nortriptyline,CNCCC=C1C2=CC=CC=C2CCC3=CC=CC=C31,Adenopathy,CID000004601,orphenadrine,CC1=CC=CC=C1C(C2=CC=CC=C2)OCCN(C)C
CID000004543,nortriptyline,CNCCC=C1C2=CC=CC=C2CCC3=CC=CC=C31,methaemoglobinaemia,CID000004691,"3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine",C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4
CID000004543,nortriptyline,CNCCC=C1C2=CC=CC=C2CCC3=CC=CC=C31,dysarthria,CID000005095,ropinirole,CCCN(CCC)CCC1=C2CC(=O)NC2=CC=C1
CID000005650,N-pentanoyl-N-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-L-valine,CCCCC(=O)N(CC1=CC=C(C=C1)C2=CC=CC=C2C3=NNN=N3)C(C(C)C)C(=O)O,apoplexy,CID000060184,"2'-epi-Perindopril, (2'R)-",CCCC(C(=O)OCC)NC(C)C(=O)N1C2CCCCC2CC1C(=O)O
CID000005650,N-pentanoyl-N-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-L-valine,CCCCC(=O)N(CC1=CC=C(C=C1)C2=CC=CC=C2C3=NNN=N3)C(C(C)C)C(=O)O,ild,CID000027686,CHEMBL4088679,C1=CC2=C(C(=C1)OCC(COC3=CC4=C(C=C3)OC(=CC4=O)C(=O)O)O)C(=O)C=C(O2)C(=O)O
CID000005650,N-pentanoyl-N-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-L-valine,CCCCC(=O)N(CC1=CC=C(C=C1)C2=CC=CC=C2C3=NNN=N3)C(C(C)C)C(=O)O,abnormal ECG,CID005493444,Aliskiren,CC(C)C(CC1=CC(=C(C=C1)OC)OCCCOC)CC(C(CC(C(C)C)C(=O)NCC(C)(C)C(=O)N)O)N
CID000005650,N-pentanoyl-N-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-L-valine,CCCCC(=O)N(CC1=CC=C(C=C1)C2=CC=CC=C2C3=NNN=N3)C(C(C)C)C(=O)O,fibrosing alveolitis,CID004479097,"cobalt;[5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] 1-[3-[2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2,7,12,17-tetrahydro-1H-corrin-21-id-3-yl]propanoylamino]propan-2-yl phosphate;hydrate",CC1=CC2=C(C=C1C)N(C=N2)C3C(C(C(O3)CO)OP(=O)([O-])OC(C)CNC(=O)CCC4(C(C5C6(C(C(C(=N6)C(=C7C(C(C(=N7)C=C8C(C(C(=N8)C(=C4[N-]5)C)CCC(=O)N)(C)C)CCC(=O)N)(C)CC(=O)N)C)CCC(=O)N)(C)CC(=O)N)C)CC(=O)N)C)O.O.[Co]
CID000005650,N-pentanoyl-N-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-L-valine,CCCCC(=O)N(CC1=CC=C(C=C1)C2=CC=CC=C2C3=NNN=N3)C(C(C)C)C(=O)O,erythema,CID000005732,zolpidem,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C
CID000005650,N-pentanoyl-N-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-L-valine,CCCCC(=O)N(CC1=CC=C(C=C1)C2=CC=CC=C2C3=NNN=N3)C(C(C)C)C(=O)O,cholecystitis,CID003468412,SCHEMBL1176571,CC1C=CC=CCCC=CC=CC=CC=CC(CC(C(C(CC(=O)CC(C(CCC(CC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)C(=O)O)O)OC2C(C(C(C(O2)C)O)N)O
CID000005650,N-pentanoyl-N-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-L-valine,CCCCC(=O)N(CC1=CC=C(C=C1)C2=CC=CC=C2C3=NNN=N3)C(C(C)C)C(=O)O,thrombocytopenia,CID000039765,Vecuronium,CC(=O)OC1CC2CCC3C(C2(CC1N4CCCCC4)C)CCC5(C3CC(C5OC(=O)C)[N+]6(CCCCC6)C)C
CID000005650,N-pentanoyl-N-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-L-valine,CCCCC(=O)N(CC1=CC=C(C=C1)C2=CC=CC=C2C3=NNN=N3)C(C(C)C)C(=O)O,gout,CID000160051,Colesevelam,CCCCCCCCCCNCC=C.C[N+](C)(C)CCCCCCNCC=C.C=CCN.C1C(O1)CCl.Cl.[Cl-]
CID000005650,N-pentanoyl-N-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-L-valine,CCCCC(=O)N(CC1=CC=C(C=C1)C2=CC=CC=C2C3=NNN=N3)C(C(C)C)C(=O)O,thrombocytopenia,CID005311082,"2-[(1R,4S,10S,13S,19S)-19-[4-(diaminomethylideneamino)butyl]-10-(1H-indol-3-ylmethyl)-3,9,12,15,18,21,27-heptaoxo-24,25-dithia-2,8,11,14,17,20-hexazatricyclo[18.6.1.04,8]heptacosan-13-yl]acetic acid",C1CC2C(=O)NC3CSSCCC(=O)N(C3=O)C(C(=O)NCC(=O)NC(C(=O)NC(C(=O)N2C1)CC4=CNC5=CC=CC=C54)CC(=O)O)CCCCN=C(N)N
CID000005650,N-pentanoyl-N-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-L-valine,CCCCC(=O)N(CC1=CC=C(C=C1)C2=CC=CC=C2C3=NNN=N3)C(C(C)C)C(=O)O,dysarthria,CID000057537,92206-54-7,CCCN(CCC1=CC=CS1)C2CCC3=C(C2)C=CC=C3O
CID000005650,N-pentanoyl-N-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-L-valine,CCCCC(=O)N(CC1=CC=C(C=C1)C2=CC=CC=C2C3=NNN=N3)C(C(C)C)C(=O)O,Adenopathy,CID000667490,6-Mercaptopurine,C1=NC2=C(N1)C(=S)N=CN2
CID000005650,N-pentanoyl-N-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-L-valine,CCCCC(=O)N(CC1=CC=C(C=C1)C2=CC=CC=C2C3=NNN=N3)C(C(C)C)C(=O)O,apoplexy,CID000060854,Ziprasidone,C1CN(CCN1CCC2=C(C=C3C(=C2)CC(=O)N3)Cl)C4=NSC5=CC=CC=C54
CID000005650,N-pentanoyl-N-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-L-valine,CCCCC(=O)N(CC1=CC=C(C=C1)C2=CC=CC=C2C3=NNN=N3)C(C(C)C)C(=O)O,eruption,CID000071616,Voriconazole,CC(C1=NC=NC=C1F)C(CN2C=NC=N2)(C3=C(C=C(C=C3)F)F)O
CID000005650,N-pentanoyl-N-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-L-valine,CCCCC(=O)N(CC1=CC=C(C=C1)C2=CC=CC=C2C3=NNN=N3)C(C(C)C)C(=O)O,Arrhythmia,CID000009052,2-hydroxy-3-[1-(4-nitrophenyl)-3-oxobutyl]chromen-4-one,CC(=O)CC(C1=CC=C(C=C1)[N+](=O)[O-])C2=C(OC3=CC=CC=C3C2=O)O
CID000005650,N-pentanoyl-N-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-L-valine,CCCCC(=O)N(CC1=CC=C(C=C1)C2=CC=CC=C2C3=NNN=N3)C(C(C)C)C(=O)O,mouth ulcer,CID000027991,DESMOPRESSIN,C1CC(N(C1)C(=O)C2CSSCCC(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N2)CC(=O)N)CCC(=O)N)CC3=CC=CC=C3)CC4=CC=C(C=C4)O)C(=O)NC(CCCN=C(N)N)C(=O)NCC(=O)N
CID000005650,N-pentanoyl-N-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-L-valine,CCCCC(=O)N(CC1=CC=C(C=C1)C2=CC=CC=C2C3=NNN=N3)C(C(C)C)C(=O)O,apoplexy,CID000005978,vincristine,CCC1(CC2CC(C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)C78CCN9C7C(C=CC9)(C(C(C8N6C=O)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O
CID000005650,N-pentanoyl-N-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-L-valine,CCCCC(=O)N(CC1=CC=C(C=C1)C2=CC=CC=C2C3=NNN=N3)C(C(C)C)C(=O)O,deglutition disorder,CID000048175,"[(6S,9R,16S,17R)-17-(2-chloroacetyl)-6,9-difluoro-11-hydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl] propanoate",CCC(=O)OC1(C(CC2C1(CC(C3(C2CC(C4=CC(=O)C=CC43C)F)F)O)C)C)C(=O)CCl
CID000005650,N-pentanoyl-N-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-L-valine,CCCCC(=O)N(CC1=CC=C(C=C1)C2=CC=CC=C2C3=NNN=N3)C(C(C)C)C(=O)O,Back Ache,CID000005719,zaleplon,CCN(C1=CC=CC(=C1)C2=CC=NC3=C(C=NN23)C#N)C(=O)C
CID000005650,N-pentanoyl-N-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-L-valine,CCCCC(=O)N(CC1=CC=C(C=C1)C2=CC=CC=C2C3=NNN=N3)C(C(C)C)C(=O)O,adenomyosis,CID006447131,Pimecrolimus,CCC1C=C(CC(CC(C2C(CC(C(O2)(C(=O)C(=O)N3CCCCC3C(=O)OC(C(C(CC1=O)O)C)C(=CC4CCC(C(C4)OC)Cl)C)O)C)OC)OC)C)C
CID000005650,N-pentanoyl-N-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-L-valine,CCCCC(=O)N(CC1=CC=C(C=C1)C2=CC=CC=C2C3=NNN=N3)C(C(C)C)C(=O)O,rotator cuff syndrome,CID000060865,(E)-Olopatadine,CN(C)CCC=C1C2=CC=CC=C2COC3=C1C=C(C=C3)CC(=O)O
CID000005650,N-pentanoyl-N-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-L-valine,CCCCC(=O)N(CC1=CC=C(C=C1)C2=CC=CC=C2C3=NNN=N3)C(C(C)C)C(=O)O,gastric inflammation,CID000060852,Ibandronic Acid,CCCCCN(C)CCC(O)(P(=O)(O)O)P(=O)(O)O
CID000005650,N-pentanoyl-N-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-L-valine,CCCCC(=O)N(CC1=CC=C(C=C1)C2=CC=CC=C2C3=NNN=N3)C(C(C)C)C(=O)O,erythema,CID000062924,"S-(fluoromethyl) (6S,9R,10S,11S,13S,14S,16R,17R)-6,9-difluoro-11,17-dihydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthrene-17-carbothioate",CC1CC2C3CC(C4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)SCF)O)C)O)F)C)F
CID000005650,N-pentanoyl-N-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-L-valine,CCCCC(=O)N(CC1=CC=C(C=C1)C2=CC=CC=C2C3=NNN=N3)C(C(C)C)C(=O)O,gastric inflammation,CID006398525,,C(C1C(C(C(C(O1)OC2(C(C(C(O2)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)COS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.[Al].[Al].[Al].[Al].[Al].[Al].[Al].[Al].[Al]
CID000005650,N-pentanoyl-N-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-L-valine,CCCCC(=O)N(CC1=CC=C(C=C1)C2=CC=CC=C2C3=NNN=N3)C(C(C)C)C(=O)O,failure to thrive,CID000019090,megestrol,CC1=CC2C(CCC3(C2CCC3(C(=O)C)O)C)C4(C1=CC(=O)CC4)C
CID000005650,N-pentanoyl-N-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-L-valine,CCCCC(=O)N(CC1=CC=C(C=C1)C2=CC=CC=C2C3=NNN=N3)C(C(C)C)C(=O)O,agitated,CID000125017,Desvenlafaxine,CN(C)CC(C1=CC=C(C=C1)O)C2(CCCCC2)O
CID000005650,N-pentanoyl-N-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-L-valine,CCCCC(=O)N(CC1=CC=C(C=C1)C2=CC=CC=C2C3=NNN=N3)C(C(C)C)C(=O)O,cholecystectomies,CID000170361,Varenicline,C1C2CNCC1C3=CC4=NC=CN=C4C=C23
CID000005650,N-pentanoyl-N-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-L-valine,CCCCC(=O)N(CC1=CC=C(C=C1)C2=CC=CC=C2C3=NNN=N3)C(C(C)C)C(=O)O,abnormal ECG,CID000071329,Dofetilide,CN(CCC1=CC=C(C=C1)NS(=O)(=O)C)CCOC2=CC=C(C=C2)NS(=O)(=O)C
CID000005650,N-pentanoyl-N-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-L-valine,CCCCC(=O)N(CC1=CC=C(C=C1)C2=CC=CC=C2C3=NNN=N3)C(C(C)C)C(=O)O,dysarthria,CID000163742,SCHEMBL1650579,COC1C(C(C(C(O1)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)COS(=O)(=O)O)OC4C(C(C(C(O4)C(=O)O)OC5C(C(C(C(O5)COS(=O)(=O)O)O)O)NS(=O)(=O)O)O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O)NS(=O)(=O)O
CID000005650,N-pentanoyl-N-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-L-valine,CCCCC(=O)N(CC1=CC=C(C=C1)C2=CC=CC=C2C3=NNN=N3)C(C(C)C)C(=O)O,cholelithiasis,CID000016231,AMILORIDE,C1(=C(N=C(C(=N1)Cl)N)N)C(=O)N=C(N)N
CID000005650,N-pentanoyl-N-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-L-valine,CCCCC(=O)N(CC1=CC=C(C=C1)C2=CC=CC=C2C3=NNN=N3)C(C(C)C)C(=O)O,gastric inflammation,CID000110635,Tadalafil,CN1CC(=O)N2C(C1=O)CC3=C(C2C4=CC5=C(C=C4)OCO5)NC6=CC=CC=C36
CID000003148,dolasetron,C1C2CC3CC(CC1N3CC2=O)OC(=O)C4=CNC5=CC=CC=C54,thrombocytopenia,CID000003333,felodipine,CCOC(=O)C1=C(NC(=C(C1C2=C(C(=CC=C2)Cl)Cl)C(=O)OC)C)C
CID000003148,dolasetron,C1C2CC3CC(CC1N3CC2=O)OC(=O)C4=CNC5=CC=CC=C54,abdominal pain upper,CID000004927,promethazine,CC(CN1C2=CC=CC=C2SC3=CC=CC=C31)N(C)C
CID000003148,dolasetron,C1C2CC3CC(CC1N3CC2=O)OC(=O)C4=CNC5=CC=CC=C54,thrombocytopenia,CID000005245,Risedronic acid,C1=CC(=CN=C1)CC(O)(P(=O)(O)O)P(=O)(O)O
CID000003148,dolasetron,C1C2CC3CC(CC1N3CC2=O)OC(=O)C4=CNC5=CC=CC=C54,insulin dependent diabetes mellitus,CID000003937,N~2~-(1-carboxy-3-phenylpropyl)lysylproline,C1CC(N(C1)C(=O)C(CCCCN)NC(CCC2=CC=CC=C2)C(=O)O)C(=O)O
CID000003148,dolasetron,C1C2CC3CC(CC1N3CC2=O)OC(=O)C4=CNC5=CC=CC=C54,eruption,CID000005544,Mycolog,CC12CC(C3(C(C1CC(C2(C(=O)CO)O)O)CCC4=CC(=O)C=CC43C)F)O
CID000003148,dolasetron,C1C2CC3CC(CC1N3CC2=O)OC(=O)C4=CNC5=CC=CC=C54,thrombocytopenia,CID000005152,Salmeterol,C1=CC=C(C=C1)CCCCOCCCCCCNCC(C2=CC(=C(C=C2)O)CO)O
CID000003148,dolasetron,C1C2CC3CC(CC1N3CC2=O)OC(=O)C4=CNC5=CC=CC=C54,Adenopathy,CID000005732,zolpidem,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C
CID000003148,dolasetron,C1C2CC3CC(CC1N3CC2=O)OC(=O)C4=CNC5=CC=CC=C54,erythema,CID000003676,lidocaine,CCN(CC)CC(=O)NC1=C(C=CC=C1C)C
CID000003148,dolasetron,C1C2CC3CC(CC1N3CC2=O)OC(=O)C4=CNC5=CC=CC=C54,loss of weight,CID000005394,temozolomide,CN1C(=O)N2C=NC(=C2N=N1)C(=O)N
CID000003148,dolasetron,C1C2CC3CC(CC1N3CC2=O)OC(=O)C4=CNC5=CC=CC=C54,High blood pressure,CID000003310,33419-42-0,CC1OCC2C(O1)C(C(C(O2)OC3C4COC(=O)C4C(C5=CC6=C(C=C35)OCO6)C7=CC(=C(C(=C7)OC)O)OC)O)O
CID000003148,dolasetron,C1C2CC3CC(CC1N3CC2=O)OC(=O)C4=CNC5=CC=CC=C54,weight gain,CID000062924,"S-(fluoromethyl) (6S,9R,10S,11S,13S,14S,16R,17R)-6,9-difluoro-11,17-dihydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthrene-17-carbothioate",CC1CC2C3CC(C4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)SCF)O)C)O)F)C)F
CID000003148,dolasetron,C1C2CC3CC(CC1N3CC2=O)OC(=O)C4=CNC5=CC=CC=C54,trigeminal neuralgia,CID000003405,2-[[4-[(2-amino-4-oxo-1H-pteridin-6-yl)methylamino]benzoyl]amino]pentanedioic acid,C1=CC(=CC=C1C(=O)NC(CCC(=O)O)C(=O)O)NCC2=CN=C3C(=N2)C(=O)N=C(N3)N
CID000003148,dolasetron,C1C2CC3CC(CC1N3CC2=O)OC(=O)C4=CNC5=CC=CC=C54,Bacteraemia,CID000004173,metronidazole,CC1=NC=C(N1CCO)[N+](=O)[O-]
CID000003148,dolasetron,C1C2CC3CC(CC1N3CC2=O)OC(=O)C4=CNC5=CC=CC=C54,edema,CID003468412,SCHEMBL1176571,CC1C=CC=CCCC=CC=CC=CC=CC(CC(C(C(CC(=O)CC(C(CCC(CC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)C(=O)O)O)OC2C(C(C(C(O2)C)O)N)O
CID000003148,dolasetron,C1C2CC3CC(CC1N3CC2=O)OC(=O)C4=CNC5=CC=CC=C54,cholecystitis,CID000004900,Fernisone,CC12CC(=O)C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C
CID000003148,dolasetron,C1C2CC3CC(CC1N3CC2=O)OC(=O)C4=CNC5=CC=CC=C54,angiitis,CID006398525,,C(C1C(C(C(C(O1)OC2(C(C(C(O2)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)COS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.[Al].[Al].[Al].[Al].[Al].[Al].[Al].[Al].[Al]
CID000003148,dolasetron,C1C2CC3CC(CC1N3CC2=O)OC(=O)C4=CNC5=CC=CC=C54,thrombocytopenia,CID000004889,Pravastatin Impurity A,CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC(CC(CC(=O)O)O)O)O
CID000003148,dolasetron,C1C2CC3CC(CC1N3CC2=O)OC(=O)C4=CNC5=CC=CC=C54,loss of weight,CID000003961,losartan,CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)CO)Cl
CID000003148,dolasetron,C1C2CC3CC(CC1N3CC2=O)OC(=O)C4=CNC5=CC=CC=C54,rhinorrhea,CID000003883,lansoprazole,CC1=C(C=CN=C1CS(=O)C2=NC3=CC=CC=C3N2)OCC(F)(F)F
CID000003148,dolasetron,C1C2CC3CC(CC1N3CC2=O)OC(=O)C4=CNC5=CC=CC=C54,loss of weight,CID000019090,megestrol,CC1=CC2C(CCC3(C2CCC3(C(=O)C)O)C)C4(C1=CC(=O)CC4)C
CID000003148,dolasetron,C1C2CC3CC(CC1N3CC2=O)OC(=O)C4=CNC5=CC=CC=C54,loss of weight,CID000003661,L-Hyoscyamine,CN1C2CCC1CC(C2)OC(=O)C(CO)C3=CC=CC=C3
CID000003148,dolasetron,C1C2CC3CC(CC1N3CC2=O)OC(=O)C4=CNC5=CC=CC=C54,angiitis,CID000004666,7-Epi Paclitaxel,CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C
CID000003148,dolasetron,C1C2CC3CC(CC1N3CC2=O)OC(=O)C4=CNC5=CC=CC=C54,Bacteraemia,CID000003749,irbesartan,CCCCC1=NC2(CCCC2)C(=O)N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5
CID000003148,dolasetron,C1C2CC3CC(CC1N3CC2=O)OC(=O)C4=CNC5=CC=CC=C54,erythema,CID000003325,famotidine,C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N
CID000003148,dolasetron,C1C2CC3CC(CC1N3CC2=O)OC(=O)C4=CNC5=CC=CC=C54,flashing lights,CID000003954,loperamide(1+),CN(C)C(=O)C(CC[NH+]1CCC(CC1)(C2=CC=C(C=C2)Cl)O)(C3=CC=CC=C3)C4=CC=CC=C4
CID000003148,dolasetron,C1C2CC3CC(CC1N3CC2=O)OC(=O)C4=CNC5=CC=CC=C54,gastric inflammation,CID000004691,"3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine",C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4
CID000003148,dolasetron,C1C2CC3CC(CC1N3CC2=O)OC(=O)C4=CNC5=CC=CC=C54,apoplexy,CID000004510,nitroglycerin,C(C(CO[N+](=O)[O-])O[N+](=O)[O-])O[N+](=O)[O-]
CID000003148,dolasetron,C1C2CC3CC(CC1N3CC2=O)OC(=O)C4=CNC5=CC=CC=C54,eruption,CID000005358,sumatriptan,CNS(=O)(=O)CC1=CC2=C(C=C1)NC=C2CCN(C)C
CID000003148,dolasetron,C1C2CC3CC(CC1N3CC2=O)OC(=O)C4=CNC5=CC=CC=C54,agitated,CID000005978,vincristine,CCC1(CC2CC(C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)C78CCN9C7C(C=CC9)(C(C(C8N6C=O)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O
CID000003148,dolasetron,C1C2CC3CC(CC1N3CC2=O)OC(=O)C4=CNC5=CC=CC=C54,hepatic neoplasia,CID000003440,furosemide,C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl
CID000003148,dolasetron,C1C2CC3CC(CC1N3CC2=O)OC(=O)C4=CNC5=CC=CC=C54,arterial pressure NOS decreased,CID000003658,hydroxyzine,C1CN(CCN1CCOCCO)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl
CID000003148,dolasetron,C1C2CC3CC(CC1N3CC2=O)OC(=O)C4=CNC5=CC=CC=C54,gastric inflammation,CID000004679,pantoprazole,COC1=C(C(=NC=C1)CS(=O)C2=NC3=C(N2)C=C(C=C3)OC(F)F)OC
CID000003325,famotidine,C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N,ear infection,CID000003516,guaifenesin,COC1=CC=CC=C1OCC(CO)O
CID000003325,famotidine,C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N,myelodysplasia,CID000003780,"D-Glucitol, 1,4:3,6-dianhydro-, 2,5-dinitrate",C1C(C2C(O1)C(CO2)O[N+](=O)[O-])O[N+](=O)[O-]
CID000003325,famotidine,C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N,eruption,CID000003414,phosphonatoformate,C(=O)([O-])P(=O)([O-])[O-]
CID000003325,famotidine,C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N,weight gain,CID000003410,formoterol,CC(CC1=CC=C(C=C1)OC)NCC(C2=CC(=C(C=C2)O)NC=O)O
CID000003325,famotidine,C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N,gout,CID000003890,TRANS (15S)-LATANOPROST,CC(C)OC(=O)CCCC=CCC1C(CC(C1CCC(CCC2=CC=CC=C2)O)O)O
CID000003325,famotidine,C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N,gastric inflammation,CID000004679,pantoprazole,COC1=C(C(=NC=C1)CS(=O)C2=NC3=C(N2)C=C(C=C3)OC(F)F)OC
CID000003325,famotidine,C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N,Infection Upper Respiratory,CID000003661,L-Hyoscyamine,CN1C2CCC1CC(C2)OC(=O)C(CO)C3=CC=CC=C3
CID000003325,famotidine,C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N,cholecystitis,CID000004201,minoxidil,C1CCN(CC1)C2=NC(=N)N(C(=C2)N)O
CID000003325,famotidine,C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N,gastric inflammation,CID000004205,mirtazapine,CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4
CID000003325,famotidine,C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N,cholecystitis,CID000003961,losartan,CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)CO)Cl
CID000003325,famotidine,C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N,gastric inflammation,CID000004909,primidone,CCC1(C(=O)NCNC1=O)C2=CC=CC=C2
CID000003325,famotidine,C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N,gastric inflammation,CID000004900,Fernisone,CC12CC(=O)C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C
CID000003325,famotidine,C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N,gastric inflammation,CID000003405,2-[[4-[(2-amino-4-oxo-1H-pteridin-6-yl)methylamino]benzoyl]amino]pentanedioic acid,C1=CC(=CC=C1C(=O)NC(CCC(=O)O)C(=O)O)NCC2=CN=C3C(=N2)C(=O)N=C(N3)N
CID000003325,famotidine,C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N,erythema,CID000060754,Gadodiamide hydrate,CNC(=O)CN(CCN(CCN(CC(=O)NC)CC(=O)[O-])CC(=O)[O-])CC(=O)[O-].O.[Gd+3]
CID000003325,famotidine,C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N,confusion,CID000074989,ATOVAQUONE,C1CC(CCC1C2=CC=C(C=C2)Cl)C3=C(C4=CC=CC=C4C(=O)C3=O)O
CID000003325,famotidine,C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N,kidney failure,CID006447131,Pimecrolimus,CCC1C=C(CC(CC(C2C(CC(C(O2)(C(=O)C(=O)N3CCCCC3C(=O)OC(C(C(CC1=O)O)C)C(=CC4CCC(C(C4)OC)Cl)C)O)C)OC)OC)C)C
CID000003325,famotidine,C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N,carotid bruit,CID000110635,Tadalafil,CN1CC(=O)N2C(C1=O)CC3=C(C2C4=CC5=C(C=C4)OCO5)NC6=CC=CC=C36
CID000003325,famotidine,C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N,gastric inflammation,CID000004601,orphenadrine,CC1=CC=CC=C1C(C2=CC=CC=C2)OCCN(C)C
CID000003325,famotidine,C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N,erythema,CID000003658,hydroxyzine,C1CN(CCN1CCOCCO)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl
CID000003325,famotidine,C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N,insulin dependent diabetes mellitus,CID000005719,zaleplon,CCN(C1=CC=CC(=C1)C2=CC=NC3=C(C=NN23)C#N)C(=O)C
CID000003325,famotidine,C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N,apoplexy,CID000003449,Epigalanthamin,CN1CCC23C=CC(CC2OC4=C(C=CC(=C34)C1)OC)O
CID000003325,famotidine,C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N,erythema,CID000003763,isoflurane,C(C(F)(F)F)(OC(F)F)Cl
CID000003325,famotidine,C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N,Adenopathy,CID000003440,furosemide,C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl
CID000003325,famotidine,C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N,bursitis,CID000004920,"1-acetyl-9a,11a-dimethyl-1H,2H,3H,3aH,3bH,4H,5H,7H,8H,9H,9aH,9bH,10H,11H,11aH-cyclopenta[a]phenanthren-7-one",CC(=O)C1CCC2C1(CCC3C2CCC4=CC(=O)CCC34C)C
CID000003325,famotidine,C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N,eruption,CID000027991,DESMOPRESSIN,C1CC(N(C1)C(=O)C2CSSCCC(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N2)CC(=O)N)CCC(=O)N)CC3=CC=CC=C3)CC4=CC=C(C=C4)O)C(=O)NC(CCCN=C(N)N)C(=O)NCC(=O)N
CID000003325,famotidine,C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N,cholecystitis,CID000062924,"S-(fluoromethyl) (6S,9R,10S,11S,13S,14S,16R,17R)-6,9-difluoro-11,17-dihydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthrene-17-carbothioate",CC1CC2C3CC(C4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)SCF)O)C)O)F)C)F
CID000003325,famotidine,C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N,abnormal ECG,CID000071329,Dofetilide,CN(CCC1=CC=C(C=C1)NS(=O)(=O)C)CCOC2=CC=C(C=C2)NS(=O)(=O)C
CID000003325,famotidine,C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N,Adenopathy,CID000005152,Salmeterol,C1=CC=C(C=C1)CCCCOCCCCCCNCC(C2=CC(=C(C=C2)O)CO)O
CID000003325,famotidine,C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N,weight gain,CID000119182,Clofarabine,C1=NC2=C(N=C(N=C2N1C3C(C(C(O3)CO)O)F)Cl)N
CID000003325,famotidine,C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N,cholecystitis,CID000005645,"3,7-Dihydroxycholan-24-oic acid",CC(CCC(=O)O)C1CCC2C1(CCC3C2C(CC4C3(CCC(C4)O)C)O)C
CID000003325,"3-[[2-(diaminomethylideneamino)-1,3-thiazol-4-yl]methylsulfanyl]-N'-sulfamoylpropanimidamide",C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N,parotitis,CID000004894,"11,17,21-Trihydroxypregna-1,4-diene-3,20-dione",CC12CC(C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C)O
CID000003325,famotidine,C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N,eruption,CID000003734,Bracco 15000,CC(C(=O)NC1=C(C(=C(C(=C1I)C(=O)NC(CO)CO)I)C(=O)NC(CO)CO)I)O
CID000003325,famotidine,C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N,cholecystitis,CID000005487,tizanidine,C1CN=C(N1)NC2=C(C=CC3=NSN=C32)Cl
CID000003325,famotidine,C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N,back injury,CID000004510,nitroglycerin,C(C(CO[N+](=O)[O-])O[N+](=O)[O-])O[N+](=O)[O-]
CID000003325,famotidine,C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N,Penile pain,CID000005073,risperidone,CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F
CID000003325,famotidine,C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N,enlarged liver,CID000131536,Fosamprenavir,CC(C)CN(CC(C(CC1=CC=CC=C1)NC(=O)OC2CCOC2)OP(=O)(O)O)S(=O)(=O)C3=CC=C(C=C3)N
CID000003325,famotidine,C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N,gastric inflammation,CID000003827,ketotifen,CN1CCC(=C2C3=C(C(=O)CC4=CC=CC=C42)SC=C3)CC1
CID000003325,famotidine,C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N,cholecystitis,CID000004173,metronidazole,CC1=NC=C(N1CCO)[N+](=O)[O-]
CID000003325,famotidine,C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N,cholecystitis,CID000004178,Mexiletine,CC1=C(C(=CC=C1)C)OCC(C)N
CID000003325,famotidine,C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N,deglutition disorder,CID000004819,"2(3H)-Furanone, 3-ethyldihydro-4-[(1-methyl-1H-imidazol-5-yl)methyl]-, (3S-cis)-",CCC1C(COC1=O)CC2=CN=CN2C
CID000003325,famotidine,C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N,erythema,CID000004666,7-Epi Paclitaxel,CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C
CID000003325,famotidine,C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N,gastric inflammation,CID000027686,CHEMBL4088679,C1=CC2=C(C(=C1)OCC(COC3=CC4=C(C=C3)OC(=CC4=O)C(=O)O)O)C(=O)C=C(O2)C(=O)O
CID000003325,famotidine,C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N,Adenopathy,CID000003937,N~2~-(1-carboxy-3-phenylpropyl)lysylproline,C1CC(N(C1)C(=O)C(CCCCN)NC(CCC2=CC=CC=C2)C(=O)O)C(=O)O
CID000003325,famotidine,C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N,Diplopia,CID000003676,lidocaine,CCN(CC)CC(=O)NC1=C(C=CC=C1C)C
CID000003325,famotidine,C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N,cholecystitis,CID000005732,zolpidem,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C
CID000003325,famotidine,C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N,Adenopathy,CID000003339,fenofibrate,CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C2=CC=C(C=C2)Cl
CID000003325,famotidine,C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N,gastric inflammation,CID000003333,felodipine,CCOC(=O)C1=C(NC(=C(C1C2=C(C(=CC=C2)Cl)Cl)C(=O)OC)C)C
CID000003325,famotidine,C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N,gastric inflammation,CID000004236,modafinil,C1=CC=C(C=C1)C(C2=CC=CC=C2)S(=O)CC(=O)N
CID000003325,famotidine,C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N,Dyspnea exertional,CID000003954,loperamide(1+),CN(C)C(=O)C(CC[NH+]1CCC(CC1)(C2=CC=C(C=C2)Cl)O)(C3=CC=CC=C3)C4=CC=CC=C4
CID000003325,famotidine,C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N,loss of weight,CID000071616,Voriconazole,CC(C1=NC=NC=C1F)C(CN2C=NC=N2)(C3=C(C=C(C=C3)F)F)O
CID000003325,famotidine,C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N,back injury,CID000003749,irbesartan,CCCCC1=NC2(CCCC2)C(=O)N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5
CID000003325,famotidine,C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N,arteriosclerotic heart disease,CID000003741,ioversol,C(CO)N(C1=C(C(=C(C(=C1I)C(=O)NCC(CO)O)I)C(=O)NCC(CO)O)I)C(=O)CO
CID000003325,famotidine,C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N,abnormal ECG,CID000004911,probenecid,CCCN(CCC)S(=O)(=O)C1=CC=C(C=C1)C(=O)O
CID000003325,famotidine,C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N,constipated,CID000005352,38194-50-2,CC1=C(C2=C(C1=CC3=CC=C(C=C3)S(=O)C)C=CC(=C2)F)CC(=O)O
CID000003325,famotidine,C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N,back injury,CID000005358,sumatriptan,CNS(=O)(=O)CC1=CC2=C(C=C1)NC=C2CCN(C)C
CID000003325,famotidine,C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N,right heart failure,CID000004170,metolazone,CC1NC2=CC(=C(C=C2C(=O)N1C3=CC=CC=C3C)S(=O)(=O)N)Cl
CID000003325,famotidine,C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N,gout,CID000170361,Varenicline,C1C2CNCC1C3=CC4=NC=CN=C4C=C23
CID000003325,famotidine,C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N,Adenopathy,CID005311082,"2-[(1R,4S,10S,13S,19S)-19-[4-(diaminomethylideneamino)butyl]-10-(1H-indol-3-ylmethyl)-3,9,12,15,18,21,27-heptaoxo-24,25-dithia-2,8,11,14,17,20-hexazatricyclo[18.6.1.04,8]heptacosan-13-yl]acetic acid",C1CC2C(=O)NC3CSSCCC(=O)N(C3=O)C(C(=O)NCC(=O)NC(C(=O)NC(C(=O)N2C1)CC4=CNC5=CC=CC=C54)CC(=O)O)CCCCN=C(N)N
CID000003325,famotidine,C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N,gastric inflammation,CID000005544,Mycolog,CC12CC(C3(C(C1CC(C2(C(=O)CO)O)O)CCC4=CC(=O)C=CC43C)F)O
CID000003325,famotidine,C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N,loss of weight,CID000005095,ropinirole,CCCN(CCC)CCC1=C2CC(=O)NC2=CC=C1
CID000003325,famotidine,C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N,hemiplegia,CID000060612,levomedetomidine,CC1=C(C(=CC=C1)C(C)C2=CN=CN2)C
CID000003325,famotidine,C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N,apoplexy,CID000004138,55-40-3,CC(CC1=CC(=C(C=C1)O)O)(C(=O)O)N
CID000003325,famotidine,C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N,loss of weight,CID000160051,Colesevelam,CCCCCCCCCCNCC=C.C[N+](C)(C)CCCCCCNCC=C.C=CCN.C1C(O1)CCl.Cl.[Cl-]
CID000003325,famotidine,C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N,loss of weight,CID000667490,6-Mercaptopurine,C1=NC2=C(N1)C(=S)N=CN2
CID000003325,famotidine,C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N,back injury,CID000005512,124936-74-9,CC1=CC(=C(C=C1)O)C(CCN(C(C)C)C(C)C)C2=CC=CC=C2
CID000003325,famotidine,C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N,loss of weight,CID000004158,methylphenidate,COC(=O)C(C1CCCCN1)C2=CC=CC=C2
CID000003325,famotidine,C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N,edema,CID000060184,"2'-epi-Perindopril, (2'R)-",CCCC(C(=O)OCC)NC(C)C(=O)N1C2CCCCC2CC1C(=O)O
CID000003325,famotidine,C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N,drug withdrawal,CID000003883,lansoprazole,CC1=C(C=CN=C1CS(=O)C2=NC3=CC=CC=C3N2)OCC(F)(F)F
CID000003325,famotidine,C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N,proctalgia,CID000019090,megestrol,CC1=CC2C(CCC3(C2CCC3(C(=O)C)O)C)C4(C1=CC(=O)CC4)C
CID000003325,famotidine,C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N,abnormal EEG,CID000005978,vincristine,CCC1(CC2CC(C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)C78CCN9C7C(C=CC9)(C(C(C8N6C=O)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O
CID000003325,famotidine,C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N,gastric inflammation,CID000060852,Ibandronic Acid,CCCCCN(C)CCC(O)(P(=O)(O)O)P(=O)(O)O
CID000003325,famotidine,C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N,gastric inflammation,CID000060854,Ziprasidone,C1CN(CCN1CCC2=C(C=C3C(=C2)CC(=O)N3)Cl)C4=NSC5=CC=CC=C54
CID000003325,famotidine,C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N,Adenopathy,CID000036339,Etomidate,CCOC(=O)C1=CN=CN1C(C)C2=CC=CC=C2
CID000003325,famotidine,C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N,gastric inflammation,CID000005478,racemic-Timolol,CC(C)(C)NCC(COC1=NSN=C1N2CCOCC2)O
CID000003325,famotidine,C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N,Acne,CID000004889,Pravastatin Impurity A,CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC(CC(CC(=O)O)O)O)O
CID000003325,famotidine,C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N,erythema multiforme,CID000039765,Vecuronium,CC(=O)OC1CC2CCC3C(C2(CC1N4CCCCC4)C)CCC5(C3CC(C5OC(=O)C)[N+]6(CCCCC6)C)C
CID000003325,famotidine,C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N,cardiovascular collapse,CID000163742,SCHEMBL1650579,COC1C(C(C(C(O1)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)COS(=O)(=O)O)OC4C(C(C(C(O4)C(=O)O)OC5C(C(C(C(O5)COS(=O)(=O)O)O)O)NS(=O)(=O)O)O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O)NS(=O)(=O)O
CID000003325,famotidine,C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N,ear infection,CID000060865,(E)-Olopatadine,CN(C)CCC=C1C2=CC=CC=C2COC3=C1C=C(C=C3)CC(=O)O
CID000003325,famotidine,C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N,cholecystitis,CID000004927,promethazine,CC(CN1C2=CC=CC=C2SC3=CC=CC=C31)N(C)C
CID000003325,famotidine,C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N,gastric inflammation,CID000004691,"3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine",C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4
CID000003325,famotidine,C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N,thrombocytopenia,CID000060787,sequinavir,CC(C)(C)NC(=O)C1CC2CCCCC2CN1CC(C(CC3=CC=CC=C3)NC(=O)C(CC(=O)N)NC(=O)C4=NC5=CC=CC=C5C=C4)O
CID000003325,famotidine,C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N,gastric inflammation,CID000004614,oxaprozin,C1=CC=C(C=C1)C2=C(OC(=N2)CCC(=O)O)C3=CC=CC=C3
CID000003325,famotidine,C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N,gastric inflammation,CID000004075,5-Aminosalicylic acid,C1=CC(=C(C=C1N)C(=O)O)O
CID000003325,famotidine,C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N,apoplexy,CID000003869,labetalol,CC(CCC1=CC=CC=C1)NCC(C2=CC(=C(C=C2)O)C(=O)N)O
CID000003325,famotidine,C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N,allergic dermatitis,CID000003642,13609-67-1,CCCC(=O)OC1(CCC2C1(CC(C3C2CCC4=CC(=O)CCC34C)O)C)C(=O)CO
CID000003325,famotidine,C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N,metabolic encephalopathy,CID003468412,SCHEMBL1176571,CC1C=CC=CCCC=CC=CC=CC=CC(CC(C(C(CC(=O)CC(C(CCC(CC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)C(=O)O)O)OC2C(C(C(C(O2)C)O)N)O
CID000003325,famotidine,C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N,allergic dermatitis,CID000004189,miconazole,C1=CC(=C(C=C1Cl)Cl)COC(CN2C=CN=C2)C3=C(C=C(C=C3)Cl)Cl
CID000003325,famotidine,C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N,cholelithiasis,CID000005771,Oxytocin acetate salt hydrate,CCC(C)C1C(=O)NC(C(=O)NC(C(=O)NC(CSSCC(C(=O)NC(C(=O)N1)CC2=CC=C(C=C2)O)N)C(=O)N3CCCC3C(=O)NC(CC(C)C)C(=O)NCC(=O)N)CC(=O)N)CCC(=O)N
CID000003325,famotidine,C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N,cholecystitis,CID000005245,Risedronic acid,C1=CC(=CN=C1)CC(O)(P(=O)(O)O)P(=O)(O)O
CID000003325,famotidine,C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N,insulin dependent diabetes mellitus,CID000004856,"3-[hydroxy-(pyridin-2-ylamino)methylidene]-2-methyl-1,1-dioxo-1lambda6,2-benzothiazin-4-one",CN1C(=C(NC2=CC=CC=N2)O)C(=O)C3=CC=CC=C3S1(=O)=O
CID000003325,famotidine,C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N,increased white blood cell count,CID000004748,perphenazine,C1CN(CCN1CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)Cl)CCO
CID000003325,famotidine,C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N,gastric inflammation,CID000004745,SCHEMBL7711911,CCCN1CC(CC2C1CC3=CNC4=CC=CC2=C34)CSC
CID000003325,famotidine,C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N,cholecystitis,CID006398525,,C(C1C(C(C(C(O1)OC2(C(C(C(O2)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)COS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.[Al].[Al].[Al].[Al].[Al].[Al].[Al].[Al].[Al]
CID000003325,famotidine,C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N,cholecystitis,CID000004585,"2-methyl-4-(4-methylpiperazin-1-yl)-5H-thieno[3,2-c][1,5]benzodiazepine",CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C
CID000003325,famotidine,C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N,Bilirubinaemia,CID000005515,hycamptamine hydrochloride hydrate,CCC1(C2=C(COC1=O)C(=O)N3CC4=CC5=C(C=CC(=C5CN(C)C)O)N=C4C3=C2)O
CID000003325,famotidine,C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N,Adenopathy,CID000005394,temozolomide,CN1C(=O)N2C=NC(=C2N=N1)C(=O)N
CID000005771,Oxytocin acetate salt hydrate,CCC(C)C1C(=O)NC(C(=O)NC(C(=O)NC(CSSCC(C(=O)NC(C(=O)N1)CC2=CC=C(C=C2)O)N)C(=O)N3CCCC3C(=O)NC(CC(C)C)C(=O)NCC(=O)N)CC(=O)N)CCC(=O)N,heart rate increased,CID000039765,Vecuronium,CC(=O)OC1CC2CCC3C(C2(CC1N4CCCCC4)C)CCC5(C3CC(C5OC(=O)C)[N+]6(CCCCC6)C)C
CID000005771,Oxytocin acetate salt hydrate,CCC(C)C1C(=O)NC(C(=O)NC(C(=O)NC(CSSCC(C(=O)NC(C(=O)N1)CC2=CC=C(C=C2)O)N)C(=O)N3CCCC3C(=O)NC(CC(C)C)C(=O)NCC(=O)N)CC(=O)N)CCC(=O)N,Bleeding,CID000036339,Etomidate,CCOC(=O)C1=CN=CN1C(C)C2=CC=CC=C2
CID000002369,betaxolol,CC(C)NCC(COC1=CC=C(C=C1)CCOCC2CC2)O,apoplexy,CID000002806,90055-48-4,COC(=O)C(C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3
CID000002369,betaxolol,CC(C)NCC(COC1=CC=C(C=C1)CCOCC2CC2)O,erythema,CID000003937,N~2~-(1-carboxy-3-phenylpropyl)lysylproline,C1CC(N(C1)C(=O)C(CCCCN)NC(CCC2=CC=CC=C2)C(=O)O)C(=O)O
CID000002369,betaxolol,CC(C)NCC(COC1=CC=C(C=C1)CCOCC2CC2)O,cholecystitis,CID000003890,TRANS (15S)-LATANOPROST,CC(C)OC(=O)CCCC=CCC1C(CC(C1CCC(CCC2=CC=CC=C2)O)O)O
CID000002369,betaxolol,CC(C)NCC(COC1=CC=C(C=C1)CCOCC2CC2)O,apoplexy,CID000004679,pantoprazole,COC1=C(C(=NC=C1)CS(=O)C2=NC3=C(N2)C=C(C=C3)OC(F)F)OC
CID000002369,betaxolol,CC(C)NCC(COC1=CC=C(C=C1)CCOCC2CC2)O,respiratory alkalosis,CID000003440,furosemide,C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl
CID000000444,bupropion,CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C,gastric inflammation,CID000004614,oxaprozin,C1=CC=C(C=C1)C2=C(OC(=N2)CCC(=O)O)C3=CC=CC=C3
CID000000444,bupropion,CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C,weight gain,CID000504578,"(2S,3S,4R,5R,6R)-5-amino-6-[(2R,3S,4R,5S)-5-[(1R,2S,3R,6R)-3-amino-6-[(1S,2R,3R,4R,5R)-2-amino-5-(aminomethyl)-3,4-dihydroxycyclohexyl]oxy-2-hydroxycyclohexyl]oxy-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl]oxy-2-(aminomethyl)oxane-3,4-diol",C1CC(C(C(C1N)O)OC2C(C(C(O2)CO)OC3C(C(C(C(O3)CN)O)O)N)O)OC4CC(C(C(C4N)O)O)CN
CID000000444,bupropion,CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C,loss of weight,CID000003869,labetalol,CC(CCC1=CC=CC=C1)NCC(C2=CC(=C(C=C2)O)C(=O)N)O
CID000000444,bupropion,CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C,gastric inflammation,CID000002099,alosetron,CC1=C(N=CN1)CN2CCC3=C(C2=O)C4=CC=CC=C4N3C
CID000000444,bupropion,CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C,back injury,CID000003059,diflunisal,C1=CC(=C(C=C1C2=C(C=C(C=C2)F)F)C(=O)O)O
CID000000444,bupropion,CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C,Adenopathy,CID000004900,Fernisone,CC12CC(=O)C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C
CID000000444,bupropion,CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C,apoplexy,CID000004909,primidone,CCC1(C(=O)NCNC1=O)C2=CC=CC=C2
CID000000444,bupropion,CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C,cardiac enlargement,CID000000596,Cytosar,C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)O
CID000000444,bupropion,CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C,allergic dermatitis,CID000131536,Fosamprenavir,CC(C)CN(CC(C(CC1=CC=CC=C1)NC(=O)OC2CCOC2)OP(=O)(O)O)S(=O)(=O)C3=CC=C(C=C3)N
CID000000444,bupropion,CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C,arteriosclerotic heart disease,CID000027686,CHEMBL4088679,C1=CC2=C(C(=C1)OCC(COC3=CC4=C(C=C3)OC(=CC4=O)C(=O)O)O)C(=O)C=C(O2)C(=O)O
CID000000444,bupropion,CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C,cholecystitis,CID000005358,sumatriptan,CNS(=O)(=O)CC1=CC2=C(C=C1)NC=C2CCN(C)C
CID000000444,bupropion,CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C,gastric inflammation,CID000005352,38194-50-2,CC1=C(C2=C(C1=CC3=CC=C(C=C3)S(=O)C)C=CC(=C2)F)CC(=O)O
CID000000444,bupropion,CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C,apoplexy,CID006447131,Pimecrolimus,CCC1C=C(CC(CC(C2C(CC(C(O2)(C(=O)C(=O)N3CCCCC3C(=O)OC(C(C(CC1=O)O)C)C(=CC4CCC(C(C4)OC)Cl)C)O)C)OC)OC)C)C
CID000000444,bupropion,CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C,gout,CID000003449,Epigalanthamin,CN1CCC23C=CC(CC2OC4=C(C=CC(=C34)C1)OC)O
CID000000444,bupropion,CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C,Adenopathy,CID000003440,furosemide,C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl
CID000000444,bupropion,CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C,apoplexy,CID000004138,55-40-3,CC(CC1=CC(=C(C=C1)O)O)(C(=O)O)N
CID000000444,bupropion,CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C,gastric inflammation,CID000002907,cyclophosphamide,C1CNP(=O)(OC1)N(CCCl)CCCl
CID000000444,bupropion,CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C,dry skin,CID000060754,Gadodiamide hydrate,CNC(=O)CN(CCN(CCN(CC(=O)NC)CC(=O)[O-])CC(=O)[O-])CC(=O)[O-].O.[Gd+3]
CID000000444,bupropion,CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C,Dyspnea exertional,CID000002733,chlorzoxazone,C1=CC2=C(C=C1Cl)NC(=O)O2
CID000000444,bupropion,CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C,cholecystitis,CID000003062,Lanicor,CC1C(C(CC(O1)OC2C(OC(CC2O)OC3C(OC(CC3O)OC4CCC5(C(C4)CCC6C5CC(C7(C6(CCC7C8=CC(=O)OC8)O)C)O)C)C)C)O)O
CID000000444,bupropion,CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C,agitated,CID000004819,"2(3H)-Furanone, 3-ethyldihydro-4-[(1-methyl-1H-imidazol-5-yl)methyl]-, (3S-cis)-",CCC1C(COC1=O)CC2=CN=CN2C
CID000000444,bupropion,CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C,cholecystectomies,CID000060854,Ziprasidone,C1CN(CCN1CCC2=C(C=C3C(=C2)CC(=O)N3)Cl)C4=NSC5=CC=CC=C54
CID000000444,bupropion,CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C,bursitis,CID000160051,Colesevelam,CCCCCCCCCCNCC=C.C[N+](C)(C)CCCCCCNCC=C.C=CCN.C1C(O1)CCl.Cl.[Cl-]
CID000000444,bupropion,CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C,cholecystitis,CID000005512,124936-74-9,CC1=CC(=C(C=C1)O)C(CCN(C(C)C)C(C)C)C2=CC=CC=C2
CID000000444,bupropion,CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C,Back Ache,CID000001986,acetazolamide,CC(=O)NC1=NN=C(S1)S(=O)(=O)N
CID000000444,bupropion,CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C,gastric inflammation,CID000001983,acetaminophen,CC(=O)NC1=CC=C(C=C1)O
CID000000444,bupropion,CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C,loss of weight,CID000004075,5-Aminosalicylic acid,C1=CC(=C(C=C1N)C(=O)O)O
CID000000444,bupropion,CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C,disorder Renal,CID000071329,Dofetilide,CN(CCC1=CC=C(C=C1)NS(=O)(=O)C)CCOC2=CC=C(C=C2)NS(=O)(=O)C
CID000000444,bupropion,CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C,rhinorrhea,CID000004536,Minovlar,CC12CCC3C(C1CCC2(C#C)O)CCC4=CC(=O)CCC34
CID000000444,bupropion,CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C,loss of weight,CID000003410,formoterol,CC(CC1=CC=C(C=C1)OC)NCC(C2=CC(=C(C=C2)O)NC=O)O
CID000000444,bupropion,CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C,gastric inflammation,CID000004679,pantoprazole,COC1=C(C(=NC=C1)CS(=O)C2=NC3=C(N2)C=C(C=C3)OC(F)F)OC
CID000000444,bupropion,CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C,cellulitis,CID000060184,"2'-epi-Perindopril, (2'R)-",CCCC(C(=O)OCC)NC(C)C(=O)N1C2CCCCC2CC1C(=O)O
CID000000444,bupropion,CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C,Adenopathy,CID000003516,guaifenesin,COC1=CC=CC=C1OCC(CO)O
CID000000444,bupropion,CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C,High blood pressure,CID000004894,"11,17,21-Trihydroxypregna-1,4-diene-3,20-dione",CC12CC(C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C)O
CID000000444,bupropion,CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C,cholecystitis,CID000005544,Mycolog,CC12CC(C3(C(C1CC(C2(C(=O)CO)O)O)CCC4=CC(=O)C=CC43C)F)O
CID000000444,bupropion,CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C,enlarged liver,CID000016231,AMILORIDE,C1(=C(N=C(C(=N1)Cl)N)N)C(=O)N=C(N)N
CID000000444,bupropion,CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C,narcolepsy,CID000002550,1-(2-methyl-3-sulfanylpropanoyl)pyrrolidine-2-carboxylic acid,CC(CS)C(=O)N1CCCC1C(=O)O
CID000000444,bupropion,CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C,bulging,CID000002375,bicalutamide,CC(CS(=O)(=O)C1=CC=C(C=C1)F)(C(=O)NC2=CC(=C(C=C2)C#N)C(F)(F)F)O
CID000000444,bupropion,CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C,apoplexy,CID000001117,sulfate,[O-]S(=O)(=O)[O-]
CID000000444,bupropion,CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C,gastric inflammation,CID000003749,irbesartan,CCCCC1=NC2(CCCC2)C(=O)N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5
CID000000444,bupropion,CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C,Sinus headache,CID000110635,Tadalafil,CN1CC(=O)N2C(C1=O)CC3=C(C2C4=CC5=C(C=C4)OCO5)NC6=CC=CC=C36
CID000000444,bupropion,CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C,back injury,CID000005245,Risedronic acid,C1=CC(=CN=C1)CC(O)(P(=O)(O)O)P(=O)(O)O
CID000000444,bupropion,CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C,apoplexy,CID000005645,"3,7-Dihydroxycholan-24-oic acid",CC(CCC(=O)O)C1CCC2C1(CCC3C2C(CC4C3(CCC(C4)O)C)O)C
CID000000444,bupropion,CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C,dysarthria,CID000125017,Desvenlafaxine,CN(C)CC(C1=CC=C(C=C1)O)C2(CCCCC2)O
CID000000444,bupropion,CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C,cholecystitis,CID000003676,lidocaine,CCN(CC)CC(=O)NC1=C(C=CC=C1C)C
CID000000444,bupropion,CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C,gastric inflammation,CID000001065,9-epi-Quinine,COC1=CC2=C(C=CN=C2C=C1)C(C3CC4CCN3CC4C=C)O
CID000000444,bupropion,CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C,thrombocytopenia,CID000004195,midodrine,COC1=CC(=C(C=C1)OC)C(CNC(=O)CN)O
CID000000444,bupropion,CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C,micturition urgency,CID000003890,TRANS (15S)-LATANOPROST,CC(C)OC(=O)CCCC=CCC1C(CC(C1CCC(CCC2=CC=CC=C2)O)O)O
CID000000444,bupropion,CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C,apoplexy,CID000003042,dicyclomine,CCN(CC)CCOC(=O)C1(CCCCC1)C2CCCCC2
CID000000444,bupropion,CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C,insulin dependent diabetes mellitus,CID000002524,32222-06-3,CC(CCCC(C)(C)O)C1CCC2C1(CCCC2=CC=C3CC(CC(C3=C)O)O)C
CID000000444,bupropion,CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C,cholecystitis,CID000004205,mirtazapine,CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4
CID000000444,bupropion,CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C,Adenopathy,CID000000581,N-Acetyl-DL-cysteine,CC(=O)NC(CS)C(=O)O
CID000000444,bupropion,CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C,bursitis,CID000002609,Lilly 99638,C1C(=C(N2C(S1)C(C2=O)NC(=O)C(C3=CC=CC=C3)N)C(=O)O)Cl
CID000000444,bupropion,CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C,back injury,CID000170361,Varenicline,C1C2CNCC1C3=CC4=NC=CN=C4C=C23
CID000000444,bupropion,CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C,Adenopathy,CID000002022,2-amino-9-(2-hydroxyethoxymethyl)-3H-purin-6-one,C1=NC2=C(N1COCCO)NC(=NC2=O)N
CID000000444,bupropion,CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C,Adenopathy,CID000002806,90055-48-4,COC(=O)C(C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3
CID000000444,bupropion,CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C,loss of weight,CID000019090,megestrol,CC1=CC2C(CCC3(C2CCC3(C(=O)C)O)C)C4(C1=CC(=O)CC4)C
CID000000444,bupropion,CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C,back injury,CID000004510,nitroglycerin,C(C(CO[N+](=O)[O-])O[N+](=O)[O-])O[N+](=O)[O-]
CID000000444,bupropion,CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C,gastric inflammation,CID000005487,tizanidine,C1CN=C(N1)NC2=C(C=CC3=NSN=C32)Cl
CID000000444,bupropion,CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C,cholecystitis,CID000005152,Salmeterol,C1=CC=C(C=C1)CCCCOCCCCCCNCC(C2=CC(=C(C=C2)O)CO)O
CID000000444,bupropion,CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C,angiitis,CID000002405,BISOPROLOL,CC(C)NCC(COC1=CC=C(C=C1)COCCOC(C)C)O
CID000000444,bupropion,CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C,loss of weight,CID000163742,SCHEMBL1650579,COC1C(C(C(C(O1)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)COS(=O)(=O)O)OC4C(C(C(C(O4)C(=O)O)OC5C(C(C(C(O5)COS(=O)(=O)O)O)O)NS(=O)(=O)O)O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O)NS(=O)(=O)O
CID000000444,bupropion,CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C,neumonia,CID000005394,temozolomide,CN1C(=O)N2C=NC(=C2N=N1)C(=O)N
CID000000444,bupropion,CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C,Adenopathy,CID000004236,modafinil,C1=CC=C(C=C1)C(C2=CC=CC=C2)S(=O)CC(=O)N
CID000000444,bupropion,CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C,abnormal EEG,CID000667490,6-Mercaptopurine,C1=NC2=C(N1)C(=S)N=CN2
CID000000444,bupropion,CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C,Adenopathy,CID000060865,(E)-Olopatadine,CN(C)CCC=C1C2=CC=CC=C2COC3=C1C=C(C=C3)CC(=O)O
CID000000444,bupropion,CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C,apoplexy,CID000012536,638-94-8,CC1(OC2CC3C4CCC5=CC(=O)C=CC5(C4C(CC3(C2(O1)C(=O)CO)C)O)C)C
CID000000444,bupropion,CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C,Adenopathy,CID000003405,2-[[4-[(2-amino-4-oxo-1H-pteridin-6-yl)methylamino]benzoyl]amino]pentanedioic acid,C1=CC(=CC=C1C(=O)NC(CCC(=O)O)C(=O)O)NCC2=CN=C3C(=N2)C(=O)N=C(N3)N
CID000000444,bupropion,CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C,apoplexy,CID000004178,Mexiletine,CC1=C(C(=CC=C1)C)OCC(C)N
CID000000444,bupropion,CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C,erythema,CID000004173,metronidazole,CC1=NC=C(N1CCO)[N+](=O)[O-]
CID000000444,bupropion,CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C,cholecystitis,CID000004170,metolazone,CC1NC2=CC(=C(C=C2C(=O)N1C3=CC=CC=C3C)S(=O)(=O)N)Cl
CID000000444,bupropion,CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C,erythema,CID003468412,SCHEMBL1176571,CC1C=CC=CCCC=CC=CC=CC=CC(CC(C(C(CC(=O)CC(C(CCC(CC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)C(=O)O)O)OC2C(C(C(C(O2)C)O)N)O
CID000000444,bupropion,CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C,Back Ache,CID000002646,Cefprozil (E)-isomer,CC=CC1=C(N2C(C(C2=O)NC(=O)C(C3=CC=C(C=C3)O)N)SC1)C(=O)O
CID000000444,bupropion,CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C,cholecystitis,CID000003937,N~2~-(1-carboxy-3-phenylpropyl)lysylproline,C1CC(N(C1)C(=O)C(CCCCN)NC(CCC2=CC=CC=C2)C(=O)O)C(=O)O
CID000000444,bupropion,CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C,loss of weight,CID000004440,naratriptan,CNS(=O)(=O)CCC1=CC2=C(C=C1)NC=C2C3CCN(CC3)C
CID000000444,bupropion,CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C,gastric inflammation,CID000002771,citalopram,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F
CID000000444,bupropion,CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C,Acne,CID000005719,zaleplon,CCN(C1=CC=CC(=C1)C2=CC=NC3=C(C=NN23)C#N)C(=O)C
CID000000444,bupropion,CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C,cholecystitis,CID000002088,ALENDRONIC ACID,C(CC(O)(P(=O)(O)O)P(=O)(O)O)CN
CID000000444,bupropion,CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C,gastric inflammation,CID000005073,risperidone,CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F
CID000000444,bupropion,CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C,gastric inflammation,CID000004856,"3-[hydroxy-(pyridin-2-ylamino)methylidene]-2-methyl-1,1-dioxo-1lambda6,2-benzothiazin-4-one",CN1C(=C(NC2=CC=CC=N2)O)C(=O)C3=CC=CC=C3S1(=O)=O
CID000000444,bupropion,CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C,gastric inflammation,CID006398525,,C(C1C(C(C(C(O1)OC2(C(C(C(O2)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)COS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.[Al].[Al].[Al].[Al].[Al].[Al].[Al].[Al].[Al]
CID000000444,bupropion,CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C,Irritation Skin,CID000057537,92206-54-7,CCCN(CCC1=CC=CS1)C2CCC3=C(C2)C=CC=C3O
CID000000444,bupropion,CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C,back injury,CID000002541,candesartan,CCOC1=NC2=CC=CC(=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5)C(=O)O
CID000000444,bupropion,CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C,allergic dermatitis,CID000115237,Paliperidone,CC1=C(C(=O)N2CCCC(C2=N1)O)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F
CID000000444,bupropion,CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C,Adenopathy,CID000002462,51372-29-3,CCCC1OC2CC3C4CCC5=CC(=O)C=CC5(C4C(CC3(C2(O1)C(=O)CO)C)O)C
CID000000444,bupropion,CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C,cholecystitis,CID000003339,fenofibrate,CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C2=CC=C(C=C2)Cl
CID000000444,bupropion,CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C,cholecystitis,CID000003333,felodipine,CCOC(=O)C1=C(NC(=C(C1C2=C(C(=CC=C2)Cl)Cl)C(=O)OC)C)C
CID000000444,bupropion,CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C,cholecystitis,CID000003961,losartan,CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)CO)Cl
CID000000444,bupropion,CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C,allergic dermatitis,CID000004189,miconazole,C1=CC(=C(C=C1Cl)Cl)COC(CN2C=CN=C2)C3=C(C=C(C=C3)Cl)Cl
CID000000444,bupropion,CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C,loss of weight,CID000005584,trimipramine,CC(CN1C2=CC=CC=C2CCC3=CC=CC=C31)CN(C)C
CID000000444,bupropion,CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C,gastric inflammation,CID000002284,baclofen,C1=CC(=CC=C1C(CC(=O)O)CN)Cl
CID000000444,bupropion,CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C,gastric inflammation,CID000003883,lansoprazole,CC1=C(C=CN=C1CS(=O)C2=NC3=CC=CC=C3N2)OCC(F)(F)F
CID000000444,bupropion,CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C,cholecystitis,CID000003075,"2-[3-acetyloxy-2-(4-methoxyphenyl)-4-oxo-2,3-dihydro-1,5-benzothiazepin-5-yl]ethyl-dimethylazanium",CC(=O)OC1C(SC2=CC=CC=C2N(C1=O)CC[NH+](C)C)C3=CC=C(C=C3)OC
CID000000444,bupropion,CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C,cholecystitis,CID000004927,promethazine,CC(CN1C2=CC=CC=C2SC3=CC=CC=C31)N(C)C
CID000000444,bupropion,CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C,Adenopathy,CID000004920,"1-acetyl-9a,11a-dimethyl-1H,2H,3H,3aH,3bH,4H,5H,7H,8H,9H,9aH,9bH,10H,11H,11aH-cyclopenta[a]phenanthren-7-one",CC(=O)C1CCC2C1(CCC3C2CCC4=CC(=O)CCC34C)C
CID000000444,bupropion,CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C,cholecystitis,CID000001971,914348-29-1,C1CC1NC2=C3C(=NC(=N2)N)N(C=N3)C4CC(C=C4)CO
CID000000444,bupropion,CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C,cholecystitis,CID000003780,"D-Glucitol, 1,4:3,6-dianhydro-, 2,5-dinitrate",C1C(C2C(O1)C(CO2)O[N+](=O)[O-])O[N+](=O)[O-]
CID000000444,bupropion,CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C,cholecystitis,CID000004889,Pravastatin Impurity A,CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC(CC(CC(=O)O)O)O)O
CID000000444,bupropion,CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C,lipoma,CID000004745,SCHEMBL7711911,CCCN1CC(CC2C1CC3=CNC4=CC=CC2=C34)CSC
CID000000444,bupropion,CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C,insulin dependent diabetes mellitus,CID000004748,perphenazine,C1CN(CCN1CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)Cl)CCO
CID000000444,bupropion,CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C,back injury,CID000004601,orphenadrine,CC1=CC=CC=C1C(C2=CC=CC=C2)OCCN(C)C
CID000000444,bupropion,CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C,gastric inflammation,CID000003658,hydroxyzine,C1CN(CCN1CCOCCO)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl
CID000000444,bupropion,CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C,gastric inflammation,CID000004158,methylphenidate,COC(=O)C(C1CCCCN1)C2=CC=CC=C2
CID000000444,bupropion,CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C,cholecystitis,CID000002891,"cobalt(2+);[5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] 1-[3-[2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2,7,12,17-tetrahydro-1H-corrin-21-id-3-yl]propanoylamino]propan-2-yl hydrogen phosphate;cyanide",CC1=CC2=C(C=C1C)N(C=N2)C3C(C(C(O3)CO)OP(=O)(O)OC(C)CNC(=O)CCC4(C(C5C6(C(C(C(=N6)C(=C7C(C(C(=N7)C=C8C(C(C(=N8)C(=C4[N-]5)C)CCC(=O)N)(C)C)CCC(=O)N)(C)CC(=O)N)C)CCC(=O)N)(C)CC(=O)N)C)CC(=O)N)C)O.[C-]#N.[Co+2]
CID000000444,bupropion,CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C,gastric inflammation,CID000004585,"2-methyl-4-(4-methylpiperazin-1-yl)-5H-thieno[3,2-c][1,5]benzodiazepine",CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C
CID000000444,bupropion,CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C,apoplexy,CID000005478,racemic-Timolol,CC(C)(C)NCC(COC1=NSN=C1N2CCOCC2)O
CID000000444,bupropion,CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C,erythema,CID000003954,loperamide(1+),CN(C)C(=O)C(CC[NH+]1CCC(CC1)(C2=CC=C(C=C2)Cl)O)(C3=CC=CC=C3)C4=CC=CC=C4
CID000000444,bupropion,CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C,rotator cuff syndrome,CID000004666,7-Epi Paclitaxel,CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C
CID000000444,bupropion,CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C,apoplexy,CID000060852,Ibandronic Acid,CCCCCN(C)CCC(O)(P(=O)(O)O)P(=O)(O)O
CID000000444,bupropion,CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C,cholecystitis,CID000005732,zolpidem,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C
CID000000444,bupropion,CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C,rotator cuff syndrome,CID000005095,ropinirole,CCCN(CCC)CCC1=C2CC(=O)NC2=CC=C1
CID000000444,bupropion,CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C,Adenopathy,CID000062924,"S-(fluoromethyl) (6S,9R,10S,11S,13S,14S,16R,17R)-6,9-difluoro-11,17-dihydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthrene-17-carbothioate",CC1CC2C3CC(C4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)SCF)O)C)O)F)C)F
CID000000444,bupropion,CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C,increased white blood cell count,CID000060787,sequinavir,CC(C)(C)NC(=O)C1CC2CCCCC2CN1CC(C(CC3=CC=CC=C3)NC(=O)C(CC(=O)N)NC(=O)C4=NC5=CC=CC=C5C=C4)O
CID000000444,bupropion,CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C,Adenopathy,CID000002656,"7-[[2-(2-amino-1,3-thiazol-4-yl)-2-methoxyiminoacetyl]amino]-3-[(2-methyl-6-oxido-5-oxo-1,2,4-triazin-3-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CN1C(=NC(=O)C(=N1)[O-])SCC2=C(N3C(C(C3=O)NC(=O)C(=NOC)C4=CSC(=N4)N)SC2)C(=O)[O-]
CID000000444,bupropion,CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C,elevated cholesterol,CID000004451,CHEMBL365442,CC1=C(C=CC=C1O)C(=O)NC(CSC2=CC=CC=C2)C(CN3CC4CCCCC4CC3C(=O)NC(C)(C)C)O
CID000000444,bupropion,CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C,neumonia,CID000074989,ATOVAQUONE,C1CC(CCC1C2=CC=C(C=C2)Cl)C3=C(C4=CC=CC=C4C(=O)C3=O)O
CID000000444,bupropion,CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C,gastric inflammation,CID000004691,"3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine",C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4
CID000000444,bupropion,CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C,right heart failure,CID000003310,33419-42-0,CC1OCC2C(O1)C(C(C(O2)OC3C4COC(=O)C4C(C5=CC6=C(C=C35)OCO6)C7=CC(=C(C(=C7)OC)O)OC)O)O
CID000004911,probenecid,CCCN(CCC)S(=O)(=O)C1=CC=C(C=C1)C(=O)O,Back Ache,CID000005512,124936-74-9,CC1=CC(=C(C=C1)O)C(CCN(C(C)C)C(C)C)C2=CC=CC=C2
CID000004911,probenecid,CCCN(CCC)S(=O)(=O)C1=CC=C(C=C1)C(=O)O,abnormal ECG,CID000004927,promethazine,CC(CN1C2=CC=CC=C2SC3=CC=CC=C31)N(C)C
CID000004911,probenecid,CCCN(CCC)S(=O)(=O)C1=CC=C(C=C1)C(=O)O,constipated,CID000005732,zolpidem,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C
CID000004911,probenecid,CCCN(CCC)S(=O)(=O)C1=CC=C(C=C1)C(=O)O,weight gain,CID000005152,Salmeterol,C1=CC=C(C=C1)CCCCOCCCCCCNCC(C2=CC(=C(C=C2)O)CO)O
CID000004911,probenecid,CCCN(CCC)S(=O)(=O)C1=CC=C(C=C1)C(=O)O,erythema,CID000062924,"S-(fluoromethyl) (6S,9R,10S,11S,13S,14S,16R,17R)-6,9-difluoro-11,17-dihydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthrene-17-carbothioate",CC1CC2C3CC(C4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)SCF)O)C)O)F)C)F
CID000027991,DESMOPRESSIN,C1CC(N(C1)C(=O)C2CSSCCC(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N2)CC(=O)N)CCC(=O)N)CC3=CC=CC=C3)CC4=CC=C(C=C4)O)C(=O)NC(CCCN=C(N)N)C(=O)NCC(=O)N,rhinorrhea,CID000062924,"S-(fluoromethyl) (6S,9R,10S,11S,13S,14S,16R,17R)-6,9-difluoro-11,17-dihydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthrene-17-carbothioate",CC1CC2C3CC(C4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)SCF)O)C)O)F)C)F
CID000160051,Colesevelam,CCCCCCCCCCNCC=C.C[N+](C)(C)CCCCCCNCC=C.C=CCN.C1C(O1)CCl.Cl.[Cl-],Light sensitivity,CID000170361,Varenicline,C1C2CNCC1C3=CC4=NC=CN=C4C=C23
CID000160051,Colesevelam,CCCCCCCCCCNCC=C.C[N+](C)(C)CCCCCCNCC=C.C=CCN.C1C(O1)CCl.Cl.[Cl-],agitated,CID006398525,,C(C1C(C(C(C(O1)OC2(C(C(C(O2)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)COS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.[Al].[Al].[Al].[Al].[Al].[Al].[Al].[Al].[Al]
CID000160051,Colesevelam,CCCCCCCCCCNCC=C.C[N+](C)(C)CCCCCCNCC=C.C=CCN.C1C(O1)CCl.Cl.[Cl-],deglutition disorder,CID005493444,Aliskiren,CC(C)C(CC1=CC(=C(C=C1)OC)OCCCOC)CC(C(CC(C(C)C)C(=O)NCC(C)(C)C(=O)N)O)N
CID000004679,pantoprazole,COC1=C(C(=NC=C1)CS(=O)C2=NC3=C(N2)C=C(C=C3)OC(F)F)OC,Acne,CID000004894,"11,17,21-Trihydroxypregna-1,4-diene-3,20-dione",CC12CC(C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C)O
CID000004679,pantoprazole,COC1=C(C(=NC=C1)CS(=O)C2=NC3=C(N2)C=C(C=C3)OC(F)F)OC,gastric inflammation,CID000110635,Tadalafil,CN1CC(=O)N2C(C1=O)CC3=C(C2C4=CC5=C(C=C4)OCO5)NC6=CC=CC=C36
CID000004679,pantoprazole,COC1=C(C(=NC=C1)CS(=O)C2=NC3=C(N2)C=C(C=C3)OC(F)F)OC,myelodysplasia,CID000005394,temozolomide,CN1C(=O)N2C=NC(=C2N=N1)C(=O)N
CID000004679,pantoprazole,COC1=C(C(=NC=C1)CS(=O)C2=NC3=C(N2)C=C(C=C3)OC(F)F)OC,bursitis,CID000060852,Ibandronic Acid,CCCCCN(C)CCC(O)(P(=O)(O)O)P(=O)(O)O
CID000004679,pantoprazole,COC1=C(C(=NC=C1)CS(=O)C2=NC3=C(N2)C=C(C=C3)OC(F)F)OC,Pain,CID005311082,"2-[(1R,4S,10S,13S,19S)-19-[4-(diaminomethylideneamino)butyl]-10-(1H-indol-3-ylmethyl)-3,9,12,15,18,21,27-heptaoxo-24,25-dithia-2,8,11,14,17,20-hexazatricyclo[18.6.1.04,8]heptacosan-13-yl]acetic acid",C1CC2C(=O)NC3CSSCCC(=O)N(C3=O)C(C(=O)NCC(=O)NC(C(=O)NC(C(=O)N2C1)CC4=CNC5=CC=CC=C54)CC(=O)O)CCCCN=C(N)N
CID000004679,pantoprazole,COC1=C(C(=NC=C1)CS(=O)C2=NC3=C(N2)C=C(C=C3)OC(F)F)OC,cholecystitis,CID000062924,"S-(fluoromethyl) (6S,9R,10S,11S,13S,14S,16R,17R)-6,9-difluoro-11,17-dihydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthrene-17-carbothioate",CC1CC2C3CC(C4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)SCF)O)C)O)F)C)F
CID000004679,pantoprazole,COC1=C(C(=NC=C1)CS(=O)C2=NC3=C(N2)C=C(C=C3)OC(F)F)OC,gastric inflammation,CID000005487,tizanidine,C1CN=C(N1)NC2=C(C=CC3=NSN=C32)Cl
CID000004679,pantoprazole,COC1=C(C(=NC=C1)CS(=O)C2=NC3=C(N2)C=C(C=C3)OC(F)F)OC,gastric inflammation,CID000060184,"2'-epi-Perindopril, (2'R)-",CCCC(C(=O)OCC)NC(C)C(=O)N1C2CCCCC2CC1C(=O)O
CID000004679,pantoprazole,COC1=C(C(=NC=C1)CS(=O)C2=NC3=C(N2)C=C(C=C3)OC(F)F)OC,gastric inflammation,CID000005512,124936-74-9,CC1=CC(=C(C=C1)O)C(CCN(C(C)C)C(C)C)C2=CC=CC=C2
CID000004679,pantoprazole,COC1=C(C(=NC=C1)CS(=O)C2=NC3=C(N2)C=C(C=C3)OC(F)F)OC,apoplexy,CID000060612,levomedetomidine,CC1=C(C(=CC=C1)C(C)C2=CN=CN2)C
CID000004679,pantoprazole,COC1=C(C(=NC=C1)CS(=O)C2=NC3=C(N2)C=C(C=C3)OC(F)F)OC,muscle disorder,CID000036811,dobutamine,CC(CCC1=CC=C(C=C1)O)NCCC2=CC(=C(C=C2)O)O
CID000004679,pantoprazole,COC1=C(C(=NC=C1)CS(=O)C2=NC3=C(N2)C=C(C=C3)OC(F)F)OC,cholecystitis,CID000005073,risperidone,CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F
CID000004679,pantoprazole,COC1=C(C(=NC=C1)CS(=O)C2=NC3=C(N2)C=C(C=C3)OC(F)F)OC,gastric inflammation,CID006398525,,C(C1C(C(C(C(O1)OC2(C(C(C(O2)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)COS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.[Al].[Al].[Al].[Al].[Al].[Al].[Al].[Al].[Al]
CID000004679,pantoprazole,COC1=C(C(=NC=C1)CS(=O)C2=NC3=C(N2)C=C(C=C3)OC(F)F)OC,erythema,CID000147912,DSSTox_GSID_49066,CCC(C(C)O)N1C(=O)N(C=N1)C2=CC=C(C=C2)N3CCN(CC3)C4=CC=C(C=C4)OCC5CC(OC5)(CN6C=NC=N6)C7=C(C=C(C=C7)F)F
CID000004679,pantoprazole,COC1=C(C(=NC=C1)CS(=O)C2=NC3=C(N2)C=C(C=C3)OC(F)F)OC,angiitis,CID000004819,"2(3H)-Furanone, 3-ethyldihydro-4-[(1-methyl-1H-imidazol-5-yl)methyl]-, (3S-cis)-",CCC1C(COC1=O)CC2=CN=CN2C
CID000004679,pantoprazole,COC1=C(C(=NC=C1)CS(=O)C2=NC3=C(N2)C=C(C=C3)OC(F)F)OC,eating disorder,CID000131536,Fosamprenavir,CC(C)CN(CC(C(CC1=CC=CC=C1)NC(=O)OC2CCOC2)OP(=O)(O)O)S(=O)(=O)C3=CC=C(C=C3)N
CID000004679,pantoprazole,COC1=C(C(=NC=C1)CS(=O)C2=NC3=C(N2)C=C(C=C3)OC(F)F)OC,cholecystitis,CID000005245,Risedronic acid,C1=CC(=CN=C1)CC(O)(P(=O)(O)O)P(=O)(O)O
CID000004679,pantoprazole,COC1=C(C(=NC=C1)CS(=O)C2=NC3=C(N2)C=C(C=C3)OC(F)F)OC,apoplexy,CID000016231,AMILORIDE,C1(=C(N=C(C(=N1)Cl)N)N)C(=O)N=C(N)N
CID000004679,pantoprazole,COC1=C(C(=NC=C1)CS(=O)C2=NC3=C(N2)C=C(C=C3)OC(F)F)OC,gastric inflammation,CID000027686,CHEMBL4088679,C1=CC2=C(C(=C1)OCC(COC3=CC4=C(C=C3)OC(=CC4=O)C(=O)O)O)C(=O)C=C(O2)C(=O)O
CID000004679,pantoprazole,COC1=C(C(=NC=C1)CS(=O)C2=NC3=C(N2)C=C(C=C3)OC(F)F)OC,Benign Neoplasm,CID000005584,trimipramine,CC(CN1C2=CC=CC=C2CCC3=CC=CC=C31)CN(C)C
CID000004679,pantoprazole,COC1=C(C(=NC=C1)CS(=O)C2=NC3=C(N2)C=C(C=C3)OC(F)F)OC,methaemoglobinaemia,CID000005732,zolpidem,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C
CID000004679,pantoprazole,COC1=C(C(=NC=C1)CS(=O)C2=NC3=C(N2)C=C(C=C3)OC(F)F)OC,cholecystitis,CID000060854,Ziprasidone,C1CN(CCN1CCC2=C(C=C3C(=C2)CC(=O)N3)Cl)C4=NSC5=CC=CC=C54
CID000004679,pantoprazole,COC1=C(C(=NC=C1)CS(=O)C2=NC3=C(N2)C=C(C=C3)OC(F)F)OC,back injury,CID000005095,ropinirole,CCCN(CCC)CCC1=C2CC(=O)NC2=CC=C1
CID000004679,pantoprazole,COC1=C(C(=NC=C1)CS(=O)C2=NC3=C(N2)C=C(C=C3)OC(F)F)OC,hypermagnesemia,CID000119182,Clofarabine,C1=NC2=C(N=C(N=C2N1C3C(C(C(O3)CO)O)F)Cl)N
CID000004679,pantoprazole,COC1=C(C(=NC=C1)CS(=O)C2=NC3=C(N2)C=C(C=C3)OC(F)F)OC,atelectasis,CID000039765,Vecuronium,CC(=O)OC1CC2CCC3C(C2(CC1N4CCCCC4)C)CCC5(C3CC(C5OC(=O)C)[N+]6(CCCCC6)C)C
CID000004679,pantoprazole,COC1=C(C(=NC=C1)CS(=O)C2=NC3=C(N2)C=C(C=C3)OC(F)F)OC,apoplexy,CID000004745,SCHEMBL7711911,CCCN1CC(CC2C1CC3=CNC4=CC=CC2=C34)CSC
CID000004679,pantoprazole,COC1=C(C(=NC=C1)CS(=O)C2=NC3=C(N2)C=C(C=C3)OC(F)F)OC,Bacteraemia,CID000004913,PROCAINAMIDE,CCN(CC)CCNC(=O)C1=CC=C(C=C1)N
CID000004679,pantoprazole,COC1=C(C(=NC=C1)CS(=O)C2=NC3=C(N2)C=C(C=C3)OC(F)F)OC,Bone Fracture Spontaneous,CID000019090,megestrol,CC1=CC2C(CCC3(C2CCC3(C(=O)C)O)C)C4(C1=CC(=O)CC4)C
CID000004679,pantoprazole,COC1=C(C(=NC=C1)CS(=O)C2=NC3=C(N2)C=C(C=C3)OC(F)F)OC,loss of weight,CID000004909,primidone,CCC1(C(=O)NCNC1=O)C2=CC=CC=C2
CID000004679,pantoprazole,COC1=C(C(=NC=C1)CS(=O)C2=NC3=C(N2)C=C(C=C3)OC(F)F)OC,elevated cholesterol,CID000048175,"[(6S,9R,16S,17R)-17-(2-chloroacetyl)-6,9-difluoro-11-hydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl] propanoate",CCC(=O)OC1(C(CC2C1(CC(C3(C2CC(C4=CC(=O)C=CC43C)F)F)O)C)C)C(=O)CCl
CID000004679,pantoprazole,COC1=C(C(=NC=C1)CS(=O)C2=NC3=C(N2)C=C(C=C3)OC(F)F)OC,thrombocytopenia,CID000005486,(R)-Tirofiban,CCCCS(=O)(=O)NC(CC1=CC=C(C=C1)OCCCCC2CCNCC2)C(=O)O
CID000004679,pantoprazole,COC1=C(C(=NC=C1)CS(=O)C2=NC3=C(N2)C=C(C=C3)OC(F)F)OC,Adenopathy,CID000005152,Salmeterol,C1=CC=C(C=C1)CCCCOCCCCCCNCC(C2=CC(=C(C=C2)O)CO)O
CID000004679,pantoprazole,COC1=C(C(=NC=C1)CS(=O)C2=NC3=C(N2)C=C(C=C3)OC(F)F)OC,gastric inflammation,CID000005978,vincristine,CCC1(CC2CC(C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)C78CCN9C7C(C=CC9)(C(C(C8N6C=O)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O
CID000004679,pantoprazole,COC1=C(C(=NC=C1)CS(=O)C2=NC3=C(N2)C=C(C=C3)OC(F)F)OC,hypermagnesemia,CID000074989,ATOVAQUONE,C1CC(CCC1C2=CC=C(C=C2)Cl)C3=C(C4=CC=CC=C4C(=O)C3=O)O
CID000004679,pantoprazole,COC1=C(C(=NC=C1)CS(=O)C2=NC3=C(N2)C=C(C=C3)OC(F)F)OC,ear ache,CID000004900,Fernisone,CC12CC(=O)C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C
CID000004679,pantoprazole,COC1=C(C(=NC=C1)CS(=O)C2=NC3=C(N2)C=C(C=C3)OC(F)F)OC,right heart failure,CID000009052,2-hydroxy-3-[1-(4-nitrophenyl)-3-oxobutyl]chromen-4-one,CC(=O)CC(C1=CC=C(C=C1)[N+](=O)[O-])C2=C(OC3=CC=CC=C3C2=O)O
CID000004679,pantoprazole,COC1=C(C(=NC=C1)CS(=O)C2=NC3=C(N2)C=C(C=C3)OC(F)F)OC,methaemoglobinaemia,CID003468412,SCHEMBL1176571,CC1C=CC=CCCC=CC=CC=CC=CC(CC(C(C(CC(=O)CC(C(CCC(CC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)C(=O)O)O)OC2C(C(C(C(O2)C)O)N)O
CID000004679,pantoprazole,COC1=C(C(=NC=C1)CS(=O)C2=NC3=C(N2)C=C(C=C3)OC(F)F)OC,gastric inflammation,CID000012536,638-94-8,CC1(OC2CC3C4CCC5=CC(=O)C=CC5(C4C(CC3(C2(O1)C(=O)CO)C)O)C)C
CID000004679,pantoprazole,COC1=C(C(=NC=C1)CS(=O)C2=NC3=C(N2)C=C(C=C3)OC(F)F)OC,connective tissue disease,CID000060754,Gadodiamide hydrate,CNC(=O)CN(CCN(CCN(CC(=O)NC)CC(=O)[O-])CC(=O)[O-])CC(=O)[O-].O.[Gd+3]
CID000004679,pantoprazole,COC1=C(C(=NC=C1)CS(=O)C2=NC3=C(N2)C=C(C=C3)OC(F)F)OC,nausea,CID000057537,92206-54-7,CCCN(CCC1=CC=CS1)C2CCC3=C(C2)C=CC=C3O
CID000004679,pantoprazole,COC1=C(C(=NC=C1)CS(=O)C2=NC3=C(N2)C=C(C=C3)OC(F)F)OC,cholecystitis,CID000667490,6-Mercaptopurine,C1=NC2=C(N1)C(=S)N=CN2
CID000004679,pantoprazole,COC1=C(C(=NC=C1)CS(=O)C2=NC3=C(N2)C=C(C=C3)OC(F)F)OC,Back Ache,CID000005719,zaleplon,CCN(C1=CC=CC(=C1)C2=CC=NC3=C(C=NN23)C#N)C(=O)C
CID000004679,pantoprazole,COC1=C(C(=NC=C1)CS(=O)C2=NC3=C(N2)C=C(C=C3)OC(F)F)OC,cholecystitis,CID000005645,"3,7-Dihydroxycholan-24-oic acid",CC(CCC(=O)O)C1CCC2C1(CCC3C2C(CC4C3(CCC(C4)O)C)O)C
CID000004679,pantoprazole,COC1=C(C(=NC=C1)CS(=O)C2=NC3=C(N2)C=C(C=C3)OC(F)F)OC,methaemoglobinaemia,CID000504578,"(2S,3S,4R,5R,6R)-5-amino-6-[(2R,3S,4R,5S)-5-[(1R,2S,3R,6R)-3-amino-6-[(1S,2R,3R,4R,5R)-2-amino-5-(aminomethyl)-3,4-dihydroxycyclohexyl]oxy-2-hydroxycyclohexyl]oxy-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl]oxy-2-(aminomethyl)oxane-3,4-diol",C1CC(C(C(C1N)O)OC2C(C(C(O2)CO)OC3C(C(C(C(O3)CN)O)O)N)O)OC4CC(C(C(C4N)O)O)CN
CID000004679,pantoprazole,COC1=C(C(=NC=C1)CS(=O)C2=NC3=C(N2)C=C(C=C3)OC(F)F)OC,gastric inflammation,CID000170361,Varenicline,C1C2CNCC1C3=CC4=NC=CN=C4C=C23
CID000004679,pantoprazole,COC1=C(C(=NC=C1)CS(=O)C2=NC3=C(N2)C=C(C=C3)OC(F)F)OC,insulin dependent diabetes mellitus,CID000004748,perphenazine,C1CN(CCN1CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)Cl)CCO
CID000004679,pantoprazole,COC1=C(C(=NC=C1)CS(=O)C2=NC3=C(N2)C=C(C=C3)OC(F)F)OC,gastric inflammation,CID000004856,"3-[hydroxy-(pyridin-2-ylamino)methylidene]-2-methyl-1,1-dioxo-1lambda6,2-benzothiazin-4-one",CN1C(=C(NC2=CC=CC=N2)O)C(=O)C3=CC=CC=C3S1(=O)=O
CID000004679,pantoprazole,COC1=C(C(=NC=C1)CS(=O)C2=NC3=C(N2)C=C(C=C3)OC(F)F)OC,Bone Fracture Spontaneous,CID000163742,SCHEMBL1650579,COC1C(C(C(C(O1)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)COS(=O)(=O)O)OC4C(C(C(C(O4)C(=O)O)OC5C(C(C(C(O5)COS(=O)(=O)O)O)O)NS(=O)(=O)O)O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O)NS(=O)(=O)O
CID000004679,pantoprazole,COC1=C(C(=NC=C1)CS(=O)C2=NC3=C(N2)C=C(C=C3)OC(F)F)OC,myelodysplasia,CID000036339,Etomidate,CCOC(=O)C1=CN=CN1C(C)C2=CC=CC=C2
CID000004679,pantoprazole,COC1=C(C(=NC=C1)CS(=O)C2=NC3=C(N2)C=C(C=C3)OC(F)F)OC,gastric inflammation,CID006447131,Pimecrolimus,CCC1C=C(CC(CC(C2C(CC(C(O2)(C(=O)C(=O)N3CCCCC3C(=O)OC(C(C(CC1=O)O)C)C(=CC4CCC(C(C4)OC)Cl)C)O)C)OC)OC)C)C
CID000004679,pantoprazole,COC1=C(C(=NC=C1)CS(=O)C2=NC3=C(N2)C=C(C=C3)OC(F)F)OC,Acne,CID000004920,"1-acetyl-9a,11a-dimethyl-1H,2H,3H,3aH,3bH,4H,5H,7H,8H,9H,9aH,9bH,10H,11H,11aH-cyclopenta[a]phenanthren-7-one",CC(=O)C1CCC2C1(CCC3C2CCC4=CC(=O)CCC34C)C
CID000004679,pantoprazole,COC1=C(C(=NC=C1)CS(=O)C2=NC3=C(N2)C=C(C=C3)OC(F)F)OC,apoplexy,CID000071329,Dofetilide,CN(CCC1=CC=C(C=C1)NS(=O)(=O)C)CCOC2=CC=C(C=C2)NS(=O)(=O)C
CID000004679,pantoprazole,COC1=C(C(=NC=C1)CS(=O)C2=NC3=C(N2)C=C(C=C3)OC(F)F)OC,cholecystitis,CID000005544,Mycolog,CC12CC(C3(C(C1CC(C2(C(=O)CO)O)O)CCC4=CC(=O)C=CC43C)F)O
CID000004679,pantoprazole,COC1=C(C(=NC=C1)CS(=O)C2=NC3=C(N2)C=C(C=C3)OC(F)F)OC,apoplexy,CID000125017,Desvenlafaxine,CN(C)CC(C1=CC=C(C=C1)O)C2(CCCCC2)O
CID000004679,pantoprazole,COC1=C(C(=NC=C1)CS(=O)C2=NC3=C(N2)C=C(C=C3)OC(F)F)OC,abnormal ECG,CID000071616,Voriconazole,CC(C1=NC=NC=C1F)C(CN2C=NC=N2)(C3=C(C=C(C=C3)F)F)O
CID000004679,pantoprazole,COC1=C(C(=NC=C1)CS(=O)C2=NC3=C(N2)C=C(C=C3)OC(F)F)OC,methaemoglobinaemia,CID000004927,promethazine,CC(CN1C2=CC=CC=C2SC3=CC=CC=C31)N(C)C
CID000004679,pantoprazole,COC1=C(C(=NC=C1)CS(=O)C2=NC3=C(N2)C=C(C=C3)OC(F)F)OC,gastric inflammation,CID000004691,"3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine",C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4
CID000004679,pantoprazole,COC1=C(C(=NC=C1)CS(=O)C2=NC3=C(N2)C=C(C=C3)OC(F)F)OC,Chronic Kidney Disease,CID005493444,Aliskiren,CC(C)C(CC1=CC(=C(C=C1)OC)OCCCOC)CC(C(CC(C(C)C)C(=O)NCC(C)(C)C(=O)N)O)N
CID000004679,pantoprazole,COC1=C(C(=NC=C1)CS(=O)C2=NC3=C(N2)C=C(C=C3)OC(F)F)OC,gastric inflammation,CID000005478,racemic-Timolol,CC(C)(C)NCC(COC1=NSN=C1N2CCOCC2)O
CID000004679,pantoprazole,COC1=C(C(=NC=C1)CS(=O)C2=NC3=C(N2)C=C(C=C3)OC(F)F)OC,nasopharyngitis,CID000060787,sequinavir,CC(C)(C)NC(=O)C1CC2CCCCC2CN1CC(C(CC3=CC=CC=C3)NC(=O)C(CC(=O)N)NC(=O)C4=NC5=CC=CC=C5C=C4)O
CID000004679,pantoprazole,COC1=C(C(=NC=C1)CS(=O)C2=NC3=C(N2)C=C(C=C3)OC(F)F)OC,gastric inflammation,CID000060865,(E)-Olopatadine,CN(C)CCC=C1C2=CC=CC=C2COC3=C1C=C(C=C3)CC(=O)O
CID000004679,pantoprazole,COC1=C(C(=NC=C1)CS(=O)C2=NC3=C(N2)C=C(C=C3)OC(F)F)OC,methaemoglobinaemia,CID000004889,Pravastatin Impurity A,CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC(CC(CC(=O)O)O)O)O
CID000004679,pantoprazole,COC1=C(C(=NC=C1)CS(=O)C2=NC3=C(N2)C=C(C=C3)OC(F)F)OC,gastric inflammation,CID000005358,sumatriptan,CNS(=O)(=O)CC1=CC2=C(C=C1)NC=C2CCN(C)C
CID000004679,pantoprazole,COC1=C(C(=NC=C1)CS(=O)C2=NC3=C(N2)C=C(C=C3)OC(F)F)OC,apoplexy,CID000005352,38194-50-2,CC1=C(C2=C(C1=CC3=CC=C(C=C3)S(=O)C)C=CC(=C2)F)CC(=O)O
CID000003449,Epigalanthamin,CN1CCC23C=CC(CC2OC4=C(C=CC(=C34)C1)OC)O,gastric inflammation,CID000003937,N~2~-(1-carboxy-3-phenylpropyl)lysylproline,C1CC(N(C1)C(=O)C(CCCCN)NC(CCC2=CC=CC=C2)C(=O)O)C(=O)O
CID000003449,Epigalanthamin,CN1CCC23C=CC(CC2OC4=C(C=CC(=C34)C1)OC)O,apoplexy,CID000003883,lansoprazole,CC1=C(C=CN=C1CS(=O)C2=NC3=CC=CC=C3N2)OCC(F)(F)F
CID000003449,Epigalanthamin,CN1CCC23C=CC(CC2OC4=C(C=CC(=C34)C1)OC)O,gastric inflammation,CID000003961,losartan,CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)CO)Cl
CID000003449,Epigalanthamin,CN1CCC23C=CC(CC2OC4=C(C=CC(=C34)C1)OC)O,gastric inflammation,CID000004510,nitroglycerin,C(C(CO[N+](=O)[O-])O[N+](=O)[O-])O[N+](=O)[O-]
CID000003449,Epigalanthamin,CN1CCC23C=CC(CC2OC4=C(C=CC(=C34)C1)OC)O,apoplexy,CID000004889,Pravastatin Impurity A,CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC(CC(CC(=O)O)O)O)O
CID000003449,Epigalanthamin,CN1CCC23C=CC(CC2OC4=C(C=CC(=C34)C1)OC)O,gastric inflammation,CID000005732,zolpidem,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C
CID000003449,Epigalanthamin,CN1CCC23C=CC(CC2OC4=C(C=CC(=C34)C1)OC)O,abnormal EEG,CID000004585,"2-methyl-4-(4-methylpiperazin-1-yl)-5H-thieno[3,2-c][1,5]benzodiazepine",CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C
CID000003449,Epigalanthamin,CN1CCC23C=CC(CC2OC4=C(C=CC(=C34)C1)OC)O,apoplexy,CID000004691,"3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine",C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4
CID000003449,Epigalanthamin,CN1CCC23C=CC(CC2OC4=C(C=CC(=C34)C1)OC)O,cholecystitis,CID000005073,risperidone,CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F
CID000003449,Epigalanthamin,CN1CCC23C=CC(CC2OC4=C(C=CC(=C34)C1)OC)O,cholecystitis,CID000004205,mirtazapine,CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4
CID000003658,hydroxyzine,C1CN(CCN1CCOCCO)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl,Bilirubinaemia,CID000004894,"11,17,21-Trihydroxypregna-1,4-diene-3,20-dione",CC12CC(C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C)O
CID000003658,hydroxyzine,C1CN(CCN1CCOCCO)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl,weight gain,CID000504578,"(2S,3S,4R,5R,6R)-5-amino-6-[(2R,3S,4R,5S)-5-[(1R,2S,3R,6R)-3-amino-6-[(1S,2R,3R,4R,5R)-2-amino-5-(aminomethyl)-3,4-dihydroxycyclohexyl]oxy-2-hydroxycyclohexyl]oxy-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl]oxy-2-(aminomethyl)oxane-3,4-diol",C1CC(C(C(C1N)O)OC2C(C(C(O2)CO)OC3C(C(C(C(O3)CN)O)O)N)O)OC4CC(C(C(C4N)O)O)CN
CID000003658,hydroxyzine,C1CN(CCN1CCOCCO)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl,cholecystitis,CID000004927,promethazine,CC(CN1C2=CC=CC=C2SC3=CC=CC=C31)N(C)C
CID000003658,hydroxyzine,C1CN(CCN1CCOCCO)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl,erythema,CID000060854,Ziprasidone,C1CN(CCN1CCC2=C(C=C3C(=C2)CC(=O)N3)Cl)C4=NSC5=CC=CC=C54
CID000003658,hydroxyzine,C1CN(CCN1CCOCCO)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl,angiitis,CID000060852,Ibandronic Acid,CCCCCN(C)CCC(O)(P(=O)(O)O)P(=O)(O)O
CID000003658,hydroxyzine,C1CN(CCN1CCOCCO)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl,Decreased Libido,CID000115237,Paliperidone,CC1=C(C(=O)N2CCCC(C2=N1)O)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F
CID000003658,hydroxyzine,C1CN(CCN1CCOCCO)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl,Pain,CID000667490,6-Mercaptopurine,C1=NC2=C(N1)C(=S)N=CN2
CID000003658,hydroxyzine,C1CN(CCN1CCOCCO)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl,apoplexy,CID006398525,,C(C1C(C(C(C(O1)OC2(C(C(C(O2)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)COS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.[Al].[Al].[Al].[Al].[Al].[Al].[Al].[Al].[Al]
CID000003658,hydroxyzine,C1CN(CCN1CCOCCO)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl,Adenopathy,CID000004173,metronidazole,CC1=NC=C(N1CCO)[N+](=O)[O-]
CID000003658,hydroxyzine,C1CN(CCN1CCOCCO)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl,dysarthria,CID000004170,metolazone,CC1NC2=CC(=C(C=C2C(=O)N1C3=CC=CC=C3C)S(=O)(=O)N)Cl
CID000003658,hydroxyzine,C1CN(CCN1CCOCCO)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl,drug toxicity NOS,CID000004178,Mexiletine,CC1=C(C(=CC=C1)C)OCC(C)N
CID000003658,hydroxyzine,C1CN(CCN1CCOCCO)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl,Acne,CID000005073,risperidone,CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F
CID000003658,hydroxyzine,C1CN(CCN1CCOCCO)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl,adenomyosis,CID000005487,tizanidine,C1CN=C(N1)NC2=C(C=CC3=NSN=C32)Cl
CID000003658,hydroxyzine,C1CN(CCN1CCOCCO)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl,enlarged liver,CID000004189,miconazole,C1=CC(=C(C=C1Cl)Cl)COC(CN2C=CN=C2)C3=C(C=C(C=C3)Cl)Cl
CID000003658,hydroxyzine,C1CN(CCN1CCOCCO)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl,cholecystitis,CID000004510,nitroglycerin,C(C(CO[N+](=O)[O-])O[N+](=O)[O-])O[N+](=O)[O-]
CID000003658,hydroxyzine,C1CN(CCN1CCOCCO)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl,dysarthria,CID000005645,"3,7-Dihydroxycholan-24-oic acid",CC(CCC(=O)O)C1CCC2C1(CCC3C2C(CC4C3(CCC(C4)O)C)O)C
CID000003658,hydroxyzine,C1CN(CCN1CCOCCO)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl,Back Ache,CID000003890,TRANS (15S)-LATANOPROST,CC(C)OC(=O)CCCC=CCC1C(CC(C1CCC(CCC2=CC=CC=C2)O)O)O
CID000003658,hydroxyzine,C1CN(CCN1CCOCCO)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl,Arrhythmia,CID000004920,"1-acetyl-9a,11a-dimethyl-1H,2H,3H,3aH,3bH,4H,5H,7H,8H,9H,9aH,9bH,10H,11H,11aH-cyclopenta[a]phenanthren-7-one",CC(=O)C1CCC2C1(CCC3C2CCC4=CC(=O)CCC34C)C
CID000003658,hydroxyzine,C1CN(CCN1CCOCCO)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl,peritonitis,CID000005978,vincristine,CCC1(CC2CC(C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)C78CCN9C7C(C=CC9)(C(C(C8N6C=O)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O
CID000003658,hydroxyzine,C1CN(CCN1CCOCCO)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl,thrombocytopenia,CID000074989,ATOVAQUONE,C1CC(CCC1C2=CC=C(C=C2)Cl)C3=C(C4=CC=CC=C4C(=O)C3=O)O
CID000003658,hydroxyzine,C1CN(CCN1CCOCCO)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl,cholecystitis,CID000062924,"S-(fluoromethyl) (6S,9R,10S,11S,13S,14S,16R,17R)-6,9-difluoro-11,17-dihydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthrene-17-carbothioate",CC1CC2C3CC(C4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)SCF)O)C)O)F)C)F
CID000003658,hydroxyzine,C1CN(CCN1CCOCCO)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl,cholecystitis,CID000004909,primidone,CCC1(C(=O)NCNC1=O)C2=CC=CC=C2
CID000003658,hydroxyzine,C1CN(CCN1CCOCCO)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl,myelodysplasia,CID000004900,Fernisone,CC12CC(=O)C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C
CID000003658,hydroxyzine,C1CN(CCN1CCOCCO)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl,Stress incontinence,CID000004601,orphenadrine,CC1=CC=CC=C1C(C2=CC=CC=C2)OCCN(C)C
CID000003658,hydroxyzine,C1CN(CCN1CCOCCO)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl,peritonitis,CID000039765,Vecuronium,CC(=O)OC1CC2CCC3C(C2(CC1N4CCCCC4)C)CCC5(C3CC(C5OC(=O)C)[N+]6(CCCCC6)C)C
CID000003658,hydroxyzine,C1CN(CCN1CCOCCO)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl,Back Ache,CID000004158,methylphenidate,COC(=O)C(C1CCCCN1)C2=CC=CC=C2
CID000003658,hydroxyzine,C1CN(CCN1CCOCCO)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl,muscle weakness,CID000003827,ketotifen,CN1CCC(=C2C3=C(C(=O)CC4=CC=CC=C42)SC=C3)CC1
CID000003658,hydroxyzine,C1CN(CCN1CCOCCO)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl,apoplexy,CID000003780,"D-Glucitol, 1,4:3,6-dianhydro-, 2,5-dinitrate",C1C(C2C(O1)C(CO2)O[N+](=O)[O-])O[N+](=O)[O-]
CID000003658,hydroxyzine,C1CN(CCN1CCOCCO)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl,angiitis,CID000005095,ropinirole,CCCN(CCC)CCC1=C2CC(=O)NC2=CC=C1
CID000003658,hydroxyzine,C1CN(CCN1CCOCCO)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl,cholecystitis,CID000005732,zolpidem,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C
CID000003658,hydroxyzine,C1CN(CCN1CCOCCO)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl,nervous tension,CID000004748,perphenazine,C1CN(CCN1CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)Cl)CCO
CID000003658,hydroxyzine,C1CN(CCN1CCOCCO)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl,bursitis,CID000004745,SCHEMBL7711911,CCCN1CC(CC2C1CC3=CNC4=CC=CC2=C34)CSC
CID000003658,hydroxyzine,C1CN(CCN1CCOCCO)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl,gastric inflammation,CID000003676,lidocaine,CCN(CC)CC(=O)NC1=C(C=CC=C1C)C
CID000003658,hydroxyzine,C1CN(CCN1CCOCCO)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl,weight gain,CID000005478,racemic-Timolol,CC(C)(C)NCC(COC1=NSN=C1N2CCOCC2)O
CID000003658,hydroxyzine,C1CN(CCN1CCOCCO)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl,erythema multiforme,CID000060865,(E)-Olopatadine,CN(C)CCC=C1C2=CC=CC=C2COC3=C1C=C(C=C3)CC(=O)O
CID000003658,hydroxyzine,C1CN(CCN1CCOCCO)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl,apoplexy,CID000004666,7-Epi Paclitaxel,CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C
CID000003658,hydroxyzine,C1CN(CCN1CCOCCO)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl,eruption,CID000005352,38194-50-2,CC1=C(C2=C(C1=CC3=CC=C(C=C3)S(=O)C)C=CC(=C2)F)CC(=O)O
CID000003658,hydroxyzine,C1CN(CCN1CCOCCO)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl,gastric inflammation,CID000005358,sumatriptan,CNS(=O)(=O)CC1=CC2=C(C=C1)NC=C2CCN(C)C
CID000003658,hydroxyzine,C1CN(CCN1CCOCCO)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl,Acne,CID000004585,"2-methyl-4-(4-methylpiperazin-1-yl)-5H-thieno[3,2-c][1,5]benzodiazepine",CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C
CID000003658,hydroxyzine,C1CN(CCN1CCOCCO)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl,Atherosclerosis,CID000048175,"[(6S,9R,16S,17R)-17-(2-chloroacetyl)-6,9-difluoro-11-hydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl] propanoate",CCC(=O)OC1(C(CC2C1(CC(C3(C2CC(C4=CC(=O)C=CC43C)F)F)O)C)C)C(=O)CCl
CID000003658,hydroxyzine,C1CN(CCN1CCOCCO)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl,gastric inflammation,CID000004614,oxaprozin,C1=CC=C(C=C1)C2=C(OC(=N2)CCC(=O)O)C3=CC=CC=C3
CID000003658,hydroxyzine,C1CN(CCN1CCOCCO)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl,cholecystitis,CID000004691,"3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine",C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4
CID000003658,hydroxyzine,C1CN(CCN1CCOCCO)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl,Acne,CID000003937,N~2~-(1-carboxy-3-phenylpropyl)lysylproline,C1CC(N(C1)C(=O)C(CCCCN)NC(CCC2=CC=CC=C2)C(=O)O)C(=O)O
CID000003658,hydroxyzine,C1CN(CCN1CCOCCO)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl,cholecystitis,CID000027686,CHEMBL4088679,C1=CC2=C(C(=C1)OCC(COC3=CC4=C(C=C3)OC(=CC4=O)C(=O)O)O)C(=O)C=C(O2)C(=O)O
CID000003658,hydroxyzine,C1CN(CCN1CCOCCO)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl,gastric inflammation,CID000003883,lansoprazole,CC1=C(C=CN=C1CS(=O)C2=NC3=CC=CC=C3N2)OCC(F)(F)F
CID000003658,hydroxyzine,C1CN(CCN1CCOCCO)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl,nasopharyngitis,CID000004075,5-Aminosalicylic acid,C1=CC(=C(C=C1N)C(=O)O)O
CID000003658,hydroxyzine,C1CN(CCN1CCOCCO)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl,muscle weakness,CID000003763,isoflurane,C(C(F)(F)F)(OC(F)F)Cl
CID000003658,hydroxyzine,C1CN(CCN1CCOCCO)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl,drowsiness,CID000131536,Fosamprenavir,CC(C)CN(CC(C(CC1=CC=CC=C1)NC(=O)OC2CCOC2)OP(=O)(O)O)S(=O)(=O)C3=CC=C(C=C3)N
CID000003658,hydroxyzine,C1CN(CCN1CCOCCO)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl,ear ache,CID000003961,losartan,CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)CO)Cl
CID000003658,hydroxyzine,C1CN(CCN1CCOCCO)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl,gastric inflammation,CID000005245,Risedronic acid,C1=CC(=CN=C1)CC(O)(P(=O)(O)O)P(=O)(O)O
CID000003658,hydroxyzine,C1CN(CCN1CCOCCO)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl,eruption,CID000012536,638-94-8,CC1(OC2CC3C4CCC5=CC(=O)C=CC5(C4C(CC3(C2(O1)C(=O)CO)C)O)C)C
CID000003658,hydroxyzine,C1CN(CCN1CCOCCO)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl,nervous tension,CID000125017,Desvenlafaxine,CN(C)CC(C1=CC=C(C=C1)O)C2(CCCCC2)O
CID000003658,hydroxyzine,C1CN(CCN1CCOCCO)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl,cholecystectomies,CID000005512,124936-74-9,CC1=CC(=C(C=C1)O)C(CCN(C(C)C)C(C)C)C2=CC=CC=C2
CID000003658,hydroxyzine,C1CN(CCN1CCOCCO)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl,apoplexy,CID000005719,zaleplon,CCN(C1=CC=CC(=C1)C2=CC=NC3=C(C=NN23)C#N)C(=O)C
CID000003658,hydroxyzine,C1CN(CCN1CCOCCO)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl,gastric inflammation,CID000003954,loperamide(1+),CN(C)C(=O)C(CC[NH+]1CCC(CC1)(C2=CC=C(C=C2)Cl)O)(C3=CC=CC=C3)C4=CC=CC=C4
CID000003658,hydroxyzine,C1CN(CCN1CCOCCO)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl,cholecystectomies,CID000170361,Varenicline,C1C2CNCC1C3=CC4=NC=CN=C4C=C23
CID000003658,hydroxyzine,C1CN(CCN1CCOCCO)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl,conjunctivitis,CID000003661,L-Hyoscyamine,CN1C2CCC1CC(C2)OC(=O)C(CO)C3=CC=CC=C3
CID000003658,hydroxyzine,C1CN(CCN1CCOCCO)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl,erythema,CID000004889,Pravastatin Impurity A,CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC(CC(CC(=O)O)O)O)O
CID000003658,hydroxyzine,C1CN(CCN1CCOCCO)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl,abnormal ECG,CID000003749,irbesartan,CCCCC1=NC2(CCCC2)C(=O)N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5
CID000003658,hydroxyzine,C1CN(CCN1CCOCCO)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl,abnormal ECG,CID003468412,SCHEMBL1176571,CC1C=CC=CCCC=CC=CC=CC=CC(CC(C(C(CC(=O)CC(C(CCC(CC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)C(=O)O)O)OC2C(C(C(C(O2)C)O)N)O
CID000003658,hydroxyzine,C1CN(CCN1CCOCCO)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl,gastric inflammation,CID000004205,mirtazapine,CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4
CID000003658,hydroxyzine,C1CN(CCN1CCOCCO)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl,neumonia,CID000004201,minoxidil,C1CCN(CC1)C2=NC(=N)N(C(=C2)N)O
CID000003658,hydroxyzine,C1CN(CCN1CCOCCO)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl,cholecystitis,CID000005152,Salmeterol,C1=CC=C(C=C1)CCCCOCCCCCCNCC(C2=CC(=C(C=C2)O)CO)O
CID000003658,hydroxyzine,C1CN(CCN1CCOCCO)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl,apoplexy,CID006447131,Pimecrolimus,CCC1C=C(CC(CC(C2C(CC(C(O2)(C(=O)C(=O)N3CCCCC3C(=O)OC(C(C(CC1=O)O)C)C(=CC4CCC(C(C4)OC)Cl)C)O)C)OC)OC)C)C
CID000003658,hydroxyzine,C1CN(CCN1CCOCCO)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl,gastric inflammation,CID000005544,Mycolog,CC12CC(C3(C(C1CC(C2(C(=O)CO)O)O)CCC4=CC(=O)C=CC43C)F)O
CID000003658,hydroxyzine,C1CN(CCN1CCOCCO)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl,abnormal EEG,CID000004536,Minovlar,CC12CCC3C(C1CCC2(C#C)O)CCC4=CC(=O)CCC34
CID000003658,hydroxyzine,C1CN(CCN1CCOCCO)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl,mouth ulcer,CID000060184,"2'-epi-Perindopril, (2'R)-",CCCC(C(=O)OCC)NC(C)C(=O)N1C2CCCCC2CC1C(=O)O
CID000003658,hydroxyzine,C1CN(CCN1CCOCCO)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl,heart rate increased,CID000110635,Tadalafil,CN1CC(=O)N2C(C1=O)CC3=C(C2C4=CC5=C(C=C4)OCO5)NC6=CC=CC=C36
CID000003658,hydroxyzine,C1CN(CCN1CCOCCO)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl,Back Ache,CID000019090,megestrol,CC1=CC2C(CCC3(C2CCC3(C(=O)C)O)C)C4(C1=CC(=O)CC4)C
CID000003658,hydroxyzine,C1CN(CCN1CCOCCO)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl,ecchymoses,CID000005394,temozolomide,CN1C(=O)N2C=NC(=C2N=N1)C(=O)N
CID000003658,hydroxyzine,C1CN(CCN1CCOCCO)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl,cholecystitis,CID000004236,modafinil,C1=CC=C(C=C1)C(C2=CC=CC=C2)S(=O)CC(=O)N
CID000004739,53910-25-1,C1C(C(OC1N2C=NC3=C2NC=NCC3O)CO)O,gout,CID000004900,Fernisone,CC12CC(=O)C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C
CID000039765,Vecuronium,CC(=O)OC1CC2CCC3C(C2(CC1N4CCCCC4)C)CCC5(C3CC(C5OC(=O)C)[N+]6(CCCCC6)C)C,erythema,CID000060612,levomedetomidine,CC1=C(C(=CC=C1)C(C)C2=CN=CN2)C
CID000039765,Vecuronium,CC(=O)OC1CC2CCC3C(C2(CC1N4CCCCC4)C)CCC5(C3CC(C5OC(=O)C)[N+]6(CCCCC6)C)C,Pain,CID000062924,"S-(fluoromethyl) (6S,9R,10S,11S,13S,14S,16R,17R)-6,9-difluoro-11,17-dihydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthrene-17-carbothioate",CC1CC2C3CC(C4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)SCF)O)C)O)F)C)F
CID000039765,Vecuronium,CC(=O)OC1CC2CCC3C(C2(CC1N4CCCCC4)C)CCC5(C3CC(C5OC(=O)C)[N+]6(CCCCC6)C)C,erythema,CID000071616,Voriconazole,CC(C1=NC=NC=C1F)C(CN2C=NC=N2)(C3=C(C=C(C=C3)F)F)O
CID000003075,"2-[3-acetyloxy-2-(4-methoxyphenyl)-4-oxo-2,3-dihydro-1,5-benzothiazepin-5-yl]ethyl-dimethylazanium",CC(=O)OC1C(SC2=CC=CC=C2N(C1=O)CC[NH+](C)C)C3=CC=C(C=C3)OC,cholecystitis,CID000062924,"S-(fluoromethyl) (6S,9R,10S,11S,13S,14S,16R,17R)-6,9-difluoro-11,17-dihydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthrene-17-carbothioate",CC1CC2C3CC(C4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)SCF)O)C)O)F)C)F
CID000003075,"2-[3-acetyloxy-2-(4-methoxyphenyl)-4-oxo-2,3-dihydro-1,5-benzothiazepin-5-yl]ethyl-dimethylazanium",CC(=O)OC1C(SC2=CC=CC=C2N(C1=O)CC[NH+](C)C)C3=CC=C(C=C3)OC,Adenopathy,CID000003749,irbesartan,CCCCC1=NC2(CCCC2)C(=O)N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5
CID000003075,"2-[3-acetyloxy-2-(4-methoxyphenyl)-4-oxo-2,3-dihydro-1,5-benzothiazepin-5-yl]ethyl-dimethylazanium",CC(=O)OC1C(SC2=CC=CC=C2N(C1=O)CC[NH+](C)C)C3=CC=C(C=C3)OC,abnormal ECG,CID000004075,5-Aminosalicylic acid,C1=CC(=C(C=C1N)C(=O)O)O
CID000003075,"2-[3-acetyloxy-2-(4-methoxyphenyl)-4-oxo-2,3-dihydro-1,5-benzothiazepin-5-yl]ethyl-dimethylazanium",CC(=O)OC1C(SC2=CC=CC=C2N(C1=O)CC[NH+](C)C)C3=CC=C(C=C3)OC,apoplexy,CID000004138,55-40-3,CC(CC1=CC(=C(C=C1)O)O)(C(=O)O)N
CID000003075,"2-[3-acetyloxy-2-(4-methoxyphenyl)-4-oxo-2,3-dihydro-1,5-benzothiazepin-5-yl]ethyl-dimethylazanium",CC(=O)OC1C(SC2=CC=CC=C2N(C1=O)CC[NH+](C)C)C3=CC=C(C=C3)OC,gastric inflammation,CID000071329,Dofetilide,CN(CCC1=CC=C(C=C1)NS(=O)(=O)C)CCOC2=CC=C(C=C2)NS(=O)(=O)C
CID000003075,"2-[3-acetyloxy-2-(4-methoxyphenyl)-4-oxo-2,3-dihydro-1,5-benzothiazepin-5-yl]ethyl-dimethylazanium",CC(=O)OC1C(SC2=CC=CC=C2N(C1=O)CC[NH+](C)C)C3=CC=C(C=C3)OC,cholecystitis,CID000009052,2-hydroxy-3-[1-(4-nitrophenyl)-3-oxobutyl]chromen-4-one,CC(=O)CC(C1=CC=C(C=C1)[N+](=O)[O-])C2=C(OC3=CC=CC=C3C2=O)O
CID000003075,"2-[3-acetyloxy-2-(4-methoxyphenyl)-4-oxo-2,3-dihydro-1,5-benzothiazepin-5-yl]ethyl-dimethylazanium",CC(=O)OC1C(SC2=CC=CC=C2N(C1=O)CC[NH+](C)C)C3=CC=C(C=C3)OC,abnormal ECG,CID005493444,Aliskiren,CC(C)C(CC1=CC(=C(C=C1)OC)OCCCOC)CC(C(CC(C(C)C)C(=O)NCC(C)(C)C(=O)N)O)N
CID000003075,"2-[3-acetyloxy-2-(4-methoxyphenyl)-4-oxo-2,3-dihydro-1,5-benzothiazepin-5-yl]ethyl-dimethylazanium",CC(=O)OC1C(SC2=CC=CC=C2N(C1=O)CC[NH+](C)C)C3=CC=C(C=C3)OC,erythema,CID000003928,Lincomycine,CCCC1CC(N(C1)C)C(=O)NC(C2C(C(C(C(O2)SC)O)O)O)C(C)O
CID000003075,"2-[3-acetyloxy-2-(4-methoxyphenyl)-4-oxo-2,3-dihydro-1,5-benzothiazepin-5-yl]ethyl-dimethylazanium",CC(=O)OC1C(SC2=CC=CC=C2N(C1=O)CC[NH+](C)C)C3=CC=C(C=C3)OC,enlarged spleen,CID000003780,"D-Glucitol, 1,4:3,6-dianhydro-, 2,5-dinitrate",C1C(C2C(O1)C(CO2)O[N+](=O)[O-])O[N+](=O)[O-]
CID000003075,"2-[3-acetyloxy-2-(4-methoxyphenyl)-4-oxo-2,3-dihydro-1,5-benzothiazepin-5-yl]ethyl-dimethylazanium",CC(=O)OC1C(SC2=CC=CC=C2N(C1=O)CC[NH+](C)C)C3=CC=C(C=C3)OC,apoplexy,CID000060865,(E)-Olopatadine,CN(C)CCC=C1C2=CC=CC=C2COC3=C1C=C(C=C3)CC(=O)O
CID000003075,"2-[3-acetyloxy-2-(4-methoxyphenyl)-4-oxo-2,3-dihydro-1,5-benzothiazepin-5-yl]ethyl-dimethylazanium",CC(=O)OC1C(SC2=CC=CC=C2N(C1=O)CC[NH+](C)C)C3=CC=C(C=C3)OC,gastric inflammation,CID000003883,lansoprazole,CC1=C(C=CN=C1CS(=O)C2=NC3=CC=CC=C3N2)OCC(F)(F)F
CID000003075,"2-[3-acetyloxy-2-(4-methoxyphenyl)-4-oxo-2,3-dihydro-1,5-benzothiazepin-5-yl]ethyl-dimethylazanium",CC(=O)OC1C(SC2=CC=CC=C2N(C1=O)CC[NH+](C)C)C3=CC=C(C=C3)OC,myelodysplasia,CID000004748,perphenazine,C1CN(CCN1CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)Cl)CCO
CID000003075,"2-[3-acetyloxy-2-(4-methoxyphenyl)-4-oxo-2,3-dihydro-1,5-benzothiazepin-5-yl]ethyl-dimethylazanium",CC(=O)OC1C(SC2=CC=CC=C2N(C1=O)CC[NH+](C)C)C3=CC=C(C=C3)OC,aptyalism,CID006447131,Pimecrolimus,CCC1C=C(CC(CC(C2C(CC(C(O2)(C(=O)C(=O)N3CCCCC3C(=O)OC(C(C(CC1=O)O)C)C(=CC4CCC(C(C4)OC)Cl)C)O)C)OC)OC)C)C
CID000003075,"2-[3-acetyloxy-2-(4-methoxyphenyl)-4-oxo-2,3-dihydro-1,5-benzothiazepin-5-yl]ethyl-dimethylazanium",CC(=O)OC1C(SC2=CC=CC=C2N(C1=O)CC[NH+](C)C)C3=CC=C(C=C3)OC,right heart failure,CID000005719,zaleplon,CCN(C1=CC=CC(=C1)C2=CC=NC3=C(C=NN23)C#N)C(=O)C
CID000003075,"2-[3-acetyloxy-2-(4-methoxyphenyl)-4-oxo-2,3-dihydro-1,5-benzothiazepin-5-yl]ethyl-dimethylazanium",CC(=O)OC1C(SC2=CC=CC=C2N(C1=O)CC[NH+](C)C)C3=CC=C(C=C3)OC,cholecystitis,CID000005152,Salmeterol,C1=CC=C(C=C1)CCCCOCCCCCCNCC(C2=CC(=C(C=C2)O)CO)O
CID000003075,"2-[3-acetyloxy-2-(4-methoxyphenyl)-4-oxo-2,3-dihydro-1,5-benzothiazepin-5-yl]ethyl-dimethylazanium",CC(=O)OC1C(SC2=CC=CC=C2N(C1=O)CC[NH+](C)C)C3=CC=C(C=C3)OC,respiratory alkalosis,CID000019090,megestrol,CC1=CC2C(CCC3(C2CCC3(C(=O)C)O)C)C4(C1=CC(=O)CC4)C
CID000003075,"2-[3-acetyloxy-2-(4-methoxyphenyl)-4-oxo-2,3-dihydro-1,5-benzothiazepin-5-yl]ethyl-dimethylazanium",CC(=O)OC1C(SC2=CC=CC=C2N(C1=O)CC[NH+](C)C)C3=CC=C(C=C3)OC,weight gain,CID000004201,minoxidil,C1CCN(CC1)C2=NC(=N)N(C(=C2)N)O
CID000003075,"2-[3-acetyloxy-2-(4-methoxyphenyl)-4-oxo-2,3-dihydro-1,5-benzothiazepin-5-yl]ethyl-dimethylazanium",CC(=O)OC1C(SC2=CC=CC=C2N(C1=O)CC[NH+](C)C)C3=CC=C(C=C3)OC,cholecystitis,CID000004205,mirtazapine,CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4
CID000003075,"2-[3-acetyloxy-2-(4-methoxyphenyl)-4-oxo-2,3-dihydro-1,5-benzothiazepin-5-yl]ethyl-dimethylazanium",CC(=O)OC1C(SC2=CC=CC=C2N(C1=O)CC[NH+](C)C)C3=CC=C(C=C3)OC,loss of weight,CID000003310,33419-42-0,CC1OCC2C(O1)C(C(C(O2)OC3C4COC(=O)C4C(C5=CC6=C(C=C35)OCO6)C7=CC(=C(C(=C7)OC)O)OC)O)O
CID000003075,"2-[3-acetyloxy-2-(4-methoxyphenyl)-4-oxo-2,3-dihydro-1,5-benzothiazepin-5-yl]ethyl-dimethylazanium",CC(=O)OC1C(SC2=CC=CC=C2N(C1=O)CC[NH+](C)C)C3=CC=C(C=C3)OC,cholecystitis,CID000005544,Mycolog,CC12CC(C3(C(C1CC(C2(C(=O)CO)O)O)CCC4=CC(=O)C=CC43C)F)O
CID000003075,"2-[3-acetyloxy-2-(4-methoxyphenyl)-4-oxo-2,3-dihydro-1,5-benzothiazepin-5-yl]ethyl-dimethylazanium",CC(=O)OC1C(SC2=CC=CC=C2N(C1=O)CC[NH+](C)C)C3=CC=C(C=C3)OC,erythema,CID000060754,Gadodiamide hydrate,CNC(=O)CN(CCN(CCN(CC(=O)NC)CC(=O)[O-])CC(=O)[O-])CC(=O)[O-].O.[Gd+3]
CID000003075,"2-[3-acetyloxy-2-(4-methoxyphenyl)-4-oxo-2,3-dihydro-1,5-benzothiazepin-5-yl]ethyl-dimethylazanium",CC(=O)OC1C(SC2=CC=CC=C2N(C1=O)CC[NH+](C)C)C3=CC=C(C=C3)OC,Back Ache,CID000004601,orphenadrine,CC1=CC=CC=C1C(C2=CC=CC=C2)OCCN(C)C
CID000003075,"2-[3-acetyloxy-2-(4-methoxyphenyl)-4-oxo-2,3-dihydro-1,5-benzothiazepin-5-yl]ethyl-dimethylazanium",CC(=O)OC1C(SC2=CC=CC=C2N(C1=O)CC[NH+](C)C)C3=CC=C(C=C3)OC,Adenopathy,CID000004889,Pravastatin Impurity A,CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC(CC(CC(=O)O)O)O)O
CID000003075,"2-[3-acetyloxy-2-(4-methoxyphenyl)-4-oxo-2,3-dihydro-1,5-benzothiazepin-5-yl]ethyl-dimethylazanium",CC(=O)OC1C(SC2=CC=CC=C2N(C1=O)CC[NH+](C)C)C3=CC=C(C=C3)OC,apoplexy,CID000003869,labetalol,CC(CCC1=CC=CC=C1)NCC(C2=CC(=C(C=C2)O)C(=O)N)O
CID000003075,"2-[3-acetyloxy-2-(4-methoxyphenyl)-4-oxo-2,3-dihydro-1,5-benzothiazepin-5-yl]ethyl-dimethylazanium",CC(=O)OC1C(SC2=CC=CC=C2N(C1=O)CC[NH+](C)C)C3=CC=C(C=C3)OC,weight gain,CID000004920,"1-acetyl-9a,11a-dimethyl-1H,2H,3H,3aH,3bH,4H,5H,7H,8H,9H,9aH,9bH,10H,11H,11aH-cyclopenta[a]phenanthren-7-one",CC(=O)C1CCC2C1(CCC3C2CCC4=CC(=O)CCC34C)C
CID000003075,"2-[3-acetyloxy-2-(4-methoxyphenyl)-4-oxo-2,3-dihydro-1,5-benzothiazepin-5-yl]ethyl-dimethylazanium",CC(=O)OC1C(SC2=CC=CC=C2N(C1=O)CC[NH+](C)C)C3=CC=C(C=C3)OC,cholecystitis,CID000004927,promethazine,CC(CN1C2=CC=CC=C2SC3=CC=CC=C31)N(C)C
CID000003075,"2-[3-acetyloxy-2-(4-methoxyphenyl)-4-oxo-2,3-dihydro-1,5-benzothiazepin-5-yl]ethyl-dimethylazanium",CC(=O)OC1C(SC2=CC=CC=C2N(C1=O)CC[NH+](C)C)C3=CC=C(C=C3)OC,cholecystitis,CID000005645,"3,7-Dihydroxycholan-24-oic acid",CC(CCC(=O)O)C1CCC2C1(CCC3C2C(CC4C3(CCC(C4)O)C)O)C
CID000003075,"2-[3-acetyloxy-2-(4-methoxyphenyl)-4-oxo-2,3-dihydro-1,5-benzothiazepin-5-yl]ethyl-dimethylazanium",CC(=O)OC1C(SC2=CC=CC=C2N(C1=O)CC[NH+](C)C)C3=CC=C(C=C3)OC,heart rate increased,CID000125017,Desvenlafaxine,CN(C)CC(C1=CC=C(C=C1)O)C2(CCCCC2)O
CID000003075,"2-[3-acetyloxy-2-(4-methoxyphenyl)-4-oxo-2,3-dihydro-1,5-benzothiazepin-5-yl]ethyl-dimethylazanium",CC(=O)OC1C(SC2=CC=CC=C2N(C1=O)CC[NH+](C)C)C3=CC=C(C=C3)OC,thrombocytopenia,CID000667490,6-Mercaptopurine,C1=NC2=C(N1)C(=S)N=CN2
CID000003075,"2-[3-acetyloxy-2-(4-methoxyphenyl)-4-oxo-2,3-dihydro-1,5-benzothiazepin-5-yl]ethyl-dimethylazanium",CC(=O)OC1C(SC2=CC=CC=C2N(C1=O)CC[NH+](C)C)C3=CC=C(C=C3)OC,apoplexy,CID000163742,SCHEMBL1650579,COC1C(C(C(C(O1)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)COS(=O)(=O)O)OC4C(C(C(C(O4)C(=O)O)OC5C(C(C(C(O5)COS(=O)(=O)O)O)O)NS(=O)(=O)O)O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O)NS(=O)(=O)O
CID000003075,"2-[3-acetyloxy-2-(4-methoxyphenyl)-4-oxo-2,3-dihydro-1,5-benzothiazepin-5-yl]ethyl-dimethylazanium",CC(=O)OC1C(SC2=CC=CC=C2N(C1=O)CC[NH+](C)C)C3=CC=C(C=C3)OC,cholecystitis,CID000004510,nitroglycerin,C(C(CO[N+](=O)[O-])O[N+](=O)[O-])O[N+](=O)[O-]
CID000003075,"2-[3-acetyloxy-2-(4-methoxyphenyl)-4-oxo-2,3-dihydro-1,5-benzothiazepin-5-yl]ethyl-dimethylazanium",CC(=O)OC1C(SC2=CC=CC=C2N(C1=O)CC[NH+](C)C)C3=CC=C(C=C3)OC,cholecystitis,CID000005073,risperidone,CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F
CID000003075,"2-[3-acetyloxy-2-(4-methoxyphenyl)-4-oxo-2,3-dihydro-1,5-benzothiazepin-5-yl]ethyl-dimethylazanium",CC(=O)OC1C(SC2=CC=CC=C2N(C1=O)CC[NH+](C)C)C3=CC=C(C=C3)OC,apoplexy,CID000004856,"3-[hydroxy-(pyridin-2-ylamino)methylidene]-2-methyl-1,1-dioxo-1lambda6,2-benzothiazin-4-one",CN1C(=C(NC2=CC=CC=N2)O)C(=O)C3=CC=CC=C3S1(=O)=O
CID000003075,"2-[3-acetyloxy-2-(4-methoxyphenyl)-4-oxo-2,3-dihydro-1,5-benzothiazepin-5-yl]ethyl-dimethylazanium",CC(=O)OC1C(SC2=CC=CC=C2N(C1=O)CC[NH+](C)C)C3=CC=C(C=C3)OC,cholecystitis,CID000004170,metolazone,CC1NC2=CC(=C(C=C2C(=O)N1C3=CC=CC=C3C)S(=O)(=O)N)Cl
CID000003075,"2-[3-acetyloxy-2-(4-methoxyphenyl)-4-oxo-2,3-dihydro-1,5-benzothiazepin-5-yl]ethyl-dimethylazanium",CC(=O)OC1C(SC2=CC=CC=C2N(C1=O)CC[NH+](C)C)C3=CC=C(C=C3)OC,gastric inflammation,CID000005487,tizanidine,C1CN=C(N1)NC2=C(C=CC3=NSN=C32)Cl
CID000003075,"2-[3-acetyloxy-2-(4-methoxyphenyl)-4-oxo-2,3-dihydro-1,5-benzothiazepin-5-yl]ethyl-dimethylazanium",CC(=O)OC1C(SC2=CC=CC=C2N(C1=O)CC[NH+](C)C)C3=CC=C(C=C3)OC,Back Ache,CID000003890,TRANS (15S)-LATANOPROST,CC(C)OC(=O)CCCC=CCC1C(CC(C1CCC(CCC2=CC=CC=C2)O)O)O
CID000003075,"2-[3-acetyloxy-2-(4-methoxyphenyl)-4-oxo-2,3-dihydro-1,5-benzothiazepin-5-yl]ethyl-dimethylazanium",CC(=O)OC1C(SC2=CC=CC=C2N(C1=O)CC[NH+](C)C)C3=CC=C(C=C3)OC,loss of weight,CID000003661,L-Hyoscyamine,CN1C2CCC1CC(C2)OC(=O)C(CO)C3=CC=CC=C3
CID000003075,"2-[3-acetyloxy-2-(4-methoxyphenyl)-4-oxo-2,3-dihydro-1,5-benzothiazepin-5-yl]ethyl-dimethylazanium",CC(=O)OC1C(SC2=CC=CC=C2N(C1=O)CC[NH+](C)C)C3=CC=C(C=C3)OC,Scleroderma,CID000016231,AMILORIDE,C1(=C(N=C(C(=N1)Cl)N)N)C(=O)N=C(N)N
CID000003075,"2-[3-acetyloxy-2-(4-methoxyphenyl)-4-oxo-2,3-dihydro-1,5-benzothiazepin-5-yl]ethyl-dimethylazanium",CC(=O)OC1C(SC2=CC=CC=C2N(C1=O)CC[NH+](C)C)C3=CC=C(C=C3)OC,Adenopathy,CID000003440,furosemide,C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl
CID000003075,"2-[3-acetyloxy-2-(4-methoxyphenyl)-4-oxo-2,3-dihydro-1,5-benzothiazepin-5-yl]ethyl-dimethylazanium",CC(=O)OC1C(SC2=CC=CC=C2N(C1=O)CC[NH+](C)C)C3=CC=C(C=C3)OC,Infection Upper Respiratory,CID000005394,temozolomide,CN1C(=O)N2C=NC(=C2N=N1)C(=O)N
CID000003075,"2-[3-acetyloxy-2-(4-methoxyphenyl)-4-oxo-2,3-dihydro-1,5-benzothiazepin-5-yl]ethyl-dimethylazanium",CC(=O)OC1C(SC2=CC=CC=C2N(C1=O)CC[NH+](C)C)C3=CC=C(C=C3)OC,cholecystitis,CID000005732,zolpidem,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C
CID000003075,"2-[3-acetyloxy-2-(4-methoxyphenyl)-4-oxo-2,3-dihydro-1,5-benzothiazepin-5-yl]ethyl-dimethylazanium",CC(=O)OC1C(SC2=CC=CC=C2N(C1=O)CC[NH+](C)C)C3=CC=C(C=C3)OC,erythema,CID000003516,guaifenesin,COC1=CC=CC=C1OCC(CO)O
CID000003075,"2-[3-acetyloxy-2-(4-methoxyphenyl)-4-oxo-2,3-dihydro-1,5-benzothiazepin-5-yl]ethyl-dimethylazanium",CC(=O)OC1C(SC2=CC=CC=C2N(C1=O)CC[NH+](C)C)C3=CC=C(C=C3)OC,cholecystitis,CID000003961,losartan,CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)CO)Cl
CID000003075,"2-[3-acetyloxy-2-(4-methoxyphenyl)-4-oxo-2,3-dihydro-1,5-benzothiazepin-5-yl]ethyl-dimethylazanium",CC(=O)OC1C(SC2=CC=CC=C2N(C1=O)CC[NH+](C)C)C3=CC=C(C=C3)OC,loss of weight,CID000004178,Mexiletine,CC1=C(C(=CC=C1)C)OCC(C)N
CID000003075,"2-[3-acetyloxy-2-(4-methoxyphenyl)-4-oxo-2,3-dihydro-1,5-benzothiazepin-5-yl]ethyl-dimethylazanium",CC(=O)OC1C(SC2=CC=CC=C2N(C1=O)CC[NH+](C)C)C3=CC=C(C=C3)OC,cholecystitis,CID000004173,metronidazole,CC1=NC=C(N1CCO)[N+](=O)[O-]
CID000003075,"2-[3-acetyloxy-2-(4-methoxyphenyl)-4-oxo-2,3-dihydro-1,5-benzothiazepin-5-yl]ethyl-dimethylazanium",CC(=O)OC1C(SC2=CC=CC=C2N(C1=O)CC[NH+](C)C)C3=CC=C(C=C3)OC,Adenopathy,CID000003410,formoterol,CC(CC1=CC=C(C=C1)OC)NCC(C2=CC(=C(C=C2)O)NC=O)O
CID000003075,"2-[3-acetyloxy-2-(4-methoxyphenyl)-4-oxo-2,3-dihydro-1,5-benzothiazepin-5-yl]ethyl-dimethylazanium",CC(=O)OC1C(SC2=CC=CC=C2N(C1=O)CC[NH+](C)C)C3=CC=C(C=C3)OC,Bleeding hemorrhoids,CID000004666,7-Epi Paclitaxel,CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C
CID000003075,"2-[3-acetyloxy-2-(4-methoxyphenyl)-4-oxo-2,3-dihydro-1,5-benzothiazepin-5-yl]ethyl-dimethylazanium",CC(=O)OC1C(SC2=CC=CC=C2N(C1=O)CC[NH+](C)C)C3=CC=C(C=C3)OC,eruption,CID005311082,"2-[(1R,4S,10S,13S,19S)-19-[4-(diaminomethylideneamino)butyl]-10-(1H-indol-3-ylmethyl)-3,9,12,15,18,21,27-heptaoxo-24,25-dithia-2,8,11,14,17,20-hexazatricyclo[18.6.1.04,8]heptacosan-13-yl]acetic acid",C1CC2C(=O)NC3CSSCCC(=O)N(C3=O)C(C(=O)NCC(=O)NC(C(=O)NC(C(=O)N2C1)CC4=CNC5=CC=CC=C54)CC(=O)O)CCCCN=C(N)N
CID000003075,"2-[3-acetyloxy-2-(4-methoxyphenyl)-4-oxo-2,3-dihydro-1,5-benzothiazepin-5-yl]ethyl-dimethylazanium",CC(=O)OC1C(SC2=CC=CC=C2N(C1=O)CC[NH+](C)C)C3=CC=C(C=C3)OC,erythema,CID000005478,racemic-Timolol,CC(C)(C)NCC(COC1=NSN=C1N2CCOCC2)O
CID000003075,"2-[3-acetyloxy-2-(4-methoxyphenyl)-4-oxo-2,3-dihydro-1,5-benzothiazepin-5-yl]ethyl-dimethylazanium",CC(=O)OC1C(SC2=CC=CC=C2N(C1=O)CC[NH+](C)C)C3=CC=C(C=C3)OC,cholecystitis,CID000004236,modafinil,C1=CC=C(C=C1)C(C2=CC=CC=C2)S(=O)CC(=O)N
CID000003075,"2-[3-acetyloxy-2-(4-methoxyphenyl)-4-oxo-2,3-dihydro-1,5-benzothiazepin-5-yl]ethyl-dimethylazanium",CC(=O)OC1C(SC2=CC=CC=C2N(C1=O)CC[NH+](C)C)C3=CC=C(C=C3)OC,gastric inflammation,CID000004900,Fernisone,CC12CC(=O)C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C
CID000003075,"2-[3-acetyloxy-2-(4-methoxyphenyl)-4-oxo-2,3-dihydro-1,5-benzothiazepin-5-yl]ethyl-dimethylazanium",CC(=O)OC1C(SC2=CC=CC=C2N(C1=O)CC[NH+](C)C)C3=CC=C(C=C3)OC,cholecystitis,CID000004909,primidone,CCC1(C(=O)NCNC1=O)C2=CC=CC=C2
CID000003075,"2-[3-acetyloxy-2-(4-methoxyphenyl)-4-oxo-2,3-dihydro-1,5-benzothiazepin-5-yl]ethyl-dimethylazanium",CC(=O)OC1C(SC2=CC=CC=C2N(C1=O)CC[NH+](C)C)C3=CC=C(C=C3)OC,dyspepsia,CID000003305,Etidronic acid,CC(O)(P(=O)(O)O)P(=O)(O)O
CID000003075,"2-[3-acetyloxy-2-(4-methoxyphenyl)-4-oxo-2,3-dihydro-1,5-benzothiazepin-5-yl]ethyl-dimethylazanium",CC(=O)OC1C(SC2=CC=CC=C2N(C1=O)CC[NH+](C)C)C3=CC=C(C=C3)OC,cholecystitis,CID000004585,"2-methyl-4-(4-methylpiperazin-1-yl)-5H-thieno[3,2-c][1,5]benzodiazepine",CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C
CID000003075,"2-[3-acetyloxy-2-(4-methoxyphenyl)-4-oxo-2,3-dihydro-1,5-benzothiazepin-5-yl]ethyl-dimethylazanium",CC(=O)OC1C(SC2=CC=CC=C2N(C1=O)CC[NH+](C)C)C3=CC=C(C=C3)OC,cellulitis,CID000071616,Voriconazole,CC(C1=NC=NC=C1F)C(CN2C=NC=N2)(C3=C(C=C(C=C3)F)F)O
CID000003075,"2-[3-acetyloxy-2-(4-methoxyphenyl)-4-oxo-2,3-dihydro-1,5-benzothiazepin-5-yl]ethyl-dimethylazanium",CC(=O)OC1C(SC2=CC=CC=C2N(C1=O)CC[NH+](C)C)C3=CC=C(C=C3)OC,cholecystitis,CID000005358,sumatriptan,CNS(=O)(=O)CC1=CC2=C(C=C1)NC=C2CCN(C)C
CID000003075,"2-[3-acetyloxy-2-(4-methoxyphenyl)-4-oxo-2,3-dihydro-1,5-benzothiazepin-5-yl]ethyl-dimethylazanium",CC(=O)OC1C(SC2=CC=CC=C2N(C1=O)CC[NH+](C)C)C3=CC=C(C=C3)OC,apoplexy,CID000005352,38194-50-2,CC1=C(C2=C(C1=CC3=CC=C(C=C3)S(=O)C)C=CC(=C2)F)CC(=O)O
CID000003075,"2-[3-acetyloxy-2-(4-methoxyphenyl)-4-oxo-2,3-dihydro-1,5-benzothiazepin-5-yl]ethyl-dimethylazanium",CC(=O)OC1C(SC2=CC=CC=C2N(C1=O)CC[NH+](C)C)C3=CC=C(C=C3)OC,Bone Fracture Spontaneous,CID000005978,vincristine,CCC1(CC2CC(C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)C78CCN9C7C(C=CC9)(C(C(C8N6C=O)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O
CID000003075,"2-[3-acetyloxy-2-(4-methoxyphenyl)-4-oxo-2,3-dihydro-1,5-benzothiazepin-5-yl]ethyl-dimethylazanium",CC(=O)OC1C(SC2=CC=CC=C2N(C1=O)CC[NH+](C)C)C3=CC=C(C=C3)OC,abdominal pain upper,CID000005095,ropinirole,CCCN(CCC)CCC1=C2CC(=O)NC2=CC=C1
CID000003075,"2-[3-acetyloxy-2-(4-methoxyphenyl)-4-oxo-2,3-dihydro-1,5-benzothiazepin-5-yl]ethyl-dimethylazanium",CC(=O)OC1C(SC2=CC=CC=C2N(C1=O)CC[NH+](C)C)C3=CC=C(C=C3)OC,apoplexy,CID000027686,CHEMBL4088679,C1=CC2=C(C(=C1)OCC(COC3=CC4=C(C=C3)OC(=CC4=O)C(=O)O)O)C(=O)C=C(O2)C(=O)O
CID000003075,"2-[3-acetyloxy-2-(4-methoxyphenyl)-4-oxo-2,3-dihydro-1,5-benzothiazepin-5-yl]ethyl-dimethylazanium",CC(=O)OC1C(SC2=CC=CC=C2N(C1=O)CC[NH+](C)C)C3=CC=C(C=C3)OC,Adenopathy,CID000170361,Varenicline,C1C2CNCC1C3=CC4=NC=CN=C4C=C23
CID000003075,"2-[3-acetyloxy-2-(4-methoxyphenyl)-4-oxo-2,3-dihydro-1,5-benzothiazepin-5-yl]ethyl-dimethylazanium",CC(=O)OC1C(SC2=CC=CC=C2N(C1=O)CC[NH+](C)C)C3=CC=C(C=C3)OC,adenomyosis,CID000003937,N~2~-(1-carboxy-3-phenylpropyl)lysylproline,C1CC(N(C1)C(=O)C(CCCCN)NC(CCC2=CC=CC=C2)C(=O)O)C(=O)O
CID000003075,"2-[3-acetyloxy-2-(4-methoxyphenyl)-4-oxo-2,3-dihydro-1,5-benzothiazepin-5-yl]ethyl-dimethylazanium",CC(=O)OC1C(SC2=CC=CC=C2N(C1=O)CC[NH+](C)C)C3=CC=C(C=C3)OC,gastric inflammation,CID003468412,SCHEMBL1176571,CC1C=CC=CCCC=CC=CC=CC=CC(CC(C(C(CC(=O)CC(C(CCC(CC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)C(=O)O)O)OC2C(C(C(C(O2)C)O)N)O
CID000003075,"2-[3-acetyloxy-2-(4-methoxyphenyl)-4-oxo-2,3-dihydro-1,5-benzothiazepin-5-yl]ethyl-dimethylazanium",CC(=O)OC1C(SC2=CC=CC=C2N(C1=O)CC[NH+](C)C)C3=CC=C(C=C3)OC,arterial pressure NOS increased,CID000060612,levomedetomidine,CC1=C(C(=CC=C1)C(C)C2=CN=CN2)C
CID000003075,"2-[3-acetyloxy-2-(4-methoxyphenyl)-4-oxo-2,3-dihydro-1,5-benzothiazepin-5-yl]ethyl-dimethylazanium",CC(=O)OC1C(SC2=CC=CC=C2N(C1=O)CC[NH+](C)C)C3=CC=C(C=C3)OC,cholecystitis,CID000110635,Tadalafil,CN1CC(=O)N2C(C1=O)CC3=C(C2C4=CC5=C(C=C4)OCO5)NC6=CC=CC=C36
CID000003075,"2-[3-acetyloxy-2-(4-methoxyphenyl)-4-oxo-2,3-dihydro-1,5-benzothiazepin-5-yl]ethyl-dimethylazanium",CC(=O)OC1C(SC2=CC=CC=C2N(C1=O)CC[NH+](C)C)C3=CC=C(C=C3)OC,myelodysplasia,CID000003405,2-[[4-[(2-amino-4-oxo-1H-pteridin-6-yl)methylamino]benzoyl]amino]pentanedioic acid,C1=CC(=CC=C1C(=O)NC(CCC(=O)O)C(=O)O)NCC2=CN=C3C(=N2)C(=O)N=C(N3)N
CID000003075,"2-[3-acetyloxy-2-(4-methoxyphenyl)-4-oxo-2,3-dihydro-1,5-benzothiazepin-5-yl]ethyl-dimethylazanium",CC(=O)OC1C(SC2=CC=CC=C2N(C1=O)CC[NH+](C)C)C3=CC=C(C=C3)OC,cholecystitis,CID000005512,124936-74-9,CC1=CC(=C(C=C1)O)C(CCN(C(C)C)C(C)C)C2=CC=CC=C2
CID000003075,"2-[3-acetyloxy-2-(4-methoxyphenyl)-4-oxo-2,3-dihydro-1,5-benzothiazepin-5-yl]ethyl-dimethylazanium",CC(=O)OC1C(SC2=CC=CC=C2N(C1=O)CC[NH+](C)C)C3=CC=C(C=C3)OC,cholecystitis,CID000060184,"2'-epi-Perindopril, (2'R)-",CCCC(C(=O)OCC)NC(C)C(=O)N1C2CCCCC2CC1C(=O)O
CID000003075,"2-[3-acetyloxy-2-(4-methoxyphenyl)-4-oxo-2,3-dihydro-1,5-benzothiazepin-5-yl]ethyl-dimethylazanium",CC(=O)OC1C(SC2=CC=CC=C2N(C1=O)CC[NH+](C)C)C3=CC=C(C=C3)OC,erythema,CID000004158,methylphenidate,COC(=O)C(C1CCCCN1)C2=CC=CC=C2
CID000003075,"2-[3-acetyloxy-2-(4-methoxyphenyl)-4-oxo-2,3-dihydro-1,5-benzothiazepin-5-yl]ethyl-dimethylazanium",CC(=O)OC1C(SC2=CC=CC=C2N(C1=O)CC[NH+](C)C)C3=CC=C(C=C3)OC,cholecystitis,CID000003676,lidocaine,CCN(CC)CC(=O)NC1=C(C=CC=C1C)C
CID000003075,"2-[3-acetyloxy-2-(4-methoxyphenyl)-4-oxo-2,3-dihydro-1,5-benzothiazepin-5-yl]ethyl-dimethylazanium",CC(=O)OC1C(SC2=CC=CC=C2N(C1=O)CC[NH+](C)C)C3=CC=C(C=C3)OC,cholecystitis,CID000005245,Risedronic acid,C1=CC(=CN=C1)CC(O)(P(=O)(O)O)P(=O)(O)O
CID000003075,"2-[3-acetyloxy-2-(4-methoxyphenyl)-4-oxo-2,3-dihydro-1,5-benzothiazepin-5-yl]ethyl-dimethylazanium",CC(=O)OC1C(SC2=CC=CC=C2N(C1=O)CC[NH+](C)C)C3=CC=C(C=C3)OC,back injury,CID000004894,"11,17,21-Trihydroxypregna-1,4-diene-3,20-dione",CC12CC(C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C)O
CID000003075,"2-[3-acetyloxy-2-(4-methoxyphenyl)-4-oxo-2,3-dihydro-1,5-benzothiazepin-5-yl]ethyl-dimethylazanium",CC(=O)OC1C(SC2=CC=CC=C2N(C1=O)CC[NH+](C)C)C3=CC=C(C=C3)OC,loss of weight,CID000004189,miconazole,C1=CC(=C(C=C1Cl)Cl)COC(CN2C=CN=C2)C3=C(C=C(C=C3)Cl)Cl
CID000003075,"2-[3-acetyloxy-2-(4-methoxyphenyl)-4-oxo-2,3-dihydro-1,5-benzothiazepin-5-yl]ethyl-dimethylazanium",CC(=O)OC1C(SC2=CC=CC=C2N(C1=O)CC[NH+](C)C)C3=CC=C(C=C3)OC,loss of weight,CID000060852,Ibandronic Acid,CCCCCN(C)CCC(O)(P(=O)(O)O)P(=O)(O)O
CID000003075,"2-[3-acetyloxy-2-(4-methoxyphenyl)-4-oxo-2,3-dihydro-1,5-benzothiazepin-5-yl]ethyl-dimethylazanium",CC(=O)OC1C(SC2=CC=CC=C2N(C1=O)CC[NH+](C)C)C3=CC=C(C=C3)OC,gastric inflammation,CID000004691,"3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine",C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4
CID000003075,"2-[3-acetyloxy-2-(4-methoxyphenyl)-4-oxo-2,3-dihydro-1,5-benzothiazepin-5-yl]ethyl-dimethylazanium",CC(=O)OC1C(SC2=CC=CC=C2N(C1=O)CC[NH+](C)C)C3=CC=C(C=C3)OC,myelodysplasia,CID006398525,,C(C1C(C(C(C(O1)OC2(C(C(C(O2)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)COS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.[Al].[Al].[Al].[Al].[Al].[Al].[Al].[Al].[Al]
CID000003075,"2-[3-acetyloxy-2-(4-methoxyphenyl)-4-oxo-2,3-dihydro-1,5-benzothiazepin-5-yl]ethyl-dimethylazanium",CC(=O)OC1C(SC2=CC=CC=C2N(C1=O)CC[NH+](C)C)C3=CC=C(C=C3)OC,cholecystitis,CID000003954,loperamide(1+),CN(C)C(=O)C(CC[NH+]1CCC(CC1)(C2=CC=C(C=C2)Cl)O)(C3=CC=CC=C3)C4=CC=CC=C4
CID000003075,"2-[3-acetyloxy-2-(4-methoxyphenyl)-4-oxo-2,3-dihydro-1,5-benzothiazepin-5-yl]ethyl-dimethylazanium",CC(=O)OC1C(SC2=CC=CC=C2N(C1=O)CC[NH+](C)C)C3=CC=C(C=C3)OC,agitated,CID000004819,"2(3H)-Furanone, 3-ethyldihydro-4-[(1-methyl-1H-imidazol-5-yl)methyl]-, (3S-cis)-",CCC1C(COC1=O)CC2=CN=CN2C
CID000003075,"2-[3-acetyloxy-2-(4-methoxyphenyl)-4-oxo-2,3-dihydro-1,5-benzothiazepin-5-yl]ethyl-dimethylazanium",CC(=O)OC1C(SC2=CC=CC=C2N(C1=O)CC[NH+](C)C)C3=CC=C(C=C3)OC,apoplexy,CID000004614,oxaprozin,C1=CC=C(C=C1)C2=C(OC(=N2)CCC(=O)O)C3=CC=CC=C3
CID000003075,"2-[3-acetyloxy-2-(4-methoxyphenyl)-4-oxo-2,3-dihydro-1,5-benzothiazepin-5-yl]ethyl-dimethylazanium",CC(=O)OC1C(SC2=CC=CC=C2N(C1=O)CC[NH+](C)C)C3=CC=C(C=C3)OC,abnormal ECG,CID000060854,Ziprasidone,C1CN(CCN1CCC2=C(C=C3C(=C2)CC(=O)N3)Cl)C4=NSC5=CC=CC=C54
CID000003075,"2-[3-acetyloxy-2-(4-methoxyphenyl)-4-oxo-2,3-dihydro-1,5-benzothiazepin-5-yl]ethyl-dimethylazanium",CC(=O)OC1C(SC2=CC=CC=C2N(C1=O)CC[NH+](C)C)C3=CC=C(C=C3)OC,cholecystitis,CID000004425,"4a,9-dihydroxy-3-prop-2-enyl-2,4,5,6,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinolin-7-one",C=CCN1CCC23C4C(=O)CCC2(C1CC5=C3C(=C(C=C5)O)O4)O
CID000003075,"2-[3-acetyloxy-2-(4-methoxyphenyl)-4-oxo-2,3-dihydro-1,5-benzothiazepin-5-yl]ethyl-dimethylazanium",CC(=O)OC1C(SC2=CC=CC=C2N(C1=O)CC[NH+](C)C)C3=CC=C(C=C3)OC,cholecystitis,CID000003333,felodipine,CCOC(=O)C1=C(NC(=C(C1C2=C(C(=CC=C2)Cl)Cl)C(=O)OC)C)C
CID000003075,"2-[3-acetyloxy-2-(4-methoxyphenyl)-4-oxo-2,3-dihydro-1,5-benzothiazepin-5-yl]ethyl-dimethylazanium",CC(=O)OC1C(SC2=CC=CC=C2N(C1=O)CC[NH+](C)C)C3=CC=C(C=C3)OC,Adenopathy,CID000003339,fenofibrate,CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C2=CC=C(C=C2)Cl
CID000005070,riluzole,C1=CC2=C(C=C1OC(F)(F)F)SC(=N2)N,decubitus ulcer,CID000005512,124936-74-9,CC1=CC(=C(C=C1)O)C(CCN(C(C)C)C(C)C)C2=CC=CC=C2
CID000005070,riluzole,C1=CC2=C(C=C1OC(F)(F)F)SC(=N2)N,hyperalimentation,CID000005095,ropinirole,CCCN(CCC)CCC1=C2CC(=O)NC2=CC=C1
CID000005070,riluzole,C1=CC2=C(C=C1OC(F)(F)F)SC(=N2)N,Adenopathy,CID000005732,zolpidem,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C
CID000003414,phosphonatoformate,C(=O)([O-])P(=O)([O-])[O-],cardiovascular collapse,CID000003440,furosemide,C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl
CID000003414,phosphonatoformate,C(=O)([O-])P(=O)([O-])[O-],weight gain,CID000071616,Voriconazole,CC(C1=NC=NC=C1F)C(CN2C=NC=N2)(C3=C(C=C(C=C3)F)F)O
CID000003414,phosphonatoformate,C(=O)([O-])P(=O)([O-])[O-],weight gain,CID000005645,"3,7-Dihydroxycholan-24-oic acid",CC(CCC(=O)O)C1CCC2C1(CCC3C2C(CC4C3(CCC(C4)O)C)O)C
CID000003414,phosphonatoformate,C(=O)([O-])P(=O)([O-])[O-],loss of weight,CID000074989,ATOVAQUONE,C1CC(CCC1C2=CC=C(C=C2)Cl)C3=C(C4=CC=CC=C4C(=O)C3=O)O
CID000003414,phosphonatoformate,C(=O)([O-])P(=O)([O-])[O-],loss of weight,CID000004894,"11,17,21-Trihydroxypregna-1,4-diene-3,20-dione",CC12CC(C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C)O
CID000005645,"3,7-Dihydroxycholan-24-oic acid",CC(CCC(=O)O)C1CCC2C1(CCC3C2C(CC4C3(CCC(C4)O)C)O)C,weight gain,CID000071616,Voriconazole,CC(C1=NC=NC=C1F)C(CN2C=NC=N2)(C3=C(C=C(C=C3)F)F)O
CID000005645,"3,7-Dihydroxycholan-24-oic acid",CC(CCC(=O)O)C1CCC2C1(CCC3C2C(CC4C3(CCC(C4)O)C)O)C,thrombocytopenia,CID000074989,ATOVAQUONE,C1CC(CCC1C2=CC=C(C=C2)Cl)C3=C(C4=CC=CC=C4C(=O)C3=O)O
CID000005645,"3,7-Dihydroxycholan-24-oic acid",CC(CCC(=O)O)C1CCC2C1(CCC3C2C(CC4C3(CCC(C4)O)C)O)C,cholecystitis,CID006398525,,C(C1C(C(C(C(O1)OC2(C(C(C(O2)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)COS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.[Al].[Al].[Al].[Al].[Al].[Al].[Al].[Al].[Al]
CID000005645,"3,7-Dihydroxycholan-24-oic acid",CC(CCC(=O)O)C1CCC2C1(CCC3C2C(CC4C3(CCC(C4)O)C)O)C,acute pancreatitis,CID000667490,6-Mercaptopurine,C1=NC2=C(N1)C(=S)N=CN2
CID000005645,"3,7-Dihydroxycholan-24-oic acid",CC(CCC(=O)O)C1CCC2C1(CCC3C2C(CC4C3(CCC(C4)O)C)O)C,eruption,CID000170361,Varenicline,C1C2CNCC1C3=CC4=NC=CN=C4C=C23
CID000005645,"3,7-Dihydroxycholan-24-oic acid",CC(CCC(=O)O)C1CCC2C1(CCC3C2C(CC4C3(CCC(C4)O)C)O)C,cholelithiasis,CID000060787,sequinavir,CC(C)(C)NC(=O)C1CC2CCCCC2CN1CC(C(CC3=CC=CC=C3)NC(=O)C(CC(=O)N)NC(=O)C4=NC5=CC=CC=C5C=C4)O
CID000005645,"3,7-Dihydroxycholan-24-oic acid",CC(CCC(=O)O)C1CCC2C1(CCC3C2C(CC4C3(CCC(C4)O)C)O)C,thrombocytopenia,CID000163742,SCHEMBL1650579,COC1C(C(C(C(O1)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)COS(=O)(=O)O)OC4C(C(C(C(O4)C(=O)O)OC5C(C(C(C(O5)COS(=O)(=O)O)O)O)NS(=O)(=O)O)O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O)NS(=O)(=O)O
CID000005645,"3,7-Dihydroxycholan-24-oic acid",CC(CCC(=O)O)C1CCC2C1(CCC3C2C(CC4C3(CCC(C4)O)C)O)C,High blood pressure,CID000062924,"S-(fluoromethyl) (6S,9R,10S,11S,13S,14S,16R,17R)-6,9-difluoro-11,17-dihydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthrene-17-carbothioate",CC1CC2C3CC(C4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)SCF)O)C)O)F)C)F
CID000005645,"3,7-Dihydroxycholan-24-oic acid",CC(CCC(=O)O)C1CCC2C1(CCC3C2C(CC4C3(CCC(C4)O)C)O)C,muscle paresis,CID000005978,vincristine,CCC1(CC2CC(C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)C78CCN9C7C(C=CC9)(C(C(C8N6C=O)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O
CID000005645,"3,7-Dihydroxycholan-24-oic acid",CC(CCC(=O)O)C1CCC2C1(CCC3C2C(CC4C3(CCC(C4)O)C)O)C,pleural pain,CID000019090,megestrol,CC1=CC2C(CCC3(C2CCC3(C(=O)C)O)C)C4(C1=CC(=O)CC4)C
CID000005645,"3,7-Dihydroxycholan-24-oic acid",CC(CCC(=O)O)C1CCC2C1(CCC3C2C(CC4C3(CCC(C4)O)C)O)C,angiitis,CID000027686,CHEMBL4088679,C1=CC2=C(C(=C1)OCC(COC3=CC4=C(C=C3)OC(=CC4=O)C(=O)O)O)C(=O)C=C(O2)C(=O)O
CID000005645,"3,7-Dihydroxycholan-24-oic acid",CC(CCC(=O)O)C1CCC2C1(CCC3C2C(CC4C3(CCC(C4)O)C)O)C,gastric inflammation,CID000005732,zolpidem,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C
CID000005645,"3,7-Dihydroxycholan-24-oic acid",CC(CCC(=O)O)C1CCC2C1(CCC3C2C(CC4C3(CCC(C4)O)C)O)C,allergic dermatitis,CID003468412,SCHEMBL1176571,CC1C=CC=CCCC=CC=CC=CC=CC(CC(C(C(CC(=O)CC(C(CCC(CC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)C(=O)O)O)OC2C(C(C(C(O2)C)O)N)O
CID000005645,"3,7-Dihydroxycholan-24-oic acid",CC(CCC(=O)O)C1CCC2C1(CCC3C2C(CC4C3(CCC(C4)O)C)O)C,hypermagnesemia,CID000119182,Clofarabine,C1=NC2=C(N=C(N=C2N1C3C(C(C(O3)CO)O)F)Cl)N
CID000005645,"3,7-Dihydroxycholan-24-oic acid",CC(CCC(=O)O)C1CCC2C1(CCC3C2C(CC4C3(CCC(C4)O)C)O)C,aphasia,CID000060612,levomedetomidine,CC1=C(C(=CC=C1)C(C)C2=CN=CN2)C
CID000065027,N-[3-[(1R)-1-[(2R)-6-hydroxy-4-oxo-2-(2-phenylethyl)-2-propyl-3H-pyran-5-yl]propyl]phenyl]-5-(trifluoromethyl)pyridine-2-sulfonamide,CCCC1(CC(=O)C(=C(O1)O)C(CC)C2=CC(=CC=C2)NS(=O)(=O)C3=NC=C(C=C3)C(F)(F)F)CCC4=CC=CC=C4,abortion spontaneous,CID000074989,ATOVAQUONE,C1CC(CCC1C2=CC=C(C=C2)Cl)C3=C(C4=CC=CC=C4C(=O)C3=O)O
CID000004601,orphenadrine,CC1=CC=CC=C1C(C2=CC=CC=C2)OCCN(C)C,Adenopathy,CID000005719,zaleplon,CCN(C1=CC=CC(=C1)C2=CC=NC3=C(C=NN23)C#N)C(=O)C
CID000004601,orphenadrine,CC1=CC=CC=C1C(C2=CC=CC=C2)OCCN(C)C,bursitis,CID000004745,SCHEMBL7711911,CCCN1CC(CC2C1CC3=CNC4=CC=CC2=C34)CSC
CID000004601,orphenadrine,CC1=CC=CC=C1C(C2=CC=CC=C2)OCCN(C)C,gastric inflammation,CID000004889,Pravastatin Impurity A,CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC(CC(CC(=O)O)O)O)O
CID000004601,orphenadrine,CC1=CC=CC=C1C(C2=CC=CC=C2)OCCN(C)C,apoplexy,CID000005487,tizanidine,C1CN=C(N1)NC2=C(C=CC3=NSN=C32)Cl
CID000004601,orphenadrine,CC1=CC=CC=C1C(C2=CC=CC=C2)OCCN(C)C,eruption,CID000005544,Mycolog,CC12CC(C3(C(C1CC(C2(C(=O)CO)O)O)CCC4=CC(=O)C=CC43C)F)O
CID000004601,orphenadrine,CC1=CC=CC=C1C(C2=CC=CC=C2)OCCN(C)C,Adenopathy,CID000004900,Fernisone,CC12CC(=O)C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C
CID000004601,orphenadrine,CC1=CC=CC=C1C(C2=CC=CC=C2)OCCN(C)C,edema,CID000005512,124936-74-9,CC1=CC(=C(C=C1)O)C(CCN(C(C)C)C(C)C)C2=CC=CC=C2
CID000004601,orphenadrine,CC1=CC=CC=C1C(C2=CC=CC=C2)OCCN(C)C,eruption,CID000005095,ropinirole,CCCN(CCC)CCC1=C2CC(=O)NC2=CC=C1
CID000004601,orphenadrine,CC1=CC=CC=C1C(C2=CC=CC=C2)OCCN(C)C,apoplexy,CID000005073,risperidone,CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F
CID000004601,orphenadrine,CC1=CC=CC=C1C(C2=CC=CC=C2)OCCN(C)C,erythema,CID000005358,sumatriptan,CNS(=O)(=O)CC1=CC2=C(C=C1)NC=C2CCN(C)C
CID000004601,orphenadrine,CC1=CC=CC=C1C(C2=CC=CC=C2)OCCN(C)C,erythema,CID000005732,zolpidem,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C
CID000004601,orphenadrine,CC1=CC=CC=C1C(C2=CC=CC=C2)OCCN(C)C,bulging,CID000004920,"1-acetyl-9a,11a-dimethyl-1H,2H,3H,3aH,3bH,4H,5H,7H,8H,9H,9aH,9bH,10H,11H,11aH-cyclopenta[a]phenanthren-7-one",CC(=O)C1CCC2C1(CCC3C2CCC4=CC(=O)CCC34C)C
CID000004601,orphenadrine,CC1=CC=CC=C1C(C2=CC=CC=C2)OCCN(C)C,cholecystitis,CID000004691,"3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine",C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4
CID000004601,orphenadrine,CC1=CC=CC=C1C(C2=CC=CC=C2)OCCN(C)C,Adenopathy,CID000004927,promethazine,CC(CN1C2=CC=CC=C2SC3=CC=CC=C31)N(C)C
CID000004601,orphenadrine,CC1=CC=CC=C1C(C2=CC=CC=C2)OCCN(C)C,loss of weight,CID000062924,"S-(fluoromethyl) (6S,9R,10S,11S,13S,14S,16R,17R)-6,9-difluoro-11,17-dihydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthrene-17-carbothioate",CC1CC2C3CC(C4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)SCF)O)C)O)F)C)F
CID000004601,orphenadrine,CC1=CC=CC=C1C(C2=CC=CC=C2)OCCN(C)C,atelectasis,CID000170361,Varenicline,C1C2CNCC1C3=CC4=NC=CN=C4C=C23
CID000005978,vincristine,CCC1(CC2CC(C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)C78CCN9C7C(C=CC9)(C(C(C8N6C=O)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O,phlebothrombosis,CID006398525,,C(C1C(C(C(C(O1)OC2(C(C(C(O2)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)COS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.[Al].[Al].[Al].[Al].[Al].[Al].[Al].[Al].[Al]
CID000005978,vincristine,CCC1(CC2CC(C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)C78CCN9C7C(C=CC9)(C(C(C8N6C=O)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O,loss of weight,CID000019090,megestrol,CC1=CC2C(CCC3(C2CCC3(C(=O)C)O)C)C4(C1=CC(=O)CC4)C
CID000005978,vincristine,CCC1(CC2CC(C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)C78CCN9C7C(C=CC9)(C(C(C8N6C=O)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O,Excoriation,CID000060754,Gadodiamide hydrate,CNC(=O)CN(CCN(CCN(CC(=O)NC)CC(=O)[O-])CC(=O)[O-])CC(=O)[O-].O.[Gd+3]
CID000005978,vincristine,CCC1(CC2CC(C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)C78CCN9C7C(C=CC9)(C(C(C8N6C=O)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O,apoplexy,CID003468412,SCHEMBL1176571,CC1C=CC=CCCC=CC=CC=CC=CC(CC(C(C(CC(=O)CC(C(CCC(CC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)C(=O)O)O)OC2C(C(C(C(O2)C)O)N)O
CID000005978,vincristine,CCC1(CC2CC(C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)C78CCN9C7C(C=CC9)(C(C(C8N6C=O)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O,elevated cholesterol,CID000060787,sequinavir,CC(C)(C)NC(=O)C1CC2CCCCC2CN1CC(C(CC3=CC=CC=C3)NC(=O)C(CC(=O)N)NC(=O)C4=NC5=CC=CC=C5C=C4)O
CID000005978,vincristine,CCC1(CC2CC(C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)C78CCN9C7C(C=CC9)(C(C(C8N6C=O)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O,erythema,CID000062924,"S-(fluoromethyl) (6S,9R,10S,11S,13S,14S,16R,17R)-6,9-difluoro-11,17-dihydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthrene-17-carbothioate",CC1CC2C3CC(C4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)SCF)O)C)O)F)C)F
CID000005978,vincristine,CCC1(CC2CC(C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)C78CCN9C7C(C=CC9)(C(C(C8N6C=O)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O,erythema,CID000071616,Voriconazole,CC(C1=NC=NC=C1F)C(CN2C=NC=N2)(C3=C(C=C(C=C3)F)F)O
CID000005978,vincristine,CCC1(CC2CC(C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)C78CCN9C7C(C=CC9)(C(C(C8N6C=O)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O,thrombocytopenia,CID000060184,"2'-epi-Perindopril, (2'R)-",CCCC(C(=O)OCC)NC(C)C(=O)N1C2CCCCC2CC1C(=O)O
CID000005978,vincristine,CCC1(CC2CC(C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)C78CCN9C7C(C=CC9)(C(C(C8N6C=O)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O,Adenopathy,CID000147912,DSSTox_GSID_49066,CCC(C(C)O)N1C(=O)N(C=N1)C2=CC=C(C=C2)N3CCN(CC3)C4=CC=C(C=C4)OCC5CC(OC5)(CN6C=NC=N6)C7=C(C=C(C=C7)F)F
CID000005978,vincristine,CCC1(CC2CC(C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)C78CCN9C7C(C=CC9)(C(C(C8N6C=O)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O,ear infection,CID000667490,6-Mercaptopurine,C1=NC2=C(N1)C(=S)N=CN2
CID000001986,acetazolamide,CC(=O)NC1=NN=C(S1)S(=O)(=O)N,thrombocytopenia,CID000003310,33419-42-0,CC1OCC2C(O1)C(C(C(O2)OC3C4COC(=O)C4C(C5=CC6=C(C=C35)OCO6)C7=CC(=C(C(=C7)OC)O)OC)O)O
CID000001986,acetazolamide,CC(=O)NC1=NN=C(S1)S(=O)(=O)N,apoplexy,CID000003405,2-[[4-[(2-amino-4-oxo-1H-pteridin-6-yl)methylamino]benzoyl]amino]pentanedioic acid,C1=CC(=CC=C1C(=O)NC(CCC(=O)O)C(=O)O)NCC2=CN=C3C(=N2)C(=O)N=C(N3)N
CID000001986,acetazolamide,CC(=O)NC1=NN=C(S1)S(=O)(=O)N,deglutition disorder,CID000004909,primidone,CCC1(C(=O)NCNC1=O)C2=CC=CC=C2
CID000001986,acetazolamide,CC(=O)NC1=NN=C(S1)S(=O)(=O)N,haematoma,CID000004900,Fernisone,CC12CC(=O)C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C
CID000001986,acetazolamide,CC(=O)NC1=NN=C(S1)S(=O)(=O)N,rhinorrhea,CID000002284,baclofen,C1=CC(=CC=C1C(CC(=O)O)CN)Cl
CID000001986,acetazolamide,CC(=O)NC1=NN=C(S1)S(=O)(=O)N,glaucoma,CID000003661,L-Hyoscyamine,CN1C2CCC1CC(C2)OC(=O)C(CO)C3=CC=CC=C3
CID000001986,acetazolamide,CC(=O)NC1=NN=C(S1)S(=O)(=O)N,glaucoma,CID000003062,Lanicor,CC1C(C(CC(O1)OC2C(OC(CC2O)OC3C(OC(CC3O)OC4CCC5(C(C4)CCC6C5CC(C7(C6(CCC7C8=CC(=O)OC8)O)C)O)C)C)C)O)O
CID000001986,acetazolamide,CC(=O)NC1=NN=C(S1)S(=O)(=O)N,increased white blood cell count,CID000004173,metronidazole,CC1=NC=C(N1CCO)[N+](=O)[O-]
CID000001986,acetazolamide,CC(=O)NC1=NN=C(S1)S(=O)(=O)N,eruption,CID000002022,2-amino-9-(2-hydroxyethoxymethyl)-3H-purin-6-one,C1=NC2=C(N1COCCO)NC(=NC2=O)N
CID000001986,acetazolamide,CC(=O)NC1=NN=C(S1)S(=O)(=O)N,drug toxicity NOS,CID000005478,racemic-Timolol,CC(C)(C)NCC(COC1=NSN=C1N2CCOCC2)O
CID000001986,acetazolamide,CC(=O)NC1=NN=C(S1)S(=O)(=O)N,Ovarian cancer,CID000003890,TRANS (15S)-LATANOPROST,CC(C)OC(=O)CCCC=CCC1C(CC(C1CCC(CCC2=CC=CC=C2)O)O)O
CID000001986,acetazolamide,CC(=O)NC1=NN=C(S1)S(=O)(=O)N,muscle disorder,CID000002806,90055-48-4,COC(=O)C(C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3
CID000001986,acetazolamide,CC(=O)NC1=NN=C(S1)S(=O)(=O)N,confusion,CID000005073,risperidone,CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F
CID000001986,acetazolamide,CC(=O)NC1=NN=C(S1)S(=O)(=O)N,Dyspnea exertional,CID000005732,zolpidem,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C
CID000001986,acetazolamide,CC(=O)NC1=NN=C(S1)S(=O)(=O)N,erythema,CID000003440,furosemide,C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl
CID000001986,acetazolamide,CC(=O)NC1=NN=C(S1)S(=O)(=O)N,hematoma subdural,CID000004691,"3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine",C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4
CID000001986,acetazolamide,CC(=O)NC1=NN=C(S1)S(=O)(=O)N,gout,CID000003937,N~2~-(1-carboxy-3-phenylpropyl)lysylproline,C1CC(N(C1)C(=O)C(CCCCN)NC(CCC2=CC=CC=C2)C(=O)O)C(=O)O
CID000001986,acetazolamide,CC(=O)NC1=NN=C(S1)S(=O)(=O)N,Back Ache,CID000002771,citalopram,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F
CID000001986,acetazolamide,CC(=O)NC1=NN=C(S1)S(=O)(=O)N,increased white blood cell count,CID000003883,lansoprazole,CC1=C(C=CN=C1CS(=O)C2=NC3=CC=CC=C3N2)OCC(F)(F)F
CID000001986,acetazolamide,CC(=O)NC1=NN=C(S1)S(=O)(=O)N,gout,CID000004894,"11,17,21-Trihydroxypregna-1,4-diene-3,20-dione",CC12CC(C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C)O
CID000001986,acetazolamide,CC(=O)NC1=NN=C(S1)S(=O)(=O)N,drug toxicity NOS,CID000004819,"2(3H)-Furanone, 3-ethyldihydro-4-[(1-methyl-1H-imidazol-5-yl)methyl]-, (3S-cis)-",CCC1C(COC1=O)CC2=CN=CN2C
CID000001986,acetazolamide,CC(=O)NC1=NN=C(S1)S(=O)(=O)N,Bacteraemia,CID006398525,,C(C1C(C(C(C(O1)OC2(C(C(C(O2)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)COS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.[Al].[Al].[Al].[Al].[Al].[Al].[Al].[Al].[Al]
CID000001986,acetazolamide,CC(=O)NC1=NN=C(S1)S(=O)(=O)N,exophthalmos,CID000003676,lidocaine,CCN(CC)CC(=O)NC1=C(C=CC=C1C)C
CID000001986,acetazolamide,CC(=O)NC1=NN=C(S1)S(=O)(=O)N,defaecation urgency,CID000004536,Minovlar,CC12CCC3C(C1CCC2(C#C)O)CCC4=CC(=O)CCC34
CID000060612,levomedetomidine,CC1=C(C(=CC=C1)C(C)C2=CN=CN2)C,High blood pressure,CID000071616,Voriconazole,CC(C1=NC=NC=C1F)C(CN2C=NC=N2)(C3=C(C=C(C=C3)F)F)O
CID000004138,55-40-3,CC(CC1=CC(=C(C=C1)O)O)(C(=O)O)N,apoplexy,CID000004173,metronidazole,CC1=NC=C(N1CCO)[N+](=O)[O-]
CID000004138,55-40-3,CC(CC1=CC(=C(C=C1)O)O)(C(=O)O)N,weight gain,CID000005478,racemic-Timolol,CC(C)(C)NCC(COC1=NSN=C1N2CCOCC2)O
CID000004138,55-40-3,CC(CC1=CC(=C(C=C1)O)O)(C(=O)O)N,edema,CID000005732,zolpidem,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C
CID000004138,55-40-3,CC(CC1=CC(=C(C=C1)O)O)(C(=O)O)N,apoplexy,CID000062924,"S-(fluoromethyl) (6S,9R,10S,11S,13S,14S,16R,17R)-6,9-difluoro-11,17-dihydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthrene-17-carbothioate",CC1CC2C3CC(C4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)SCF)O)C)O)F)C)F
CID000004138,55-40-3,CC(CC1=CC(=C(C=C1)O)O)(C(=O)O)N,Excess potassium,CID000004691,"3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine",C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4
CID000004138,55-40-3,CC(CC1=CC(=C(C=C1)O)O)(C(=O)O)N,apoplexy,CID000004927,promethazine,CC(CN1C2=CC=CC=C2SC3=CC=CC=C31)N(C)C
CID000004138,55-40-3,CC(CC1=CC(=C(C=C1)O)O)(C(=O)O)N,psoriasis,CID000004920,"1-acetyl-9a,11a-dimethyl-1H,2H,3H,3aH,3bH,4H,5H,7H,8H,9H,9aH,9bH,10H,11H,11aH-cyclopenta[a]phenanthren-7-one",CC(=O)C1CCC2C1(CCC3C2CCC4=CC(=O)CCC34C)C
CID000004138,55-40-3,CC(CC1=CC(=C(C=C1)O)O)(C(=O)O)N,apoplexy,CID000004889,Pravastatin Impurity A,CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC(CC(CC(=O)O)O)O)O
CID000004138,55-40-3,CC(CC1=CC(=C(C=C1)O)O)(C(=O)O)N,apoplexy,CID003468412,SCHEMBL1176571,CC1C=CC=CCCC=CC=CC=CC=CC(CC(C(C(CC(=O)CC(C(CCC(CC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)C(=O)O)O)OC2C(C(C(C(O2)C)O)N)O
CID000004138,55-40-3,CC(CC1=CC(=C(C=C1)O)O)(C(=O)O)N,gastric inflammation,CID000004900,Fernisone,CC12CC(=O)C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C
CID000004138,55-40-3,CC(CC1=CC(=C(C=C1)O)O)(C(=O)O)N,neonatal respiratory distress syndrome,CID000005544,Mycolog,CC12CC(C3(C(C1CC(C2(C(=O)CO)O)O)CCC4=CC(=O)C=CC43C)F)O
CID000004138,55-40-3,CC(CC1=CC(=C(C=C1)O)O)(C(=O)O)N,acute brain syndrome,CID000004585,"2-methyl-4-(4-methylpiperazin-1-yl)-5H-thieno[3,2-c][1,5]benzodiazepine",CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C
CID000004138,55-40-3,CC(CC1=CC(=C(C=C1)O)O)(C(=O)O)N,confusion,CID000005245,Risedronic acid,C1=CC(=CN=C1)CC(O)(P(=O)(O)O)P(=O)(O)O
CID000004138,55-40-3,CC(CC1=CC(=C(C=C1)O)O)(C(=O)O)N,thrombocytopenia,CID000004510,nitroglycerin,C(C(CO[N+](=O)[O-])O[N+](=O)[O-])O[N+](=O)[O-]
CID000004138,55-40-3,CC(CC1=CC(=C(C=C1)O)O)(C(=O)O)N,thrombocytopenia,CID000004894,"11,17,21-Trihydroxypregna-1,4-diene-3,20-dione",CC12CC(C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C)O
CID000119182,Clofarabine,C1=NC2=C(N=C(N=C2N1C3C(C(C(O3)CO)O)F)Cl)N,hypermagnesemia,CID003468412,SCHEMBL1176571,CC1C=CC=CCCC=CC=CC=CC=CC(CC(C(C(CC(=O)CC(C(CCC(CC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)C(=O)O)O)OC2C(C(C(C(O2)C)O)N)O
CID000002375,bicalutamide,CC(CS(=O)(=O)C1=CC=C(C=C1)F)(C(=O)NC2=CC(=C(C=C2)C#N)C(F)(F)F)O,Adenopathy,CID000004894,"11,17,21-Trihydroxypregna-1,4-diene-3,20-dione",CC12CC(C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C)O
CID000002375,bicalutamide,CC(CS(=O)(=O)C1=CC=C(C=C1)F)(C(=O)NC2=CC(=C(C=C2)C#N)C(F)(F)F)O,Adenopathy,CID000005732,zolpidem,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C
CID000002375,bicalutamide,CC(CS(=O)(=O)C1=CC=C(C=C1)F)(C(=O)NC2=CC(=C(C=C2)C#N)C(F)(F)F)O,loss of weight,CID000005512,124936-74-9,CC1=CC(=C(C=C1)O)C(CCN(C(C)C)C(C)C)C2=CC=CC=C2
CID000002375,bicalutamide,CC(CS(=O)(=O)C1=CC=C(C=C1)F)(C(=O)NC2=CC(=C(C=C2)C#N)C(F)(F)F)O,cholecystitis,CID000003440,furosemide,C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl
CID000002375,bicalutamide,CC(CS(=O)(=O)C1=CC=C(C=C1)F)(C(=O)NC2=CC(=C(C=C2)C#N)C(F)(F)F)O,abnormal ECG,CID000002771,citalopram,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F
CID000002375,bicalutamide,CC(CS(=O)(=O)C1=CC=C(C=C1)F)(C(=O)NC2=CC(=C(C=C2)C#N)C(F)(F)F)O,gastric inflammation,CID000003961,losartan,CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)CO)Cl
CID000002375,bicalutamide,CC(CS(=O)(=O)C1=CC=C(C=C1)F)(C(=O)NC2=CC(=C(C=C2)C#N)C(F)(F)F)O,colitis ischemic,CID000003937,N~2~-(1-carboxy-3-phenylpropyl)lysylproline,C1CC(N(C1)C(=O)C(CCCCN)NC(CCC2=CC=CC=C2)C(=O)O)C(=O)O
CID000002375,bicalutamide,CC(CS(=O)(=O)C1=CC=C(C=C1)F)(C(=O)NC2=CC(=C(C=C2)C#N)C(F)(F)F)O,gastric inflammation,CID000002524,32222-06-3,CC(CCCC(C)(C)O)C1CCC2C1(CCCC2=CC=C3CC(CC(C3=C)O)O)C
CID000002375,bicalutamide,CC(CS(=O)(=O)C1=CC=C(C=C1)F)(C(=O)NC2=CC(=C(C=C2)C#N)C(F)(F)F)O,constipated,CID000002541,candesartan,CCOC1=NC2=CC=CC(=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5)C(=O)O
CID000002375,bicalutamide,CC(CS(=O)(=O)C1=CC=C(C=C1)F)(C(=O)NC2=CC(=C(C=C2)C#N)C(F)(F)F)O,Back Ache,CID000004510,nitroglycerin,C(C(CO[N+](=O)[O-])O[N+](=O)[O-])O[N+](=O)[O-]
CID000002375,bicalutamide,CC(CS(=O)(=O)C1=CC=C(C=C1)F)(C(=O)NC2=CC(=C(C=C2)C#N)C(F)(F)F)O,myelodysplasia,CID000002806,90055-48-4,COC(=O)C(C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3
CID000002375,bicalutamide,CC(CS(=O)(=O)C1=CC=C(C=C1)F)(C(=O)NC2=CC(=C(C=C2)C#N)C(F)(F)F)O,cholecystitis,CID000003405,2-[[4-[(2-amino-4-oxo-1H-pteridin-6-yl)methylamino]benzoyl]amino]pentanedioic acid,C1=CC(=CC=C1C(=O)NC(CCC(=O)O)C(=O)O)NCC2=CN=C3C(=N2)C(=O)N=C(N3)N
CID000002375,bicalutamide,CC(CS(=O)(=O)C1=CC=C(C=C1)F)(C(=O)NC2=CC(=C(C=C2)C#N)C(F)(F)F)O,apoplexy,CID000003062,Lanicor,CC1C(C(CC(O1)OC2C(OC(CC2O)OC3C(OC(CC3O)OC4CCC5(C(C4)CCC6C5CC(C7(C6(CCC7C8=CC(=O)OC8)O)C)O)C)C)C)O)O
CID000002375,bicalutamide,CC(CS(=O)(=O)C1=CC=C(C=C1)F)(C(=O)NC2=CC(=C(C=C2)C#N)C(F)(F)F)O,gastric inflammation,CID000004900,Fernisone,CC12CC(=O)C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C
CID000002375,bicalutamide,CC(CS(=O)(=O)C1=CC=C(C=C1)F)(C(=O)NC2=CC(=C(C=C2)C#N)C(F)(F)F)O,hypochloraemia,CID000003883,lansoprazole,CC1=C(C=CN=C1CS(=O)C2=NC3=CC=CC=C3N2)OCC(F)(F)F
CID000002375,bicalutamide,CC(CS(=O)(=O)C1=CC=C(C=C1)F)(C(=O)NC2=CC(=C(C=C2)C#N)C(F)(F)F)O,cellulitis,CID000004666,7-Epi Paclitaxel,CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C
CID000002375,bicalutamide,CC(CS(=O)(=O)C1=CC=C(C=C1)F)(C(=O)NC2=CC(=C(C=C2)C#N)C(F)(F)F)O,apoplexy,CID000004889,Pravastatin Impurity A,CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC(CC(CC(=O)O)O)O)O
CID000002375,bicalutamide,CC(CS(=O)(=O)C1=CC=C(C=C1)F)(C(=O)NC2=CC(=C(C=C2)C#N)C(F)(F)F)O,cholecystitis,CID000019090,megestrol,CC1=CC2C(CCC3(C2CCC3(C(=O)C)O)C)C4(C1=CC(=O)CC4)C
CID000027686,CHEMBL4088679,C1=CC2=C(C(=C1)OCC(COC3=CC4=C(C=C3)OC(=CC4=O)C(=O)O)O)C(=O)C=C(O2)C(=O)O,nausea,CID000060865,(E)-Olopatadine,CN(C)CCC=C1C2=CC=CC=C2COC3=C1C=C(C=C3)CC(=O)O
CID000027686,CHEMBL4088679,C1=CC2=C(C(=C1)OCC(COC3=CC4=C(C=C3)OC(=CC4=O)C(=O)O)O)C(=O)C=C(O2)C(=O)O,apoplexy,CID003468412,SCHEMBL1176571,CC1C=CC=CCCC=CC=CC=CC=CC(CC(C(C(CC(=O)CC(C(CCC(CC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)C(=O)O)O)OC2C(C(C(C(O2)C)O)N)O
CID000027686,CHEMBL4088679,C1=CC2=C(C(=C1)OCC(COC3=CC4=C(C=C3)OC(=CC4=O)C(=O)O)O)C(=O)C=C(O2)C(=O)O,loss of weight,CID000062924,"S-(fluoromethyl) (6S,9R,10S,11S,13S,14S,16R,17R)-6,9-difluoro-11,17-dihydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthrene-17-carbothioate",CC1CC2C3CC(C4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)SCF)O)C)O)F)C)F
CID000002907,cyclophosphamide,C1CNP(=O)(OC1)N(CCCl)CCCl,cholecystitis,CID003468412,SCHEMBL1176571,CC1C=CC=CCCC=CC=CC=CC=CC(CC(C(C(CC(=O)CC(C(CCC(CC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)C(=O)O)O)OC2C(C(C(C(O2)C)O)N)O
CID000002907,cyclophosphamide,C1CNP(=O)(OC1)N(CCCl)CCCl,Adenopathy,CID000004927,promethazine,CC(CN1C2=CC=CC=C2SC3=CC=CC=C31)N(C)C
CID000002907,cyclophosphamide,C1CNP(=O)(OC1)N(CCCl)CCCl,cholecystitis,CID000003062,Lanicor,CC1C(C(CC(O1)OC2C(OC(CC2O)OC3C(OC(CC3O)OC4CCC5(C(C4)CCC6C5CC(C7(C6(CCC7C8=CC(=O)OC8)O)C)O)C)C)C)O)O
CID000002907,cyclophosphamide,C1CNP(=O)(OC1)N(CCCl)CCCl,angiitis,CID000060184,"2'-epi-Perindopril, (2'R)-",CCCC(C(=O)OCC)NC(C)C(=O)N1C2CCCCC2CC1C(=O)O
CID000002907,cyclophosphamide,C1CNP(=O)(OC1)N(CCCl)CCCl,Bacteraemia,CID000004158,methylphenidate,COC(=O)C(C1CCCCN1)C2=CC=CC=C2
CID000002907,cyclophosphamide,C1CNP(=O)(OC1)N(CCCl)CCCl,gastric inflammation,CID000003405,2-[[4-[(2-amino-4-oxo-1H-pteridin-6-yl)methylamino]benzoyl]amino]pentanedioic acid,C1=CC(=CC=C1C(=O)NC(CCC(=O)O)C(=O)O)NCC2=CN=C3C(=N2)C(=O)N=C(N3)N
CID000002907,cyclophosphamide,C1CNP(=O)(OC1)N(CCCl)CCCl,haemorrhage intracranial,CID000074989,ATOVAQUONE,C1CC(CCC1C2=CC=C(C=C2)Cl)C3=C(C4=CC=CC=C4C(=O)C3=O)O
CID000002907,cyclophosphamide,C1CNP(=O)(OC1)N(CCCl)CCCl,apoplexy,CID000003516,guaifenesin,COC1=CC=CC=C1OCC(CO)O
CID000002907,cyclophosphamide,C1CNP(=O)(OC1)N(CCCl)CCCl,gastric inflammation,CID000004666,7-Epi Paclitaxel,CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C
CID000002907,cyclophosphamide,C1CNP(=O)(OC1)N(CCCl)CCCl,Bone Fracture Spontaneous,CID000004900,Fernisone,CC12CC(=O)C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C
CID000002907,cyclophosphamide,C1CNP(=O)(OC1)N(CCCl)CCCl,angiitis,CID000003661,L-Hyoscyamine,CN1C2CCC1CC(C2)OC(=O)C(CO)C3=CC=CC=C3
CID000002907,cyclophosphamide,C1CNP(=O)(OC1)N(CCCl)CCCl,cholecystitis,CID000004585,"2-methyl-4-(4-methylpiperazin-1-yl)-5H-thieno[3,2-c][1,5]benzodiazepine",CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C
CID000002907,cyclophosphamide,C1CNP(=O)(OC1)N(CCCl)CCCl,cellulitis,CID000003749,irbesartan,CCCCC1=NC2(CCCC2)C(=O)N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5
CID000002907,cyclophosphamide,C1CNP(=O)(OC1)N(CCCl)CCCl,disseminated lupus erythematosus,CID000016231,AMILORIDE,C1(=C(N=C(C(=N1)Cl)N)N)C(=O)N=C(N)N
CID000002907,cyclophosphamide,C1CNP(=O)(OC1)N(CCCl)CCCl,Adenopathy,CID000005732,zolpidem,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C
CID000002907,cyclophosphamide,C1CNP(=O)(OC1)N(CCCl)CCCl,elevated cholesterol,CID000060787,sequinavir,CC(C)(C)NC(=O)C1CC2CCCCC2CN1CC(C(CC3=CC=CC=C3)NC(=O)C(CC(=O)N)NC(=O)C4=NC5=CC=CC=C5C=C4)O
CID000002907,cyclophosphamide,C1CNP(=O)(OC1)N(CCCl)CCCl,angiitis,CID000004691,"3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine",C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4
CID000002907,cyclophosphamide,C1CNP(=O)(OC1)N(CCCl)CCCl,periodontitis,CID000005073,risperidone,CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F
CID000002907,cyclophosphamide,C1CNP(=O)(OC1)N(CCCl)CCCl,CMV infection,CID000004856,"3-[hydroxy-(pyridin-2-ylamino)methylidene]-2-methyl-1,1-dioxo-1lambda6,2-benzothiazin-4-one",CN1C(=C(NC2=CC=CC=N2)O)C(=O)C3=CC=CC=C3S1(=O)=O
CID000002907,cyclophosphamide,C1CNP(=O)(OC1)N(CCCl)CCCl,loss of weight,CID000060852,Ibandronic Acid,CCCCCN(C)CCC(O)(P(=O)(O)O)P(=O)(O)O
CID000002907,cyclophosphamide,C1CNP(=O)(OC1)N(CCCl)CCCl,drug toxicity NOS,CID000147912,DSSTox_GSID_49066,CCC(C(C)O)N1C(=O)N(C=N1)C2=CC=C(C=C2)N3CCN(CC3)C4=CC=C(C=C4)OCC5CC(OC5)(CN6C=NC=N6)C7=C(C=C(C=C7)F)F
CID000002907,cyclophosphamide,C1CNP(=O)(OC1)N(CCCl)CCCl,proctalgia,CID000005512,124936-74-9,CC1=CC(=C(C=C1)O)C(CCN(C(C)C)C(C)C)C2=CC=CC=C2
CID000002907,cyclophosphamide,C1CNP(=O)(OC1)N(CCCl)CCCl,acute pancreatitis,CID000004889,Pravastatin Impurity A,CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC(CC(CC(=O)O)O)O)O
CID000002907,cyclophosphamide,C1CNP(=O)(OC1)N(CCCl)CCCl,apoplexy,CID000004205,mirtazapine,CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4
CID000002907,cyclophosphamide,C1CNP(=O)(OC1)N(CCCl)CCCl,thrombocytopenia,CID000003890,TRANS (15S)-LATANOPROST,CC(C)OC(=O)CCCC=CCC1C(CC(C1CCC(CCC2=CC=CC=C2)O)O)O
CID000002907,cyclophosphamide,C1CNP(=O)(OC1)N(CCCl)CCCl,Bilirubinaemia,CID000003333,felodipine,CCOC(=O)C1=C(NC(=C(C1C2=C(C(=CC=C2)Cl)Cl)C(=O)OC)C)C
CID000002907,cyclophosphamide,C1CNP(=O)(OC1)N(CCCl)CCCl,apoplexy,CID000003339,fenofibrate,CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C2=CC=C(C=C2)Cl
CID000002907,cyclophosphamide,C1CNP(=O)(OC1)N(CCCl)CCCl,cholecystitis,CID000003440,furosemide,C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl
CID000002907,cyclophosphamide,C1CNP(=O)(OC1)N(CCCl)CCCl,angiitis,CID000005245,Risedronic acid,C1=CC(=CN=C1)CC(O)(P(=O)(O)O)P(=O)(O)O
CID000002907,cyclophosphamide,C1CNP(=O)(OC1)N(CCCl)CCCl,thrombocytopenia,CID000004170,metolazone,CC1NC2=CC(=C(C=C2C(=O)N1C3=CC=CC=C3C)S(=O)(=O)N)Cl
CID000002907,cyclophosphamide,C1CNP(=O)(OC1)N(CCCl)CCCl,myelodysplasia,CID000005544,Mycolog,CC12CC(C3(C(C1CC(C2(C(=O)CO)O)O)CCC4=CC(=O)C=CC43C)F)O
CID000002907,cyclophosphamide,C1CNP(=O)(OC1)N(CCCl)CCCl,ear infection,CID000667490,6-Mercaptopurine,C1=NC2=C(N1)C(=S)N=CN2
CID000002907,cyclophosphamide,C1CNP(=O)(OC1)N(CCCl)CCCl,Excoriation,CID000060754,Gadodiamide hydrate,CNC(=O)CN(CCN(CCN(CC(=O)NC)CC(=O)[O-])CC(=O)[O-])CC(=O)[O-].O.[Gd+3]
CID000002907,cyclophosphamide,C1CNP(=O)(OC1)N(CCCl)CCCl,loss of weight,CID000062924,"S-(fluoromethyl) (6S,9R,10S,11S,13S,14S,16R,17R)-6,9-difluoro-11,17-dihydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthrene-17-carbothioate",CC1CC2C3CC(C4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)SCF)O)C)O)F)C)F
CID000002907,cyclophosphamide,C1CNP(=O)(OC1)N(CCCl)CCCl,angiitis,CID000071616,Voriconazole,CC(C1=NC=NC=C1F)C(CN2C=NC=N2)(C3=C(C=C(C=C3)F)F)O
CID000002907,cyclophosphamide,C1CNP(=O)(OC1)N(CCCl)CCCl,apoplexy,CID000019090,megestrol,CC1=CC2C(CCC3(C2CCC3(C(=O)C)O)C)C4(C1=CC(=O)CC4)C
CID000002907,cyclophosphamide,C1CNP(=O)(OC1)N(CCCl)CCCl,apoplexy,CID000003780,"D-Glucitol, 1,4:3,6-dianhydro-, 2,5-dinitrate",C1C(C2C(O1)C(CO2)O[N+](=O)[O-])O[N+](=O)[O-]
CID000002907,cyclophosphamide,C1CNP(=O)(OC1)N(CCCl)CCCl,muscle paresis,CID000005394,temozolomide,CN1C(=O)N2C=NC(=C2N=N1)C(=O)N
CID000002907,cyclophosphamide,C1CNP(=O)(OC1)N(CCCl)CCCl,methaemoglobinaemia,CID000003937,N~2~-(1-carboxy-3-phenylpropyl)lysylproline,C1CC(N(C1)C(=O)C(CCCCN)NC(CCC2=CC=CC=C2)C(=O)O)C(=O)O
CID000002907,cyclophosphamide,C1CNP(=O)(OC1)N(CCCl)CCCl,Adenopathy,CID006398525,,C(C1C(C(C(C(O1)OC2(C(C(C(O2)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)COS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.[Al].[Al].[Al].[Al].[Al].[Al].[Al].[Al].[Al]
CID000002907,cyclophosphamide,C1CNP(=O)(OC1)N(CCCl)CCCl,cholecystitis,CID000004173,metronidazole,CC1=NC=C(N1CCO)[N+](=O)[O-]
CID000002907,cyclophosphamide,C1CNP(=O)(OC1)N(CCCl)CCCl,gastric inflammation,CID000003310,33419-42-0,CC1OCC2C(O1)C(C(C(O2)OC3C4COC(=O)C4C(C5=CC6=C(C=C35)OCO6)C7=CC(=C(C(=C7)OC)O)OC)O)O
CID000002907,cyclophosphamide,C1CNP(=O)(OC1)N(CCCl)CCCl,cholecystitis,CID000004425,"4a,9-dihydroxy-3-prop-2-enyl-2,4,5,6,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinolin-7-one",C=CCN1CCC23C4C(=O)CCC2(C1CC5=C3C(=C(C=C5)O)O4)O
CID000002907,cyclophosphamide,C1CNP(=O)(OC1)N(CCCl)CCCl,myelodysplasia,CID000004894,"11,17,21-Trihydroxypregna-1,4-diene-3,20-dione",CC12CC(C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C)O
CID000002907,cyclophosphamide,C1CNP(=O)(OC1)N(CCCl)CCCl,increased white blood cell count,CID000003676,lidocaine,CCN(CC)CC(=O)NC1=C(C=CC=C1C)C
CID000002907,cyclophosphamide,C1CNP(=O)(OC1)N(CCCl)CCCl,cholecystitis,CID000003954,loperamide(1+),CN(C)C(=O)C(CC[NH+]1CCC(CC1)(C2=CC=C(C=C2)Cl)O)(C3=CC=CC=C3)C4=CC=CC=C4
CID000002907,cyclophosphamide,C1CNP(=O)(OC1)N(CCCl)CCCl,weight gain,CID000004510,nitroglycerin,C(C(CO[N+](=O)[O-])O[N+](=O)[O-])O[N+](=O)[O-]
CID000002907,cyclophosphamide,C1CNP(=O)(OC1)N(CCCl)CCCl,cholecystitis,CID000003883,lansoprazole,CC1=C(C=CN=C1CS(=O)C2=NC3=CC=CC=C3N2)OCC(F)(F)F
CID000002907,cyclophosphamide,C1CNP(=O)(OC1)N(CCCl)CCCl,gastric inflammation,CID000003961,losartan,CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)CO)Cl
CID000002907,cyclophosphamide,C1CNP(=O)(OC1)N(CCCl)CCCl,disseminated lupus erythematosus,CID000004819,"2(3H)-Furanone, 3-ethyldihydro-4-[(1-methyl-1H-imidazol-5-yl)methyl]-, (3S-cis)-",CCC1C(COC1=O)CC2=CN=CN2C
CID000004046,mefloquine,C1CCNC(C1)C(C2=CC(=NC3=C2C=CC=C3C(F)(F)F)C(F)(F)F)O,epididymitis,CID000005732,zolpidem,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C
CID000004046,mefloquine,C1CCNC(C1)C(C2=CC(=NC3=C2C=CC=C3C(F)(F)F)C(F)(F)F)O,ecchymoses,CID000004173,metronidazole,CC1=NC=C(N1CCO)[N+](=O)[O-]
CID000004046,mefloquine,C1CCNC(C1)C(C2=CC(=NC3=C2C=CC=C3C(F)(F)F)C(F)(F)F)O,weight gain,CID000004900,Fernisone,CC12CC(=O)C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C
CID000004046,mefloquine,C1CCNC(C1)C(C2=CC(=NC3=C2C=CC=C3C(F)(F)F)C(F)(F)F)O,Anorexia,CID000170361,Varenicline,C1C2CNCC1C3=CC4=NC=CN=C4C=C23
CID000004046,mefloquine,C1CCNC(C1)C(C2=CC(=NC3=C2C=CC=C3C(F)(F)F)C(F)(F)F)O,weight gain,CID000004927,promethazine,CC(CN1C2=CC=CC=C2SC3=CC=CC=C31)N(C)C
CID000110635,Tadalafil,CN1CC(=O)N2C(C1=O)CC3=C(C2C4=CC5=C(C=C4)OCO5)NC6=CC=CC=C36,eruption,CID000170361,Varenicline,C1C2CNCC1C3=CC4=NC=CN=C4C=C23
CID000004856,"3-[hydroxy-(pyridin-2-ylamino)methylidene]-2-methyl-1,1-dioxo-1lambda6,2-benzothiazin-4-one",CN1C(=C(NC2=CC=CC=N2)O)C(=O)C3=CC=CC=C3S1(=O)=O,apoplexy,CID000005352,38194-50-2,CC1=C(C2=C(C1=CC3=CC=C(C=C3)S(=O)C)C=CC(=C2)F)CC(=O)O
CID000004856,"3-[hydroxy-(pyridin-2-ylamino)methylidene]-2-methyl-1,1-dioxo-1lambda6,2-benzothiazin-4-one",CN1C(=C(NC2=CC=CC=N2)O)C(=O)C3=CC=CC=C3S1(=O)=O,Adenopathy,CID000005512,124936-74-9,CC1=CC(=C(C=C1)O)C(CCN(C(C)C)C(C)C)C2=CC=CC=C2
CID000004856,"3-[hydroxy-(pyridin-2-ylamino)methylidene]-2-methyl-1,1-dioxo-1lambda6,2-benzothiazin-4-one",CN1C(=C(NC2=CC=CC=N2)O)C(=O)C3=CC=CC=C3S1(=O)=O,gastric inflammation,CID000005073,risperidone,CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F
CID000004856,"3-[hydroxy-(pyridin-2-ylamino)methylidene]-2-methyl-1,1-dioxo-1lambda6,2-benzothiazin-4-one",CN1C(=C(NC2=CC=CC=N2)O)C(=O)C3=CC=CC=C3S1(=O)=O,confusion,CID000170361,Varenicline,C1C2CNCC1C3=CC4=NC=CN=C4C=C23
CID000004856,"3-[hydroxy-(pyridin-2-ylamino)methylidene]-2-methyl-1,1-dioxo-1lambda6,2-benzothiazin-4-one",CN1C(=C(NC2=CC=CC=N2)O)C(=O)C3=CC=CC=C3S1(=O)=O,confusion,CID000071329,Dofetilide,CN(CCC1=CC=C(C=C1)NS(=O)(=O)C)CCOC2=CC=C(C=C2)NS(=O)(=O)C
CID000004856,"3-[hydroxy-(pyridin-2-ylamino)methylidene]-2-methyl-1,1-dioxo-1lambda6,2-benzothiazin-4-one",CN1C(=C(NC2=CC=CC=N2)O)C(=O)C3=CC=CC=C3S1(=O)=O,cholecystitis,CID000062924,"S-(fluoromethyl) (6S,9R,10S,11S,13S,14S,16R,17R)-6,9-difluoro-11,17-dihydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthrene-17-carbothioate",CC1CC2C3CC(C4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)SCF)O)C)O)F)C)F
CID000004856,"3-[hydroxy-(pyridin-2-ylamino)methylidene]-2-methyl-1,1-dioxo-1lambda6,2-benzothiazin-4-one",CN1C(=C(NC2=CC=CC=N2)O)C(=O)C3=CC=CC=C3S1(=O)=O,gastric inflammation,CID000004889,Pravastatin Impurity A,CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC(CC(CC(=O)O)O)O)O
CID000004856,"3-[hydroxy-(pyridin-2-ylamino)methylidene]-2-methyl-1,1-dioxo-1lambda6,2-benzothiazin-4-one",CN1C(=C(NC2=CC=CC=N2)O)C(=O)C3=CC=CC=C3S1(=O)=O,loss of weight,CID000004927,promethazine,CC(CN1C2=CC=CC=C2SC3=CC=CC=C31)N(C)C
CID000004856,"3-[hydroxy-(pyridin-2-ylamino)methylidene]-2-methyl-1,1-dioxo-1lambda6,2-benzothiazin-4-one",CN1C(=C(NC2=CC=CC=N2)O)C(=O)C3=CC=CC=C3S1(=O)=O,eruption,CID000005095,ropinirole,CCCN(CCC)CCC1=C2CC(=O)NC2=CC=C1
CID000004856,"3-[hydroxy-(pyridin-2-ylamino)methylidene]-2-methyl-1,1-dioxo-1lambda6,2-benzothiazin-4-one",CN1C(=C(NC2=CC=CC=N2)O)C(=O)C3=CC=CC=C3S1(=O)=O,loss of weight,CID006398525,,C(C1C(C(C(C(O1)OC2(C(C(C(O2)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)COS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.[Al].[Al].[Al].[Al].[Al].[Al].[Al].[Al].[Al]
CID000004856,"3-[hydroxy-(pyridin-2-ylamino)methylidene]-2-methyl-1,1-dioxo-1lambda6,2-benzothiazin-4-one",CN1C(=C(NC2=CC=CC=N2)O)C(=O)C3=CC=CC=C3S1(=O)=O,insulin dependent diabetes mellitus,CID000005719,zaleplon,CCN(C1=CC=CC(=C1)C2=CC=NC3=C(C=NN23)C#N)C(=O)C
CID000004856,"3-[hydroxy-(pyridin-2-ylamino)methylidene]-2-methyl-1,1-dioxo-1lambda6,2-benzothiazin-4-one",CN1C(=C(NC2=CC=CC=N2)O)C(=O)C3=CC=CC=C3S1(=O)=O,colitis,CID000004920,"1-acetyl-9a,11a-dimethyl-1H,2H,3H,3aH,3bH,4H,5H,7H,8H,9H,9aH,9bH,10H,11H,11aH-cyclopenta[a]phenanthren-7-one",CC(=O)C1CCC2C1(CCC3C2CCC4=CC(=O)CCC34C)C
CID000004856,"3-[hydroxy-(pyridin-2-ylamino)methylidene]-2-methyl-1,1-dioxo-1lambda6,2-benzothiazin-4-one",CN1C(=C(NC2=CC=CC=N2)O)C(=O)C3=CC=CC=C3S1(=O)=O,angiitis,CID000005245,Risedronic acid,C1=CC(=CN=C1)CC(O)(P(=O)(O)O)P(=O)(O)O
CID000004856,"3-[hydroxy-(pyridin-2-ylamino)methylidene]-2-methyl-1,1-dioxo-1lambda6,2-benzothiazin-4-one",CN1C(=C(NC2=CC=CC=N2)O)C(=O)C3=CC=CC=C3S1(=O)=O,cholecystectomies,CID000004900,Fernisone,CC12CC(=O)C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C
CID000004856,"3-[hydroxy-(pyridin-2-ylamino)methylidene]-2-methyl-1,1-dioxo-1lambda6,2-benzothiazin-4-one",CN1C(=C(NC2=CC=CC=N2)O)C(=O)C3=CC=CC=C3S1(=O)=O,nervous tension,CID000005152,Salmeterol,C1=CC=C(C=C1)CCCCOCCCCCCNCC(C2=CC(=C(C=C2)O)CO)O
CID000004856,"3-[hydroxy-(pyridin-2-ylamino)methylidene]-2-methyl-1,1-dioxo-1lambda6,2-benzothiazin-4-one",CN1C(=C(NC2=CC=CC=N2)O)C(=O)C3=CC=CC=C3S1(=O)=O,Adenopathy,CID000005732,zolpidem,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C
CID000004856,"3-[hydroxy-(pyridin-2-ylamino)methylidene]-2-methyl-1,1-dioxo-1lambda6,2-benzothiazin-4-one",CN1C(=C(NC2=CC=CC=N2)O)C(=O)C3=CC=CC=C3S1(=O)=O,loss of weight,CID000005478,racemic-Timolol,CC(C)(C)NCC(COC1=NSN=C1N2CCOCC2)O
CID000004856,"3-[hydroxy-(pyridin-2-ylamino)methylidene]-2-methyl-1,1-dioxo-1lambda6,2-benzothiazin-4-one",CN1C(=C(NC2=CC=CC=N2)O)C(=O)C3=CC=CC=C3S1(=O)=O,angiitis,CID000004894,"11,17,21-Trihydroxypregna-1,4-diene-3,20-dione",CC12CC(C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C)O
CID000004856,"3-[hydroxy-(pyridin-2-ylamino)methylidene]-2-methyl-1,1-dioxo-1lambda6,2-benzothiazin-4-one",CN1C(=C(NC2=CC=CC=N2)O)C(=O)C3=CC=CC=C3S1(=O)=O,apoplexy,CID000005358,sumatriptan,CNS(=O)(=O)CC1=CC2=C(C=C1)NC=C2CCN(C)C
CID000004856,"3-[hydroxy-(pyridin-2-ylamino)methylidene]-2-methyl-1,1-dioxo-1lambda6,2-benzothiazin-4-one",CN1C(=C(NC2=CC=CC=N2)O)C(=O)C3=CC=CC=C3S1(=O)=O,insulin dependent diabetes mellitus,CID000005544,Mycolog,CC12CC(C3(C(C1CC(C2(C(=O)CO)O)O)CCC4=CC(=O)C=CC43C)F)O
CID000062924,"S-(fluoromethyl) (6S,9R,10S,11S,13S,14S,16R,17R)-6,9-difluoro-11,17-dihydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthrene-17-carbothioate",CC1CC2C3CC(C4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)SCF)O)C)O)F)C)F,Tracheobronchitis,CID000074989,ATOVAQUONE,C1CC(CCC1C2=CC=C(C=C2)Cl)C3=C(C4=CC=CC=C4C(=O)C3=O)O
CID000062924,"S-(fluoromethyl) (6S,9R,10S,11S,13S,14S,16R,17R)-6,9-difluoro-11,17-dihydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthrene-17-carbothioate",CC1CC2C3CC(C4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)SCF)O)C)O)F)C)F,apoplexy,CID006447131,Pimecrolimus,CCC1C=C(CC(CC(C2C(CC(C(O2)(C(=O)C(=O)N3CCCCC3C(=O)OC(C(C(CC1=O)O)C)C(=CC4CCC(C(C4)OC)Cl)C)O)C)OC)OC)C)C
CID000062924,"S-(fluoromethyl) (6S,9R,10S,11S,13S,14S,16R,17R)-6,9-difluoro-11,17-dihydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthrene-17-carbothioate",CC1CC2C3CC(C4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)SCF)O)C)O)F)C)F,Adenopathy,CID006398525,,C(C1C(C(C(C(O1)OC2(C(C(C(O2)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)COS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.[Al].[Al].[Al].[Al].[Al].[Al].[Al].[Al].[Al]
CID000062924,"S-(fluoromethyl) (6S,9R,10S,11S,13S,14S,16R,17R)-6,9-difluoro-11,17-dihydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthrene-17-carbothioate",CC1CC2C3CC(C4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)SCF)O)C)O)F)C)F,cholecystitis,CID000170361,Varenicline,C1C2CNCC1C3=CC4=NC=CN=C4C=C23
CID000062924,"S-(fluoromethyl) (6S,9R,10S,11S,13S,14S,16R,17R)-6,9-difluoro-11,17-dihydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthrene-17-carbothioate",CC1CC2C3CC(C4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)SCF)O)C)O)F)C)F,dysarthria,CID000504578,"(2S,3S,4R,5R,6R)-5-amino-6-[(2R,3S,4R,5S)-5-[(1R,2S,3R,6R)-3-amino-6-[(1S,2R,3R,4R,5R)-2-amino-5-(aminomethyl)-3,4-dihydroxycyclohexyl]oxy-2-hydroxycyclohexyl]oxy-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl]oxy-2-(aminomethyl)oxane-3,4-diol",C1CC(C(C(C1N)O)OC2C(C(C(O2)CO)OC3C(C(C(C(O3)CN)O)O)N)O)OC4CC(C(C(C4N)O)O)CN
CID000062924,"S-(fluoromethyl) (6S,9R,10S,11S,13S,14S,16R,17R)-6,9-difluoro-11,17-dihydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthrene-17-carbothioate",CC1CC2C3CC(C4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)SCF)O)C)O)F)C)F,gout,CID000071329,Dofetilide,CN(CCC1=CC=C(C=C1)NS(=O)(=O)C)CCOC2=CC=C(C=C2)NS(=O)(=O)C
CID000062924,"S-(fluoromethyl) (6S,9R,10S,11S,13S,14S,16R,17R)-6,9-difluoro-11,17-dihydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthrene-17-carbothioate",CC1CC2C3CC(C4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)SCF)O)C)O)F)C)F,Arrhythmia,CID005493444,Aliskiren,CC(C)C(CC1=CC(=C(C=C1)OC)OCCCOC)CC(C(CC(C(C)C)C(=O)NCC(C)(C)C(=O)N)O)N
CID000062924,"S-(fluoromethyl) (6S,9R,10S,11S,13S,14S,16R,17R)-6,9-difluoro-11,17-dihydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthrene-17-carbothioate",CC1CC2C3CC(C4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)SCF)O)C)O)F)C)F,apoplexy,CID000667490,6-Mercaptopurine,C1=NC2=C(N1)C(=S)N=CN2
CID000062924,"S-(fluoromethyl) (6S,9R,10S,11S,13S,14S,16R,17R)-6,9-difluoro-11,17-dihydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthrene-17-carbothioate",CC1CC2C3CC(C4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)SCF)O)C)O)F)C)F,enlarged liver,CID000131536,Fosamprenavir,CC(C)CN(CC(C(CC1=CC=CC=C1)NC(=O)OC2CCOC2)OP(=O)(O)O)S(=O)(=O)C3=CC=C(C=C3)N
CID000062924,"S-(fluoromethyl) (6S,9R,10S,11S,13S,14S,16R,17R)-6,9-difluoro-11,17-dihydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthrene-17-carbothioate",CC1CC2C3CC(C4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)SCF)O)C)O)F)C)F,weight gain,CID000115237,Paliperidone,CC1=C(C(=O)N2CCCC(C2=N1)O)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F
CID000062924,"S-(fluoromethyl) (6S,9R,10S,11S,13S,14S,16R,17R)-6,9-difluoro-11,17-dihydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthrene-17-carbothioate",CC1CC2C3CC(C4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)SCF)O)C)O)F)C)F,Adenopathy,CID003468412,SCHEMBL1176571,CC1C=CC=CCCC=CC=CC=CC=CC(CC(C(C(CC(=O)CC(C(CCC(CC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)C(=O)O)O)OC2C(C(C(C(O2)C)O)N)O
CID000062924,"S-(fluoromethyl) (6S,9R,10S,11S,13S,14S,16R,17R)-6,9-difluoro-11,17-dihydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthrene-17-carbothioate",CC1CC2C3CC(C4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)SCF)O)C)O)F)C)F,angiitis,CID000071616,Voriconazole,CC(C1=NC=NC=C1F)C(CN2C=NC=N2)(C3=C(C=C(C=C3)F)F)O
CID000504578,"(2S,3S,4R,5R,6R)-5-amino-6-[(2R,3S,4R,5S)-5-[(1R,2S,3R,6R)-3-amino-6-[(1S,2R,3R,4R,5R)-2-amino-5-(aminomethyl)-3,4-dihydroxycyclohexyl]oxy-2-hydroxycyclohexyl]oxy-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl]oxy-2-(aminomethyl)oxane-3,4-diol",C1CC(C(C(C1N)O)OC2C(C(C(O2)CO)OC3C(C(C(C(O3)CN)O)O)N)O)OC4CC(C(C(C4N)O)O)CN,dysarthria,CID003468412,SCHEMBL1176571,CC1C=CC=CCCC=CC=CC=CC=CC(CC(C(C(CC(=O)CC(C(CCC(CC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)C(=O)O)O)OC2C(C(C(C(O2)C)O)N)O
CID000003410,formoterol,CC(CC1=CC=C(C=C1)OC)NCC(C2=CC(=C(C=C2)O)NC=O)O,gastric inflammation,CID000003883,lansoprazole,CC1=C(C=CN=C1CS(=O)C2=NC3=CC=CC=C3N2)OCC(F)(F)F
CID000003410,formoterol,CC(CC1=CC=C(C=C1)OC)NCC(C2=CC(=C(C=C2)O)NC=O)O,loss of weight,CID000005245,Risedronic acid,C1=CC(=CN=C1)CC(O)(P(=O)(O)O)P(=O)(O)O
CID000003410,formoterol,CC(CC1=CC=C(C=C1)OC)NCC(C2=CC(=C(C=C2)O)NC=O)O,angiitis,CID000004894,"11,17,21-Trihydroxypregna-1,4-diene-3,20-dione",CC12CC(C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C)O
CID000003410,formoterol,CC(CC1=CC=C(C=C1)OC)NCC(C2=CC(=C(C=C2)O)NC=O)O,angiitis,CID000005732,zolpidem,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C
CID000003410,formoterol,CC(CC1=CC=C(C=C1)OC)NCC(C2=CC(=C(C=C2)O)NC=O)O,Adenopathy,CID000003516,guaifenesin,COC1=CC=CC=C1OCC(CO)O
CID000003410,formoterol,CC(CC1=CC=C(C=C1)OC)NCC(C2=CC(=C(C=C2)O)NC=O)O,eruption,CID000003440,furosemide,C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl
CID000003410,formoterol,CC(CC1=CC=C(C=C1)OC)NCC(C2=CC(=C(C=C2)O)NC=O)O,angiitis,CID000003937,N~2~-(1-carboxy-3-phenylpropyl)lysylproline,C1CC(N(C1)C(=O)C(CCCCN)NC(CCC2=CC=CC=C2)C(=O)O)C(=O)O
CID000003410,formoterol,CC(CC1=CC=C(C=C1)OC)NCC(C2=CC(=C(C=C2)O)NC=O)O,angiitis,CID000005152,Salmeterol,C1=CC=C(C=C1)CCCCOCCCCCCNCC(C2=CC(=C(C=C2)O)CO)O
CID000003410,formoterol,CC(CC1=CC=C(C=C1)OC)NCC(C2=CC(=C(C=C2)O)NC=O)O,apoplexy,CID000004510,nitroglycerin,C(C(CO[N+](=O)[O-])O[N+](=O)[O-])O[N+](=O)[O-]
CID000003410,formoterol,CC(CC1=CC=C(C=C1)OC)NCC(C2=CC(=C(C=C2)O)NC=O)O,eruption,CID000004900,Fernisone,CC12CC(=O)C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C
CID000003410,formoterol,CC(CC1=CC=C(C=C1)OC)NCC(C2=CC(=C(C=C2)O)NC=O)O,loss of weight,CID000170361,Varenicline,C1C2CNCC1C3=CC4=NC=CN=C4C=C23
CID000003410,formoterol,CC(CC1=CC=C(C=C1)OC)NCC(C2=CC(=C(C=C2)O)NC=O)O,respiratory alkalosis,CID000005544,Mycolog,CC12CC(C3(C(C1CC(C2(C(=O)CO)O)O)CCC4=CC(=O)C=CC43C)F)O
CID000003410,formoterol,CC(CC1=CC=C(C=C1)OC)NCC(C2=CC(=C(C=C2)O)NC=O)O,apoplexy,CID000004927,promethazine,CC(CN1C2=CC=CC=C2SC3=CC=CC=C31)N(C)C
CID000003410,formoterol,CC(CC1=CC=C(C=C1)OC)NCC(C2=CC(=C(C=C2)O)NC=O)O,loss of weight,CID000003961,losartan,CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)CO)Cl
CID000003410,formoterol,CC(CC1=CC=C(C=C1)OC)NCC(C2=CC(=C(C=C2)O)NC=O)O,Adenopathy,CID000004691,"3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine",C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4
CID000003410,formoterol,CC(CC1=CC=C(C=C1)OC)NCC(C2=CC(=C(C=C2)O)NC=O)O,Clotting,CID000004889,Pravastatin Impurity A,CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC(CC(CC(=O)O)O)O)O
CID000003410,formoterol,CC(CC1=CC=C(C=C1)OC)NCC(C2=CC(=C(C=C2)O)NC=O)O,nasopharyngitis,CID000005512,124936-74-9,CC1=CC(=C(C=C1)O)C(CCN(C(C)C)C(C)C)C2=CC=CC=C2
CID000004425,"4a,9-dihydroxy-3-prop-2-enyl-2,4,5,6,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinolin-7-one",C=CCN1CCC23C4C(=O)CCC2(C1CC5=C3C(=C(C=C5)O)O4)O,constipated,CID000004691,"3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine",C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4
CID000004425,"4a,9-dihydroxy-3-prop-2-enyl-2,4,5,6,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinolin-7-one",C=CCN1CCC23C4C(=O)CCC2(C1CC5=C3C(=C(C=C5)O)O4)O,Bacteraemia,CID000147912,DSSTox_GSID_49066,CCC(C(C)O)N1C(=O)N(C=N1)C2=CC=C(C=C2)N3CCN(CC3)C4=CC=C(C=C4)OCC5CC(OC5)(CN6C=NC=N6)C7=C(C=C(C=C7)F)F
CID000004425,"4a,9-dihydroxy-3-prop-2-enyl-2,4,5,6,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinolin-7-one",C=CCN1CCC23C4C(=O)CCC2(C1CC5=C3C(=C(C=C5)O)O4)O,thrombocytopenia,CID000004510,nitroglycerin,C(C(CO[N+](=O)[O-])O[N+](=O)[O-])O[N+](=O)[O-]
CID000004425,"4a,9-dihydroxy-3-prop-2-enyl-2,4,5,6,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinolin-7-one",C=CCN1CCC23C4C(=O)CCC2(C1CC5=C3C(=C(C=C5)O)O4)O,constipated,CID000004927,promethazine,CC(CN1C2=CC=CC=C2SC3=CC=CC=C31)N(C)C
CID000002806,90055-48-4,COC(=O)C(C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3,gastric inflammation,CID000003440,furosemide,C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl
CID000002806,90055-48-4,COC(=O)C(C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3,aspiration pneumonia,CID000003198,econazole,C1=CC(=CC=C1COC(CN2C=CN=C2)C3=C(C=C(C=C3)Cl)Cl)Cl
CID000002806,90055-48-4,COC(=O)C(C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3,excessive salivation,CID000019090,megestrol,CC1=CC2C(CCC3(C2CCC3(C(=O)C)O)C)C4(C1=CC(=O)CC4)C
CID000002806,90055-48-4,COC(=O)C(C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3,right heart failure,CID000004510,nitroglycerin,C(C(CO[N+](=O)[O-])O[N+](=O)[O-])O[N+](=O)[O-]
CID000002806,90055-48-4,COC(=O)C(C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3,abnormal EEG,CID000004195,midodrine,COC1=CC(=C(C=C1)OC)C(CNC(=O)CN)O
CID000002806,90055-48-4,COC(=O)C(C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3,Dyspnea exertional,CID000003954,loperamide(1+),CN(C)C(=O)C(CC[NH+]1CCC(CC1)(C2=CC=C(C=C2)Cl)O)(C3=CC=CC=C3)C4=CC=CC=C4
CID000002806,90055-48-4,COC(=O)C(C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3,gastric inflammation,CID000170361,Varenicline,C1C2CNCC1C3=CC4=NC=CN=C4C=C23
CID000002806,90055-48-4,COC(=O)C(C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3,cholelithiasis,CID000036339,Etomidate,CCOC(=O)C1=CN=CN1C(C)C2=CC=CC=C2
CID000002806,90055-48-4,COC(=O)C(C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3,apoplexy,CID000003042,dicyclomine,CCN(CC)CCOC(=O)C1(CCCCC1)C2CCCCC2
CID000002806,90055-48-4,COC(=O)C(C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3,loss of weight,CID000057537,92206-54-7,CCCN(CCC1=CC=CS1)C2CCC3=C(C2)C=CC=C3O
CID000002806,90055-48-4,COC(=O)C(C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3,rectal prolapse,CID000005245,Risedronic acid,C1=CC(=CN=C1)CC(O)(P(=O)(O)O)P(=O)(O)O
CID000002806,90055-48-4,COC(=O)C(C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3,cholecystitis,CID000004909,primidone,CCC1(C(=O)NCNC1=O)C2=CC=CC=C2
CID000002806,90055-48-4,COC(=O)C(C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3,back injury,CID000004900,Fernisone,CC12CC(=O)C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C
CID000002806,90055-48-4,COC(=O)C(C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3,gastric inflammation,CID000004205,mirtazapine,CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4
CID000002806,90055-48-4,COC(=O)C(C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3,erythema,CID000004201,minoxidil,C1CCN(CC1)C2=NC(=N)N(C(=C2)N)O
CID000002806,90055-48-4,COC(=O)C(C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3,cholecystitis,CID000005152,Salmeterol,C1=CC=C(C=C1)CCCCOCCCCCCNCC(C2=CC(=C(C=C2)O)CO)O
CID000002806,90055-48-4,COC(=O)C(C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3,myelodysplasia,CID000003869,labetalol,CC(CCC1=CC=CC=C1)NCC(C2=CC(=C(C=C2)O)C(=O)N)O
CID000002806,90055-48-4,COC(=O)C(C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3,gastric inflammation,CID000003516,guaifenesin,COC1=CC=CC=C1OCC(CO)O
CID000002806,90055-48-4,COC(=O)C(C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3,Dyspnea exertional,CID000003780,"D-Glucitol, 1,4:3,6-dianhydro-, 2,5-dinitrate",C1C(C2C(O1)C(CO2)O[N+](=O)[O-])O[N+](=O)[O-]
CID000002806,90055-48-4,COC(=O)C(C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3,cholecystitis,CID000002949,MLS003115428,CC12CCC3C(C1CCC2(C#C)O)CCC4=CC5=C(CC34C)C=NO5
CID000002806,90055-48-4,COC(=O)C(C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3,ear infection,CID000060865,(E)-Olopatadine,CN(C)CCC=C1C2=CC=CC=C2COC3=C1C=C(C=C3)CC(=O)O
CID000002806,90055-48-4,COC(=O)C(C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3,cholecystitis,CID000004236,modafinil,C1=CC=C(C=C1)C(C2=CC=CC=C2)S(=O)CC(=O)N
CID000002806,90055-48-4,COC(=O)C(C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3,apoplexy,CID000004748,perphenazine,C1CN(CCN1CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)Cl)CCO
CID000002806,90055-48-4,COC(=O)C(C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3,back injury,CID000004745,SCHEMBL7711911,CCCN1CC(CC2C1CC3=CNC4=CC=CC2=C34)CSC
CID000002806,90055-48-4,COC(=O)C(C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3,right heart failure,CID005311082,"2-[(1R,4S,10S,13S,19S)-19-[4-(diaminomethylideneamino)butyl]-10-(1H-indol-3-ylmethyl)-3,9,12,15,18,21,27-heptaoxo-24,25-dithia-2,8,11,14,17,20-hexazatricyclo[18.6.1.04,8]heptacosan-13-yl]acetic acid",C1CC2C(=O)NC3CSSCCC(=O)N(C3=O)C(C(=O)NCC(=O)NC(C(=O)NC(C(=O)N2C1)CC4=CNC5=CC=CC=C54)CC(=O)O)CCCCN=C(N)N
CID000002806,90055-48-4,COC(=O)C(C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3,cholecystitis,CID000003676,lidocaine,CCN(CC)CC(=O)NC1=C(C=CC=C1C)C
CID000002806,90055-48-4,COC(=O)C(C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3,angina,CID000003734,Bracco 15000,CC(C(=O)NC1=C(C(=C(C(=C1I)C(=O)NC(CO)CO)I)C(=O)NC(CO)CO)I)O
CID000002806,90055-48-4,COC(=O)C(C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3,gastric inflammation,CID000005478,racemic-Timolol,CC(C)(C)NCC(COC1=NSN=C1N2CCOCC2)O
CID000002806,90055-48-4,COC(=O)C(C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3,cholecystitis,CID000005732,zolpidem,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C
CID000002806,90055-48-4,COC(=O)C(C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3,erythema,CID000004666,7-Epi Paclitaxel,CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C
CID000002806,90055-48-4,COC(=O)C(C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3,cholecystitis,CID000004585,"2-methyl-4-(4-methylpiperazin-1-yl)-5H-thieno[3,2-c][1,5]benzodiazepine",CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C
CID000002806,90055-48-4,COC(=O)C(C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3,gout,CID000004178,Mexiletine,CC1=C(C(=CC=C1)C)OCC(C)N
CID000002806,90055-48-4,COC(=O)C(C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3,gastric inflammation,CID000004173,metronidazole,CC1=NC=C(N1CCO)[N+](=O)[O-]
CID000002806,90055-48-4,COC(=O)C(C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3,gastric inflammation,CID000004170,metolazone,CC1NC2=CC(=C(C=C2C(=O)N1C3=CC=CC=C3C)S(=O)(=O)N)Cl
CID000002806,90055-48-4,COC(=O)C(C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3,cholecystitis,CID000005073,risperidone,CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F
CID000002806,90055-48-4,COC(=O)C(C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3,Dyspnea exertional,CID000009052,2-hydroxy-3-[1-(4-nitrophenyl)-3-oxobutyl]chromen-4-one,CC(=O)CC(C1=CC=C(C=C1)[N+](=O)[O-])C2=C(OC3=CC=CC=C3C2=O)O
CID000002806,90055-48-4,COC(=O)C(C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3,gastric inflammation,CID000004691,"3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine",C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4
CID000002806,90055-48-4,COC(=O)C(C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3,angiitis,CID000005486,(R)-Tirofiban,CCCCS(=O)(=O)NC(CC1=CC=C(C=C1)OCCCCC2CCNCC2)C(=O)O
CID000002806,90055-48-4,COC(=O)C(C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3,bursitis,CID000003305,Etidronic acid,CC(O)(P(=O)(O)O)P(=O)(O)O
CID000002806,90055-48-4,COC(=O)C(C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3,rectal prolapse,CID000004189,miconazole,C1=CC(=C(C=C1Cl)Cl)COC(CN2C=CN=C2)C3=C(C=C(C=C3)Cl)Cl
CID000002806,90055-48-4,COC(=O)C(C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3,gastric inflammation,CID000004614,oxaprozin,C1=CC=C(C=C1)C2=C(OC(=N2)CCC(=O)O)C3=CC=CC=C3
CID000002806,90055-48-4,COC(=O)C(C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3,abdominal pain upper,CID000071329,Dofetilide,CN(CCC1=CC=C(C=C1)NS(=O)(=O)C)CCOC2=CC=C(C=C2)NS(=O)(=O)C
CID000002806,90055-48-4,COC(=O)C(C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3,Dyspnea exertional,CID000002891,"cobalt(2+);[5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] 1-[3-[2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2,7,12,17-tetrahydro-1H-corrin-21-id-3-yl]propanoylamino]propan-2-yl hydrogen phosphate;cyanide",CC1=CC2=C(C=C1C)N(C=N2)C3C(C(C(O3)CO)OP(=O)(O)OC(C)CNC(=O)CCC4(C(C5C6(C(C(C(=N6)C(=C7C(C(C(=N7)C=C8C(C(C(=N8)C(=C4[N-]5)C)CCC(=O)N)(C)C)CCC(=O)N)(C)CC(=O)N)C)CCC(=O)N)(C)CC(=O)N)C)CC(=O)N)C)O.[C-]#N.[Co+2]
CID000002806,90055-48-4,COC(=O)C(C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3,erythema,CID000060754,Gadodiamide hydrate,CNC(=O)CN(CCN(CCN(CC(=O)NC)CC(=O)[O-])CC(=O)[O-])CC(=O)[O-].O.[Gd+3]
CID000002806,90055-48-4,COC(=O)C(C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3,Adenopathy,CID000131536,Fosamprenavir,CC(C)CN(CC(C(CC1=CC=CC=C1)NC(=O)OC2CCOC2)OP(=O)(O)O)S(=O)(=O)C3=CC=C(C=C3)N
CID000002806,90055-48-4,COC(=O)C(C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3,bladder retention,CID000004889,Pravastatin Impurity A,CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC(CC(CC(=O)O)O)O)O
CID000002806,90055-48-4,COC(=O)C(C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3,gastric inflammation,CID000003405,2-[[4-[(2-amino-4-oxo-1H-pteridin-6-yl)methylamino]benzoyl]amino]pentanedioic acid,C1=CC(=CC=C1C(=O)NC(CCC(=O)O)C(=O)O)NCC2=CN=C3C(=N2)C(=O)N=C(N3)N
CID000002806,90055-48-4,COC(=O)C(C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3,cholecystitis,CID000003890,TRANS (15S)-LATANOPROST,CC(C)OC(=O)CCCC=CCC1C(CC(C1CCC(CCC2=CC=CC=C2)O)O)O
CID000002806,90055-48-4,COC(=O)C(C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3,ear infection,CID000003339,fenofibrate,CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C2=CC=C(C=C2)Cl
CID000002806,90055-48-4,COC(=O)C(C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3,metabolic encephalopathy,CID000003333,felodipine,CCOC(=O)C1=C(NC(=C(C1C2=C(C(=CC=C2)Cl)Cl)C(=O)OC)C)C
CID000002806,90055-48-4,COC(=O)C(C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3,apoplexy,CID000005719,zaleplon,CCN(C1=CC=CC(=C1)C2=CC=NC3=C(C=NN23)C#N)C(=O)C
CID000002806,90055-48-4,COC(=O)C(C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3,thrombocytopenia,CID004479097,"cobalt;[5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] 1-[3-[2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2,7,12,17-tetrahydro-1H-corrin-21-id-3-yl]propanoylamino]propan-2-yl phosphate;hydrate",CC1=CC2=C(C=C1C)N(C=N2)C3C(C(C(O3)CO)OP(=O)([O-])OC(C)CNC(=O)CCC4(C(C5C6(C(C(C(=N6)C(=C7C(C(C(=N7)C=C8C(C(C(=N8)C(=C4[N-]5)C)CCC(=O)N)(C)C)CCC(=O)N)(C)CC(=O)N)C)CCC(=O)N)(C)CC(=O)N)C)CC(=O)N)C)O.O.[Co]
CID000002806,90055-48-4,COC(=O)C(C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3,Acne,CID000005512,124936-74-9,CC1=CC(=C(C=C1)O)C(CCN(C(C)C)C(C)C)C2=CC=CC=C2
CID000002806,90055-48-4,COC(=O)C(C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3,apoplexy,CID000004158,methylphenidate,COC(=O)C(C1CCCCN1)C2=CC=CC=C2
CID000002806,90055-48-4,COC(=O)C(C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3,nausea,CID000003827,ketotifen,CN1CCC(=C2C3=C(C(=O)CC4=CC=CC=C42)SC=C3)CC1
CID000002806,90055-48-4,COC(=O)C(C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3,abnormal ECG,CID000003661,L-Hyoscyamine,CN1C2CCC1CC(C2)OC(=O)C(CO)C3=CC=CC=C3
CID000002806,90055-48-4,COC(=O)C(C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3,colitis ischemic,CID000005095,ropinirole,CCCN(CCC)CCC1=C2CC(=O)NC2=CC=C1
CID000002806,90055-48-4,COC(=O)C(C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3,Dyspnea exertional,CID000003749,irbesartan,CCCCC1=NC2(CCCC2)C(=O)N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5
CID000002806,90055-48-4,COC(=O)C(C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3,dysarthria,CID000003741,ioversol,C(CO)N(C1=C(C(=C(C(=C1I)C(=O)NCC(CO)O)I)C(=O)NCC(CO)O)I)C(=O)CO
CID000002806,90055-48-4,COC(=O)C(C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3,Adenopathy,CID003468412,SCHEMBL1176571,CC1C=CC=CCCC=CC=CC=CC=CC(CC(C(C(CC(=O)CC(C(CCC(CC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)C(=O)O)O)OC2C(C(C(C(O2)C)O)N)O
CID000002806,90055-48-4,COC(=O)C(C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3,cholecystitis,CID000005544,Mycolog,CC12CC(C3(C(C1CC(C2(C(=O)CO)O)O)CCC4=CC(=O)C=CC43C)F)O
CID000002806,90055-48-4,COC(=O)C(C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3,thrombocytopenia,CID000003059,diflunisal,C1=CC(=C(C=C1C2=C(C=C(C=C2)F)F)C(=O)O)O
CID000002806,90055-48-4,COC(=O)C(C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3,Adenopathy,CID006398525,,C(C1C(C(C(C(O1)OC2(C(C(C(O2)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)COS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.[Al].[Al].[Al].[Al].[Al].[Al].[Al].[Al].[Al]
CID000002806,90055-48-4,COC(=O)C(C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3,apoplexy,CID000012536,638-94-8,CC1(OC2CC3C4CCC5=CC(=O)C=CC5(C4C(CC3(C2(O1)C(=O)CO)C)O)C)C
CID000002806,90055-48-4,COC(=O)C(C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3,nasopharyngitis,CID000005352,38194-50-2,CC1=C(C2=C(C1=CC3=CC=C(C=C3)S(=O)C)C=CC(=C2)F)CC(=O)O
CID000002806,90055-48-4,COC(=O)C(C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3,weight gain,CID000071616,Voriconazole,CC(C1=NC=NC=C1F)C(CN2C=NC=N2)(C3=C(C=C(C=C3)F)F)O
CID000002806,90055-48-4,COC(=O)C(C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3,gastric inflammation,CID000003310,33419-42-0,CC1OCC2C(O1)C(C(C(O2)OC3C4COC(=O)C4C(C5=CC6=C(C=C35)OCO6)C7=CC(=C(C(=C7)OC)O)OC)O)O
CID000002806,90055-48-4,COC(=O)C(C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3,dysarthria,CID000125017,Desvenlafaxine,CN(C)CC(C1=CC=C(C=C1)O)C2(CCCCC2)O
CID000002806,90055-48-4,COC(=O)C(C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3,erythema,CID000005358,sumatriptan,CNS(=O)(=O)CC1=CC2=C(C=C1)NC=C2CCN(C)C
CID000002806,90055-48-4,COC(=O)C(C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3,abdominal pain upper,CID000004819,"2(3H)-Furanone, 3-ethyldihydro-4-[(1-methyl-1H-imidazol-5-yl)methyl]-, (3S-cis)-",CCC1C(COC1=O)CC2=CN=CN2C
CID000002806,90055-48-4,COC(=O)C(C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3,adenomyosis,CID000003937,N~2~-(1-carboxy-3-phenylpropyl)lysylproline,C1CC(N(C1)C(=O)C(CCCCN)NC(CCC2=CC=CC=C2)C(=O)O)C(=O)O
CID000002806,90055-48-4,COC(=O)C(C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3,methaemoglobinaemia,CID000003062,Lanicor,CC1C(C(CC(O1)OC2C(OC(CC2O)OC3C(OC(CC3O)OC4CCC5(C(C4)CCC6C5CC(C7(C6(CCC7C8=CC(=O)OC8)O)C)O)C)C)C)O)O
CID000002806,90055-48-4,COC(=O)C(C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3,micturition urgency,CID000004894,"11,17,21-Trihydroxypregna-1,4-diene-3,20-dione",CC12CC(C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C)O
CID000002806,90055-48-4,COC(=O)C(C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3,gastric inflammation,CID000005487,tizanidine,C1CN=C(N1)NC2=C(C=CC3=NSN=C32)Cl
CID000002806,90055-48-4,COC(=O)C(C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3,Penile pain,CID000003883,lansoprazole,CC1=C(C=CN=C1CS(=O)C2=NC3=CC=CC=C3N2)OCC(F)(F)F
CID000002806,90055-48-4,COC(=O)C(C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3,loss of weight,CID000667490,6-Mercaptopurine,C1=NC2=C(N1)C(=S)N=CN2
CID000002806,90055-48-4,COC(=O)C(C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3,thrombocytopenia,CID000002951,dantrolene(1-),C1C(=NC(=O)N1N=CC2=CC=C(O2)C3=CC=C(C=C3)[N+](=O)[O-])[O-]
CID000002806,90055-48-4,COC(=O)C(C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3,gastric inflammation,CID000004075,5-Aminosalicylic acid,C1=CC(=C(C=C1N)C(=O)O)O
CID000002806,90055-48-4,COC(=O)C(C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3,arteriosclerotic heart disease,CID000004920,"1-acetyl-9a,11a-dimethyl-1H,2H,3H,3aH,3bH,4H,5H,7H,8H,9H,9aH,9bH,10H,11H,11aH-cyclopenta[a]phenanthren-7-one",CC(=O)C1CCC2C1(CCC3C2CCC4=CC(=O)CCC34C)C
CID000002806,90055-48-4,COC(=O)C(C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3,Adenopathy,CID000004927,promethazine,CC(CN1C2=CC=CC=C2SC3=CC=CC=C31)N(C)C
CID000002806,90055-48-4,COC(=O)C(C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3,Dyspnea exertional,CID000060854,Ziprasidone,C1CN(CCN1CCC2=C(C=C3C(=C2)CC(=O)N3)Cl)C4=NSC5=CC=CC=C54
CID000002806,90055-48-4,COC(=O)C(C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3,gastric inflammation,CID000060852,Ibandronic Acid,CCCCCN(C)CCC(O)(P(=O)(O)O)P(=O)(O)O
CID000002806,90055-48-4,COC(=O)C(C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3,failure to thrive,CID000163742,SCHEMBL1650579,COC1C(C(C(C(O1)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)COS(=O)(=O)O)OC4C(C(C(C(O4)C(=O)O)OC5C(C(C(C(O5)COS(=O)(=O)O)O)O)NS(=O)(=O)O)O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O)NS(=O)(=O)O
CID000002806,90055-48-4,COC(=O)C(C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3,erythema,CID005493444,Aliskiren,CC(C)C(CC1=CC(=C(C=C1)OC)OCCCOC)CC(C(CC(C(C)C)C(=O)NCC(C)(C)C(=O)N)O)N
CID000002806,90055-48-4,COC(=O)C(C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3,apoplexy,CID006447131,Pimecrolimus,CCC1C=C(CC(CC(C2C(CC(C(O2)(C(=O)C(=O)N3CCCCC3C(=O)OC(C(C(CC1=O)O)C)C(=CC4CCC(C(C4)OC)Cl)C)O)C)OC)OC)C)C
CID000002806,90055-48-4,COC(=O)C(C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3,gastric inflammation,CID000060184,"2'-epi-Perindopril, (2'R)-",CCCC(C(=O)OCC)NC(C)C(=O)N1C2CCCCC2CC1C(=O)O
CID000002806,90055-48-4,COC(=O)C(C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3,gastric inflammation,CID000003961,losartan,CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)CO)Cl
CID000001117,sulfate,[O-]S(=O)(=O)[O-],angiitis,CID000004666,7-Epi Paclitaxel,CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C
CID000001117,sulfate,[O-]S(=O)(=O)[O-],apoplexy,CID000002462,51372-29-3,CCCC1OC2CC3C4CCC5=CC(=O)C=CC5(C4C(CC3(C2(O1)C(=O)CO)C)O)C
CID000001117,sulfate,[O-]S(=O)(=O)[O-],apoplexy,CID000003869,labetalol,CC(CCC1=CC=CC=C1)NCC(C2=CC(=C(C=C2)O)C(=O)N)O
CID000001117,sulfate,[O-]S(=O)(=O)[O-],cholecystitis,CID000002284,baclofen,C1=CC(=CC=C1C(CC(=O)O)CN)Cl
CID000001117,sulfate,[O-]S(=O)(=O)[O-],weight gain,CID000005478,racemic-Timolol,CC(C)(C)NCC(COC1=NSN=C1N2CCOCC2)O
CID000001117,sulfate,[O-]S(=O)(=O)[O-],elevated cholesterol,CID000060865,(E)-Olopatadine,CN(C)CCC=C1C2=CC=CC=C2COC3=C1C=C(C=C3)CC(=O)O
CID000001117,sulfate,[O-]S(=O)(=O)[O-],Acne,CID000004889,Pravastatin Impurity A,CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC(CC(CC(=O)O)O)O)O
CID000001117,sulfate,[O-]S(=O)(=O)[O-],cholecystitis,CID000003405,2-[[4-[(2-amino-4-oxo-1H-pteridin-6-yl)methylamino]benzoyl]amino]pentanedioic acid,C1=CC(=CC=C1C(=O)NC(CCC(=O)O)C(=O)O)NCC2=CN=C3C(=N2)C(=O)N=C(N3)N
CID000001117,sulfate,[O-]S(=O)(=O)[O-],cholecystitis,CID000005732,zolpidem,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C
CID000001117,sulfate,[O-]S(=O)(=O)[O-],weight gain,CID000002550,1-(2-methyl-3-sulfanylpropanoyl)pyrrolidine-2-carboxylic acid,CC(CS)C(=O)N1CCCC1C(=O)O
CID000001117,sulfate,[O-]S(=O)(=O)[O-],right heart failure,CID000147912,DSSTox_GSID_49066,CCC(C(C)O)N1C(=O)N(C=N1)C2=CC=C(C=C2)N3CCN(CC3)C4=CC=C(C=C4)OCC5CC(OC5)(CN6C=NC=N6)C7=C(C=C(C=C7)F)F
CID000001117,sulfate,[O-]S(=O)(=O)[O-],Adenopathy,CID000003310,33419-42-0,CC1OCC2C(O1)C(C(C(O2)OC3C4COC(=O)C4C(C5=CC6=C(C=C35)OCO6)C7=CC(=C(C(=C7)OC)O)OC)O)O
CID000001117,sulfate,[O-]S(=O)(=O)[O-],cholecystitis,CID000003937,N~2~-(1-carboxy-3-phenylpropyl)lysylproline,C1CC(N(C1)C(=O)C(CCCCN)NC(CCC2=CC=CC=C2)C(=O)O)C(=O)O
CID000001117,sulfate,[O-]S(=O)(=O)[O-],cholecystitis,CID000060852,Ibandronic Acid,CCCCCN(C)CCC(O)(P(=O)(O)O)P(=O)(O)O
CID000001117,sulfate,[O-]S(=O)(=O)[O-],Adenopathy,CID000019090,megestrol,CC1=CC2C(CCC3(C2CCC3(C(=O)C)O)C)C4(C1=CC(=O)CC4)C
CID000001117,sulfate,[O-]S(=O)(=O)[O-],neumonia,CID000005152,Salmeterol,C1=CC=C(C=C1)CCCCOCCCCCCNCC(C2=CC(=C(C=C2)O)CO)O
CID000001117,sulfate,[O-]S(=O)(=O)[O-],edema,CID000002405,BISOPROLOL,CC(C)NCC(COC1=CC=C(C=C1)COCCOC(C)C)O
CID000001117,sulfate,[O-]S(=O)(=O)[O-],hypermagnesemia,CID000074989,ATOVAQUONE,C1CC(CCC1C2=CC=C(C=C2)Cl)C3=C(C4=CC=CC=C4C(=O)C3=O)O
CID000001117,sulfate,[O-]S(=O)(=O)[O-],apoplexy,CID000003961,losartan,CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)CO)Cl
CID000001117,sulfate,[O-]S(=O)(=O)[O-],Adenopathy,CID000002771,citalopram,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F
CID000001117,sulfate,[O-]S(=O)(=O)[O-],allergic dermatitis,CID000002478,busulfan,CS(=O)(=O)OCCCCOS(=O)(=O)C
CID000001117,sulfate,[O-]S(=O)(=O)[O-],alopecia,CID000004205,mirtazapine,CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4
CID000001117,sulfate,[O-]S(=O)(=O)[O-],weight gain,CID000003890,TRANS (15S)-LATANOPROST,CC(C)OC(=O)CCCC=CCC1C(CC(C1CCC(CCC2=CC=CC=C2)O)O)O
CID000001117,sulfate,[O-]S(=O)(=O)[O-],cholecystitis,CID000004585,"2-methyl-4-(4-methylpiperazin-1-yl)-5H-thieno[3,2-c][1,5]benzodiazepine",CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C
CID000001117,sulfate,[O-]S(=O)(=O)[O-],gastric inflammation,CID000170361,Varenicline,C1C2CNCC1C3=CC4=NC=CN=C4C=C23
CID000001117,sulfate,[O-]S(=O)(=O)[O-],erythema,CID000003042,dicyclomine,CCN(CC)CCOC(=O)C1(CCCCC1)C2CCCCC2
CID000001117,sulfate,[O-]S(=O)(=O)[O-],failure to thrive,CID000005719,zaleplon,CCN(C1=CC=CC(=C1)C2=CC=NC3=C(C=NN23)C#N)C(=O)C
CID000001117,sulfate,[O-]S(=O)(=O)[O-],gastric inflammation,CID000003661,L-Hyoscyamine,CN1C2CCC1CC(C2)OC(=O)C(CO)C3=CC=CC=C3
CID000001117,sulfate,[O-]S(=O)(=O)[O-],cholecystitis,CID000003333,felodipine,CCOC(=O)C1=C(NC(=C(C1C2=C(C(=CC=C2)Cl)Cl)C(=O)OC)C)C
CID000001117,sulfate,[O-]S(=O)(=O)[O-],High blood pressure,CID000003339,fenofibrate,CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C2=CC=C(C=C2)Cl
CID000001117,sulfate,[O-]S(=O)(=O)[O-],thrombocytopenia,CID000004819,"2(3H)-Furanone, 3-ethyldihydro-4-[(1-methyl-1H-imidazol-5-yl)methyl]-, (3S-cis)-",CCC1C(COC1=O)CC2=CN=CN2C
CID000001117,sulfate,[O-]S(=O)(=O)[O-],cholecystitis,CID000001983,acetaminophen,CC(=O)NC1=CC=C(C=C1)O
CID000001117,sulfate,[O-]S(=O)(=O)[O-],erythema,CID000004894,"11,17,21-Trihydroxypregna-1,4-diene-3,20-dione",CC12CC(C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C)O
CID000001117,sulfate,[O-]S(=O)(=O)[O-],thrombocytopenia,CID000163742,SCHEMBL1650579,COC1C(C(C(C(O1)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)COS(=O)(=O)O)OC4C(C(C(C(O4)C(=O)O)OC5C(C(C(C(O5)COS(=O)(=O)O)O)O)NS(=O)(=O)O)O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O)NS(=O)(=O)O
CID000001117,sulfate,[O-]S(=O)(=O)[O-],Adenopathy,CID000667490,6-Mercaptopurine,C1=NC2=C(N1)C(=S)N=CN2
CID000001117,sulfate,[O-]S(=O)(=O)[O-],erythema,CID000003780,"D-Glucitol, 1,4:3,6-dianhydro-, 2,5-dinitrate",C1C(C2C(O1)C(CO2)O[N+](=O)[O-])O[N+](=O)[O-]
CID000001117,sulfate,[O-]S(=O)(=O)[O-],eruption,CID000002541,candesartan,CCOC1=NC2=CC=CC(=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5)C(=O)O
CID000001117,sulfate,[O-]S(=O)(=O)[O-],apoplexy,CID000004189,miconazole,C1=CC(=C(C=C1Cl)Cl)COC(CN2C=CN=C2)C3=C(C=C(C=C3)Cl)Cl
CID000001117,sulfate,[O-]S(=O)(=O)[O-],erythema,CID000002656,"7-[[2-(2-amino-1,3-thiazol-4-yl)-2-methoxyiminoacetyl]amino]-3-[(2-methyl-6-oxido-5-oxo-1,2,4-triazin-3-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CN1C(=NC(=O)C(=N1)[O-])SCC2=C(N3C(C(C3=O)NC(=O)C(=NOC)C4=CSC(=N4)N)SC2)C(=O)[O-]
CID000001117,sulfate,[O-]S(=O)(=O)[O-],increased white blood cell count,CID006398525,,C(C1C(C(C(C(O1)OC2(C(C(C(O2)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)COS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.[Al].[Al].[Al].[Al].[Al].[Al].[Al].[Al].[Al]
CID000001117,sulfate,[O-]S(=O)(=O)[O-],gastric inflammation,CID000002713,55-56-1,C1=CC(=CC=C1NC(=NC(=NCCCCCCN=C(N)N=C(N)NC2=CC=C(C=C2)Cl)N)N)Cl
CID000001117,sulfate,[O-]S(=O)(=O)[O-],Adenopathy,CID000003440,furosemide,C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl
CID000001117,sulfate,[O-]S(=O)(=O)[O-],arterial pressure NOS decreased,CID005311082,"2-[(1R,4S,10S,13S,19S)-19-[4-(diaminomethylideneamino)butyl]-10-(1H-indol-3-ylmethyl)-3,9,12,15,18,21,27-heptaoxo-24,25-dithia-2,8,11,14,17,20-hexazatricyclo[18.6.1.04,8]heptacosan-13-yl]acetic acid",C1CC2C(=O)NC3CSSCCC(=O)N(C3=O)C(C(=O)NCC(=O)NC(C(=O)NC(C(=O)N2C1)CC4=CNC5=CC=CC=C54)CC(=O)O)CCCCN=C(N)N
CID000001117,sulfate,[O-]S(=O)(=O)[O-],cholecystitis,CID000004691,"3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine",C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4
CID000001117,sulfate,[O-]S(=O)(=O)[O-],elevated erythrocyte sedimentation rate,CID000002088,ALENDRONIC ACID,C(CC(O)(P(=O)(O)O)P(=O)(O)O)CN
CID000001117,sulfate,[O-]S(=O)(=O)[O-],cholecystitis,CID000003062,Lanicor,CC1C(C(CC(O1)OC2C(OC(CC2O)OC3C(OC(CC3O)OC4CCC5(C(C4)CCC6C5CC(C7(C6(CCC7C8=CC(=O)OC8)O)C)O)C)C)C)O)O
CID000001117,sulfate,[O-]S(=O)(=O)[O-],apoplexy,CID000004158,methylphenidate,COC(=O)C(C1CCCCN1)C2=CC=CC=C2
CID000001117,sulfate,[O-]S(=O)(=O)[O-],Adenopathy,CID000003883,lansoprazole,CC1=C(C=CN=C1CS(=O)C2=NC3=CC=CC=C3N2)OCC(F)(F)F
CID000001117,sulfate,[O-]S(=O)(=O)[O-],deglutition disorder,CID000036811,dobutamine,CC(CCC1=CC=C(C=C1)O)NCCC2=CC(=C(C=C2)O)O
CID000001117,sulfate,[O-]S(=O)(=O)[O-],cholecystitis,CID000002524,32222-06-3,CC(CCCC(C)(C)O)C1CCC2C1(CCCC2=CC=C3CC(CC(C3=C)O)O)C
CID000001117,sulfate,[O-]S(=O)(=O)[O-],cholecystitis,CID000004900,Fernisone,CC12CC(=O)C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C
CID000001117,sulfate,[O-]S(=O)(=O)[O-],Adenopathy,CID000036339,Etomidate,CCOC(=O)C1=CN=CN1C(C)C2=CC=CC=C2
CID000001117,sulfate,[O-]S(=O)(=O)[O-],constipated,CID000005095,ropinirole,CCCN(CCC)CCC1=C2CC(=O)NC2=CC=C1
CID000001117,sulfate,[O-]S(=O)(=O)[O-],erythema,CID000003516,guaifenesin,COC1=CC=CC=C1OCC(CO)O
CID000001117,sulfate,[O-]S(=O)(=O)[O-],Adenopathy,CID000002891,"cobalt(2+);[5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] 1-[3-[2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2,7,12,17-tetrahydro-1H-corrin-21-id-3-yl]propanoylamino]propan-2-yl hydrogen phosphate;cyanide",CC1=CC2=C(C=C1C)N(C=N2)C3C(C(C(O3)CO)OP(=O)(O)OC(C)CNC(=O)CCC4(C(C5C6(C(C(C(=N6)C(=C7C(C(C(=N7)C=C8C(C(C(=N8)C(=C4[N-]5)C)CCC(=O)N)(C)C)CCC(=O)N)(C)CC(=O)N)C)CCC(=O)N)(C)CC(=O)N)C)CC(=O)N)C)O.[C-]#N.[Co+2]
CID000001117,sulfate,[O-]S(=O)(=O)[O-],erythema,CID000060754,Gadodiamide hydrate,CNC(=O)CN(CCN(CCN(CC(=O)NC)CC(=O)[O-])CC(=O)[O-])CC(=O)[O-].O.[Gd+3]
CID000001117,sulfate,[O-]S(=O)(=O)[O-],erythema,CID000071616,Voriconazole,CC(C1=NC=NC=C1F)C(CN2C=NC=N2)(C3=C(C=C(C=C3)F)F)O
CID000001117,sulfate,[O-]S(=O)(=O)[O-],Sinus headache,CID000005512,124936-74-9,CC1=CC(=C(C=C1)O)C(CCN(C(C)C)C(C)C)C2=CC=CC=C2
CID000001117,sulfate,[O-]S(=O)(=O)[O-],cholecystitis,CID000002022,2-amino-9-(2-hydroxyethoxymethyl)-3H-purin-6-one,C1=NC2=C(N1COCCO)NC(=NC2=O)N
CID000001117,sulfate,[O-]S(=O)(=O)[O-],loss of weight,CID000003749,irbesartan,CCCCC1=NC2(CCCC2)C(=O)N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5
CID000001117,sulfate,[O-]S(=O)(=O)[O-],abnormal EEG,CID000005358,sumatriptan,CNS(=O)(=O)CC1=CC2=C(C=C1)NC=C2CCN(C)C
CID000001117,sulfate,[O-]S(=O)(=O)[O-],metabolic encephalopathy,CID000004170,metolazone,CC1NC2=CC(=C(C=C2C(=O)N1C3=CC=CC=C3C)S(=O)(=O)N)Cl
CID000001117,sulfate,[O-]S(=O)(=O)[O-],cholecystitis,CID000004173,metronidazole,CC1=NC=C(N1CCO)[N+](=O)[O-]
CID000001117,sulfate,[O-]S(=O)(=O)[O-],cholecystitis,CID000003954,loperamide(1+),CN(C)C(=O)C(CC[NH+]1CCC(CC1)(C2=CC=C(C=C2)Cl)O)(C3=CC=CC=C3)C4=CC=CC=C4
CID000001117,sulfate,[O-]S(=O)(=O)[O-],loss of weight,CID000005073,risperidone,CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F
CID000001117,sulfate,[O-]S(=O)(=O)[O-],erythema,CID000004510,nitroglycerin,C(C(CO[N+](=O)[O-])O[N+](=O)[O-])O[N+](=O)[O-]
CID000001117,sulfate,[O-]S(=O)(=O)[O-],cancer,CID000071329,Dofetilide,CN(CCC1=CC=C(C=C1)NS(=O)(=O)C)CCOC2=CC=C(C=C2)NS(=O)(=O)C
CID000001117,sulfate,[O-]S(=O)(=O)[O-],loss of weight,CID000004236,modafinil,C1=CC=C(C=C1)C(C2=CC=CC=C2)S(=O)CC(=O)N
CID000001117,sulfate,[O-]S(=O)(=O)[O-],Dyspnea exertional,CID000005544,Mycolog,CC12CC(C3(C(C1CC(C2(C(=O)CO)O)O)CCC4=CC(=O)C=CC43C)F)O
CID000001117,sulfate,[O-]S(=O)(=O)[O-],Sinus headache,CID000005245,Risedronic acid,C1=CC(=CN=C1)CC(O)(P(=O)(O)O)P(=O)(O)O
CID000001117,sulfate,[O-]S(=O)(=O)[O-],loss of weight,CID000004920,"1-acetyl-9a,11a-dimethyl-1H,2H,3H,3aH,3bH,4H,5H,7H,8H,9H,9aH,9bH,10H,11H,11aH-cyclopenta[a]phenanthren-7-one",CC(=O)C1CCC2C1(CCC3C2CCC4=CC(=O)CCC34C)C
CID000001117,sulfate,[O-]S(=O)(=O)[O-],cholecystitis,CID000004927,promethazine,CC(CN1C2=CC=CC=C2SC3=CC=CC=C31)N(C)C
CID000001117,sulfate,[O-]S(=O)(=O)[O-],right heart failure,CID003468412,SCHEMBL1176571,CC1C=CC=CCCC=CC=CC=CC=CC(CC(C(C(CC(=O)CC(C(CCC(CC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)C(=O)O)O)OC2C(C(C(C(O2)C)O)N)O
CID000001117,sulfate,[O-]S(=O)(=O)[O-],gastric inflammation,CID000003676,lidocaine,CCN(CC)CC(=O)NC1=C(C=CC=C1C)C
CID000060754,Gadodiamide hydrate,CNC(=O)CN(CCN(CCN(CC(=O)NC)CC(=O)[O-])CC(=O)[O-])CC(=O)[O-].O.[Gd+3],Excoriation,CID000667490,6-Mercaptopurine,C1=NC2=C(N1)C(=S)N=CN2
CID000000581,N-Acetyl-DL-cysteine,CC(=O)NC(CS)C(=O)O,Adenopathy,CID000002656,"7-[[2-(2-amino-1,3-thiazol-4-yl)-2-methoxyiminoacetyl]amino]-3-[(2-methyl-6-oxido-5-oxo-1,2,4-triazin-3-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CN1C(=NC(=O)C(=N1)[O-])SCC2=C(N3C(C(C3=O)NC(=O)C(=NOC)C4=CSC(=N4)N)SC2)C(=O)[O-]
CID000000581,N-Acetyl-DL-cysteine,CC(=O)NC(CS)C(=O)O,gastric inflammation,CID000002713,55-56-1,C1=CC(=CC=C1NC(=NC(=NCCCCCCN=C(N)N=C(N)NC2=CC=C(C=C2)Cl)N)N)Cl
CID000000581,N-Acetyl-DL-cysteine,CC(=O)NC(CS)C(=O)O,agitated,CID000004900,Fernisone,CC12CC(=O)C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C
CID000000581,N-Acetyl-DL-cysteine,CC(=O)NC(CS)C(=O)O,thrombocytopenia,CID000000596,Cytosar,C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)O
CID000000581,N-Acetyl-DL-cysteine,CC(=O)NC(CS)C(=O)O,loss of weight,CID000002524,32222-06-3,CC(CCCC(C)(C)O)C1CCC2C1(CCCC2=CC=C3CC(CC(C3=C)O)O)C
CID000000581,N-Acetyl-DL-cysteine,CC(=O)NC(CS)C(=O)O,loss of weight,CID000004205,mirtazapine,CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4
CID000000581,N-Acetyl-DL-cysteine,CC(=O)NC(CS)C(=O)O,weight gain,CID000004510,nitroglycerin,C(C(CO[N+](=O)[O-])O[N+](=O)[O-])O[N+](=O)[O-]
CID000000581,N-Acetyl-DL-cysteine,CC(=O)NC(CS)C(=O)O,thrombocytopenia,CID005311082,"2-[(1R,4S,10S,13S,19S)-19-[4-(diaminomethylideneamino)butyl]-10-(1H-indol-3-ylmethyl)-3,9,12,15,18,21,27-heptaoxo-24,25-dithia-2,8,11,14,17,20-hexazatricyclo[18.6.1.04,8]heptacosan-13-yl]acetic acid",C1CC2C(=O)NC3CSSCCC(=O)N(C3=O)C(C(=O)NCC(=O)NC(C(=O)NC(C(=O)N2C1)CC4=CNC5=CC=CC=C54)CC(=O)O)CCCCN=C(N)N
CID000000581,N-Acetyl-DL-cysteine,CC(=O)NC(CS)C(=O)O,erythema,CID000005152,Salmeterol,C1=CC=C(C=C1)CCCCOCCCCCCNCC(C2=CC(=C(C=C2)O)CO)O
CID000000581,N-Acetyl-DL-cysteine,CC(=O)NC(CS)C(=O)O,erythema,CID006398525,,C(C1C(C(C(C(O1)OC2(C(C(C(O2)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)COS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.[Al].[Al].[Al].[Al].[Al].[Al].[Al].[Al].[Al]
CID000000581,N-Acetyl-DL-cysteine,CC(=O)NC(CS)C(=O)O,glaucoma,CID000071616,Voriconazole,CC(C1=NC=NC=C1F)C(CN2C=NC=N2)(C3=C(C=C(C=C3)F)F)O
CID000000581,N-Acetyl-DL-cysteine,CC(=O)NC(CS)C(=O)O,Excess potassium,CID000003937,N~2~-(1-carboxy-3-phenylpropyl)lysylproline,C1CC(N(C1)C(=O)C(CCCCN)NC(CCC2=CC=CC=C2)C(=O)O)C(=O)O
CID000000581,N-Acetyl-DL-cysteine,CC(=O)NC(CS)C(=O)O,loss of weight,CID000003405,2-[[4-[(2-amino-4-oxo-1H-pteridin-6-yl)methylamino]benzoyl]amino]pentanedioic acid,C1=CC(=CC=C1C(=O)NC(CCC(=O)O)C(=O)O)NCC2=CN=C3C(=N2)C(=O)N=C(N3)N
CID000000581,N-Acetyl-DL-cysteine,CC(=O)NC(CS)C(=O)O,cholecystitis,CID000004173,metronidazole,CC1=NC=C(N1CCO)[N+](=O)[O-]
CID000000581,N-Acetyl-DL-cysteine,CC(=O)NC(CS)C(=O)O,cellulitis,CID000004170,metolazone,CC1NC2=CC(=C(C=C2C(=O)N1C3=CC=CC=C3C)S(=O)(=O)N)Cl
CID000000581,N-Acetyl-DL-cysteine,CC(=O)NC(CS)C(=O)O,back injury,CID000001983,acetaminophen,CC(=O)NC1=CC=C(C=C1)O
CID000000581,N-Acetyl-DL-cysteine,CC(=O)NC(CS)C(=O)O,abnormal ECG,CID000003883,lansoprazole,CC1=C(C=CN=C1CS(=O)C2=NC3=CC=CC=C3N2)OCC(F)(F)F
CID000000581,N-Acetyl-DL-cysteine,CC(=O)NC(CS)C(=O)O,encephalopathy,CID000005073,risperidone,CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F
CID000000581,N-Acetyl-DL-cysteine,CC(=O)NC(CS)C(=O)O,eruption,CID000002541,candesartan,CCOC1=NC2=CC=CC(=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5)C(=O)O
CID000000581,N-Acetyl-DL-cysteine,CC(=O)NC(CS)C(=O)O,Back Ache,CID000004889,Pravastatin Impurity A,CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC(CC(CC(=O)O)O)O)O
CID000000581,N-Acetyl-DL-cysteine,CC(=O)NC(CS)C(=O)O,myelodysplasia,CID000003961,losartan,CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)CO)Cl
CID000000581,N-Acetyl-DL-cysteine,CC(=O)NC(CS)C(=O)O,Back Ache,CID000002284,baclofen,C1=CC(=CC=C1C(CC(=O)O)CN)Cl
CID000000581,N-Acetyl-DL-cysteine,CC(=O)NC(CS)C(=O)O,gastric inflammation,CID000003661,L-Hyoscyamine,CN1C2CCC1CC(C2)OC(=O)C(CO)C3=CC=CC=C3
CID000000581,N-Acetyl-DL-cysteine,CC(=O)NC(CS)C(=O)O,hiccough,CID000002891,"cobalt(2+);[5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] 1-[3-[2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2,7,12,17-tetrahydro-1H-corrin-21-id-3-yl]propanoylamino]propan-2-yl hydrogen phosphate;cyanide",CC1=CC2=C(C=C1C)N(C=N2)C3C(C(C(O3)CO)OP(=O)(O)OC(C)CNC(=O)CCC4(C(C5C6(C(C(C(=N6)C(=C7C(C(C(=N7)C=C8C(C(C(=N8)C(=C4[N-]5)C)CCC(=O)N)(C)C)CCC(=O)N)(C)CC(=O)N)C)CCC(=O)N)(C)CC(=O)N)C)CC(=O)N)C)O.[C-]#N.[Co+2]
CID000000581,N-Acetyl-DL-cysteine,CC(=O)NC(CS)C(=O)O,myelodysplasia,CID000002462,51372-29-3,CCCC1OC2CC3C4CCC5=CC(=O)C=CC5(C4C(CC3(C2(O1)C(=O)CO)C)O)C
CID000000581,N-Acetyl-DL-cysteine,CC(=O)NC(CS)C(=O)O,gastric inflammation,CID000003333,felodipine,CCOC(=O)C1=C(NC(=C(C1C2=C(C(=CC=C2)Cl)Cl)C(=O)OC)C)C
CID000000581,N-Acetyl-DL-cysteine,CC(=O)NC(CS)C(=O)O,Back Ache,CID000003339,fenofibrate,CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C2=CC=C(C=C2)Cl
CID000000581,N-Acetyl-DL-cysteine,CC(=O)NC(CS)C(=O)O,abnormal ECG,CID000004666,7-Epi Paclitaxel,CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C
CID000000581,N-Acetyl-DL-cysteine,CC(=O)NC(CS)C(=O)O,erythema,CID000009052,2-hydroxy-3-[1-(4-nitrophenyl)-3-oxobutyl]chromen-4-one,CC(=O)CC(C1=CC=C(C=C1)[N+](=O)[O-])C2=C(OC3=CC=CC=C3C2=O)O
CID000000581,N-Acetyl-DL-cysteine,CC(=O)NC(CS)C(=O)O,nervous tension,CID000005394,temozolomide,CN1C(=O)N2C=NC(=C2N=N1)C(=O)N
CID000000581,N-Acetyl-DL-cysteine,CC(=O)NC(CS)C(=O)O,apoplexy,CID000003749,irbesartan,CCCCC1=NC2(CCCC2)C(=O)N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5
CID000000581,N-Acetyl-DL-cysteine,CC(=O)NC(CS)C(=O)O,gastric inflammation,CID000004585,"2-methyl-4-(4-methylpiperazin-1-yl)-5H-thieno[3,2-c][1,5]benzodiazepine",CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C
CID000000581,N-Acetyl-DL-cysteine,CC(=O)NC(CS)C(=O)O,thrombocytopenia,CID000004211,mitotane,C1=CC=C(C(=C1)C(C2=CC=C(C=C2)Cl)C(Cl)Cl)Cl
CID000000581,N-Acetyl-DL-cysteine,CC(=O)NC(CS)C(=O)O,dizziness,CID000060184,"2'-epi-Perindopril, (2'R)-",CCCC(C(=O)OCC)NC(C)C(=O)N1C2CCCCC2CC1C(=O)O
CID000000581,N-Acetyl-DL-cysteine,CC(=O)NC(CS)C(=O)O,Infection Upper Respiratory,CID000002771,citalopram,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F
CID000000581,N-Acetyl-DL-cysteine,CC(=O)NC(CS)C(=O)O,loss of weight,CID000003954,loperamide(1+),CN(C)C(=O)C(CC[NH+]1CCC(CC1)(C2=CC=C(C=C2)Cl)O)(C3=CC=CC=C3)C4=CC=CC=C4
CID000000581,N-Acetyl-DL-cysteine,CC(=O)NC(CS)C(=O)O,gastric inflammation,CID000002022,2-amino-9-(2-hydroxyethoxymethyl)-3H-purin-6-one,C1=NC2=C(N1COCCO)NC(=NC2=O)N
CID000000581,N-Acetyl-DL-cysteine,CC(=O)NC(CS)C(=O)O,cholecystitis,CID000002405,BISOPROLOL,CC(C)NCC(COC1=CC=C(C=C1)COCCOC(C)C)O
CID000000581,N-Acetyl-DL-cysteine,CC(=O)NC(CS)C(=O)O,back injury,CID000005732,zolpidem,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C
CID000000581,N-Acetyl-DL-cysteine,CC(=O)NC(CS)C(=O)O,abnormal ECG,CID000004691,"3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine",C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4
CID000000581,N-Acetyl-DL-cysteine,CC(=O)NC(CS)C(=O)O,Bleeding,CID000019090,megestrol,CC1=CC2C(CCC3(C2CCC3(C(=O)C)O)C)C4(C1=CC(=O)CC4)C
CID000000581,N-Acetyl-DL-cysteine,CC(=O)NC(CS)C(=O)O,thrombocytopenia,CID000003310,33419-42-0,CC1OCC2C(O1)C(C(C(O2)OC3C4COC(=O)C4C(C5=CC6=C(C=C35)OCO6)C7=CC(=C(C(=C7)OC)O)OC)O)O
CID000000581,N-Acetyl-DL-cysteine,CC(=O)NC(CS)C(=O)O,confusion,CID000163742,SCHEMBL1650579,COC1C(C(C(C(O1)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)COS(=O)(=O)O)OC4C(C(C(C(O4)C(=O)O)OC5C(C(C(C(O5)COS(=O)(=O)O)O)O)NS(=O)(=O)O)O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O)NS(=O)(=O)O
CID000000581,N-Acetyl-DL-cysteine,CC(=O)NC(CS)C(=O)O,right heart failure,CID000004894,"11,17,21-Trihydroxypregna-1,4-diene-3,20-dione",CC12CC(C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C)O
CID000000581,N-Acetyl-DL-cysteine,CC(=O)NC(CS)C(=O)O,myelodysplasia,CID000003440,furosemide,C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl
CID000000581,N-Acetyl-DL-cysteine,CC(=O)NC(CS)C(=O)O,Back Ache,CID000005544,Mycolog,CC12CC(C3(C(C1CC(C2(C(=O)CO)O)O)CCC4=CC(=O)C=CC43C)F)O
CID000000581,N-Acetyl-DL-cysteine,CC(=O)NC(CS)C(=O)O,gastric inflammation,CID000036339,Etomidate,CCOC(=O)C1=CN=CN1C(C)C2=CC=CC=C2
CID000000581,N-Acetyl-DL-cysteine,CC(=O)NC(CS)C(=O)O,gastric inflammation,CID000003062,Lanicor,CC1C(C(CC(O1)OC2C(OC(CC2O)OC3C(OC(CC3O)OC4CCC5(C(C4)CCC6C5CC(C7(C6(CCC7C8=CC(=O)OC8)O)C)O)C)C)C)O)O
CID000000581,N-Acetyl-DL-cysteine,CC(=O)NC(CS)C(=O)O,gastric inflammation,CID000004927,promethazine,CC(CN1C2=CC=CC=C2SC3=CC=CC=C31)N(C)C
CID000000581,N-Acetyl-DL-cysteine,CC(=O)NC(CS)C(=O)O,angiitis,CID000002088,ALENDRONIC ACID,C(CC(O)(P(=O)(O)O)P(=O)(O)O)CN
CID000000581,N-Acetyl-DL-cysteine,CC(=O)NC(CS)C(=O)O,disorder Renal,CID000003516,guaifenesin,COC1=CC=CC=C1OCC(CO)O
CID000000581,N-Acetyl-DL-cysteine,CC(=O)NC(CS)C(=O)O,abnormal ECG,CID003468412,SCHEMBL1176571,CC1C=CC=CCCC=CC=CC=CC=CC(CC(C(C(CC(=O)CC(C(CCC(CC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)C(=O)O)O)OC2C(C(C(C(O2)C)O)N)O
CID000000581,N-Acetyl-DL-cysteine,CC(=O)NC(CS)C(=O)O,apoplexy,CID000003780,"D-Glucitol, 1,4:3,6-dianhydro-, 2,5-dinitrate",C1C(C2C(O1)C(CO2)O[N+](=O)[O-])O[N+](=O)[O-]
CID000000581,N-Acetyl-DL-cysteine,CC(=O)NC(CS)C(=O)O,Back Ache,CID000002550,1-(2-methyl-3-sulfanylpropanoyl)pyrrolidine-2-carboxylic acid,CC(CS)C(=O)N1CCCC1C(=O)O
CID000000581,N-Acetyl-DL-cysteine,CC(=O)NC(CS)C(=O)O,drug toxicity NOS,CID000003676,lidocaine,CCN(CC)CC(=O)NC1=C(C=CC=C1C)C
CID000000581,N-Acetyl-DL-cysteine,CC(=O)NC(CS)C(=O)O,apoplexy,CID000005245,Risedronic acid,C1=CC(=CN=C1)CC(O)(P(=O)(O)O)P(=O)(O)O
CID000002951,dantrolene(1-),C1C(=NC(=O)N1N=CC2=CC=C(O2)C3=CC=C(C=C3)[N+](=O)[O-])[O-],loss of weight,CID000004691,"3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine",C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4
CID000002951,dantrolene(1-),C1C(=NC(=O)N1N=CC2=CC=C(O2)C3=CC=C(C=C3)[N+](=O)[O-])[O-],heart rate increased,CID000004585,"2-methyl-4-(4-methylpiperazin-1-yl)-5H-thieno[3,2-c][1,5]benzodiazepine",CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C
CID000002951,dantrolene(1-),C1C(=NC(=O)N1N=CC2=CC=C(O2)C3=CC=C(C=C3)[N+](=O)[O-])[O-],convulsion,CID000003062,Lanicor,CC1C(C(CC(O1)OC2C(OC(CC2O)OC3C(OC(CC3O)OC4CCC5(C(C4)CCC6C5CC(C7(C6(CCC7C8=CC(=O)OC8)O)C)O)C)C)C)O)O
CID000002951,dantrolene(1-),C1C(=NC(=O)N1N=CC2=CC=C(O2)C3=CC=C(C=C3)[N+](=O)[O-])[O-],loss of weight,CID000004236,modafinil,C1=CC=C(C=C1)C(C2=CC=CC=C2)S(=O)CC(=O)N
CID000002951,dantrolene(1-),C1C(=NC(=O)N1N=CC2=CC=C(O2)C3=CC=C(C=C3)[N+](=O)[O-])[O-],apoplexy,CID000004205,mirtazapine,CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4
CID000002951,dantrolene(1-),C1C(=NC(=O)N1N=CC2=CC=C(O2)C3=CC=C(C=C3)[N+](=O)[O-])[O-],apoplexy,CID000003937,N~2~-(1-carboxy-3-phenylpropyl)lysylproline,C1CC(N(C1)C(=O)C(CCCCN)NC(CCC2=CC=CC=C2)C(=O)O)C(=O)O
CID000002951,dantrolene(1-),C1C(=NC(=O)N1N=CC2=CC=C(O2)C3=CC=C(C=C3)[N+](=O)[O-])[O-],gastric inflammation,CID000003440,furosemide,C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl
CID000002951,dantrolene(1-),C1C(=NC(=O)N1N=CC2=CC=C(O2)C3=CC=C(C=C3)[N+](=O)[O-])[O-],dysarthria,CID000005073,risperidone,CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F
CID000002951,dantrolene(1-),C1C(=NC(=O)N1N=CC2=CC=C(O2)C3=CC=C(C=C3)[N+](=O)[O-])[O-],blood sodium decreased,CID000005512,124936-74-9,CC1=CC(=C(C=C1)O)C(CCN(C(C)C)C(C)C)C2=CC=CC=C2
CID000002951,dantrolene(1-),C1C(=NC(=O)N1N=CC2=CC=C(O2)C3=CC=C(C=C3)[N+](=O)[O-])[O-],nasopharyngitis,CID000005487,tizanidine,C1CN=C(N1)NC2=C(C=CC3=NSN=C32)Cl
CID000002951,dantrolene(1-),C1C(=NC(=O)N1N=CC2=CC=C(O2)C3=CC=C(C=C3)[N+](=O)[O-])[O-],apoplexy,CID000005732,zolpidem,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C
CID000002951,dantrolene(1-),C1C(=NC(=O)N1N=CC2=CC=C(O2)C3=CC=C(C=C3)[N+](=O)[O-])[O-],elevated cholesterol,CID000003339,fenofibrate,CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C2=CC=C(C=C2)Cl
CID000002951,dantrolene(1-),C1C(=NC(=O)N1N=CC2=CC=C(O2)C3=CC=C(C=C3)[N+](=O)[O-])[O-],apoplexy,CID000003883,lansoprazole,CC1=C(C=CN=C1CS(=O)C2=NC3=CC=CC=C3N2)OCC(F)(F)F
CID000002951,dantrolene(1-),C1C(=NC(=O)N1N=CC2=CC=C(O2)C3=CC=C(C=C3)[N+](=O)[O-])[O-],cholelithiasis,CID000004927,promethazine,CC(CN1C2=CC=CC=C2SC3=CC=CC=C31)N(C)C
CID000002951,dantrolene(1-),C1C(=NC(=O)N1N=CC2=CC=C(O2)C3=CC=C(C=C3)[N+](=O)[O-])[O-],apoplexy,CID000004158,methylphenidate,COC(=O)C(C1CCCCN1)C2=CC=CC=C2
CID000009052,2-hydroxy-3-[1-(4-nitrophenyl)-3-oxobutyl]chromen-4-one,CC(=O)CC(C1=CC=C(C=C1)[N+](=O)[O-])C2=C(OC3=CC=CC=C3C2=O)O,haematoma,CID000163742,SCHEMBL1650579,COC1C(C(C(C(O1)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)COS(=O)(=O)O)OC4C(C(C(C(O4)C(=O)O)OC5C(C(C(C(O5)COS(=O)(=O)O)O)O)NS(=O)(=O)O)O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O)NS(=O)(=O)O
CID000009052,2-hydroxy-3-[1-(4-nitrophenyl)-3-oxobutyl]chromen-4-one,CC(=O)CC(C1=CC=C(C=C1)[N+](=O)[O-])C2=C(OC3=CC=CC=C3C2=O)O,Convulsions Grand Mal,CID000060852,Ibandronic Acid,CCCCCN(C)CCC(O)(P(=O)(O)O)P(=O)(O)O
CID000009052,2-hydroxy-3-[1-(4-nitrophenyl)-3-oxobutyl]chromen-4-one,CC(=O)CC(C1=CC=C(C=C1)[N+](=O)[O-])C2=C(OC3=CC=CC=C3C2=O)O,Arrhythmia,CID005493444,Aliskiren,CC(C)C(CC1=CC(=C(C=C1)OC)OCCCOC)CC(C(CC(C(C)C)C(=O)NCC(C)(C)C(=O)N)O)N
CID000009052,2-hydroxy-3-[1-(4-nitrophenyl)-3-oxobutyl]chromen-4-one,CC(=O)CC(C1=CC=C(C=C1)[N+](=O)[O-])C2=C(OC3=CC=CC=C3C2=O)O,Neuromuscular Disorder,CID000060184,"2'-epi-Perindopril, (2'R)-",CCCC(C(=O)OCC)NC(C)C(=O)N1C2CCCCC2CC1C(=O)O
CID000009052,2-hydroxy-3-[1-(4-nitrophenyl)-3-oxobutyl]chromen-4-one,CC(=O)CC(C1=CC=C(C=C1)[N+](=O)[O-])C2=C(OC3=CC=CC=C3C2=O)O,right heart failure,CID000071616,Voriconazole,CC(C1=NC=NC=C1F)C(CN2C=NC=N2)(C3=C(C=C(C=C3)F)F)O
CID000003883,lansoprazole,CC1=C(C=CN=C1CS(=O)C2=NC3=CC=CC=C3N2)OCC(F)(F)F,gastric inflammation,CID000004178,Mexiletine,CC1=C(C(=CC=C1)C)OCC(C)N
CID000003883,lansoprazole,CC1=C(C=CN=C1CS(=O)C2=NC3=CC=CC=C3N2)OCC(F)(F)F,gastric inflammation,CID000667490,6-Mercaptopurine,C1=NC2=C(N1)C(=S)N=CN2
CID000003883,lansoprazole,CC1=C(C=CN=C1CS(=O)C2=NC3=CC=CC=C3N2)OCC(F)(F)F,Paraesthesia,CID000057537,92206-54-7,CCCN(CCC1=CC=CS1)C2CCC3=C(C2)C=CC=C3O
CID000003883,lansoprazole,CC1=C(C=CN=C1CS(=O)C2=NC3=CC=CC=C3N2)OCC(F)(F)F,cholecystitis,CID000005512,124936-74-9,CC1=CC(=C(C=C1)O)C(CCN(C(C)C)C(C)C)C2=CC=CC=C2
CID000003883,lansoprazole,CC1=C(C=CN=C1CS(=O)C2=NC3=CC=CC=C3N2)OCC(F)(F)F,dysarthria,CID005493444,Aliskiren,CC(C)C(CC1=CC(=C(C=C1)OC)OCCCOC)CC(C(CC(C(C)C)C(=O)NCC(C)(C)C(=O)N)O)N
CID000003883,lansoprazole,CC1=C(C=CN=C1CS(=O)C2=NC3=CC=CC=C3N2)OCC(F)(F)F,hyperacusia,CID000004894,"11,17,21-Trihydroxypregna-1,4-diene-3,20-dione",CC12CC(C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C)O
CID000003883,lansoprazole,CC1=C(C=CN=C1CS(=O)C2=NC3=CC=CC=C3N2)OCC(F)(F)F,erythema,CID000004819,"2(3H)-Furanone, 3-ethyldihydro-4-[(1-methyl-1H-imidazol-5-yl)methyl]-, (3S-cis)-",CCC1C(COC1=O)CC2=CN=CN2C
CID000003883,lansoprazole,CC1=C(C=CN=C1CS(=O)C2=NC3=CC=CC=C3N2)OCC(F)(F)F,cholecystitis,CID000004170,metolazone,CC1NC2=CC(=C(C=C2C(=O)N1C3=CC=CC=C3C)S(=O)(=O)N)Cl
CID000003883,lansoprazole,CC1=C(C=CN=C1CS(=O)C2=NC3=CC=CC=C3N2)OCC(F)(F)F,adenomyosis,CID000004173,metronidazole,CC1=NC=C(N1CCO)[N+](=O)[O-]
CID000003883,lansoprazole,CC1=C(C=CN=C1CS(=O)C2=NC3=CC=CC=C3N2)OCC(F)(F)F,panic attack,CID000005073,risperidone,CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F
CID000003883,lansoprazole,CC1=C(C=CN=C1CS(=O)C2=NC3=CC=CC=C3N2)OCC(F)(F)F,drug withdrawal,CID000003937,N~2~-(1-carboxy-3-phenylpropyl)lysylproline,C1CC(N(C1)C(=O)C(CCCCN)NC(CCC2=CC=CC=C2)C(=O)O)C(=O)O
CID000003883,lansoprazole,CC1=C(C=CN=C1CS(=O)C2=NC3=CC=CC=C3N2)OCC(F)(F)F,icterus,CID004479097,"cobalt;[5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] 1-[3-[2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2,7,12,17-tetrahydro-1H-corrin-21-id-3-yl]propanoylamino]propan-2-yl phosphate;hydrate",CC1=CC2=C(C=C1C)N(C=N2)C3C(C(C(O3)CO)OP(=O)([O-])OC(C)CNC(=O)CCC4(C(C5C6(C(C(C(=N6)C(=C7C(C(C(=N7)C=C8C(C(C(=N8)C(=C4[N-]5)C)CCC(=O)N)(C)C)CCC(=O)N)(C)CC(=O)N)C)CCC(=O)N)(C)CC(=O)N)C)CC(=O)N)C)O.O.[Co]
CID000003883,lansoprazole,CC1=C(C=CN=C1CS(=O)C2=NC3=CC=CC=C3N2)OCC(F)(F)F,gastric inflammation,CID000004236,modafinil,C1=CC=C(C=C1)C(C2=CC=CC=C2)S(=O)CC(=O)N
CID000003883,lansoprazole,CC1=C(C=CN=C1CS(=O)C2=NC3=CC=CC=C3N2)OCC(F)(F)F,pharyngeal inflammation,CID000005245,Risedronic acid,C1=CC(=CN=C1)CC(O)(P(=O)(O)O)P(=O)(O)O
CID000003883,lansoprazole,CC1=C(C=CN=C1CS(=O)C2=NC3=CC=CC=C3N2)OCC(F)(F)F,cholecystitis,CID000005544,Mycolog,CC12CC(C3(C(C1CC(C2(C(=O)CO)O)O)CCC4=CC(=O)C=CC43C)F)O
CID000003883,lansoprazole,CC1=C(C=CN=C1CS(=O)C2=NC3=CC=CC=C3N2)OCC(F)(F)F,gastric inflammation,CID003468412,SCHEMBL1176571,CC1C=CC=CCCC=CC=CC=CC=CC(CC(C(C(CC(=O)CC(C(CCC(CC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)C(=O)O)O)OC2C(C(C(C(O2)C)O)N)O
CID000003883,lansoprazole,CC1=C(C=CN=C1CS(=O)C2=NC3=CC=CC=C3N2)OCC(F)(F)F,Dyspnea exertional,CID000005478,racemic-Timolol,CC(C)(C)NCC(COC1=NSN=C1N2CCOCC2)O
CID000003883,lansoprazole,CC1=C(C=CN=C1CS(=O)C2=NC3=CC=CC=C3N2)OCC(F)(F)F,Adenopathy,CID000004614,oxaprozin,C1=CC=C(C=C1)C2=C(OC(=N2)CCC(=O)O)C3=CC=CC=C3
CID000003883,lansoprazole,CC1=C(C=CN=C1CS(=O)C2=NC3=CC=CC=C3N2)OCC(F)(F)F,diarrhea,CID000004195,midodrine,COC1=CC(=C(C=C1)OC)C(CNC(=O)CN)O
CID000003883,lansoprazole,CC1=C(C=CN=C1CS(=O)C2=NC3=CC=CC=C3N2)OCC(F)(F)F,gastric inflammation,CID000004889,Pravastatin Impurity A,CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC(CC(CC(=O)O)O)O)O
CID000003883,lansoprazole,CC1=C(C=CN=C1CS(=O)C2=NC3=CC=CC=C3N2)OCC(F)(F)F,gastric inflammation,CID000005732,zolpidem,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C
CID000003883,lansoprazole,CC1=C(C=CN=C1CS(=O)C2=NC3=CC=CC=C3N2)OCC(F)(F)F,cholecystitis,CID000003961,losartan,CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)CO)Cl
CID000003883,lansoprazole,CC1=C(C=CN=C1CS(=O)C2=NC3=CC=CC=C3N2)OCC(F)(F)F,gastric inflammation,CID000005487,tizanidine,C1CN=C(N1)NC2=C(C=CC3=NSN=C32)Cl
CID000003883,lansoprazole,CC1=C(C=CN=C1CS(=O)C2=NC3=CC=CC=C3N2)OCC(F)(F)F,cholecystitis,CID000005152,Salmeterol,C1=CC=C(C=C1)CCCCOCCCCCCNCC(C2=CC(=C(C=C2)O)CO)O
CID000003883,lansoprazole,CC1=C(C=CN=C1CS(=O)C2=NC3=CC=CC=C3N2)OCC(F)(F)F,loss of weight,CID000004440,naratriptan,CNS(=O)(=O)CCC1=CC2=C(C=C1)NC=C2C3CCN(CC3)C
CID000003883,lansoprazole,CC1=C(C=CN=C1CS(=O)C2=NC3=CC=CC=C3N2)OCC(F)(F)F,High blood pressure,CID000060184,"2'-epi-Perindopril, (2'R)-",CCCC(C(=O)OCC)NC(C)C(=O)N1C2CCCCC2CC1C(=O)O
CID000003883,lansoprazole,CC1=C(C=CN=C1CS(=O)C2=NC3=CC=CC=C3N2)OCC(F)(F)F,thrombocytopenia,CID000036339,Etomidate,CCOC(=O)C1=CN=CN1C(C)C2=CC=CC=C2
CID000003883,lansoprazole,CC1=C(C=CN=C1CS(=O)C2=NC3=CC=CC=C3N2)OCC(F)(F)F,Excess potassium,CID000071616,Voriconazole,CC(C1=NC=NC=C1F)C(CN2C=NC=N2)(C3=C(C=C(C=C3)F)F)O
CID000003883,lansoprazole,CC1=C(C=CN=C1CS(=O)C2=NC3=CC=CC=C3N2)OCC(F)(F)F,cholecystitis,CID000003890,TRANS (15S)-LATANOPROST,CC(C)OC(=O)CCCC=CCC1C(CC(C1CCC(CCC2=CC=CC=C2)O)O)O
CID000003883,lansoprazole,CC1=C(C=CN=C1CS(=O)C2=NC3=CC=CC=C3N2)OCC(F)(F)F,gastric inflammation,CID000004536,Minovlar,CC12CCC3C(C1CCC2(C#C)O)CCC4=CC(=O)CCC34
CID000003883,lansoprazole,CC1=C(C=CN=C1CS(=O)C2=NC3=CC=CC=C3N2)OCC(F)(F)F,loss of weight,CID000163742,SCHEMBL1650579,COC1C(C(C(C(O1)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)COS(=O)(=O)O)OC4C(C(C(C(O4)C(=O)O)OC5C(C(C(C(O5)COS(=O)(=O)O)O)O)NS(=O)(=O)O)O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O)NS(=O)(=O)O
CID000003883,lansoprazole,CC1=C(C=CN=C1CS(=O)C2=NC3=CC=CC=C3N2)OCC(F)(F)F,Dyspnea exertional,CID000004909,primidone,CCC1(C(=O)NCNC1=O)C2=CC=CC=C2
CID000003883,lansoprazole,CC1=C(C=CN=C1CS(=O)C2=NC3=CC=CC=C3N2)OCC(F)(F)F,gastric inflammation,CID000004900,Fernisone,CC12CC(=O)C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C
CID000003883,lansoprazole,CC1=C(C=CN=C1CS(=O)C2=NC3=CC=CC=C3N2)OCC(F)(F)F,cholecystitis,CID000005719,zaleplon,CCN(C1=CC=CC(=C1)C2=CC=NC3=C(C=NN23)C#N)C(=O)C
CID000003883,lansoprazole,CC1=C(C=CN=C1CS(=O)C2=NC3=CC=CC=C3N2)OCC(F)(F)F,gastric inflammation,CID000060852,Ibandronic Acid,CCCCCN(C)CCC(O)(P(=O)(O)O)P(=O)(O)O
CID000003883,lansoprazole,CC1=C(C=CN=C1CS(=O)C2=NC3=CC=CC=C3N2)OCC(F)(F)F,Dyspnea exertional,CID000005394,temozolomide,CN1C(=O)N2C=NC(=C2N=N1)C(=O)N
CID000003883,lansoprazole,CC1=C(C=CN=C1CS(=O)C2=NC3=CC=CC=C3N2)OCC(F)(F)F,cholecystitis,CID006398525,,C(C1C(C(C(C(O1)OC2(C(C(C(O2)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)COS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.[Al].[Al].[Al].[Al].[Al].[Al].[Al].[Al].[Al]
CID000003883,lansoprazole,CC1=C(C=CN=C1CS(=O)C2=NC3=CC=CC=C3N2)OCC(F)(F)F,Adenopathy,CID000004585,"2-methyl-4-(4-methylpiperazin-1-yl)-5H-thieno[3,2-c][1,5]benzodiazepine",CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C
CID000003883,lansoprazole,CC1=C(C=CN=C1CS(=O)C2=NC3=CC=CC=C3N2)OCC(F)(F)F,Adenopathy,CID000004075,5-Aminosalicylic acid,C1=CC(=C(C=C1N)C(=O)O)O
CID000003883,lansoprazole,CC1=C(C=CN=C1CS(=O)C2=NC3=CC=CC=C3N2)OCC(F)(F)F,cholecystitis,CID000004205,mirtazapine,CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4
CID000003883,lansoprazole,CC1=C(C=CN=C1CS(=O)C2=NC3=CC=CC=C3N2)OCC(F)(F)F,adenomyosis,CID000004201,minoxidil,C1CCN(CC1)C2=NC(=N)N(C(=C2)N)O
CID000003883,lansoprazole,CC1=C(C=CN=C1CS(=O)C2=NC3=CC=CC=C3N2)OCC(F)(F)F,Adenopathy,CID000060787,sequinavir,CC(C)(C)NC(=O)C1CC2CCCCC2CN1CC(C(CC3=CC=CC=C3)NC(=O)C(CC(=O)N)NC(=O)C4=NC5=CC=CC=C5C=C4)O
CID000003883,lansoprazole,CC1=C(C=CN=C1CS(=O)C2=NC3=CC=CC=C3N2)OCC(F)(F)F,gastric inflammation,CID000060865,(E)-Olopatadine,CN(C)CCC=C1C2=CC=CC=C2COC3=C1C=C(C=C3)CC(=O)O
CID000003883,lansoprazole,CC1=C(C=CN=C1CS(=O)C2=NC3=CC=CC=C3N2)OCC(F)(F)F,apoplexy,CID006447131,Pimecrolimus,CCC1C=C(CC(CC(C2C(CC(C(O2)(C(=O)C(=O)N3CCCCC3C(=O)OC(C(C(CC1=O)O)C)C(=CC4CCC(C(C4)OC)Cl)C)O)C)OC)OC)C)C
CID000003883,lansoprazole,CC1=C(C=CN=C1CS(=O)C2=NC3=CC=CC=C3N2)OCC(F)(F)F,thrombocytopenia,CID000036811,dobutamine,CC(CCC1=CC=C(C=C1)O)NCCC2=CC(=C(C=C2)O)O
CID000003883,lansoprazole,CC1=C(C=CN=C1CS(=O)C2=NC3=CC=CC=C3N2)OCC(F)(F)F,hyperalimentation,CID000004745,SCHEMBL7711911,CCCN1CC(CC2C1CC3=CNC4=CC=CC2=C34)CSC
CID000003883,lansoprazole,CC1=C(C=CN=C1CS(=O)C2=NC3=CC=CC=C3N2)OCC(F)(F)F,Atherosclerosis,CID000012536,638-94-8,CC1(OC2CC3C4CCC5=CC(=O)C=CC5(C4C(CC3(C2(O1)C(=O)CO)C)O)C)C
CID000003883,lansoprazole,CC1=C(C=CN=C1CS(=O)C2=NC3=CC=CC=C3N2)OCC(F)(F)F,Adenopathy,CID000004666,7-Epi Paclitaxel,CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C
CID000003883,lansoprazole,CC1=C(C=CN=C1CS(=O)C2=NC3=CC=CC=C3N2)OCC(F)(F)F,Alcoholic intoxication,CID000005584,trimipramine,CC(CN1C2=CC=CC=C2CCC3=CC=CC=C31)CN(C)C
CID000003883,lansoprazole,CC1=C(C=CN=C1CS(=O)C2=NC3=CC=CC=C3N2)OCC(F)(F)F,apoplexy,CID000004189,miconazole,C1=CC(=C(C=C1Cl)Cl)COC(CN2C=CN=C2)C3=C(C=C(C=C3)Cl)Cl
CID000003883,lansoprazole,CC1=C(C=CN=C1CS(=O)C2=NC3=CC=CC=C3N2)OCC(F)(F)F,cholecystitis,CID000004510,nitroglycerin,C(C(CO[N+](=O)[O-])O[N+](=O)[O-])O[N+](=O)[O-]
CID000003883,lansoprazole,CC1=C(C=CN=C1CS(=O)C2=NC3=CC=CC=C3N2)OCC(F)(F)F,adenomyosis,CID000004920,"1-acetyl-9a,11a-dimethyl-1H,2H,3H,3aH,3bH,4H,5H,7H,8H,9H,9aH,9bH,10H,11H,11aH-cyclopenta[a]phenanthren-7-one",CC(=O)C1CCC2C1(CCC3C2CCC4=CC(=O)CCC34C)C
CID000003883,lansoprazole,CC1=C(C=CN=C1CS(=O)C2=NC3=CC=CC=C3N2)OCC(F)(F)F,Adenopathy,CID000004927,promethazine,CC(CN1C2=CC=CC=C2SC3=CC=CC=C31)N(C)C
CID000003883,lansoprazole,CC1=C(C=CN=C1CS(=O)C2=NC3=CC=CC=C3N2)OCC(F)(F)F,cholecystitis,CID000060854,Ziprasidone,C1CN(CCN1CCC2=C(C=C3C(=C2)CC(=O)N3)Cl)C4=NSC5=CC=CC=C54
CID000003883,lansoprazole,CC1=C(C=CN=C1CS(=O)C2=NC3=CC=CC=C3N2)OCC(F)(F)F,gastric inflammation,CID000004691,"3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine",C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4
CID000003883,lansoprazole,CC1=C(C=CN=C1CS(=O)C2=NC3=CC=CC=C3N2)OCC(F)(F)F,thrombocytopenia,CID005311082,"2-[(1R,4S,10S,13S,19S)-19-[4-(diaminomethylideneamino)butyl]-10-(1H-indol-3-ylmethyl)-3,9,12,15,18,21,27-heptaoxo-24,25-dithia-2,8,11,14,17,20-hexazatricyclo[18.6.1.04,8]heptacosan-13-yl]acetic acid",C1CC2C(=O)NC3CSSCCC(=O)N(C3=O)C(C(=O)NCC(=O)NC(C(=O)NC(C(=O)N2C1)CC4=CNC5=CC=CC=C54)CC(=O)O)CCCCN=C(N)N
CID000003883,lansoprazole,CC1=C(C=CN=C1CS(=O)C2=NC3=CC=CC=C3N2)OCC(F)(F)F,Adenopathy,CID000019090,megestrol,CC1=CC2C(CCC3(C2CCC3(C(=O)C)O)C)C4(C1=CC(=O)CC4)C
CID000003883,lansoprazole,CC1=C(C=CN=C1CS(=O)C2=NC3=CC=CC=C3N2)OCC(F)(F)F,diarrhea,CID000125017,Desvenlafaxine,CN(C)CC(C1=CC=C(C=C1)O)C2(CCCCC2)O
CID000003883,lansoprazole,CC1=C(C=CN=C1CS(=O)C2=NC3=CC=CC=C3N2)OCC(F)(F)F,loss of weight,CID000131536,Fosamprenavir,CC(C)CN(CC(C(CC1=CC=CC=C1)NC(=O)OC2CCOC2)OP(=O)(O)O)S(=O)(=O)C3=CC=C(C=C3)N
CID000003883,lansoprazole,CC1=C(C=CN=C1CS(=O)C2=NC3=CC=CC=C3N2)OCC(F)(F)F,apoplexy,CID000048175,"[(6S,9R,16S,17R)-17-(2-chloroacetyl)-6,9-difluoro-11-hydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl] propanoate",CCC(=O)OC1(C(CC2C1(CC(C3(C2CC(C4=CC(=O)C=CC43C)F)F)O)C)C)C(=O)CCl
CID000003883,lansoprazole,CC1=C(C=CN=C1CS(=O)C2=NC3=CC=CC=C3N2)OCC(F)(F)F,back injury,CID000170361,Varenicline,C1C2CNCC1C3=CC4=NC=CN=C4C=C23
CID000003883,lansoprazole,CC1=C(C=CN=C1CS(=O)C2=NC3=CC=CC=C3N2)OCC(F)(F)F,abnormal ECG,CID000071329,Dofetilide,CN(CCC1=CC=C(C=C1)NS(=O)(=O)C)CCOC2=CC=C(C=C2)NS(=O)(=O)C
CID000003883,lansoprazole,CC1=C(C=CN=C1CS(=O)C2=NC3=CC=CC=C3N2)OCC(F)(F)F,cholelithiasis,CID000147912,DSSTox_GSID_49066,CCC(C(C)O)N1C(=O)N(C=N1)C2=CC=C(C=C2)N3CCN(CC3)C4=CC=C(C=C4)OCC5CC(OC5)(CN6C=NC=N6)C7=C(C=C(C=C7)F)F
CID000003883,lansoprazole,CC1=C(C=CN=C1CS(=O)C2=NC3=CC=CC=C3N2)OCC(F)(F)F,gastric inflammation,CID000005352,38194-50-2,CC1=C(C2=C(C1=CC3=CC=C(C=C3)S(=O)C)C=CC(=C2)F)CC(=O)O
CID000003883,lansoprazole,CC1=C(C=CN=C1CS(=O)C2=NC3=CC=CC=C3N2)OCC(F)(F)F,cholecystitis,CID000005358,sumatriptan,CNS(=O)(=O)CC1=CC2=C(C=C1)NC=C2CCN(C)C
CID000003883,lansoprazole,CC1=C(C=CN=C1CS(=O)C2=NC3=CC=CC=C3N2)OCC(F)(F)F,loss of weight,CID000115237,Paliperidone,CC1=C(C(=O)N2CCCC(C2=N1)O)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F
CID000003883,lansoprazole,CC1=C(C=CN=C1CS(=O)C2=NC3=CC=CC=C3N2)OCC(F)(F)F,alopecia,CID000005095,ropinirole,CCCN(CCC)CCC1=C2CC(=O)NC2=CC=C1
CID000003883,lansoprazole,CC1=C(C=CN=C1CS(=O)C2=NC3=CC=CC=C3N2)OCC(F)(F)F,thrombocytopenia,CID000074989,ATOVAQUONE,C1CC(CCC1C2=CC=C(C=C2)Cl)C3=C(C4=CC=CC=C4C(=O)C3=O)O
CID000003883,lansoprazole,CC1=C(C=CN=C1CS(=O)C2=NC3=CC=CC=C3N2)OCC(F)(F)F,Adenopathy,CID000003954,loperamide(1+),CN(C)C(=O)C(CC[NH+]1CCC(CC1)(C2=CC=C(C=C2)Cl)O)(C3=CC=CC=C3)C4=CC=CC=C4
CID000003883,lansoprazole,CC1=C(C=CN=C1CS(=O)C2=NC3=CC=CC=C3N2)OCC(F)(F)F,cholecystitis,CID000004158,methylphenidate,COC(=O)C(C1CCCCN1)C2=CC=CC=C2
CID000003883,lansoprazole,CC1=C(C=CN=C1CS(=O)C2=NC3=CC=CC=C3N2)OCC(F)(F)F,insulin dependent diabetes mellitus,CID000004748,perphenazine,C1CN(CCN1CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)Cl)CCO
CID000004927,promethazine,CC(CN1C2=CC=CC=C2SC3=CC=CC=C31)N(C)C,haemorrhage rectum,CID000005487,tizanidine,C1CN=C(N1)NC2=C(C=CC3=NSN=C32)Cl
CID000004927,promethazine,CC(CN1C2=CC=CC=C2SC3=CC=CC=C31)N(C)C,enlarged liver,CID000131536,Fosamprenavir,CC(C)CN(CC(C(CC1=CC=CC=C1)NC(=O)OC2CCOC2)OP(=O)(O)O)S(=O)(=O)C3=CC=C(C=C3)N
CID000004927,promethazine,CC(CN1C2=CC=CC=C2SC3=CC=CC=C31)N(C)C,Adenopathy,CID000005719,zaleplon,CCN(C1=CC=CC(=C1)C2=CC=NC3=C(C=NN23)C#N)C(=O)C
CID000004927,promethazine,CC(CN1C2=CC=CC=C2SC3=CC=CC=C31)N(C)C,Back Ache,CID000005245,Risedronic acid,C1=CC(=CN=C1)CC(O)(P(=O)(O)O)P(=O)(O)O
CID000004927,promethazine,CC(CN1C2=CC=CC=C2SC3=CC=CC=C31)N(C)C,cholecystitis,CID003468412,SCHEMBL1176571,CC1C=CC=CCCC=CC=CC=CC=CC(CC(C(C(CC(=O)CC(C(CCC(CC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)C(=O)O)O)OC2C(C(C(C(O2)C)O)N)O
CID000004927,promethazine,CC(CN1C2=CC=CC=C2SC3=CC=CC=C31)N(C)C,cholecystitis,CID000005152,Salmeterol,C1=CC=C(C=C1)CCCCOCCCCCCNCC(C2=CC(=C(C=C2)O)CO)O
CID000004927,promethazine,CC(CN1C2=CC=CC=C2SC3=CC=CC=C31)N(C)C,abnormal ECG,CID000060854,Ziprasidone,C1CN(CCN1CCC2=C(C=C3C(=C2)CC(=O)N3)Cl)C4=NSC5=CC=CC=C54
CID000004927,promethazine,CC(CN1C2=CC=CC=C2SC3=CC=CC=C31)N(C)C,right heart failure,CID005311082,"2-[(1R,4S,10S,13S,19S)-19-[4-(diaminomethylideneamino)butyl]-10-(1H-indol-3-ylmethyl)-3,9,12,15,18,21,27-heptaoxo-24,25-dithia-2,8,11,14,17,20-hexazatricyclo[18.6.1.04,8]heptacosan-13-yl]acetic acid",C1CC2C(=O)NC3CSSCCC(=O)N(C3=O)C(C(=O)NCC(=O)NC(C(=O)NC(C(=O)N2C1)CC4=CNC5=CC=CC=C54)CC(=O)O)CCCCN=C(N)N
CID000004927,promethazine,CC(CN1C2=CC=CC=C2SC3=CC=CC=C31)N(C)C,dysarthria,CID000005394,temozolomide,CN1C(=O)N2C=NC(=C2N=N1)C(=O)N
CID000004927,promethazine,CC(CN1C2=CC=CC=C2SC3=CC=CC=C31)N(C)C,allergic dermatitis,CID000005478,racemic-Timolol,CC(C)(C)NCC(COC1=NSN=C1N2CCOCC2)O
CID000004927,promethazine,CC(CN1C2=CC=CC=C2SC3=CC=CC=C31)N(C)C,gastric inflammation,CID000005732,zolpidem,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C
CID000004927,promethazine,CC(CN1C2=CC=CC=C2SC3=CC=CC=C31)N(C)C,Bleeding,CID000163742,SCHEMBL1650579,COC1C(C(C(C(O1)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)COS(=O)(=O)O)OC4C(C(C(C(O4)C(=O)O)OC5C(C(C(C(O5)COS(=O)(=O)O)O)O)NS(=O)(=O)O)O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O)NS(=O)(=O)O
CID000004927,promethazine,CC(CN1C2=CC=CC=C2SC3=CC=CC=C31)N(C)C,back injury,CID006398525,,C(C1C(C(C(C(O1)OC2(C(C(C(O2)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)COS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.[Al].[Al].[Al].[Al].[Al].[Al].[Al].[Al].[Al]
CID000004927,promethazine,CC(CN1C2=CC=CC=C2SC3=CC=CC=C31)N(C)C,gastric inflammation,CID000005073,risperidone,CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F
CID000004927,promethazine,CC(CN1C2=CC=CC=C2SC3=CC=CC=C31)N(C)C,eruption,CID000060852,Ibandronic Acid,CCCCCN(C)CCC(O)(P(=O)(O)O)P(=O)(O)O
CID000004927,promethazine,CC(CN1C2=CC=CC=C2SC3=CC=CC=C31)N(C)C,erythema,CID000019090,megestrol,CC1=CC2C(CCC3(C2CCC3(C(=O)C)O)C)C4(C1=CC(=O)CC4)C
CID000004927,promethazine,CC(CN1C2=CC=CC=C2SC3=CC=CC=C31)N(C)C,neumonia,CID000074989,ATOVAQUONE,C1CC(CCC1C2=CC=C(C=C2)Cl)C3=C(C4=CC=CC=C4C(=O)C3=O)O
CID000004927,promethazine,CC(CN1C2=CC=CC=C2SC3=CC=CC=C31)N(C)C,Adenopathy,CID000170361,Varenicline,C1C2CNCC1C3=CC4=NC=CN=C4C=C23
CID000004927,promethazine,CC(CN1C2=CC=CC=C2SC3=CC=CC=C31)N(C)C,gastric inflammation,CID000060865,(E)-Olopatadine,CN(C)CCC=C1C2=CC=CC=C2COC3=C1C=C(C=C3)CC(=O)O
CID000004927,promethazine,CC(CN1C2=CC=CC=C2SC3=CC=CC=C31)N(C)C,cholecystitis,CID000005512,124936-74-9,CC1=CC(=C(C=C1)O)C(CCN(C(C)C)C(C)C)C2=CC=CC=C2
CID000004927,promethazine,CC(CN1C2=CC=CC=C2SC3=CC=CC=C31)N(C)C,Aching joints,CID005493444,Aliskiren,CC(C)C(CC1=CC(=C(C=C1)OC)OCCCOC)CC(C(CC(C(C)C)C(=O)NCC(C)(C)C(=O)N)O)N
CID000004927,promethazine,CC(CN1C2=CC=CC=C2SC3=CC=CC=C31)N(C)C,eruption,CID000667490,6-Mercaptopurine,C1=NC2=C(N1)C(=S)N=CN2
CID000004927,promethazine,CC(CN1C2=CC=CC=C2SC3=CC=CC=C31)N(C)C,Acne,CID000005544,Mycolog,CC12CC(C3(C(C1CC(C2(C(=O)CO)O)O)CCC4=CC(=O)C=CC43C)F)O
CID000004927,promethazine,CC(CN1C2=CC=CC=C2SC3=CC=CC=C31)N(C)C,diarrhea infectious,CID000012536,638-94-8,CC1(OC2CC3C4CCC5=CC(=O)C=CC5(C4C(CC3(C2(O1)C(=O)CO)C)O)C)C
CID000004927,promethazine,CC(CN1C2=CC=CC=C2SC3=CC=CC=C31)N(C)C,constipated,CID000005352,38194-50-2,CC1=C(C2=C(C1=CC3=CC=C(C=C3)S(=O)C)C=CC(=C2)F)CC(=O)O
CID000004927,promethazine,CC(CN1C2=CC=CC=C2SC3=CC=CC=C31)N(C)C,drug withdrawal,CID000005358,sumatriptan,CNS(=O)(=O)CC1=CC2=C(C=C1)NC=C2CCN(C)C
CID000004927,promethazine,CC(CN1C2=CC=CC=C2SC3=CC=CC=C31)N(C)C,erythema,CID000005095,ropinirole,CCCN(CCC)CCC1=C2CC(=O)NC2=CC=C1
CID000004927,promethazine,CC(CN1C2=CC=CC=C2SC3=CC=CC=C31)N(C)C,Paraesthesia,CID000060787,sequinavir,CC(C)(C)NC(=O)C1CC2CCCCC2CN1CC(C(CC3=CC=CC=C3)NC(=O)C(CC(=O)N)NC(=O)C4=NC5=CC=CC=C5C=C4)O
CID000002732,chlorthalidone,C1=CC=C2C(=C1)C(=O)NC2(C3=CC(=C(C=C3)Cl)S(=O)(=O)N)O,apoplexy,CID000004585,"2-methyl-4-(4-methylpiperazin-1-yl)-5H-thieno[3,2-c][1,5]benzodiazepine",CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C
CID000002732,chlorthalidone,C1=CC=C2C(=C1)C(=O)NC2(C3=CC(=C(C=C3)Cl)S(=O)(=O)N)O,Acne,CID000002771,citalopram,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F
CID000002732,chlorthalidone,C1=CC=C2C(=C1)C(=O)NC2(C3=CC(=C(C=C3)Cl)S(=O)(=O)N)O,Acne,CID000005245,Risedronic acid,C1=CC(=CN=C1)CC(O)(P(=O)(O)O)P(=O)(O)O
CID000002732,chlorthalidone,C1=CC=C2C(=C1)C(=O)NC2(C3=CC(=C(C=C3)Cl)S(=O)(=O)N)O,loss of weight,CID000003749,irbesartan,CCCCC1=NC2(CCCC2)C(=O)N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5
CID000002732,chlorthalidone,C1=CC=C2C(=C1)C(=O)NC2(C3=CC(=C(C=C3)Cl)S(=O)(=O)N)O,loss of weight,CID000004691,"3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine",C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4
CID000002732,chlorthalidone,C1=CC=C2C(=C1)C(=O)NC2(C3=CC(=C(C=C3)Cl)S(=O)(=O)N)O,apoplexy,CID000003333,felodipine,CCOC(=O)C1=C(NC(=C(C1C2=C(C(=CC=C2)Cl)Cl)C(=O)OC)C)C
CID000002732,chlorthalidone,C1=CC=C2C(=C1)C(=O)NC2(C3=CC(=C(C=C3)Cl)S(=O)(=O)N)O,apoplexy,CID000003676,lidocaine,CCN(CC)CC(=O)NC1=C(C=CC=C1C)C
CID000002732,chlorthalidone,C1=CC=C2C(=C1)C(=O)NC2(C3=CC(=C(C=C3)Cl)S(=O)(=O)N)O,apoplexy,CID000004900,Fernisone,CC12CC(=O)C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C
CID000002732,chlorthalidone,C1=CC=C2C(=C1)C(=O)NC2(C3=CC(=C(C=C3)Cl)S(=O)(=O)N)O,apoplexy,CID000003440,furosemide,C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl
CID000002732,chlorthalidone,C1=CC=C2C(=C1)C(=O)NC2(C3=CC(=C(C=C3)Cl)S(=O)(=O)N)O,Infection Upper Respiratory,CID000003937,N~2~-(1-carboxy-3-phenylpropyl)lysylproline,C1CC(N(C1)C(=O)C(CCCCN)NC(CCC2=CC=CC=C2)C(=O)O)C(=O)O
CID000002732,chlorthalidone,C1=CC=C2C(=C1)C(=O)NC2(C3=CC(=C(C=C3)Cl)S(=O)(=O)N)O,drug toxicity NOS,CID000003062,Lanicor,CC1C(C(CC(O1)OC2C(OC(CC2O)OC3C(OC(CC3O)OC4CCC5(C(C4)CCC6C5CC(C7(C6(CCC7C8=CC(=O)OC8)O)C)O)C)C)C)O)O
CID000002732,chlorthalidone,C1=CC=C2C(=C1)C(=O)NC2(C3=CC(=C(C=C3)Cl)S(=O)(=O)N)O,apoplexy,CID000005512,124936-74-9,CC1=CC(=C(C=C1)O)C(CCN(C(C)C)C(C)C)C2=CC=CC=C2
CID000002732,chlorthalidone,C1=CC=C2C(=C1)C(=O)NC2(C3=CC(=C(C=C3)Cl)S(=O)(=O)N)O,Ekbom Syndrome,CID000003961,losartan,CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)CO)Cl
CID000002732,chlorthalidone,C1=CC=C2C(=C1)C(=O)NC2(C3=CC(=C(C=C3)Cl)S(=O)(=O)N)O,apoplexy,CID000005073,risperidone,CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F
CID000002732,chlorthalidone,C1=CC=C2C(=C1)C(=O)NC2(C3=CC(=C(C=C3)Cl)S(=O)(=O)N)O,High blood pressure,CID000003516,guaifenesin,COC1=CC=CC=C1OCC(CO)O
CID000002732,chlorthalidone,C1=CC=C2C(=C1)C(=O)NC2(C3=CC(=C(C=C3)Cl)S(=O)(=O)N)O,Chronic Kidney Disease,CID000004510,nitroglycerin,C(C(CO[N+](=O)[O-])O[N+](=O)[O-])O[N+](=O)[O-]
CID000002732,chlorthalidone,C1=CC=C2C(=C1)C(=O)NC2(C3=CC(=C(C=C3)Cl)S(=O)(=O)N)O,apoplexy,CID000004236,modafinil,C1=CC=C(C=C1)C(C2=CC=CC=C2)S(=O)CC(=O)N
CID000002732,chlorthalidone,C1=CC=C2C(=C1)C(=O)NC2(C3=CC(=C(C=C3)Cl)S(=O)(=O)N)O,cholelithiasis,CID000004889,Pravastatin Impurity A,CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC(CC(CC(=O)O)O)O)O
CID000002732,chlorthalidone,C1=CC=C2C(=C1)C(=O)NC2(C3=CC(=C(C=C3)Cl)S(=O)(=O)N)O,apoplexy,CID000003780,"D-Glucitol, 1,4:3,6-dianhydro-, 2,5-dinitrate",C1C(C2C(O1)C(CO2)O[N+](=O)[O-])O[N+](=O)[O-]
CID000002732,chlorthalidone,C1=CC=C2C(=C1)C(=O)NC2(C3=CC(=C(C=C3)Cl)S(=O)(=O)N)O,apoplexy,CID000005732,zolpidem,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C
CID000002732,chlorthalidone,C1=CC=C2C(=C1)C(=O)NC2(C3=CC(=C(C=C3)Cl)S(=O)(=O)N)O,elevated cholesterol,CID000003339,fenofibrate,CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C2=CC=C(C=C2)Cl
CID000002732,chlorthalidone,C1=CC=C2C(=C1)C(=O)NC2(C3=CC(=C(C=C3)Cl)S(=O)(=O)N)O,apoplexy,CID000005487,tizanidine,C1CN=C(N1)NC2=C(C=CC3=NSN=C32)Cl
CID000002732,chlorthalidone,C1=CC=C2C(=C1)C(=O)NC2(C3=CC(=C(C=C3)Cl)S(=O)(=O)N)O,glaucoma,CID000003405,2-[[4-[(2-amino-4-oxo-1H-pteridin-6-yl)methylamino]benzoyl]amino]pentanedioic acid,C1=CC(=CC=C1C(=O)NC(CCC(=O)O)C(=O)O)NCC2=CN=C3C(=N2)C(=O)N=C(N3)N
CID000003198,econazole,C1=CC(=CC=C1COC(CN2C=CN=C2)C3=C(C=C(C=C3)Cl)Cl)Cl,angiitis,CID000003937,N~2~-(1-carboxy-3-phenylpropyl)lysylproline,C1CC(N(C1)C(=O)C(CCCCN)NC(CCC2=CC=CC=C2)C(=O)O)C(=O)O
CID000003198,econazole,C1=CC(=CC=C1COC(CN2C=CN=C2)C3=C(C=C(C=C3)Cl)Cl)Cl,angiitis,CID000003440,furosemide,C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl
CID000003198,econazole,C1=CC(=CC=C1COC(CN2C=CN=C2)C3=C(C=C(C=C3)Cl)Cl)Cl,angiitis,CID000003890,TRANS (15S)-LATANOPROST,CC(C)OC(=O)CCCC=CCC1C(CC(C1CCC(CCC2=CC=CC=C2)O)O)O
CID000003198,econazole,C1=CC(=CC=C1COC(CN2C=CN=C2)C3=C(C=C(C=C3)Cl)Cl)Cl,Adenopathy,CID000003405,2-[[4-[(2-amino-4-oxo-1H-pteridin-6-yl)methylamino]benzoyl]amino]pentanedioic acid,C1=CC(=CC=C1C(=O)NC(CCC(=O)O)C(=O)O)NCC2=CN=C3C(=N2)C(=O)N=C(N3)N
CID000003198,econazole,C1=CC(=CC=C1COC(CN2C=CN=C2)C3=C(C=C(C=C3)Cl)Cl)Cl,elevated cholesterol,CID000004691,"3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine",C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4
CID000003198,econazole,C1=CC(=CC=C1COC(CN2C=CN=C2)C3=C(C=C(C=C3)Cl)Cl)Cl,atelectasis,CID000003954,loperamide(1+),CN(C)C(=O)C(CC[NH+]1CCC(CC1)(C2=CC=C(C=C2)Cl)O)(C3=CC=CC=C3)C4=CC=CC=C4
CID000003198,econazole,C1=CC(=CC=C1COC(CN2C=CN=C2)C3=C(C=C(C=C3)Cl)Cl)Cl,apoplexy,CID000005073,risperidone,CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F
CID000003198,econazole,C1=CC(=CC=C1COC(CN2C=CN=C2)C3=C(C=C(C=C3)Cl)Cl)Cl,angiitis,CID000003961,losartan,CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)CO)Cl
CID000003198,econazole,C1=CC(=CC=C1COC(CN2C=CN=C2)C3=C(C=C(C=C3)Cl)Cl)Cl,Multiple Myeloma,CID000005732,zolpidem,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C
CID000003890,TRANS (15S)-LATANOPROST,CC(C)OC(=O)CCCC=CCC1C(CC(C1CCC(CCC2=CC=CC=C2)O)O)O,gastric inflammation,CID000019090,megestrol,CC1=CC2C(CCC3(C2CCC3(C(=O)C)O)C)C4(C1=CC(=O)CC4)C
CID000003890,TRANS (15S)-LATANOPROST,CC(C)OC(=O)CCCC=CCC1C(CC(C1CCC(CCC2=CC=CC=C2)O)O)O,erythema,CID000005512,124936-74-9,CC1=CC(=C(C=C1)O)C(CCN(C(C)C)C(C)C)C2=CC=CC=C2
CID000003890,TRANS (15S)-LATANOPROST,CC(C)OC(=O)CCCC=CCC1C(CC(C1CCC(CCC2=CC=CC=C2)O)O)O,Back Ache,CID000003937,N~2~-(1-carboxy-3-phenylpropyl)lysylproline,C1CC(N(C1)C(=O)C(CCCCN)NC(CCC2=CC=CC=C2)C(=O)O)C(=O)O
CID000003890,TRANS (15S)-LATANOPROST,CC(C)OC(=O)CCCC=CCC1C(CC(C1CCC(CCC2=CC=CC=C2)O)O)O,ear infection,CID000005732,zolpidem,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C
CID000003890,TRANS (15S)-LATANOPROST,CC(C)OC(=O)CCCC=CCC1C(CC(C1CCC(CCC2=CC=CC=C2)O)O)O,abnormal movements,CID000057537,92206-54-7,CCCN(CCC1=CC=CS1)C2CCC3=C(C2)C=CC=C3O
CID000003890,TRANS (15S)-LATANOPROST,CC(C)OC(=O)CCCC=CCC1C(CC(C1CCC(CCC2=CC=CC=C2)O)O)O,loss of weight,CID000005152,Salmeterol,C1=CC=C(C=C1)CCCCOCCCCCCNCC(C2=CC(=C(C=C2)O)CO)O
CID000003890,TRANS (15S)-LATANOPROST,CC(C)OC(=O)CCCC=CCC1C(CC(C1CCC(CCC2=CC=CC=C2)O)O)O,erythema,CID000004510,nitroglycerin,C(C(CO[N+](=O)[O-])O[N+](=O)[O-])O[N+](=O)[O-]
CID000003890,TRANS (15S)-LATANOPROST,CC(C)OC(=O)CCCC=CCC1C(CC(C1CCC(CCC2=CC=CC=C2)O)O)O,cholecystitis,CID000003961,losartan,CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)CO)Cl
CID000003890,TRANS (15S)-LATANOPROST,CC(C)OC(=O)CCCC=CCC1C(CC(C1CCC(CCC2=CC=CC=C2)O)O)O,Adenopathy,CID000005478,racemic-Timolol,CC(C)(C)NCC(COC1=NSN=C1N2CCOCC2)O
CID000003890,TRANS (15S)-LATANOPROST,CC(C)OC(=O)CCCC=CCC1C(CC(C1CCC(CCC2=CC=CC=C2)O)O)O,loss of weight,CID000004666,7-Epi Paclitaxel,CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C
CID000003890,TRANS (15S)-LATANOPROST,CC(C)OC(=O)CCCC=CCC1C(CC(C1CCC(CCC2=CC=CC=C2)O)O)O,increased white blood cell count,CID000004201,minoxidil,C1CCN(CC1)C2=NC(=N)N(C(=C2)N)O
CID000003890,TRANS (15S)-LATANOPROST,CC(C)OC(=O)CCCC=CCC1C(CC(C1CCC(CCC2=CC=CC=C2)O)O)O,erythema,CID000004819,"2(3H)-Furanone, 3-ethyldihydro-4-[(1-methyl-1H-imidazol-5-yl)methyl]-, (3S-cis)-",CCC1C(COC1=O)CC2=CN=CN2C
CID000003890,TRANS (15S)-LATANOPROST,CC(C)OC(=O)CCCC=CCC1C(CC(C1CCC(CCC2=CC=CC=C2)O)O)O,angiitis,CID000005544,Mycolog,CC12CC(C3(C(C1CC(C2(C(=O)CO)O)O)CCC4=CC(=O)C=CC43C)F)O
CID000003890,TRANS (15S)-LATANOPROST,CC(C)OC(=O)CCCC=CCC1C(CC(C1CCC(CCC2=CC=CC=C2)O)O)O,loss of weight,CID000004894,"11,17,21-Trihydroxypregna-1,4-diene-3,20-dione",CC12CC(C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C)O
CID000003890,TRANS (15S)-LATANOPROST,CC(C)OC(=O)CCCC=CCC1C(CC(C1CCC(CCC2=CC=CC=C2)O)O)O,edema,CID000071329,Dofetilide,CN(CCC1=CC=C(C=C1)NS(=O)(=O)C)CCOC2=CC=C(C=C2)NS(=O)(=O)C
CID000003890,TRANS (15S)-LATANOPROST,CC(C)OC(=O)CCCC=CCC1C(CC(C1CCC(CCC2=CC=CC=C2)O)O)O,cholecystitis,CID000005245,Risedronic acid,C1=CC(=CN=C1)CC(O)(P(=O)(O)O)P(=O)(O)O
CID000003890,TRANS (15S)-LATANOPROST,CC(C)OC(=O)CCCC=CCC1C(CC(C1CCC(CCC2=CC=CC=C2)O)O)O,Neuralgia,CID000004236,modafinil,C1=CC=C(C=C1)C(C2=CC=CC=C2)S(=O)CC(=O)N
CID000003890,TRANS (15S)-LATANOPROST,CC(C)OC(=O)CCCC=CCC1C(CC(C1CCC(CCC2=CC=CC=C2)O)O)O,dysarthria,CID000004909,primidone,CCC1(C(=O)NCNC1=O)C2=CC=CC=C2
CID000003890,TRANS (15S)-LATANOPROST,CC(C)OC(=O)CCCC=CCC1C(CC(C1CCC(CCC2=CC=CC=C2)O)O)O,gastric inflammation,CID000004900,Fernisone,CC12CC(=O)C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C
CID000003890,TRANS (15S)-LATANOPROST,CC(C)OC(=O)CCCC=CCC1C(CC(C1CCC(CCC2=CC=CC=C2)O)O)O,apoplexy,CID000005358,sumatriptan,CNS(=O)(=O)CC1=CC2=C(C=C1)NC=C2CCN(C)C
CID000003890,TRANS (15S)-LATANOPROST,CC(C)OC(=O)CCCC=CCC1C(CC(C1CCC(CCC2=CC=CC=C2)O)O)O,Back Ache,CID000004585,"2-methyl-4-(4-methylpiperazin-1-yl)-5H-thieno[3,2-c][1,5]benzodiazepine",CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C
CID000003890,TRANS (15S)-LATANOPROST,CC(C)OC(=O)CCCC=CCC1C(CC(C1CCC(CCC2=CC=CC=C2)O)O)O,weight gain,CID000004158,methylphenidate,COC(=O)C(C1CCCCN1)C2=CC=CC=C2
CID000003890,TRANS (15S)-LATANOPROST,CC(C)OC(=O)CCCC=CCC1C(CC(C1CCC(CCC2=CC=CC=C2)O)O)O,loss of weight,CID000060865,(E)-Olopatadine,CN(C)CCC=C1C2=CC=CC=C2COC3=C1C=C(C=C3)CC(=O)O
CID000003890,TRANS (15S)-LATANOPROST,CC(C)OC(=O)CCCC=CCC1C(CC(C1CCC(CCC2=CC=CC=C2)O)O)O,abnormal movements,CID000005095,ropinirole,CCCN(CCC)CCC1=C2CC(=O)NC2=CC=C1
CID000003890,TRANS (15S)-LATANOPROST,CC(C)OC(=O)CCCC=CCC1C(CC(C1CCC(CCC2=CC=CC=C2)O)O)O,Bacteraemia,CID000004075,5-Aminosalicylic acid,C1=CC(=C(C=C1N)C(=O)O)O
CID000003890,TRANS (15S)-LATANOPROST,CC(C)OC(=O)CCCC=CCC1C(CC(C1CCC(CCC2=CC=CC=C2)O)O)O,gastric inflammation,CID000004205,mirtazapine,CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4
CID000003890,TRANS (15S)-LATANOPROST,CC(C)OC(=O)CCCC=CCC1C(CC(C1CCC(CCC2=CC=CC=C2)O)O)O,Adenopathy,CID003468412,SCHEMBL1176571,CC1C=CC=CCCC=CC=CC=CC=CC(CC(C(C(CC(=O)CC(C(CCC(CC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)C(=O)O)O)OC2C(C(C(C(O2)C)O)N)O
CID000003890,TRANS (15S)-LATANOPROST,CC(C)OC(=O)CCCC=CCC1C(CC(C1CCC(CCC2=CC=CC=C2)O)O)O,erythema,CID000004691,"3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine",C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4
CID000003890,TRANS (15S)-LATANOPROST,CC(C)OC(=O)CCCC=CCC1C(CC(C1CCC(CCC2=CC=CC=C2)O)O)O,aptyalism,CID000060852,Ibandronic Acid,CCCCCN(C)CCC(O)(P(=O)(O)O)P(=O)(O)O
CID000003890,TRANS (15S)-LATANOPROST,CC(C)OC(=O)CCCC=CCC1C(CC(C1CCC(CCC2=CC=CC=C2)O)O)O,atelectasis,CID000003954,loperamide(1+),CN(C)C(=O)C(CC[NH+]1CCC(CC1)(C2=CC=C(C=C2)Cl)O)(C3=CC=CC=C3)C4=CC=CC=C4
CID000003890,TRANS (15S)-LATANOPROST,CC(C)OC(=O)CCCC=CCC1C(CC(C1CCC(CCC2=CC=CC=C2)O)O)O,weight gain,CID000170361,Varenicline,C1C2CNCC1C3=CC4=NC=CN=C4C=C23
CID000003890,TRANS (15S)-LATANOPROST,CC(C)OC(=O)CCCC=CCC1C(CC(C1CCC(CCC2=CC=CC=C2)O)O)O,Bleeding,CID000004920,"1-acetyl-9a,11a-dimethyl-1H,2H,3H,3aH,3bH,4H,5H,7H,8H,9H,9aH,9bH,10H,11H,11aH-cyclopenta[a]phenanthren-7-one",CC(=O)C1CCC2C1(CCC3C2CCC4=CC(=O)CCC34C)C
CID000003890,TRANS (15S)-LATANOPROST,CC(C)OC(=O)CCCC=CCC1C(CC(C1CCC(CCC2=CC=CC=C2)O)O)O,angina,CID000060184,"2'-epi-Perindopril, (2'R)-",CCCC(C(=O)OCC)NC(C)C(=O)N1C2CCCCC2CC1C(=O)O
CID000003890,TRANS (15S)-LATANOPROST,CC(C)OC(=O)CCCC=CCC1C(CC(C1CCC(CCC2=CC=CC=C2)O)O)O,loss of weight,CID000004170,metolazone,CC1NC2=CC(=C(C=C2C(=O)N1C3=CC=CC=C3C)S(=O)(=O)N)Cl
CID000003890,TRANS (15S)-LATANOPROST,CC(C)OC(=O)CCCC=CCC1C(CC(C1CCC(CCC2=CC=CC=C2)O)O)O,apoplexy,CID000005073,risperidone,CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F
CID000003890,TRANS (15S)-LATANOPROST,CC(C)OC(=O)CCCC=CCC1C(CC(C1CCC(CCC2=CC=CC=C2)O)O)O,loss of weight,CID000004173,metronidazole,CC1=NC=C(N1CCO)[N+](=O)[O-]
CID000003890,TRANS (15S)-LATANOPROST,CC(C)OC(=O)CCCC=CCC1C(CC(C1CCC(CCC2=CC=CC=C2)O)O)O,angiitis,CID006398525,,C(C1C(C(C(C(O1)OC2(C(C(C(O2)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)COS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.[Al].[Al].[Al].[Al].[Al].[Al].[Al].[Al].[Al]
CID000003890,TRANS (15S)-LATANOPROST,CC(C)OC(=O)CCCC=CCC1C(CC(C1CCC(CCC2=CC=CC=C2)O)O)O,Back Ache,CID000004889,Pravastatin Impurity A,CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC(CC(CC(=O)O)O)O)O
CID000002646,Cefprozil (E)-isomer,CC=CC1=C(N2C(C(C2=O)NC(=O)C(C3=CC=C(C=C3)O)N)SC1)C(=O)O,gastric inflammation,CID000004691,"3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine",C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4
CID000002646,Cefprozil (E)-isomer,CC=CC1=C(N2C(C(C2=O)NC(=O)C(C3=CC=C(C=C3)O)N)SC1)C(=O)O,loss of weight,CID000003405,2-[[4-[(2-amino-4-oxo-1H-pteridin-6-yl)methylamino]benzoyl]amino]pentanedioic acid,C1=CC(=CC=C1C(=O)NC(CCC(=O)O)C(=O)O)NCC2=CN=C3C(=N2)C(=O)N=C(N3)N
CID000002646,Cefprozil (E)-isomer,CC=CC1=C(N2C(C(C2=O)NC(=O)C(C3=CC=C(C=C3)O)N)SC1)C(=O)O,stridor,CID000004158,methylphenidate,COC(=O)C(C1CCCCN1)C2=CC=CC=C2
CID000002646,Cefprozil (E)-isomer,CC=CC1=C(N2C(C(C2=O)NC(=O)C(C3=CC=C(C=C3)O)N)SC1)C(=O)O,eruption,CID000002656,"7-[[2-(2-amino-1,3-thiazol-4-yl)-2-methoxyiminoacetyl]amino]-3-[(2-methyl-6-oxido-5-oxo-1,2,4-triazin-3-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CN1C(=NC(=O)C(=N1)[O-])SCC2=C(N3C(C(C3=O)NC(=O)C(=NOC)C4=CSC(=N4)N)SC2)C(=O)[O-]
CID000002646,Cefprozil (E)-isomer,CC=CC1=C(N2C(C(C2=O)NC(=O)C(C3=CC=C(C=C3)O)N)SC1)C(=O)O,erythema,CID000003928,Lincomycine,CCCC1CC(N(C1)C)C(=O)NC(C2C(C(C(C(O2)SC)O)O)O)C(C)O
CID000002646,Cefprozil (E)-isomer,CC=CC1=C(N2C(C(C2=O)NC(=O)C(C3=CC=C(C=C3)O)N)SC1)C(=O)O,back injury,CID000004900,Fernisone,CC12CC(=O)C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C
CID000002646,Cefprozil (E)-isomer,CC=CC1=C(N2C(C(C2=O)NC(=O)C(C3=CC=C(C=C3)O)N)SC1)C(=O)O,erythema,CID000003062,Lanicor,CC1C(C(CC(O1)OC2C(OC(CC2O)OC3C(OC(CC3O)OC4CCC5(C(C4)CCC6C5CC(C7(C6(CCC7C8=CC(=O)OC8)O)C)O)C)C)C)O)O
CID000002646,Cefprozil (E)-isomer,CC=CC1=C(N2C(C(C2=O)NC(=O)C(C3=CC=C(C=C3)O)N)SC1)C(=O)O,gastric inflammation,CID000002771,citalopram,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F
CID000002646,Cefprozil (E)-isomer,CC=CC1=C(N2C(C(C2=O)NC(=O)C(C3=CC=C(C=C3)O)N)SC1)C(=O)O,erythema,CID000003333,felodipine,CCOC(=O)C1=C(NC(=C(C1C2=C(C(=CC=C2)Cl)Cl)C(=O)OC)C)C
CID000002646,Cefprozil (E)-isomer,CC=CC1=C(N2C(C(C2=O)NC(=O)C(C3=CC=C(C=C3)O)N)SC1)C(=O)O,erythema,CID000004510,nitroglycerin,C(C(CO[N+](=O)[O-])O[N+](=O)[O-])O[N+](=O)[O-]
CID000002646,Cefprozil (E)-isomer,CC=CC1=C(N2C(C(C2=O)NC(=O)C(C3=CC=C(C=C3)O)N)SC1)C(=O)O,Back Ache,CID000003937,N~2~-(1-carboxy-3-phenylpropyl)lysylproline,C1CC(N(C1)C(=O)C(CCCCN)NC(CCC2=CC=CC=C2)C(=O)O)C(=O)O
CID000002646,Cefprozil (E)-isomer,CC=CC1=C(N2C(C(C2=O)NC(=O)C(C3=CC=C(C=C3)O)N)SC1)C(=O)O,erythema,CID000005544,Mycolog,CC12CC(C3(C(C1CC(C2(C(=O)CO)O)O)CCC4=CC(=O)C=CC43C)F)O
CID000002646,Cefprozil (E)-isomer,CC=CC1=C(N2C(C(C2=O)NC(=O)C(C3=CC=C(C=C3)O)N)SC1)C(=O)O,back injury,CID000005732,zolpidem,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C
CID000002646,Cefprozil (E)-isomer,CC=CC1=C(N2C(C(C2=O)NC(=O)C(C3=CC=C(C=C3)O)N)SC1)C(=O)O,dizziness,CID000002713,55-56-1,C1=CC(=CC=C1NC(=NC(=NCCCCCCN=C(N)N=C(N)NC2=CC=C(C=C2)Cl)N)N)Cl
CID000002646,Cefprozil (E)-isomer,CC=CC1=C(N2C(C(C2=O)NC(=O)C(C3=CC=C(C=C3)O)N)SC1)C(=O)O,haemorrhage rectum,CID000003440,furosemide,C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl
CID000002646,Cefprozil (E)-isomer,CC=CC1=C(N2C(C(C2=O)NC(=O)C(C3=CC=C(C=C3)O)N)SC1)C(=O)O,stridor,CID000004894,"11,17,21-Trihydroxypregna-1,4-diene-3,20-dione",CC12CC(C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C)O
CID000003763,isoflurane,C(C(F)(F)F)(OC(F)F)Cl,thrombocytopenia,CID000004691,"3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine",C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4
CID000003763,isoflurane,C(C(F)(F)F)(OC(F)F)Cl,hepatitis,CID000004173,metronidazole,CC1=NC=C(N1CCO)[N+](=O)[O-]
CID000003763,isoflurane,C(C(F)(F)F)(OC(F)F)Cl,drug toxicity NOS,CID000004585,"2-methyl-4-(4-methylpiperazin-1-yl)-5H-thieno[3,2-c][1,5]benzodiazepine",CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C
CID000003763,isoflurane,C(C(F)(F)F)(OC(F)F)Cl,Drug hypersensitivity,CID000036339,Etomidate,CCOC(=O)C1=CN=CN1C(C)C2=CC=CC=C2
CID000003763,isoflurane,C(C(F)(F)F)(OC(F)F)Cl,anaphylactic reaction,CID000003937,N~2~-(1-carboxy-3-phenylpropyl)lysylproline,C1CC(N(C1)C(=O)C(CCCCN)NC(CCC2=CC=CC=C2)C(=O)O)C(=O)O
CID000003763,isoflurane,C(C(F)(F)F)(OC(F)F)Cl,enlarged liver,CID000005732,zolpidem,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C
CID000003763,isoflurane,C(C(F)(F)F)(OC(F)F)Cl,gastric inflammation,CID000004510,nitroglycerin,C(C(CO[N+](=O)[O-])O[N+](=O)[O-])O[N+](=O)[O-]
CID000003763,isoflurane,C(C(F)(F)F)(OC(F)F)Cl,enlarged liver,CID000004536,Minovlar,CC12CCC3C(C1CCC2(C#C)O)CCC4=CC(=O)CCC34
CID000005478,racemic-Timolol,CC(C)(C)NCC(COC1=NSN=C1N2CCOCC2)O,allergic dermatitis,CID006398525,,C(C1C(C(C(C(O1)OC2(C(C(C(O2)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)COS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.[Al].[Al].[Al].[Al].[Al].[Al].[Al].[Al].[Al]
CID000005478,racemic-Timolol,CC(C)(C)NCC(COC1=NSN=C1N2CCOCC2)O,loss of weight,CID000019090,megestrol,CC1=CC2C(CCC3(C2CCC3(C(=O)C)O)C)C4(C1=CC(=O)CC4)C
CID000005478,racemic-Timolol,CC(C)(C)NCC(COC1=NSN=C1N2CCOCC2)O,apoplexy,CID000170361,Varenicline,C1C2CNCC1C3=CC4=NC=CN=C4C=C23
CID000005478,racemic-Timolol,CC(C)(C)NCC(COC1=NSN=C1N2CCOCC2)O,loss of weight,CID000005512,124936-74-9,CC1=CC(=C(C=C1)O)C(CCN(C(C)C)C(C)C)C2=CC=CC=C2
CID000005478,racemic-Timolol,CC(C)(C)NCC(COC1=NSN=C1N2CCOCC2)O,gastric inflammation,CID000005544,Mycolog,CC12CC(C3(C(C1CC(C2(C(=O)CO)O)O)CCC4=CC(=O)C=CC43C)F)O
CID000005478,racemic-Timolol,CC(C)(C)NCC(COC1=NSN=C1N2CCOCC2)O,gastric inflammation,CID000005732,zolpidem,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C
CID000036339,Etomidate,CCOC(=O)C1=CN=CN1C(C)C2=CC=CC=C2,haemorrhage intracranial,CID003468412,SCHEMBL1176571,CC1C=CC=CCCC=CC=CC=CC=CC(CC(C(C(CC(=O)CC(C(CCC(CC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)C(=O)O)O)OC2C(C(C(C(O2)C)O)N)O
CID000005512,124936-74-9,CC1=CC(=C(C=C1)O)C(CCN(C(C)C)C(C)C)C2=CC=CC=C2,thrombocytopenia,CID000071616,Voriconazole,CC(C1=NC=NC=C1F)C(CN2C=NC=N2)(C3=C(C=C(C=C3)F)F)O
CID000005512,124936-74-9,CC1=CC(=C(C=C1)O)C(CCN(C(C)C)C(C)C)C2=CC=CC=C2,nausea,CID000125017,Desvenlafaxine,CN(C)CC(C1=CC=C(C=C1)O)C2(CCCCC2)O
CID000005512,124936-74-9,CC1=CC(=C(C=C1)O)C(CCN(C(C)C)C(C)C)C2=CC=CC=C2,loss of weight,CID000057537,92206-54-7,CCCN(CCC1=CC=CS1)C2CCC3=C(C2)C=CC=C3O
CID000005512,124936-74-9,CC1=CC(=C(C=C1)O)C(CCN(C(C)C)C(C)C)C2=CC=CC=C2,cellulitis,CID000019090,megestrol,CC1=CC2C(CCC3(C2CCC3(C(=O)C)O)C)C4(C1=CC(=O)CC4)C
CID000005512,124936-74-9,CC1=CC(=C(C=C1)O)C(CCN(C(C)C)C(C)C)C2=CC=CC=C2,Back Ache,CID000667490,6-Mercaptopurine,C1=NC2=C(N1)C(=S)N=CN2
CID000005512,124936-74-9,CC1=CC(=C(C=C1)O)C(CCN(C(C)C)C(C)C)C2=CC=CC=C2,gastric inflammation,CID006398525,,C(C1C(C(C(C(O1)OC2(C(C(C(O2)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)COS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.[Al].[Al].[Al].[Al].[Al].[Al].[Al].[Al].[Al]
CID000005512,124936-74-9,CC1=CC(=C(C=C1)O)C(CCN(C(C)C)C(C)C)C2=CC=CC=C2,gastric inflammation,CID003468412,SCHEMBL1176571,CC1C=CC=CCCC=CC=CC=CC=CC(CC(C(C(CC(=O)CC(C(CCC(CC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)C(=O)O)O)OC2C(C(C(C(O2)C)O)N)O
CID000005512,124936-74-9,CC1=CC(=C(C=C1)O)C(CCN(C(C)C)C(C)C)C2=CC=CC=C2,apoplexy,CID006447131,Pimecrolimus,CCC1C=C(CC(CC(C2C(CC(C(O2)(C(=O)C(=O)N3CCCCC3C(=O)OC(C(C(CC1=O)O)C)C(=CC4CCC(C(C4)OC)Cl)C)O)C)OC)OC)C)C
CID000005512,124936-74-9,CC1=CC(=C(C=C1)O)C(CCN(C(C)C)C(C)C)C2=CC=CC=C2,cholecystitis,CID000005544,Mycolog,CC12CC(C3(C(C1CC(C2(C(=O)CO)O)O)CCC4=CC(=O)C=CC43C)F)O
CID000005512,124936-74-9,CC1=CC(=C(C=C1)O)C(CCN(C(C)C)C(C)C)C2=CC=CC=C2,apoplexy,CID000060854,Ziprasidone,C1CN(CCN1CCC2=C(C=C3C(=C2)CC(=O)N3)Cl)C4=NSC5=CC=CC=C54
CID000005512,124936-74-9,CC1=CC(=C(C=C1)O)C(CCN(C(C)C)C(C)C)C2=CC=CC=C2,apoplexy,CID000005719,zaleplon,CCN(C1=CC=CC(=C1)C2=CC=NC3=C(C=NN23)C#N)C(=O)C
CID000005512,124936-74-9,CC1=CC(=C(C=C1)O)C(CCN(C(C)C)C(C)C)C2=CC=CC=C2,gastric inflammation,CID000060184,"2'-epi-Perindopril, (2'R)-",CCCC(C(=O)OCC)NC(C)C(=O)N1C2CCCCC2CC1C(=O)O
CID000005512,124936-74-9,CC1=CC(=C(C=C1)O)C(CCN(C(C)C)C(C)C)C2=CC=CC=C2,abdominal pain upper,CID000170361,Varenicline,C1C2CNCC1C3=CC4=NC=CN=C4C=C23
CID000005512,124936-74-9,CC1=CC(=C(C=C1)O)C(CCN(C(C)C)C(C)C)C2=CC=CC=C2,apoplexy,CID000060852,Ibandronic Acid,CCCCCN(C)CCC(O)(P(=O)(O)O)P(=O)(O)O
CID000005512,124936-74-9,CC1=CC(=C(C=C1)O)C(CCN(C(C)C)C(C)C)C2=CC=CC=C2,cholecystitis,CID000005732,zolpidem,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C
CID000005512,124936-74-9,CC1=CC(=C(C=C1)O)C(CCN(C(C)C)C(C)C)C2=CC=CC=C2,confusion,CID000060865,(E)-Olopatadine,CN(C)CCC=C1C2=CC=CC=C2COC3=C1C=C(C=C3)CC(=O)O
CID000004889,Pravastatin Impurity A,CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC(CC(CC(=O)O)O)O)O,confusion,CID000036811,dobutamine,CC(CCC1=CC=C(C=C1)O)NCCC2=CC(=C(C=C2)O)O
CID000004889,Pravastatin Impurity A,CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC(CC(CC(=O)O)O)O)O,erythema,CID000012536,638-94-8,CC1(OC2CC3C4CCC5=CC(=O)C=CC5(C4C(CC3(C2(O1)C(=O)CO)C)O)C)C
CID000004889,Pravastatin Impurity A,CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC(CC(CC(=O)O)O)O)O,insulin dependent diabetes mellitus,CID000060787,sequinavir,CC(C)(C)NC(=O)C1CC2CCCCC2CN1CC(C(CC3=CC=CC=C3)NC(=O)C(CC(=O)N)NC(=O)C4=NC5=CC=CC=C5C=C4)O
CID000004889,Pravastatin Impurity A,CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC(CC(CC(=O)O)O)O)O,gastric inflammation,CID003468412,SCHEMBL1176571,CC1C=CC=CCCC=CC=CC=CC=CC(CC(C(C(CC(=O)CC(C(CCC(CC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)C(=O)O)O)OC2C(C(C(C(O2)C)O)N)O
CID000004889,Pravastatin Impurity A,CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC(CC(CC(=O)O)O)O)O,apoplexy,CID000060854,Ziprasidone,C1CN(CCN1CCC2=C(C=C3C(=C2)CC(=O)N3)Cl)C4=NSC5=CC=CC=C54
CID000004889,Pravastatin Impurity A,CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC(CC(CC(=O)O)O)O)O,loss of weight,CID000060852,Ibandronic Acid,CCCCCN(C)CCC(O)(P(=O)(O)O)P(=O)(O)O
CID000004889,Pravastatin Impurity A,CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC(CC(CC(=O)O)O)O)O,insulin dependent diabetes mellitus,CID000005394,temozolomide,CN1C(=O)N2C=NC(=C2N=N1)C(=O)N
CID000004889,Pravastatin Impurity A,CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC(CC(CC(=O)O)O)O)O,Dyspnea exertional,CID000005073,risperidone,CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F
CID000004889,Pravastatin Impurity A,CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC(CC(CC(=O)O)O)O)O,loss of weight,CID000060865,(E)-Olopatadine,CN(C)CCC=C1C2=CC=CC=C2COC3=C1C=C(C=C3)CC(=O)O
CID000004889,Pravastatin Impurity A,CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC(CC(CC(=O)O)O)O)O,weight gain,CID000004909,primidone,CCC1(C(=O)NCNC1=O)C2=CC=CC=C2
CID000004889,Pravastatin Impurity A,CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC(CC(CC(=O)O)O)O)O,cholecystitis,CID000004900,Fernisone,CC12CC(=O)C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C
CID000004889,Pravastatin Impurity A,CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC(CC(CC(=O)O)O)O)O,abdominal pain upper,CID006398525,,C(C1C(C(C(C(O1)OC2(C(C(C(O2)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)COS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.[Al].[Al].[Al].[Al].[Al].[Al].[Al].[Al].[Al]
CID000004889,Pravastatin Impurity A,CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC(CC(CC(=O)O)O)O)O,thrombocytopenia,CID000005486,(R)-Tirofiban,CCCCS(=O)(=O)NC(CC1=CC=C(C=C1)OCCCCC2CCNCC2)C(=O)O
CID000004889,Pravastatin Impurity A,CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC(CC(CC(=O)O)O)O)O,Back Ache,CID000005487,tizanidine,C1CN=C(N1)NC2=C(C=CC3=NSN=C32)Cl
CID000004889,Pravastatin Impurity A,CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC(CC(CC(=O)O)O)O)O,gastric inflammation,CID000005732,zolpidem,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C
CID000004889,Pravastatin Impurity A,CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC(CC(CC(=O)O)O)O)O,conjunctivitis,CID000163742,SCHEMBL1650579,COC1C(C(C(C(O1)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)COS(=O)(=O)O)OC4C(C(C(C(O4)C(=O)O)OC5C(C(C(C(O5)COS(=O)(=O)O)O)O)NS(=O)(=O)O)O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O)NS(=O)(=O)O
CID000004889,Pravastatin Impurity A,CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC(CC(CC(=O)O)O)O)O,metabolic alkalosis,CID000131536,Fosamprenavir,CC(C)CN(CC(C(CC1=CC=CC=C1)NC(=O)OC2CCOC2)OP(=O)(O)O)S(=O)(=O)C3=CC=C(C=C3)N
CID000004889,Pravastatin Impurity A,CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC(CC(CC(=O)O)O)O)O,cholecystitis,CID000005245,Risedronic acid,C1=CC(=CN=C1)CC(O)(P(=O)(O)O)P(=O)(O)O
CID000004889,Pravastatin Impurity A,CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC(CC(CC(=O)O)O)O)O,right heart failure,CID000071616,Voriconazole,CC(C1=NC=NC=C1F)C(CN2C=NC=N2)(C3=C(C=C(C=C3)F)F)O
CID000004889,Pravastatin Impurity A,CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC(CC(CC(=O)O)O)O)O,abnormal ECG,CID000071329,Dofetilide,CN(CCC1=CC=C(C=C1)NS(=O)(=O)C)CCOC2=CC=C(C=C2)NS(=O)(=O)C
CID000004889,Pravastatin Impurity A,CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC(CC(CC(=O)O)O)O)O,cellulitis,CID000019090,megestrol,CC1=CC2C(CCC3(C2CCC3(C(=O)C)O)C)C4(C1=CC(=O)CC4)C
CID000004889,Pravastatin Impurity A,CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC(CC(CC(=O)O)O)O)O,cholecystitis,CID000005544,Mycolog,CC12CC(C3(C(C1CC(C2(C(=O)CO)O)O)CCC4=CC(=O)C=CC43C)F)O
CID000004889,Pravastatin Impurity A,CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC(CC(CC(=O)O)O)O)O,Decreased Libido,CID000125017,Desvenlafaxine,CN(C)CC(C1=CC=C(C=C1)O)C2(CCCCC2)O
CID000004889,Pravastatin Impurity A,CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC(CC(CC(=O)O)O)O)O,right heart failure,CID000004894,"11,17,21-Trihydroxypregna-1,4-diene-3,20-dione",CC12CC(C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C)O
CID000004889,Pravastatin Impurity A,CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC(CC(CC(=O)O)O)O)O,drug withdrawal,CID000060184,"2'-epi-Perindopril, (2'R)-",CCCC(C(=O)OCC)NC(C)C(=O)N1C2CCCCC2CC1C(=O)O
CID000004889,Pravastatin Impurity A,CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC(CC(CC(=O)O)O)O)O,gastric inflammation,CID000005352,38194-50-2,CC1=C(C2=C(C1=CC3=CC=C(C=C3)S(=O)C)C=CC(=C2)F)CC(=O)O
CID000004889,Pravastatin Impurity A,CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC(CC(CC(=O)O)O)O)O,gastric inflammation,CID000005358,sumatriptan,CNS(=O)(=O)CC1=CC2=C(C=C1)NC=C2CCN(C)C
CID000004889,Pravastatin Impurity A,CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC(CC(CC(=O)O)O)O)O,allergic dermatitis,CID000005095,ropinirole,CCCN(CCC)CCC1=C2CC(=O)NC2=CC=C1
CID000004889,Pravastatin Impurity A,CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC(CC(CC(=O)O)O)O)O,loss of weight,CID000170361,Varenicline,C1C2CNCC1C3=CC4=NC=CN=C4C=C23
CID000004889,Pravastatin Impurity A,CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC(CC(CC(=O)O)O)O)O,apoplexy,CID000005719,zaleplon,CCN(C1=CC=CC(=C1)C2=CC=NC3=C(C=NN23)C#N)C(=O)C
CID000004889,Pravastatin Impurity A,CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC(CC(CC(=O)O)O)O)O,Back Ache,CID000005152,Salmeterol,C1=CC=C(C=C1)CCCCOCCCCCCNCC(C2=CC(=C(C=C2)O)CO)O
CID000004889,Pravastatin Impurity A,CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC(CC(CC(=O)O)O)O)O,erythema,CID006447131,Pimecrolimus,CCC1C=C(CC(CC(C2C(CC(C(O2)(C(=O)C(=O)N3CCCCC3C(=O)OC(C(C(CC1=O)O)C)C(=CC4CCC(C(C4)OC)Cl)C)O)C)OC)OC)C)C
CID000004889,Pravastatin Impurity A,CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC(CC(CC(=O)O)O)O)O,Amnesia,CID000004920,"1-acetyl-9a,11a-dimethyl-1H,2H,3H,3aH,3bH,4H,5H,7H,8H,9H,9aH,9bH,10H,11H,11aH-cyclopenta[a]phenanthren-7-one",CC(=O)C1CCC2C1(CCC3C2CCC4=CC(=O)CCC34C)C
CID000004889,Pravastatin Impurity A,CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC(CC(CC(=O)O)O)O)O,Pain,CID000057537,92206-54-7,CCCN(CCC1=CC=CS1)C2CCC3=C(C2)C=CC=C3O
CID000004889,Pravastatin Impurity A,CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC(CC(CC(=O)O)O)O)O,loss of weight,CID000005584,trimipramine,CC(CN1C2=CC=CC=C2CCC3=CC=CC=C31)CN(C)C
CID000002550,1-(2-methyl-3-sulfanylpropanoyl)pyrrolidine-2-carboxylic acid,CC(CS)C(=O)N1CCCC1C(=O)O,gastric inflammation,CID000003440,furosemide,C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl
CID000002550,1-(2-methyl-3-sulfanylpropanoyl)pyrrolidine-2-carboxylic acid,CC(CS)C(=O)N1CCCC1C(=O)O,acanthosis nigricans,CID000004894,"11,17,21-Trihydroxypregna-1,4-diene-3,20-dione",CC12CC(C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C)O
CID000002550,1-(2-methyl-3-sulfanylpropanoyl)pyrrolidine-2-carboxylic acid,CC(CS)C(=O)N1CCCC1C(=O)O,cholecystitis,CID000002771,citalopram,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F
CID000002550,1-(2-methyl-3-sulfanylpropanoyl)pyrrolidine-2-carboxylic acid,CC(CS)C(=O)N1CCCC1C(=O)O,elevated cholesterol,CID000170361,Varenicline,C1C2CNCC1C3=CC4=NC=CN=C4C=C23
CID000002550,1-(2-methyl-3-sulfanylpropanoyl)pyrrolidine-2-carboxylic acid,CC(CS)C(=O)N1CCCC1C(=O)O,coughing blood,CID000005544,Mycolog,CC12CC(C3(C(C1CC(C2(C(=O)CO)O)O)CCC4=CC(=O)C=CC43C)F)O
CID000002550,1-(2-methyl-3-sulfanylpropanoyl)pyrrolidine-2-carboxylic acid,CC(CS)C(=O)N1CCCC1C(=O)O,cholecystitis,CID000003339,fenofibrate,CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C2=CC=C(C=C2)Cl
CID000002550,1-(2-methyl-3-sulfanylpropanoyl)pyrrolidine-2-carboxylic acid,CC(CS)C(=O)N1CCCC1C(=O)O,cholecystitis,CID000003333,felodipine,CCOC(=O)C1=C(NC(=C(C1C2=C(C(=CC=C2)Cl)Cl)C(=O)OC)C)C
CID000002550,1-(2-methyl-3-sulfanylpropanoyl)pyrrolidine-2-carboxylic acid,CC(CS)C(=O)N1CCCC1C(=O)O,peritonitis,CID000005245,Risedronic acid,C1=CC(=CN=C1)CC(O)(P(=O)(O)O)P(=O)(O)O
CID000002550,1-(2-methyl-3-sulfanylpropanoyl)pyrrolidine-2-carboxylic acid,CC(CS)C(=O)N1CCCC1C(=O)O,Bacteraemia,CID000060852,Ibandronic Acid,CCCCCN(C)CCC(O)(P(=O)(O)O)P(=O)(O)O
CID000002550,1-(2-methyl-3-sulfanylpropanoyl)pyrrolidine-2-carboxylic acid,CC(CS)C(=O)N1CCCC1C(=O)O,apoplexy,CID000060854,Ziprasidone,C1CN(CCN1CCC2=C(C=C3C(=C2)CC(=O)N3)Cl)C4=NSC5=CC=CC=C54
CID000002550,1-(2-methyl-3-sulfanylpropanoyl)pyrrolidine-2-carboxylic acid,CC(CS)C(=O)N1CCCC1C(=O)O,insulin dependent diabetes mellitus,CID000004585,"2-methyl-4-(4-methylpiperazin-1-yl)-5H-thieno[3,2-c][1,5]benzodiazepine",CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C
CID000002550,1-(2-methyl-3-sulfanylpropanoyl)pyrrolidine-2-carboxylic acid,CC(CS)C(=O)N1CCCC1C(=O)O,gastric inflammation,CID000004201,minoxidil,C1CCN(CC1)C2=NC(=N)N(C(=C2)N)O
CID000002550,1-(2-methyl-3-sulfanylpropanoyl)pyrrolidine-2-carboxylic acid,CC(CS)C(=O)N1CCCC1C(=O)O,apoplexy,CID000004205,mirtazapine,CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4
CID000002550,1-(2-methyl-3-sulfanylpropanoyl)pyrrolidine-2-carboxylic acid,CC(CS)C(=O)N1CCCC1C(=O)O,arteriosclerotic heart disease,CID000005487,tizanidine,C1CN=C(N1)NC2=C(C=CC3=NSN=C32)Cl
CID000002550,1-(2-methyl-3-sulfanylpropanoyl)pyrrolidine-2-carboxylic acid,CC(CS)C(=O)N1CCCC1C(=O)O,Amnesia,CID000005152,Salmeterol,C1=CC=C(C=C1)CCCCOCCCCCCNCC(C2=CC(=C(C=C2)O)CO)O
CID000002550,1-(2-methyl-3-sulfanylpropanoyl)pyrrolidine-2-carboxylic acid,CC(CS)C(=O)N1CCCC1C(=O)O,cholecystitis,CID000005732,zolpidem,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C
CID000002550,1-(2-methyl-3-sulfanylpropanoyl)pyrrolidine-2-carboxylic acid,CC(CS)C(=O)N1CCCC1C(=O)O,Extrasystoles Ventricular,CID000003676,lidocaine,CCN(CC)CC(=O)NC1=C(C=CC=C1C)C
CID000002550,1-(2-methyl-3-sulfanylpropanoyl)pyrrolidine-2-carboxylic acid,CC(CS)C(=O)N1CCCC1C(=O)O,Pain,CID000004236,modafinil,C1=CC=C(C=C1)C(C2=CC=CC=C2)S(=O)CC(=O)N
CID000002550,1-(2-methyl-3-sulfanylpropanoyl)pyrrolidine-2-carboxylic acid,CC(CS)C(=O)N1CCCC1C(=O)O,weight gain,CID000003310,33419-42-0,CC1OCC2C(O1)C(C(C(O2)OC3C4COC(=O)C4C(C5=CC6=C(C=C35)OCO6)C7=CC(=C(C(=C7)OC)O)OC)O)O
CID000002550,1-(2-methyl-3-sulfanylpropanoyl)pyrrolidine-2-carboxylic acid,CC(CS)C(=O)N1CCCC1C(=O)O,erythema,CID000003405,2-[[4-[(2-amino-4-oxo-1H-pteridin-6-yl)methylamino]benzoyl]amino]pentanedioic acid,C1=CC(=CC=C1C(=O)NC(CCC(=O)O)C(=O)O)NCC2=CN=C3C(=N2)C(=O)N=C(N3)N
CID000002550,1-(2-methyl-3-sulfanylpropanoyl)pyrrolidine-2-carboxylic acid,CC(CS)C(=O)N1CCCC1C(=O)O,angiitis,CID000004173,metronidazole,CC1=NC=C(N1CCO)[N+](=O)[O-]
CID000002550,1-(2-methyl-3-sulfanylpropanoyl)pyrrolidine-2-carboxylic acid,CC(CS)C(=O)N1CCCC1C(=O)O,cerebral vascular disorder,CID000004170,metolazone,CC1NC2=CC(=C(C=C2C(=O)N1C3=CC=CC=C3C)S(=O)(=O)N)Cl
CID000002550,1-(2-methyl-3-sulfanylpropanoyl)pyrrolidine-2-carboxylic acid,CC(CS)C(=O)N1CCCC1C(=O)O,gastric inflammation,CID000003780,"D-Glucitol, 1,4:3,6-dianhydro-, 2,5-dinitrate",C1C(C2C(O1)C(CO2)O[N+](=O)[O-])O[N+](=O)[O-]
CID000002550,1-(2-methyl-3-sulfanylpropanoyl)pyrrolidine-2-carboxylic acid,CC(CS)C(=O)N1CCCC1C(=O)O,insulin dependent diabetes mellitus,CID003468412,SCHEMBL1176571,CC1C=CC=CCCC=CC=CC=CC=CC(CC(C(C(CC(=O)CC(C(CCC(CC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)C(=O)O)O)OC2C(C(C(C(O2)C)O)N)O
CID000002550,1-(2-methyl-3-sulfanylpropanoyl)pyrrolidine-2-carboxylic acid,CC(CS)C(=O)N1CCCC1C(=O)O,cholecystitis,CID000003937,N~2~-(1-carboxy-3-phenylpropyl)lysylproline,C1CC(N(C1)C(=O)C(CCCCN)NC(CCC2=CC=CC=C2)C(=O)O)C(=O)O
CID000002550,1-(2-methyl-3-sulfanylpropanoyl)pyrrolidine-2-carboxylic acid,CC(CS)C(=O)N1CCCC1C(=O)O,right heart failure,CID000004900,Fernisone,CC12CC(=O)C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C
CID000002550,1-(2-methyl-3-sulfanylpropanoyl)pyrrolidine-2-carboxylic acid,CC(CS)C(=O)N1CCCC1C(=O)O,lung edema,CID006398525,,C(C1C(C(C(C(O1)OC2(C(C(C(O2)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)COS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.[Al].[Al].[Al].[Al].[Al].[Al].[Al].[Al].[Al]
CID000002550,1-(2-methyl-3-sulfanylpropanoyl)pyrrolidine-2-carboxylic acid,CC(CS)C(=O)N1CCCC1C(=O)O,apoplexy,CID000005073,risperidone,CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F
CID000002550,1-(2-methyl-3-sulfanylpropanoyl)pyrrolidine-2-carboxylic acid,CC(CS)C(=O)N1CCCC1C(=O)O,right heart failure,CID000003062,Lanicor,CC1C(C(CC(O1)OC2C(OC(CC2O)OC3C(OC(CC3O)OC4CCC5(C(C4)CCC6C5CC(C7(C6(CCC7C8=CC(=O)OC8)O)C)O)C)C)C)O)O
CID000002550,1-(2-methyl-3-sulfanylpropanoyl)pyrrolidine-2-carboxylic acid,CC(CS)C(=O)N1CCCC1C(=O)O,cholecystitis,CID000003961,losartan,CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)CO)Cl
CID000002550,1-(2-methyl-3-sulfanylpropanoyl)pyrrolidine-2-carboxylic acid,CC(CS)C(=O)N1CCCC1C(=O)O,loss of weight,CID000002676,"7-[4-(4-fluorophenyl)-5-(methoxymethyl)-2,6-di(propan-2-yl)pyridin-3-yl]-3,5-dihydroxyhept-6-enoic acid",CC(C)C1=C(C(=C(C(=N1)C(C)C)COC)C2=CC=C(C=C2)F)C=CC(CC(CC(=O)O)O)O
CID000002550,1-(2-methyl-3-sulfanylpropanoyl)pyrrolidine-2-carboxylic acid,CC(CS)C(=O)N1CCCC1C(=O)O,loss of weight,CID000019090,megestrol,CC1=CC2C(CCC3(C2CCC3(C(=O)C)O)C)C4(C1=CC(=O)CC4)C
CID000002550,1-(2-methyl-3-sulfanylpropanoyl)pyrrolidine-2-carboxylic acid,CC(CS)C(=O)N1CCCC1C(=O)O,angiitis,CID000002656,"7-[[2-(2-amino-1,3-thiazol-4-yl)-2-methoxyiminoacetyl]amino]-3-[(2-methyl-6-oxido-5-oxo-1,2,4-triazin-3-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CN1C(=NC(=O)C(=N1)[O-])SCC2=C(N3C(C(C3=O)NC(=O)C(=NOC)C4=CSC(=N4)N)SC2)C(=O)[O-]
CID000002550,1-(2-methyl-3-sulfanylpropanoyl)pyrrolidine-2-carboxylic acid,CC(CS)C(=O)N1CCCC1C(=O)O,neumonia,CID000003661,L-Hyoscyamine,CN1C2CCC1CC(C2)OC(=O)C(CO)C3=CC=CC=C3
CID000002550,1-(2-methyl-3-sulfanylpropanoyl)pyrrolidine-2-carboxylic acid,CC(CS)C(=O)N1CCCC1C(=O)O,alopecia,CID000002891,"cobalt(2+);[5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] 1-[3-[2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2,7,12,17-tetrahydro-1H-corrin-21-id-3-yl]propanoylamino]propan-2-yl hydrogen phosphate;cyanide",CC1=CC2=C(C=C1C)N(C=N2)C3C(C(C(O3)CO)OP(=O)(O)OC(C)CNC(=O)CCC4(C(C5C6(C(C(C(=N6)C(=C7C(C(C(=N7)C=C8C(C(C(=N8)C(=C4[N-]5)C)CCC(=O)N)(C)C)CCC(=O)N)(C)CC(=O)N)C)CCC(=O)N)(C)CC(=O)N)C)CC(=O)N)C)O.[C-]#N.[Co+2]
CID000002550,1-(2-methyl-3-sulfanylpropanoyl)pyrrolidine-2-carboxylic acid,CC(CS)C(=O)N1CCCC1C(=O)O,loss of weight,CID000003954,loperamide(1+),CN(C)C(=O)C(CC[NH+]1CCC(CC1)(C2=CC=C(C=C2)Cl)O)(C3=CC=CC=C3)C4=CC=CC=C4
CID000002550,1-(2-methyl-3-sulfanylpropanoyl)pyrrolidine-2-carboxylic acid,CC(CS)C(=O)N1CCCC1C(=O)O,thrombocytopenia,CID000004666,7-Epi Paclitaxel,CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C
CID000002550,1-(2-methyl-3-sulfanylpropanoyl)pyrrolidine-2-carboxylic acid,CC(CS)C(=O)N1CCCC1C(=O)O,allergic dermatitis,CID000003749,irbesartan,CCCCC1=NC2(CCCC2)C(=O)N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5
CID000002550,1-(2-methyl-3-sulfanylpropanoyl)pyrrolidine-2-carboxylic acid,CC(CS)C(=O)N1CCCC1C(=O)O,nasopharyngitis,CID000005095,ropinirole,CCCN(CCC)CCC1=C2CC(=O)NC2=CC=C1
CID000002550,1-(2-methyl-3-sulfanylpropanoyl)pyrrolidine-2-carboxylic acid,CC(CS)C(=O)N1CCCC1C(=O)O,bleeding Vaginal,CID000004691,"3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine",C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4
CID000002550,1-(2-methyl-3-sulfanylpropanoyl)pyrrolidine-2-carboxylic acid,CC(CS)C(=O)N1CCCC1C(=O)O,Acute Respiratory Distress Syndrome,CID000036811,dobutamine,CC(CCC1=CC=C(C=C1)O)NCCC2=CC(=C(C=C2)O)O
CID000002550,1-(2-methyl-3-sulfanylpropanoyl)pyrrolidine-2-carboxylic acid,CC(CS)C(=O)N1CCCC1C(=O)O,cholecystitis,CID000004510,nitroglycerin,C(C(CO[N+](=O)[O-])O[N+](=O)[O-])O[N+](=O)[O-]
CID000002550,1-(2-methyl-3-sulfanylpropanoyl)pyrrolidine-2-carboxylic acid,CC(CS)C(=O)N1CCCC1C(=O)O,Pain,CID005311082,"2-[(1R,4S,10S,13S,19S)-19-[4-(diaminomethylideneamino)butyl]-10-(1H-indol-3-ylmethyl)-3,9,12,15,18,21,27-heptaoxo-24,25-dithia-2,8,11,14,17,20-hexazatricyclo[18.6.1.04,8]heptacosan-13-yl]acetic acid",C1CC2C(=O)NC3CSSCCC(=O)N(C3=O)C(C(=O)NCC(=O)NC(C(=O)NC(C(=O)N2C1)CC4=CNC5=CC=CC=C54)CC(=O)O)CCCCN=C(N)N
CID000002550,1-(2-methyl-3-sulfanylpropanoyl)pyrrolidine-2-carboxylic acid,CC(CS)C(=O)N1CCCC1C(=O)O,erythema,CID000003869,labetalol,CC(CCC1=CC=CC=C1)NCC(C2=CC(=C(C=C2)O)C(=O)N)O
CID000002550,1-(2-methyl-3-sulfanylpropanoyl)pyrrolidine-2-carboxylic acid,CC(CS)C(=O)N1CCCC1C(=O)O,angiitis,CID000071616,Voriconazole,CC(C1=NC=NC=C1F)C(CN2C=NC=N2)(C3=C(C=C(C=C3)F)F)O
CID000002550,1-(2-methyl-3-sulfanylpropanoyl)pyrrolidine-2-carboxylic acid,CC(CS)C(=O)N1CCCC1C(=O)O,apoplexy,CID000005358,sumatriptan,CNS(=O)(=O)CC1=CC2=C(C=C1)NC=C2CCN(C)C
CID000002550,1-(2-methyl-3-sulfanylpropanoyl)pyrrolidine-2-carboxylic acid,CC(CS)C(=O)N1CCCC1C(=O)O,weight gain,CID000005352,38194-50-2,CC1=C(C2=C(C1=CC3=CC=C(C=C3)S(=O)C)C=CC(=C2)F)CC(=O)O
CID000004236,modafinil,C1=CC=C(C=C1)C(C2=CC=CC=C2)S(=O)CC(=O)N,Dyspnea exertional,CID000005095,ropinirole,CCCN(CCC)CCC1=C2CC(=O)NC2=CC=C1
CID000004236,modafinil,C1=CC=C(C=C1)C(C2=CC=CC=C2)S(=O)CC(=O)N,difficulty in walking,CID000004691,"3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine",C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4
CID000004236,modafinil,C1=CC=C(C=C1)C(C2=CC=CC=C2)S(=O)CC(=O)N,cholecystitis,CID000004909,primidone,CCC1(C(=O)NCNC1=O)C2=CC=CC=C2
CID000004236,modafinil,C1=CC=C(C=C1)C(C2=CC=CC=C2)S(=O)CC(=O)N,agitated,CID000004900,Fernisone,CC12CC(=O)C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C
CID000004236,modafinil,C1=CC=C(C=C1)C(C2=CC=CC=C2)S(=O)CC(=O)N,cholecystitis,CID000004585,"2-methyl-4-(4-methylpiperazin-1-yl)-5H-thieno[3,2-c][1,5]benzodiazepine",CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C
CID000004236,modafinil,C1=CC=C(C=C1)C(C2=CC=CC=C2)S(=O)CC(=O)N,rotator cuff syndrome,CID000005719,zaleplon,CCN(C1=CC=CC(=C1)C2=CC=NC3=C(C=NN23)C#N)C(=O)C
CID000004236,modafinil,C1=CC=C(C=C1)C(C2=CC=CC=C2)S(=O)CC(=O)N,bulging,CID000004819,"2(3H)-Furanone, 3-ethyldihydro-4-[(1-methyl-1H-imidazol-5-yl)methyl]-, (3S-cis)-",CCC1C(COC1=O)CC2=CN=CN2C
CID000004236,modafinil,C1=CC=C(C=C1)C(C2=CC=CC=C2)S(=O)CC(=O)N,dysarthria,CID003468412,SCHEMBL1176571,CC1C=CC=CCCC=CC=CC=CC=CC(CC(C(C(CC(=O)CC(C(CCC(CC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)C(=O)O)O)OC2C(C(C(C(O2)C)O)N)O
CID000004236,modafinil,C1=CC=C(C=C1)C(C2=CC=CC=C2)S(=O)CC(=O)N,bruxism,CID000170361,Varenicline,C1C2CNCC1C3=CC4=NC=CN=C4C=C23
CID000004236,modafinil,C1=CC=C(C=C1)C(C2=CC=CC=C2)S(=O)CC(=O)N,cellulitis,CID006398525,,C(C1C(C(C(C(O1)OC2(C(C(C(O2)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)COS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.[Al].[Al].[Al].[Al].[Al].[Al].[Al].[Al].[Al]
CID000004236,modafinil,C1=CC=C(C=C1)C(C2=CC=CC=C2)S(=O)CC(=O)N,erythema,CID000005394,temozolomide,CN1C(=O)N2C=NC(=C2N=N1)C(=O)N
CID000004236,modafinil,C1=CC=C(C=C1)C(C2=CC=CC=C2)S(=O)CC(=O)N,cholecystitis,CID000004510,nitroglycerin,C(C(CO[N+](=O)[O-])O[N+](=O)[O-])O[N+](=O)[O-]
CID000004236,modafinil,C1=CC=C(C=C1)C(C2=CC=CC=C2)S(=O)CC(=O)N,abnormal ECG,CID000005152,Salmeterol,C1=CC=C(C=C1)CCCCOCCCCCCNCC(C2=CC(=C(C=C2)O)CO)O
CID000004236,modafinil,C1=CC=C(C=C1)C(C2=CC=CC=C2)S(=O)CC(=O)N,Dyspnea exertional,CID000005487,tizanidine,C1CN=C(N1)NC2=C(C=CC3=NSN=C32)Cl
CID000004236,modafinil,C1=CC=C(C=C1)C(C2=CC=CC=C2)S(=O)CC(=O)N,cholecystitis,CID000005732,zolpidem,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C
CID000004236,modafinil,C1=CC=C(C=C1)C(C2=CC=CC=C2)S(=O)CC(=O)N,abuse,CID000004745,SCHEMBL7711911,CCCN1CC(CC2C1CC3=CNC4=CC=CC2=C34)CSC
CID000004236,modafinil,C1=CC=C(C=C1)C(C2=CC=CC=C2)S(=O)CC(=O)N,cholecystitis,CID000060854,Ziprasidone,C1CN(CCN1CCC2=C(C=C3C(=C2)CC(=O)N3)Cl)C4=NSC5=CC=CC=C54
CID000004236,modafinil,C1=CC=C(C=C1)C(C2=CC=CC=C2)S(=O)CC(=O)N,hyperglycaemia,CID000057537,92206-54-7,CCCN(CCC1=CC=CS1)C2CCC3=C(C2)C=CC=C3O
CID000004236,modafinil,C1=CC=C(C=C1)C(C2=CC=CC=C2)S(=O)CC(=O)N,disseminated lupus erythematosus,CID000005245,Risedronic acid,C1=CC(=CN=C1)CC(O)(P(=O)(O)O)P(=O)(O)O
CID000004236,modafinil,C1=CC=C(C=C1)C(C2=CC=CC=C2)S(=O)CC(=O)N,apoplexy,CID000019090,megestrol,CC1=CC2C(CCC3(C2CCC3(C(=O)C)O)C)C4(C1=CC(=O)CC4)C
CID000004236,modafinil,C1=CC=C(C=C1)C(C2=CC=CC=C2)S(=O)CC(=O)N,angiitis,CID000005544,Mycolog,CC12CC(C3(C(C1CC(C2(C(=O)CO)O)O)CCC4=CC(=O)C=CC43C)F)O
CID000004236,modafinil,C1=CC=C(C=C1)C(C2=CC=CC=C2)S(=O)CC(=O)N,angiitis,CID000060852,Ibandronic Acid,CCCCCN(C)CCC(O)(P(=O)(O)O)P(=O)(O)O
CID000004236,modafinil,C1=CC=C(C=C1)C(C2=CC=CC=C2)S(=O)CC(=O)N,weight gain,CID000125017,Desvenlafaxine,CN(C)CC(C1=CC=C(C=C1)O)C2(CCCCC2)O
CID000004236,modafinil,C1=CC=C(C=C1)C(C2=CC=CC=C2)S(=O)CC(=O)N,gastric inflammation,CID000005073,risperidone,CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F
CID000004236,modafinil,C1=CC=C(C=C1)C(C2=CC=CC=C2)S(=O)CC(=O)N,erythema,CID000004920,"1-acetyl-9a,11a-dimethyl-1H,2H,3H,3aH,3bH,4H,5H,7H,8H,9H,9aH,9bH,10H,11H,11aH-cyclopenta[a]phenanthren-7-one",CC(=O)C1CCC2C1(CCC3C2CCC4=CC(=O)CCC34C)C
CID000004236,modafinil,C1=CC=C(C=C1)C(C2=CC=CC=C2)S(=O)CC(=O)N,fracture nonunion,CID000005358,sumatriptan,CNS(=O)(=O)CC1=CC2=C(C=C1)NC=C2CCN(C)C
CID000004236,modafinil,C1=CC=C(C=C1)C(C2=CC=CC=C2)S(=O)CC(=O)N,bursitis,CID000060865,(E)-Olopatadine,CN(C)CCC=C1C2=CC=CC=C2COC3=C1C=C(C=C3)CC(=O)O
CID000004075,5-Aminosalicylic acid,C1=CC(=C(C=C1N)C(=O)O)O,Arrhythmia,CID000004920,"1-acetyl-9a,11a-dimethyl-1H,2H,3H,3aH,3bH,4H,5H,7H,8H,9H,9aH,9bH,10H,11H,11aH-cyclopenta[a]phenanthren-7-one",CC(=O)C1CCC2C1(CCC3C2CCC4=CC(=O)CCC34C)C
CID000004075,5-Aminosalicylic acid,C1=CC(=C(C=C1N)C(=O)O)O,apoplexy,CID000004585,"2-methyl-4-(4-methylpiperazin-1-yl)-5H-thieno[3,2-c][1,5]benzodiazepine",CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C
CID000004075,5-Aminosalicylic acid,C1=CC(=C(C=C1N)C(=O)O)O,gastric inflammation,CID000005732,zolpidem,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C
CID000004075,5-Aminosalicylic acid,C1=CC(=C(C=C1N)C(=O)O)O,rhinorrhea,CID000005095,ropinirole,CCCN(CCC)CCC1=C2CC(=O)NC2=CC=C1
CID000004075,5-Aminosalicylic acid,C1=CC(=C(C=C1N)C(=O)O)O,Bleeding,CID003468412,SCHEMBL1176571,CC1C=CC=CCCC=CC=CC=CC=CC(CC(C(C(CC(=O)CC(C(CCC(CC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)C(=O)O)O)OC2C(C(C(C(O2)C)O)N)O
CID000004075,5-Aminosalicylic acid,C1=CC(=C(C=C1N)C(=O)O)O,erythema,CID000004691,"3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine",C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4
CID000004075,5-Aminosalicylic acid,C1=CC(=C(C=C1N)C(=O)O)O,angiitis,CID000060852,Ibandronic Acid,CCCCCN(C)CCC(O)(P(=O)(O)O)P(=O)(O)O
CID000004075,5-Aminosalicylic acid,C1=CC(=C(C=C1N)C(=O)O)O,Adenopathy,CID000004900,Fernisone,CC12CC(=O)C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C
CID000004075,5-Aminosalicylic acid,C1=CC(=C(C=C1N)C(=O)O)O,hepatic necrosis,CID000005358,sumatriptan,CNS(=O)(=O)CC1=CC2=C(C=C1)NC=C2CCN(C)C
CID000004075,5-Aminosalicylic acid,C1=CC(=C(C=C1N)C(=O)O)O,loss of weight,CID000005352,38194-50-2,CC1=C(C2=C(C1=CC3=CC=C(C=C3)S(=O)C)C=CC(=C2)F)CC(=O)O
CID000004075,5-Aminosalicylic acid,C1=CC(=C(C=C1N)C(=O)O)O,increased white blood cell count,CID000019090,megestrol,CC1=CC2C(CCC3(C2CCC3(C(=O)C)O)C)C4(C1=CC(=O)CC4)C
CID000004075,5-Aminosalicylic acid,C1=CC(=C(C=C1N)C(=O)O)O,edema,CID006398525,,C(C1C(C(C(C(O1)OC2(C(C(C(O2)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)COS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.[Al].[Al].[Al].[Al].[Al].[Al].[Al].[Al].[Al]
CID000004075,5-Aminosalicylic acid,C1=CC(=C(C=C1N)C(=O)O)O,gastric inflammation,CID000005544,Mycolog,CC12CC(C3(C(C1CC(C2(C(=O)CO)O)O)CCC4=CC(=O)C=CC43C)F)O
CID000004075,5-Aminosalicylic acid,C1=CC(=C(C=C1N)C(=O)O)O,loss of weight,CID000005245,Risedronic acid,C1=CC(=CN=C1)CC(O)(P(=O)(O)O)P(=O)(O)O
CID000004075,5-Aminosalicylic acid,C1=CC(=C(C=C1N)C(=O)O)O,angiitis,CID000004205,mirtazapine,CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4
CID000004075,5-Aminosalicylic acid,C1=CC(=C(C=C1N)C(=O)O)O,loss of weight,CID000004909,primidone,CCC1(C(=O)NCNC1=O)C2=CC=CC=C2
CID000004075,5-Aminosalicylic acid,C1=CC(=C(C=C1N)C(=O)O)O,loss of weight,CID000004510,nitroglycerin,C(C(CO[N+](=O)[O-])O[N+](=O)[O-])O[N+](=O)[O-]
CID000004075,5-Aminosalicylic acid,C1=CC(=C(C=C1N)C(=O)O)O,loss of weight,CID000005487,tizanidine,C1CN=C(N1)NC2=C(C=CC3=NSN=C32)Cl
CID000004075,5-Aminosalicylic acid,C1=CC(=C(C=C1N)C(=O)O)O,disseminated lupus erythematosus,CID000005152,Salmeterol,C1=CC=C(C=C1)CCCCOCCCCCCNCC(C2=CC(=C(C=C2)O)CO)O
CID000004075,5-Aminosalicylic acid,C1=CC(=C(C=C1N)C(=O)O)O,Adenopathy,CID000667490,6-Mercaptopurine,C1=NC2=C(N1)C(=S)N=CN2
CID000004075,5-Aminosalicylic acid,C1=CC(=C(C=C1N)C(=O)O)O,loss of weight,CID000004173,metronidazole,CC1=NC=C(N1CCO)[N+](=O)[O-]
CID000004075,5-Aminosalicylic acid,C1=CC(=C(C=C1N)C(=O)O)O,cholecystitis,CID000004894,"11,17,21-Trihydroxypregna-1,4-diene-3,20-dione",CC12CC(C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C)O
CID000004075,5-Aminosalicylic acid,C1=CC(=C(C=C1N)C(=O)O)O,thrombocytopenia,CID000163742,SCHEMBL1650579,COC1C(C(C(C(O1)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)COS(=O)(=O)O)OC4C(C(C(C(O4)C(=O)O)OC5C(C(C(C(O5)COS(=O)(=O)O)O)O)NS(=O)(=O)O)O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O)NS(=O)(=O)O
CID000004075,5-Aminosalicylic acid,C1=CC(=C(C=C1N)C(=O)O)O,loss of weight,CID000170361,Varenicline,C1C2CNCC1C3=CC4=NC=CN=C4C=C23
CID000004075,5-Aminosalicylic acid,C1=CC(=C(C=C1N)C(=O)O)O,erythema,CID000005073,risperidone,CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F
CID000003741,ioversol,C(CO)N(C1=C(C(=C(C(=C1I)C(=O)NCC(CO)O)I)C(=O)NCC(CO)O)I)C(=O)CO,bradycardia,CID000004510,nitroglycerin,C(C(CO[N+](=O)[O-])O[N+](=O)[O-])O[N+](=O)[O-]
CID000003741,ioversol,C(CO)N(C1=C(C(=C(C(=C1I)C(=O)NCC(CO)O)I)C(=O)NCC(CO)O)I)C(=O)CO,anaphylactic reaction,CID000003780,"D-Glucitol, 1,4:3,6-dianhydro-, 2,5-dinitrate",C1C(C2C(O1)C(CO2)O[N+](=O)[O-])O[N+](=O)[O-]
CID000003741,ioversol,C(CO)N(C1=C(C(=C(C(=C1I)C(=O)NCC(CO)O)I)C(=O)NCC(CO)O)I)C(=O)CO,deglutition disorder,CID000004900,Fernisone,CC12CC(=O)C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C
CID000060852,Ibandronic Acid,CCCCCN(C)CCC(O)(P(=O)(O)O)P(=O)(O)O,Pain,CID000060865,(E)-Olopatadine,CN(C)CCC=C1C2=CC=CC=C2COC3=C1C=C(C=C3)CC(=O)O
CID000060852,Ibandronic Acid,CCCCCN(C)CCC(O)(P(=O)(O)O)P(=O)(O)O,heart rate increased,CID000125017,Desvenlafaxine,CN(C)CC(C1=CC=C(C=C1)O)C2(CCCCC2)O
CID000060852,Ibandronic Acid,CCCCCN(C)CCC(O)(P(=O)(O)O)P(=O)(O)O,inflammatory bowel disease,CID000667490,6-Mercaptopurine,C1=NC2=C(N1)C(=S)N=CN2
CID000060852,Ibandronic Acid,CCCCCN(C)CCC(O)(P(=O)(O)O)P(=O)(O)O,gastric inflammation,CID006398525,,C(C1C(C(C(C(O1)OC2(C(C(C(O2)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)COS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.[Al].[Al].[Al].[Al].[Al].[Al].[Al].[Al].[Al]
CID000060852,Ibandronic Acid,CCCCCN(C)CCC(O)(P(=O)(O)O)P(=O)(O)O,apoplexy,CID000170361,Varenicline,C1C2CNCC1C3=CC4=NC=CN=C4C=C23
CID000060852,Ibandronic Acid,CCCCCN(C)CCC(O)(P(=O)(O)O)P(=O)(O)O,glossodynia,CID000115237,Paliperidone,CC1=C(C(=O)N2CCCC(C2=N1)O)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F
CID000004909,primidone,CCC1(C(=O)NCNC1=O)C2=CC=CC=C2,gastric inflammation,CID000005487,tizanidine,C1CN=C(N1)NC2=C(C=CC3=NSN=C32)Cl
CID000004909,primidone,CCC1(C(=O)NCNC1=O)C2=CC=CC=C2,abnormal EEG,CID000005073,risperidone,CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F
CID000004909,primidone,CCC1(C(=O)NCNC1=O)C2=CC=CC=C2,cholecystitis,CID000005152,Salmeterol,C1=CC=C(C=C1)CCCCOCCCCCCNCC(C2=CC(=C(C=C2)O)CO)O
CID000004909,primidone,CCC1(C(=O)NCNC1=O)C2=CC=CC=C2,loss of weight,CID000170361,Varenicline,C1C2CNCC1C3=CC4=NC=CN=C4C=C23
CID000004909,primidone,CCC1(C(=O)NCNC1=O)C2=CC=CC=C2,dizziness,CID000071329,Dofetilide,CN(CCC1=CC=C(C=C1)NS(=O)(=O)C)CCOC2=CC=C(C=C2)NS(=O)(=O)C
CID000004909,primidone,CCC1(C(=O)NCNC1=O)C2=CC=CC=C2,weight gain,CID000005245,Risedronic acid,C1=CC(=CN=C1)CC(O)(P(=O)(O)O)P(=O)(O)O
CID000004909,primidone,CCC1(C(=O)NCNC1=O)C2=CC=CC=C2,haemorrhage rectum,CID000005732,zolpidem,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C
CID000004909,primidone,CCC1(C(=O)NCNC1=O)C2=CC=CC=C2,cholecystitis,CID000005095,ropinirole,CCCN(CCC)CCC1=C2CC(=O)NC2=CC=C1
CID000004909,primidone,CCC1(C(=O)NCNC1=O)C2=CC=CC=C2,gastric inflammation,CID000005358,sumatriptan,CNS(=O)(=O)CC1=CC2=C(C=C1)NC=C2CCN(C)C
CID000004909,primidone,CCC1(C(=O)NCNC1=O)C2=CC=CC=C2,loss of weight,CID000060854,Ziprasidone,C1CN(CCN1CCC2=C(C=C3C(=C2)CC(=O)N3)Cl)C4=NSC5=CC=CC=C54
CID000004909,primidone,CCC1(C(=O)NCNC1=O)C2=CC=CC=C2,loss of weight,CID000005544,Mycolog,CC12CC(C3(C(C1CC(C2(C(=O)CO)O)O)CCC4=CC(=O)C=CC43C)F)O
CID000071329,Dofetilide,CN(CCC1=CC=C(C=C1)NS(=O)(=O)C)CCOC2=CC=C(C=C2)NS(=O)(=O)C,confusion,CID000170361,Varenicline,C1C2CNCC1C3=CC4=NC=CN=C4C=C23
CID000003661,L-Hyoscyamine,CN1C2CCC1CC(C2)OC(=O)C(CO)C3=CC=CC=C3,bradycardia,CID005311082,"2-[(1R,4S,10S,13S,19S)-19-[4-(diaminomethylideneamino)butyl]-10-(1H-indol-3-ylmethyl)-3,9,12,15,18,21,27-heptaoxo-24,25-dithia-2,8,11,14,17,20-hexazatricyclo[18.6.1.04,8]heptacosan-13-yl]acetic acid",C1CC2C(=O)NC3CSSCCC(=O)N(C3=O)C(C(=O)NCC(=O)NC(C(=O)NC(C(=O)N2C1)CC4=CNC5=CC=CC=C54)CC(=O)O)CCCCN=C(N)N
CID000003661,L-Hyoscyamine,CN1C2CCC1CC(C2)OC(=O)C(CO)C3=CC=CC=C3,thrombocytopenia,CID000004140,Isomethergine,CCC(CO)NC(=O)C1CN(C2CC3=CNC4=CC=CC(=C34)C2=C1)C
CID000003661,L-Hyoscyamine,CN1C2CCC1CC(C2)OC(=O)C(CO)C3=CC=CC=C3,agitated,CID000003954,loperamide(1+),CN(C)C(=O)C(CC[NH+]1CCC(CC1)(C2=CC=C(C=C2)Cl)O)(C3=CC=CC=C3)C4=CC=CC=C4
CID000003661,L-Hyoscyamine,CN1C2CCC1CC(C2)OC(=O)C(CO)C3=CC=CC=C3,increased white blood cell count,CID000005245,Risedronic acid,C1=CC(=CN=C1)CC(O)(P(=O)(O)O)P(=O)(O)O
CID000003661,L-Hyoscyamine,CN1C2CCC1CC(C2)OC(=O)C(CO)C3=CC=CC=C3,Adenopathy,CID003468412,SCHEMBL1176571,CC1C=CC=CCCC=CC=CC=CC=CC(CC(C(C(CC(=O)CC(C(CCC(CC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)C(=O)O)O)OC2C(C(C(C(O2)C)O)N)O
CID000003661,L-Hyoscyamine,CN1C2CCC1CC(C2)OC(=O)C(CO)C3=CC=CC=C3,confusion,CID000004205,mirtazapine,CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4
CID000003661,L-Hyoscyamine,CN1C2CCC1CC(C2)OC(=O)C(CO)C3=CC=CC=C3,haemorrhage intracranial,CID000003869,labetalol,CC(CCC1=CC=CC=C1)NCC(C2=CC(=C(C=C2)O)C(=O)N)O
CID000003661,L-Hyoscyamine,CN1C2CCC1CC(C2)OC(=O)C(CO)C3=CC=CC=C3,coughing blood,CID000003961,losartan,CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)CO)Cl
CID000003661,L-Hyoscyamine,CN1C2CCC1CC(C2)OC(=O)C(CO)C3=CC=CC=C3,nasopharyngitis,CID000071616,Voriconazole,CC(C1=NC=NC=C1F)C(CN2C=NC=N2)(C3=C(C=C(C=C3)F)F)O
CID000003661,L-Hyoscyamine,CN1C2CCC1CC(C2)OC(=O)C(CO)C3=CC=CC=C3,thrombocytopenia,CID000019090,megestrol,CC1=CC2C(CCC3(C2CCC3(C(=O)C)O)C)C4(C1=CC(=O)CC4)C
CID000003661,L-Hyoscyamine,CN1C2CCC1CC(C2)OC(=O)C(CO)C3=CC=CC=C3,atelectasis,CID000005394,temozolomide,CN1C(=O)N2C=NC(=C2N=N1)C(=O)N
CID000003661,L-Hyoscyamine,CN1C2CCC1CC(C2)OC(=O)C(CO)C3=CC=CC=C3,Bleeding,CID000004819,"2(3H)-Furanone, 3-ethyldihydro-4-[(1-methyl-1H-imidazol-5-yl)methyl]-, (3S-cis)-",CCC1C(COC1=O)CC2=CN=CN2C
CID000003661,L-Hyoscyamine,CN1C2CCC1CC(C2)OC(=O)C(CO)C3=CC=CC=C3,angiitis,CID000004894,"11,17,21-Trihydroxypregna-1,4-diene-3,20-dione",CC12CC(C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C)O
CID000003661,L-Hyoscyamine,CN1C2CCC1CC(C2)OC(=O)C(CO)C3=CC=CC=C3,Cardiomyopathy,CID000163742,SCHEMBL1650579,COC1C(C(C(C(O1)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)COS(=O)(=O)O)OC4C(C(C(C(O4)C(=O)O)OC5C(C(C(C(O5)COS(=O)(=O)O)O)O)NS(=O)(=O)O)O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O)NS(=O)(=O)O
CID000003661,L-Hyoscyamine,CN1C2CCC1CC(C2)OC(=O)C(CO)C3=CC=CC=C3,High blood pressure,CID006398525,,C(C1C(C(C(C(O1)OC2(C(C(C(O2)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)COS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.[Al].[Al].[Al].[Al].[Al].[Al].[Al].[Al].[Al]
CID000003661,L-Hyoscyamine,CN1C2CCC1CC(C2)OC(=O)C(CO)C3=CC=CC=C3,cholecystitis,CID000004173,metronidazole,CC1=NC=C(N1CCO)[N+](=O)[O-]
CID000003661,L-Hyoscyamine,CN1C2CCC1CC(C2)OC(=O)C(CO)C3=CC=CC=C3,atelectasis,CID000005732,zolpidem,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C
CID000003661,L-Hyoscyamine,CN1C2CCC1CC(C2)OC(=O)C(CO)C3=CC=CC=C3,drowsiness,CID000005095,ropinirole,CCCN(CCC)CCC1=C2CC(=O)NC2=CC=C1
CID000003661,L-Hyoscyamine,CN1C2CCC1CC(C2)OC(=O)C(CO)C3=CC=CC=C3,thrombocytopenia,CID000004189,miconazole,C1=CC(=C(C=C1Cl)Cl)COC(CN2C=CN=C2)C3=C(C=C(C=C3)Cl)Cl
CID000003661,L-Hyoscyamine,CN1C2CCC1CC(C2)OC(=O)C(CO)C3=CC=CC=C3,gastric inflammation,CID000004510,nitroglycerin,C(C(CO[N+](=O)[O-])O[N+](=O)[O-])O[N+](=O)[O-]
CID000003661,L-Hyoscyamine,CN1C2CCC1CC(C2)OC(=O)C(CO)C3=CC=CC=C3,gastric inflammation,CID000005544,Mycolog,CC12CC(C3(C(C1CC(C2(C(=O)CO)O)O)CCC4=CC(=O)C=CC43C)F)O
CID000003661,L-Hyoscyamine,CN1C2CCC1CC(C2)OC(=O)C(CO)C3=CC=CC=C3,Cough,CID000004900,Fernisone,CC12CC(=O)C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C
CID000003661,L-Hyoscyamine,CN1C2CCC1CC(C2)OC(=O)C(CO)C3=CC=CC=C3,dysarthria,CID000003780,"D-Glucitol, 1,4:3,6-dianhydro-, 2,5-dinitrate",C1C(C2C(O1)C(CO2)O[N+](=O)[O-])O[N+](=O)[O-]
CID000003661,L-Hyoscyamine,CN1C2CCC1CC(C2)OC(=O)C(CO)C3=CC=CC=C3,bundle branch block right,CID000003676,lidocaine,CCN(CC)CC(=O)NC1=C(C=CC=C1C)C
CID000003661,L-Hyoscyamine,CN1C2CCC1CC(C2)OC(=O)C(CO)C3=CC=CC=C3,angina,CID000003734,Bracco 15000,CC(C(=O)NC1=C(C(=C(C(=C1I)C(=O)NC(CO)CO)I)C(=O)NC(CO)CO)I)O
CID000003661,L-Hyoscyamine,CN1C2CCC1CC(C2)OC(=O)C(CO)C3=CC=CC=C3,loss of weight,CID000004666,7-Epi Paclitaxel,CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C
CID000003661,L-Hyoscyamine,CN1C2CCC1CC(C2)OC(=O)C(CO)C3=CC=CC=C3,enlarged liver,CID000005358,sumatriptan,CNS(=O)(=O)CC1=CC2=C(C=C1)NC=C2CCN(C)C
CID000003661,L-Hyoscyamine,CN1C2CCC1CC(C2)OC(=O)C(CO)C3=CC=CC=C3,Adenopathy,CID000004585,"2-methyl-4-(4-methylpiperazin-1-yl)-5H-thieno[3,2-c][1,5]benzodiazepine",CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C
CID000003661,L-Hyoscyamine,CN1C2CCC1CC(C2)OC(=O)C(CO)C3=CC=CC=C3,Acne,CID000004691,"3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine",C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4
CID000003661,L-Hyoscyamine,CN1C2CCC1CC(C2)OC(=O)C(CO)C3=CC=CC=C3,apoplexy,CID000003937,N~2~-(1-carboxy-3-phenylpropyl)lysylproline,C1CC(N(C1)C(=O)C(CCCCN)NC(CCC2=CC=CC=C2)C(=O)O)C(=O)O
CID000003278,ETHACRYNIC ACID,CCC(=C)C(=O)C1=C(C(=C(C=C1)OCC(=O)O)Cl)Cl,dermatitis exfoliative,CID000003440,furosemide,C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl
CID000071616,Voriconazole,CC(C1=NC=NC=C1F)C(CN2C=NC=N2)(C3=C(C=C(C=C3)F)F)O,weight gain,CID003468412,SCHEMBL1176571,CC1C=CC=CCCC=CC=CC=CC=CC(CC(C(C(CC(=O)CC(C(CCC(CC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)C(=O)O)O)OC2C(C(C(C(O2)C)O)N)O
CID000071616,Voriconazole,CC(C1=NC=NC=C1F)C(CN2C=NC=N2)(C3=C(C=C(C=C3)F)F)O,confusion,CID006398525,,C(C1C(C(C(C(O1)OC2(C(C(C(O2)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)COS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.[Al].[Al].[Al].[Al].[Al].[Al].[Al].[Al].[Al]
CID000071616,Voriconazole,CC(C1=NC=NC=C1F)C(CN2C=NC=N2)(C3=C(C=C(C=C3)F)F)O,Back Ache,CID000667490,6-Mercaptopurine,C1=NC2=C(N1)C(=S)N=CN2
CID000071616,Voriconazole,CC(C1=NC=NC=C1F)C(CN2C=NC=N2)(C3=C(C=C(C=C3)F)F)O,eruption,CID000147912,DSSTox_GSID_49066,CCC(C(C)O)N1C(=O)N(C=N1)C2=CC=C(C=C2)N3CCN(CC3)C4=CC=C(C=C4)OCC5CC(OC5)(CN6C=NC=N6)C7=C(C=C(C=C7)F)F
CID000004178,Mexiletine,CC1=C(C(=CC=C1)C)OCC(C)N,aspiration pneumonia,CID000004666,7-Epi Paclitaxel,CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C
CID000004178,Mexiletine,CC1=C(C(=CC=C1)C)OCC(C)N,eruption,CID000005732,zolpidem,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C
CID000004178,Mexiletine,CC1=C(C(=CC=C1)C)OCC(C)N,loss of weight,CID000005073,risperidone,CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F
CID000004178,Mexiletine,CC1=C(C(=CC=C1)C)OCC(C)N,dysarthria,CID000004510,nitroglycerin,C(C(CO[N+](=O)[O-])O[N+](=O)[O-])O[N+](=O)[O-]
CID000004178,Mexiletine,CC1=C(C(=CC=C1)C)OCC(C)N,nasopharyngitis,CID000004691,"3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine",C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4
CID000004178,Mexiletine,CC1=C(C(=CC=C1)C)OCC(C)N,chondrocalcinosis pyrophosphate,CID006398525,,C(C1C(C(C(C(O1)OC2(C(C(C(O2)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)COS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.[Al].[Al].[Al].[Al].[Al].[Al].[Al].[Al].[Al]
CID000004178,Mexiletine,CC1=C(C(=CC=C1)C)OCC(C)N,ild,CID000005245,Risedronic acid,C1=CC(=CN=C1)CC(O)(P(=O)(O)O)P(=O)(O)O
CID000004178,Mexiletine,CC1=C(C(=CC=C1)C)OCC(C)N,dysarthria,CID000004894,"11,17,21-Trihydroxypregna-1,4-diene-3,20-dione",CC12CC(C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C)O
CID000001071,9-cis retinol,CC1=C(C(CCC1)(C)C)C=CC(=CC=CC(=CCO)C)C,hemiparesis,CID000002891,"cobalt(2+);[5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] 1-[3-[2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2,7,12,17-tetrahydro-1H-corrin-21-id-3-yl]propanoylamino]propan-2-yl hydrogen phosphate;cyanide",CC1=CC2=C(C=C1C)N(C=N2)C3C(C(C(O3)CO)OP(=O)(O)OC(C)CNC(=O)CCC4(C(C5C6(C(C(C(=N6)C(=C7C(C(C(=N7)C=C8C(C(C(=N8)C(=C4[N-]5)C)CCC(=O)N)(C)C)CCC(=O)N)(C)CC(=O)N)C)CCC(=O)N)(C)CC(=O)N)C)CC(=O)N)C)O.[C-]#N.[Co+2]
CID000001071,9-cis retinol,CC1=C(C(CCC1)(C)C)C=CC(=CC=CC(=CCO)C)C,cellulitis,CID000001971,914348-29-1,C1CC1NC2=C3C(=NC(=N2)N)N(C=N3)C4CC(C=C4)CO
CID000001071,9-cis retinol,CC1=C(C(CCC1)(C)C)C=CC(=CC=CC(=CCO)C)C,increased white blood cell count,CID000003937,N~2~-(1-carboxy-3-phenylpropyl)lysylproline,C1CC(N(C1)C(=O)C(CCCCN)NC(CCC2=CC=CC=C2)C(=O)O)C(=O)O
CID000001071,9-cis retinol,CC1=C(C(CCC1)(C)C)C=CC(=CC=CC(=CCO)C)C,allergic dermatitis,CID000003440,furosemide,C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl
CID000001071,9-cis retinol,CC1=C(C(CCC1)(C)C)C=CC(=CC=CC(=CCO)C)C,loss of weight,CID000005732,zolpidem,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C
CID000001071,9-cis retinol,CC1=C(C(CCC1)(C)C)C=CC(=CC=CC(=CCO)C)C,apoplexy,CID000004900,Fernisone,CC12CC(=O)C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C
CID000001071,9-cis retinol,CC1=C(C(CCC1)(C)C)C=CC(=CC=CC(=CCO)C)C,thrombocytopenia,CID000003310,33419-42-0,CC1OCC2C(O1)C(C(C(O2)OC3C4COC(=O)C4C(C5=CC6=C(C=C35)OCO6)C7=CC(=C(C(=C7)OC)O)OC)O)O
CID000001071,9-cis retinol,CC1=C(C(CCC1)(C)C)C=CC(=CC=CC(=CCO)C)C,loss of weight,CID000001983,acetaminophen,CC(=O)NC1=CC=C(C=C1)O
CID000001071,9-cis retinol,CC1=C(C(CCC1)(C)C)C=CC(=CC=CC(=CCO)C)C,loss of weight,CID000003405,2-[[4-[(2-amino-4-oxo-1H-pteridin-6-yl)methylamino]benzoyl]amino]pentanedioic acid,C1=CC(=CC=C1C(=O)NC(CCC(=O)O)C(=O)O)NCC2=CN=C3C(=N2)C(=O)N=C(N3)N
CID000001071,9-cis retinol,CC1=C(C(CCC1)(C)C)C=CC(=CC=CC(=CCO)C)C,weight gain,CID000170361,Varenicline,C1C2CNCC1C3=CC4=NC=CN=C4C=C23
CID000001071,9-cis retinol,CC1=C(C(CCC1)(C)C)C=CC(=CC=CC(=CCO)C)C,loss of weight,CID000005544,Mycolog,CC12CC(C3(C(C1CC(C2(C(=O)CO)O)O)CCC4=CC(=O)C=CC43C)F)O
CID000001071,9-cis retinol,CC1=C(C(CCC1)(C)C)C=CC(=CC=CC(=CCO)C)C,bradycardia,CID000003954,loperamide(1+),CN(C)C(=O)C(CC[NH+]1CCC(CC1)(C2=CC=C(C=C2)Cl)O)(C3=CC=CC=C3)C4=CC=CC=C4
CID000002519,caffeine,CN1C=NC2=C1C(=O)N(C(=O)N2C)C,drug toxicity NOS,CID000002771,citalopram,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F
CID000002519,caffeine,CN1C=NC2=C1C(=O)N(C(=O)N2C)C,dysarthria,CID000003405,2-[[4-[(2-amino-4-oxo-1H-pteridin-6-yl)methylamino]benzoyl]amino]pentanedioic acid,C1=CC(=CC=C1C(=O)NC(CCC(=O)O)C(=O)O)NCC2=CN=C3C(=N2)C(=O)N=C(N3)N
CID000002519,caffeine,CN1C=NC2=C1C(=O)N(C(=O)N2C)C,neonatal respiratory distress syndrome,CID003468412,SCHEMBL1176571,CC1C=CC=CCCC=CC=CC=CC=CC(CC(C(C(CC(=O)CC(C(CCC(CC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)C(=O)O)O)OC2C(C(C(C(O2)C)O)N)O
CID000002519,caffeine,CN1C=NC2=C1C(=O)N(C(=O)N2C)C,abnormal ECG,CID000005732,zolpidem,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C
CID000002519,caffeine,CN1C=NC2=C1C(=O)N(C(=O)N2C)C,cerebral vascular disorder,CID000170361,Varenicline,C1C2CNCC1C3=CC4=NC=CN=C4C=C23
CID000004666,7-Epi Paclitaxel,CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C,right heart failure,CID000005073,risperidone,CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F
CID000004666,7-Epi Paclitaxel,CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C,Adenopathy,CID000163742,SCHEMBL1650579,COC1C(C(C(C(O1)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)COS(=O)(=O)O)OC4C(C(C(C(O4)C(=O)O)OC5C(C(C(C(O5)COS(=O)(=O)O)O)O)NS(=O)(=O)O)O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O)NS(=O)(=O)O
CID000004666,7-Epi Paclitaxel,CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C,thrombocytopenia,CID000060184,"2'-epi-Perindopril, (2'R)-",CCCC(C(=O)OCC)NC(C)C(=O)N1C2CCCCC2CC1C(=O)O
CID000004666,7-Epi Paclitaxel,CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C,erythema,CID000019090,megestrol,CC1=CC2C(CCC3(C2CCC3(C(=O)C)O)C)C4(C1=CC(=O)CC4)C
CID000004666,7-Epi Paclitaxel,CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C,nausea,CID000170361,Varenicline,C1C2CNCC1C3=CC4=NC=CN=C4C=C23
CID000004666,7-Epi Paclitaxel,CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C,cholecystitis,CID000005732,zolpidem,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C
CID000004666,7-Epi Paclitaxel,CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C,apoplexy,CID000005152,Salmeterol,C1=CC=C(C=C1)CCCCOCCCCCCNCC(C2=CC(=C(C=C2)O)CO)O
CID000004666,7-Epi Paclitaxel,CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C,gastric inflammation,CID006398525,,C(C1C(C(C(C(O1)OC2(C(C(C(O2)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)COS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.[Al].[Al].[Al].[Al].[Al].[Al].[Al].[Al].[Al]
CID000004666,7-Epi Paclitaxel,CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C,hypermagnesemia,CID000004894,"11,17,21-Trihydroxypregna-1,4-diene-3,20-dione",CC12CC(C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C)O
CID000004666,7-Epi Paclitaxel,CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C,loss of weight,CID003468412,SCHEMBL1176571,CC1C=CC=CCCC=CC=CC=CC=CC(CC(C(C(CC(=O)CC(C(CCC(CC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)C(=O)O)O)OC2C(C(C(C(O2)C)O)N)O
CID000004666,7-Epi Paclitaxel,CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C,erythema,CID000005544,Mycolog,CC12CC(C3(C(C1CC(C2(C(=O)CO)O)O)CCC4=CC(=O)C=CC43C)F)O
CID000004666,7-Epi Paclitaxel,CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C,nausea,CID000005487,tizanidine,C1CN=C(N1)NC2=C(C=CC3=NSN=C32)Cl
CID000004666,7-Epi Paclitaxel,CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C,deglutition disorder,CID000060787,sequinavir,CC(C)(C)NC(=O)C1CC2CCCCC2CN1CC(C(CC3=CC=CC=C3)NC(=O)C(CC(=O)N)NC(=O)C4=NC5=CC=CC=C5C=C4)O
CID000004666,7-Epi Paclitaxel,CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C,Drug hypersensitivity,CID000004819,"2(3H)-Furanone, 3-ethyldihydro-4-[(1-methyl-1H-imidazol-5-yl)methyl]-, (3S-cis)-",CCC1C(COC1=O)CC2=CN=CN2C
CID000004666,7-Epi Paclitaxel,CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C,loss of weight,CID000005245,Risedronic acid,C1=CC(=CN=C1)CC(O)(P(=O)(O)O)P(=O)(O)O
CID000004666,7-Epi Paclitaxel,CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C,Ovarian cancer,CID000005358,sumatriptan,CNS(=O)(=O)CC1=CC2=C(C=C1)NC=C2CCN(C)C
CID000004666,7-Epi Paclitaxel,CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C,gastric inflammation,CID000004900,Fernisone,CC12CC(=O)C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C
CID000004666,7-Epi Paclitaxel,CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C,constipated,CID000005394,temozolomide,CN1C(=O)N2C=NC(=C2N=N1)C(=O)N
CID000004666,7-Epi Paclitaxel,CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C,High blood pressure,CID000060865,(E)-Olopatadine,CN(C)CCC=C1C2=CC=CC=C2COC3=C1C=C(C=C3)CC(=O)O
CID000004666,7-Epi Paclitaxel,CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C,aspiration pneumonia,CID000005095,ropinirole,CCCN(CCC)CCC1=C2CC(=O)NC2=CC=C1
CID000004666,7-Epi Paclitaxel,CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C,Adenopathy,CID000004691,"3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine",C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4
CID000003642,13609-67-1,CCCC(=O)OC1(CCC2C1(CC(C3C2CCC4=CC(=O)CCC34C)O)C)C(=O)CO,heart rate increased,CID000003827,ketotifen,CN1CCC(=C2C3=C(C(=O)CC4=CC=CC=C42)SC=C3)CC1
CID000003642,13609-67-1,CCCC(=O)OC1(CCC2C1(CC(C3C2CCC4=CC(=O)CCC34C)O)C)C(=O)CO,Sinus headache,CID000005732,zolpidem,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C
CID000003642,13609-67-1,CCCC(=O)OC1(CCC2C1(CC(C3C2CCC4=CC(=O)CCC34C)O)C)C(=O)CO,dry skin,CID000003676,lidocaine,CCN(CC)CC(=O)NC1=C(C=CC=C1C)C
CID000002022,2-amino-9-(2-hydroxyethoxymethyl)-3H-purin-6-one,C1=NC2=C(N1COCCO)NC(=NC2=O)N,elevated cholesterol,CID000004920,"1-acetyl-9a,11a-dimethyl-1H,2H,3H,3aH,3bH,4H,5H,7H,8H,9H,9aH,9bH,10H,11H,11aH-cyclopenta[a]phenanthren-7-one",CC(=O)C1CCC2C1(CCC3C2CCC4=CC(=O)CCC34C)C
CID000002022,2-amino-9-(2-hydroxyethoxymethyl)-3H-purin-6-one,C1=NC2=C(N1COCCO)NC(=NC2=O)N,back injury,CID000002541,candesartan,CCOC1=NC2=CC=CC(=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5)C(=O)O
CID000002022,2-amino-9-(2-hydroxyethoxymethyl)-3H-purin-6-one,C1=NC2=C(N1COCCO)NC(=NC2=O)N,drug toxicity NOS,CID000060854,Ziprasidone,C1CN(CCN1CCC2=C(C=C3C(=C2)CC(=O)N3)Cl)C4=NSC5=CC=CC=C54
CID000002022,2-amino-9-(2-hydroxyethoxymethyl)-3H-purin-6-one,C1=NC2=C(N1COCCO)NC(=NC2=O)N,cholecystitis,CID000004691,"3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine",C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4
CID000002022,2-amino-9-(2-hydroxyethoxymethyl)-3H-purin-6-one,C1=NC2=C(N1COCCO)NC(=NC2=O)N,gastric inflammation,CID000003405,2-[[4-[(2-amino-4-oxo-1H-pteridin-6-yl)methylamino]benzoyl]amino]pentanedioic acid,C1=CC(=CC=C1C(=O)NC(CCC(=O)O)C(=O)O)NCC2=CN=C3C(=N2)C(=O)N=C(N3)N
CID000002022,2-amino-9-(2-hydroxyethoxymethyl)-3H-purin-6-one,C1=NC2=C(N1COCCO)NC(=NC2=O)N,loss of weight,CID000004451,CHEMBL365442,CC1=C(C=CC=C1O)C(=O)NC(CSC2=CC=CC=C2)C(CN3CC4CCCCC4CC3C(=O)NC(C)(C)C)O
CID000002022,2-amino-9-(2-hydroxyethoxymethyl)-3H-purin-6-one,C1=NC2=C(N1COCCO)NC(=NC2=O)N,gastric inflammation,CID000004158,methylphenidate,COC(=O)C(C1CCCCN1)C2=CC=CC=C2
CID000002022,2-amino-9-(2-hydroxyethoxymethyl)-3H-purin-6-one,C1=NC2=C(N1COCCO)NC(=NC2=O)N,cholecystitis,CID000002656,"7-[[2-(2-amino-1,3-thiazol-4-yl)-2-methoxyiminoacetyl]amino]-3-[(2-methyl-6-oxido-5-oxo-1,2,4-triazin-3-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CN1C(=NC(=O)C(=N1)[O-])SCC2=C(N3C(C(C3=O)NC(=O)C(=NOC)C4=CSC(=N4)N)SC2)C(=O)[O-]
CID000002022,2-amino-9-(2-hydroxyethoxymethyl)-3H-purin-6-one,C1=NC2=C(N1COCCO)NC(=NC2=O)N,apoplexy,CID000003780,"D-Glucitol, 1,4:3,6-dianhydro-, 2,5-dinitrate",C1C(C2C(O1)C(CO2)O[N+](=O)[O-])O[N+](=O)[O-]
CID000002022,2-amino-9-(2-hydroxyethoxymethyl)-3H-purin-6-one,C1=NC2=C(N1COCCO)NC(=NC2=O)N,cholecystitis,CID000002284,baclofen,C1=CC(=CC=C1C(CC(=O)O)CN)Cl
CID000002022,2-amino-9-(2-hydroxyethoxymethyl)-3H-purin-6-one,C1=NC2=C(N1COCCO)NC(=NC2=O)N,back injury,CID006398525,,C(C1C(C(C(C(O1)OC2(C(C(C(O2)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)COS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.[Al].[Al].[Al].[Al].[Al].[Al].[Al].[Al].[Al]
CID000002022,2-amino-9-(2-hydroxyethoxymethyl)-3H-purin-6-one,C1=NC2=C(N1COCCO)NC(=NC2=O)N,Adenopathy,CID000019090,megestrol,CC1=CC2C(CCC3(C2CCC3(C(=O)C)O)C)C4(C1=CC(=O)CC4)C
CID000002022,2-amino-9-(2-hydroxyethoxymethyl)-3H-purin-6-one,C1=NC2=C(N1COCCO)NC(=NC2=O)N,gastric inflammation,CID000003310,33419-42-0,CC1OCC2C(O1)C(C(C(O2)OC3C4COC(=O)C4C(C5=CC6=C(C=C35)OCO6)C7=CC(=C(C(=C7)OC)O)OC)O)O
CID000002022,2-amino-9-(2-hydroxyethoxymethyl)-3H-purin-6-one,C1=NC2=C(N1COCCO)NC(=NC2=O)N,gastric inflammation,CID000131536,Fosamprenavir,CC(C)CN(CC(C(CC1=CC=CC=C1)NC(=O)OC2CCOC2)OP(=O)(O)O)S(=O)(=O)C3=CC=C(C=C3)N
CID000002022,2-amino-9-(2-hydroxyethoxymethyl)-3H-purin-6-one,C1=NC2=C(N1COCCO)NC(=NC2=O)N,Adenopathy,CID000002891,"cobalt(2+);[5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] 1-[3-[2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2,7,12,17-tetrahydro-1H-corrin-21-id-3-yl]propanoylamino]propan-2-yl hydrogen phosphate;cyanide",CC1=CC2=C(C=C1C)N(C=N2)C3C(C(C(O3)CO)OP(=O)(O)OC(C)CNC(=O)CCC4(C(C5C6(C(C(C(=N6)C(=C7C(C(C(=N7)C=C8C(C(C(=N8)C(=C4[N-]5)C)CCC(=O)N)(C)C)CCC(=O)N)(C)CC(=O)N)C)CCC(=O)N)(C)CC(=O)N)C)CC(=O)N)C)O.[C-]#N.[Co+2]
CID000002022,2-amino-9-(2-hydroxyethoxymethyl)-3H-purin-6-one,C1=NC2=C(N1COCCO)NC(=NC2=O)N,Adenopathy,CID000147912,DSSTox_GSID_49066,CCC(C(C)O)N1C(=O)N(C=N1)C2=CC=C(C=C2)N3CCN(CC3)C4=CC=C(C=C4)OCC5CC(OC5)(CN6C=NC=N6)C7=C(C=C(C=C7)F)F
CID000002022,2-amino-9-(2-hydroxyethoxymethyl)-3H-purin-6-one,C1=NC2=C(N1COCCO)NC(=NC2=O)N,methaemoglobinaemia,CID000003440,furosemide,C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl
CID000002022,2-amino-9-(2-hydroxyethoxymethyl)-3H-purin-6-one,C1=NC2=C(N1COCCO)NC(=NC2=O)N,apoplexy,CID000005352,38194-50-2,CC1=C(C2=C(C1=CC3=CC=C(C=C3)S(=O)C)C=CC(=C2)F)CC(=O)O
CID000002022,2-amino-9-(2-hydroxyethoxymethyl)-3H-purin-6-one,C1=NC2=C(N1COCCO)NC(=NC2=O)N,gastric inflammation,CID000005358,sumatriptan,CNS(=O)(=O)CC1=CC2=C(C=C1)NC=C2CCN(C)C
CID000002022,2-amino-9-(2-hydroxyethoxymethyl)-3H-purin-6-one,C1=NC2=C(N1COCCO)NC(=NC2=O)N,erythema,CID000005095,ropinirole,CCCN(CCC)CCC1=C2CC(=O)NC2=CC=C1
CID000002022,2-amino-9-(2-hydroxyethoxymethyl)-3H-purin-6-one,C1=NC2=C(N1COCCO)NC(=NC2=O)N,Sinus headache,CID000003333,felodipine,CCOC(=O)C1=C(NC(=C(C1C2=C(C(=CC=C2)Cl)Cl)C(=O)OC)C)C
CID000002022,2-amino-9-(2-hydroxyethoxymethyl)-3H-purin-6-one,C1=NC2=C(N1COCCO)NC(=NC2=O)N,hypermagnesemia,CID000074989,ATOVAQUONE,C1CC(CCC1C2=CC=C(C=C2)Cl)C3=C(C4=CC=CC=C4C(=O)C3=O)O
CID000002022,2-amino-9-(2-hydroxyethoxymethyl)-3H-purin-6-one,C1=NC2=C(N1COCCO)NC(=NC2=O)N,drug toxicity NOS,CID000002524,32222-06-3,CC(CCCC(C)(C)O)C1CCC2C1(CCCC2=CC=C3CC(CC(C3=C)O)O)C
CID000002022,2-amino-9-(2-hydroxyethoxymethyl)-3H-purin-6-one,C1=NC2=C(N1COCCO)NC(=NC2=O)N,cholecystitis,CID000003954,loperamide(1+),CN(C)C(=O)C(CC[NH+]1CCC(CC1)(C2=CC=C(C=C2)Cl)O)(C3=CC=CC=C3)C4=CC=CC=C4
CID000002022,2-amino-9-(2-hydroxyethoxymethyl)-3H-purin-6-one,C1=NC2=C(N1COCCO)NC(=NC2=O)N,methaemoglobinaemia,CID000002771,citalopram,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F
CID000002022,2-amino-9-(2-hydroxyethoxymethyl)-3H-purin-6-one,C1=NC2=C(N1COCCO)NC(=NC2=O)N,apoplexy,CID000004170,metolazone,CC1NC2=CC(=C(C=C2C(=O)N1C3=CC=CC=C3C)S(=O)(=O)N)Cl
CID000002022,2-amino-9-(2-hydroxyethoxymethyl)-3H-purin-6-one,C1=NC2=C(N1COCCO)NC(=NC2=O)N,cholecystitis,CID000004173,metronidazole,CC1=NC=C(N1CCO)[N+](=O)[O-]
CID000002022,2-amino-9-(2-hydroxyethoxymethyl)-3H-purin-6-one,C1=NC2=C(N1COCCO)NC(=NC2=O)N,muscle inflammation,CID000002349,Cillin,CC1(C(N2C(S1)C(C2=O)NC(=O)CC3=CC=CC=C3)C(=O)O)C
CID000002022,2-amino-9-(2-hydroxyethoxymethyl)-3H-purin-6-one,C1=NC2=C(N1COCCO)NC(=NC2=O)N,acute pancreatitis,CID000003827,ketotifen,CN1CCC(=C2C3=C(C(=O)CC4=CC=CC=C42)SC=C3)CC1
CID000002022,2-amino-9-(2-hydroxyethoxymethyl)-3H-purin-6-one,C1=NC2=C(N1COCCO)NC(=NC2=O)N,agitated,CID000667490,6-Mercaptopurine,C1=NC2=C(N1)C(=S)N=CN2
CID000002022,2-amino-9-(2-hydroxyethoxymethyl)-3H-purin-6-one,C1=NC2=C(N1COCCO)NC(=NC2=O)N,Adenopathy,CID000003339,fenofibrate,CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C2=CC=C(C=C2)Cl
CID000002022,2-amino-9-(2-hydroxyethoxymethyl)-3H-purin-6-one,C1=NC2=C(N1COCCO)NC(=NC2=O)N,erythema,CID000004894,"11,17,21-Trihydroxypregna-1,4-diene-3,20-dione",CC12CC(C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C)O
CID000002022,2-amino-9-(2-hydroxyethoxymethyl)-3H-purin-6-one,C1=NC2=C(N1COCCO)NC(=NC2=O)N,apoplexy,CID000004819,"2(3H)-Furanone, 3-ethyldihydro-4-[(1-methyl-1H-imidazol-5-yl)methyl]-, (3S-cis)-",CCC1C(COC1=O)CC2=CN=CN2C
CID000002022,2-amino-9-(2-hydroxyethoxymethyl)-3H-purin-6-one,C1=NC2=C(N1COCCO)NC(=NC2=O)N,apoplexy,CID000003749,irbesartan,CCCCC1=NC2(CCCC2)C(=O)N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5
CID000002022,2-amino-9-(2-hydroxyethoxymethyl)-3H-purin-6-one,C1=NC2=C(N1COCCO)NC(=NC2=O)N,gastric inflammation,CID000005073,risperidone,CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F
CID000002022,2-amino-9-(2-hydroxyethoxymethyl)-3H-purin-6-one,C1=NC2=C(N1COCCO)NC(=NC2=O)N,Bacteraemia,CID000003042,dicyclomine,CCN(CC)CCOC(=O)C1(CCCCC1)C2CCCCC2
CID000002022,2-amino-9-(2-hydroxyethoxymethyl)-3H-purin-6-one,C1=NC2=C(N1COCCO)NC(=NC2=O)N,cholecystitis,CID000003937,N~2~-(1-carboxy-3-phenylpropyl)lysylproline,C1CC(N(C1)C(=O)C(CCCCN)NC(CCC2=CC=CC=C2)C(=O)O)C(=O)O
CID000002022,2-amino-9-(2-hydroxyethoxymethyl)-3H-purin-6-one,C1=NC2=C(N1COCCO)NC(=NC2=O)N,gastric inflammation,CID000005544,Mycolog,CC12CC(C3(C(C1CC(C2(C(=O)CO)O)O)CCC4=CC(=O)C=CC43C)F)O
CID000002022,2-amino-9-(2-hydroxyethoxymethyl)-3H-purin-6-one,C1=NC2=C(N1COCCO)NC(=NC2=O)N,methaemoglobinaemia,CID000005732,zolpidem,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C
CID000002022,2-amino-9-(2-hydroxyethoxymethyl)-3H-purin-6-one,C1=NC2=C(N1COCCO)NC(=NC2=O)N,cholecystitis,CID000005245,Risedronic acid,C1=CC(=CN=C1)CC(O)(P(=O)(O)O)P(=O)(O)O
CID000002022,2-amino-9-(2-hydroxyethoxymethyl)-3H-purin-6-one,C1=NC2=C(N1COCCO)NC(=NC2=O)N,gastric inflammation,CID000002713,55-56-1,C1=CC(=CC=C1NC(=NC(=NCCCCCCN=C(N)N=C(N)NC2=CC=C(C=C2)Cl)N)N)Cl
CID000002022,2-amino-9-(2-hydroxyethoxymethyl)-3H-purin-6-one,C1=NC2=C(N1COCCO)NC(=NC2=O)N,gastric inflammation,CID000003676,lidocaine,CCN(CC)CC(=O)NC1=C(C=CC=C1C)C
CID000002022,2-amino-9-(2-hydroxyethoxymethyl)-3H-purin-6-one,C1=NC2=C(N1COCCO)NC(=NC2=O)N,bladder retention,CID003468412,SCHEMBL1176571,CC1C=CC=CCCC=CC=CC=CC=CC(CC(C(C(CC(=O)CC(C(CCC(CC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)C(=O)O)O)OC2C(C(C(C(O2)C)O)N)O
CID000002022,2-amino-9-(2-hydroxyethoxymethyl)-3H-purin-6-one,C1=NC2=C(N1COCCO)NC(=NC2=O)N,gastric inflammation,CID000002462,51372-29-3,CCCC1OC2CC3C4CCC5=CC(=O)C=CC5(C4C(CC3(C2(O1)C(=O)CO)C)O)C
CID000002022,2-amino-9-(2-hydroxyethoxymethyl)-3H-purin-6-one,C1=NC2=C(N1COCCO)NC(=NC2=O)N,ADH inappropriate,CID000060184,"2'-epi-Perindopril, (2'R)-",CCCC(C(=O)OCC)NC(C)C(=O)N1C2CCCCC2CC1C(=O)O
CID000002022,2-amino-9-(2-hydroxyethoxymethyl)-3H-purin-6-one,C1=NC2=C(N1COCCO)NC(=NC2=O)N,gastric inflammation,CID000002088,ALENDRONIC ACID,C(CC(O)(P(=O)(O)O)P(=O)(O)O)CN
CID000002022,2-amino-9-(2-hydroxyethoxymethyl)-3H-purin-6-one,C1=NC2=C(N1COCCO)NC(=NC2=O)N,Adenopathy,CID000003961,losartan,CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)CO)Cl
CID000002022,2-amino-9-(2-hydroxyethoxymethyl)-3H-purin-6-one,C1=NC2=C(N1COCCO)NC(=NC2=O)N,insulin dependent diabetes mellitus,CID000005394,temozolomide,CN1C(=O)N2C=NC(=C2N=N1)C(=O)N
CID000002022,2-amino-9-(2-hydroxyethoxymethyl)-3H-purin-6-one,C1=NC2=C(N1COCCO)NC(=NC2=O)N,cellulitis,CID000005487,tizanidine,C1CN=C(N1)NC2=C(C=CC3=NSN=C32)Cl
CID000002022,2-amino-9-(2-hydroxyethoxymethyl)-3H-purin-6-one,C1=NC2=C(N1COCCO)NC(=NC2=O)N,gastric inflammation,CID000005152,Salmeterol,C1=CC=C(C=C1)CCCCOCCCCCCNCC(C2=CC(=C(C=C2)O)CO)O
CID000002022,2-amino-9-(2-hydroxyethoxymethyl)-3H-purin-6-one,C1=NC2=C(N1COCCO)NC(=NC2=O)N,gastric inflammation,CID000003516,guaifenesin,COC1=CC=CC=C1OCC(CO)O
CID000002022,2-amino-9-(2-hydroxyethoxymethyl)-3H-purin-6-one,C1=NC2=C(N1COCCO)NC(=NC2=O)N,cholecystitis,CID000003062,Lanicor,CC1C(C(CC(O1)OC2C(OC(CC2O)OC3C(OC(CC3O)OC4CCC5(C(C4)CCC6C5CC(C7(C6(CCC7C8=CC(=O)OC8)O)C)O)C)C)C)O)O
CID000002022,2-amino-9-(2-hydroxyethoxymethyl)-3H-purin-6-one,C1=NC2=C(N1COCCO)NC(=NC2=O)N,apoplexy,CID000012536,638-94-8,CC1(OC2CC3C4CCC5=CC(=O)C=CC5(C4C(CC3(C2(O1)C(=O)CO)C)O)C)C
CID000002022,2-amino-9-(2-hydroxyethoxymethyl)-3H-purin-6-one,C1=NC2=C(N1COCCO)NC(=NC2=O)N,allergic dermatitis,CID000004536,Minovlar,CC12CCC3C(C1CCC2(C#C)O)CCC4=CC(=O)CCC34
CID000002022,2-amino-9-(2-hydroxyethoxymethyl)-3H-purin-6-one,C1=NC2=C(N1COCCO)NC(=NC2=O)N,gastric inflammation,CID000004900,Fernisone,CC12CC(=O)C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C
CID000002022,2-amino-9-(2-hydroxyethoxymethyl)-3H-purin-6-one,C1=NC2=C(N1COCCO)NC(=NC2=O)N,loss of weight,CID000005719,zaleplon,CCN(C1=CC=CC(=C1)C2=CC=NC3=C(C=NN23)C#N)C(=O)C
CID000002022,2-amino-9-(2-hydroxyethoxymethyl)-3H-purin-6-one,C1=NC2=C(N1COCCO)NC(=NC2=O)N,cholecystitis,CID000004585,"2-methyl-4-(4-methylpiperazin-1-yl)-5H-thieno[3,2-c][1,5]benzodiazepine",CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C
CID000002022,2-amino-9-(2-hydroxyethoxymethyl)-3H-purin-6-one,C1=NC2=C(N1COCCO)NC(=NC2=O)N,hypermagnesemia,CID000002405,BISOPROLOL,CC(C)NCC(COC1=CC=C(C=C1)COCCOC(C)C)O
CID000002022,2-amino-9-(2-hydroxyethoxymethyl)-3H-purin-6-one,C1=NC2=C(N1COCCO)NC(=NC2=O)N,metabolic encephalopathy,CID000003869,labetalol,CC(CCC1=CC=CC=C1)NCC(C2=CC(=C(C=C2)O)C(=O)N)O
CID000002022,2-amino-9-(2-hydroxyethoxymethyl)-3H-purin-6-one,C1=NC2=C(N1COCCO)NC(=NC2=O)N,gastric inflammation,CID000004205,mirtazapine,CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4
CID000002022,2-amino-9-(2-hydroxyethoxymethyl)-3H-purin-6-one,C1=NC2=C(N1COCCO)NC(=NC2=O)N,cholecystitis,CID000060787,sequinavir,CC(C)(C)NC(=O)C1CC2CCCCC2CN1CC(C(CC3=CC=CC=C3)NC(=O)C(CC(=O)N)NC(=O)C4=NC5=CC=CC=C5C=C4)O
CID000002022,2-amino-9-(2-hydroxyethoxymethyl)-3H-purin-6-one,C1=NC2=C(N1COCCO)NC(=NC2=O)N,apoplexy,CID000060865,(E)-Olopatadine,CN(C)CCC=C1C2=CC=CC=C2COC3=C1C=C(C=C3)CC(=O)O
CID000002022,2-amino-9-(2-hydroxyethoxymethyl)-3H-purin-6-one,C1=NC2=C(N1COCCO)NC(=NC2=O)N,gastric inflammation,CID000002478,busulfan,CS(=O)(=O)OCCCCOS(=O)(=O)C
CID000002022,2-amino-9-(2-hydroxyethoxymethyl)-3H-purin-6-one,C1=NC2=C(N1COCCO)NC(=NC2=O)N,gastric inflammation,CID000004510,nitroglycerin,C(C(CO[N+](=O)[O-])O[N+](=O)[O-])O[N+](=O)[O-]
CID000002022,2-amino-9-(2-hydroxyethoxymethyl)-3H-purin-6-one,C1=NC2=C(N1COCCO)NC(=NC2=O)N,Back Ache,CID000170361,Varenicline,C1C2CNCC1C3=CC4=NC=CN=C4C=C23
CID000002022,2-amino-9-(2-hydroxyethoxymethyl)-3H-purin-6-one,C1=NC2=C(N1COCCO)NC(=NC2=O)N,Adenopathy,CID000003706,SCHEMBL1176257,CC(C)(C)NC(=O)C1CN(CCN1CC(CC(CC2=CC=CC=C2)C(=O)NC3C(CC4=CC=CC=C34)O)O)CC5=CN=CC=C5
CID000002022,2-amino-9-(2-hydroxyethoxymethyl)-3H-purin-6-one,C1=NC2=C(N1COCCO)NC(=NC2=O)N,neumonia,CID000004189,miconazole,C1=CC(=C(C=C1Cl)Cl)COC(CN2C=CN=C2)C3=C(C=C(C=C3)Cl)Cl
CID000004173,metronidazole,CC1=NC=C(N1CCO)[N+](=O)[O-],erythema,CID000004920,"1-acetyl-9a,11a-dimethyl-1H,2H,3H,3aH,3bH,4H,5H,7H,8H,9H,9aH,9bH,10H,11H,11aH-cyclopenta[a]phenanthren-7-one",CC(=O)C1CCC2C1(CCC3C2CCC4=CC(=O)CCC34C)C
CID000004173,metronidazole,CC1=NC=C(N1CCO)[N+](=O)[O-],cholecystitis,CID000005487,tizanidine,C1CN=C(N1)NC2=C(C=CC3=NSN=C32)Cl
CID000004173,metronidazole,CC1=NC=C(N1CCO)[N+](=O)[O-],cholecystitis,CID000004894,"11,17,21-Trihydroxypregna-1,4-diene-3,20-dione",CC12CC(C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C)O
CID000004173,metronidazole,CC1=NC=C(N1CCO)[N+](=O)[O-],erythema,CID000147912,DSSTox_GSID_49066,CCC(C(C)O)N1C(=O)N(C=N1)C2=CC=C(C=C2)N3CCN(CC3)C4=CC=C(C=C4)OCC5CC(OC5)(CN6C=NC=N6)C7=C(C=C(C=C7)F)F
CID000004173,metronidazole,CC1=NC=C(N1CCO)[N+](=O)[O-],periodontitis,CID000004819,"2(3H)-Furanone, 3-ethyldihydro-4-[(1-methyl-1H-imidazol-5-yl)methyl]-, (3S-cis)-",CCC1C(COC1=O)CC2=CN=CN2C
CID000004173,metronidazole,CC1=NC=C(N1CCO)[N+](=O)[O-],Adenopathy,CID006447131,Pimecrolimus,CCC1C=C(CC(CC(C2C(CC(C(O2)(C(=O)C(=O)N3CCCCC3C(=O)OC(C(C(CC1=O)O)C)C(=CC4CCC(C(C4)OC)Cl)C)O)C)OC)OC)C)C
CID000004173,metronidazole,CC1=NC=C(N1CCO)[N+](=O)[O-],gastric inflammation,CID000004691,"3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine",C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4
CID000004173,metronidazole,CC1=NC=C(N1CCO)[N+](=O)[O-],cellulitis,CID000004451,CHEMBL365442,CC1=C(C=CC=C1O)C(=O)NC(CSC2=CC=CC=C2)C(CN3CC4CCCCC4CC3C(=O)NC(C)(C)C)O
CID000004173,metronidazole,CC1=NC=C(N1CCO)[N+](=O)[O-],insulin dependent diabetes mellitus,CID000005719,zaleplon,CCN(C1=CC=CC(=C1)C2=CC=NC3=C(C=NN23)C#N)C(=O)C
CID000004173,metronidazole,CC1=NC=C(N1CCO)[N+](=O)[O-],weight gain,CID000005095,ropinirole,CCCN(CCC)CCC1=C2CC(=O)NC2=CC=C1
CID000004173,metronidazole,CC1=NC=C(N1CCO)[N+](=O)[O-],cholecystitis,CID000004205,mirtazapine,CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4
CID000004173,metronidazole,CC1=NC=C(N1CCO)[N+](=O)[O-],Back Ache,CID005311082,"2-[(1R,4S,10S,13S,19S)-19-[4-(diaminomethylideneamino)butyl]-10-(1H-indol-3-ylmethyl)-3,9,12,15,18,21,27-heptaoxo-24,25-dithia-2,8,11,14,17,20-hexazatricyclo[18.6.1.04,8]heptacosan-13-yl]acetic acid",C1CC2C(=O)NC3CSSCCC(=O)N(C3=O)C(C(=O)NCC(=O)NC(C(=O)NC(C(=O)N2C1)CC4=CNC5=CC=CC=C54)CC(=O)O)CCCCN=C(N)N
CID000004173,metronidazole,CC1=NC=C(N1CCO)[N+](=O)[O-],myelodysplasia,CID000005394,temozolomide,CN1C(=O)N2C=NC(=C2N=N1)C(=O)N
CID000004173,metronidazole,CC1=NC=C(N1CCO)[N+](=O)[O-],cholecystitis,CID000004585,"2-methyl-4-(4-methylpiperazin-1-yl)-5H-thieno[3,2-c][1,5]benzodiazepine",CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C
CID000004173,metronidazole,CC1=NC=C(N1CCO)[N+](=O)[O-],angiitis,CID000005358,sumatriptan,CNS(=O)(=O)CC1=CC2=C(C=C1)NC=C2CCN(C)C
CID000004173,metronidazole,CC1=NC=C(N1CCO)[N+](=O)[O-],hepatitis,CID000005352,38194-50-2,CC1=C(C2=C(C1=CC3=CC=C(C=C3)S(=O)C)C=CC(=C2)F)CC(=O)O
CID000004173,metronidazole,CC1=NC=C(N1CCO)[N+](=O)[O-],gastric inflammation,CID000012536,638-94-8,CC1(OC2CC3C4CCC5=CC(=O)C=CC5(C4C(CC3(C2(O1)C(=O)CO)C)O)C)C
CID000004173,metronidazole,CC1=NC=C(N1CCO)[N+](=O)[O-],nausea,CID000074989,ATOVAQUONE,C1CC(CCC1C2=CC=C(C=C2)Cl)C3=C(C4=CC=CC=C4C(=O)C3=O)O
CID000004173,metronidazole,CC1=NC=C(N1CCO)[N+](=O)[O-],loss of weight,CID000060184,"2'-epi-Perindopril, (2'R)-",CCCC(C(=O)OCC)NC(C)C(=O)N1C2CCCCC2CC1C(=O)O
CID000004173,metronidazole,CC1=NC=C(N1CCO)[N+](=O)[O-],apoplexy,CID000004189,miconazole,C1=CC(=C(C=C1Cl)Cl)COC(CN2C=CN=C2)C3=C(C=C(C=C3)Cl)Cl
CID000004173,metronidazole,CC1=NC=C(N1CCO)[N+](=O)[O-],bladder retention,CID000005073,risperidone,CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F
CID000004173,metronidazole,CC1=NC=C(N1CCO)[N+](=O)[O-],cholecystitis,CID003468412,SCHEMBL1176571,CC1C=CC=CCCC=CC=CC=CC=CC(CC(C(C(CC(=O)CC(C(CCC(CC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)C(=O)O)O)OC2C(C(C(C(O2)C)O)N)O
CID000004173,metronidazole,CC1=NC=C(N1CCO)[N+](=O)[O-],herpes zoster,CID000060787,sequinavir,CC(C)(C)NC(=O)C1CC2CCCCC2CN1CC(C(CC3=CC=CC=C3)NC(=O)C(CC(=O)N)NC(=O)C4=NC5=CC=CC=C5C=C4)O
CID000004173,metronidazole,CC1=NC=C(N1CCO)[N+](=O)[O-],colitis ischemic,CID000060854,Ziprasidone,C1CN(CCN1CCC2=C(C=C3C(=C2)CC(=O)N3)Cl)C4=NSC5=CC=CC=C54
CID000004173,metronidazole,CC1=NC=C(N1CCO)[N+](=O)[O-],cholecystectomies,CID006398525,,C(C1C(C(C(C(O1)OC2(C(C(C(O2)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)COS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.[Al].[Al].[Al].[Al].[Al].[Al].[Al].[Al].[Al]
CID000004173,metronidazole,CC1=NC=C(N1CCO)[N+](=O)[O-],myocarditis,CID000036811,dobutamine,CC(CCC1=CC=C(C=C1)O)NCCC2=CC(=C(C=C2)O)O
CID000004173,metronidazole,CC1=NC=C(N1CCO)[N+](=O)[O-],gastric inflammation,CID000004201,minoxidil,C1CCN(CC1)C2=NC(=N)N(C(=C2)N)O
CID000004173,metronidazole,CC1=NC=C(N1CCO)[N+](=O)[O-],perirectal abscess,CID000131536,Fosamprenavir,CC(C)CN(CC(C(CC1=CC=CC=C1)NC(=O)OC2CCOC2)OP(=O)(O)O)S(=O)(=O)C3=CC=C(C=C3)N
CID000004173,metronidazole,CC1=NC=C(N1CCO)[N+](=O)[O-],gastric inflammation,CID000005732,zolpidem,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C
CID000004173,metronidazole,CC1=NC=C(N1CCO)[N+](=O)[O-],Adenopathy,CID000005544,Mycolog,CC12CC(C3(C(C1CC(C2(C(=O)CO)O)O)CCC4=CC(=O)C=CC43C)F)O
CID000004173,metronidazole,CC1=NC=C(N1CCO)[N+](=O)[O-],deglutition disorder,CID000170361,Varenicline,C1C2CNCC1C3=CC4=NC=CN=C4C=C23
CID000004173,metronidazole,CC1=NC=C(N1CCO)[N+](=O)[O-],periodontitis,CID000060865,(E)-Olopatadine,CN(C)CCC=C1C2=CC=CC=C2COC3=C1C=C(C=C3)CC(=O)O
CID000004173,metronidazole,CC1=NC=C(N1CCO)[N+](=O)[O-],Dyspnea exertional,CID000667490,6-Mercaptopurine,C1=NC2=C(N1)C(=S)N=CN2
CID000004173,metronidazole,CC1=NC=C(N1CCO)[N+](=O)[O-],cholecystectomies,CID000004510,nitroglycerin,C(C(CO[N+](=O)[O-])O[N+](=O)[O-])O[N+](=O)[O-]
CID000004173,metronidazole,CC1=NC=C(N1CCO)[N+](=O)[O-],cholecystitis,CID000019090,megestrol,CC1=CC2C(CCC3(C2CCC3(C(=O)C)O)C)C4(C1=CC(=O)CC4)C
CID000004173,metronidazole,CC1=NC=C(N1CCO)[N+](=O)[O-],erythema,CID000005152,Salmeterol,C1=CC=C(C=C1)CCCCOCCCCCCNCC(C2=CC(=C(C=C2)O)CO)O
CID000004173,metronidazole,CC1=NC=C(N1CCO)[N+](=O)[O-],gastric inflammation,CID000004900,Fernisone,CC12CC(=O)C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C
CID000004173,metronidazole,CC1=NC=C(N1CCO)[N+](=O)[O-],apoplexy,CID000005245,Risedronic acid,C1=CC(=CN=C1)CC(O)(P(=O)(O)O)P(=O)(O)O
CID000003305,Etidronic acid,CC(O)(P(=O)(O)O)P(=O)(O)O,Alcoholic intoxication,CID000005073,risperidone,CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F
CID000003305,Etidronic acid,CC(O)(P(=O)(O)O)P(=O)(O)O,myelodysplasia,CID000005245,Risedronic acid,C1=CC(=CN=C1)CC(O)(P(=O)(O)O)P(=O)(O)O
CID000003305,Etidronic acid,CC(O)(P(=O)(O)O)P(=O)(O)O,hepatitis,CID000003339,fenofibrate,CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C2=CC=C(C=C2)Cl
CID000003305,Etidronic acid,CC(O)(P(=O)(O)O)P(=O)(O)O,Diplopia,CID000003440,furosemide,C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl
CID000003305,Etidronic acid,CC(O)(P(=O)(O)O)P(=O)(O)O,Back Ache,CID000004900,Fernisone,CC12CC(=O)C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C
CID000003305,Etidronic acid,CC(O)(P(=O)(O)O)P(=O)(O)O,agitated,CID000004510,nitroglycerin,C(C(CO[N+](=O)[O-])O[N+](=O)[O-])O[N+](=O)[O-]
CID000003305,Etidronic acid,CC(O)(P(=O)(O)O)P(=O)(O)O,agitated,CID000003954,loperamide(1+),CN(C)C(=O)C(CC[NH+]1CCC(CC1)(C2=CC=C(C=C2)Cl)O)(C3=CC=CC=C3)C4=CC=CC=C4
CID000003305,Etidronic acid,CC(O)(P(=O)(O)O)P(=O)(O)O,High blood pressure,CID000004691,"3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine",C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4
CID000003305,Etidronic acid,CC(O)(P(=O)(O)O)P(=O)(O)O,anaemia,CID000004158,methylphenidate,COC(=O)C(C1CCCCN1)C2=CC=CC=C2
CID000003305,Etidronic acid,CC(O)(P(=O)(O)O)P(=O)(O)O,proctitis,CID000003961,losartan,CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)CO)Cl
CID000003305,Etidronic acid,CC(O)(P(=O)(O)O)P(=O)(O)O,atelectasis,CID000003405,2-[[4-[(2-amino-4-oxo-1H-pteridin-6-yl)methylamino]benzoyl]amino]pentanedioic acid,C1=CC(=CC=C1C(=O)NC(CCC(=O)O)C(=O)O)NCC2=CN=C3C(=N2)C(=O)N=C(N3)N
CID000003305,Etidronic acid,CC(O)(P(=O)(O)O)P(=O)(O)O,loss of weight,CID000005732,zolpidem,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C
CID000003305,Etidronic acid,CC(O)(P(=O)(O)O)P(=O)(O)O,Dyspnea exertional,CID000004894,"11,17,21-Trihydroxypregna-1,4-diene-3,20-dione",CC12CC(C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C)O
CID000003305,Etidronic acid,CC(O)(P(=O)(O)O)P(=O)(O)O,gastric inflammation,CID000003937,N~2~-(1-carboxy-3-phenylpropyl)lysylproline,C1CC(N(C1)C(=O)C(CCCCN)NC(CCC2=CC=CC=C2)C(=O)O)C(=O)O
CID000003305,Etidronic acid,CC(O)(P(=O)(O)O)P(=O)(O)O,agitated,CID000003676,lidocaine,CCN(CC)CC(=O)NC1=C(C=CC=C1C)C
CID000003305,Etidronic acid,CC(O)(P(=O)(O)O)P(=O)(O)O,Pain,CID003468412,SCHEMBL1176571,CC1C=CC=CCCC=CC=CC=CC=CC(CC(C(C(CC(=O)CC(C(CCC(CC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)C(=O)O)O)OC2C(C(C(C(O2)C)O)N)O
CID000003305,Etidronic acid,CC(O)(P(=O)(O)O)P(=O)(O)O,thrombocytopenia,CID000005352,38194-50-2,CC1=C(C2=C(C1=CC3=CC=C(C=C3)S(=O)C)C=CC(=C2)F)CC(=O)O
CID000002541,candesartan,CCOC1=NC2=CC=CC(=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5)C(=O)O,cholecystitis,CID000003961,losartan,CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)CO)Cl
CID000002541,candesartan,CCOC1=NC2=CC=CC(=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5)C(=O)O,malabsorption,CID000003440,furosemide,C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl
CID000002541,candesartan,CCOC1=NC2=CC=CC(=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5)C(=O)O,apoplexy,CID000005095,ropinirole,CCCN(CCC)CCC1=C2CC(=O)NC2=CC=C1
CID000002541,candesartan,CCOC1=NC2=CC=CC(=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5)C(=O)O,angiitis,CID000005544,Mycolog,CC12CC(C3(C(C1CC(C2(C(=O)CO)O)O)CCC4=CC(=O)C=CC43C)F)O
CID000002541,candesartan,CCOC1=NC2=CC=CC(=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5)C(=O)O,loss of weight,CID000004170,metolazone,CC1NC2=CC(=C(C=C2C(=O)N1C3=CC=CC=C3C)S(=O)(=O)N)Cl
CID000002541,candesartan,CCOC1=NC2=CC=CC(=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5)C(=O)O,gastric inflammation,CID000004894,"11,17,21-Trihydroxypregna-1,4-diene-3,20-dione",CC12CC(C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C)O
CID000002541,candesartan,CCOC1=NC2=CC=CC(=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5)C(=O)O,Adenopathy,CID000003516,guaifenesin,COC1=CC=CC=C1OCC(CO)O
CID000002541,candesartan,CCOC1=NC2=CC=CC(=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5)C(=O)O,abdominal pain upper,CID000004819,"2(3H)-Furanone, 3-ethyldihydro-4-[(1-methyl-1H-imidazol-5-yl)methyl]-, (3S-cis)-",CCC1C(COC1=O)CC2=CN=CN2C
CID000002541,candesartan,CCOC1=NC2=CC=CC(=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5)C(=O)O,weight gain,CID000060184,"2'-epi-Perindopril, (2'R)-",CCCC(C(=O)OCC)NC(C)C(=O)N1C2CCCCC2CC1C(=O)O
CID000002541,candesartan,CCOC1=NC2=CC=CC(=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5)C(=O)O,contact dermatitis,CID000003869,labetalol,CC(CCC1=CC=CC=C1)NCC(C2=CC(=C(C=C2)O)C(=O)N)O
CID000002541,candesartan,CCOC1=NC2=CC=CC(=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5)C(=O)O,gastric inflammation,CID000005245,Risedronic acid,C1=CC(=CN=C1)CC(O)(P(=O)(O)O)P(=O)(O)O
CID000002541,candesartan,CCOC1=NC2=CC=CC(=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5)C(=O)O,Bleeding,CID000060787,sequinavir,CC(C)(C)NC(=O)C1CC2CCCCC2CN1CC(C(CC3=CC=CC=C3)NC(=O)C(CC(=O)N)NC(=O)C4=NC5=CC=CC=C5C=C4)O
CID000002541,candesartan,CCOC1=NC2=CC=CC(=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5)C(=O)O,abnormal ECG,CID000003780,"D-Glucitol, 1,4:3,6-dianhydro-, 2,5-dinitrate",C1C(C2C(O1)C(CO2)O[N+](=O)[O-])O[N+](=O)[O-]
CID000002541,candesartan,CCOC1=NC2=CC=CC(=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5)C(=O)O,gastric inflammation,CID006398525,,C(C1C(C(C(C(O1)OC2(C(C(C(O2)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)COS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.[Al].[Al].[Al].[Al].[Al].[Al].[Al].[Al].[Al]
CID000002541,candesartan,CCOC1=NC2=CC=CC(=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5)C(=O)O,thrombocytopenia,CID000004201,minoxidil,C1CCN(CC1)C2=NC(=N)N(C(=C2)N)O
CID000002541,candesartan,CCOC1=NC2=CC=CC(=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5)C(=O)O,apoplexy,CID003468412,SCHEMBL1176571,CC1C=CC=CCCC=CC=CC=CC=CC(CC(C(C(CC(=O)CC(C(CCC(CC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)C(=O)O)O)OC2C(C(C(C(O2)C)O)N)O
CID000002541,candesartan,CCOC1=NC2=CC=CC(=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5)C(=O)O,respiratory alkalosis,CID000003310,33419-42-0,CC1OCC2C(O1)C(C(C(O2)OC3C4COC(=O)C4C(C5=CC6=C(C=C35)OCO6)C7=CC(=C(C(=C7)OC)O)OC)O)O
CID000002541,candesartan,CCOC1=NC2=CC=CC(=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5)C(=O)O,cholecystitis,CID000003062,Lanicor,CC1C(C(CC(O1)OC2C(OC(CC2O)OC3C(OC(CC3O)OC4CCC5(C(C4)CCC6C5CC(C7(C6(CCC7C8=CC(=O)OC8)O)C)O)C)C)C)O)O
CID000002541,candesartan,CCOC1=NC2=CC=CC(=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5)C(=O)O,gastric inflammation,CID000003405,2-[[4-[(2-amino-4-oxo-1H-pteridin-6-yl)methylamino]benzoyl]amino]pentanedioic acid,C1=CC(=CC=C1C(=O)NC(CCC(=O)O)C(=O)O)NCC2=CN=C3C(=N2)C(=O)N=C(N3)N
CID000002541,candesartan,CCOC1=NC2=CC=CC(=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5)C(=O)O,myelodysplasia,CID000004510,nitroglycerin,C(C(CO[N+](=O)[O-])O[N+](=O)[O-])O[N+](=O)[O-]
CID000002541,candesartan,CCOC1=NC2=CC=CC(=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5)C(=O)O,back injury,CID000004900,Fernisone,CC12CC(=O)C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C
CID000002541,candesartan,CCOC1=NC2=CC=CC(=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5)C(=O)O,atelectasis,CID000002656,"7-[[2-(2-amino-1,3-thiazol-4-yl)-2-methoxyiminoacetyl]amino]-3-[(2-methyl-6-oxido-5-oxo-1,2,4-triazin-3-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CN1C(=NC(=O)C(=N1)[O-])SCC2=C(N3C(C(C3=O)NC(=O)C(=NOC)C4=CSC(=N4)N)SC2)C(=O)[O-]
CID000002541,candesartan,CCOC1=NC2=CC=CC(=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5)C(=O)O,apoplexy,CID000170361,Varenicline,C1C2CNCC1C3=CC4=NC=CN=C4C=C23
CID000002541,candesartan,CCOC1=NC2=CC=CC(=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5)C(=O)O,loss of weight,CID000004205,mirtazapine,CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4
CID000002541,candesartan,CCOC1=NC2=CC=CC(=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5)C(=O)O,apoplexy,CID000002891,"cobalt(2+);[5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] 1-[3-[2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2,7,12,17-tetrahydro-1H-corrin-21-id-3-yl]propanoylamino]propan-2-yl hydrogen phosphate;cyanide",CC1=CC2=C(C=C1C)N(C=N2)C3C(C(C(O3)CO)OP(=O)(O)OC(C)CNC(=O)CCC4(C(C5C6(C(C(C(=N6)C(=C7C(C(C(=N7)C=C8C(C(C(=N8)C(=C4[N-]5)C)CCC(=O)N)(C)C)CCC(=O)N)(C)CC(=O)N)C)CCC(=O)N)(C)CC(=O)N)C)CC(=O)N)C)O.[C-]#N.[Co+2]
CID000002541,candesartan,CCOC1=NC2=CC=CC(=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5)C(=O)O,cholecystitis,CID000005732,zolpidem,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C
CID000002541,candesartan,CCOC1=NC2=CC=CC(=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5)C(=O)O,abnormal EEG,CID000005152,Salmeterol,C1=CC=C(C=C1)CCCCOCCCCCCNCC(C2=CC(=C(C=C2)O)CO)O
CID000002541,candesartan,CCOC1=NC2=CC=CC(=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5)C(=O)O,cholecystitis,CID000004691,"3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine",C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4
CID000002541,candesartan,CCOC1=NC2=CC=CC(=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5)C(=O)O,loss of weight,CID000003954,loperamide(1+),CN(C)C(=O)C(CC[NH+]1CCC(CC1)(C2=CC=C(C=C2)Cl)O)(C3=CC=CC=C3)C4=CC=CC=C4
CID000002541,candesartan,CCOC1=NC2=CC=CC(=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5)C(=O)O,abnormal ECG,CID000003749,irbesartan,CCCCC1=NC2(CCCC2)C(=O)N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5
CID000002541,candesartan,CCOC1=NC2=CC=CC(=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5)C(=O)O,constipated,CID000002609,Lilly 99638,C1C(=C(N2C(S1)C(C2=O)NC(=O)C(C3=CC=CC=C3)N)C(=O)O)Cl
CID000002541,candesartan,CCOC1=NC2=CC=CC(=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5)C(=O)O,gastric inflammation,CID000003339,fenofibrate,CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C2=CC=C(C=C2)Cl
CID000002541,candesartan,CCOC1=NC2=CC=CC(=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5)C(=O)O,Dyspnea exertional,CID000003333,felodipine,CCOC(=O)C1=C(NC(=C(C1C2=C(C(=CC=C2)Cl)Cl)C(=O)OC)C)C
CID000002541,candesartan,CCOC1=NC2=CC=CC(=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5)C(=O)O,hyperlipaemia,CID000003827,ketotifen,CN1CCC(=C2C3=C(C(=O)CC4=CC=CC=C42)SC=C3)CC1
CID000002541,candesartan,CCOC1=NC2=CC=CC(=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5)C(=O)O,myelodysplasia,CID000002771,citalopram,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F
CID000002541,candesartan,CCOC1=NC2=CC=CC(=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5)C(=O)O,Back Ache,CID000005487,tizanidine,C1CN=C(N1)NC2=C(C=CC3=NSN=C32)Cl
CID000002541,candesartan,CCOC1=NC2=CC=CC(=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5)C(=O)O,cellulitis,CID000004920,"1-acetyl-9a,11a-dimethyl-1H,2H,3H,3aH,3bH,4H,5H,7H,8H,9H,9aH,9bH,10H,11H,11aH-cyclopenta[a]phenanthren-7-one",CC(=O)C1CCC2C1(CCC3C2CCC4=CC(=O)CCC34C)C
CID000002541,candesartan,CCOC1=NC2=CC=CC(=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5)C(=O)O,thrombocytopenia,CID000004158,methylphenidate,COC(=O)C(C1CCCCN1)C2=CC=CC=C2
CID000002541,candesartan,CCOC1=NC2=CC=CC(=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5)C(=O)O,abnormal ECG,CID000004585,"2-methyl-4-(4-methylpiperazin-1-yl)-5H-thieno[3,2-c][1,5]benzodiazepine",CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C
CID000002541,candesartan,CCOC1=NC2=CC=CC(=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5)C(=O)O,cholecystitis,CID000003937,N~2~-(1-carboxy-3-phenylpropyl)lysylproline,C1CC(N(C1)C(=O)C(CCCCN)NC(CCC2=CC=CC=C2)C(=O)O)C(=O)O
CID000002541,candesartan,CCOC1=NC2=CC=CC(=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5)C(=O)O,Infection Upper Respiratory,CID000003676,lidocaine,CCN(CC)CC(=O)NC1=C(C=CC=C1C)C
CID000002541,candesartan,CCOC1=NC2=CC=CC(=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5)C(=O)O,insulin dependent diabetes mellitus,CID000005073,risperidone,CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F
CID000002541,candesartan,CCOC1=NC2=CC=CC(=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5)C(=O)O,gingivitis,CID000019090,megestrol,CC1=CC2C(CCC3(C2CCC3(C(=O)C)O)C)C4(C1=CC(=O)CC4)C
CID000002541,candesartan,CCOC1=NC2=CC=CC(=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5)C(=O)O,erythema,CID000005358,sumatriptan,CNS(=O)(=O)CC1=CC2=C(C=C1)NC=C2CCN(C)C
CID000003937,N~2~-(1-carboxy-3-phenylpropyl)lysylproline,C1CC(N(C1)C(=O)C(CCCCN)NC(CCC2=CC=CC=C2)C(=O)O)C(=O)O,agitated,CID006398525,,C(C1C(C(C(C(O1)OC2(C(C(C(O2)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)COS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.[Al].[Al].[Al].[Al].[Al].[Al].[Al].[Al].[Al]
CID000003937,N~2~-(1-carboxy-3-phenylpropyl)lysylproline,C1CC(N(C1)C(=O)C(CCCCN)NC(CCC2=CC=CC=C2)C(=O)O)C(=O)O,loss of weight,CID000667490,6-Mercaptopurine,C1=NC2=C(N1)C(=S)N=CN2
CID000003937,N~2~-(1-carboxy-3-phenylpropyl)lysylproline,C1CC(N(C1)C(=O)C(CCCCN)NC(CCC2=CC=CC=C2)C(=O)O)C(=O)O,abnormal ECG,CID000147912,DSSTox_GSID_49066,CCC(C(C)O)N1C(=O)N(C=N1)C2=CC=C(C=C2)N3CCN(CC3)C4=CC=C(C=C4)OCC5CC(OC5)(CN6C=NC=N6)C7=C(C=C(C=C7)F)F
CID000003937,N~2~-(1-carboxy-3-phenylpropyl)lysylproline,C1CC(N(C1)C(=O)C(CCCCN)NC(CCC2=CC=CC=C2)C(=O)O)C(=O)O,gastric inflammation,CID000005352,38194-50-2,CC1=C(C2=C(C1=CC3=CC=C(C=C3)S(=O)C)C=CC(=C2)F)CC(=O)O
CID000003937,N~2~-(1-carboxy-3-phenylpropyl)lysylproline,C1CC(N(C1)C(=O)C(CCCCN)NC(CCC2=CC=CC=C2)C(=O)O)C(=O)O,Adenopathy,CID000005732,zolpidem,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C
CID000003937,N~2~-(1-carboxy-3-phenylpropyl)lysylproline,C1CC(N(C1)C(=O)C(CCCCN)NC(CCC2=CC=CC=C2)C(=O)O)C(=O)O,allergic dermatitis,CID000004195,midodrine,COC1=CC(=C(C=C1)OC)C(CNC(=O)CN)O
CID000003937,N~2~-(1-carboxy-3-phenylpropyl)lysylproline,C1CC(N(C1)C(=O)C(CCCCN)NC(CCC2=CC=CC=C2)C(=O)O)C(=O)O,Adenopathy,CID000005245,Risedronic acid,C1=CC(=CN=C1)CC(O)(P(=O)(O)O)P(=O)(O)O
CID000003937,N~2~-(1-carboxy-3-phenylpropyl)lysylproline,C1CC(N(C1)C(=O)C(CCCCN)NC(CCC2=CC=CC=C2)C(=O)O)C(=O)O,cholecystitis,CID000005487,tizanidine,C1CN=C(N1)NC2=C(C=CC3=NSN=C32)Cl
CID000003937,N~2~-(1-carboxy-3-phenylpropyl)lysylproline,C1CC(N(C1)C(=O)C(CCCCN)NC(CCC2=CC=CC=C2)C(=O)O)C(=O)O,Acne,CID000005073,risperidone,CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F
CID000003937,N~2~-(1-carboxy-3-phenylpropyl)lysylproline,C1CC(N(C1)C(=O)C(CCCCN)NC(CCC2=CC=CC=C2)C(=O)O)C(=O)O,Adenopathy,CID000060787,sequinavir,CC(C)(C)NC(=O)C1CC2CCCCC2CN1CC(C(CC3=CC=CC=C3)NC(=O)C(CC(=O)N)NC(=O)C4=NC5=CC=CC=C5C=C4)O
CID000003937,N~2~-(1-carboxy-3-phenylpropyl)lysylproline,C1CC(N(C1)C(=O)C(CCCCN)NC(CCC2=CC=CC=C2)C(=O)O)C(=O)O,gastric inflammation,CID000004158,methylphenidate,COC(=O)C(C1CCCCN1)C2=CC=CC=C2
CID000003937,N~2~-(1-carboxy-3-phenylpropyl)lysylproline,C1CC(N(C1)C(=O)C(CCCCN)NC(CCC2=CC=CC=C2)C(=O)O)C(=O)O,Adenopathy,CID000003961,losartan,CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)CO)Cl
CID000003937,N~2~-(1-carboxy-3-phenylpropyl)lysylproline,C1CC(N(C1)C(=O)C(CCCCN)NC(CCC2=CC=CC=C2)C(=O)O)C(=O)O,Back Ache,CID000005719,zaleplon,CCN(C1=CC=CC(=C1)C2=CC=NC3=C(C=NN23)C#N)C(=O)C
CID000003937,N~2~-(1-carboxy-3-phenylpropyl)lysylproline,C1CC(N(C1)C(=O)C(CCCCN)NC(CCC2=CC=CC=C2)C(=O)O)C(=O)O,apoplexy,CID000004614,oxaprozin,C1=CC=C(C=C1)C2=C(OC(=N2)CCC(=O)O)C3=CC=CC=C3
CID000003937,N~2~-(1-carboxy-3-phenylpropyl)lysylproline,C1CC(N(C1)C(=O)C(CCCCN)NC(CCC2=CC=CC=C2)C(=O)O)C(=O)O,erythema,CID000115237,Paliperidone,CC1=C(C(=O)N2CCCC(C2=N1)O)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F
CID000003937,N~2~-(1-carboxy-3-phenylpropyl)lysylproline,C1CC(N(C1)C(=O)C(CCCCN)NC(CCC2=CC=CC=C2)C(=O)O)C(=O)O,metabolic encephalopathy,CID005311082,"2-[(1R,4S,10S,13S,19S)-19-[4-(diaminomethylideneamino)butyl]-10-(1H-indol-3-ylmethyl)-3,9,12,15,18,21,27-heptaoxo-24,25-dithia-2,8,11,14,17,20-hexazatricyclo[18.6.1.04,8]heptacosan-13-yl]acetic acid",C1CC2C(=O)NC3CSSCCC(=O)N(C3=O)C(C(=O)NCC(=O)NC(C(=O)NC(C(=O)N2C1)CC4=CNC5=CC=CC=C54)CC(=O)O)CCCCN=C(N)N
CID000003937,N~2~-(1-carboxy-3-phenylpropyl)lysylproline,C1CC(N(C1)C(=O)C(CCCCN)NC(CCC2=CC=CC=C2)C(=O)O)C(=O)O,Acne,CID000004585,"2-methyl-4-(4-methylpiperazin-1-yl)-5H-thieno[3,2-c][1,5]benzodiazepine",CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C
CID000003937,N~2~-(1-carboxy-3-phenylpropyl)lysylproline,C1CC(N(C1)C(=O)C(CCCCN)NC(CCC2=CC=CC=C2)C(=O)O)C(=O)O,myelodysplasia,CID000004201,minoxidil,C1CCN(CC1)C2=NC(=N)N(C(=C2)N)O
CID000003937,N~2~-(1-carboxy-3-phenylpropyl)lysylproline,C1CC(N(C1)C(=O)C(CCCCN)NC(CCC2=CC=CC=C2)C(=O)O)C(=O)O,cholecystitis,CID000004205,mirtazapine,CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4
CID000003937,N~2~-(1-carboxy-3-phenylpropyl)lysylproline,C1CC(N(C1)C(=O)C(CCCCN)NC(CCC2=CC=CC=C2)C(=O)O)C(=O)O,pain in throat,CID000004189,miconazole,C1=CC(=C(C=C1Cl)Cl)COC(CN2C=CN=C2)C3=C(C=C(C=C3)Cl)Cl
CID000003937,N~2~-(1-carboxy-3-phenylpropyl)lysylproline,C1CC(N(C1)C(=O)C(CCCCN)NC(CCC2=CC=CC=C2)C(=O)O)C(=O)O,cholecystitis,CID000019090,megestrol,CC1=CC2C(CCC3(C2CCC3(C(=O)C)O)C)C4(C1=CC(=O)CC4)C
CID000003937,N~2~-(1-carboxy-3-phenylpropyl)lysylproline,C1CC(N(C1)C(=O)C(CCCCN)NC(CCC2=CC=CC=C2)C(=O)O)C(=O)O,eczema,CID000004894,"11,17,21-Trihydroxypregna-1,4-diene-3,20-dione",CC12CC(C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C)O
CID000003937,N~2~-(1-carboxy-3-phenylpropyl)lysylproline,C1CC(N(C1)C(=O)C(CCCCN)NC(CCC2=CC=CC=C2)C(=O)O)C(=O)O,erythema,CID000005394,temozolomide,CN1C(=O)N2C=NC(=C2N=N1)C(=O)N
CID000003937,N~2~-(1-carboxy-3-phenylpropyl)lysylproline,C1CC(N(C1)C(=O)C(CCCCN)NC(CCC2=CC=CC=C2)C(=O)O)C(=O)O,abnormal ECG,CID000004819,"2(3H)-Furanone, 3-ethyldihydro-4-[(1-methyl-1H-imidazol-5-yl)methyl]-, (3S-cis)-",CCC1C(COC1=O)CC2=CN=CN2C
CID000003937,N~2~-(1-carboxy-3-phenylpropyl)lysylproline,C1CC(N(C1)C(=O)C(CCCCN)NC(CCC2=CC=CC=C2)C(=O)O)C(=O)O,Extrasystoles Ventricular,CID000060865,(E)-Olopatadine,CN(C)CCC=C1C2=CC=CC=C2COC3=C1C=C(C=C3)CC(=O)O
CID000003937,N~2~-(1-carboxy-3-phenylpropyl)lysylproline,C1CC(N(C1)C(=O)C(CCCCN)NC(CCC2=CC=CC=C2)C(=O)O)C(=O)O,Adenopathy,CID000005152,Salmeterol,C1=CC=C(C=C1)CCCCOCCCCCCNCC(C2=CC(=C(C=C2)O)CO)O
CID000003937,N~2~-(1-carboxy-3-phenylpropyl)lysylproline,C1CC(N(C1)C(=O)C(CCCCN)NC(CCC2=CC=CC=C2)C(=O)O)C(=O)O,cholecystitis,CID003468412,SCHEMBL1176571,CC1C=CC=CCCC=CC=CC=CC=CC(CC(C(C(CC(=O)CC(C(CCC(CC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)C(=O)O)O)OC2C(C(C(C(O2)C)O)N)O
CID000003937,N~2~-(1-carboxy-3-phenylpropyl)lysylproline,C1CC(N(C1)C(=O)C(CCCCN)NC(CCC2=CC=CC=C2)C(=O)O)C(=O)O,loss of weight,CID000004748,perphenazine,C1CN(CCN1CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)Cl)CCO
CID000003937,N~2~-(1-carboxy-3-phenylpropyl)lysylproline,C1CC(N(C1)C(=O)C(CCCCN)NC(CCC2=CC=CC=C2)C(=O)O)C(=O)O,agitated,CID000060854,Ziprasidone,C1CN(CCN1CCC2=C(C=C3C(=C2)CC(=O)N3)Cl)C4=NSC5=CC=CC=C54
CID000003937,N~2~-(1-carboxy-3-phenylpropyl)lysylproline,C1CC(N(C1)C(=O)C(CCCCN)NC(CCC2=CC=CC=C2)C(=O)O)C(=O)O,weight gain,CID000004536,Minovlar,CC12CCC3C(C1CCC2(C#C)O)CCC4=CC(=O)CCC34
CID000003937,N~2~-(1-carboxy-3-phenylpropyl)lysylproline,C1CC(N(C1)C(=O)C(CCCCN)NC(CCC2=CC=CC=C2)C(=O)O)C(=O)O,loss of weight,CID000012536,638-94-8,CC1(OC2CC3C4CCC5=CC(=O)C=CC5(C4C(CC3(C2(O1)C(=O)CO)C)O)C)C
CID000003937,N~2~-(1-carboxy-3-phenylpropyl)lysylproline,C1CC(N(C1)C(=O)C(CCCCN)NC(CCC2=CC=CC=C2)C(=O)O)C(=O)O,gastric inflammation,CID000060184,"2'-epi-Perindopril, (2'R)-",CCCC(C(=O)OCC)NC(C)C(=O)N1C2CCCCC2CC1C(=O)O
CID000003937,N~2~-(1-carboxy-3-phenylpropyl)lysylproline,C1CC(N(C1)C(=O)C(CCCCN)NC(CCC2=CC=CC=C2)C(=O)O)C(=O)O,back injury,CID000004745,SCHEMBL7711911,CCCN1CC(CC2C1CC3=CNC4=CC=CC2=C34)CSC
CID000003937,N~2~-(1-carboxy-3-phenylpropyl)lysylproline,C1CC(N(C1)C(=O)C(CCCCN)NC(CCC2=CC=CC=C2)C(=O)O)C(=O)O,erythema,CID000004920,"1-acetyl-9a,11a-dimethyl-1H,2H,3H,3aH,3bH,4H,5H,7H,8H,9H,9aH,9bH,10H,11H,11aH-cyclopenta[a]phenanthren-7-one",CC(=O)C1CCC2C1(CCC3C2CCC4=CC(=O)CCC34C)C
CID000003937,N~2~-(1-carboxy-3-phenylpropyl)lysylproline,C1CC(N(C1)C(=O)C(CCCCN)NC(CCC2=CC=CC=C2)C(=O)O)C(=O)O,deglutition disorder,CID006447131,Pimecrolimus,CCC1C=C(CC(CC(C2C(CC(C(O2)(C(=O)C(=O)N3CCCCC3C(=O)OC(C(C(CC1=O)O)C)C(=CC4CCC(C(C4)OC)Cl)C)O)C)OC)OC)C)C
CID000003937,N~2~-(1-carboxy-3-phenylpropyl)lysylproline,C1CC(N(C1)C(=O)C(CCCCN)NC(CCC2=CC=CC=C2)C(=O)O)C(=O)O,loss of weight,CID000057537,92206-54-7,CCCN(CCC1=CC=CS1)C2CCC3=C(C2)C=CC=C3O
CID000003937,N~2~-(1-carboxy-3-phenylpropyl)lysylproline,C1CC(N(C1)C(=O)C(CCCCN)NC(CCC2=CC=CC=C2)C(=O)O)C(=O)O,Acne,CID000004691,"3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine",C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4
CID000003937,N~2~-(1-carboxy-3-phenylpropyl)lysylproline,C1CC(N(C1)C(=O)C(CCCCN)NC(CCC2=CC=CC=C2)C(=O)O)C(=O)O,Adenopathy,CID000004510,nitroglycerin,C(C(CO[N+](=O)[O-])O[N+](=O)[O-])O[N+](=O)[O-]
CID000003937,N~2~-(1-carboxy-3-phenylpropyl)lysylproline,C1CC(N(C1)C(=O)C(CCCCN)NC(CCC2=CC=CC=C2)C(=O)O)C(=O)O,sleep disorder,CID000004211,mitotane,C1=CC=C(C(=C1)C(C2=CC=C(C=C2)Cl)C(Cl)Cl)Cl
CID000003937,N~2~-(1-carboxy-3-phenylpropyl)lysylproline,C1CC(N(C1)C(=O)C(CCCCN)NC(CCC2=CC=CC=C2)C(=O)O)C(=O)O,gastric inflammation,CID000004900,Fernisone,CC12CC(=O)C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C
CID000003937,N~2~-(1-carboxy-3-phenylpropyl)lysylproline,C1CC(N(C1)C(=O)C(CCCCN)NC(CCC2=CC=CC=C2)C(=O)O)C(=O)O,cholecystectomies,CID000170361,Varenicline,C1C2CNCC1C3=CC4=NC=CN=C4C=C23
CID000003937,N~2~-(1-carboxy-3-phenylpropyl)lysylproline,C1CC(N(C1)C(=O)C(CCCCN)NC(CCC2=CC=CC=C2)C(=O)O)C(=O)O,enlarged liver,CID000131536,Fosamprenavir,CC(C)CN(CC(C(CC1=CC=CC=C1)NC(=O)OC2CCOC2)OP(=O)(O)O)S(=O)(=O)C3=CC=C(C=C3)N
CID000003937,N~2~-(1-carboxy-3-phenylpropyl)lysylproline,C1CC(N(C1)C(=O)C(CCCCN)NC(CCC2=CC=CC=C2)C(=O)O)C(=O)O,eruption,CID000074989,ATOVAQUONE,C1CC(CCC1C2=CC=C(C=C2)Cl)C3=C(C4=CC=CC=C4C(=O)C3=O)O
CID000003937,N~2~-(1-carboxy-3-phenylpropyl)lysylproline,C1CC(N(C1)C(=O)C(CCCCN)NC(CCC2=CC=CC=C2)C(=O)O)C(=O)O,Bacteraemia,CID000004913,PROCAINAMIDE,CCN(CC)CCNC(=O)C1=CC=C(C=C1)N
CID000003937,N~2~-(1-carboxy-3-phenylpropyl)lysylproline,C1CC(N(C1)C(=O)C(CCCCN)NC(CCC2=CC=CC=C2)C(=O)O)C(=O)O,esophageal stenosis,CID000004451,CHEMBL365442,CC1=C(C=CC=C1O)C(=O)NC(CSC2=CC=CC=C2)C(CN3CC4CCCCC4CC3C(=O)NC(C)(C)C)O
CID000003937,N~2~-(1-carboxy-3-phenylpropyl)lysylproline,C1CC(N(C1)C(=O)C(CCCCN)NC(CCC2=CC=CC=C2)C(=O)O)C(=O)O,Dyspnea exertional,CID000005358,sumatriptan,CNS(=O)(=O)CC1=CC2=C(C=C1)NC=C2CCN(C)C
CID000003937,N~2~-(1-carboxy-3-phenylpropyl)lysylproline,C1CC(N(C1)C(=O)C(CCCCN)NC(CCC2=CC=CC=C2)C(=O)O)C(=O)O,cholecystitis,CID000004170,metolazone,CC1NC2=CC(=C(C=C2C(=O)N1C3=CC=CC=C3C)S(=O)(=O)N)Cl
CID000003937,N~2~-(1-carboxy-3-phenylpropyl)lysylproline,C1CC(N(C1)C(=O)C(CCCCN)NC(CCC2=CC=CC=C2)C(=O)O)C(=O)O,myelodysplasia,CID000003954,loperamide(1+),CN(C)C(=O)C(CC[NH+]1CCC(CC1)(C2=CC=C(C=C2)Cl)O)(C3=CC=CC=C3)C4=CC=CC=C4
CID000003937,N~2~-(1-carboxy-3-phenylpropyl)lysylproline,C1CC(N(C1)C(=O)C(CCCCN)NC(CCC2=CC=CC=C2)C(=O)O)C(=O)O,cholecystitis,CID000005095,ropinirole,CCCN(CCC)CCC1=C2CC(=O)NC2=CC=C1
CID000003937,N~2~-(1-carboxy-3-phenylpropyl)lysylproline,C1CC(N(C1)C(=O)C(CCCCN)NC(CCC2=CC=CC=C2)C(=O)O)C(=O)O,Superficial thrombophlebitis,CID000005544,Mycolog,CC12CC(C3(C(C1CC(C2(C(=O)CO)O)O)CCC4=CC(=O)C=CC43C)F)O
CID000004195,midodrine,COC1=CC(=C(C=C1)OC)C(CNC(=O)CN)O,loss of weight,CID000005095,ropinirole,CCCN(CCC)CCC1=C2CC(=O)NC2=CC=C1
CID000004195,midodrine,COC1=CC(=C(C=C1)OC)C(CNC(=O)CN)O,Alcoholic intoxication,CID000004691,"3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine",C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4
CID000004819,"2(3H)-Furanone, 3-ethyldihydro-4-[(1-methyl-1H-imidazol-5-yl)methyl]-, (3S-cis)-",CCC1C(COC1=O)CC2=CN=CN2C,heart rate increased,CID000005358,sumatriptan,CNS(=O)(=O)CC1=CC2=C(C=C1)NC=C2CCN(C)C
CID000004819,"2(3H)-Furanone, 3-ethyldihydro-4-[(1-methyl-1H-imidazol-5-yl)methyl]-, (3S-cis)-",CCC1C(COC1=O)CC2=CN=CN2C,nausea,CID000170361,Varenicline,C1C2CNCC1C3=CC4=NC=CN=C4C=C23
CID000004819,"2(3H)-Furanone, 3-ethyldihydro-4-[(1-methyl-1H-imidazol-5-yl)methyl]-, (3S-cis)-",CCC1C(COC1=O)CC2=CN=CN2C,apoplexy,CID000005544,Mycolog,CC12CC(C3(C(C1CC(C2(C(=O)CO)O)O)CCC4=CC(=O)C=CC43C)F)O
CID000004819,"2(3H)-Furanone, 3-ethyldihydro-4-[(1-methyl-1H-imidazol-5-yl)methyl]-, (3S-cis)-",CCC1C(COC1=O)CC2=CN=CN2C,apoplexy,CID003468412,SCHEMBL1176571,CC1C=CC=CCCC=CC=CC=CC=CC(CC(C(C(CC(=O)CC(C(CCC(CC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)C(=O)O)O)OC2C(C(C(C(O2)C)O)N)O
CID000004819,"2(3H)-Furanone, 3-ethyldihydro-4-[(1-methyl-1H-imidazol-5-yl)methyl]-, (3S-cis)-",CCC1C(COC1=O)CC2=CN=CN2C,cholecystitis,CID000019090,megestrol,CC1=CC2C(CCC3(C2CCC3(C(=O)C)O)C)C4(C1=CC(=O)CC4)C
CID000004819,"2(3H)-Furanone, 3-ethyldihydro-4-[(1-methyl-1H-imidazol-5-yl)methyl]-, (3S-cis)-",CCC1C(COC1=O)CC2=CN=CN2C,Back Ache,CID000004900,Fernisone,CC12CC(=O)C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C
CID000004819,"2(3H)-Furanone, 3-ethyldihydro-4-[(1-methyl-1H-imidazol-5-yl)methyl]-, (3S-cis)-",CCC1C(COC1=O)CC2=CN=CN2C,eruption,CID000004894,"11,17,21-Trihydroxypregna-1,4-diene-3,20-dione",CC12CC(C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C)O
CID000004819,"2(3H)-Furanone, 3-ethyldihydro-4-[(1-methyl-1H-imidazol-5-yl)methyl]-, (3S-cis)-",CCC1C(COC1=O)CC2=CN=CN2C,angiitis,CID000005245,Risedronic acid,C1=CC(=CN=C1)CC(O)(P(=O)(O)O)P(=O)(O)O
CID000004819,"2(3H)-Furanone, 3-ethyldihydro-4-[(1-methyl-1H-imidazol-5-yl)methyl]-, (3S-cis)-",CCC1C(COC1=O)CC2=CN=CN2C,agitated,CID000005073,risperidone,CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F
CID000004819,"2(3H)-Furanone, 3-ethyldihydro-4-[(1-methyl-1H-imidazol-5-yl)methyl]-, (3S-cis)-",CCC1C(COC1=O)CC2=CN=CN2C,Pleural Effusion,CID006398525,,C(C1C(C(C(C(O1)OC2(C(C(C(O2)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)COS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.[Al].[Al].[Al].[Al].[Al].[Al].[Al].[Al].[Al]
CID000004819,"2(3H)-Furanone, 3-ethyldihydro-4-[(1-methyl-1H-imidazol-5-yl)methyl]-, (3S-cis)-",CCC1C(COC1=O)CC2=CN=CN2C,Pain,CID000005732,zolpidem,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C
CID000004819,"2(3H)-Furanone, 3-ethyldihydro-4-[(1-methyl-1H-imidazol-5-yl)methyl]-, (3S-cis)-",CCC1C(COC1=O)CC2=CN=CN2C,Drug hypersensitivity,CID000005152,Salmeterol,C1=CC=C(C=C1)CCCCOCCCCCCNCC(C2=CC(=C(C=C2)O)CO)O
CID000003516,guaifenesin,COC1=CC=CC=C1OCC(CO)O,Back Ache,CID000005732,zolpidem,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C
CID000003516,guaifenesin,COC1=CC=CC=C1OCC(CO)O,ear infection,CID000004510,nitroglycerin,C(C(CO[N+](=O)[O-])O[N+](=O)[O-])O[N+](=O)[O-]
CID000003516,guaifenesin,COC1=CC=CC=C1OCC(CO)O,erythema,CID000004585,"2-methyl-4-(4-methylpiperazin-1-yl)-5H-thieno[3,2-c][1,5]benzodiazepine",CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C
CID000003516,guaifenesin,COC1=CC=CC=C1OCC(CO)O,angiitis,CID000003749,irbesartan,CCCCC1=NC2(CCCC2)C(=O)N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5
CID000003516,guaifenesin,COC1=CC=CC=C1OCC(CO)O,eruption,CID000005152,Salmeterol,C1=CC=C(C=C1)CCCCOCCCCCCNCC(C2=CC(=C(C=C2)O)CO)O
CID000003516,guaifenesin,COC1=CC=CC=C1OCC(CO)O,Infection Upper Respiratory,CID000003961,losartan,CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)CO)Cl
CID000003516,guaifenesin,COC1=CC=CC=C1OCC(CO)O,apoplexy,CID000005245,Risedronic acid,C1=CC(=CN=C1)CC(O)(P(=O)(O)O)P(=O)(O)O
CID000003516,guaifenesin,COC1=CC=CC=C1OCC(CO)O,gastric inflammation,CID000004205,mirtazapine,CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4
CID000003516,guaifenesin,COC1=CC=CC=C1OCC(CO)O,apoplexy,CID003468412,SCHEMBL1176571,CC1C=CC=CCCC=CC=CC=CC=CC(CC(C(C(CC(=O)CC(C(CCC(CC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)C(=O)O)O)OC2C(C(C(C(O2)C)O)N)O
CID000003516,guaifenesin,COC1=CC=CC=C1OCC(CO)O,gastric inflammation,CID000004900,Fernisone,CC12CC(=O)C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C
CID000003516,guaifenesin,COC1=CC=CC=C1OCC(CO)O,Adenopathy,CID000004691,"3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine",C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4
CID000003516,guaifenesin,COC1=CC=CC=C1OCC(CO)O,gastric inflammation,CID000170361,Varenicline,C1C2CNCC1C3=CC4=NC=CN=C4C=C23
CID000003516,guaifenesin,COC1=CC=CC=C1OCC(CO)O,gastric inflammation,CID000005487,tizanidine,C1CN=C(N1)NC2=C(C=CC3=NSN=C32)Cl
CID000003516,guaifenesin,COC1=CC=CC=C1OCC(CO)O,Sinus headache,CID000004170,metolazone,CC1NC2=CC(=C(C=C2C(=O)N1C3=CC=CC=C3C)S(=O)(=O)N)Cl
CID000003516,guaifenesin,COC1=CC=CC=C1OCC(CO)O,erythema,CID000003676,lidocaine,CCN(CC)CC(=O)NC1=C(C=CC=C1C)C
CID000003516,guaifenesin,COC1=CC=CC=C1OCC(CO)O,loss of weight,CID000003954,loperamide(1+),CN(C)C(=O)C(CC[NH+]1CCC(CC1)(C2=CC=C(C=C2)Cl)O)(C3=CC=CC=C3)C4=CC=CC=C4
CID000003516,guaifenesin,COC1=CC=CC=C1OCC(CO)O,Adenopathy,CID000005544,Mycolog,CC12CC(C3(C(C1CC(C2(C(=O)CO)O)O)CCC4=CC(=O)C=CC43C)F)O
CID000003516,guaifenesin,COC1=CC=CC=C1OCC(CO)O,apoplexy,CID000005073,risperidone,CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F
CID000003516,guaifenesin,COC1=CC=CC=C1OCC(CO)O,Back Ache,CID000005095,ropinirole,CCCN(CCC)CCC1=C2CC(=O)NC2=CC=C1
CID000003516,guaifenesin,COC1=CC=CC=C1OCC(CO)O,apoplexy,CID000060865,(E)-Olopatadine,CN(C)CCC=C1C2=CC=CC=C2COC3=C1C=C(C=C3)CC(=O)O
CID000003516,guaifenesin,COC1=CC=CC=C1OCC(CO)O,insulin dependent diabetes mellitus,CID000003780,"D-Glucitol, 1,4:3,6-dianhydro-, 2,5-dinitrate",C1C(C2C(O1)C(CO2)O[N+](=O)[O-])O[N+](=O)[O-]
CID000003516,guaifenesin,COC1=CC=CC=C1OCC(CO)O,apoplexy,CID000019090,megestrol,CC1=CC2C(CCC3(C2CCC3(C(=O)C)O)C)C4(C1=CC(=O)CC4)C
CID000005544,Mycolog,CC12CC(C3(C(C1CC(C2(C(=O)CO)O)O)CCC4=CC(=O)C=CC43C)F)O,gastric inflammation,CID006398525,,C(C1C(C(C(C(O1)OC2(C(C(C(O2)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)COS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.[Al].[Al].[Al].[Al].[Al].[Al].[Al].[Al].[Al]
CID000005544,Mycolog,CC12CC(C3(C(C1CC(C2(C(=O)CO)O)O)CCC4=CC(=O)C=CC43C)F)O,back injury,CID000170361,Varenicline,C1C2CNCC1C3=CC4=NC=CN=C4C=C23
CID000005544,Mycolog,CC12CC(C3(C(C1CC(C2(C(=O)CO)O)O)CCC4=CC(=O)C=CC43C)F)O,insulin dependent diabetes mellitus,CID000012536,638-94-8,CC1(OC2CC3C4CCC5=CC(=O)C=CC5(C4C(CC3(C2(O1)C(=O)CO)C)O)C)C
CID000005544,Mycolog,CC12CC(C3(C(C1CC(C2(C(=O)CO)O)O)CCC4=CC(=O)C=CC43C)F)O,hypermagnesemia,CID000074989,ATOVAQUONE,C1CC(CCC1C2=CC=C(C=C2)Cl)C3=C(C4=CC=CC=C4C(=O)C3=O)O
CID000005544,Mycolog,CC12CC(C3(C(C1CC(C2(C(=O)CO)O)O)CCC4=CC(=O)C=CC43C)F)O,cholecystitis,CID000005732,zolpidem,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C
CID000005544,Mycolog,CC12CC(C3(C(C1CC(C2(C(=O)CO)O)O)CCC4=CC(=O)C=CC43C)F)O,Back Ache,CID000060865,(E)-Olopatadine,CN(C)CCC=C1C2=CC=CC=C2COC3=C1C=C(C=C3)CC(=O)O
CID000005544,Mycolog,CC12CC(C3(C(C1CC(C2(C(=O)CO)O)O)CCC4=CC(=O)C=CC43C)F)O,palpitation,CID006447131,Pimecrolimus,CCC1C=C(CC(CC(C2C(CC(C(O2)(C(=O)C(=O)N3CCCCC3C(=O)OC(C(C(CC1=O)O)C)C(=CC4CCC(C(C4)OC)Cl)C)O)C)OC)OC)C)C
CID000005544,Mycolog,CC12CC(C3(C(C1CC(C2(C(=O)CO)O)O)CCC4=CC(=O)C=CC43C)F)O,insulin dependent diabetes mellitus,CID000005719,zaleplon,CCN(C1=CC=CC(=C1)C2=CC=NC3=C(C=NN23)C#N)C(=O)C
CID000005544,Mycolog,CC12CC(C3(C(C1CC(C2(C(=O)CO)O)O)CCC4=CC(=O)C=CC43C)F)O,gastric inflammation,CID003468412,SCHEMBL1176571,CC1C=CC=CCCC=CC=CC=CC=CC(CC(C(C(CC(=O)CC(C(CCC(CC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)C(=O)O)O)OC2C(C(C(C(O2)C)O)N)O
CID000005544,Mycolog,CC12CC(C3(C(C1CC(C2(C(=O)CO)O)O)CCC4=CC(=O)C=CC43C)F)O,weight gain,CID000060854,Ziprasidone,C1CN(CCN1CCC2=C(C=C3C(=C2)CC(=O)N3)Cl)C4=NSC5=CC=CC=C54
CID000005544,Mycolog,CC12CC(C3(C(C1CC(C2(C(=O)CO)O)O)CCC4=CC(=O)C=CC43C)F)O,myelodysplasia,CID000019090,megestrol,CC1=CC2C(CCC3(C2CCC3(C(=O)C)O)C)C4(C1=CC(=O)CC4)C
CID000005544,Mycolog,CC12CC(C3(C(C1CC(C2(C(=O)CO)O)O)CCC4=CC(=O)C=CC43C)F)O,deglutition disorder,CID000077992,Frovatriptan,CNC1CCC2=C(C1)C3=C(N2)C=CC(=C3)C(=O)N
CID000003706,SCHEMBL1176257,CC(C)(C)NC(=O)C1CN(CCN1CC(CC(CC2=CC=CC=C2)C(=O)NC3C(CC4=CC=CC=C34)O)O)CC5=CN=CC=C5,gastric inflammation,CID000003954,loperamide(1+),CN(C)C(=O)C(CC[NH+]1CCC(CC1)(C2=CC=C(C=C2)Cl)O)(C3=CC=CC=C3)C4=CC=CC=C4
CID000003706,SCHEMBL1176257,CC(C)(C)NC(=O)C1CN(CCN1CC(CC(CC2=CC=CC=C2)C(=O)NC3C(CC4=CC=CC=C34)O)O)CC5=CN=CC=C5,abnormal EEG,CID000060787,sequinavir,CC(C)(C)NC(=O)C1CC2CCCCC2CN1CC(C(CC3=CC=CC=C3)NC(=O)C(CC(=O)N)NC(=O)C4=NC5=CC=CC=C5C=C4)O
CID000003706,SCHEMBL1176257,CC(C)(C)NC(=O)C1CN(CCN1CC(CC(CC2=CC=CC=C2)C(=O)NC3C(CC4=CC=CC=C34)O)O)CC5=CN=CC=C5,elevated cholesterol,CID000004894,"11,17,21-Trihydroxypregna-1,4-diene-3,20-dione",CC12CC(C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C)O
CID000003706,SCHEMBL1176257,CC(C)(C)NC(=O)C1CN(CCN1CC(CC(CC2=CC=CC=C2)C(=O)NC3C(CC4=CC=CC=C34)O)O)CC5=CN=CC=C5,Aching joints,CID000005732,zolpidem,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C
CID000003706,SCHEMBL1176257,CC(C)(C)NC(=O)C1CN(CCN1CC(CC(CC2=CC=CC=C2)C(=O)NC3C(CC4=CC=CC=C34)O)O)CC5=CN=CC=C5,sleep disorder,CID000005073,risperidone,CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F
CID000003706,SCHEMBL1176257,CC(C)(C)NC(=O)C1CN(CCN1CC(CC(CC2=CC=CC=C2)C(=O)NC3C(CC4=CC=CC=C34)O)O)CC5=CN=CC=C5,insulin dependent diabetes mellitus,CID000004451,CHEMBL365442,CC1=C(C=CC=C1O)C(=O)NC(CSC2=CC=CC=C2)C(CN3CC4CCCCC4CC3C(=O)NC(C)(C)C)O
CID000005073,risperidone,CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F,abnormal ECG,CID000005152,Salmeterol,C1=CC=C(C=C1)CCCCOCCCCCCNCC(C2=CC(=C(C=C2)O)CO)O
CID000005073,risperidone,CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F,gastric inflammation,CID000005487,tizanidine,C1CN=C(N1)NC2=C(C=CC3=NSN=C32)Cl
CID000005073,risperidone,CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F,gastric inflammation,CID000170361,Varenicline,C1C2CNCC1C3=CC4=NC=CN=C4C=C23
CID000005073,risperidone,CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F,abdominal pain upper,CID000019090,megestrol,CC1=CC2C(CCC3(C2CCC3(C(=O)C)O)C)C4(C1=CC(=O)CC4)C
CID000005073,risperidone,CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F,apoplexy,CID000005245,Risedronic acid,C1=CC(=CN=C1)CC(O)(P(=O)(O)O)P(=O)(O)O
CID000005073,risperidone,CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F,Acne,CID000115237,Paliperidone,CC1=C(C(=O)N2CCCC(C2=N1)O)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F
CID000005073,risperidone,CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F,apoplexy,CID003468412,SCHEMBL1176571,CC1C=CC=CCCC=CC=CC=CC=CC(CC(C(C(CC(=O)CC(C(CCC(CC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)C(=O)O)O)OC2C(C(C(C(O2)C)O)N)O
CID000005073,risperidone,CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F,cholecystitis,CID000060854,Ziprasidone,C1CN(CCN1CCC2=C(C=C3C(=C2)CC(=O)N3)Cl)C4=NSC5=CC=CC=C54
CID000005073,risperidone,CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F,cholecystectomies,CID006398525,,C(C1C(C(C(C(O1)OC2(C(C(C(O2)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)COS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.[Al].[Al].[Al].[Al].[Al].[Al].[Al].[Al].[Al]
CID000005073,risperidone,CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F,apoplexy,CID006447131,Pimecrolimus,CCC1C=C(CC(CC(C2C(CC(C(O2)(C(=O)C(=O)N3CCCCC3C(=O)OC(C(C(CC1=O)O)C)C(=CC4CCC(C(C4)OC)Cl)C)O)C)OC)OC)C)C
CID000005073,risperidone,CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F,eruption,CID000005352,38194-50-2,CC1=C(C2=C(C1=CC3=CC=C(C=C3)S(=O)C)C=CC(=C2)F)CC(=O)O
CID000005073,risperidone,CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F,gastric inflammation,CID000005358,sumatriptan,CNS(=O)(=O)CC1=CC2=C(C=C1)NC=C2CCN(C)C
CID000005073,risperidone,CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F,Abnormal Gait,CID000057537,92206-54-7,CCCN(CCC1=CC=CS1)C2CCC3=C(C2)C=CC=C3O
CID000005073,risperidone,CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F,drug toxicity NOS,CID000060787,sequinavir,CC(C)(C)NC(=O)C1CC2CCCCC2CN1CC(C(CC3=CC=CC=C3)NC(=O)C(CC(=O)N)NC(=O)C4=NC5=CC=CC=C5C=C4)O
CID000005073,risperidone,CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F,nasopharyngitis,CID000005095,ropinirole,CCCN(CCC)CCC1=C2CC(=O)NC2=CC=C1
CID000005073,risperidone,CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F,methaemoglobinaemia,CID000005732,zolpidem,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C
CID000005073,risperidone,CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F,loss of weight,CID000060184,"2'-epi-Perindopril, (2'R)-",CCCC(C(=O)OCC)NC(C)C(=O)N1C2CCCCC2CC1C(=O)O
CID000005073,risperidone,CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F,apoplexy,CID000005719,zaleplon,CCN(C1=CC=CC(=C1)C2=CC=NC3=C(C=NN23)C#N)C(=O)C
CID000005073,risperidone,CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F,constipated,CID000005584,trimipramine,CC(CN1C2=CC=CC=C2CCC3=CC=CC=C31)CN(C)C
CID000005073,risperidone,CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F,edema,CID000005394,temozolomide,CN1C(=O)N2C=NC(=C2N=N1)C(=O)N
CID000002478,busulfan,CS(=O)(=O)OCCCCOS(=O)(=O)C,dysarthria,CID000003310,33419-42-0,CC1OCC2C(O1)C(C(C(O2)OC3C4COC(=O)C4C(C5=CC6=C(C=C35)OCO6)C7=CC(=C(C(=C7)OC)O)OC)O)O
CID000002478,busulfan,CS(=O)(=O)OCCCCOS(=O)(=O)C,drug toxicity NOS,CID000002771,citalopram,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F
CID000002478,busulfan,CS(=O)(=O)OCCCCOS(=O)(=O)C,eruption,CID000005732,zolpidem,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C
CID000002478,busulfan,CS(=O)(=O)OCCCCOS(=O)(=O)C,abnormal EEG,CID000003440,furosemide,C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl
CID000002478,busulfan,CS(=O)(=O)OCCCCOS(=O)(=O)C,myelodysplasia,CID000667490,6-Mercaptopurine,C1=NC2=C(N1)C(=S)N=CN2
CID000002478,busulfan,CS(=O)(=O)OCCCCOS(=O)(=O)C,allergic dermatitis,CID000004900,Fernisone,CC12CC(=O)C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C
CID000002478,busulfan,CS(=O)(=O)OCCCCOS(=O)(=O)C,myelodysplasia,CID000004894,"11,17,21-Trihydroxypregna-1,4-diene-3,20-dione",CC12CC(C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C)O
CID000003954,loperamide(1+),CN(C)C(=O)C(CC[NH+]1CCC(CC1)(C2=CC=C(C=C2)Cl)O)(C3=CC=CC=C3)C4=CC=CC=C4,angiitis,CID000005095,ropinirole,CCCN(CCC)CCC1=C2CC(=O)NC2=CC=C1
CID000003954,loperamide(1+),CN(C)C(=O)C(CC[NH+]1CCC(CC1)(C2=CC=C(C=C2)Cl)O)(C3=CC=CC=C3)C4=CC=CC=C4,confusion,CID000005352,38194-50-2,CC1=C(C2=C(C1=CC3=CC=C(C=C3)S(=O)C)C=CC(=C2)F)CC(=O)O
CID000003954,loperamide(1+),CN(C)C(=O)C(CC[NH+]1CCC(CC1)(C2=CC=C(C=C2)Cl)O)(C3=CC=CC=C3)C4=CC=CC=C4,apoplexy,CID000005358,sumatriptan,CNS(=O)(=O)CC1=CC2=C(C=C1)NC=C2CCN(C)C
CID000003954,loperamide(1+),CN(C)C(=O)C(CC[NH+]1CCC(CC1)(C2=CC=C(C=C2)Cl)O)(C3=CC=CC=C3)C4=CC=CC=C4,Infection Upper Respiratory,CID000005152,Salmeterol,C1=CC=C(C=C1)CCCCOCCCCCCNCC(C2=CC(=C(C=C2)O)CO)O
CID000003954,loperamide(1+),CN(C)C(=O)C(CC[NH+]1CCC(CC1)(C2=CC=C(C=C2)Cl)O)(C3=CC=CC=C3)C4=CC=CC=C4,apoplexy,CID000005719,zaleplon,CCN(C1=CC=CC(=C1)C2=CC=NC3=C(C=NN23)C#N)C(=O)C
CID000003954,loperamide(1+),CN(C)C(=O)C(CC[NH+]1CCC(CC1)(C2=CC=C(C=C2)Cl)O)(C3=CC=CC=C3)C4=CC=CC=C4,myelodysplasia,CID000005732,zolpidem,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C
CID000003954,loperamide(1+),CN(C)C(=O)C(CC[NH+]1CCC(CC1)(C2=CC=C(C=C2)Cl)O)(C3=CC=CC=C3)C4=CC=CC=C4,cholecystitis,CID000004585,"2-methyl-4-(4-methylpiperazin-1-yl)-5H-thieno[3,2-c][1,5]benzodiazepine",CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C
CID000003954,loperamide(1+),CN(C)C(=O)C(CC[NH+]1CCC(CC1)(C2=CC=C(C=C2)Cl)O)(C3=CC=CC=C3)C4=CC=CC=C4,High blood pressure,CID000004158,methylphenidate,COC(=O)C(C1CCCCN1)C2=CC=CC=C2
CID000003954,loperamide(1+),CN(C)C(=O)C(CC[NH+]1CCC(CC1)(C2=CC=C(C=C2)Cl)O)(C3=CC=CC=C3)C4=CC=CC=C4,angiitis,CID000004894,"11,17,21-Trihydroxypregna-1,4-diene-3,20-dione",CC12CC(C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C)O
CID000003954,loperamide(1+),CN(C)C(=O)C(CC[NH+]1CCC(CC1)(C2=CC=C(C=C2)Cl)O)(C3=CC=CC=C3)C4=CC=CC=C4,Neuromuscular Disorder,CID000060184,"2'-epi-Perindopril, (2'R)-",CCCC(C(=O)OCC)NC(C)C(=O)N1C2CCCCC2CC1C(=O)O
CID000003954,loperamide(1+),CN(C)C(=O)C(CC[NH+]1CCC(CC1)(C2=CC=C(C=C2)Cl)O)(C3=CC=CC=C3)C4=CC=CC=C4,Back Ache,CID003468412,SCHEMBL1176571,CC1C=CC=CCCC=CC=CC=CC=CC(CC(C(C(CC(=O)CC(C(CCC(CC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)C(=O)O)O)OC2C(C(C(C(O2)C)O)N)O
CID000003954,loperamide(1+),CN(C)C(=O)C(CC[NH+]1CCC(CC1)(C2=CC=C(C=C2)Cl)O)(C3=CC=CC=C3)C4=CC=CC=C4,eruption,CID000004189,miconazole,C1=CC(=C(C=C1Cl)Cl)COC(CN2C=CN=C2)C3=C(C=C(C=C3)Cl)Cl
CID000003954,loperamide(1+),CN(C)C(=O)C(CC[NH+]1CCC(CC1)(C2=CC=C(C=C2)Cl)O)(C3=CC=CC=C3)C4=CC=CC=C4,right heart failure,CID000004691,"3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine",C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4
CID000003954,loperamide(1+),CN(C)C(=O)C(CC[NH+]1CCC(CC1)(C2=CC=C(C=C2)Cl)O)(C3=CC=CC=C3)C4=CC=CC=C4,gastric inflammation,CID000005245,Risedronic acid,C1=CC(=CN=C1)CC(O)(P(=O)(O)O)P(=O)(O)O
CID000003954,loperamide(1+),CN(C)C(=O)C(CC[NH+]1CCC(CC1)(C2=CC=C(C=C2)Cl)O)(C3=CC=CC=C3)C4=CC=CC=C4,Adenopathy,CID000019090,megestrol,CC1=CC2C(CCC3(C2CCC3(C(=O)C)O)C)C4(C1=CC(=O)CC4)C
CID000003954,loperamide(1+),CN(C)C(=O)C(CC[NH+]1CCC(CC1)(C2=CC=C(C=C2)Cl)O)(C3=CC=CC=C3)C4=CC=CC=C4,Adenopathy,CID000667490,6-Mercaptopurine,C1=NC2=C(N1)C(=S)N=CN2
CID000003954,loperamide(1+),CN(C)C(=O)C(CC[NH+]1CCC(CC1)(C2=CC=C(C=C2)Cl)O)(C3=CC=CC=C3)C4=CC=CC=C4,hypermagnesemia,CID000074989,ATOVAQUONE,C1CC(CCC1C2=CC=C(C=C2)Cl)C3=C(C4=CC=CC=C4C(=O)C3=O)O
CID000003954,loperamide(1+),CN(C)C(=O)C(CC[NH+]1CCC(CC1)(C2=CC=C(C=C2)Cl)O)(C3=CC=CC=C3)C4=CC=CC=C4,Dyspnea exertional,CID000004205,mirtazapine,CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4
CID000003954,loperamide(1+),CN(C)C(=O)C(CC[NH+]1CCC(CC1)(C2=CC=C(C=C2)Cl)O)(C3=CC=CC=C3)C4=CC=CC=C4,neumonia,CID000005487,tizanidine,C1CN=C(N1)NC2=C(C=CC3=NSN=C32)Cl
CID000003954,loperamide(1+),CN(C)C(=O)C(CC[NH+]1CCC(CC1)(C2=CC=C(C=C2)Cl)O)(C3=CC=CC=C3)C4=CC=CC=C4,right heart failure,CID000004170,metolazone,CC1NC2=CC(=C(C=C2C(=O)N1C3=CC=CC=C3C)S(=O)(=O)N)Cl
CID000003954,loperamide(1+),CN(C)C(=O)C(CC[NH+]1CCC(CC1)(C2=CC=C(C=C2)Cl)O)(C3=CC=CC=C3)C4=CC=CC=C4,cholecystitis,CID000004900,Fernisone,CC12CC(=O)C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C
CID000003954,loperamide(1+),CN(C)C(=O)C(CC[NH+]1CCC(CC1)(C2=CC=C(C=C2)Cl)O)(C3=CC=CC=C3)C4=CC=CC=C4,gastric inflammation,CID000004510,nitroglycerin,C(C(CO[N+](=O)[O-])O[N+](=O)[O-])O[N+](=O)[O-]
CID000003954,loperamide(1+),CN(C)C(=O)C(CC[NH+]1CCC(CC1)(C2=CC=C(C=C2)Cl)O)(C3=CC=CC=C3)C4=CC=CC=C4,neurogenic bladder,CID000004451,CHEMBL365442,CC1=C(C=CC=C1O)C(=O)NC(CSC2=CC=CC=C2)C(CN3CC4CCCCC4CC3C(=O)NC(C)(C)C)O
CID000003954,loperamide(1+),CN(C)C(=O)C(CC[NH+]1CCC(CC1)(C2=CC=C(C=C2)Cl)O)(C3=CC=CC=C3)C4=CC=CC=C4,loss of weight,CID000005394,temozolomide,CN1C(=O)N2C=NC(=C2N=N1)C(=O)N
CID000003954,loperamide(1+),CN(C)C(=O)C(CC[NH+]1CCC(CC1)(C2=CC=C(C=C2)Cl)O)(C3=CC=CC=C3)C4=CC=CC=C4,inflammatory bowel disease,CID000004614,oxaprozin,C1=CC=C(C=C1)C2=C(OC(=N2)CCC(=O)O)C3=CC=CC=C3
CID000003954,loperamide(1+),CN(C)C(=O)C(CC[NH+]1CCC(CC1)(C2=CC=C(C=C2)Cl)O)(C3=CC=CC=C3)C4=CC=CC=C4,neumonia,CID000004920,"1-acetyl-9a,11a-dimethyl-1H,2H,3H,3aH,3bH,4H,5H,7H,8H,9H,9aH,9bH,10H,11H,11aH-cyclopenta[a]phenanthren-7-one",CC(=O)C1CCC2C1(CCC3C2CCC4=CC(=O)CCC34C)C
CID000003954,loperamide(1+),CN(C)C(=O)C(CC[NH+]1CCC(CC1)(C2=CC=C(C=C2)Cl)O)(C3=CC=CC=C3)C4=CC=CC=C4,Bacteraemia,CID000147912,DSSTox_GSID_49066,CCC(C(C)O)N1C(=O)N(C=N1)C2=CC=C(C=C2)N3CCN(CC3)C4=CC=C(C=C4)OCC5CC(OC5)(CN6C=NC=N6)C7=C(C=C(C=C7)F)F
CID000003954,loperamide(1+),CN(C)C(=O)C(CC[NH+]1CCC(CC1)(C2=CC=C(C=C2)Cl)O)(C3=CC=CC=C3)C4=CC=CC=C4,gastric inflammation,CID000060787,sequinavir,CC(C)(C)NC(=O)C1CC2CCCCC2CN1CC(C(CC3=CC=CC=C3)NC(=O)C(CC(=O)N)NC(=O)C4=NC5=CC=CC=C5C=C4)O
CID000003954,loperamide(1+),CN(C)C(=O)C(CC[NH+]1CCC(CC1)(C2=CC=C(C=C2)Cl)O)(C3=CC=CC=C3)C4=CC=CC=C4,erythema,CID000003961,losartan,CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)CO)Cl
CID000003954,loperamide(1+),CN(C)C(=O)C(CC[NH+]1CCC(CC1)(C2=CC=C(C=C2)Cl)O)(C3=CC=CC=C3)C4=CC=CC=C4,erosive gastritis,CID006398525,,C(C1C(C(C(C(O1)OC2(C(C(C(O2)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)COS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.[Al].[Al].[Al].[Al].[Al].[Al].[Al].[Al].[Al]
CID000003954,loperamide(1+),CN(C)C(=O)C(CC[NH+]1CCC(CC1)(C2=CC=C(C=C2)Cl)O)(C3=CC=CC=C3)C4=CC=CC=C4,myelodysplasia,CID000060865,(E)-Olopatadine,CN(C)CCC=C1C2=CC=CC=C2COC3=C1C=C(C=C3)CC(=O)O
CID000005352,38194-50-2,CC1=C(C2=C(C1=CC3=CC=C(C=C3)S(=O)C)C=CC(=C2)F)CC(=O)O,neumonia,CID006398525,,C(C1C(C(C(C(O1)OC2(C(C(C(O2)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)COS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.[Al].[Al].[Al].[Al].[Al].[Al].[Al].[Al].[Al]
CID000005352,38194-50-2,CC1=C(C2=C(C1=CC3=CC=C(C=C3)S(=O)C)C=CC(=C2)F)CC(=O)O,cholecystitis,CID000005358,sumatriptan,CNS(=O)(=O)CC1=CC2=C(C=C1)NC=C2CCN(C)C
CID000005352,38194-50-2,CC1=C(C2=C(C1=CC3=CC=C(C=C3)S(=O)C)C=CC(=C2)F)CC(=O)O,back injury,CID000005487,tizanidine,C1CN=C(N1)NC2=C(C=CC3=NSN=C32)Cl
CID000005352,38194-50-2,CC1=C(C2=C(C1=CC3=CC=C(C=C3)S(=O)C)C=CC(=C2)F)CC(=O)O,cholecystitis,CID000005732,zolpidem,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C
CID000005352,38194-50-2,CC1=C(C2=C(C1=CC3=CC=C(C=C3)S(=O)C)C=CC(=C2)F)CC(=O)O,confusion,CID000170361,Varenicline,C1C2CNCC1C3=CC4=NC=CN=C4C=C23
CID000005584,trimipramine,CC(CN1C2=CC=CC=C2CCC3=CC=CC=C31)CN(C)C,loss of weight,CID000005732,zolpidem,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C
CID000004440,naratriptan,CNS(=O)(=O)CCC1=CC2=C(C=C1)NC=C2C3CCN(CC3)C,confusion,CID000004585,"2-methyl-4-(4-methylpiperazin-1-yl)-5H-thieno[3,2-c][1,5]benzodiazepine",CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C
CID000004440,naratriptan,CNS(=O)(=O)CCC1=CC2=C(C=C1)NC=C2C3CCN(CC3)C,agitated,CID000004691,"3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine",C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4
CID000004440,naratriptan,CNS(=O)(=O)CCC1=CC2=C(C=C1)NC=C2C3CCN(CC3)C,angiitis,CID000005732,zolpidem,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C
CID000004440,naratriptan,CNS(=O)(=O)CCC1=CC2=C(C=C1)NC=C2C3CCN(CC3)C,angiitis,CID000005095,ropinirole,CCCN(CCC)CCC1=C2CC(=O)NC2=CC=C1
CID000004440,naratriptan,CNS(=O)(=O)CCC1=CC2=C(C=C1)NC=C2C3CCN(CC3)C,dysarthria,CID000005358,sumatriptan,CNS(=O)(=O)CC1=CC2=C(C=C1)NC=C2CCN(C)C
CID000004440,naratriptan,CNS(=O)(=O)CCC1=CC2=C(C=C1)NC=C2C3CCN(CC3)C,confusion,CID000060854,Ziprasidone,C1CN(CCN1CCC2=C(C=C3C(=C2)CC(=O)N3)Cl)C4=NSC5=CC=CC=C54
CID000004440,naratriptan,CNS(=O)(=O)CCC1=CC2=C(C=C1)NC=C2C3CCN(CC3)C,dysarthria,CID000004900,Fernisone,CC12CC(=O)C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C
CID000004440,naratriptan,CNS(=O)(=O)CCC1=CC2=C(C=C1)NC=C2C3CCN(CC3)C,dysarthria,CID000005719,zaleplon,CCN(C1=CC=CC(=C1)C2=CC=NC3=C(C=NN23)C#N)C(=O)C
CID000004440,naratriptan,CNS(=O)(=O)CCC1=CC2=C(C=C1)NC=C2C3CCN(CC3)C,insomnia,CID000077992,Frovatriptan,CNC1CCC2=C(C1)C3=C(N2)C=CC(=C3)C(=O)N
CID000002713,55-56-1,C1=CC(=CC=C1NC(=NC(=NCCCCCCN=C(N)N=C(N)NC2=CC=C(C=C2)Cl)N)N)Cl,gastric inflammation,CID000004510,nitroglycerin,C(C(CO[N+](=O)[O-])O[N+](=O)[O-])O[N+](=O)[O-]
CID000002713,55-56-1,C1=CC(=CC=C1NC(=NC(=NCCCCCCN=C(N)N=C(N)NC2=CC=C(C=C2)Cl)N)N)Cl,cholecystectomies,CID000003405,2-[[4-[(2-amino-4-oxo-1H-pteridin-6-yl)methylamino]benzoyl]amino]pentanedioic acid,C1=CC(=CC=C1C(=O)NC(CCC(=O)O)C(=O)O)NCC2=CN=C3C(=N2)C(=O)N=C(N3)N
CID000002713,55-56-1,C1=CC(=CC=C1NC(=NC(=NCCCCCCN=C(N)N=C(N)NC2=CC=C(C=C2)Cl)N)N)Cl,gastric inflammation,CID000003062,Lanicor,CC1C(C(CC(O1)OC2C(OC(CC2O)OC3C(OC(CC3O)OC4CCC5(C(C4)CCC6C5CC(C7(C6(CCC7C8=CC(=O)OC8)O)C)O)C)C)C)O)O
CID000002713,2-[6-[[amino-[[amino-(4-chloroanilino)methylidene]amino]methylidene]amino]hexyl]-1-[amino-(4-chloroanilino)methylidene]guanidine,C1=CC(=CC=C1NC(=NC(=NCCCCCCN=C(N)N=C(N)NC2=CC=C(C=C2)Cl)N)N)Cl,atelectasis,CID000004894,"11,17,21-Trihydroxypregna-1,4-diene-3,20-dione",CC12CC(C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C)O
CID000002713,55-56-1,C1=CC(=CC=C1NC(=NC(=NCCCCCCN=C(N)N=C(N)NC2=CC=C(C=C2)Cl)N)N)Cl,thrombocytopenia,CID006398525,,C(C1C(C(C(C(O1)OC2(C(C(C(O2)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)COS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.[Al].[Al].[Al].[Al].[Al].[Al].[Al].[Al].[Al]
CID000002713,55-56-1,C1=CC(=CC=C1NC(=NC(=NCCCCCCN=C(N)N=C(N)NC2=CC=C(C=C2)Cl)N)N)Cl,myocarditis,CID000005732,zolpidem,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C
CID000002713,55-56-1,C1=CC(=CC=C1NC(=NC(=NCCCCCCN=C(N)N=C(N)NC2=CC=C(C=C2)Cl)N)N)Cl,hyperalimentation,CID000005095,ropinirole,CCCN(CCC)CCC1=C2CC(=O)NC2=CC=C1
CID000002713,55-56-1,C1=CC(=CC=C1NC(=NC(=NCCCCCCN=C(N)N=C(N)NC2=CC=C(C=C2)Cl)N)N)Cl,gastric inflammation,CID000003676,lidocaine,CCN(CC)CC(=O)NC1=C(C=CC=C1C)C
CID000002713,55-56-1,C1=CC(=CC=C1NC(=NC(=NCCCCCCN=C(N)N=C(N)NC2=CC=C(C=C2)Cl)N)N)Cl,myocarditis,CID000147912,DSSTox_GSID_49066,CCC(C(C)O)N1C(=O)N(C=N1)C2=CC=C(C=C2)N3CCN(CC3)C4=CC=C(C=C4)OCC5CC(OC5)(CN6C=NC=N6)C7=C(C=C(C=C7)F)F
CID000002713,55-56-1,C1=CC(=CC=C1NC(=NC(=NCCCCCCN=C(N)N=C(N)NC2=CC=C(C=C2)Cl)N)N)Cl,Pain,CID003468412,SCHEMBL1176571,CC1C=CC=CCCC=CC=CC=CC=CC(CC(C(C(CC(=O)CC(C(CCC(CC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)C(=O)O)O)OC2C(C(C(C(O2)C)O)N)O
CID000002713,55-56-1,C1=CC(=CC=C1NC(=NC(=NCCCCCCN=C(N)N=C(N)NC2=CC=C(C=C2)Cl)N)N)Cl,gastric inflammation,CID000003440,furosemide,C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl
CID000002713,55-56-1,C1=CC(=CC=C1NC(=NC(=NCCCCCCN=C(N)N=C(N)NC2=CC=C(C=C2)Cl)N)N)Cl,neumonia,CID000004205,mirtazapine,CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4
CID000002713,55-56-1,C1=CC(=CC=C1NC(=NC(=NCCCCCCN=C(N)N=C(N)NC2=CC=C(C=C2)Cl)N)N)Cl,loss of weight,CID000004691,"3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine",C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4
CID000002713,55-56-1,C1=CC(=CC=C1NC(=NC(=NCCCCCCN=C(N)N=C(N)NC2=CC=C(C=C2)Cl)N)N)Cl,loss of weight,CID000004900,Fernisone,CC12CC(=O)C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C
CID000002713,55-56-1,C1=CC(=CC=C1NC(=NC(=NCCCCCCN=C(N)N=C(N)NC2=CC=C(C=C2)Cl)N)N)Cl,bronchiectasis,CID000003310,33419-42-0,CC1OCC2C(O1)C(C(C(O2)OC3C4COC(=O)C4C(C5=CC6=C(C=C35)OCO6)C7=CC(=C(C(=C7)OC)O)OC)O)O
CID000002713,55-56-1,C1=CC(=CC=C1NC(=NC(=NCCCCCCN=C(N)N=C(N)NC2=CC=C(C=C2)Cl)N)N)Cl,dry skin,CID000004189,miconazole,C1=CC(=C(C=C1Cl)Cl)COC(CN2C=CN=C2)C3=C(C=C(C=C3)Cl)Cl
CID000002713,55-56-1,C1=CC(=CC=C1NC(=NC(=NCCCCCCN=C(N)N=C(N)NC2=CC=C(C=C2)Cl)N)N)Cl,apoplexy,CID000002771,citalopram,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F
CID000002462,51372-29-3,CCCC1OC2CC3C4CCC5=CC(=O)C=CC5(C4C(CC3(C2(O1)C(=O)CO)C)O)C,loss of weight,CID000060854,Ziprasidone,C1CN(CCN1CCC2=C(C=C3C(=C2)CC(=O)N3)Cl)C4=NSC5=CC=CC=C54
CID000002462,51372-29-3,CCCC1OC2CC3C4CCC5=CC(=O)C=CC5(C4C(CC3(C2(O1)C(=O)CO)C)O)C,gastric inflammation,CID000004205,mirtazapine,CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4
CID000002462,51372-29-3,CCCC1OC2CC3C4CCC5=CC(=O)C=CC5(C4C(CC3(C2(O1)C(=O)CO)C)O)C,loss of weight,CID006398525,,C(C1C(C(C(C(O1)OC2(C(C(C(O2)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)COS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.[Al].[Al].[Al].[Al].[Al].[Al].[Al].[Al].[Al]
CID000002462,51372-29-3,CCCC1OC2CC3C4CCC5=CC(=O)C=CC5(C4C(CC3(C2(O1)C(=O)CO)C)O)C,insulin dependent diabetes mellitus,CID000003042,dicyclomine,CCN(CC)CCOC(=O)C1(CCCCC1)C2CCCCC2
CID000002462,51372-29-3,CCCC1OC2CC3C4CCC5=CC(=O)C=CC5(C4C(CC3(C2(O1)C(=O)CO)C)O)C,eruption,CID000003780,"D-Glucitol, 1,4:3,6-dianhydro-, 2,5-dinitrate",C1C(C2C(O1)C(CO2)O[N+](=O)[O-])O[N+](=O)[O-]
CID000002462,51372-29-3,CCCC1OC2CC3C4CCC5=CC(=O)C=CC5(C4C(CC3(C2(O1)C(=O)CO)C)O)C,loss of weight,CID000003333,felodipine,CCOC(=O)C1=C(NC(=C(C1C2=C(C(=CC=C2)Cl)Cl)C(=O)OC)C)C
CID000002462,51372-29-3,CCCC1OC2CC3C4CCC5=CC(=O)C=CC5(C4C(CC3(C2(O1)C(=O)CO)C)O)C,eruption,CID000004189,miconazole,C1=CC(=C(C=C1Cl)Cl)COC(CN2C=CN=C2)C3=C(C=C(C=C3)Cl)Cl
CID000002462,51372-29-3,CCCC1OC2CC3C4CCC5=CC(=O)C=CC5(C4C(CC3(C2(O1)C(=O)CO)C)O)C,gastric inflammation,CID000170361,Varenicline,C1C2CNCC1C3=CC4=NC=CN=C4C=C23
CID000002462,51372-29-3,CCCC1OC2CC3C4CCC5=CC(=O)C=CC5(C4C(CC3(C2(O1)C(=O)CO)C)O)C,gout,CID000004614,oxaprozin,C1=CC=C(C=C1)C2=C(OC(=N2)CCC(=O)O)C3=CC=CC=C3
CID000002462,51372-29-3,CCCC1OC2CC3C4CCC5=CC(=O)C=CC5(C4C(CC3(C2(O1)C(=O)CO)C)O)C,ear infection,CID000004691,"3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine",C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4
CID000002462,51372-29-3,CCCC1OC2CC3C4CCC5=CC(=O)C=CC5(C4C(CC3(C2(O1)C(=O)CO)C)O)C,gastric inflammation,CID000003405,2-[[4-[(2-amino-4-oxo-1H-pteridin-6-yl)methylamino]benzoyl]amino]pentanedioic acid,C1=CC(=CC=C1C(=O)NC(CCC(=O)O)C(=O)O)NCC2=CN=C3C(=N2)C(=O)N=C(N3)N
CID000002462,51372-29-3,CCCC1OC2CC3C4CCC5=CC(=O)C=CC5(C4C(CC3(C2(O1)C(=O)CO)C)O)C,erythema,CID000004158,methylphenidate,COC(=O)C(C1CCCCN1)C2=CC=CC=C2
CID000002462,51372-29-3,CCCC1OC2CC3C4CCC5=CC(=O)C=CC5(C4C(CC3(C2(O1)C(=O)CO)C)O)C,atelectasis,CID000002656,"7-[[2-(2-amino-1,3-thiazol-4-yl)-2-methoxyiminoacetyl]amino]-3-[(2-methyl-6-oxido-5-oxo-1,2,4-triazin-3-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CN1C(=NC(=O)C(=N1)[O-])SCC2=C(N3C(C(C3=O)NC(=O)C(=NOC)C4=CSC(=N4)N)SC2)C(=O)[O-]
CID000002462,51372-29-3,CCCC1OC2CC3C4CCC5=CC(=O)C=CC5(C4C(CC3(C2(O1)C(=O)CO)C)O)C,confusion,CID000019090,megestrol,CC1=CC2C(CCC3(C2CCC3(C(=O)C)O)C)C4(C1=CC(=O)CC4)C
CID000002462,51372-29-3,CCCC1OC2CC3C4CCC5=CC(=O)C=CC5(C4C(CC3(C2(O1)C(=O)CO)C)O)C,abdominal pain upper,CID000002891,"cobalt(2+);[5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] 1-[3-[2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2,7,12,17-tetrahydro-1H-corrin-21-id-3-yl]propanoylamino]propan-2-yl hydrogen phosphate;cyanide",CC1=CC2=C(C=C1C)N(C=N2)C3C(C(C(O3)CO)OP(=O)(O)OC(C)CNC(=O)CCC4(C(C5C6(C(C(C(=N6)C(=C7C(C(C(=N7)C=C8C(C(C(=N8)C(=C4[N-]5)C)CCC(=O)N)(C)C)CCC(=O)N)(C)CC(=O)N)C)CCC(=O)N)(C)CC(=O)N)C)CC(=O)N)C)O.[C-]#N.[Co+2]
CID000002462,51372-29-3,CCCC1OC2CC3C4CCC5=CC(=O)C=CC5(C4C(CC3(C2(O1)C(=O)CO)C)O)C,Back Ache,CID000005358,sumatriptan,CNS(=O)(=O)CC1=CC2=C(C=C1)NC=C2CCN(C)C
CID000002462,51372-29-3,CCCC1OC2CC3C4CCC5=CC(=O)C=CC5(C4C(CC3(C2(O1)C(=O)CO)C)O)C,gastric inflammation,CID000004900,Fernisone,CC12CC(=O)C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C
CID000002462,51372-29-3,CCCC1OC2CC3C4CCC5=CC(=O)C=CC5(C4C(CC3(C2(O1)C(=O)CO)C)O)C,apoplexy,CID000002609,Lilly 99638,C1C(=C(N2C(S1)C(C2=O)NC(=O)C(C3=CC=CC=C3)N)C(=O)O)Cl
CID000002462,51372-29-3,CCCC1OC2CC3C4CCC5=CC(=O)C=CC5(C4C(CC3(C2(O1)C(=O)CO)C)O)C,erythema,CID003468412,SCHEMBL1176571,CC1C=CC=CCCC=CC=CC=CC=CC(CC(C(C(CC(=O)CC(C(CCC(CC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)C(=O)O)O)OC2C(C(C(C(O2)C)O)N)O
CID000002462,51372-29-3,CCCC1OC2CC3C4CCC5=CC(=O)C=CC5(C4C(CC3(C2(O1)C(=O)CO)C)O)C,Back Ache,CID000005095,ropinirole,CCCN(CCC)CCC1=C2CC(=O)NC2=CC=C1
CID000002462,51372-29-3,CCCC1OC2CC3C4CCC5=CC(=O)C=CC5(C4C(CC3(C2(O1)C(=O)CO)C)O)C,gastric inflammation,CID000002771,citalopram,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F
CID000002462,51372-29-3,CCCC1OC2CC3C4CCC5=CC(=O)C=CC5(C4C(CC3(C2(O1)C(=O)CO)C)O)C,neumonia,CID000002524,32222-06-3,CC(CCCC(C)(C)O)C1CCC2C1(CCCC2=CC=C3CC(CC(C3=C)O)O)C
CID000002462,51372-29-3,CCCC1OC2CC3C4CCC5=CC(=O)C=CC5(C4C(CC3(C2(O1)C(=O)CO)C)O)C,erythema,CID000060865,(E)-Olopatadine,CN(C)CCC=C1C2=CC=CC=C2COC3=C1C=C(C=C3)CC(=O)O
CID000002462,51372-29-3,CCCC1OC2CC3C4CCC5=CC(=O)C=CC5(C4C(CC3(C2(O1)C(=O)CO)C)O)C,weight gain,CID000003827,ketotifen,CN1CCC(=C2C3=C(C(=O)CC4=CC=CC=C42)SC=C3)CC1
CID000002462,51372-29-3,CCCC1OC2CC3C4CCC5=CC(=O)C=CC5(C4C(CC3(C2(O1)C(=O)CO)C)O)C,gastric inflammation,CID000003339,fenofibrate,CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C2=CC=C(C=C2)Cl
CID000002462,51372-29-3,CCCC1OC2CC3C4CCC5=CC(=O)C=CC5(C4C(CC3(C2(O1)C(=O)CO)C)O)C,thrombocytopenia,CID000003310,33419-42-0,CC1OCC2C(O1)C(C(C(O2)OC3C4COC(=O)C4C(C5=CC6=C(C=C35)OCO6)C7=CC(=C(C(=C7)OC)O)OC)O)O
CID000002462,51372-29-3,CCCC1OC2CC3C4CCC5=CC(=O)C=CC5(C4C(CC3(C2(O1)C(=O)CO)C)O)C,constipated,CID000060184,"2'-epi-Perindopril, (2'R)-",CCCC(C(=O)OCC)NC(C)C(=O)N1C2CCCCC2CC1C(=O)O
CID000002462,51372-29-3,CCCC1OC2CC3C4CCC5=CC(=O)C=CC5(C4C(CC3(C2(O1)C(=O)CO)C)O)C,right heart failure,CID000003749,irbesartan,CCCCC1=NC2(CCCC2)C(=O)N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5
CID000002462,51372-29-3,CCCC1OC2CC3C4CCC5=CC(=O)C=CC5(C4C(CC3(C2(O1)C(=O)CO)C)O)C,loss of weight,CID000004920,"1-acetyl-9a,11a-dimethyl-1H,2H,3H,3aH,3bH,4H,5H,7H,8H,9H,9aH,9bH,10H,11H,11aH-cyclopenta[a]phenanthren-7-one",CC(=O)C1CCC2C1(CCC3C2CCC4=CC(=O)CCC34C)C
CID000002462,51372-29-3,CCCC1OC2CC3C4CCC5=CC(=O)C=CC5(C4C(CC3(C2(O1)C(=O)CO)C)O)C,cholecystitis,CID000004510,nitroglycerin,C(C(CO[N+](=O)[O-])O[N+](=O)[O-])O[N+](=O)[O-]
CID000002462,51372-29-3,CCCC1OC2CC3C4CCC5=CC(=O)C=CC5(C4C(CC3(C2(O1)C(=O)CO)C)O)C,gastric inflammation,CID000005732,zolpidem,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C
CID000002462,51372-29-3,CCCC1OC2CC3C4CCC5=CC(=O)C=CC5(C4C(CC3(C2(O1)C(=O)CO)C)O)C,elevated erythrocyte sedimentation rate,CID000005245,Risedronic acid,C1=CC(=CN=C1)CC(O)(P(=O)(O)O)P(=O)(O)O
CID000002462,51372-29-3,CCCC1OC2CC3C4CCC5=CC(=O)C=CC5(C4C(CC3(C2(O1)C(=O)CO)C)O)C,myelodysplasia,CID000003440,furosemide,C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl
CID000002462,51372-29-3,CCCC1OC2CC3C4CCC5=CC(=O)C=CC5(C4C(CC3(C2(O1)C(=O)CO)C)O)C,erythema,CID000003676,lidocaine,CCN(CC)CC(=O)NC1=C(C=CC=C1C)C
CID000002462,51372-29-3,CCCC1OC2CC3C4CCC5=CC(=O)C=CC5(C4C(CC3(C2(O1)C(=O)CO)C)O)C,back injury,CID000003961,losartan,CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)CO)Cl
CID000002462,51372-29-3,CCCC1OC2CC3C4CCC5=CC(=O)C=CC5(C4C(CC3(C2(O1)C(=O)CO)C)O)C,apoplexy,CID000004170,metolazone,CC1NC2=CC(=C(C=C2C(=O)N1C3=CC=CC=C3C)S(=O)(=O)N)Cl
CID000002462,51372-29-3,CCCC1OC2CC3C4CCC5=CC(=O)C=CC5(C4C(CC3(C2(O1)C(=O)CO)C)O)C,loss of weight,CID000005487,tizanidine,C1CN=C(N1)NC2=C(C=CC3=NSN=C32)Cl
CID000002462,51372-29-3,CCCC1OC2CC3C4CCC5=CC(=O)C=CC5(C4C(CC3(C2(O1)C(=O)CO)C)O)C,back injury,CID000005152,Salmeterol,C1=CC=C(C=C1)CCCCOCCCCCCNCC(C2=CC(=C(C=C2)O)CO)O
CID000002462,51372-29-3,CCCC1OC2CC3C4CCC5=CC(=O)C=CC5(C4C(CC3(C2(O1)C(=O)CO)C)O)C,rhinorrhea,CID000004536,Minovlar,CC12CCC3C(C1CCC2(C#C)O)CCC4=CC(=O)CCC34
CID000002462,51372-29-3,CCCC1OC2CC3C4CCC5=CC(=O)C=CC5(C4C(CC3(C2(O1)C(=O)CO)C)O)C,cholecystectomies,CID000003062,Lanicor,CC1C(C(CC(O1)OC2C(OC(CC2O)OC3C(OC(CC3O)OC4CCC5(C(C4)CCC6C5CC(C7(C6(CCC7C8=CC(=O)OC8)O)C)O)C)C)C)O)O
CID000002462,51372-29-3,CCCC1OC2CC3C4CCC5=CC(=O)C=CC5(C4C(CC3(C2(O1)C(=O)CO)C)O)C,erythema,CID000005719,zaleplon,CCN(C1=CC=CC(=C1)C2=CC=NC3=C(C=NN23)C#N)C(=O)C
CID000002462,51372-29-3,CCCC1OC2CC3C4CCC5=CC(=O)C=CC5(C4C(CC3(C2(O1)C(=O)CO)C)O)C,Adenopathy,CID000667490,6-Mercaptopurine,C1=NC2=C(N1)C(=S)N=CN2
CID000002462,51372-29-3,CCCC1OC2CC3C4CCC5=CC(=O)C=CC5(C4C(CC3(C2(O1)C(=O)CO)C)O)C,insulin dependent diabetes mellitus,CID000004585,"2-methyl-4-(4-methylpiperazin-1-yl)-5H-thieno[3,2-c][1,5]benzodiazepine",CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C
CID000002462,51372-29-3,CCCC1OC2CC3C4CCC5=CC(=O)C=CC5(C4C(CC3(C2(O1)C(=O)CO)C)O)C,cholecystitis,CID000004894,"11,17,21-Trihydroxypregna-1,4-diene-3,20-dione",CC12CC(C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C)O
CID000004011,maprotiline,CNCCCC12CCC(C3=CC=CC=C31)C4=CC=CC=C24,drug toxicity NOS,CID000004205,mirtazapine,CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4
CID000003059,diflunisal,C1=CC(=C(C=C1C2=C(C=C(C=C2)F)F)C(=O)O)O,loss of weight,CID000004691,"3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine",C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4
CID000003059,diflunisal,C1=CC(=C(C=C1C2=C(C=C(C=C2)F)F)C(=O)O)O,nasopharyngitis,CID000003405,2-[[4-[(2-amino-4-oxo-1H-pteridin-6-yl)methylamino]benzoyl]amino]pentanedioic acid,C1=CC(=CC=C1C(=O)NC(CCC(=O)O)C(=O)O)NCC2=CN=C3C(=N2)C(=O)N=C(N3)N
CID000003059,diflunisal,C1=CC(=C(C=C1C2=C(C=C(C=C2)F)F)C(=O)O)O,loss of weight,CID000005732,zolpidem,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C
CID000003059,diflunisal,C1=CC(=C(C=C1C2=C(C=C(C=C2)F)F)C(=O)O)O,apoplexy,CID000003440,furosemide,C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl
CID000003059,diflunisal,C1=CC(=C(C=C1C2=C(C=C(C=C2)F)F)C(=O)O)O,Back Ache,CID000004900,Fernisone,CC12CC(=O)C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C
CID000001065,9-epi-Quinine,COC1=CC2=C(C=CN=C2C=C1)C(C3CC4CCN3CC4C=C)O,cholecystitis,CID000004900,Fernisone,CC12CC(=O)C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C
CID000001065,9-epi-Quinine,COC1=CC2=C(C=CN=C2C=C1)C(C3CC4CCN3CC4C=C)O,dysarthria,CID000004170,metolazone,CC1NC2=CC(=C(C=C2C(=O)N1C3=CC=CC=C3C)S(=O)(=O)N)Cl
CID000001065,9-epi-Quinine,COC1=CC2=C(C=CN=C2C=C1)C(C3CC4CCN3CC4C=C)O,Endometrial cancer,CID000002088,ALENDRONIC ACID,C(CC(O)(P(=O)(O)O)P(=O)(O)O)CN
CID000001065,9-epi-Quinine,COC1=CC2=C(C=CN=C2C=C1)C(C3CC4CCN3CC4C=C)O,cholecystitis,CID000004585,"2-methyl-4-(4-methylpiperazin-1-yl)-5H-thieno[3,2-c][1,5]benzodiazepine",CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C
CID000001065,9-epi-Quinine,COC1=CC2=C(C=CN=C2C=C1)C(C3CC4CCN3CC4C=C)O,loss of weight,CID000003749,irbesartan,CCCCC1=NC2(CCCC2)C(=O)N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5
CID000001065,9-epi-Quinine,COC1=CC2=C(C=CN=C2C=C1)C(C3CC4CCN3CC4C=C)O,allergic dermatitis,CID000004614,oxaprozin,C1=CC=C(C=C1)C2=C(OC(=N2)CCC(=O)O)C3=CC=CC=C3
CID000001065,9-epi-Quinine,COC1=CC2=C(C=CN=C2C=C1)C(C3CC4CCN3CC4C=C)O,cholecystitis,CID000005732,zolpidem,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C
CID000001065,9-epi-Quinine,COC1=CC2=C(C=CN=C2C=C1)C(C3CC4CCN3CC4C=C)O,cholecystitis,CID000004691,"3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine",C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4
CID000001065,9-epi-Quinine,COC1=CC2=C(C=CN=C2C=C1)C(C3CC4CCN3CC4C=C)O,allergic dermatitis,CID000002524,32222-06-3,CC(CCCC(C)(C)O)C1CCC2C1(CCCC2=CC=C3CC(CC(C3=C)O)O)C
CID000001065,9-epi-Quinine,COC1=CC2=C(C=CN=C2C=C1)C(C3CC4CCN3CC4C=C)O,cholecystitis,CID000003062,Lanicor,CC1C(C(CC(O1)OC2C(OC(CC2O)OC3C(OC(CC3O)OC4CCC5(C(C4)CCC6C5CC(C7(C6(CCC7C8=CC(=O)OC8)O)C)O)C)C)C)O)O
CID000001065,9-epi-Quinine,COC1=CC2=C(C=CN=C2C=C1)C(C3CC4CCN3CC4C=C)O,angiitis,CID000002405,BISOPROLOL,CC(C)NCC(COC1=CC=C(C=C1)COCCOC(C)C)O
CID000001065,9-epi-Quinine,COC1=CC2=C(C=CN=C2C=C1)C(C3CC4CCN3CC4C=C)O,rhinorrhea,CID000004158,methylphenidate,COC(=O)C(C1CCCCN1)C2=CC=CC=C2
CID000001065,9-epi-Quinine,COC1=CC2=C(C=CN=C2C=C1)C(C3CC4CCN3CC4C=C)O,gastric inflammation,CID000002771,citalopram,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F
CID000001065,9-epi-Quinine,COC1=CC2=C(C=CN=C2C=C1)C(C3CC4CCN3CC4C=C)O,cholecystitis,CID000003440,furosemide,C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl
CID000001065,9-epi-Quinine,COC1=CC2=C(C=CN=C2C=C1)C(C3CC4CCN3CC4C=C)O,loss of weight,CID000005095,ropinirole,CCCN(CCC)CCC1=C2CC(=O)NC2=CC=C1
CID000001065,9-epi-Quinine,COC1=CC2=C(C=CN=C2C=C1)C(C3CC4CCN3CC4C=C)O,apoplexy,CID000005358,sumatriptan,CNS(=O)(=O)CC1=CC2=C(C=C1)NC=C2CCN(C)C
CID000001065,9-epi-Quinine,COC1=CC2=C(C=CN=C2C=C1)C(C3CC4CCN3CC4C=C)O,elevated erythrocyte sedimentation rate,CID003468412,SCHEMBL1176571,CC1C=CC=CCCC=CC=CC=CC=CC(CC(C(C(CC(=O)CC(C(CCC(CC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)C(=O)O)O)OC2C(C(C(C(O2)C)O)N)O
CID000001065,9-epi-Quinine,COC1=CC2=C(C=CN=C2C=C1)C(C3CC4CCN3CC4C=C)O,Back Ache,CID000019090,megestrol,CC1=CC2C(CCC3(C2CCC3(C(=O)C)O)C)C4(C1=CC(=O)CC4)C
CID000001065,9-epi-Quinine,COC1=CC2=C(C=CN=C2C=C1)C(C3CC4CCN3CC4C=C)O,gastric inflammation,CID000170361,Varenicline,C1C2CNCC1C3=CC4=NC=CN=C4C=C23
CID000001065,9-epi-Quinine,COC1=CC2=C(C=CN=C2C=C1)C(C3CC4CCN3CC4C=C)O,respiratory alkalosis,CID000003780,"D-Glucitol, 1,4:3,6-dianhydro-, 2,5-dinitrate",C1C(C2C(O1)C(CO2)O[N+](=O)[O-])O[N+](=O)[O-]
CID000001065,9-epi-Quinine,COC1=CC2=C(C=CN=C2C=C1)C(C3CC4CCN3CC4C=C)O,back injury,CID000001983,acetaminophen,CC(=O)NC1=CC=C(C=C1)O
CID000001065,9-epi-Quinine,COC1=CC2=C(C=CN=C2C=C1)C(C3CC4CCN3CC4C=C)O,allergic dermatitis,CID006398525,,C(C1C(C(C(C(O1)OC2(C(C(C(O2)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)COS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.[Al].[Al].[Al].[Al].[Al].[Al].[Al].[Al].[Al]
CID000001065,9-epi-Quinine,COC1=CC2=C(C=CN=C2C=C1)C(C3CC4CCN3CC4C=C)O,dysarthria,CID000002656,"7-[[2-(2-amino-1,3-thiazol-4-yl)-2-methoxyiminoacetyl]amino]-3-[(2-methyl-6-oxido-5-oxo-1,2,4-triazin-3-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CN1C(=NC(=O)C(=N1)[O-])SCC2=C(N3C(C(C3=O)NC(=O)C(=NOC)C4=CSC(=N4)N)SC2)C(=O)[O-]
CID000001065,9-epi-Quinine,COC1=CC2=C(C=CN=C2C=C1)C(C3CC4CCN3CC4C=C)O,gastric inflammation,CID000002284,baclofen,C1=CC(=CC=C1C(CC(=O)O)CN)Cl
CID000001065,9-epi-Quinine,COC1=CC2=C(C=CN=C2C=C1)C(C3CC4CCN3CC4C=C)O,apoplexy,CID000005487,tizanidine,C1CN=C(N1)NC2=C(C=CC3=NSN=C32)Cl
CID000001065,9-epi-Quinine,COC1=CC2=C(C=CN=C2C=C1)C(C3CC4CCN3CC4C=C)O,apoplexy,CID000004894,"11,17,21-Trihydroxypregna-1,4-diene-3,20-dione",CC12CC(C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C)O
CID000001065,9-epi-Quinine,COC1=CC2=C(C=CN=C2C=C1)C(C3CC4CCN3CC4C=C)O,loss of weight,CID000003676,lidocaine,CCN(CC)CC(=O)NC1=C(C=CC=C1C)C
CID000001065,9-epi-Quinine,COC1=CC2=C(C=CN=C2C=C1)C(C3CC4CCN3CC4C=C)O,cholecystitis,CID000004510,nitroglycerin,C(C(CO[N+](=O)[O-])O[N+](=O)[O-])O[N+](=O)[O-]
CID000001065,9-epi-Quinine,COC1=CC2=C(C=CN=C2C=C1)C(C3CC4CCN3CC4C=C)O,aspiration pneumonia,CID000002891,"cobalt(2+);[5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] 1-[3-[2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2,7,12,17-tetrahydro-1H-corrin-21-id-3-yl]propanoylamino]propan-2-yl hydrogen phosphate;cyanide",CC1=CC2=C(C=C1C)N(C=N2)C3C(C(C(O3)CO)OP(=O)(O)OC(C)CNC(=O)CCC4(C(C5C6(C(C(C(=N6)C(=C7C(C(C(=N7)C=C8C(C(C(=N8)C(=C4[N-]5)C)CCC(=O)N)(C)C)CCC(=O)N)(C)CC(=O)N)C)CCC(=O)N)(C)CC(=O)N)C)CC(=O)N)C)O.[C-]#N.[Co+2]
CID000001065,9-epi-Quinine,COC1=CC2=C(C=CN=C2C=C1)C(C3CC4CCN3CC4C=C)O,cholecystitis,CID000003961,losartan,CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)CO)Cl
CID000001065,9-epi-Quinine,COC1=CC2=C(C=CN=C2C=C1)C(C3CC4CCN3CC4C=C)O,apoplexy,CID000004205,mirtazapine,CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4
CID000001065,9-epi-Quinine,COC1=CC2=C(C=CN=C2C=C1)C(C3CC4CCN3CC4C=C)O,angiitis,CID000003333,felodipine,CCOC(=O)C1=C(NC(=C(C1C2=C(C(=CC=C2)Cl)Cl)C(=O)OC)C)C
CID000001065,9-epi-Quinine,COC1=CC2=C(C=CN=C2C=C1)C(C3CC4CCN3CC4C=C)O,cholecystitis,CID000003339,fenofibrate,CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C2=CC=C(C=C2)Cl
CID000001065,9-epi-Quinine,COC1=CC2=C(C=CN=C2C=C1)C(C3CC4CCN3CC4C=C)O,constipated,CID000005245,Risedronic acid,C1=CC(=CN=C1)CC(O)(P(=O)(O)O)P(=O)(O)O
CID000001065,9-epi-Quinine,COC1=CC2=C(C=CN=C2C=C1)C(C3CC4CCN3CC4C=C)O,asthenia,CID000060184,"2'-epi-Perindopril, (2'R)-",CCCC(C(=O)OCC)NC(C)C(=O)N1C2CCCCC2CC1C(=O)O
CID000001065,9-epi-Quinine,COC1=CC2=C(C=CN=C2C=C1)C(C3CC4CCN3CC4C=C)O,myelodysplasia,CID000003405,2-[[4-[(2-amino-4-oxo-1H-pteridin-6-yl)methylamino]benzoyl]amino]pentanedioic acid,C1=CC(=CC=C1C(=O)NC(CCC(=O)O)C(=O)O)NCC2=CN=C3C(=N2)C(=O)N=C(N3)N
CID000001065,9-epi-Quinine,COC1=CC2=C(C=CN=C2C=C1)C(C3CC4CCN3CC4C=C)O,elevated cholesterol,CID000003869,labetalol,CC(CCC1=CC=CC=C1)NCC(C2=CC(=C(C=C2)O)C(=O)N)O
CID000001065,9-epi-Quinine,COC1=CC2=C(C=CN=C2C=C1)C(C3CC4CCN3CC4C=C)O,insulin dependent diabetes mellitus,CID000012536,638-94-8,CC1(OC2CC3C4CCC5=CC(=O)C=CC5(C4C(CC3(C2(O1)C(=O)CO)C)O)C)C
CID000001065,9-epi-Quinine,COC1=CC2=C(C=CN=C2C=C1)C(C3CC4CCN3CC4C=C)O,loss of weight,CID000005152,Salmeterol,C1=CC=C(C=C1)CCCCOCCCCCCNCC(C2=CC(=C(C=C2)O)CO)O
CID000001065,9-epi-Quinine,COC1=CC2=C(C=CN=C2C=C1)C(C3CC4CCN3CC4C=C)O,loss of weight,CID000005394,temozolomide,CN1C(=O)N2C=NC(=C2N=N1)C(=O)N
CID000003780,"D-Glucitol, 1,4:3,6-dianhydro-, 2,5-dinitrate",C1C(C2C(O1)C(CO2)O[N+](=O)[O-])O[N+](=O)[O-],apoplexy,CID000005245,Risedronic acid,C1=CC(=CN=C1)CC(O)(P(=O)(O)O)P(=O)(O)O
CID000003780,"D-Glucitol, 1,4:3,6-dianhydro-, 2,5-dinitrate",C1C(C2C(O1)C(CO2)O[N+](=O)[O-])O[N+](=O)[O-],apoplexy,CID000004585,"2-methyl-4-(4-methylpiperazin-1-yl)-5H-thieno[3,2-c][1,5]benzodiazepine",CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C
CID000003780,"D-Glucitol, 1,4:3,6-dianhydro-, 2,5-dinitrate",C1C(C2C(O1)C(CO2)O[N+](=O)[O-])O[N+](=O)[O-],apoplexy,CID003468412,SCHEMBL1176571,CC1C=CC=CCCC=CC=CC=CC=CC(CC(C(C(CC(=O)CC(C(CCC(CC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)C(=O)O)O)OC2C(C(C(C(O2)C)O)N)O
CID000003780,"D-Glucitol, 1,4:3,6-dianhydro-, 2,5-dinitrate",C1C(C2C(O1)C(CO2)O[N+](=O)[O-])O[N+](=O)[O-],loss of weight,CID000170361,Varenicline,C1C2CNCC1C3=CC4=NC=CN=C4C=C23
CID000003780,"D-Glucitol, 1,4:3,6-dianhydro-, 2,5-dinitrate",C1C(C2C(O1)C(CO2)O[N+](=O)[O-])O[N+](=O)[O-],gastric inflammation,CID000004900,Fernisone,CC12CC(=O)C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C
CID000003780,"D-Glucitol, 1,4:3,6-dianhydro-, 2,5-dinitrate",C1C(C2C(O1)C(CO2)O[N+](=O)[O-])O[N+](=O)[O-],eruption,CID000005152,Salmeterol,C1=CC=C(C=C1)CCCCOCCCCCCNCC(C2=CC(=C(C=C2)O)CO)O
CID000003780,"D-Glucitol, 1,4:3,6-dianhydro-, 2,5-dinitrate",C1C(C2C(O1)C(CO2)O[N+](=O)[O-])O[N+](=O)[O-],abnormal ECG,CID000004205,mirtazapine,CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4
CID000003780,"D-Glucitol, 1,4:3,6-dianhydro-, 2,5-dinitrate",C1C(C2C(O1)C(CO2)O[N+](=O)[O-])O[N+](=O)[O-],Adenopathy,CID000004510,nitroglycerin,C(C(CO[N+](=O)[O-])O[N+](=O)[O-])O[N+](=O)[O-]
CID000003780,"D-Glucitol, 1,4:3,6-dianhydro-, 2,5-dinitrate",C1C(C2C(O1)C(CO2)O[N+](=O)[O-])O[N+](=O)[O-],erythema,CID000005732,zolpidem,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C
CID000003780,"D-Glucitol, 1,4:3,6-dianhydro-, 2,5-dinitrate",C1C(C2C(O1)C(CO2)O[N+](=O)[O-])O[N+](=O)[O-],loss of weight,CID000005095,ropinirole,CCCN(CCC)CCC1=C2CC(=O)NC2=CC=C1
CID000003780,"D-Glucitol, 1,4:3,6-dianhydro-, 2,5-dinitrate",C1C(C2C(O1)C(CO2)O[N+](=O)[O-])O[N+](=O)[O-],loss of weight,CID000004201,minoxidil,C1CCN(CC1)C2=NC(=N)N(C(=C2)N)O
CID000003780,"D-Glucitol, 1,4:3,6-dianhydro-, 2,5-dinitrate",C1C(C2C(O1)C(CO2)O[N+](=O)[O-])O[N+](=O)[O-],weight gain,CID000060854,Ziprasidone,C1CN(CCN1CCC2=C(C=C3C(=C2)CC(=O)N3)Cl)C4=NSC5=CC=CC=C54
CID000003780,"D-Glucitol, 1,4:3,6-dianhydro-, 2,5-dinitrate",C1C(C2C(O1)C(CO2)O[N+](=O)[O-])O[N+](=O)[O-],right heart failure,CID000003961,losartan,CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)CO)Cl
CID000003780,"D-Glucitol, 1,4:3,6-dianhydro-, 2,5-dinitrate",C1C(C2C(O1)C(CO2)O[N+](=O)[O-])O[N+](=O)[O-],cholecystitis,CID000004691,"3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine",C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4
CID000003780,"D-Glucitol, 1,4:3,6-dianhydro-, 2,5-dinitrate",C1C(C2C(O1)C(CO2)O[N+](=O)[O-])O[N+](=O)[O-],apoplexy,CID006398525,,C(C1C(C(C(C(O1)OC2(C(C(C(O2)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)COS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.[Al].[Al].[Al].[Al].[Al].[Al].[Al].[Al].[Al]
CID000003780,"D-Glucitol, 1,4:3,6-dianhydro-, 2,5-dinitrate",C1C(C2C(O1)C(CO2)O[N+](=O)[O-])O[N+](=O)[O-],deglutition disorder,CID000004614,oxaprozin,C1=CC=C(C=C1)C2=C(OC(=N2)CCC(=O)O)C3=CC=CC=C3
CID000003780,"D-Glucitol, 1,4:3,6-dianhydro-, 2,5-dinitrate",C1C(C2C(O1)C(CO2)O[N+](=O)[O-])O[N+](=O)[O-],gastric inflammation,CID000004894,"11,17,21-Trihydroxypregna-1,4-diene-3,20-dione",CC12CC(C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C)O
CID000003780,"D-Glucitol, 1,4:3,6-dianhydro-, 2,5-dinitrate",C1C(C2C(O1)C(CO2)O[N+](=O)[O-])O[N+](=O)[O-],nasopharyngitis,CID000004170,metolazone,CC1NC2=CC(=C(C=C2C(=O)N1C3=CC=CC=C3C)S(=O)(=O)N)Cl
CID000003780,"D-Glucitol, 1,4:3,6-dianhydro-, 2,5-dinitrate",C1C(C2C(O1)C(CO2)O[N+](=O)[O-])O[N+](=O)[O-],Pain,CID000005487,tizanidine,C1CN=C(N1)NC2=C(C=CC3=NSN=C32)Cl
CID000003780,"D-Glucitol, 1,4:3,6-dianhydro-, 2,5-dinitrate",C1C(C2C(O1)C(CO2)O[N+](=O)[O-])O[N+](=O)[O-],thrombocytopenia,CID000005486,(R)-Tirofiban,CCCCS(=O)(=O)NC(CC1=CC=C(C=C1)OCCCCC2CCNCC2)C(=O)O
CID000002656,"7-[[2-(2-amino-1,3-thiazol-4-yl)-2-methoxyiminoacetyl]amino]-3-[(2-methyl-6-oxido-5-oxo-1,2,4-triazin-3-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CN1C(=NC(=O)C(=N1)[O-])SCC2=C(N3C(C(C3=O)NC(=O)C(=NOC)C4=CSC(=N4)N)SC2)C(=O)[O-],erythema,CID000004189,miconazole,C1=CC(=C(C=C1Cl)Cl)COC(CN2C=CN=C2)C3=C(C=C(C=C3)Cl)Cl
CID000002656,"7-[[2-(2-amino-1,3-thiazol-4-yl)-2-methoxyiminoacetyl]amino]-3-[(2-methyl-6-oxido-5-oxo-1,2,4-triazin-3-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CN1C(=NC(=O)C(=N1)[O-])SCC2=C(N3C(C(C3=O)NC(=O)C(=NOC)C4=CSC(=N4)N)SC2)C(=O)[O-],cholecystitis,CID000004691,"3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine",C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4
CID000002656,"7-[[2-(2-amino-1,3-thiazol-4-yl)-2-methoxyiminoacetyl]amino]-3-[(2-methyl-6-oxido-5-oxo-1,2,4-triazin-3-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CN1C(=NC(=O)C(=N1)[O-])SCC2=C(N3C(C(C3=O)NC(=O)C(=NOC)C4=CSC(=N4)N)SC2)C(=O)[O-],drug withdrawal,CID006398525,,C(C1C(C(C(C(O1)OC2(C(C(C(O2)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)COS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.[Al].[Al].[Al].[Al].[Al].[Al].[Al].[Al].[Al]
CID000002656,"7-[[2-(2-amino-1,3-thiazol-4-yl)-2-methoxyiminoacetyl]amino]-3-[(2-methyl-6-oxido-5-oxo-1,2,4-triazin-3-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CN1C(=NC(=O)C(=N1)[O-])SCC2=C(N3C(C(C3=O)NC(=O)C(=NOC)C4=CSC(=N4)N)SC2)C(=O)[O-],loss of weight,CID000004170,metolazone,CC1NC2=CC(=C(C=C2C(=O)N1C3=CC=CC=C3C)S(=O)(=O)N)Cl
CID000002656,"7-[[2-(2-amino-1,3-thiazol-4-yl)-2-methoxyiminoacetyl]amino]-3-[(2-methyl-6-oxido-5-oxo-1,2,4-triazin-3-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CN1C(=NC(=O)C(=N1)[O-])SCC2=C(N3C(C(C3=O)NC(=O)C(=NOC)C4=CSC(=N4)N)SC2)C(=O)[O-],gastric inflammation,CID000004894,"11,17,21-Trihydroxypregna-1,4-diene-3,20-dione",CC12CC(C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C)O
CID000002656,"7-[[2-(2-amino-1,3-thiazol-4-yl)-2-methoxyiminoacetyl]amino]-3-[(2-methyl-6-oxido-5-oxo-1,2,4-triazin-3-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CN1C(=NC(=O)C(=N1)[O-])SCC2=C(N3C(C(C3=O)NC(=O)C(=NOC)C4=CSC(=N4)N)SC2)C(=O)[O-],increased white blood cell count,CID000060854,Ziprasidone,C1CN(CCN1CCC2=C(C=C3C(=C2)CC(=O)N3)Cl)C4=NSC5=CC=CC=C54
CID000002656,"7-[[2-(2-amino-1,3-thiazol-4-yl)-2-methoxyiminoacetyl]amino]-3-[(2-methyl-6-oxido-5-oxo-1,2,4-triazin-3-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CN1C(=NC(=O)C(=N1)[O-])SCC2=C(N3C(C(C3=O)NC(=O)C(=NOC)C4=CSC(=N4)N)SC2)C(=O)[O-],Back Ache,CID000003333,felodipine,CCOC(=O)C1=C(NC(=C(C1C2=C(C(=CC=C2)Cl)Cl)C(=O)OC)C)C
CID000002656,"7-[[2-(2-amino-1,3-thiazol-4-yl)-2-methoxyiminoacetyl]amino]-3-[(2-methyl-6-oxido-5-oxo-1,2,4-triazin-3-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CN1C(=NC(=O)C(=N1)[O-])SCC2=C(N3C(C(C3=O)NC(=O)C(=NOC)C4=CSC(=N4)N)SC2)C(=O)[O-],eruption,CID000002891,"cobalt(2+);[5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] 1-[3-[2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2,7,12,17-tetrahydro-1H-corrin-21-id-3-yl]propanoylamino]propan-2-yl hydrogen phosphate;cyanide",CC1=CC2=C(C=C1C)N(C=N2)C3C(C(C(O3)CO)OP(=O)(O)OC(C)CNC(=O)CCC4(C(C5C6(C(C(C(=N6)C(=C7C(C(C(=N7)C=C8C(C(C(=N8)C(=C4[N-]5)C)CCC(=O)N)(C)C)CCC(=O)N)(C)CC(=O)N)C)CCC(=O)N)(C)CC(=O)N)C)CC(=O)N)C)O.[C-]#N.[Co+2]
CID000002656,"7-[[2-(2-amino-1,3-thiazol-4-yl)-2-methoxyiminoacetyl]amino]-3-[(2-methyl-6-oxido-5-oxo-1,2,4-triazin-3-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CN1C(=NC(=O)C(=N1)[O-])SCC2=C(N3C(C(C3=O)NC(=O)C(=NOC)C4=CSC(=N4)N)SC2)C(=O)[O-],abnormal ECG,CID000003310,33419-42-0,CC1OCC2C(O1)C(C(C(O2)OC3C4COC(=O)C4C(C5=CC6=C(C=C35)OCO6)C7=CC(=C(C(=C7)OC)O)OC)O)O
CID000002656,"7-[[2-(2-amino-1,3-thiazol-4-yl)-2-methoxyiminoacetyl]amino]-3-[(2-methyl-6-oxido-5-oxo-1,2,4-triazin-3-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CN1C(=NC(=O)C(=N1)[O-])SCC2=C(N3C(C(C3=O)NC(=O)C(=NOC)C4=CSC(=N4)N)SC2)C(=O)[O-],cholecystitis,CID000002771,citalopram,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F
CID000002656,"7-[[2-(2-amino-1,3-thiazol-4-yl)-2-methoxyiminoacetyl]amino]-3-[(2-methyl-6-oxido-5-oxo-1,2,4-triazin-3-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CN1C(=NC(=O)C(=N1)[O-])SCC2=C(N3C(C(C3=O)NC(=O)C(=NOC)C4=CSC(=N4)N)SC2)C(=O)[O-],erythema,CID000147912,DSSTox_GSID_49066,CCC(C(C)O)N1C(=O)N(C=N1)C2=CC=C(C=C2)N3CCN(CC3)C4=CC=C(C=C4)OCC5CC(OC5)(CN6C=NC=N6)C7=C(C=C(C=C7)F)F
CID000002656,"7-[[2-(2-amino-1,3-thiazol-4-yl)-2-methoxyiminoacetyl]amino]-3-[(2-methyl-6-oxido-5-oxo-1,2,4-triazin-3-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CN1C(=NC(=O)C(=N1)[O-])SCC2=C(N3C(C(C3=O)NC(=O)C(=NOC)C4=CSC(=N4)N)SC2)C(=O)[O-],Back Ache,CID000004585,"2-methyl-4-(4-methylpiperazin-1-yl)-5H-thieno[3,2-c][1,5]benzodiazepine",CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C
CID000002656,"7-[[2-(2-amino-1,3-thiazol-4-yl)-2-methoxyiminoacetyl]amino]-3-[(2-methyl-6-oxido-5-oxo-1,2,4-triazin-3-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CN1C(=NC(=O)C(=N1)[O-])SCC2=C(N3C(C(C3=O)NC(=O)C(=NOC)C4=CSC(=N4)N)SC2)C(=O)[O-],apoplexy,CID000005394,temozolomide,CN1C(=O)N2C=NC(=C2N=N1)C(=O)N
CID000002656,"7-[[2-(2-amino-1,3-thiazol-4-yl)-2-methoxyiminoacetyl]amino]-3-[(2-methyl-6-oxido-5-oxo-1,2,4-triazin-3-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CN1C(=NC(=O)C(=N1)[O-])SCC2=C(N3C(C(C3=O)NC(=O)C(=NOC)C4=CSC(=N4)N)SC2)C(=O)[O-],eruption,CID000003827,ketotifen,CN1CCC(=C2C3=C(C(=O)CC4=CC=CC=C42)SC=C3)CC1
CID000002656,"7-[[2-(2-amino-1,3-thiazol-4-yl)-2-methoxyiminoacetyl]amino]-3-[(2-methyl-6-oxido-5-oxo-1,2,4-triazin-3-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CN1C(=NC(=O)C(=N1)[O-])SCC2=C(N3C(C(C3=O)NC(=O)C(=NOC)C4=CSC(=N4)N)SC2)C(=O)[O-],Adenopathy,CID000005152,Salmeterol,C1=CC=C(C=C1)CCCCOCCCCCCNCC(C2=CC(=C(C=C2)O)CO)O
CID000002656,"7-[[2-(2-amino-1,3-thiazol-4-yl)-2-methoxyiminoacetyl]amino]-3-[(2-methyl-6-oxido-5-oxo-1,2,4-triazin-3-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CN1C(=NC(=O)C(=N1)[O-])SCC2=C(N3C(C(C3=O)NC(=O)C(=NOC)C4=CSC(=N4)N)SC2)C(=O)[O-],apoplexy,CID000019090,megestrol,CC1=CC2C(CCC3(C2CCC3(C(=O)C)O)C)C4(C1=CC(=O)CC4)C
CID000002656,"7-[[2-(2-amino-1,3-thiazol-4-yl)-2-methoxyiminoacetyl]amino]-3-[(2-methyl-6-oxido-5-oxo-1,2,4-triazin-3-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CN1C(=NC(=O)C(=N1)[O-])SCC2=C(N3C(C(C3=O)NC(=O)C(=NOC)C4=CSC(=N4)N)SC2)C(=O)[O-],thrombocytopenia,CID000005245,Risedronic acid,C1=CC(=CN=C1)CC(O)(P(=O)(O)O)P(=O)(O)O
CID000002656,"7-[[2-(2-amino-1,3-thiazol-4-yl)-2-methoxyiminoacetyl]amino]-3-[(2-methyl-6-oxido-5-oxo-1,2,4-triazin-3-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CN1C(=NC(=O)C(=N1)[O-])SCC2=C(N3C(C(C3=O)NC(=O)C(=NOC)C4=CSC(=N4)N)SC2)C(=O)[O-],enlarged liver,CID000667490,6-Mercaptopurine,C1=NC2=C(N1)C(=S)N=CN2
CID000002656,"7-[[2-(2-amino-1,3-thiazol-4-yl)-2-methoxyiminoacetyl]amino]-3-[(2-methyl-6-oxido-5-oxo-1,2,4-triazin-3-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CN1C(=NC(=O)C(=N1)[O-])SCC2=C(N3C(C(C3=O)NC(=O)C(=NOC)C4=CSC(=N4)N)SC2)C(=O)[O-],Dyspnea exertional,CID000004510,nitroglycerin,C(C(CO[N+](=O)[O-])O[N+](=O)[O-])O[N+](=O)[O-]
CID000002656,"7-[[2-(2-amino-1,3-thiazol-4-yl)-2-methoxyiminoacetyl]amino]-3-[(2-methyl-6-oxido-5-oxo-1,2,4-triazin-3-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CN1C(=NC(=O)C(=N1)[O-])SCC2=C(N3C(C(C3=O)NC(=O)C(=NOC)C4=CSC(=N4)N)SC2)C(=O)[O-],Chest infection,CID000036811,dobutamine,CC(CCC1=CC=C(C=C1)O)NCCC2=CC(=C(C=C2)O)O
CID000002656,"7-[[2-(2-amino-1,3-thiazol-4-yl)-2-methoxyiminoacetyl]amino]-3-[(2-methyl-6-oxido-5-oxo-1,2,4-triazin-3-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CN1C(=NC(=O)C(=N1)[O-])SCC2=C(N3C(C(C3=O)NC(=O)C(=NOC)C4=CSC(=N4)N)SC2)C(=O)[O-],cholecystitis,CID000004205,mirtazapine,CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4
CID000002656,"7-[[2-(2-amino-1,3-thiazol-4-yl)-2-methoxyiminoacetyl]amino]-3-[(2-methyl-6-oxido-5-oxo-1,2,4-triazin-3-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CN1C(=NC(=O)C(=N1)[O-])SCC2=C(N3C(C(C3=O)NC(=O)C(=NOC)C4=CSC(=N4)N)SC2)C(=O)[O-],methaemoglobinaemia,CID000005732,zolpidem,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C
CID000002656,"7-[[2-(2-amino-1,3-thiazol-4-yl)-2-methoxyiminoacetyl]amino]-3-[(2-methyl-6-oxido-5-oxo-1,2,4-triazin-3-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CN1C(=NC(=O)C(=N1)[O-])SCC2=C(N3C(C(C3=O)NC(=O)C(=NOC)C4=CSC(=N4)N)SC2)C(=O)[O-],cholecystitis,CID000003339,fenofibrate,CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C2=CC=C(C=C2)Cl
CID000002656,"7-[[2-(2-amino-1,3-thiazol-4-yl)-2-methoxyiminoacetyl]amino]-3-[(2-methyl-6-oxido-5-oxo-1,2,4-triazin-3-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CN1C(=NC(=O)C(=N1)[O-])SCC2=C(N3C(C(C3=O)NC(=O)C(=NOC)C4=CSC(=N4)N)SC2)C(=O)[O-],nasopharyngitis,CID000170361,Varenicline,C1C2CNCC1C3=CC4=NC=CN=C4C=C23
CID000002656,"7-[[2-(2-amino-1,3-thiazol-4-yl)-2-methoxyiminoacetyl]amino]-3-[(2-methyl-6-oxido-5-oxo-1,2,4-triazin-3-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CN1C(=NC(=O)C(=N1)[O-])SCC2=C(N3C(C(C3=O)NC(=O)C(=NOC)C4=CSC(=N4)N)SC2)C(=O)[O-],Adenopathy,CID000003062,Lanicor,CC1C(C(CC(O1)OC2C(OC(CC2O)OC3C(OC(CC3O)OC4CCC5(C(C4)CCC6C5CC(C7(C6(CCC7C8=CC(=O)OC8)O)C)O)C)C)C)O)O
CID000002656,"7-[[2-(2-amino-1,3-thiazol-4-yl)-2-methoxyiminoacetyl]amino]-3-[(2-methyl-6-oxido-5-oxo-1,2,4-triazin-3-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CN1C(=NC(=O)C(=N1)[O-])SCC2=C(N3C(C(C3=O)NC(=O)C(=NOC)C4=CSC(=N4)N)SC2)C(=O)[O-],eruption,CID000074989,ATOVAQUONE,C1CC(CCC1C2=CC=C(C=C2)Cl)C3=C(C4=CC=CC=C4C(=O)C3=O)O
CID000002656,"7-[[2-(2-amino-1,3-thiazol-4-yl)-2-methoxyiminoacetyl]amino]-3-[(2-methyl-6-oxido-5-oxo-1,2,4-triazin-3-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CN1C(=NC(=O)C(=N1)[O-])SCC2=C(N3C(C(C3=O)NC(=O)C(=NOC)C4=CSC(=N4)N)SC2)C(=O)[O-],colitis pseudomembranous,CID000003961,losartan,CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)CO)Cl
CID000002656,"7-[[2-(2-amino-1,3-thiazol-4-yl)-2-methoxyiminoacetyl]amino]-3-[(2-methyl-6-oxido-5-oxo-1,2,4-triazin-3-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CN1C(=NC(=O)C(=N1)[O-])SCC2=C(N3C(C(C3=O)NC(=O)C(=NOC)C4=CSC(=N4)N)SC2)C(=O)[O-],erythema,CID000003676,lidocaine,CCN(CC)CC(=O)NC1=C(C=CC=C1C)C
CID000002656,"7-[[2-(2-amino-1,3-thiazol-4-yl)-2-methoxyiminoacetyl]amino]-3-[(2-methyl-6-oxido-5-oxo-1,2,4-triazin-3-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CN1C(=NC(=O)C(=N1)[O-])SCC2=C(N3C(C(C3=O)NC(=O)C(=NOC)C4=CSC(=N4)N)SC2)C(=O)[O-],cholecystitis,CID000004900,Fernisone,CC12CC(=O)C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C
CID000002656,"7-[[2-(2-amino-1,3-thiazol-4-yl)-2-methoxyiminoacetyl]amino]-3-[(2-methyl-6-oxido-5-oxo-1,2,4-triazin-3-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CN1C(=NC(=O)C(=N1)[O-])SCC2=C(N3C(C(C3=O)NC(=O)C(=NOC)C4=CSC(=N4)N)SC2)C(=O)[O-],Back Ache,CID000003749,irbesartan,CCCCC1=NC2(CCCC2)C(=O)N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5
CID000002656,"7-[[2-(2-amino-1,3-thiazol-4-yl)-2-methoxyiminoacetyl]amino]-3-[(2-methyl-6-oxido-5-oxo-1,2,4-triazin-3-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CN1C(=NC(=O)C(=N1)[O-])SCC2=C(N3C(C(C3=O)NC(=O)C(=NOC)C4=CSC(=N4)N)SC2)C(=O)[O-],loss of weight,CID000005358,sumatriptan,CNS(=O)(=O)CC1=CC2=C(C=C1)NC=C2CCN(C)C
CID000002656,"7-[[2-(2-amino-1,3-thiazol-4-yl)-2-methoxyiminoacetyl]amino]-3-[(2-methyl-6-oxido-5-oxo-1,2,4-triazin-3-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CN1C(=NC(=O)C(=N1)[O-])SCC2=C(N3C(C(C3=O)NC(=O)C(=NOC)C4=CSC(=N4)N)SC2)C(=O)[O-],nasopharyngitis,CID000005095,ropinirole,CCCN(CCC)CCC1=C2CC(=O)NC2=CC=C1
CID000002656,"7-[[2-(2-amino-1,3-thiazol-4-yl)-2-methoxyiminoacetyl]amino]-3-[(2-methyl-6-oxido-5-oxo-1,2,4-triazin-3-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CN1C(=NC(=O)C(=N1)[O-])SCC2=C(N3C(C(C3=O)NC(=O)C(=NOC)C4=CSC(=N4)N)SC2)C(=O)[O-],cholecystitis,CID000003440,furosemide,C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl
CID000002656,"7-[[2-(2-amino-1,3-thiazol-4-yl)-2-methoxyiminoacetyl]amino]-3-[(2-methyl-6-oxido-5-oxo-1,2,4-triazin-3-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CN1C(=NC(=O)C(=N1)[O-])SCC2=C(N3C(C(C3=O)NC(=O)C(=NOC)C4=CSC(=N4)N)SC2)C(=O)[O-],Adenopathy,CID003468412,SCHEMBL1176571,CC1C=CC=CCCC=CC=CC=CC=CC(CC(C(C(CC(=O)CC(C(CCC(CC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)C(=O)O)O)OC2C(C(C(C(O2)C)O)N)O
CID000002656,"7-[[2-(2-amino-1,3-thiazol-4-yl)-2-methoxyiminoacetyl]amino]-3-[(2-methyl-6-oxido-5-oxo-1,2,4-triazin-3-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CN1C(=NC(=O)C(=N1)[O-])SCC2=C(N3C(C(C3=O)NC(=O)C(=NOC)C4=CSC(=N4)N)SC2)C(=O)[O-],thrombocytopenia,CID000060184,"2'-epi-Perindopril, (2'R)-",CCCC(C(=O)OCC)NC(C)C(=O)N1C2CCCCC2CC1C(=O)O
CID000002656,"7-[[2-(2-amino-1,3-thiazol-4-yl)-2-methoxyiminoacetyl]amino]-3-[(2-methyl-6-oxido-5-oxo-1,2,4-triazin-3-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CN1C(=NC(=O)C(=N1)[O-])SCC2=C(N3C(C(C3=O)NC(=O)C(=NOC)C4=CSC(=N4)N)SC2)C(=O)[O-],atelectasis,CID000004158,methylphenidate,COC(=O)C(C1CCCCN1)C2=CC=CC=C2
CID000002656,"7-[[2-(2-amino-1,3-thiazol-4-yl)-2-methoxyiminoacetyl]amino]-3-[(2-methyl-6-oxido-5-oxo-1,2,4-triazin-3-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CN1C(=NC(=O)C(=N1)[O-])SCC2=C(N3C(C(C3=O)NC(=O)C(=NOC)C4=CSC(=N4)N)SC2)C(=O)[O-],Adenopathy,CID000003405,2-[[4-[(2-amino-4-oxo-1H-pteridin-6-yl)methylamino]benzoyl]amino]pentanedioic acid,C1=CC(=CC=C1C(=O)NC(CCC(=O)O)C(=O)O)NCC2=CN=C3C(=N2)C(=O)N=C(N3)N
CID000003749,irbesartan,CCCCC1=NC2(CCCC2)C(=O)N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5,erythema,CID000004201,minoxidil,C1CCN(CC1)C2=NC(=N)N(C(=C2)N)O
CID000003749,irbesartan,CCCCC1=NC2(CCCC2)C(=O)N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5,weight gain,CID000005095,ropinirole,CCCN(CCC)CCC1=C2CC(=O)NC2=CC=C1
CID000003749,irbesartan,CCCCC1=NC2(CCCC2)C(=O)N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5,rhinorrhea,CID000004158,methylphenidate,COC(=O)C(C1CCCCN1)C2=CC=CC=C2
CID000003749,irbesartan,CCCCC1=NC2(CCCC2)C(=O)N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5,loss of weight,CID000005358,sumatriptan,CNS(=O)(=O)CC1=CC2=C(C=C1)NC=C2CCN(C)C
CID000003749,irbesartan,CCCCC1=NC2(CCCC2)C(=O)N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5,apoplexy,CID000060184,"2'-epi-Perindopril, (2'R)-",CCCC(C(=O)OCC)NC(C)C(=O)N1C2CCCCC2CC1C(=O)O
CID000003749,irbesartan,CCCCC1=NC2(CCCC2)C(=O)N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5,rotator cuff syndrome,CID000005487,tizanidine,C1CN=C(N1)NC2=C(C=CC3=NSN=C32)Cl
CID000003749,irbesartan,CCCCC1=NC2(CCCC2)C(=O)N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5,thrombocytopenia,CID005311082,"2-[(1R,4S,10S,13S,19S)-19-[4-(diaminomethylideneamino)butyl]-10-(1H-indol-3-ylmethyl)-3,9,12,15,18,21,27-heptaoxo-24,25-dithia-2,8,11,14,17,20-hexazatricyclo[18.6.1.04,8]heptacosan-13-yl]acetic acid",C1CC2C(=O)NC3CSSCCC(=O)N(C3=O)C(C(=O)NCC(=O)NC(C(=O)NC(C(=O)N2C1)CC4=CNC5=CC=CC=C54)CC(=O)O)CCCCN=C(N)N
CID000003749,irbesartan,CCCCC1=NC2(CCCC2)C(=O)N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5,weight gain,CID000004170,metolazone,CC1NC2=CC(=C(C=C2C(=O)N1C3=CC=CC=C3C)S(=O)(=O)N)Cl
CID000003749,irbesartan,CCCCC1=NC2(CCCC2)C(=O)N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5,apoplexy,CID003468412,SCHEMBL1176571,CC1C=CC=CCCC=CC=CC=CC=CC(CC(C(C(CC(=O)CC(C(CCC(CC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)C(=O)O)O)OC2C(C(C(C(O2)C)O)N)O
CID000003749,irbesartan,CCCCC1=NC2(CCCC2)C(=O)N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5,apoplexy,CID006398525,,C(C1C(C(C(C(O1)OC2(C(C(C(O2)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)COS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.[Al].[Al].[Al].[Al].[Al].[Al].[Al].[Al].[Al]
CID000003749,irbesartan,CCCCC1=NC2(CCCC2)C(=O)N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5,High blood pressure,CID000077992,Frovatriptan,CNC1CCC2=C(C1)C3=C(N2)C=CC(=C3)C(=O)N
CID000003749,irbesartan,CCCCC1=NC2(CCCC2)C(=O)N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5,Back Ache,CID000060865,(E)-Olopatadine,CN(C)CCC=C1C2=CC=CC=C2COC3=C1C=C(C=C3)CC(=O)O
CID000003749,irbesartan,CCCCC1=NC2(CCCC2)C(=O)N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5,apoplexy,CID000004205,mirtazapine,CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4
CID000003749,irbesartan,CCCCC1=NC2(CCCC2)C(=O)N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5,Fainting,CID000057537,92206-54-7,CCCN(CCC1=CC=CS1)C2CCC3=C(C2)C=CC=C3O
CID000003749,irbesartan,CCCCC1=NC2(CCCC2)C(=O)N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5,loss of weight,CID000170361,Varenicline,C1C2CNCC1C3=CC4=NC=CN=C4C=C23
CID000003749,irbesartan,CCCCC1=NC2(CCCC2)C(=O)N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5,Adenopathy,CID000005732,zolpidem,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C
CID000003749,irbesartan,CCCCC1=NC2(CCCC2)C(=O)N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5,Back Ache,CID000004510,nitroglycerin,C(C(CO[N+](=O)[O-])O[N+](=O)[O-])O[N+](=O)[O-]
CID000003749,irbesartan,CCCCC1=NC2(CCCC2)C(=O)N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5,thrombocytopenia,CID000019090,megestrol,CC1=CC2C(CCC3(C2CCC3(C(=O)C)O)C)C4(C1=CC(=O)CC4)C
CID000003749,irbesartan,CCCCC1=NC2(CCCC2)C(=O)N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5,muscle inflammation,CID000003869,labetalol,CC(CCC1=CC=CC=C1)NCC(C2=CC(=C(C=C2)O)C(=O)N)O
CID000003749,irbesartan,CCCCC1=NC2(CCCC2)C(=O)N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5,Adenopathy,CID000005152,Salmeterol,C1=CC=C(C=C1)CCCCOCCCCCCNCC(C2=CC(=C(C=C2)O)CO)O
CID000003749,irbesartan,CCCCC1=NC2(CCCC2)C(=O)N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5,cholecystitis,CID000004900,Fernisone,CC12CC(=O)C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C
CID000003749,irbesartan,CCCCC1=NC2(CCCC2)C(=O)N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5,arteriosclerotic heart disease,CID000012536,638-94-8,CC1(OC2CC3C4CCC5=CC(=O)C=CC5(C4C(CC3(C2(O1)C(=O)CO)C)O)C)C
CID000003749,irbesartan,CCCCC1=NC2(CCCC2)C(=O)N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5,gastric inflammation,CID000005245,Risedronic acid,C1=CC(=CN=C1)CC(O)(P(=O)(O)O)P(=O)(O)O
CID000003749,irbesartan,CCCCC1=NC2(CCCC2)C(=O)N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5,increased white blood cell count,CID000005719,zaleplon,CCN(C1=CC=CC(=C1)C2=CC=NC3=C(C=NN23)C#N)C(=O)C
CID000003749,irbesartan,CCCCC1=NC2(CCCC2)C(=O)N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5,gastric inflammation,CID000003961,losartan,CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)CO)Cl
CID000003749,irbesartan,CCCCC1=NC2(CCCC2)C(=O)N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5,gastric inflammation,CID000060854,Ziprasidone,C1CN(CCN1CCC2=C(C=C3C(=C2)CC(=O)N3)Cl)C4=NSC5=CC=CC=C54
CID000003749,irbesartan,CCCCC1=NC2(CCCC2)C(=O)N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5,loss of weight,CID000004920,"1-acetyl-9a,11a-dimethyl-1H,2H,3H,3aH,3bH,4H,5H,7H,8H,9H,9aH,9bH,10H,11H,11aH-cyclopenta[a]phenanthren-7-one",CC(=O)C1CCC2C1(CCC3C2CCC4=CC(=O)CCC34C)C
CID000003749,irbesartan,CCCCC1=NC2(CCCC2)C(=O)N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5,right heart failure,CID000004894,"11,17,21-Trihydroxypregna-1,4-diene-3,20-dione",CC12CC(C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C)O
CID000003749,irbesartan,CCCCC1=NC2(CCCC2)C(=O)N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5,gastric inflammation,CID000004691,"3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine",C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4
CID000003749,irbesartan,CCCCC1=NC2(CCCC2)C(=O)N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5,metabolic encephalopathy,CID000004585,"2-methyl-4-(4-methylpiperazin-1-yl)-5H-thieno[3,2-c][1,5]benzodiazepine",CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C
CID000003827,ketotifen,CN1CCC(=C2C3=C(C(=O)CC4=CC=CC=C42)SC=C3)CC1,Adenopathy,CID000004158,methylphenidate,COC(=O)C(C1CCCCN1)C2=CC=CC=C2
CID000003827,ketotifen,CN1CCC(=C2C3=C(C(=O)CC4=CC=CC=C42)SC=C3)CC1,confusion,CID000060865,(E)-Olopatadine,CN(C)CCC=C1C2=CC=CC=C2COC3=C1C=C(C=C3)CC(=O)O
CID000003827,ketotifen,CN1CCC(=C2C3=C(C(=O)CC4=CC=CC=C42)SC=C3)CC1,elevated cholesterol,CID000060787,sequinavir,CC(C)(C)NC(=O)C1CC2CCCCC2CN1CC(C(CC3=CC=CC=C3)NC(=O)C(CC(=O)N)NC(=O)C4=NC5=CC=CC=C5C=C4)O
CID000003827,ketotifen,CN1CCC(=C2C3=C(C(=O)CC4=CC=CC=C42)SC=C3)CC1,edema,CID000004510,nitroglycerin,C(C(CO[N+](=O)[O-])O[N+](=O)[O-])O[N+](=O)[O-]
CID000003827,ketotifen,CN1CCC(=C2C3=C(C(=O)CC4=CC=CC=C42)SC=C3)CC1,weight gain,CID000005152,Salmeterol,C1=CC=C(C=C1)CCCCOCCCCCCNCC(C2=CC(=C(C=C2)O)CO)O
CID000003827,ketotifen,CN1CCC(=C2C3=C(C(=O)CC4=CC=CC=C42)SC=C3)CC1,gastric inflammation,CID000004894,"11,17,21-Trihydroxypregna-1,4-diene-3,20-dione",CC12CC(C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C)O
CID000003827,ketotifen,CN1CCC(=C2C3=C(C(=O)CC4=CC=CC=C42)SC=C3)CC1,thrombocytopenia,CID000003961,losartan,CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)CO)Cl
CID000003827,ketotifen,CN1CCC(=C2C3=C(C(=O)CC4=CC=CC=C42)SC=C3)CC1,Sinusitis,CID006398525,,C(C1C(C(C(C(O1)OC2(C(C(C(O2)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)COS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.[Al].[Al].[Al].[Al].[Al].[Al].[Al].[Al].[Al]
CID000003827,ketotifen,CN1CCC(=C2C3=C(C(=O)CC4=CC=CC=C42)SC=C3)CC1,confusion,CID000004691,"3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine",C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4
CID000003827,ketotifen,CN1CCC(=C2C3=C(C(=O)CC4=CC=CC=C42)SC=C3)CC1,hepatitis,CID000005732,zolpidem,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C
CID000004158,methylphenidate,COC(=O)C(C1CCCCN1)C2=CC=CC=C2,Adenopathy,CID000004900,Fernisone,CC12CC(=O)C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C
CID000004158,methylphenidate,COC(=O)C(C1CCCCN1)C2=CC=CC=C2,Adenopathy,CID000004205,mirtazapine,CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4
CID000004158,methylphenidate,COC(=O)C(C1CCCCN1)C2=CC=CC=C2,gastric inflammation,CID000019090,megestrol,CC1=CC2C(CCC3(C2CCC3(C(=O)C)O)C)C4(C1=CC(=O)CC4)C
CID000004158,methylphenidate,COC(=O)C(C1CCCCN1)C2=CC=CC=C2,abnormal EEG,CID000170361,Varenicline,C1C2CNCC1C3=CC4=NC=CN=C4C=C23
CID000004158,methylphenidate,COC(=O)C(C1CCCCN1)C2=CC=CC=C2,gastric inflammation,CID000005358,sumatriptan,CNS(=O)(=O)CC1=CC2=C(C=C1)NC=C2CCN(C)C
CID000004158,methylphenidate,COC(=O)C(C1CCCCN1)C2=CC=CC=C2,loss of weight,CID000005152,Salmeterol,C1=CC=C(C=C1)CCCCOCCCCCCNCC(C2=CC(=C(C=C2)O)CO)O
CID000004158,methylphenidate,COC(=O)C(C1CCCCN1)C2=CC=CC=C2,eruption,CID000004510,nitroglycerin,C(C(CO[N+](=O)[O-])O[N+](=O)[O-])O[N+](=O)[O-]
CID000004158,methylphenidate,COC(=O)C(C1CCCCN1)C2=CC=CC=C2,erythema,CID000004894,"11,17,21-Trihydroxypregna-1,4-diene-3,20-dione",CC12CC(C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C)O
CID000004158,methylphenidate,COC(=O)C(C1CCCCN1)C2=CC=CC=C2,loss of weight,CID000115237,Paliperidone,CC1=C(C(=O)N2CCCC(C2=N1)O)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F
CID000004158,methylphenidate,COC(=O)C(C1CCCCN1)C2=CC=CC=C2,abnormal ECG,CID000005487,tizanidine,C1CN=C(N1)NC2=C(C=CC3=NSN=C32)Cl
CID000004158,methylphenidate,COC(=O)C(C1CCCCN1)C2=CC=CC=C2,dysarthria,CID000005245,Risedronic acid,C1=CC(=CN=C1)CC(O)(P(=O)(O)O)P(=O)(O)O
CID000004158,methylphenidate,COC(=O)C(C1CCCCN1)C2=CC=CC=C2,Multiple Myeloma,CID000074989,ATOVAQUONE,C1CC(CCC1C2=CC=C(C=C2)Cl)C3=C(C4=CC=CC=C4C(=O)C3=O)O
CID000004158,methylphenidate,COC(=O)C(C1CCCCN1)C2=CC=CC=C2,Adenopathy,CID000004920,"1-acetyl-9a,11a-dimethyl-1H,2H,3H,3aH,3bH,4H,5H,7H,8H,9H,9aH,9bH,10H,11H,11aH-cyclopenta[a]phenanthren-7-one",CC(=O)C1CCC2C1(CCC3C2CCC4=CC(=O)CCC34C)C
CID000004158,methylphenidate,COC(=O)C(C1CCCCN1)C2=CC=CC=C2,cholecystitis,CID000004585,"2-methyl-4-(4-methylpiperazin-1-yl)-5H-thieno[3,2-c][1,5]benzodiazepine",CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C
CID000004158,methylphenidate,COC(=O)C(C1CCCCN1)C2=CC=CC=C2,angiitis,CID000005394,temozolomide,CN1C(=O)N2C=NC(=C2N=N1)C(=O)N
CID000004158,methylphenidate,COC(=O)C(C1CCCCN1)C2=CC=CC=C2,gastric inflammation,CID000005732,zolpidem,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C
CID000004158,methylphenidate,COC(=O)C(C1CCCCN1)C2=CC=CC=C2,thrombocytopenia,CID000005095,ropinirole,CCCN(CCC)CCC1=C2CC(=O)NC2=CC=C1
CID000004158,methylphenidate,COC(=O)C(C1CCCCN1)C2=CC=CC=C2,Pain,CID003468412,SCHEMBL1176571,CC1C=CC=CCCC=CC=CC=CC=CC(CC(C(C(CC(=O)CC(C(CCC(CC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)C(=O)O)O)OC2C(C(C(C(O2)C)O)N)O
CID000004158,methylphenidate,COC(=O)C(C1CCCCN1)C2=CC=CC=C2,cholecystitis,CID000060854,Ziprasidone,C1CN(CCN1CCC2=C(C=C3C(=C2)CC(=O)N3)Cl)C4=NSC5=CC=CC=C54
CID000004158,methylphenidate,COC(=O)C(C1CCCCN1)C2=CC=CC=C2,gastric inflammation,CID000004691,"3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine",C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4
CID000004158,methylphenidate,COC(=O)C(C1CCCCN1)C2=CC=CC=C2,loss of weight,CID000005719,zaleplon,CCN(C1=CC=CC(=C1)C2=CC=NC3=C(C=NN23)C#N)C(=O)C
CID000004158,methylphenidate,COC(=O)C(C1CCCCN1)C2=CC=CC=C2,gastric inflammation,CID006398525,,C(C1C(C(C(C(O1)OC2(C(C(C(O2)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)COS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.[Al].[Al].[Al].[Al].[Al].[Al].[Al].[Al].[Al]
CID000002088,ALENDRONIC ACID,C(CC(O)(P(=O)(O)O)P(=O)(O)O)CN,loss of weight,CID000005394,temozolomide,CN1C(=O)N2C=NC(=C2N=N1)C(=O)N
CID000002088,ALENDRONIC ACID,C(CC(O)(P(=O)(O)O)P(=O)(O)O)CN,abnormal ECG,CID000060854,Ziprasidone,C1CN(CCN1CCC2=C(C=C3C(=C2)CC(=O)N3)Cl)C4=NSC5=CC=CC=C54
CID000002088,ALENDRONIC ACID,C(CC(O)(P(=O)(O)O)P(=O)(O)O)CN,cholecystitis,CID000003961,losartan,CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)CO)Cl
CID000002088,ALENDRONIC ACID,C(CC(O)(P(=O)(O)O)P(=O)(O)O)CN,drug toxicity NOS,CID000074989,ATOVAQUONE,C1CC(CCC1C2=CC=C(C=C2)Cl)C3=C(C4=CC=CC=C4C(=O)C3=O)O
CID000002088,(4-amino-1-hydroxy-1-phosphonobutyl)phosphonic acid,C(CC(O)(P(=O)(O)O)P(=O)(O)O)CN,methaemoglobinaemia,CID000003440,furosemide,C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl
CID000002088,ALENDRONIC ACID,C(CC(O)(P(=O)(O)O)P(=O)(O)O)CN,Adenopathy,CID000004614,oxaprozin,C1=CC=C(C=C1)C2=C(OC(=N2)CCC(=O)O)C3=CC=CC=C3
CID000002088,ALENDRONIC ACID,C(CC(O)(P(=O)(O)O)P(=O)(O)O)CN,High blood pressure,CID000060865,(E)-Olopatadine,CN(C)CCC=C1C2=CC=CC=C2COC3=C1C=C(C=C3)CC(=O)O
CID000002088,ALENDRONIC ACID,C(CC(O)(P(=O)(O)O)P(=O)(O)O)CN,cholecystitis,CID000005152,Salmeterol,C1=CC=C(C=C1)CCCCOCCCCCCNCC(C2=CC(=C(C=C2)O)CO)O
CID000002088,ALENDRONIC ACID,C(CC(O)(P(=O)(O)O)P(=O)(O)O)CN,cholecystitis,CID000004170,metolazone,CC1NC2=CC(=C(C=C2C(=O)N1C3=CC=CC=C3C)S(=O)(=O)N)Cl
CID000002088,ALENDRONIC ACID,C(CC(O)(P(=O)(O)O)P(=O)(O)O)CN,methaemoglobinaemia,CID000004691,"3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine",C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4
CID000002088,ALENDRONIC ACID,C(CC(O)(P(=O)(O)O)P(=O)(O)O)CN,Back Ache,CID003468412,SCHEMBL1176571,CC1C=CC=CCCC=CC=CC=CC=CC(CC(C(C(CC(=O)CC(C(CCC(CC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)C(=O)O)O)OC2C(C(C(C(O2)C)O)N)O
CID000002088,ALENDRONIC ACID,C(CC(O)(P(=O)(O)O)P(=O)(O)O)CN,Sinus headache,CID000667490,6-Mercaptopurine,C1=NC2=C(N1)C(=S)N=CN2
CID000002088,ALENDRONIC ACID,C(CC(O)(P(=O)(O)O)P(=O)(O)O)CN,cholecystitis,CID000003339,fenofibrate,CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C2=CC=C(C=C2)Cl
CID000002088,ALENDRONIC ACID,C(CC(O)(P(=O)(O)O)P(=O)(O)O)CN,methaemoglobinaemia,CID000003333,felodipine,CCOC(=O)C1=C(NC(=C(C1C2=C(C(=CC=C2)Cl)Cl)C(=O)OC)C)C
CID000002088,ALENDRONIC ACID,C(CC(O)(P(=O)(O)O)P(=O)(O)O)CN,gastric inflammation,CID000004585,"2-methyl-4-(4-methylpiperazin-1-yl)-5H-thieno[3,2-c][1,5]benzodiazepine",CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C
CID000002088,ALENDRONIC ACID,C(CC(O)(P(=O)(O)O)P(=O)(O)O)CN,gastric inflammation,CID000004900,Fernisone,CC12CC(=O)C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C
CID000002088,ALENDRONIC ACID,C(CC(O)(P(=O)(O)O)P(=O)(O)O)CN,loss of weight,CID000003869,labetalol,CC(CCC1=CC=CC=C1)NCC(C2=CC(=C(C=C2)O)C(=O)N)O
CID000002088,ALENDRONIC ACID,C(CC(O)(P(=O)(O)O)P(=O)(O)O)CN,adenomyosis,CID000004920,"1-acetyl-9a,11a-dimethyl-1H,2H,3H,3aH,3bH,4H,5H,7H,8H,9H,9aH,9bH,10H,11H,11aH-cyclopenta[a]phenanthren-7-one",CC(=O)C1CCC2C1(CCC3C2CCC4=CC(=O)CCC34C)C
CID000002088,ALENDRONIC ACID,C(CC(O)(P(=O)(O)O)P(=O)(O)O)CN,erythema,CID000060184,"2'-epi-Perindopril, (2'R)-",CCCC(C(=O)OCC)NC(C)C(=O)N1C2CCCCC2CC1C(=O)O
CID000002088,ALENDRONIC ACID,C(CC(O)(P(=O)(O)O)P(=O)(O)O)CN,myelodysplasia,CID000002405,BISOPROLOL,CC(C)NCC(COC1=CC=C(C=C1)COCCOC(C)C)O
CID000002088,ALENDRONIC ACID,C(CC(O)(P(=O)(O)O)P(=O)(O)O)CN,gastric inflammation,CID000002676,"7-[4-(4-fluorophenyl)-5-(methoxymethyl)-2,6-di(propan-2-yl)pyridin-3-yl]-3,5-dihydroxyhept-6-enoic acid",CC(C)C1=C(C(=C(C(=N1)C(C)C)COC)C2=CC=C(C=C2)F)C=CC(CC(CC(=O)O)O)O
CID000002088,ALENDRONIC ACID,C(CC(O)(P(=O)(O)O)P(=O)(O)O)CN,loss of weight,CID000005719,zaleplon,CCN(C1=CC=CC(=C1)C2=CC=NC3=C(C=NN23)C#N)C(=O)C
CID000002088,ALENDRONIC ACID,C(CC(O)(P(=O)(O)O)P(=O)(O)O)CN,gastric inflammation,CID006398525,,C(C1C(C(C(C(O1)OC2(C(C(C(O2)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)COS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.[Al].[Al].[Al].[Al].[Al].[Al].[Al].[Al].[Al]
CID000002088,ALENDRONIC ACID,C(CC(O)(P(=O)(O)O)P(=O)(O)O)CN,gastric inflammation,CID000002524,32222-06-3,CC(CCCC(C)(C)O)C1CCC2C1(CCCC2=CC=C3CC(CC(C3=C)O)O)C
CID000002088,ALENDRONIC ACID,C(CC(O)(P(=O)(O)O)P(=O)(O)O)CN,apoplexy,CID000003042,dicyclomine,CCN(CC)CCOC(=O)C1(CCCCC1)C2CCCCC2
CID000002088,ALENDRONIC ACID,C(CC(O)(P(=O)(O)O)P(=O)(O)O)CN,cholecystitis,CID000005358,sumatriptan,CNS(=O)(=O)CC1=CC2=C(C=C1)NC=C2CCN(C)C
CID000002088,ALENDRONIC ACID,C(CC(O)(P(=O)(O)O)P(=O)(O)O)CN,muscle disorder,CID000002949,MLS003115428,CC12CCC3C(C1CCC2(C#C)O)CCC4=CC5=C(CC34C)C=NO5
CID000002088,ALENDRONIC ACID,C(CC(O)(P(=O)(O)O)P(=O)(O)O)CN,cholecystitis,CID000003062,Lanicor,CC1C(C(CC(O1)OC2C(OC(CC2O)OC3C(OC(CC3O)OC4CCC5(C(C4)CCC6C5CC(C7(C6(CCC7C8=CC(=O)OC8)O)C)O)C)C)C)O)O
CID000002088,ALENDRONIC ACID,C(CC(O)(P(=O)(O)O)P(=O)(O)O)CN,Bilirubinaemia,CID000005095,ropinirole,CCCN(CCC)CCC1=C2CC(=O)NC2=CC=C1
CID000002088,ALENDRONIC ACID,C(CC(O)(P(=O)(O)O)P(=O)(O)O)CN,cholecystitis,CID000003405,2-[[4-[(2-amino-4-oxo-1H-pteridin-6-yl)methylamino]benzoyl]amino]pentanedioic acid,C1=CC(=CC=C1C(=O)NC(CCC(=O)O)C(=O)O)NCC2=CN=C3C(=N2)C(=O)N=C(N3)N
CID000002088,ALENDRONIC ACID,C(CC(O)(P(=O)(O)O)P(=O)(O)O)CN,abnormal EEG,CID000057537,92206-54-7,CCCN(CCC1=CC=CS1)C2CCC3=C(C2)C=CC=C3O
CID000002088,ALENDRONIC ACID,C(CC(O)(P(=O)(O)O)P(=O)(O)O)CN,cholecystitis,CID000004510,nitroglycerin,C(C(CO[N+](=O)[O-])O[N+](=O)[O-])O[N+](=O)[O-]
CID000002088,ALENDRONIC ACID,C(CC(O)(P(=O)(O)O)P(=O)(O)O)CN,cholecystitis,CID000004205,mirtazapine,CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4
CID000002088,ALENDRONIC ACID,C(CC(O)(P(=O)(O)O)P(=O)(O)O)CN,erythema,CID000170361,Varenicline,C1C2CNCC1C3=CC4=NC=CN=C4C=C23
CID000002088,ALENDRONIC ACID,C(CC(O)(P(=O)(O)O)P(=O)(O)O)CN,arterial pressure NOS decreased,CID000004201,minoxidil,C1CCN(CC1)C2=NC(=N)N(C(=C2)N)O
CID000002088,ALENDRONIC ACID,C(CC(O)(P(=O)(O)O)P(=O)(O)O)CN,gastric inflammation,CID000002891,"cobalt(2+);[5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] 1-[3-[2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2,7,12,17-tetrahydro-1H-corrin-21-id-3-yl]propanoylamino]propan-2-yl hydrogen phosphate;cyanide",CC1=CC2=C(C=C1C)N(C=N2)C3C(C(C(O3)CO)OP(=O)(O)OC(C)CNC(=O)CCC4(C(C5C6(C(C(C(=N6)C(=C7C(C(C(=N7)C=C8C(C(C(=N8)C(=C4[N-]5)C)CCC(=O)N)(C)C)CCC(=O)N)(C)CC(=O)N)C)CCC(=O)N)(C)CC(=O)N)C)CC(=O)N)C)O.[C-]#N.[Co+2]
CID000002088,ALENDRONIC ACID,C(CC(O)(P(=O)(O)O)P(=O)(O)O)CN,Pain,CID000147912,DSSTox_GSID_49066,CCC(C(C)O)N1C(=O)N(C=N1)C2=CC=C(C=C2)N3CCN(CC3)C4=CC=C(C=C4)OCC5CC(OC5)(CN6C=NC=N6)C7=C(C=C(C=C7)F)F
CID000002088,ALENDRONIC ACID,C(CC(O)(P(=O)(O)O)P(=O)(O)O)CN,cholecystitis,CID000005732,zolpidem,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C
CID000002088,ALENDRONIC ACID,C(CC(O)(P(=O)(O)O)P(=O)(O)O)CN,loss of weight,CID000019090,megestrol,CC1=CC2C(CCC3(C2CCC3(C(=O)C)O)C)C4(C1=CC(=O)CC4)C
CID000002088,ALENDRONIC ACID,C(CC(O)(P(=O)(O)O)P(=O)(O)O)CN,Abnormal Laboratory Findings,CID000002725,chlorpheniramine,CN(C)CCC(C1=CC=C(C=C1)Cl)C2=CC=CC=N2
CID000002088,ALENDRONIC ACID,C(CC(O)(P(=O)(O)O)P(=O)(O)O)CN,malabsorption,CID000004894,"11,17,21-Trihydroxypregna-1,4-diene-3,20-dione",CC12CC(C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C)O
CID000002088,ALENDRONIC ACID,C(CC(O)(P(=O)(O)O)P(=O)(O)O)CN,apoplexy,CID000002609,Lilly 99638,C1C(=C(N2C(S1)C(C2=O)NC(=O)C(C3=CC=CC=C3)N)C(=O)O)Cl
CID000002088,ALENDRONIC ACID,C(CC(O)(P(=O)(O)O)P(=O)(O)O)CN,deglutition disorder,CID000004189,miconazole,C1=CC(=C(C=C1Cl)Cl)COC(CN2C=CN=C2)C3=C(C=C(C=C3)Cl)Cl
CID000002088,ALENDRONIC ACID,C(CC(O)(P(=O)(O)O)P(=O)(O)O)CN,gastric inflammation,CID000005245,Risedronic acid,C1=CC(=CN=C1)CC(O)(P(=O)(O)O)P(=O)(O)O
CID000002088,ALENDRONIC ACID,C(CC(O)(P(=O)(O)O)P(=O)(O)O)CN,methaemoglobinaemia,CID000002771,citalopram,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F
CID000002088,ALENDRONIC ACID,C(CC(O)(P(=O)(O)O)P(=O)(O)O)CN,gastric inflammation,CID000005487,tizanidine,C1CN=C(N1)NC2=C(C=CC3=NSN=C32)Cl
CID000002088,ALENDRONIC ACID,C(CC(O)(P(=O)(O)O)P(=O)(O)O)CN,proteinuria,CID000004536,Minovlar,CC12CCC3C(C1CCC2(C#C)O)CCC4=CC(=O)CCC34
CID000002088,ALENDRONIC ACID,C(CC(O)(P(=O)(O)O)P(=O)(O)O)CN,apoplexy,CID000002099,alosetron,CC1=C(N=CN1)CN2CCC3=C(C2=O)C4=CC=CC=C4N3C
CID000002088,ALENDRONIC ACID,C(CC(O)(P(=O)(O)O)P(=O)(O)O)CN,gastric inflammation,CID000002284,baclofen,C1=CC(=CC=C1C(CC(=O)O)CN)Cl
CID000002088,ALENDRONIC ACID,C(CC(O)(P(=O)(O)O)P(=O)(O)O)CN,Anxiety,CID000004748,perphenazine,C1CN(CCN1CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)Cl)CCO
CID000002088,ALENDRONIC ACID,C(CC(O)(P(=O)(O)O)P(=O)(O)O)CN,loss of weight,CID000004745,SCHEMBL7711911,CCCN1CC(CC2C1CC3=CNC4=CC=CC2=C34)CSC
CID000002088,ALENDRONIC ACID,C(CC(O)(P(=O)(O)O)P(=O)(O)O)CN,atelectasis,CID000003310,33419-42-0,CC1OCC2C(O1)C(C(C(O2)OC3C4COC(=O)C4C(C5=CC6=C(C=C35)OCO6)C7=CC(=C(C(=C7)OC)O)OC)O)O
CID000002088,ALENDRONIC ACID,C(CC(O)(P(=O)(O)O)P(=O)(O)O)CN,methaemoglobinaemia,CID000003676,lidocaine,CCN(CC)CC(=O)NC1=C(C=CC=C1C)C
CID000001546,5542-92-7,C1C(C(OC1N2C=NC3=C(N=C(N=C32)Cl)N)CO)O,thrombocytopenia,CID000004894,"11,17,21-Trihydroxypregna-1,4-diene-3,20-dione",CC12CC(C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C)O
CID000001546,5542-92-7,C1C(C(OC1N2C=NC3=C(N=C(N=C32)Cl)N)CO)O,enlarged liver,CID000003310,33419-42-0,CC1OCC2C(O1)C(C(C(O2)OC3C4COC(=O)C4C(C5=CC6=C(C=C35)OCO6)C7=CC(=C(C(=C7)OC)O)OC)O)O
CID000001546,5542-92-7,C1C(C(OC1N2C=NC3=C(N=C(N=C32)Cl)N)CO)O,Gastric Cancer,CID000004900,Fernisone,CC12CC(=O)C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C
CID000001546,5542-92-7,C1C(C(OC1N2C=NC3=C(N=C(N=C32)Cl)N)CO)O,enlarged liver,CID000667490,6-Mercaptopurine,C1=NC2=C(N1)C(=S)N=CN2
CID000004900,Fernisone,CC12CC(=O)C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C,loss of weight,CID000074989,ATOVAQUONE,C1CC(CCC1C2=CC=C(C=C2)Cl)C3=C(C4=CC=CC=C4C(=O)C3=O)O
CID000004900,Fernisone,CC12CC(=O)C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C,apoplexy,CID000077992,Frovatriptan,CNC1CCC2=C(C1)C3=C(N2)C=CC(=C3)C(=O)N
CID000004900,Fernisone,CC12CC(=O)C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C,apoplexy,CID000060184,"2'-epi-Perindopril, (2'R)-",CCCC(C(=O)OCC)NC(C)C(=O)N1C2CCCCC2CC1C(=O)O
CID000004900,Fernisone,CC12CC(=O)C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C,thrombocytopenia,CID005311082,"2-[(1R,4S,10S,13S,19S)-19-[4-(diaminomethylideneamino)butyl]-10-(1H-indol-3-ylmethyl)-3,9,12,15,18,21,27-heptaoxo-24,25-dithia-2,8,11,14,17,20-hexazatricyclo[18.6.1.04,8]heptacosan-13-yl]acetic acid",C1CC2C(=O)NC3CSSCCC(=O)N(C3=O)C(C(=O)NCC(=O)NC(C(=O)NC(C(=O)N2C1)CC4=CNC5=CC=CC=C54)CC(=O)O)CCCCN=C(N)N
CID000004900,Fernisone,CC12CC(=O)C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C,Dyspnea exertional,CID000019090,megestrol,CC1=CC2C(CCC3(C2CCC3(C(=O)C)O)C)C4(C1=CC(=O)CC4)C
CID000004900,Fernisone,CC12CC(=O)C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C,eruption,CID000005394,temozolomide,CN1C(=O)N2C=NC(=C2N=N1)C(=O)N
CID000004900,Fernisone,CC12CC(=O)C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C,cholecystitis,CID000005245,Risedronic acid,C1=CC(=CN=C1)CC(O)(P(=O)(O)O)P(=O)(O)O
CID000004900,Fernisone,CC12CC(=O)C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C,gastric inflammation,CID000005719,zaleplon,CCN(C1=CC=CC(=C1)C2=CC=NC3=C(C=NN23)C#N)C(=O)C
CID000004900,Fernisone,CC12CC(=O)C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C,cholecystitis,CID003468412,SCHEMBL1176571,CC1C=CC=CCCC=CC=CC=CC=CC(CC(C(C(CC(=O)CC(C(CCC(CC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)C(=O)O)O)OC2C(C(C(C(O2)C)O)N)O
CID000004900,Fernisone,CC12CC(=O)C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C,haemorrhage rectum,CID000060854,Ziprasidone,C1CN(CCN1CCC2=C(C=C3C(=C2)CC(=O)N3)Cl)C4=NSC5=CC=CC=C54
CID000004900,Fernisone,CC12CC(=O)C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C,cholecystitis,CID000667490,6-Mercaptopurine,C1=NC2=C(N1)C(=S)N=CN2
CID000004900,Fernisone,CC12CC(=O)C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C,gastric inflammation,CID000060787,sequinavir,CC(C)(C)NC(=O)C1CC2CCCCC2CN1CC(C(CC3=CC=CC=C3)NC(=O)C(CC(=O)N)NC(=O)C4=NC5=CC=CC=C5C=C4)O
CID000004900,Fernisone,CC12CC(=O)C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C,gastric inflammation,CID000147912,DSSTox_GSID_49066,CCC(C(C)O)N1C(=O)N(C=N1)C2=CC=C(C=C2)N3CCN(CC3)C4=CC=C(C=C4)OCC5CC(OC5)(CN6C=NC=N6)C7=C(C=C(C=C7)F)F
CID000004900,Fernisone,CC12CC(=O)C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C,gastric inflammation,CID000005358,sumatriptan,CNS(=O)(=O)CC1=CC2=C(C=C1)NC=C2CCN(C)C
CID000004900,Fernisone,CC12CC(=O)C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C,ear infection,CID000060865,(E)-Olopatadine,CN(C)CCC=C1C2=CC=CC=C2COC3=C1C=C(C=C3)CC(=O)O
CID000004900,Fernisone,CC12CC(=O)C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C,gastric inflammation,CID000005487,tizanidine,C1CN=C(N1)NC2=C(C=CC3=NSN=C32)Cl
CID000004900,Fernisone,CC12CC(=O)C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C,erythema,CID000005095,ropinirole,CCCN(CCC)CCC1=C2CC(=O)NC2=CC=C1
CID000004900,Fernisone,CC12CC(=O)C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C,back injury,CID000170361,Varenicline,C1C2CNCC1C3=CC4=NC=CN=C4C=C23
CID000004900,Fernisone,CC12CC(=O)C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C,gastric inflammation,CID000005732,zolpidem,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C
CID000004900,Fernisone,CC12CC(=O)C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C,gastric inflammation,CID006398525,,C(C1C(C(C(C(O1)OC2(C(C(C(O2)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)COS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.[Al].[Al].[Al].[Al].[Al].[Al].[Al].[Al].[Al]
CID000004900,Fernisone,CC12CC(=O)C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C,cholecystitis,CID000005152,Salmeterol,C1=CC=C(C=C1)CCCCOCCCCCCNCC(C2=CC(=C(C=C2)O)CO)O
CID000004900,Fernisone,CC12CC(=O)C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C,Dyspnea exertional,CID000004920,"1-acetyl-9a,11a-dimethyl-1H,2H,3H,3aH,3bH,4H,5H,7H,8H,9H,9aH,9bH,10H,11H,11aH-cyclopenta[a]phenanthren-7-one",CC(=O)C1CCC2C1(CCC3C2CCC4=CC(=O)CCC34C)C
CID000004900,Fernisone,CC12CC(=O)C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C,gastric inflammation,CID000012536,638-94-8,CC1(OC2CC3C4CCC5=CC(=O)C=CC5(C4C(CC3(C2(O1)C(=O)CO)C)O)C)C
CID000003676,lidocaine,CCN(CC)CC(=O)NC1=C(C=CC=C1C)C,deglutition disorder,CID000057537,92206-54-7,CCCN(CCC1=CC=CS1)C2CCC3=C(C2)C=CC=C3O
CID000003676,lidocaine,CCN(CC)CC(=O)NC1=C(C=CC=C1C)C,erythema,CID000005245,Risedronic acid,C1=CC(=CN=C1)CC(O)(P(=O)(O)O)P(=O)(O)O
CID000003676,lidocaine,CCN(CC)CC(=O)NC1=C(C=CC=C1C)C,myelodysplasia,CID003468412,SCHEMBL1176571,CC1C=CC=CCCC=CC=CC=CC=CC(CC(C(C(CC(=O)CC(C(CCC(CC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)C(=O)O)O)OC2C(C(C(C(O2)C)O)N)O
CID000003676,lidocaine,CCN(CC)CC(=O)NC1=C(C=CC=C1C)C,cholecystitis,CID000004205,mirtazapine,CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4
CID000003676,lidocaine,CCN(CC)CC(=O)NC1=C(C=CC=C1C)C,cholecystitis,CID000005152,Salmeterol,C1=CC=C(C=C1)CCCCOCCCCCCNCC(C2=CC(=C(C=C2)O)CO)O
CID000003676,lidocaine,CCN(CC)CC(=O)NC1=C(C=CC=C1C)C,cholecystitis,CID000003961,losartan,CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)CO)Cl
CID000003676,lidocaine,CCN(CC)CC(=O)NC1=C(C=CC=C1C)C,micturition urgency,CID000005487,tizanidine,C1CN=C(N1)NC2=C(C=CC3=NSN=C32)Cl
CID000003676,lidocaine,CCN(CC)CC(=O)NC1=C(C=CC=C1C)C,nephrotic syndrome,CID000003928,Lincomycine,CCCC1CC(N(C1)C)C(=O)NC(C2C(C(C(C(O2)SC)O)O)O)C(C)O
CID000003676,lidocaine,CCN(CC)CC(=O)NC1=C(C=CC=C1C)C,cholecystitis,CID000005732,zolpidem,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C
CID000003676,lidocaine,CCN(CC)CC(=O)NC1=C(C=CC=C1C)C,loss of weight,CID000004920,"1-acetyl-9a,11a-dimethyl-1H,2H,3H,3aH,3bH,4H,5H,7H,8H,9H,9aH,9bH,10H,11H,11aH-cyclopenta[a]phenanthren-7-one",CC(=O)C1CCC2C1(CCC3C2CCC4=CC(=O)CCC34C)C
CID000003676,lidocaine,CCN(CC)CC(=O)NC1=C(C=CC=C1C)C,cellulitis,CID000060854,Ziprasidone,C1CN(CCN1CCC2=C(C=C3C(=C2)CC(=O)N3)Cl)C4=NSC5=CC=CC=C54
CID000003676,lidocaine,CCN(CC)CC(=O)NC1=C(C=CC=C1C)C,gastric inflammation,CID006398525,,C(C1C(C(C(C(O1)OC2(C(C(C(O2)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)COS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.[Al].[Al].[Al].[Al].[Al].[Al].[Al].[Al].[Al]
CID000003676,lidocaine,CCN(CC)CC(=O)NC1=C(C=CC=C1C)C,cholecystitis,CID000004170,metolazone,CC1NC2=CC(=C(C=C2C(=O)N1C3=CC=CC=C3C)S(=O)(=O)N)Cl
CID000003676,lidocaine,CCN(CC)CC(=O)NC1=C(C=CC=C1C)C,erythema,CID000004510,nitroglycerin,C(C(CO[N+](=O)[O-])O[N+](=O)[O-])O[N+](=O)[O-]
CID000003676,lidocaine,CCN(CC)CC(=O)NC1=C(C=CC=C1C)C,loss of weight,CID000667490,6-Mercaptopurine,C1=NC2=C(N1)C(=S)N=CN2
CID000003676,lidocaine,CCN(CC)CC(=O)NC1=C(C=CC=C1C)C,erythema,CID000005095,ropinirole,CCCN(CCC)CCC1=C2CC(=O)NC2=CC=C1
CID000003676,lidocaine,CCN(CC)CC(=O)NC1=C(C=CC=C1C)C,drug toxicity NOS,CID000004913,PROCAINAMIDE,CCN(CC)CCNC(=O)C1=CC=C(C=C1)N
CID000003676,lidocaine,CCN(CC)CC(=O)NC1=C(C=CC=C1C)C,metabolic encephalopathy,CID000019090,megestrol,CC1=CC2C(CCC3(C2CCC3(C(=O)C)O)C)C4(C1=CC(=O)CC4)C
CID000003676,lidocaine,CCN(CC)CC(=O)NC1=C(C=CC=C1C)C,loss of weight,CID000004748,perphenazine,C1CN(CCN1CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)Cl)CCO
CID000003676,lidocaine,CCN(CC)CC(=O)NC1=C(C=CC=C1C)C,angina,CID000003734,Bracco 15000,CC(C(=O)NC1=C(C(=C(C(=C1I)C(=O)NC(CO)CO)I)C(=O)NC(CO)CO)I)O
CID000003676,lidocaine,CCN(CC)CC(=O)NC1=C(C=CC=C1C)C,cholecystitis,CID000005358,sumatriptan,CNS(=O)(=O)CC1=CC2=C(C=C1)NC=C2CCN(C)C
CID000003676,lidocaine,CCN(CC)CC(=O)NC1=C(C=CC=C1C)C,angiitis,CID000004585,"2-methyl-4-(4-methylpiperazin-1-yl)-5H-thieno[3,2-c][1,5]benzodiazepine",CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C
CID000003676,lidocaine,CCN(CC)CC(=O)NC1=C(C=CC=C1C)C,deglutition disorder,CID000036811,dobutamine,CC(CCC1=CC=C(C=C1)O)NCCC2=CC(=C(C=C2)O)O
CID000003676,lidocaine,CCN(CC)CC(=O)NC1=C(C=CC=C1C)C,methaemoglobinaemia,CID000004691,"3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine",C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4
CID000003676,lidocaine,CCN(CC)CC(=O)NC1=C(C=CC=C1C)C,ecchymoses,CID005311082,"2-[(1R,4S,10S,13S,19S)-19-[4-(diaminomethylideneamino)butyl]-10-(1H-indol-3-ylmethyl)-3,9,12,15,18,21,27-heptaoxo-24,25-dithia-2,8,11,14,17,20-hexazatricyclo[18.6.1.04,8]heptacosan-13-yl]acetic acid",C1CC2C(=O)NC3CSSCCC(=O)N(C3=O)C(C(=O)NCC(=O)NC(C(=O)NC(C(=O)N2C1)CC4=CNC5=CC=CC=C54)CC(=O)O)CCCCN=C(N)N
CID000003676,lidocaine,CCN(CC)CC(=O)NC1=C(C=CC=C1C)C,Irritation Skin,CID000012536,638-94-8,CC1(OC2CC3C4CCC5=CC(=O)C=CC5(C4C(CC3(C2(O1)C(=O)CO)C)O)C)C
CID000003676,lidocaine,CCN(CC)CC(=O)NC1=C(C=CC=C1C)C,Dyspnea exertional,CID000004894,"11,17,21-Trihydroxypregna-1,4-diene-3,20-dione",CC12CC(C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C)O
CID000003676,lidocaine,CCN(CC)CC(=O)NC1=C(C=CC=C1C)C,angiitis,CID000005719,zaleplon,CCN(C1=CC=CC(=C1)C2=CC=NC3=C(C=NN23)C#N)C(=O)C
CID000003676,lidocaine,CCN(CC)CC(=O)NC1=C(C=CC=C1C)C,erythema,CID000170361,Varenicline,C1C2CNCC1C3=CC4=NC=CN=C4C=C23
CID000005245,Risedronic acid,C1=CC(=CN=C1)CC(O)(P(=O)(O)O)P(=O)(O)O,apoplexy,CID000005487,tizanidine,C1CN=C(N1)NC2=C(C=CC3=NSN=C32)Cl
CID000005245,Risedronic acid,C1=CC(=CN=C1)CC(O)(P(=O)(O)O)P(=O)(O)O,anaphylactic reaction,CID000060865,(E)-Olopatadine,CN(C)CCC=C1C2=CC=CC=C2COC3=C1C=C(C=C3)CC(=O)O
CID000005245,Risedronic acid,C1=CC(=CN=C1)CC(O)(P(=O)(O)O)P(=O)(O)O,gastric inflammation,CID000060184,"2'-epi-Perindopril, (2'R)-",CCCC(C(=O)OCC)NC(C)C(=O)N1C2CCCCC2CC1C(=O)O
CID000005245,Risedronic acid,C1=CC(=CN=C1)CC(O)(P(=O)(O)O)P(=O)(O)O,loss of weight,CID000019090,megestrol,CC1=CC2C(CCC3(C2CCC3(C(=O)C)O)C)C4(C1=CC(=O)CC4)C
CID000005245,Risedronic acid,C1=CC(=CN=C1)CC(O)(P(=O)(O)O)P(=O)(O)O,loss of weight,CID000005719,zaleplon,CCN(C1=CC=CC(=C1)C2=CC=NC3=C(C=NN23)C#N)C(=O)C
CID000005245,Risedronic acid,C1=CC(=CN=C1)CC(O)(P(=O)(O)O)P(=O)(O)O,insulin dependent diabetes mellitus,CID000005394,temozolomide,CN1C(=O)N2C=NC(=C2N=N1)C(=O)N
CID000005245,Risedronic acid,C1=CC(=CN=C1)CC(O)(P(=O)(O)O)P(=O)(O)O,Pain,CID000667490,6-Mercaptopurine,C1=NC2=C(N1)C(=S)N=CN2
CID000005245,Risedronic acid,C1=CC(=CN=C1)CC(O)(P(=O)(O)O)P(=O)(O)O,abnormal ECG,CID000170361,Varenicline,C1C2CNCC1C3=CC4=NC=CN=C4C=C23
CID000005245,Risedronic acid,C1=CC(=CN=C1)CC(O)(P(=O)(O)O)P(=O)(O)O,erythema,CID000005732,zolpidem,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C
CID000005245,Risedronic acid,C1=CC(=CN=C1)CC(O)(P(=O)(O)O)P(=O)(O)O,erythema,CID000005358,sumatriptan,CNS(=O)(=O)CC1=CC2=C(C=C1)NC=C2CCN(C)C
CID000005245,Risedronic acid,C1=CC(=CN=C1)CC(O)(P(=O)(O)O)P(=O)(O)O,erythema,CID000057537,92206-54-7,CCCN(CCC1=CC=CS1)C2CCC3=C(C2)C=CC=C3O
CID000005245,Risedronic acid,C1=CC(=CN=C1)CC(O)(P(=O)(O)O)P(=O)(O)O,loss of weight,CID003468412,SCHEMBL1176571,CC1C=CC=CCCC=CC=CC=CC=CC(CC(C(C(CC(=O)CC(C(CCC(CC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)C(=O)O)O)OC2C(C(C(C(O2)C)O)N)O
CID000005245,Risedronic acid,C1=CC(=CN=C1)CC(O)(P(=O)(O)O)P(=O)(O)O,angiitis,CID006398525,,C(C1C(C(C(C(O1)OC2(C(C(C(O2)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)COS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.[Al].[Al].[Al].[Al].[Al].[Al].[Al].[Al].[Al]
CID000003405,2-[[4-[(2-amino-4-oxo-1H-pteridin-6-yl)methylamino]benzoyl]amino]pentanedioic acid,C1=CC(=CC=C1C(=O)NC(CCC(=O)O)C(=O)O)NCC2=CN=C3C(=N2)C(=O)N=C(N3)N,Adenopathy,CID000004451,CHEMBL365442,CC1=C(C=CC=C1O)C(=O)NC(CSC2=CC=CC=C2)C(CN3CC4CCCCC4CC3C(=O)NC(C)(C)C)O
CID000003405,2-[[4-[(2-amino-4-oxo-1H-pteridin-6-yl)methylamino]benzoyl]amino]pentanedioic acid,C1=CC(=CC=C1C(=O)NC(CCC(=O)O)C(=O)O)NCC2=CN=C3C(=N2)C(=O)N=C(N3)N,constipated,CID000170361,Varenicline,C1C2CNCC1C3=CC4=NC=CN=C4C=C23
CID000003405,2-[[4-[(2-amino-4-oxo-1H-pteridin-6-yl)methylamino]benzoyl]amino]pentanedioic acid,C1=CC(=CC=C1C(=O)NC(CCC(=O)O)C(=O)O)NCC2=CN=C3C(=N2)C(=O)N=C(N3)N,gastric inflammation,CID000004614,oxaprozin,C1=CC=C(C=C1)C2=C(OC(=N2)CCC(=O)O)C3=CC=CC=C3
CID000003405,2-[[4-[(2-amino-4-oxo-1H-pteridin-6-yl)methylamino]benzoyl]amino]pentanedioic acid,C1=CC(=CC=C1C(=O)NC(CCC(=O)O)C(=O)O)NCC2=CN=C3C(=N2)C(=O)N=C(N3)N,Adenopathy,CID000667490,6-Mercaptopurine,C1=NC2=C(N1)C(=S)N=CN2
CID000003405,2-[[4-[(2-amino-4-oxo-1H-pteridin-6-yl)methylamino]benzoyl]amino]pentanedioic acid,C1=CC(=CC=C1C(=O)NC(CCC(=O)O)C(=O)O)NCC2=CN=C3C(=N2)C(=O)N=C(N3)N,apoplexy,CID000003961,losartan,CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)CO)Cl
CID000003405,2-[[4-[(2-amino-4-oxo-1H-pteridin-6-yl)methylamino]benzoyl]amino]pentanedioic acid,C1=CC(=CC=C1C(=O)NC(CCC(=O)O)C(=O)O)NCC2=CN=C3C(=N2)C(=O)N=C(N3)N,gastric inflammation,CID000005095,ropinirole,CCCN(CCC)CCC1=C2CC(=O)NC2=CC=C1
CID000003405,2-[[4-[(2-amino-4-oxo-1H-pteridin-6-yl)methylamino]benzoyl]amino]pentanedioic acid,C1=CC(=CC=C1C(=O)NC(CCC(=O)O)C(=O)O)NCC2=CN=C3C(=N2)C(=O)N=C(N3)N,erythema,CID000019090,megestrol,CC1=CC2C(CCC3(C2CCC3(C(=O)C)O)C)C4(C1=CC(=O)CC4)C
CID000003405,2-[[4-[(2-amino-4-oxo-1H-pteridin-6-yl)methylamino]benzoyl]amino]pentanedioic acid,C1=CC(=CC=C1C(=O)NC(CCC(=O)O)C(=O)O)NCC2=CN=C3C(=N2)C(=O)N=C(N3)N,Enuresis,CID000060854,Ziprasidone,C1CN(CCN1CCC2=C(C=C3C(=C2)CC(=O)N3)Cl)C4=NSC5=CC=CC=C54
CID000003405,2-[[4-[(2-amino-4-oxo-1H-pteridin-6-yl)methylamino]benzoyl]amino]pentanedioic acid,C1=CC(=CC=C1C(=O)NC(CCC(=O)O)C(=O)O)NCC2=CN=C3C(=N2)C(=O)N=C(N3)N,gastric inflammation,CID006398525,,C(C1C(C(C(C(O1)OC2(C(C(C(O2)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)COS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.[Al].[Al].[Al].[Al].[Al].[Al].[Al].[Al].[Al]
CID000003405,2-[[4-[(2-amino-4-oxo-1H-pteridin-6-yl)methylamino]benzoyl]amino]pentanedioic acid,C1=CC(=CC=C1C(=O)NC(CCC(=O)O)C(=O)O)NCC2=CN=C3C(=N2)C(=O)N=C(N3)N,Adenopathy,CID000004205,mirtazapine,CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4
CID000003405,2-[[4-[(2-amino-4-oxo-1H-pteridin-6-yl)methylamino]benzoyl]amino]pentanedioic acid,C1=CC(=CC=C1C(=O)NC(CCC(=O)O)C(=O)O)NCC2=CN=C3C(=N2)C(=O)N=C(N3)N,back injury,CID000005358,sumatriptan,CNS(=O)(=O)CC1=CC2=C(C=C1)NC=C2CCN(C)C
CID000003405,2-[[4-[(2-amino-4-oxo-1H-pteridin-6-yl)methylamino]benzoyl]amino]pentanedioic acid,C1=CC(=CC=C1C(=O)NC(CCC(=O)O)C(=O)O)NCC2=CN=C3C(=N2)C(=O)N=C(N3)N,neumonia,CID000004894,"11,17,21-Trihydroxypregna-1,4-diene-3,20-dione",CC12CC(C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C)O
CID000003405,2-[[4-[(2-amino-4-oxo-1H-pteridin-6-yl)methylamino]benzoyl]amino]pentanedioic acid,C1=CC(=CC=C1C(=O)NC(CCC(=O)O)C(=O)O)NCC2=CN=C3C(=N2)C(=O)N=C(N3)N,apoplexy,CID000060184,"2'-epi-Perindopril, (2'R)-",CCCC(C(=O)OCC)NC(C)C(=O)N1C2CCCCC2CC1C(=O)O
CID000003405,2-[[4-[(2-amino-4-oxo-1H-pteridin-6-yl)methylamino]benzoyl]amino]pentanedioic acid,C1=CC(=CC=C1C(=O)NC(CCC(=O)O)C(=O)O)NCC2=CN=C3C(=N2)C(=O)N=C(N3)N,cholecystitis,CID003468412,SCHEMBL1176571,CC1C=CC=CCCC=CC=CC=CC=CC(CC(C(C(CC(=O)CC(C(CCC(CC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)C(=O)O)O)OC2C(C(C(C(O2)C)O)N)O
CID000003405,2-[[4-[(2-amino-4-oxo-1H-pteridin-6-yl)methylamino]benzoyl]amino]pentanedioic acid,C1=CC(=CC=C1C(=O)NC(CCC(=O)O)C(=O)O)NCC2=CN=C3C(=N2)C(=O)N=C(N3)N,gastric inflammation,CID000004585,"2-methyl-4-(4-methylpiperazin-1-yl)-5H-thieno[3,2-c][1,5]benzodiazepine",CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C
CID000003405,2-[[4-[(2-amino-4-oxo-1H-pteridin-6-yl)methylamino]benzoyl]amino]pentanedioic acid,C1=CC(=CC=C1C(=O)NC(CCC(=O)O)C(=O)O)NCC2=CN=C3C(=N2)C(=O)N=C(N3)N,erythema,CID000003440,furosemide,C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl
CID000003405,2-[[4-[(2-amino-4-oxo-1H-pteridin-6-yl)methylamino]benzoyl]amino]pentanedioic acid,C1=CC(=CC=C1C(=O)NC(CCC(=O)O)C(=O)O)NCC2=CN=C3C(=N2)C(=O)N=C(N3)N,Back Ache,CID000004510,nitroglycerin,C(C(CO[N+](=O)[O-])O[N+](=O)[O-])O[N+](=O)[O-]
CID000003405,2-[[4-[(2-amino-4-oxo-1H-pteridin-6-yl)methylamino]benzoyl]amino]pentanedioic acid,C1=CC(=CC=C1C(=O)NC(CCC(=O)O)C(=O)O)NCC2=CN=C3C(=N2)C(=O)N=C(N3)N,icterus,CID000074989,ATOVAQUONE,C1CC(CCC1C2=CC=C(C=C2)Cl)C3=C(C4=CC=CC=C4C(=O)C3=O)O
CID000003405,2-[[4-[(2-amino-4-oxo-1H-pteridin-6-yl)methylamino]benzoyl]amino]pentanedioic acid,C1=CC(=CC=C1C(=O)NC(CCC(=O)O)C(=O)O)NCC2=CN=C3C(=N2)C(=O)N=C(N3)N,Extrasystoles Ventricular,CID000003869,labetalol,CC(CCC1=CC=CC=C1)NCC(C2=CC(=C(C=C2)O)C(=O)N)O
CID000003405,2-[[4-[(2-amino-4-oxo-1H-pteridin-6-yl)methylamino]benzoyl]amino]pentanedioic acid,C1=CC(=CC=C1C(=O)NC(CCC(=O)O)C(=O)O)NCC2=CN=C3C(=N2)C(=O)N=C(N3)N,fracture nonunion,CID000005487,tizanidine,C1CN=C(N1)NC2=C(C=CC3=NSN=C32)Cl
CID000003405,2-[[4-[(2-amino-4-oxo-1H-pteridin-6-yl)methylamino]benzoyl]amino]pentanedioic acid,C1=CC(=CC=C1C(=O)NC(CCC(=O)O)C(=O)O)NCC2=CN=C3C(=N2)C(=O)N=C(N3)N,cholecystitis,CID000005152,Salmeterol,C1=CC=C(C=C1)CCCCOCCCCCCNCC(C2=CC(=C(C=C2)O)CO)O
CID000003405,2-[[4-[(2-amino-4-oxo-1H-pteridin-6-yl)methylamino]benzoyl]amino]pentanedioic acid,C1=CC(=CC=C1C(=O)NC(CCC(=O)O)C(=O)O)NCC2=CN=C3C(=N2)C(=O)N=C(N3)N,angiitis,CID000004920,"1-acetyl-9a,11a-dimethyl-1H,2H,3H,3aH,3bH,4H,5H,7H,8H,9H,9aH,9bH,10H,11H,11aH-cyclopenta[a]phenanthren-7-one",CC(=O)C1CCC2C1(CCC3C2CCC4=CC(=O)CCC34C)C
CID000003405,2-[[4-[(2-amino-4-oxo-1H-pteridin-6-yl)methylamino]benzoyl]amino]pentanedioic acid,C1=CC(=CC=C1C(=O)NC(CCC(=O)O)C(=O)O)NCC2=CN=C3C(=N2)C(=O)N=C(N3)N,Adenopathy,CID000005719,zaleplon,CCN(C1=CC=CC(=C1)C2=CC=NC3=C(C=NN23)C#N)C(=O)C
CID000003405,2-[[4-[(2-amino-4-oxo-1H-pteridin-6-yl)methylamino]benzoyl]amino]pentanedioic acid,C1=CC(=CC=C1C(=O)NC(CCC(=O)O)C(=O)O)NCC2=CN=C3C(=N2)C(=O)N=C(N3)N,apoplexy,CID000005732,zolpidem,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C
CID000003405,2-[[4-[(2-amino-4-oxo-1H-pteridin-6-yl)methylamino]benzoyl]amino]pentanedioic acid,C1=CC(=CC=C1C(=O)NC(CCC(=O)O)C(=O)O)NCC2=CN=C3C(=N2)C(=O)N=C(N3)N,loss of weight,CID000004170,metolazone,CC1NC2=CC(=C(C=C2C(=O)N1C3=CC=CC=C3C)S(=O)(=O)N)Cl
CID000003405,2-[[4-[(2-amino-4-oxo-1H-pteridin-6-yl)methylamino]benzoyl]amino]pentanedioic acid,C1=CC(=CC=C1C(=O)NC(CCC(=O)O)C(=O)O)NCC2=CN=C3C(=N2)C(=O)N=C(N3)N,colitis ischemic,CID000060865,(E)-Olopatadine,CN(C)CCC=C1C2=CC=CC=C2COC3=C1C=C(C=C3)CC(=O)O
CID000003405,2-[[4-[(2-amino-4-oxo-1H-pteridin-6-yl)methylamino]benzoyl]amino]pentanedioic acid,C1=CC(=CC=C1C(=O)NC(CCC(=O)O)C(=O)O)NCC2=CN=C3C(=N2)C(=O)N=C(N3)N,loss of weight,CID000004201,minoxidil,C1CCN(CC1)C2=NC(=N)N(C(=C2)N)O
CID000003405,2-[[4-[(2-amino-4-oxo-1H-pteridin-6-yl)methylamino]benzoyl]amino]pentanedioic acid,C1=CC(=CC=C1C(=O)NC(CCC(=O)O)C(=O)O)NCC2=CN=C3C(=N2)C(=O)N=C(N3)N,right heart failure,CID000004691,"3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine",C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4
CID000004920,"1-acetyl-9a,11a-dimethyl-1H,2H,3H,3aH,3bH,4H,5H,7H,8H,9H,9aH,9bH,10H,11H,11aH-cyclopenta[a]phenanthren-7-one",CC(=O)C1CCC2C1(CCC3C2CCC4=CC(=O)CCC34C)C,weight gain,CID000170361,Varenicline,C1C2CNCC1C3=CC4=NC=CN=C4C=C23
CID000004920,"1-acetyl-9a,11a-dimethyl-1H,2H,3H,3aH,3bH,4H,5H,7H,8H,9H,9aH,9bH,10H,11H,11aH-cyclopenta[a]phenanthren-7-one",CC(=O)C1CCC2C1(CCC3C2CCC4=CC(=O)CCC34C)C,loss of weight,CID003468412,SCHEMBL1176571,CC1C=CC=CCCC=CC=CC=CC=CC(CC(C(C(CC(=O)CC(C(CCC(CC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)C(=O)O)O)OC2C(C(C(C(O2)C)O)N)O
CID000004920,"1-acetyl-9a,11a-dimethyl-1H,2H,3H,3aH,3bH,4H,5H,7H,8H,9H,9aH,9bH,10H,11H,11aH-cyclopenta[a]phenanthren-7-one",CC(=O)C1CCC2C1(CCC3C2CCC4=CC(=O)CCC34C)C,rotator cuff syndrome,CID000005719,zaleplon,CCN(C1=CC=CC(=C1)C2=CC=NC3=C(C=NN23)C#N)C(=O)C
CID000004920,"1-acetyl-9a,11a-dimethyl-1H,2H,3H,3aH,3bH,4H,5H,7H,8H,9H,9aH,9bH,10H,11H,11aH-cyclopenta[a]phenanthren-7-one",CC(=O)C1CCC2C1(CCC3C2CCC4=CC(=O)CCC34C)C,loss of weight,CID000005358,sumatriptan,CNS(=O)(=O)CC1=CC2=C(C=C1)NC=C2CCN(C)C
CID000004920,"1-acetyl-9a,11a-dimethyl-1H,2H,3H,3aH,3bH,4H,5H,7H,8H,9H,9aH,9bH,10H,11H,11aH-cyclopenta[a]phenanthren-7-one",CC(=O)C1CCC2C1(CCC3C2CCC4=CC(=O)CCC34C)C,adenomyosis,CID000005732,zolpidem,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C
CID000004920,"1-acetyl-9a,11a-dimethyl-1H,2H,3H,3aH,3bH,4H,5H,7H,8H,9H,9aH,9bH,10H,11H,11aH-cyclopenta[a]phenanthren-7-one",CC(=O)C1CCC2C1(CCC3C2CCC4=CC(=O)CCC34C)C,drug withdrawal,CID000060865,(E)-Olopatadine,CN(C)CCC=C1C2=CC=CC=C2COC3=C1C=C(C=C3)CC(=O)O
CID000004920,"1-acetyl-9a,11a-dimethyl-1H,2H,3H,3aH,3bH,4H,5H,7H,8H,9H,9aH,9bH,10H,11H,11aH-cyclopenta[a]phenanthren-7-one",CC(=O)C1CCC2C1(CCC3C2CCC4=CC(=O)CCC34C)C,drug withdrawal,CID000005095,ropinirole,CCCN(CCC)CCC1=C2CC(=O)NC2=CC=C1
CID000004920,"1-acetyl-9a,11a-dimethyl-1H,2H,3H,3aH,3bH,4H,5H,7H,8H,9H,9aH,9bH,10H,11H,11aH-cyclopenta[a]phenanthren-7-one",CC(=O)C1CCC2C1(CCC3C2CCC4=CC(=O)CCC34C)C,gastric inflammation,CID000005152,Salmeterol,C1=CC=C(C=C1)CCCCOCCCCCCNCC(C2=CC(=C(C=C2)O)CO)O
CID000002891,"cobalt(2+);[5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] 1-[3-[2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2,7,12,17-tetrahydro-1H-corrin-21-id-3-yl]propanoylamino]propan-2-yl hydrogen phosphate;cyanide",CC1=CC2=C(C=C1C)N(C=N2)C3C(C(C(O3)CO)OP(=O)(O)OC(C)CNC(=O)CCC4(C(C5C6(C(C(C(=N6)C(=C7C(C(C(=N7)C=C8C(C(C(=N8)C(=C4[N-]5)C)CCC(=O)N)(C)C)CCC(=O)N)(C)CC(=O)N)C)CCC(=O)N)(C)CC(=O)N)C)CC(=O)N)C)O.[C-]#N.[Co+2],bursitis,CID000060865,(E)-Olopatadine,CN(C)CCC=C1C2=CC=CC=C2COC3=C1C=C(C=C3)CC(=O)O
CID000002891,"cobalt(2+);[5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] 1-[3-[2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2,7,12,17-tetrahydro-1H-corrin-21-id-3-yl]propanoylamino]propan-2-yl hydrogen phosphate;cyanide",CC1=CC2=C(C=C1C)N(C=N2)C3C(C(C(O3)CO)OP(=O)(O)OC(C)CNC(=O)CCC4(C(C5C6(C(C(C(=N6)C(=C7C(C(C(=N7)C=C8C(C(C(=N8)C(=C4[N-]5)C)CCC(=O)N)(C)C)CCC(=O)N)(C)CC(=O)N)C)CCC(=O)N)(C)CC(=O)N)C)CC(=O)N)C)O.[C-]#N.[Co+2],Gastric Cancer,CID006398525,,C(C1C(C(C(C(O1)OC2(C(C(C(O2)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)COS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.[Al].[Al].[Al].[Al].[Al].[Al].[Al].[Al].[Al]
CID000002891,"cobalt(2+);[5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] 1-[3-[2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2,7,12,17-tetrahydro-1H-corrin-21-id-3-yl]propanoylamino]propan-2-yl hydrogen phosphate;cyanide",CC1=CC2=C(C=C1C)N(C=N2)C3C(C(C(O3)CO)OP(=O)(O)OC(C)CNC(=O)CCC4(C(C5C6(C(C(C(=N6)C(=C7C(C(C(=N7)C=C8C(C(C(=N8)C(=C4[N-]5)C)CCC(=O)N)(C)C)CCC(=O)N)(C)CC(=O)N)C)CCC(=O)N)(C)CC(=O)N)C)CC(=O)N)C)O.[C-]#N.[Co+2],proctalgia,CID000004170,metolazone,CC1NC2=CC(=C(C=C2C(=O)N1C3=CC=CC=C3C)S(=O)(=O)N)Cl
CID000002891,"cobalt(2+);[5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] 1-[3-[2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2,7,12,17-tetrahydro-1H-corrin-21-id-3-yl]propanoylamino]propan-2-yl hydrogen phosphate;cyanide",CC1=CC2=C(C=C1C)N(C=N2)C3C(C(C(O3)CO)OP(=O)(O)OC(C)CNC(=O)CCC4(C(C5C6(C(C(C(=N6)C(=C7C(C(C(=N7)C=C8C(C(C(=N8)C(=C4[N-]5)C)CCC(=O)N)(C)C)CCC(=O)N)(C)CC(=O)N)C)CCC(=O)N)(C)CC(=O)N)C)CC(=O)N)C)O.[C-]#N.[Co+2],erythema,CID000005487,tizanidine,C1CN=C(N1)NC2=C(C=CC3=NSN=C32)Cl
CID000002891,"cobalt(2+);[5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] 1-[3-[2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2,7,12,17-tetrahydro-1H-corrin-21-id-3-yl]propanoylamino]propan-2-yl hydrogen phosphate;cyanide",CC1=CC2=C(C=C1C)N(C=N2)C3C(C(C(O3)CO)OP(=O)(O)OC(C)CNC(=O)CCC4(C(C5C6(C(C(C(=N6)C(=C7C(C(C(=N7)C=C8C(C(C(=N8)C(=C4[N-]5)C)CCC(=O)N)(C)C)CCC(=O)N)(C)CC(=O)N)C)CCC(=O)N)(C)CC(=O)N)C)CC(=O)N)C)O.[C-]#N.[Co+2],Back Ache,CID000004894,"11,17,21-Trihydroxypregna-1,4-diene-3,20-dione",CC12CC(C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C)O
CID000002891,"cobalt(2+);[5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] 1-[3-[2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2,7,12,17-tetrahydro-1H-corrin-21-id-3-yl]propanoylamino]propan-2-yl hydrogen phosphate;cyanide",CC1=CC2=C(C=C1C)N(C=N2)C3C(C(C(O3)CO)OP(=O)(O)OC(C)CNC(=O)CCC4(C(C5C6(C(C(C(=N6)C(=C7C(C(C(=N7)C=C8C(C(C(=N8)C(=C4[N-]5)C)CCC(=O)N)(C)C)CCC(=O)N)(C)CC(=O)N)C)CCC(=O)N)(C)CC(=O)N)C)CC(=O)N)C)O.[C-]#N.[Co+2],gastric inflammation,CID000004510,nitroglycerin,C(C(CO[N+](=O)[O-])O[N+](=O)[O-])O[N+](=O)[O-]
CID000002891,"cobalt(2+);[5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] 1-[3-[2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2,7,12,17-tetrahydro-1H-corrin-21-id-3-yl]propanoylamino]propan-2-yl hydrogen phosphate;cyanide",CC1=CC2=C(C=C1C)N(C=N2)C3C(C(C(O3)CO)OP(=O)(O)OC(C)CNC(=O)CCC4(C(C5C6(C(C(C(=N6)C(=C7C(C(C(=N7)C=C8C(C(C(=N8)C(=C4[N-]5)C)CCC(=O)N)(C)C)CCC(=O)N)(C)CC(=O)N)C)CCC(=O)N)(C)CC(=O)N)C)CC(=O)N)C)O.[C-]#N.[Co+2],back injury,CID000003961,losartan,CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)CO)Cl
CID000002891,"cobalt(2+);[5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] 1-[3-[2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2,7,12,17-tetrahydro-1H-corrin-21-id-3-yl]propanoylamino]propan-2-yl hydrogen phosphate;cyanide",CC1=CC2=C(C=C1C)N(C=N2)C3C(C(C(O3)CO)OP(=O)(O)OC(C)CNC(=O)CCC4(C(C5C6(C(C(C(=N6)C(=C7C(C(C(=N7)C=C8C(C(C(=N8)C(=C4[N-]5)C)CCC(=O)N)(C)C)CCC(=O)N)(C)CC(=O)N)C)CCC(=O)N)(C)CC(=O)N)C)CC(=O)N)C)O.[C-]#N.[Co+2],loss of weight,CID003468412,SCHEMBL1176571,CC1C=CC=CCCC=CC=CC=CC=CC(CC(C(C(CC(=O)CC(C(CCC(CC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)C(=O)O)O)OC2C(C(C(C(O2)C)O)N)O
CID000002891,"cobalt(2+);[5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] 1-[3-[2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2,7,12,17-tetrahydro-1H-corrin-21-id-3-yl]propanoylamino]propan-2-yl hydrogen phosphate;cyanide",CC1=CC2=C(C=C1C)N(C=N2)C3C(C(C(O3)CO)OP(=O)(O)OC(C)CNC(=O)CCC4(C(C5C6(C(C(C(=N6)C(=C7C(C(C(=N7)C=C8C(C(C(=N8)C(=C4[N-]5)C)CCC(=O)N)(C)C)CCC(=O)N)(C)CC(=O)N)C)CCC(=O)N)(C)CC(=O)N)C)CC(=O)N)C)O.[C-]#N.[Co+2],gastric inflammation,CID000003062,"3-[3-[5-[5-(4,5-dihydroxy-6-methyloxan-2-yl)oxy-4-hydroxy-6-methyloxan-2-yl]oxy-4-hydroxy-6-methyloxan-2-yl]oxy-12,14-dihydroxy-10,13-dimethyl-1,2,3,4,5,6,7,8,9,11,12,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl]-2H-furan-5-one",CC1C(C(CC(O1)OC2C(OC(CC2O)OC3C(OC(CC3O)OC4CCC5(C(C4)CCC6C5CC(C7(C6(CCC7C8=CC(=O)OC8)O)C)O)C)C)C)O)O
CID000002891,"cobalt(2+);[5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] 1-[3-[2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2,7,12,17-tetrahydro-1H-corrin-21-id-3-yl]propanoylamino]propan-2-yl hydrogen phosphate;cyanide",CC1=CC2=C(C=C1C)N(C=N2)C3C(C(C(O3)CO)OP(=O)(O)OC(C)CNC(=O)CCC4(C(C5C6(C(C(C(=N6)C(=C7C(C(C(=N7)C=C8C(C(C(=N8)C(=C4[N-]5)C)CCC(=O)N)(C)C)CCC(=O)N)(C)CC(=O)N)C)CCC(=O)N)(C)CC(=O)N)C)CC(=O)N)C)O.[C-]#N.[Co+2],atrioventricular block,CID000060184,"2'-epi-Perindopril, (2'R)-",CCCC(C(=O)OCC)NC(C)C(=O)N1C2CCCCC2CC1C(=O)O
CID000002891,"cobalt(2+);[5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] 1-[3-[2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2,7,12,17-tetrahydro-1H-corrin-21-id-3-yl]propanoylamino]propan-2-yl hydrogen phosphate;cyanide",CC1=CC2=C(C=C1C)N(C=N2)C3C(C(C(O3)CO)OP(=O)(O)OC(C)CNC(=O)CCC4(C(C5C6(C(C(C(=N6)C(=C7C(C(C(=N7)C=C8C(C(C(=N8)C(=C4[N-]5)C)CCC(=O)N)(C)C)CCC(=O)N)(C)CC(=O)N)C)CCC(=O)N)(C)CC(=O)N)C)CC(=O)N)C)O.[C-]#N.[Co+2],bursitis,CID000005719,zaleplon,CCN(C1=CC=CC(=C1)C2=CC=NC3=C(C=NN23)C#N)C(=O)C
CID000002891,"cobalt(2+);[5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] 1-[3-[2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2,7,12,17-tetrahydro-1H-corrin-21-id-3-yl]propanoylamino]propan-2-yl hydrogen phosphate;cyanide",CC1=CC2=C(C=C1C)N(C=N2)C3C(C(C(O3)CO)OP(=O)(O)OC(C)CNC(=O)CCC4(C(C5C6(C(C(C(=N6)C(=C7C(C(C(=N7)C=C8C(C(C(=N8)C(=C4[N-]5)C)CCC(=O)N)(C)C)CCC(=O)N)(C)CC(=O)N)C)CCC(=O)N)(C)CC(=O)N)C)CC(=O)N)C)O.[C-]#N.[Co+2],Dyspnea exertional,CID000004205,mirtazapine,CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4
CID000002891,"cobalt(2+);[5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] 1-[3-[2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2,7,12,17-tetrahydro-1H-corrin-21-id-3-yl]propanoylamino]propan-2-yl hydrogen phosphate;cyanide",CC1=CC2=C(C=C1C)N(C=N2)C3C(C(C(O3)CO)OP(=O)(O)OC(C)CNC(=O)CCC4(C(C5C6(C(C(C(=N6)C(=C7C(C(C(=N7)C=C8C(C(C(=N8)C(=C4[N-]5)C)CCC(=O)N)(C)C)CCC(=O)N)(C)CC(=O)N)C)CCC(=O)N)(C)CC(=O)N)C)CC(=O)N)C)O.[C-]#N.[Co+2],apoplexy,CID000005152,Salmeterol,C1=CC=C(C=C1)CCCCOCCCCCCNCC(C2=CC(=C(C=C2)O)CO)O
CID000002891,"cobalt(2+);[5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] 1-[3-[2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2,7,12,17-tetrahydro-1H-corrin-21-id-3-yl]propanoylamino]propan-2-yl hydrogen phosphate;cyanide",CC1=CC2=C(C=C1C)N(C=N2)C3C(C(C(O3)CO)OP(=O)(O)OC(C)CNC(=O)CCC4(C(C5C6(C(C(C(=N6)C(=C7C(C(C(=N7)C=C8C(C(C(=N8)C(=C4[N-]5)C)CCC(=O)N)(C)C)CCC(=O)N)(C)CC(=O)N)C)CCC(=O)N)(C)CC(=O)N)C)CC(=O)N)C)O.[C-]#N.[Co+2],apoplexy,CID000005358,sumatriptan,CNS(=O)(=O)CC1=CC2=C(C=C1)NC=C2CCN(C)C
CID000002891,"cobalt(2+);[5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] 1-[3-[2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2,7,12,17-tetrahydro-1H-corrin-21-id-3-yl]propanoylamino]propan-2-yl hydrogen phosphate;cyanide",CC1=CC2=C(C=C1C)N(C=N2)C3C(C(C(O3)CO)OP(=O)(O)OC(C)CNC(=O)CCC4(C(C5C6(C(C(C(=N6)C(=C7C(C(C(=N7)C=C8C(C(C(=N8)C(=C4[N-]5)C)CCC(=O)N)(C)C)CCC(=O)N)(C)CC(=O)N)C)CCC(=O)N)(C)CC(=O)N)C)CC(=O)N)C)O.[C-]#N.[Co+2],apoplexy,CID000003042,dicyclomine,CCN(CC)CCOC(=O)C1(CCCCC1)C2CCCCC2
CID000002891,"cobalt(2+);[5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] 1-[3-[2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2,7,12,17-tetrahydro-1H-corrin-21-id-3-yl]propanoylamino]propan-2-yl hydrogen phosphate;cyanide",CC1=CC2=C(C=C1C)N(C=N2)C3C(C(C(O3)CO)OP(=O)(O)OC(C)CNC(=O)CCC4(C(C5C6(C(C(C(=N6)C(=C7C(C(C(=N7)C=C8C(C(C(=N8)C(=C4[N-]5)C)CCC(=O)N)(C)C)CCC(=O)N)(C)CC(=O)N)C)CCC(=O)N)(C)CC(=O)N)C)CC(=O)N)C)O.[C-]#N.[Co+2],right heart failure,CID000004585,"2-methyl-4-(4-methylpiperazin-1-yl)-5H-thieno[3,2-c][1,5]benzodiazepine",CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C
CID000002891,"cobalt(2+);[5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] 1-[3-[2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2,7,12,17-tetrahydro-1H-corrin-21-id-3-yl]propanoylamino]propan-2-yl hydrogen phosphate;cyanide",CC1=CC2=C(C=C1C)N(C=N2)C3C(C(C(O3)CO)OP(=O)(O)OC(C)CNC(=O)CCC4(C(C5C6(C(C(C(=N6)C(=C7C(C(C(=N7)C=C8C(C(C(=N8)C(=C4[N-]5)C)CCC(=O)N)(C)C)CCC(=O)N)(C)CC(=O)N)C)CCC(=O)N)(C)CC(=O)N)C)CC(=O)N)C)O.[C-]#N.[Co+2],gastric inflammation,CID000005732,zolpidem,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C
CID000002891,"cobalt(2+);[5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] 1-[3-[2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2,7,12,17-tetrahydro-1H-corrin-21-id-3-yl]propanoylamino]propan-2-yl hydrogen phosphate;cyanide",CC1=CC2=C(C=C1C)N(C=N2)C3C(C(C(O3)CO)OP(=O)(O)OC(C)CNC(=O)CCC4(C(C5C6(C(C(C(=N6)C(=C7C(C(C(=N7)C=C8C(C(C(=N8)C(=C4[N-]5)C)CCC(=O)N)(C)C)CCC(=O)N)(C)CC(=O)N)C)CCC(=O)N)(C)CC(=O)N)C)CC(=O)N)C)O.[C-]#N.[Co+2],cholecystitis,CID000004691,"3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine",C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4
CID000002891,"cobalt(2+);[5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] 1-[3-[2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2,7,12,17-tetrahydro-1H-corrin-21-id-3-yl]propanoylamino]propan-2-yl hydrogen phosphate;cyanide",CC1=CC2=C(C=C1C)N(C=N2)C3C(C(C(O3)CO)OP(=O)(O)OC(C)CNC(=O)CCC4(C(C5C6(C(C(C(=N6)C(=C7C(C(C(=N7)C=C8C(C(C(=N8)C(=C4[N-]5)C)CCC(=O)N)(C)C)CCC(=O)N)(C)CC(=O)N)C)CCC(=O)N)(C)CC(=O)N)C)CC(=O)N)C)O.[C-]#N.[Co+2],weight gain,CID000170361,Varenicline,C1C2CNCC1C3=CC4=NC=CN=C4C=C23
CID000002891,"cobalt(2+);[5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] 1-[3-[2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2,7,12,17-tetrahydro-1H-corrin-21-id-3-yl]propanoylamino]propan-2-yl hydrogen phosphate;cyanide",CC1=CC2=C(C=C1C)N(C=N2)C3C(C(C(O3)CO)OP(=O)(O)OC(C)CNC(=O)CCC4(C(C5C6(C(C(C(=N6)C(=C7C(C(C(=N7)C=C8C(C(C(=N8)C(=C4[N-]5)C)CCC(=O)N)(C)C)CCC(=O)N)(C)CC(=O)N)C)CCC(=O)N)(C)CC(=O)N)C)CC(=O)N)C)O.[C-]#N.[Co+2],angiitis,CID000003333,felodipine,CCOC(=O)C1=C(NC(=C(C1C2=C(C(=CC=C2)Cl)Cl)C(=O)OC)C)C
CID000002891,"cobalt(2+);[5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] 1-[3-[2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2,7,12,17-tetrahydro-1H-corrin-21-id-3-yl]propanoylamino]propan-2-yl hydrogen phosphate;cyanide",CC1=CC2=C(C=C1C)N(C=N2)C3C(C(C(O3)CO)OP(=O)(O)OC(C)CNC(=O)CCC4(C(C5C6(C(C(C(=N6)C(=C7C(C(C(=N7)C=C8C(C(C(=N8)C(=C4[N-]5)C)CCC(=O)N)(C)C)CCC(=O)N)(C)CC(=O)N)C)CCC(=O)N)(C)CC(=O)N)C)CC(=O)N)C)O.[C-]#N.[Co+2],back injury,CID000003339,fenofibrate,CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C2=CC=C(C=C2)Cl
CID000002891,"cobalt(2+);[5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] 1-[3-[2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2,7,12,17-tetrahydro-1H-corrin-21-id-3-yl]propanoylamino]propan-2-yl hydrogen phosphate;cyanide",CC1=CC2=C(C=C1C)N(C=N2)C3C(C(C(O3)CO)OP(=O)(O)OC(C)CNC(=O)CCC4(C(C5C6(C(C(C(=N6)C(=C7C(C(C(=N7)C=C8C(C(C(=N8)C(=C4[N-]5)C)CCC(=O)N)(C)C)CCC(=O)N)(C)CC(=O)N)C)CCC(=O)N)(C)CC(=O)N)C)CC(=O)N)C)O.[C-]#N.[Co+2],back injury,CID000003440,furosemide,C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl
CID000002891,"cobalt(2+);[5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] 1-[3-[2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2,7,12,17-tetrahydro-1H-corrin-21-id-3-yl]propanoylamino]propan-2-yl hydrogen phosphate;cyanide",CC1=CC2=C(C=C1C)N(C=N2)C3C(C(C(O3)CO)OP(=O)(O)OC(C)CNC(=O)CCC4(C(C5C6(C(C(C(=N6)C(=C7C(C(C(=N7)C=C8C(C(C(=N8)C(=C4[N-]5)C)CCC(=O)N)(C)C)CCC(=O)N)(C)CC(=O)N)C)CCC(=O)N)(C)CC(=O)N)C)CC(=O)N)C)O.[C-]#N.[Co+2],bursitis,CID000005095,ropinirole,CCCN(CCC)CCC1=C2CC(=O)NC2=CC=C1
CID000002891,"cobalt(2+);[5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] 1-[3-[2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2,7,12,17-tetrahydro-1H-corrin-21-id-3-yl]propanoylamino]propan-2-yl hydrogen phosphate;cyanide",CC1=CC2=C(C=C1C)N(C=N2)C3C(C(C(O3)CO)OP(=O)(O)OC(C)CNC(=O)CCC4(C(C5C6(C(C(C(=N6)C(=C7C(C(C(=N7)C=C8C(C(C(=N8)C(=C4[N-]5)C)CCC(=O)N)(C)C)CCC(=O)N)(C)CC(=O)N)C)CCC(=O)N)(C)CC(=O)N)C)CC(=O)N)C)O.[C-]#N.[Co+2],elevated cholesterol,CID000667490,6-Mercaptopurine,C1=NC2=C(N1)C(=S)N=CN2
CID000002891,"cobalt(2+);[5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] 1-[3-[2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2,7,12,17-tetrahydro-1H-corrin-21-id-3-yl]propanoylamino]propan-2-yl hydrogen phosphate;cyanide",CC1=CC2=C(C=C1C)N(C=N2)C3C(C(C(O3)CO)OP(=O)(O)OC(C)CNC(=O)CCC4(C(C5C6(C(C(C(=N6)C(=C7C(C(C(=N7)C=C8C(C(C(=N8)C(=C4[N-]5)C)CCC(=O)N)(C)C)CCC(=O)N)(C)CC(=O)N)C)CCC(=O)N)(C)CC(=O)N)C)CC(=O)N)C)O.[C-]#N.[Co+2],loss of weight,CID000019090,megestrol,CC1=CC2C(CCC3(C2CCC3(C(=O)C)O)C)C4(C1=CC(=O)CC4)C
CID000002891,"cobalt(2+);[5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] 1-[3-[2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2,7,12,17-tetrahydro-1H-corrin-21-id-3-yl]propanoylamino]propan-2-yl hydrogen phosphate;cyanide",CC1=CC2=C(C=C1C)N(C=N2)C3C(C(C(O3)CO)OP(=O)(O)OC(C)CNC(=O)CCC4(C(C5C6(C(C(C(=N6)C(=C7C(C(C(=N7)C=C8C(C(C(=N8)C(=C4[N-]5)C)CCC(=O)N)(C)C)CCC(=O)N)(C)CC(=O)N)C)CCC(=O)N)(C)CC(=O)N)C)CC(=O)N)C)O.[C-]#N.[Co+2],aspiration pneumonia,CID000005394,temozolomide,CN1C(=O)N2C=NC(=C2N=N1)C(=O)N
CID000001971,914348-29-1,C1CC1NC2=C3C(=NC(=N2)N)N(C=N3)C4CC(C=C4)CO,apoplexy,CID000004691,"3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine",C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4
CID000001971,914348-29-1,C1CC1NC2=C3C(=NC(=N2)N)N(C=N3)C4CC(C=C4)CO,cholecystectomies,CID000004451,CHEMBL365442,CC1=C(C=CC=C1O)C(=O)NC(CSC2=CC=CC=C2)C(CN3CC4CCCCC4CC3C(=O)NC(C)(C)C)O
CID000001971,914348-29-1,C1CC1NC2=C3C(=NC(=N2)N)N(C=N3)C4CC(C=C4)CO,loss of weight,CID006398525,,C(C1C(C(C(C(O1)OC2(C(C(C(O2)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)COS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.[Al].[Al].[Al].[Al].[Al].[Al].[Al].[Al].[Al]
CID000001971,914348-29-1,C1CC1NC2=C3C(=NC(=N2)N)N(C=N3)C4CC(C=C4)CO,body temperature increased,CID000147912,DSSTox_GSID_49066,CCC(C(C)O)N1C(=O)N(C=N1)C2=CC=C(C=C2)N3CCN(CC3)C4=CC=C(C=C4)OCC5CC(OC5)(CN6C=NC=N6)C7=C(C=C(C=C7)F)F
CID000001971,914348-29-1,C1CC1NC2=C3C(=NC(=N2)N)N(C=N3)C4CC(C=C4)CO,Adenopathy,CID000074989,ATOVAQUONE,C1CC(CCC1C2=CC=C(C=C2)Cl)C3=C(C4=CC=CC=C4C(=O)C3=O)O
CID000001971,914348-29-1,C1CC1NC2=C3C(=NC(=N2)N)N(C=N3)C4CC(C=C4)CO,erythema,CID000002771,citalopram,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F
CID000001971,914348-29-1,C1CC1NC2=C3C(=NC(=N2)N)N(C=N3)C4CC(C=C4)CO,gastric inflammation,CID000003339,fenofibrate,CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C2=CC=C(C=C2)Cl
CID000001971,914348-29-1,C1CC1NC2=C3C(=NC(=N2)N)N(C=N3)C4CC(C=C4)CO,respiratory alkalosis,CID000001983,acetaminophen,CC(=O)NC1=CC=C(C=C1)O
CID000001971,914348-29-1,C1CC1NC2=C3C(=NC(=N2)N)N(C=N3)C4CC(C=C4)CO,drug toxicity NOS,CID000004894,"11,17,21-Trihydroxypregna-1,4-diene-3,20-dione",CC12CC(C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C)O
CID000001971,914348-29-1,C1CC1NC2=C3C(=NC(=N2)N)N(C=N3)C4CC(C=C4)CO,Clotting,CID000004510,nitroglycerin,C(C(CO[N+](=O)[O-])O[N+](=O)[O-])O[N+](=O)[O-]
CID000001971,914348-29-1,C1CC1NC2=C3C(=NC(=N2)N)N(C=N3)C4CC(C=C4)CO,abnormal ECG,CID000005732,zolpidem,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C
CID000001971,914348-29-1,C1CC1NC2=C3C(=NC(=N2)N)N(C=N3)C4CC(C=C4)CO,right heart failure,CID000003440,furosemide,C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl
CID000001971,914348-29-1,C1CC1NC2=C3C(=NC(=N2)N)N(C=N3)C4CC(C=C4)CO,cholelithiasis,CID003468412,SCHEMBL1176571,CC1C=CC=CCCC=CC=CC=CC=CC(CC(C(C(CC(=O)CC(C(CCC(CC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)C(=O)O)O)OC2C(C(C(C(O2)C)O)N)O
CID000001971,914348-29-1,C1CC1NC2=C3C(=NC(=N2)N)N(C=N3)C4CC(C=C4)CO,hepatitis,CID000003961,losartan,CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)CO)Cl
CID000001971,914348-29-1,C1CC1NC2=C3C(=NC(=N2)N)N(C=N3)C4CC(C=C4)CO,sarcoma,CID000003062,Lanicor,CC1C(C(CC(O1)OC2C(OC(CC2O)OC3C(OC(CC3O)OC4CCC5(C(C4)CCC6C5CC(C7(C6(CCC7C8=CC(=O)OC8)O)C)O)C)C)C)O)O
CID000001971,914348-29-1,C1CC1NC2=C3C(=NC(=N2)N)N(C=N3)C4CC(C=C4)CO,apoplexy,CID000004585,"2-methyl-4-(4-methylpiperazin-1-yl)-5H-thieno[3,2-c][1,5]benzodiazepine",CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C
CID000001971,914348-29-1,C1CC1NC2=C3C(=NC(=N2)N)N(C=N3)C4CC(C=C4)CO,apoplexy,CID000004205,mirtazapine,CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4
CID000001971,914348-29-1,C1CC1NC2=C3C(=NC(=N2)N)N(C=N3)C4CC(C=C4)CO,gastric inflammation,CID000060787,sequinavir,CC(C)(C)NC(=O)C1CC2CCCCC2CN1CC(C(CC3=CC=CC=C3)NC(=O)C(CC(=O)N)NC(=O)C4=NC5=CC=CC=C5C=C4)O
CID000005719,zaleplon,CCN(C1=CC=CC(=C1)C2=CC=NC3=C(C=NN23)C#N)C(=O)C,gastric inflammation,CID000005732,zolpidem,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C
CID000005719,zaleplon,CCN(C1=CC=CC(=C1)C2=CC=NC3=C(C=NN23)C#N)C(=O)C,rhinorrhea,CID000060865,(E)-Olopatadine,CN(C)CCC=C1C2=CC=CC=C2COC3=C1C=C(C=C3)CC(=O)O
CID000005719,zaleplon,CCN(C1=CC=CC(=C1)C2=CC=NC3=C(C=NN23)C#N)C(=O)C,cholecystitis,CID000060854,Ziprasidone,C1CN(CCN1CCC2=C(C=C3C(=C2)CC(=O)N3)Cl)C4=NSC5=CC=CC=C54
CID000005719,zaleplon,CCN(C1=CC=CC(=C1)C2=CC=NC3=C(C=NN23)C#N)C(=O)C,apoplexy,CID006398525,,C(C1C(C(C(C(O1)OC2(C(C(C(O2)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)COS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.[Al].[Al].[Al].[Al].[Al].[Al].[Al].[Al].[Al]
CID000005719,zaleplon,CCN(C1=CC=CC(=C1)C2=CC=NC3=C(C=NN23)C#N)C(=O)C,Adenopathy,CID000170361,Varenicline,C1C2CNCC1C3=CC4=NC=CN=C4C=C23
CID000005719,zaleplon,CCN(C1=CC=CC(=C1)C2=CC=NC3=C(C=NN23)C#N)C(=O)C,apoplexy,CID003468412,SCHEMBL1176571,CC1C=CC=CCCC=CC=CC=CC=CC(CC(C(C(CC(=O)CC(C(CCC(CC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)C(=O)O)O)OC2C(C(C(C(O2)C)O)N)O
CID000004189,miconazole,C1=CC(=C(C=C1Cl)Cl)COC(CN2C=CN=C2)C3=C(C=C(C=C3)Cl)Cl,loss of weight,CID000004894,"11,17,21-Trihydroxypregna-1,4-diene-3,20-dione",CC12CC(C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C)O
CID000004189,miconazole,C1=CC(=C(C=C1Cl)Cl)COC(CN2C=CN=C2)C3=C(C=C(C=C3)Cl)Cl,apoplexy,CID003468412,SCHEMBL1176571,CC1C=CC=CCCC=CC=CC=CC=CC(CC(C(C(CC(=O)CC(C(CCC(CC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)C(=O)O)O)OC2C(C(C(C(O2)C)O)N)O
CID000004189,miconazole,C1=CC(=C(C=C1Cl)Cl)COC(CN2C=CN=C2)C3=C(C=C(C=C3)Cl)Cl,thrombocytopenia,CID000019090,megestrol,CC1=CC2C(CCC3(C2CCC3(C(=O)C)O)C)C4(C1=CC(=O)CC4)C
CID000004189,miconazole,C1=CC(=C(C=C1Cl)Cl)COC(CN2C=CN=C2)C3=C(C=C(C=C3)Cl)Cl,eruption,CID000004510,nitroglycerin,C(C(CO[N+](=O)[O-])O[N+](=O)[O-])O[N+](=O)[O-]
CID000004189,miconazole,C1=CC(=C(C=C1Cl)Cl)COC(CN2C=CN=C2)C3=C(C=C(C=C3)Cl)Cl,High blood pressure,CID000004205,mirtazapine,CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4
CID000004189,miconazole,C1=CC(=C(C=C1Cl)Cl)COC(CN2C=CN=C2)C3=C(C=C(C=C3)Cl)Cl,eruption,CID000005732,zolpidem,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C
CID000004189,miconazole,C1=CC(=C(C=C1Cl)Cl)COC(CN2C=CN=C2)C3=C(C=C(C=C3)Cl)Cl,loss of weight,CID000004691,"3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine",C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4
CID000004189,miconazole,C1=CC(=C(C=C1Cl)Cl)COC(CN2C=CN=C2)C3=C(C=C(C=C3)Cl)Cl,loss of weight,CID000004585,"2-methyl-4-(4-methylpiperazin-1-yl)-5H-thieno[3,2-c][1,5]benzodiazepine",CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C
CID000060865,(E)-Olopatadine,CN(C)CCC=C1C2=CC=CC=C2COC3=C1C=C(C=C3)CC(=O)O,rhinorrhea,CID003468412,SCHEMBL1176571,CC1C=CC=CCCC=CC=CC=CC=CC(CC(C(C(CC(=O)CC(C(CCC(CC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)C(=O)O)O)OC2C(C(C(C(O2)C)O)N)O
CID000060865,(E)-Olopatadine,CN(C)CCC=C1C2=CC=CC=C2COC3=C1C=C(C=C3)CC(=O)O,dysarthria,CID006398525,,C(C1C(C(C(C(O1)OC2(C(C(C(O2)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)COS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.[Al].[Al].[Al].[Al].[Al].[Al].[Al].[Al].[Al]
CID000060865,(E)-Olopatadine,CN(C)CCC=C1C2=CC=CC=C2COC3=C1C=C(C=C3)CC(=O)O,weight gain,CID000170361,Varenicline,C1C2CNCC1C3=CC4=NC=CN=C4C=C23
CID000003440,furosemide,C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl,erythema,CID000003869,labetalol,CC(CCC1=CC=CC=C1)NCC(C2=CC(=C(C=C2)O)C(=O)N)O
CID000003440,furosemide,C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl,back injury,CID000004745,SCHEMBL7711911,CCCN1CC(CC2C1CC3=CNC4=CC=CC2=C34)CSC
CID000003440,furosemide,C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl,excessive thirst,CID000005487,tizanidine,C1CN=C(N1)NC2=C(C=CC3=NSN=C32)Cl
CID000003440,furosemide,C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl,drug toxicity NOS,CID003468412,SCHEMBL1176571,CC1C=CC=CCCC=CC=CC=CC=CC(CC(C(C(CC(=O)CC(C(CCC(CC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)C(=O)O)O)OC2C(C(C(C(O2)C)O)N)O
CID000003440,furosemide,C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl,myelodysplasia,CID000004748,perphenazine,C1CN(CCN1CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)Cl)CCO
CID000003440,furosemide,C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl,gastric inflammation,CID006398525,,C(C1C(C(C(C(O1)OC2(C(C(C(O2)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)COS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.[Al].[Al].[Al].[Al].[Al].[Al].[Al].[Al].[Al]
CID000003440,furosemide,C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl,Adenopathy,CID000004585,"2-methyl-4-(4-methylpiperazin-1-yl)-5H-thieno[3,2-c][1,5]benzodiazepine",CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C
CID000003440,furosemide,C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl,right heart failure,CID000005152,Salmeterol,C1=CC=C(C=C1)CCCCOCCCCCCNCC(C2=CC(=C(C=C2)O)CO)O
CID000003440,furosemide,C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl,metabolic encephalopathy,CID000005394,temozolomide,CN1C(=O)N2C=NC(=C2N=N1)C(=O)N
CID000003440,furosemide,C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl,loss of weight,CID000004201,minoxidil,C1CCN(CC1)C2=NC(=N)N(C(=C2)N)O
CID000003440,furosemide,C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl,cholecystitis,CID000004205,mirtazapine,CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4
CID000003440,furosemide,C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl,peritonitis,CID000074989,ATOVAQUONE,C1CC(CCC1C2=CC=C(C=C2)Cl)C3=C(C4=CC=CC=C4C(=O)C3=O)O
CID000003440,furosemide,C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl,Extrasystoles Ventricular,CID000060854,Ziprasidone,C1CN(CCN1CCC2=C(C=C3C(=C2)CC(=O)N3)Cl)C4=NSC5=CC=CC=C54
CID000003440,furosemide,C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl,folate deficiency,CID000004451,CHEMBL365442,CC1=C(C=CC=C1O)C(=O)NC(CSC2=CC=CC=C2)C(CN3CC4CCCCC4CC3C(=O)NC(C)(C)C)O
CID000003440,furosemide,C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl,weight gain,CID000005095,ropinirole,CCCN(CCC)CCC1=C2CC(=O)NC2=CC=C1
CID000003440,furosemide,C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl,gastric inflammation,CID000004691,"3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine",C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4
CID000003440,furosemide,C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl,myelodysplasia,CID000036811,dobutamine,CC(CCC1=CC=C(C=C1)O)NCCC2=CC(=C(C=C2)O)O
CID000003440,furosemide,C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl,gastric inflammation,CID000060787,sequinavir,CC(C)(C)NC(=O)C1CC2CCCCC2CN1CC(C(CC3=CC=CC=C3)NC(=O)C(CC(=O)N)NC(=O)C4=NC5=CC=CC=C5C=C4)O
CID000003440,furosemide,C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl,cellulitis,CID000005486,(R)-Tirofiban,CCCCS(=O)(=O)NC(CC1=CC=C(C=C1)OCCCCC2CCNCC2)C(=O)O
CID000003440,furosemide,C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl,haemorrhage rectum,CID000004510,nitroglycerin,C(C(CO[N+](=O)[O-])O[N+](=O)[O-])O[N+](=O)[O-]
CID000003440,furosemide,C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl,gastric inflammation,CID000060184,"2'-epi-Perindopril, (2'R)-",CCCC(C(=O)OCC)NC(C)C(=O)N1C2CCCCC2CC1C(=O)O
CID000003440,furosemide,C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl,right heart failure,CID000004170,metolazone,CC1NC2=CC(=C(C=C2C(=O)N1C3=CC=CC=C3C)S(=O)(=O)N)Cl
CID000003440,furosemide,C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl,fracture nonunion,CID000005732,zolpidem,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C
CID000003440,furosemide,C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl,gastric inflammation,CID000003961,losartan,CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)CO)Cl
CID000003440,furosemide,C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl,respiratory alkalosis,CID000005358,sumatriptan,CNS(=O)(=O)CC1=CC2=C(C=C1)NC=C2CCN(C)C
CID000003440,furosemide,C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl,gastric inflammation,CID000667490,6-Mercaptopurine,C1=NC2=C(N1)C(=S)N=CN2
CID000003440,furosemide,C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl,High blood pressure,CID000170361,Varenicline,C1C2CNCC1C3=CC4=NC=CN=C4C=C23
CID000003440,furosemide,C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl,gastric inflammation,CID000004614,oxaprozin,C1=CC=C(C=C1)C2=C(OC(=N2)CCC(=O)O)C3=CC=CC=C3
CID000003440,furosemide,C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl,apoplexy,CID005311082,"2-[(1R,4S,10S,13S,19S)-19-[4-(diaminomethylideneamino)butyl]-10-(1H-indol-3-ylmethyl)-3,9,12,15,18,21,27-heptaoxo-24,25-dithia-2,8,11,14,17,20-hexazatricyclo[18.6.1.04,8]heptacosan-13-yl]acetic acid",C1CC2C(=O)NC3CSSCCC(=O)N(C3=O)C(C(=O)NCC(=O)NC(C(=O)NC(C(=O)N2C1)CC4=CNC5=CC=CC=C54)CC(=O)O)CCCCN=C(N)N
CID000003440,furosemide,C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl,respiratory alkalosis,CID000019090,megestrol,CC1=CC2C(CCC3(C2CCC3(C(=O)C)O)C)C4(C1=CC(=O)CC4)C
CID000003440,furosemide,C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl,cardiovascular collapse,CID000004894,"11,17,21-Trihydroxypregna-1,4-diene-3,20-dione",CC12CC(C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C)O
CID000147912,DSSTox_GSID_49066,CCC(C(C)O)N1C(=O)N(C=N1)C2=CC=C(C=C2)N3CCN(CC3)C4=CC=C(C=C4)OCC5CC(OC5)(CN6C=NC=N6)C7=C(C=C(C=C7)F)F,thrombocytopenia,CID000667490,6-Mercaptopurine,C1=NC2=C(N1)C(=S)N=CN2
CID000003961,losartan,CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)CO)Cl,Adenopathy,CID000170361,Varenicline,C1C2CNCC1C3=CC4=NC=CN=C4C=C23
CID000003961,losartan,CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)CO)Cl,cholecystitis,CID000004614,oxaprozin,C1=CC=C(C=C1)C2=C(OC(=N2)CCC(=O)O)C3=CC=CC=C3
CID000003961,losartan,CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)CO)Cl,cholecystitis,CID000005487,tizanidine,C1CN=C(N1)NC2=C(C=CC3=NSN=C32)Cl
CID000003961,losartan,CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)CO)Cl,rotator cuff syndrome,CID000012536,638-94-8,CC1(OC2CC3C4CCC5=CC(=O)C=CC5(C4C(CC3(C2(O1)C(=O)CO)C)O)C)C
CID000003961,losartan,CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)CO)Cl,gastric inflammation,CID006398525,,C(C1C(C(C(C(O1)OC2(C(C(C(O2)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)COS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.[Al].[Al].[Al].[Al].[Al].[Al].[Al].[Al].[Al]
CID000003961,losartan,CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)CO)Cl,weight gain,CID000060854,Ziprasidone,C1CN(CCN1CCC2=C(C=C3C(=C2)CC(=O)N3)Cl)C4=NSC5=CC=CC=C54
CID000003961,losartan,CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)CO)Cl,deglutition disorder,CID000036811,dobutamine,CC(CCC1=CC=C(C=C1)O)NCCC2=CC(=C(C=C2)O)O
CID000003961,losartan,CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)CO)Cl,cholecystitis,CID000005732,zolpidem,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C
CID000003961,losartan,CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)CO)Cl,gastric inflammation,CID000005095,ropinirole,CCCN(CCC)CCC1=C2CC(=O)NC2=CC=C1
CID000003961,losartan,CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)CO)Cl,gastric inflammation,CID000005358,sumatriptan,CNS(=O)(=O)CC1=CC2=C(C=C1)NC=C2CCN(C)C
CID000003961,losartan,CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)CO)Cl,cholecystitis,CID000004585,"2-methyl-4-(4-methylpiperazin-1-yl)-5H-thieno[3,2-c][1,5]benzodiazepine",CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C
CID000003961,losartan,CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)CO)Cl,apoplexy,CID000060184,"2'-epi-Perindopril, (2'R)-",CCCC(C(=O)OCC)NC(C)C(=O)N1C2CCCCC2CC1C(=O)O
CID000003961,losartan,CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)CO)Cl,gastric inflammation,CID000004894,"11,17,21-Trihydroxypregna-1,4-diene-3,20-dione",CC12CC(C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C)O
CID000003961,losartan,CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)CO)Cl,Adenopathy,CID003468412,SCHEMBL1176571,CC1C=CC=CCCC=CC=CC=CC=CC(CC(C(C(CC(=O)CC(C(CCC(CC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)C(=O)O)O)OC2C(C(C(C(O2)C)O)N)O
CID000003961,losartan,CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)CO)Cl,Adenopathy,CID000004691,"3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine",C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4
CID000003961,losartan,CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)CO)Cl,Adenopathy,CID000005152,Salmeterol,C1=CC=C(C=C1)CCCCOCCCCCCNCC(C2=CC(=C(C=C2)O)CO)O
CID000003961,losartan,CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)CO)Cl,respiratory alkalosis,CID000019090,megestrol,CC1=CC2C(CCC3(C2CCC3(C(=O)C)O)C)C4(C1=CC(=O)CC4)C
CID000003961,losartan,CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)CO)Cl,polymyalgia rheumatica,CID000667490,6-Mercaptopurine,C1=NC2=C(N1)C(=S)N=CN2
CID000003961,losartan,CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)CO)Cl,Hepatitis C,CID000074989,ATOVAQUONE,C1CC(CCC1C2=CC=C(C=C2)Cl)C3=C(C4=CC=CC=C4C(=O)C3=O)O
CID000003961,losartan,CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)CO)Cl,gastric inflammation,CID000004205,mirtazapine,CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4
CID000003961,losartan,CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)CO)Cl,cholecystitis,CID000004201,minoxidil,C1CCN(CC1)C2=NC(=N)N(C(=C2)N)O
CID000003961,losartan,CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)CO)Cl,gastric inflammation,CID000004170,metolazone,CC1NC2=CC(=C(C=C2C(=O)N1C3=CC=CC=C3C)S(=O)(=O)N)Cl
CID000003961,losartan,CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)CO)Cl,cholecystitis,CID000004510,nitroglycerin,C(C(CO[N+](=O)[O-])O[N+](=O)[O-])O[N+](=O)[O-]
CID000003961,losartan,CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)CO)Cl,insulin dependent diabetes mellitus,CID000005394,temozolomide,CN1C(=O)N2C=NC(=C2N=N1)C(=O)N
CID000005095,ropinirole,CCCN(CCC)CCC1=C2CC(=O)NC2=CC=C1,angiitis,CID006398525,,C(C1C(C(C(C(O1)OC2(C(C(C(O2)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)COS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.[Al].[Al].[Al].[Al].[Al].[Al].[Al].[Al].[Al]
CID000005095,ropinirole,CCCN(CCC)CCC1=C2CC(=O)NC2=CC=C1,erythema,CID000005358,sumatriptan,CNS(=O)(=O)CC1=CC2=C(C=C1)NC=C2CCN(C)C
CID000005095,ropinirole,CCCN(CCC)CCC1=C2CC(=O)NC2=CC=C1,loss of weight,CID000170361,Varenicline,C1C2CNCC1C3=CC4=NC=CN=C4C=C23
CID000005095,ropinirole,CCCN(CCC)CCC1=C2CC(=O)NC2=CC=C1,abnormal ECG,CID000005487,tizanidine,C1CN=C(N1)NC2=C(C=CC3=NSN=C32)Cl
CID000005095,ropinirole,CCCN(CCC)CCC1=C2CC(=O)NC2=CC=C1,diarrhea,CID000012536,638-94-8,CC1(OC2CC3C4CCC5=CC(=O)C=CC5(C4C(CC3(C2(O1)C(=O)CO)C)O)C)C
CID000005095,ropinirole,CCCN(CCC)CCC1=C2CC(=O)NC2=CC=C1,aspiration pneumonia,CID000019090,megestrol,CC1=CC2C(CCC3(C2CCC3(C(=O)C)O)C)C4(C1=CC(=O)CC4)C
CID000005095,ropinirole,CCCN(CCC)CCC1=C2CC(=O)NC2=CC=C1,weight gain,CID003468412,SCHEMBL1176571,CC1C=CC=CCCC=CC=CC=CC=CC(CC(C(C(CC(=O)CC(C(CCC(CC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)C(=O)O)O)OC2C(C(C(C(O2)C)O)N)O
CID000005095,ropinirole,CCCN(CCC)CCC1=C2CC(=O)NC2=CC=C1,weight gain,CID000060854,Ziprasidone,C1CN(CCN1CCC2=C(C=C3C(=C2)CC(=O)N3)Cl)C4=NSC5=CC=CC=C54
CID000005095,ropinirole,CCCN(CCC)CCC1=C2CC(=O)NC2=CC=C1,loss of weight,CID000005152,Salmeterol,C1=CC=C(C=C1)CCCCOCCCCCCNCC(C2=CC(=C(C=C2)O)CO)O
CID000005095,ropinirole,CCCN(CCC)CCC1=C2CC(=O)NC2=CC=C1,agitated,CID000005732,zolpidem,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C
CID000005095,ropinirole,CCCN(CCC)CCC1=C2CC(=O)NC2=CC=C1,abnormal EEG,CID000060184,"2'-epi-Perindopril, (2'R)-",CCCC(C(=O)OCC)NC(C)C(=O)N1C2CCCCC2CC1C(=O)O
CID000667490,"3,7-dihydropurine-6-thione",C1=NC2=C(N1)C(=S)N=CN2,eruption,CID003468412,SCHEMBL1176571,CC1C=CC=CCCC=CC=CC=CC=CC(CC(C(C(CC(=O)CC(C(CCC(CC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)C(=O)O)O)OC2C(C(C(C(O2)C)O)N)O
CID000003062,Lanicor,CC1C(C(CC(O1)OC2C(OC(CC2O)OC3C(OC(CC3O)OC4CCC5(C(C4)CCC6C5CC(C7(C6(CCC7C8=CC(=O)OC8)O)C)O)C)C)C)O)O,gastric inflammation,CID003468412,SCHEMBL1176571,CC1C=CC=CCCC=CC=CC=CC=CC(CC(C(C(CC(=O)CC(C(CCC(CC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)C(=O)O)O)OC2C(C(C(C(O2)C)O)N)O
CID000003062,Lanicor,CC1C(C(CC(O1)OC2C(OC(CC2O)OC3C(OC(CC3O)OC4CCC5(C(C4)CCC6C5CC(C7(C6(CCC7C8=CC(=O)OC8)O)C)O)C)C)C)O)O,loss of weight,CID000003869,labetalol,CC(CCC1=CC=CC=C1)NCC(C2=CC(=C(C=C2)O)C(=O)N)O
CID000003062,Lanicor,CC1C(C(CC(O1)OC2C(OC(CC2O)OC3C(OC(CC3O)OC4CCC5(C(C4)CCC6C5CC(C7(C6(CCC7C8=CC(=O)OC8)O)C)O)C)C)C)O)O,eruption,CID000004913,PROCAINAMIDE,CCN(CC)CCNC(=O)C1=CC=C(C=C1)N
CID000003062,Lanicor,CC1C(C(CC(O1)OC2C(OC(CC2O)OC3C(OC(CC3O)OC4CCC5(C(C4)CCC6C5CC(C7(C6(CCC7C8=CC(=O)OC8)O)C)O)C)C)C)O)O,cholecystitis,CID006398525,,C(C1C(C(C(C(O1)OC2(C(C(C(O2)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)COS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.[Al].[Al].[Al].[Al].[Al].[Al].[Al].[Al].[Al]
CID000003062,Lanicor,CC1C(C(CC(O1)OC2C(OC(CC2O)OC3C(OC(CC3O)OC4CCC5(C(C4)CCC6C5CC(C7(C6(CCC7C8=CC(=O)OC8)O)C)O)C)C)C)O)O,myelodysplasia,CID000004170,metolazone,CC1NC2=CC(=C(C=C2C(=O)N1C3=CC=CC=C3C)S(=O)(=O)N)Cl
CID000003062,Lanicor,CC1C(C(CC(O1)OC2C(OC(CC2O)OC3C(OC(CC3O)OC4CCC5(C(C4)CCC6C5CC(C7(C6(CCC7C8=CC(=O)OC8)O)C)O)C)C)C)O)O,gastric inflammation,CID000003333,felodipine,CCOC(=O)C1=C(NC(=C(C1C2=C(C(=CC=C2)Cl)Cl)C(=O)OC)C)C
CID000003062,Lanicor,CC1C(C(CC(O1)OC2C(OC(CC2O)OC3C(OC(CC3O)OC4CCC5(C(C4)CCC6C5CC(C7(C6(CCC7C8=CC(=O)OC8)O)C)O)C)C)C)O)O,erythema,CID000003339,fenofibrate,CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C2=CC=C(C=C2)Cl
CID000003062,Lanicor,CC1C(C(CC(O1)OC2C(OC(CC2O)OC3C(OC(CC3O)OC4CCC5(C(C4)CCC6C5CC(C7(C6(CCC7C8=CC(=O)OC8)O)C)O)C)C)C)O)O,Drug hypersensitivity,CID000005358,sumatriptan,CNS(=O)(=O)CC1=CC2=C(C=C1)NC=C2CCN(C)C
CID000003062,Lanicor,CC1C(C(CC(O1)OC2C(OC(CC2O)OC3C(OC(CC3O)OC4CCC5(C(C4)CCC6C5CC(C7(C6(CCC7C8=CC(=O)OC8)O)C)O)C)C)C)O)O,Back Ache,CID000004614,oxaprozin,C1=CC=C(C=C1)C2=C(OC(=N2)CCC(=O)O)C3=CC=CC=C3
CID000003062,Lanicor,CC1C(C(CC(O1)OC2C(OC(CC2O)OC3C(OC(CC3O)OC4CCC5(C(C4)CCC6C5CC(C7(C6(CCC7C8=CC(=O)OC8)O)C)O)C)C)C)O)O,gastric inflammation,CID000004691,"3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine",C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4
CID000003062,Lanicor,CC1C(C(CC(O1)OC2C(OC(CC2O)OC3C(OC(CC3O)OC4CCC5(C(C4)CCC6C5CC(C7(C6(CCC7C8=CC(=O)OC8)O)C)O)C)C)C)O)O,cholecystectomies,CID000060184,"2'-epi-Perindopril, (2'R)-",CCCC(C(=O)OCC)NC(C)C(=O)N1C2CCCCC2CC1C(=O)O
CID000003062,Lanicor,CC1C(C(CC(O1)OC2C(OC(CC2O)OC3C(OC(CC3O)OC4CCC5(C(C4)CCC6C5CC(C7(C6(CCC7C8=CC(=O)OC8)O)C)O)C)C)C)O)O,cholecystitis,CID000004585,"2-methyl-4-(4-methylpiperazin-1-yl)-5H-thieno[3,2-c][1,5]benzodiazepine",CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C
CID000003062,Lanicor,CC1C(C(CC(O1)OC2C(OC(CC2O)OC3C(OC(CC3O)OC4CCC5(C(C4)CCC6C5CC(C7(C6(CCC7C8=CC(=O)OC8)O)C)O)C)C)C)O)O,acute pancreatitis,CID005311082,"2-[(1R,4S,10S,13S,19S)-19-[4-(diaminomethylideneamino)butyl]-10-(1H-indol-3-ylmethyl)-3,9,12,15,18,21,27-heptaoxo-24,25-dithia-2,8,11,14,17,20-hexazatricyclo[18.6.1.04,8]heptacosan-13-yl]acetic acid",C1CC2C(=O)NC3CSSCCC(=O)N(C3=O)C(C(=O)NCC(=O)NC(C(=O)NC(C(=O)N2C1)CC4=CNC5=CC=CC=C54)CC(=O)O)CCCCN=C(N)N
CID000003062,Lanicor,CC1C(C(CC(O1)OC2C(OC(CC2O)OC3C(OC(CC3O)OC4CCC5(C(C4)CCC6C5CC(C7(C6(CCC7C8=CC(=O)OC8)O)C)O)C)C)C)O)O,Cardiomyopathy,CID000003310,33419-42-0,CC1OCC2C(O1)C(C(C(O2)OC3C4COC(=O)C4C(C5=CC6=C(C=C35)OCO6)C7=CC(=C(C(=C7)OC)O)OC)O)O
CID000003062,Lanicor,CC1C(C(CC(O1)OC2C(OC(CC2O)OC3C(OC(CC3O)OC4CCC5(C(C4)CCC6C5CC(C7(C6(CCC7C8=CC(=O)OC8)O)C)O)C)C)C)O)O,loss of weight,CID000004748,perphenazine,C1CN(CCN1CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)Cl)CCO
CID000003062,Lanicor,CC1C(C(CC(O1)OC2C(OC(CC2O)OC3C(OC(CC3O)OC4CCC5(C(C4)CCC6C5CC(C7(C6(CCC7C8=CC(=O)OC8)O)C)O)C)C)C)O)O,loss of weight,CID000004745,SCHEMBL7711911,CCCN1CC(CC2C1CC3=CNC4=CC=CC2=C34)CSC
CID000003062,Lanicor,CC1C(C(CC(O1)OC2C(OC(CC2O)OC3C(OC(CC3O)OC4CCC5(C(C4)CCC6C5CC(C7(C6(CCC7C8=CC(=O)OC8)O)C)O)C)C)C)O)O,eruption,CID000036811,dobutamine,CC(CCC1=CC=C(C=C1)O)NCCC2=CC(=C(C=C2)O)O
CID000003062,Lanicor,CC1C(C(CC(O1)OC2C(OC(CC2O)OC3C(OC(CC3O)OC4CCC5(C(C4)CCC6C5CC(C7(C6(CCC7C8=CC(=O)OC8)O)C)O)C)C)C)O)O,adenomyosis,CID000005732,zolpidem,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C
CID000003062,Lanicor,CC1C(C(CC(O1)OC2C(OC(CC2O)OC3C(OC(CC3O)OC4CCC5(C(C4)CCC6C5CC(C7(C6(CCC7C8=CC(=O)OC8)O)C)O)C)C)C)O)O,metabolic encephalopathy,CID000005394,temozolomide,CN1C(=O)N2C=NC(=C2N=N1)C(=O)N
CID000003062,Lanicor,CC1C(C(CC(O1)OC2C(OC(CC2O)OC3C(OC(CC3O)OC4CCC5(C(C4)CCC6C5CC(C7(C6(CCC7C8=CC(=O)OC8)O)C)O)C)C)C)O)O,cholecystitis,CID000004510,nitroglycerin,C(C(CO[N+](=O)[O-])O[N+](=O)[O-])O[N+](=O)[O-]
CID000003062,Lanicor,CC1C(C(CC(O1)OC2C(OC(CC2O)OC3C(OC(CC3O)OC4CCC5(C(C4)CCC6C5CC(C7(C6(CCC7C8=CC(=O)OC8)O)C)O)C)C)C)O)O,Adenopathy,CID000005152,Salmeterol,C1=CC=C(C=C1)CCCCOCCCCCCNCC(C2=CC(=C(C=C2)O)CO)O
CID000003062,Lanicor,CC1C(C(CC(O1)OC2C(OC(CC2O)OC3C(OC(CC3O)OC4CCC5(C(C4)CCC6C5CC(C7(C6(CCC7C8=CC(=O)OC8)O)C)O)C)C)C)O)O,gastric inflammation,CID000004205,mirtazapine,CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4
CID000003062,Lanicor,CC1C(C(CC(O1)OC2C(OC(CC2O)OC3C(OC(CC3O)OC4CCC5(C(C4)CCC6C5CC(C7(C6(CCC7C8=CC(=O)OC8)O)C)O)C)C)C)O)O,loss of weight,CID000004201,minoxidil,C1CCN(CC1)C2=NC(=N)N(C(=C2)N)O
CID000003062,Lanicor,CC1C(C(CC(O1)OC2C(OC(CC2O)OC3C(OC(CC3O)OC4CCC5(C(C4)CCC6C5CC(C7(C6(CCC7C8=CC(=O)OC8)O)C)O)C)C)C)O)O,erythema,CID000003928,Lincomycine,CCCC1CC(N(C1)C)C(=O)NC(C2C(C(C(C(O2)SC)O)O)O)C(C)O
CID000003062,Lanicor,CC1C(C(CC(O1)OC2C(OC(CC2O)OC3C(OC(CC3O)OC4CCC5(C(C4)CCC6C5CC(C7(C6(CCC7C8=CC(=O)OC8)O)C)O)C)C)C)O)O,thrombocytopenia,CID000005486,(R)-Tirofiban,CCCCS(=O)(=O)NC(CC1=CC=C(C=C1)OCCCCC2CCNCC2)C(=O)O
CID000003062,Lanicor,CC1C(C(CC(O1)OC2C(OC(CC2O)OC3C(OC(CC3O)OC4CCC5(C(C4)CCC6C5CC(C7(C6(CCC7C8=CC(=O)OC8)O)C)O)C)C)C)O)O,cholecystitis,CID000005487,tizanidine,C1CN=C(N1)NC2=C(C=CC3=NSN=C32)Cl
CID000003062,Lanicor,CC1C(C(CC(O1)OC2C(OC(CC2O)OC3C(OC(CC3O)OC4CCC5(C(C4)CCC6C5CC(C7(C6(CCC7C8=CC(=O)OC8)O)C)O)C)C)C)O)O,Adenopathy,CID000019090,megestrol,CC1=CC2C(CCC3(C2CCC3(C(=O)C)O)C)C4(C1=CC(=O)CC4)C
CID000003062,Lanicor,CC1C(C(CC(O1)OC2C(OC(CC2O)OC3C(OC(CC3O)OC4CCC5(C(C4)CCC6C5CC(C7(C6(CCC7C8=CC(=O)OC8)O)C)O)C)C)C)O)O,angiitis,CID000170361,Varenicline,C1C2CNCC1C3=CC4=NC=CN=C4C=C23
CID000003062,Lanicor,CC1C(C(CC(O1)OC2C(OC(CC2O)OC3C(OC(CC3O)OC4CCC5(C(C4)CCC6C5CC(C7(C6(CCC7C8=CC(=O)OC8)O)C)O)C)C)C)O)O,apoplexy,CID000060854,Ziprasidone,C1CN(CCN1CCC2=C(C=C3C(=C2)CC(=O)N3)Cl)C4=NSC5=CC=CC=C54
CID000003062,Lanicor,CC1C(C(CC(O1)OC2C(OC(CC2O)OC3C(OC(CC3O)OC4CCC5(C(C4)CCC6C5CC(C7(C6(CCC7C8=CC(=O)OC8)O)C)O)C)C)C)O)O,sarcoidosis,CID000004894,"11,17,21-Trihydroxypregna-1,4-diene-3,20-dione",CC12CC(C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C)O
CID000002405,BISOPROLOL,CC(C)NCC(COC1=CC=C(C=C1)COCCOC(C)C)O,elevated erythrocyte sedimentation rate,CID000003333,felodipine,CCOC(=O)C1=C(NC(=C(C1C2=C(C(=CC=C2)Cl)Cl)C(=O)OC)C)C
CID000002405,BISOPROLOL,CC(C)NCC(COC1=CC=C(C=C1)COCCOC(C)C)O,loss of weight,CID000003339,fenofibrate,CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C2=CC=C(C=C2)Cl
CID000002405,BISOPROLOL,CC(C)NCC(COC1=CC=C(C=C1)COCCOC(C)C)O,angiitis,CID000004894,"11,17,21-Trihydroxypregna-1,4-diene-3,20-dione",CC12CC(C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C)O
CID000002405,BISOPROLOL,CC(C)NCC(COC1=CC=C(C=C1)COCCOC(C)C)O,erythema,CID000004691,"3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine",C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4
CID000002405,BISOPROLOL,CC(C)NCC(COC1=CC=C(C=C1)COCCOC(C)C)O,cholecystitis,CID000060184,"2'-epi-Perindopril, (2'R)-",CCCC(C(=O)OCC)NC(C)C(=O)N1C2CCCCC2CC1C(=O)O
CID000002405,BISOPROLOL,CC(C)NCC(COC1=CC=C(C=C1)COCCOC(C)C)O,myelodysplasia,CID000005732,zolpidem,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C
CID000002405,BISOPROLOL,CC(C)NCC(COC1=CC=C(C=C1)COCCOC(C)C)O,angiitis,CID000004205,mirtazapine,CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4
CID000002405,BISOPROLOL,CC(C)NCC(COC1=CC=C(C=C1)COCCOC(C)C)O,angiitis,CID000002771,citalopram,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F
CID000002405,BISOPROLOL,CC(C)NCC(COC1=CC=C(C=C1)COCCOC(C)C)O,apoplexy,CID000002524,32222-06-3,CC(CCCC(C)(C)O)C1CCC2C1(CCCC2=CC=C3CC(CC(C3=C)O)O)C
CID000002405,BISOPROLOL,CC(C)NCC(COC1=CC=C(C=C1)COCCOC(C)C)O,loss of weight,CID000005394,temozolomide,CN1C(=O)N2C=NC(=C2N=N1)C(=O)N
CID000002405,BISOPROLOL,CC(C)NCC(COC1=CC=C(C=C1)COCCOC(C)C)O,autonomic instability,CID000004510,nitroglycerin,C(C(CO[N+](=O)[O-])O[N+](=O)[O-])O[N+](=O)[O-]
CID000002405,BISOPROLOL,CC(C)NCC(COC1=CC=C(C=C1)COCCOC(C)C)O,dysarthria,CID000004585,"2-methyl-4-(4-methylpiperazin-1-yl)-5H-thieno[3,2-c][1,5]benzodiazepine",CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C
CID000003869,labetalol,CC(CCC1=CC=CC=C1)NCC(C2=CC(=C(C=C2)O)C(=O)N)O,erythema,CID000005732,zolpidem,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C
CID000003869,labetalol,CC(CCC1=CC=CC=C1)NCC(C2=CC(=C(C=C2)O)C(=O)N)O,Back Ache,CID000004691,"3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine",C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4
CID000003869,labetalol,CC(CCC1=CC=CC=C1)NCC(C2=CC(=C(C=C2)O)C(=O)N)O,loss of weight,CID000004894,"11,17,21-Trihydroxypregna-1,4-diene-3,20-dione",CC12CC(C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C)O
CID000003869,labetalol,CC(CCC1=CC=CC=C1)NCC(C2=CC(=C(C=C2)O)C(=O)N)O,erythema,CID003468412,SCHEMBL1176571,CC1C=CC=CCCC=CC=CC=CC=CC(CC(C(C(CC(=O)CC(C(CCC(CC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)C(=O)O)O)OC2C(C(C(C(O2)C)O)N)O
CID000003869,labetalol,CC(CCC1=CC=CC=C1)NCC(C2=CC(=C(C=C2)O)C(=O)N)O,edema,CID000004510,nitroglycerin,C(C(CO[N+](=O)[O-])O[N+](=O)[O-])O[N+](=O)[O-]
CID000003869,labetalol,CC(CCC1=CC=CC=C1)NCC(C2=CC(=C(C=C2)O)C(=O)N)O,erythema,CID000004201,minoxidil,C1CCN(CC1)C2=NC(=N)N(C(=C2)N)O
CID000003869,labetalol,CC(CCC1=CC=CC=C1)NCC(C2=CC(=C(C=C2)O)C(=O)N)O,neumonia,CID000004205,mirtazapine,CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4
CID000003869,labetalol,CC(CCC1=CC=CC=C1)NCC(C2=CC(=C(C=C2)O)C(=O)N)O,neonatal respiratory distress syndrome,CID000004585,"2-methyl-4-(4-methylpiperazin-1-yl)-5H-thieno[3,2-c][1,5]benzodiazepine",CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C
CID000003869,labetalol,CC(CCC1=CC=CC=C1)NCC(C2=CC(=C(C=C2)O)C(=O)N)O,Back Ache,CID005311082,"2-[(1R,4S,10S,13S,19S)-19-[4-(diaminomethylideneamino)butyl]-10-(1H-indol-3-ylmethyl)-3,9,12,15,18,21,27-heptaoxo-24,25-dithia-2,8,11,14,17,20-hexazatricyclo[18.6.1.04,8]heptacosan-13-yl]acetic acid",C1CC2C(=O)NC3CSSCCC(=O)N(C3=O)C(C(=O)NCC(=O)NC(C(=O)NC(C(=O)N2C1)CC4=CNC5=CC=CC=C54)CC(=O)O)CCCCN=C(N)N
CID000004211,mitotane,C1=CC=C(C(=C1)C(C2=CC=C(C=C2)Cl)C(Cl)Cl)Cl,thrombocytopenia,CID000005732,zolpidem,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C
CID000005358,sumatriptan,CNS(=O)(=O)CC1=CC2=C(C=C1)NC=C2CCN(C)C,cholecystitis,CID000060854,Ziprasidone,C1CN(CCN1CCC2=C(C=C3C(=C2)CC(=O)N3)Cl)C4=NSC5=CC=CC=C54
CID000005358,sumatriptan,CNS(=O)(=O)CC1=CC2=C(C=C1)NC=C2CCN(C)C,Ovarian cancer,CID000019090,megestrol,CC1=CC2C(CCC3(C2CCC3(C(=O)C)O)C)C4(C1=CC(=O)CC4)C
CID000005358,sumatriptan,CNS(=O)(=O)CC1=CC2=C(C=C1)NC=C2CCN(C)C,Cardiomyopathy,CID000077992,Frovatriptan,CNC1CCC2=C(C1)C3=C(N2)C=CC(=C3)C(=O)N
CID000005358,sumatriptan,CNS(=O)(=O)CC1=CC2=C(C=C1)NC=C2CCN(C)C,gastric inflammation,CID000005487,tizanidine,C1CN=C(N1)NC2=C(C=CC3=NSN=C32)Cl
CID000005358,sumatriptan,CNS(=O)(=O)CC1=CC2=C(C=C1)NC=C2CCN(C)C,nausea,CID003468412,SCHEMBL1176571,CC1C=CC=CCCC=CC=CC=CC=CC(CC(C(C(CC(=O)CC(C(CCC(CC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)C(=O)O)O)OC2C(C(C(C(O2)C)O)N)O
CID000005358,sumatriptan,CNS(=O)(=O)CC1=CC2=C(C=C1)NC=C2CCN(C)C,gastric inflammation,CID006398525,,C(C1C(C(C(C(O1)OC2(C(C(C(O2)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)COS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.[Al].[Al].[Al].[Al].[Al].[Al].[Al].[Al].[Al]
CID000005358,sumatriptan,CNS(=O)(=O)CC1=CC2=C(C=C1)NC=C2CCN(C)C,Acne,CID000170361,Varenicline,C1C2CNCC1C3=CC4=NC=CN=C4C=C23
CID000005358,sumatriptan,CNS(=O)(=O)CC1=CC2=C(C=C1)NC=C2CCN(C)C,cholecystitis,CID000005732,zolpidem,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C
CID000002771,citalopram,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F,Adenopathy,CID000003310,33419-42-0,CC1OCC2C(O1)C(C(C(O2)OC3C4COC(=O)C4C(C5=CC6=C(C=C35)OCO6)C7=CC(=C(C(=C7)OC)O)OC)O)O
CID000002771,citalopram,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F,stridor,CID000004536,Minovlar,CC12CCC3C(C1CCC2(C#C)O)CCC4=CC(=O)CCC34
CID000002771,citalopram,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F,dysarthria,CID000004748,perphenazine,C1CN(CCN1CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)Cl)CCO
CID000002771,citalopram,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F,cholelithiasis,CID000004745,SCHEMBL7711911,CCCN1CC(CC2C1CC3=CNC4=CC=CC2=C34)CSC
CID000002771,citalopram,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F,cholecystitis,CID000005152,Salmeterol,C1=CC=C(C=C1)CCCCOCCCCCCNCC(C2=CC(=C(C=C2)O)CO)O
CID000002771,citalopram,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F,Decreased Libido,CID000060787,sequinavir,CC(C)(C)NC(=O)C1CC2CCCCC2CN1CC(C(CC3=CC=CC=C3)NC(=O)C(CC(=O)N)NC(=O)C4=NC5=CC=CC=C5C=C4)O
CID000002771,citalopram,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F,myelodysplasia,CID000005394,temozolomide,CN1C(=O)N2C=NC(=C2N=N1)C(=O)N
CID000002771,citalopram,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F,cholecystitis,CID000004510,nitroglycerin,C(C(CO[N+](=O)[O-])O[N+](=O)[O-])O[N+](=O)[O-]
CID000002771,citalopram,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F,gastric inflammation,CID000170361,Varenicline,C1C2CNCC1C3=CC4=NC=CN=C4C=C23
CID000002771,citalopram,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F,drug withdrawal,CID000004205,mirtazapine,CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4
CID000002771,citalopram,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F,insulin dependent diabetes mellitus,CID000004201,minoxidil,C1CCN(CC1)C2=NC(=N)N(C(=C2)N)O
CID000002771,citalopram,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F,galactorrhea,CID000115237,Paliperidone,CC1=C(C(=O)N2CCCC(C2=N1)O)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F
CID000002771,citalopram,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F,adenomyosis,CID000005487,tizanidine,C1CN=C(N1)NC2=C(C=CC3=NSN=C32)Cl
CID000002771,citalopram,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F,Adenopathy,CID000005732,zolpidem,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C
CID000002771,citalopram,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F,Adenopathy,CID000019090,megestrol,CC1=CC2C(CCC3(C2CCC3(C(=O)C)O)C)C4(C1=CC(=O)CC4)C
CID000002771,citalopram,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F,ear ache,CID000077992,Frovatriptan,CNC1CCC2=C(C1)C3=C(N2)C=CC(=C3)C(=O)N
CID000002771,citalopram,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F,cholecystitis,CID000060854,Ziprasidone,C1CN(CCN1CCC2=C(C=C3C(=C2)CC(=O)N3)Cl)C4=NSC5=CC=CC=C54
CID000002771,citalopram,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F,loss of weight,CID000002949,MLS003115428,CC12CCC3C(C1CCC2(C#C)O)CCC4=CC5=C(CC34C)C=NO5
CID000002771,citalopram,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F,cholecystitis,CID000003042,dicyclomine,CCN(CC)CCOC(=O)C1(CCCCC1)C2CCCCC2
CID000002771,citalopram,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F,cholecystitis,CID003468412,SCHEMBL1176571,CC1C=CC=CCCC=CC=CC=CC=CC(CC(C(C(CC(=O)CC(C(CCC(CC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)C(=O)O)O)OC2C(C(C(C(O2)C)O)N)O
CID000002771,citalopram,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F,gastric inflammation,CID000004894,"11,17,21-Trihydroxypregna-1,4-diene-3,20-dione",CC12CC(C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C)O
CID000002771,citalopram,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F,gastric inflammation,CID006398525,,C(C1C(C(C(C(O1)OC2(C(C(C(O2)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)COS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.[Al].[Al].[Al].[Al].[Al].[Al].[Al].[Al].[Al]
CID000002771,citalopram,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F,erythema,CID000074989,ATOVAQUONE,C1CC(CCC1C2=CC=C(C=C2)Cl)C3=C(C4=CC=CC=C4C(=O)C3=O)O
CID000002771,citalopram,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F,cholecystitis,CID000004170,metolazone,CC1NC2=CC(=C(C=C2C(=O)N1C3=CC=CC=C3C)S(=O)(=O)N)Cl
CID000002771,citalopram,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F,gastric inflammation,CID000003333,felodipine,CCOC(=O)C1=C(NC(=C(C1C2=C(C(=CC=C2)Cl)Cl)C(=O)OC)C)C
CID000002771,citalopram,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F,cholecystitis,CID000003339,fenofibrate,CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C2=CC=C(C=C2)Cl
CID000002771,citalopram,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F,drug toxicity NOS,CID000004451,CHEMBL365442,CC1=C(C=CC=C1O)C(=O)NC(CSC2=CC=CC=C2)C(CN3CC4CCCCC4CC3C(=O)NC(C)(C)C)O
CID000002771,citalopram,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F,apoplexy,CID000012536,638-94-8,CC1(OC2CC3C4CCC5=CC(=O)C=CC5(C4C(CC3(C2(O1)C(=O)CO)C)O)C)C
CID000002771,citalopram,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F,apoplexy,CID000004614,oxaprozin,C1=CC=C(C=C1)C2=C(OC(=N2)CCC(=O)O)C3=CC=CC=C3
CID000002771,citalopram,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F,gastric inflammation,CID000004691,"3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine",C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4
CID000002771,citalopram,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F,gastric inflammation,CID000060184,"2'-epi-Perindopril, (2'R)-",CCCC(C(=O)OCC)NC(C)C(=O)N1C2CCCCC2CC1C(=O)O
CID000002771,citalopram,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F,gastric inflammation,CID000004585,"2-methyl-4-(4-methylpiperazin-1-yl)-5H-thieno[3,2-c][1,5]benzodiazepine",CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C
CID000002524,32222-06-3,CC(CCCC(C)(C)O)C1CCC2C1(CCCC2=CC=C3CC(CC(C3=C)O)O)C,loss of weight,CID006398525,,C(C1C(C(C(C(O1)OC2(C(C(C(O2)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)COS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.[Al].[Al].[Al].[Al].[Al].[Al].[Al].[Al].[Al]
CID000002524,32222-06-3,CC(CCCC(C)(C)O)C1CCC2C1(CCCC2=CC=C3CC(CC(C3=C)O)O)C,thrombocytopenia,CID000005394,temozolomide,CN1C(=O)N2C=NC(=C2N=N1)C(=O)N
CID000002524,32222-06-3,CC(CCCC(C)(C)O)C1CCC2C1(CCCC2=CC=C3CC(CC(C3=C)O)O)C,emesis,CID000060184,"2'-epi-Perindopril, (2'R)-",CCCC(C(=O)OCC)NC(C)C(=O)N1C2CCCCC2CC1C(=O)O
CID000002524,32222-06-3,CC(CCCC(C)(C)O)C1CCC2C1(CCCC2=CC=C3CC(CC(C3=C)O)O)C,pneumonia staphylococcal,CID000005487,tizanidine,C1CN=C(N1)NC2=C(C=CC3=NSN=C32)Cl
CID000002524,32222-06-3,CC(CCCC(C)(C)O)C1CCC2C1(CCCC2=CC=C3CC(CC(C3=C)O)O)C,drug toxicity NOS,CID000004510,nitroglycerin,C(C(CO[N+](=O)[O-])O[N+](=O)[O-])O[N+](=O)[O-]
CID000002524,32222-06-3,CC(CCCC(C)(C)O)C1CCC2C1(CCCC2=CC=C3CC(CC(C3=C)O)O)C,increased white blood cell count,CID000019090,megestrol,CC1=CC2C(CCC3(C2CCC3(C(=O)C)O)C)C4(C1=CC(=O)CC4)C
CID000002524,32222-06-3,CC(CCCC(C)(C)O)C1CCC2C1(CCCC2=CC=C3CC(CC(C3=C)O)O)C,drug toxicity NOS,CID000005152,Salmeterol,C1=CC=C(C=C1)CCCCOCCCCCCNCC(C2=CC(=C(C=C2)O)CO)O
CID000002524,32222-06-3,CC(CCCC(C)(C)O)C1CCC2C1(CCCC2=CC=C3CC(CC(C3=C)O)O)C,increased white blood cell count,CID000004205,mirtazapine,CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4
CID000002524,32222-06-3,CC(CCCC(C)(C)O)C1CCC2C1(CCCC2=CC=C3CC(CC(C3=C)O)O)C,gastric inflammation,CID000004201,minoxidil,C1CCN(CC1)C2=NC(=N)N(C(=C2)N)O
CID000002524,32222-06-3,CC(CCCC(C)(C)O)C1CCC2C1(CCCC2=CC=C3CC(CC(C3=C)O)O)C,cholecystitis,CID000005732,zolpidem,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C
CID000002524,32222-06-3,CC(CCCC(C)(C)O)C1CCC2C1(CCCC2=CC=C3CC(CC(C3=C)O)O)C,cholecystitis,CID000004894,"11,17,21-Trihydroxypregna-1,4-diene-3,20-dione",CC12CC(C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C)O
CID000002524,32222-06-3,CC(CCCC(C)(C)O)C1CCC2C1(CCCC2=CC=C3CC(CC(C3=C)O)O)C,allergic dermatitis,CID000004170,metolazone,CC1NC2=CC(=C(C=C2C(=O)N1C3=CC=CC=C3C)S(=O)(=O)N)Cl
CID000002524,32222-06-3,CC(CCCC(C)(C)O)C1CCC2C1(CCCC2=CC=C3CC(CC(C3=C)O)O)C,apoplexy,CID000003339,fenofibrate,CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C2=CC=C(C=C2)Cl
CID000002524,32222-06-3,CC(CCCC(C)(C)O)C1CCC2C1(CCCC2=CC=C3CC(CC(C3=C)O)O)C,insulin dependent diabetes mellitus,CID000003333,felodipine,CCOC(=O)C1=C(NC(=C(C1C2=C(C(=CC=C2)Cl)Cl)C(=O)OC)C)C
CID000002524,32222-06-3,CC(CCCC(C)(C)O)C1CCC2C1(CCCC2=CC=C3CC(CC(C3=C)O)O)C,abdominal pain upper,CID000004691,"3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine",C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4
CID000002524,32222-06-3,CC(CCCC(C)(C)O)C1CCC2C1(CCCC2=CC=C3CC(CC(C3=C)O)O)C,gastric inflammation,CID000004585,"2-methyl-4-(4-methylpiperazin-1-yl)-5H-thieno[3,2-c][1,5]benzodiazepine",CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C
CID000002524,32222-06-3,CC(CCCC(C)(C)O)C1CCC2C1(CCCC2=CC=C3CC(CC(C3=C)O)O)C,increased white blood cell count,CID003468412,SCHEMBL1176571,CC1C=CC=CCCC=CC=CC=CC=CC(CC(C(C(CC(=O)CC(C(CCC(CC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)C(=O)O)O)OC2C(C(C(C(O2)C)O)N)O
CID000002524,32222-06-3,CC(CCCC(C)(C)O)C1CCC2C1(CCCC2=CC=C3CC(CC(C3=C)O)O)C,Dyspnea exertional,CID000003310,33419-42-0,CC1OCC2C(O1)C(C(C(O2)OC3C4COC(=O)C4C(C5=CC6=C(C=C35)OCO6)C7=CC(=C(C(=C7)OC)O)OC)O)O
CID000002524,32222-06-3,CC(CCCC(C)(C)O)C1CCC2C1(CCCC2=CC=C3CC(CC(C3=C)O)O)C,allergic dermatitis,CID000002609,Lilly 99638,C1C(=C(N2C(S1)C(C2=O)NC(=O)C(C3=CC=CC=C3)N)C(=O)O)Cl
CID000004510,nitroglycerin,C(C(CO[N+](=O)[O-])O[N+](=O)[O-])O[N+](=O)[O-],edema,CID000004585,"2-methyl-4-(4-methylpiperazin-1-yl)-5H-thieno[3,2-c][1,5]benzodiazepine",CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C
CID000004510,nitroglycerin,C(C(CO[N+](=O)[O-])O[N+](=O)[O-])O[N+](=O)[O-],Back Ache,CID000019090,megestrol,CC1=CC2C(CCC3(C2CCC3(C(=O)C)O)C)C4(C1=CC(=O)CC4)C
CID000004510,nitroglycerin,C(C(CO[N+](=O)[O-])O[N+](=O)[O-])O[N+](=O)[O-],thrombocytopenia,CID000005486,(R)-Tirofiban,CCCCS(=O)(=O)NC(CC1=CC=C(C=C1)OCCCCC2CCNCC2)C(=O)O
CID000004510,nitroglycerin,C(C(CO[N+](=O)[O-])O[N+](=O)[O-])O[N+](=O)[O-],thrombocytopenia,CID000036811,dobutamine,CC(CCC1=CC=C(C=C1)O)NCCC2=CC(=C(C=C2)O)O
CID000004510,nitroglycerin,C(C(CO[N+](=O)[O-])O[N+](=O)[O-])O[N+](=O)[O-],cholecystitis,CID006398525,,C(C1C(C(C(C(O1)OC2(C(C(C(O2)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)COS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.[Al].[Al].[Al].[Al].[Al].[Al].[Al].[Al].[Al]
CID000004510,nitroglycerin,C(C(CO[N+](=O)[O-])O[N+](=O)[O-])O[N+](=O)[O-],peritonitis,CID000060854,Ziprasidone,C1CN(CCN1CCC2=C(C=C3C(=C2)CC(=O)N3)Cl)C4=NSC5=CC=CC=C54
CID000004510,nitroglycerin,C(C(CO[N+](=O)[O-])O[N+](=O)[O-])O[N+](=O)[O-],Atherosclerosis,CID000012536,638-94-8,CC1(OC2CC3C4CCC5=CC(=O)C=CC5(C4C(CC3(C2(O1)C(=O)CO)C)O)C)C
CID000004510,nitroglycerin,C(C(CO[N+](=O)[O-])O[N+](=O)[O-])O[N+](=O)[O-],cholecystitis,CID000005152,Salmeterol,C1=CC=C(C=C1)CCCCOCCCCCCNCC(C2=CC(=C(C=C2)O)CO)O
CID000004510,nitroglycerin,C(C(CO[N+](=O)[O-])O[N+](=O)[O-])O[N+](=O)[O-],edema,CID000005394,temozolomide,CN1C(=O)N2C=NC(=C2N=N1)C(=O)N
CID000004510,nitroglycerin,C(C(CO[N+](=O)[O-])O[N+](=O)[O-])O[N+](=O)[O-],subarachnoid haemorrhage,CID005311082,"2-[(1R,4S,10S,13S,19S)-19-[4-(diaminomethylideneamino)butyl]-10-(1H-indol-3-ylmethyl)-3,9,12,15,18,21,27-heptaoxo-24,25-dithia-2,8,11,14,17,20-hexazatricyclo[18.6.1.04,8]heptacosan-13-yl]acetic acid",C1CC2C(=O)NC3CSSCCC(=O)N(C3=O)C(C(=O)NCC(=O)NC(C(=O)NC(C(=O)N2C1)CC4=CNC5=CC=CC=C54)CC(=O)O)CCCCN=C(N)N
CID000004510,nitroglycerin,C(C(CO[N+](=O)[O-])O[N+](=O)[O-])O[N+](=O)[O-],Back Ache,CID000170361,Varenicline,C1C2CNCC1C3=CC4=NC=CN=C4C=C23
CID000004510,nitroglycerin,C(C(CO[N+](=O)[O-])O[N+](=O)[O-])O[N+](=O)[O-],cholecystitis,CID000005732,zolpidem,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C
CID000004510,nitroglycerin,C(C(CO[N+](=O)[O-])O[N+](=O)[O-])O[N+](=O)[O-],right heart failure,CID000004894,"11,17,21-Trihydroxypregna-1,4-diene-3,20-dione",CC12CC(C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C)O
CID000004510,nitroglycerin,C(C(CO[N+](=O)[O-])O[N+](=O)[O-])O[N+](=O)[O-],abnormal EEG,CID000004536,Minovlar,CC12CCC3C(C1CCC2(C#C)O)CCC4=CC(=O)CCC34
CID000004510,nitroglycerin,C(C(CO[N+](=O)[O-])O[N+](=O)[O-])O[N+](=O)[O-],right heart failure,CID003468412,SCHEMBL1176571,CC1C=CC=CCCC=CC=CC=CC=CC(CC(C(C(CC(=O)CC(C(CCC(CC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)C(=O)O)O)OC2C(C(C(C(O2)C)O)N)O
CID000004510,nitroglycerin,C(C(CO[N+](=O)[O-])O[N+](=O)[O-])O[N+](=O)[O-],gastric inflammation,CID000004691,"3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine",C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4
CID000004510,nitroglycerin,C(C(CO[N+](=O)[O-])O[N+](=O)[O-])O[N+](=O)[O-],gastric inflammation,CID000005487,tizanidine,C1CN=C(N1)NC2=C(C=CC3=NSN=C32)Cl
CID000004510,nitroglycerin,C(C(CO[N+](=O)[O-])O[N+](=O)[O-])O[N+](=O)[O-],loss of weight,CID000004614,oxaprozin,C1=CC=C(C=C1)C2=C(OC(=N2)CCC(=O)O)C3=CC=CC=C3
CID000004510,nitroglycerin,C(C(CO[N+](=O)[O-])O[N+](=O)[O-])O[N+](=O)[O-],gastric inflammation,CID000060184,"2'-epi-Perindopril, (2'R)-",CCCC(C(=O)OCC)NC(C)C(=O)N1C2CCCCC2CC1C(=O)O
CID000004536,Minovlar,CC12CCC3C(C1CCC2(C#C)O)CCC4=CC(=O)CCC34,abnormal EEG,CID000170361,Varenicline,C1C2CNCC1C3=CC4=NC=CN=C4C=C23
CID000004536,Minovlar,CC12CCC3C(C1CCC2(C#C)O)CCC4=CC(=O)CCC34,heart rate increased,CID006398525,,C(C1C(C(C(C(O1)OC2(C(C(C(O2)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)COS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.[Al].[Al].[Al].[Al].[Al].[Al].[Al].[Al].[Al]
CID000004536,Minovlar,CC12CCC3C(C1CCC2(C#C)O)CCC4=CC(=O)CCC34,stridor,CID000005732,zolpidem,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C
CID000004536,Minovlar,CC12CCC3C(C1CCC2(C#C)O)CCC4=CC(=O)CCC34,weight gain,CID000004691,"3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine",C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4
CID000004536,Minovlar,CC12CCC3C(C1CCC2(C#C)O)CCC4=CC(=O)CCC34,abnormal EEG,CID000004585,"2-methyl-4-(4-methylpiperazin-1-yl)-5H-thieno[3,2-c][1,5]benzodiazepine",CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C
CID000004536,Minovlar,CC12CCC3C(C1CCC2(C#C)O)CCC4=CC(=O)CCC34,Enuresis,CID003468412,SCHEMBL1176571,CC1C=CC=CCCC=CC=CC=CC=CC(CC(C(C(CC(=O)CC(C(CCC(CC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)C(=O)O)O)OC2C(C(C(C(O2)C)O)N)O
CID000005152,Salmeterol,C1=CC=C(C=C1)CCCCOCCCCCCNCC(C2=CC(=C(C=C2)O)CO)O,Adenopathy,CID003468412,SCHEMBL1176571,CC1C=CC=CCCC=CC=CC=CC=CC(CC(C(C(CC(=O)CC(C(CCC(CC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)C(=O)O)O)OC2C(C(C(C(O2)C)O)N)O
CID000005152,Salmeterol,C1=CC=C(C=C1)CCCCOCCCCCCNCC(C2=CC(=C(C=C2)O)CO)O,cholecystitis,CID000005732,zolpidem,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C
CID000005152,Salmeterol,C1=CC=C(C=C1)CCCCOCCCCCCNCC(C2=CC(=C(C=C2)O)CO)O,loss of weight,CID000005487,tizanidine,C1CN=C(N1)NC2=C(C=CC3=NSN=C32)Cl
CID000005152,Salmeterol,C1=CC=C(C=C1)CCCCOCCCCCCNCC(C2=CC(=C(C=C2)O)CO)O,constipated,CID000019090,megestrol,CC1=CC2C(CCC3(C2CCC3(C(=O)C)O)C)C4(C1=CC(=O)CC4)C
CID000005152,Salmeterol,C1=CC=C(C=C1)CCCCOCCCCCCNCC(C2=CC(=C(C=C2)O)CO)O,loss of weight,CID000005394,temozolomide,CN1C(=O)N2C=NC(=C2N=N1)C(=O)N
CID000005152,Salmeterol,C1=CC=C(C=C1)CCCCOCCCCCCNCC(C2=CC(=C(C=C2)O)CO)O,thrombocytopenia,CID000060184,"2'-epi-Perindopril, (2'R)-",CCCC(C(=O)OCC)NC(C)C(=O)N1C2CCCCC2CC1C(=O)O
CID000005152,Salmeterol,C1=CC=C(C=C1)CCCCOCCCCCCNCC(C2=CC(=C(C=C2)O)CO)O,apoplexy,CID006398525,,C(C1C(C(C(C(O1)OC2(C(C(C(O2)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)COS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.[Al].[Al].[Al].[Al].[Al].[Al].[Al].[Al].[Al]
CID000005152,Salmeterol,C1=CC=C(C=C1)CCCCOCCCCCCNCC(C2=CC(=C(C=C2)O)CO)O,thrombocytopenia,CID000060854,Ziprasidone,C1CN(CCN1CCC2=C(C=C3C(=C2)CC(=O)N3)Cl)C4=NSC5=CC=CC=C54
CID000005152,Salmeterol,C1=CC=C(C=C1)CCCCOCCCCCCNCC(C2=CC(=C(C=C2)O)CO)O,loss of weight,CID000170361,Varenicline,C1C2CNCC1C3=CC4=NC=CN=C4C=C23
CID000002733,chlorzoxazone,C1=CC2=C(C=C1Cl)NC(=O)O2,apoplexy,CID000004691,"3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine",C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4
CID000002733,chlorzoxazone,C1=CC2=C(C=C1Cl)NC(=O)O2,weight gain,CID000170361,Varenicline,C1C2CNCC1C3=CC4=NC=CN=C4C=C23
CID000002733,chlorzoxazone,C1=CC2=C(C=C1Cl)NC(=O)O2,loss of weight,CID000005487,tizanidine,C1CN=C(N1)NC2=C(C=CC3=NSN=C32)Cl
CID000002733,chlorzoxazone,C1=CC2=C(C=C1Cl)NC(=O)O2,nasopharyngitis,CID000005732,zolpidem,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C
CID000000596,Cytosar,C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)O,cholecystitis,CID000002284,baclofen,C1=CC(=CC=C1C(CC(=O)O)CN)Cl
CID000000596,Cytosar,C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)O,gastric inflammation,CID000004894,"11,17,21-Trihydroxypregna-1,4-diene-3,20-dione",CC12CC(C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C)O
CID000000596,Cytosar,C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)O,thrombocytopenia,CID000002725,chlorpheniramine,CN(C)CCC(C1=CC=C(C=C1)Cl)C2=CC=CC=N2
CID000000596,Cytosar,C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)O,erythema,CID000005732,zolpidem,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C
CID000000596,Cytosar,C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)O,Adenopathy,CID003468412,SCHEMBL1176571,CC1C=CC=CCCC=CC=CC=CC=CC(CC(C(C(CC(=O)CC(C(CCC(CC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)C(=O)O)O)OC2C(C(C(C(O2)C)O)N)O
CID000000596,Cytosar,C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)O,myelodysplasia,CID000004691,"3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine",C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4
CID000000596,Cytosar,C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)O,edema,CID006398525,,C(C1C(C(C(C(O1)OC2(C(C(C(O2)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)COS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.[Al].[Al].[Al].[Al].[Al].[Al].[Al].[Al].[Al]
CID000000596,Cytosar,C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)O,elevated cholesterol,CID000060787,sequinavir,CC(C)(C)NC(=O)C1CC2CCCCC2CN1CC(C(CC3=CC=CC=C3)NC(=O)C(CC(=O)N)NC(=O)C4=NC5=CC=CC=C5C=C4)O
CID000000596,Cytosar,C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)O,proctalgia,CID000001983,acetaminophen,CC(=O)NC1=CC=C(C=C1)O
CID000000596,Cytosar,C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)O,allergic dermatitis,CID000019090,megestrol,CC1=CC2C(CCC3(C2CCC3(C(=O)C)O)C)C4(C1=CC(=O)CC4)C
CID000000596,Cytosar,C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)O,cholecystitis,CID000003310,33419-42-0,CC1OCC2C(O1)C(C(C(O2)OC3C4COC(=O)C4C(C5=CC6=C(C=C35)OCO6)C7=CC(=C(C(=C7)OC)O)OC)O)O
CID000000596,Cytosar,C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)O,thrombocytopenia,CID000060184,"2'-epi-Perindopril, (2'R)-",CCCC(C(=O)OCC)NC(C)C(=O)N1C2CCCCC2CC1C(=O)O
CID000000596,Cytosar,C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)O,Back Ache,CID000005394,temozolomide,CN1C(=O)N2C=NC(=C2N=N1)C(=O)N
CID000003339,fenofibrate,CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C2=CC=C(C=C2)Cl,abnormal ECG,CID000004894,"11,17,21-Trihydroxypregna-1,4-diene-3,20-dione",CC12CC(C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C)O
CID000003339,fenofibrate,CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C2=CC=C(C=C2)Cl,insulin dependent diabetes mellitus,CID000060787,sequinavir,CC(C)(C)NC(=O)C1CC2CCCCC2CN1CC(C(CC3=CC=CC=C3)NC(=O)C(CC(=O)N)NC(=O)C4=NC5=CC=CC=C5C=C4)O
CID000003339,fenofibrate,CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C2=CC=C(C=C2)Cl,neumonia,CID000019090,megestrol,CC1=CC2C(CCC3(C2CCC3(C(=O)C)O)C)C4(C1=CC(=O)CC4)C
CID000003339,fenofibrate,CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C2=CC=C(C=C2)Cl,abnormal ECG,CID000004170,metolazone,CC1NC2=CC(=C(C=C2C(=O)N1C3=CC=CC=C3C)S(=O)(=O)N)Cl
CID000003339,fenofibrate,CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C2=CC=C(C=C2)Cl,cholecystitis,CID000004585,"2-methyl-4-(4-methylpiperazin-1-yl)-5H-thieno[3,2-c][1,5]benzodiazepine",CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C
CID000003339,fenofibrate,CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C2=CC=C(C=C2)Cl,deglutition disorder,CID000005394,temozolomide,CN1C(=O)N2C=NC(=C2N=N1)C(=O)N
CID000003339,fenofibrate,CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C2=CC=C(C=C2)Cl,Arrhythmia,CID000004748,perphenazine,C1CN(CCN1CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)Cl)CCO
CID000003339,fenofibrate,CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C2=CC=C(C=C2)Cl,loss of weight,CID000060854,Ziprasidone,C1CN(CCN1CCC2=C(C=C3C(=C2)CC(=O)N3)Cl)C4=NSC5=CC=CC=C54
CID000003339,fenofibrate,CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C2=CC=C(C=C2)Cl,myelodysplasia,CID000004691,"3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine",C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4
CID000003339,fenofibrate,CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C2=CC=C(C=C2)Cl,eruption,CID000074989,ATOVAQUONE,C1CC(CCC1C2=CC=C(C=C2)Cl)C3=C(C4=CC=CC=C4C(=O)C3=O)O
CID000003339,fenofibrate,CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C2=CC=C(C=C2)Cl,loss of weight,CID000004614,oxaprozin,C1=CC=C(C=C1)C2=C(OC(=N2)CCC(=O)O)C3=CC=CC=C3
CID000003339,fenofibrate,CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C2=CC=C(C=C2)Cl,loss of weight,CID000060184,"2'-epi-Perindopril, (2'R)-",CCCC(C(=O)OCC)NC(C)C(=O)N1C2CCCCC2CC1C(=O)O
CID000003339,fenofibrate,CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C2=CC=C(C=C2)Cl,apoplexy,CID006398525,,C(C1C(C(C(C(O1)OC2(C(C(C(O2)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)COS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.[Al].[Al].[Al].[Al].[Al].[Al].[Al].[Al].[Al]
CID000003339,fenofibrate,CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C2=CC=C(C=C2)Cl,Back Ache,CID000005487,tizanidine,C1CN=C(N1)NC2=C(C=CC3=NSN=C32)Cl
CID000003339,fenofibrate,CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C2=CC=C(C=C2)Cl,Adenopathy,CID003468412,SCHEMBL1176571,CC1C=CC=CCCC=CC=CC=CC=CC(CC(C(C(CC(=O)CC(C(CCC(CC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)C(=O)O)O)OC2C(C(C(C(O2)C)O)N)O
CID000003339,fenofibrate,CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C2=CC=C(C=C2)Cl,rotator cuff syndrome,CID000170361,Varenicline,C1C2CNCC1C3=CC4=NC=CN=C4C=C23
CID000003339,fenofibrate,CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C2=CC=C(C=C2)Cl,Pain,CID000005732,zolpidem,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C
CID000003339,fenofibrate,CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C2=CC=C(C=C2)Cl,gastric inflammation,CID000004201,minoxidil,C1CCN(CC1)C2=NC(=N)N(C(=C2)N)O
CID000003339,fenofibrate,CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C2=CC=C(C=C2)Cl,erythema,CID000004205,mirtazapine,CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4
CID000060184,"2'-epi-Perindopril, (2'R)-",CCCC(C(=O)OCC)NC(C)C(=O)N1C2CCCCC2CC1C(=O)O,arterial pressure NOS decreased,CID005311082,"2-[(1R,4S,10S,13S,19S)-19-[4-(diaminomethylideneamino)butyl]-10-(1H-indol-3-ylmethyl)-3,9,12,15,18,21,27-heptaoxo-24,25-dithia-2,8,11,14,17,20-hexazatricyclo[18.6.1.04,8]heptacosan-13-yl]acetic acid",C1CC2C(=O)NC3CSSCCC(=O)N(C3=O)C(C(=O)NCC(=O)NC(C(=O)NC(C(=O)N2C1)CC4=CNC5=CC=CC=C54)CC(=O)O)CCCCN=C(N)N
CID000060184,"2'-epi-Perindopril, (2'R)-",CCCC(C(=O)OCC)NC(C)C(=O)N1C2CCCCC2CC1C(=O)O,drug toxicity NOS,CID003468412,SCHEMBL1176571,CC1C=CC=CCCC=CC=CC=CC=CC(CC(C(C(CC(=O)CC(C(CCC(CC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)C(=O)O)O)OC2C(C(C(C(O2)C)O)N)O
CID000060184,"2'-epi-Perindopril, (2'R)-",CCCC(C(=O)OCC)NC(C)C(=O)N1C2CCCCC2CC1C(=O)O,nervous tension,CID000170361,Varenicline,C1C2CNCC1C3=CC4=NC=CN=C4C=C23
CID000004748,perphenazine,C1CN(CCN1CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)Cl)CCO,insulin dependent diabetes mellitus,CID000060854,Ziprasidone,C1CN(CCN1CCC2=C(C=C3C(=C2)CC(=O)N3)Cl)C4=NSC5=CC=CC=C54
CID000004748,perphenazine,C1CN(CCN1CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)Cl)CCO,apoplexy,CID006398525,,C(C1C(C(C(C(O1)OC2(C(C(C(O2)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)COS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.[Al].[Al].[Al].[Al].[Al].[Al].[Al].[Al].[Al]
CID000004748,perphenazine,C1CN(CCN1CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)Cl)CCO,panic attack,CID000170361,Varenicline,C1C2CNCC1C3=CC4=NC=CN=C4C=C23
CID000004748,perphenazine,C1CN(CCN1CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)Cl)CCO,loss of weight,CID000005732,zolpidem,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C
CID000002099,alosetron,CC1=C(N=CN1)CN2CCC3=C(C2=O)C4=CC=CC=C4N3C,apoplexy,CID000003042,dicyclomine,CCN(CC)CCOC(=O)C1(CCCCC1)C2CCCCC2
CID000002099,alosetron,CC1=C(N=CN1)CN2CCC3=C(C2=O)C4=CC=CC=C4N3C,gastric inflammation,CID000005732,zolpidem,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C
CID000002099,alosetron,CC1=C(N=CN1)CN2CCC3=C(C2=O)C4=CC=CC=C4N3C,apoplexy,CID000004691,"3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine",C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4
CID000005732,zolpidem,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C,cellulitis,CID000074989,ATOVAQUONE,C1CC(CCC1C2=CC=C(C=C2)Cl)C3=C(C4=CC=CC=C4C(=O)C3=O)O
CID000005732,zolpidem,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C,insulin dependent diabetes mellitus,CID000012536,638-94-8,CC1(OC2CC3C4CCC5=CC(=O)C=CC5(C4C(CC3(C2(O1)C(=O)CO)C)O)C)C
CID000005732,zolpidem,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C,dysarthria,CID000115237,Paliperidone,CC1=C(C(=O)N2CCCC(C2=N1)O)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F
CID000005732,zolpidem,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C,right heart failure,CID000019090,megestrol,CC1=CC2C(CCC3(C2CCC3(C(=O)C)O)C)C4(C1=CC(=O)CC4)C
CID000005732,zolpidem,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C,Adenopathy,CID006398525,,C(C1C(C(C(C(O1)OC2(C(C(C(O2)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)COS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.[Al].[Al].[Al].[Al].[Al].[Al].[Al].[Al].[Al]
CID000005732,zolpidem,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C,gastric inflammation,CID003468412,SCHEMBL1176571,CC1C=CC=CCCC=CC=CC=CC=CC(CC(C(C(CC(=O)CC(C(CCC(CC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)C(=O)O)O)OC2C(C(C(C(O2)C)O)N)O
CID000005732,zolpidem,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C,back injury,CID000170361,Varenicline,C1C2CNCC1C3=CC4=NC=CN=C4C=C23
CID000005732,zolpidem,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C,cholecystectomies,CID000060854,Ziprasidone,C1CN(CCN1CCC2=C(C=C3C(=C2)CC(=O)N3)Cl)C4=NSC5=CC=CC=C54
CID000005732,zolpidem,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C,Pain,CID005311082,"2-[(1R,4S,10S,13S,19S)-19-[4-(diaminomethylideneamino)butyl]-10-(1H-indol-3-ylmethyl)-3,9,12,15,18,21,27-heptaoxo-24,25-dithia-2,8,11,14,17,20-hexazatricyclo[18.6.1.04,8]heptacosan-13-yl]acetic acid",C1CC2C(=O)NC3CSSCCC(=O)N(C3=O)C(C(=O)NCC(=O)NC(C(=O)NC(C(=O)N2C1)CC4=CNC5=CC=CC=C54)CC(=O)O)CCCCN=C(N)N
CID000005732,zolpidem,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C,Adenopathy,CID000060787,sequinavir,CC(C)(C)NC(=O)C1CC2CCCCC2CN1CC(C(CC3=CC=CC=C3)NC(=O)C(CC(=O)N)NC(=O)C4=NC5=CC=CC=C5C=C4)O
CID000001983,acetaminophen,CC(=O)NC1=CC=C(C=C1)O,Adenopathy,CID000002349,Cillin,CC1(C(N2C(S1)C(C2=O)NC(=O)CC3=CC=CC=C3)C(=O)O)C
CID000001983,acetaminophen,CC(=O)NC1=CC=C(C=C1)O,heart rate increased,CID000003734,Bracco 15000,CC(C(=O)NC1=C(C(=C(C(=C1I)C(=O)NC(CO)CO)I)C(=O)NC(CO)CO)I)O
CID000001983,acetaminophen,CC(=O)NC1=CC=C(C=C1)O,Adenopathy,CID000004691,"3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine",C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4
CID000001983,acetaminophen,CC(=O)NC1=CC=C(C=C1)O,haemorrhage rectum,CID006398525,,C(C1C(C(C(C(O1)OC2(C(C(C(O2)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)COS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.[Al].[Al].[Al].[Al].[Al].[Al].[Al].[Al].[Al]
CID000001983,acetaminophen,CC(=O)NC1=CC=C(C=C1)O,gastric inflammation,CID000004614,oxaprozin,C1=CC=C(C=C1)C2=C(OC(=N2)CCC(=O)O)C3=CC=CC=C3
CID000001983,acetaminophen,CC(=O)NC1=CC=C(C=C1)O,erythema,CID000004894,"11,17,21-Trihydroxypregna-1,4-diene-3,20-dione",CC12CC(C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C)O
CID000001983,acetaminophen,CC(=O)NC1=CC=C(C=C1)O,myelodysplasia,CID000060854,Ziprasidone,C1CN(CCN1CCC2=C(C=C3C(=C2)CC(=O)N3)Cl)C4=NSC5=CC=CC=C54
CID000001983,acetaminophen,CC(=O)NC1=CC=C(C=C1)O,cholecystitis,CID000003333,felodipine,CCOC(=O)C1=C(NC(=C(C1C2=C(C(=CC=C2)Cl)Cl)C(=O)OC)C)C
CID000001983,acetaminophen,CC(=O)NC1=CC=C(C=C1)O,gastric inflammation,CID000002284,baclofen,C1=CC(=CC=C1C(CC(=O)O)CN)Cl
CID000001983,acetaminophen,CC(=O)NC1=CC=C(C=C1)O,folate deficiency,CID000002637,3-[(carbamoyloxy)methyl]-7-methoxy-8-oxo-7-[(thiophen-2-ylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate,COC1(C2N(C1=O)C(=C(CS2)COC(=O)N)C(=O)[O-])NC(=O)CC3=CC=CS3
CID000001983,acetaminophen,CC(=O)NC1=CC=C(C=C1)O,cholecystitis,CID000004585,"2-methyl-4-(4-methylpiperazin-1-yl)-5H-thieno[3,2-c][1,5]benzodiazepine",CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C
CID000001983,acetaminophen,CC(=O)NC1=CC=C(C=C1)O,erythema,CID000005394,temozolomide,CN1C(=O)N2C=NC(=C2N=N1)C(=O)N
CID000001983,acetaminophen,CC(=O)NC1=CC=C(C=C1)O,eruption,CID000115237,Paliperidone,CC1=C(C(=O)N2CCCC(C2=N1)O)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F
CID000001983,acetaminophen,CC(=O)NC1=CC=C(C=C1)O,Aspartate Aminotransferase Increase,CID000002609,Lilly 99638,C1C(=C(N2C(S1)C(C2=O)NC(=O)C(C3=CC=CC=C3)N)C(=O)O)Cl
CID000001983,acetaminophen,CC(=O)NC1=CC=C(C=C1)O,myelodysplasia,CID000002949,MLS003115428,CC12CCC3C(C1CCC2(C#C)O)CCC4=CC5=C(CC34C)C=NO5
CID000001983,acetaminophen,CC(=O)NC1=CC=C(C=C1)O,abnormal EEG,CID000002725,chlorpheniramine,CN(C)CCC(C1=CC=C(C=C1)Cl)C2=CC=CC=N2
CID000001983,acetaminophen,CC(=O)NC1=CC=C(C=C1)O,cellulitis,CID000012536,638-94-8,CC1(OC2CC3C4CCC5=CC(=O)C=CC5(C4C(CC3(C2(O1)C(=O)CO)C)O)C)C
CID000001983,acetaminophen,CC(=O)NC1=CC=C(C=C1)O,hematoma subdural,CID000004201,minoxidil,C1CCN(CC1)C2=NC(=N)N(C(=C2)N)O
CID000001983,acetaminophen,CC(=O)NC1=CC=C(C=C1)O,Adenopathy,CID000019090,megestrol,CC1=CC2C(CCC3(C2CCC3(C(=O)C)O)C)C4(C1=CC(=O)CC4)C
CID000001983,acetaminophen,CC(=O)NC1=CC=C(C=C1)O,Porphyria,CID000004205,mirtazapine,CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4
CID000001983,acetaminophen,CC(=O)NC1=CC=C(C=C1)O,cholecystitis,CID000003310,33419-42-0,CC1OCC2C(O1)C(C(C(O2)OC3C4COC(=O)C4C(C5=CC6=C(C=C35)OCO6)C7=CC(=C(C(=C7)OC)O)OC)O)O
CID000001983,acetaminophen,CC(=O)NC1=CC=C(C=C1)O,Arrhythmia,CID000036811,dobutamine,CC(CCC1=CC=C(C=C1)O)NCCC2=CC(=C(C=C2)O)O
CID000001983,acetaminophen,CC(=O)NC1=CC=C(C=C1)O,thrombocytopenia,CID000005486,(R)-Tirofiban,CCCCS(=O)(=O)NC(CC1=CC=C(C=C1)OCCCCC2CCNCC2)C(=O)O
CID000001983,acetaminophen,CC(=O)NC1=CC=C(C=C1)O,gastric inflammation,CID000005487,tizanidine,C1CN=C(N1)NC2=C(C=CC3=NSN=C32)Cl
CID000001983,acetaminophen,CC(=O)NC1=CC=C(C=C1)O,respiratory alkalosis,CID000002676,"7-[4-(4-fluorophenyl)-5-(methoxymethyl)-2,6-di(propan-2-yl)pyridin-3-yl]-3,5-dihydroxyhept-6-enoic acid",CC(C)C1=C(C(=C(C(=N1)C(C)C)COC)C2=CC=C(C=C2)F)C=CC(CC(CC(=O)O)O)O
CID000001983,acetaminophen,CC(=O)NC1=CC=C(C=C1)O,High blood pressure,CID000074989,ATOVAQUONE,C1CC(CCC1C2=CC=C(C=C2)Cl)C3=C(C4=CC=CC=C4C(=O)C3=O)O
CID000001983,acetaminophen,CC(=O)NC1=CC=C(C=C1)O,Adenopathy,CID000004170,metolazone,CC1NC2=CC(=C(C=C2C(=O)N1C3=CC=CC=C3C)S(=O)(=O)N)Cl
CID000001983,acetaminophen,CC(=O)NC1=CC=C(C=C1)O,atelectasis,CID005311082,"2-[(1R,4S,10S,13S,19S)-19-[4-(diaminomethylideneamino)butyl]-10-(1H-indol-3-ylmethyl)-3,9,12,15,18,21,27-heptaoxo-24,25-dithia-2,8,11,14,17,20-hexazatricyclo[18.6.1.04,8]heptacosan-13-yl]acetic acid",C1CC2C(=O)NC3CSSCCC(=O)N(C3=O)C(C(=O)NCC(=O)NC(C(=O)NC(C(=O)N2C1)CC4=CNC5=CC=CC=C54)CC(=O)O)CCCCN=C(N)N
CID000001983,acetaminophen,CC(=O)NC1=CC=C(C=C1)O,Adenopathy,CID000170361,Varenicline,C1C2CNCC1C3=CC4=NC=CN=C4C=C23
CID000001983,acetaminophen,CC(=O)NC1=CC=C(C=C1)O,Adenopathy,CID003468412,SCHEMBL1176571,CC1C=CC=CCCC=CC=CC=CC=CC(CC(C(C(CC(=O)CC(C(CCC(CC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)C(=O)O)O)OC2C(C(C(C(O2)C)O)N)O
CID000001983,acetaminophen,CC(=O)NC1=CC=C(C=C1)O,loss of weight,CID000003042,dicyclomine,CCN(CC)CCOC(=O)C1(CCCCC1)C2CCCCC2
CID000001983,acetaminophen,CC(=O)NC1=CC=C(C=C1)O,eruption,CID000004451,CHEMBL365442,CC1=C(C=CC=C1O)C(=O)NC(CSC2=CC=CC=C2)C(CN3CC4CCCCC4CC3C(=O)NC(C)(C)C)O
CID000004894,"11,17,21-Trihydroxypregna-1,4-diene-3,20-dione",CC12CC(C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C)O,confusion,CID000005487,tizanidine,C1CN=C(N1)NC2=C(C=CC3=NSN=C32)Cl
CID000004894,"11,17,21-Trihydroxypregna-1,4-diene-3,20-dione",CC12CC(C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C)O,right heart failure,CID000005394,temozolomide,CN1C(=O)N2C=NC(=C2N=N1)C(=O)N
CID000004894,"11,17,21-Trihydroxypregna-1,4-diene-3,20-dione",CC12CC(C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C)O,increased white blood cell count,CID000019090,megestrol,CC1=CC2C(CCC3(C2CCC3(C(=O)C)O)C)C4(C1=CC(=O)CC4)C
CID000004894,"11,17,21-Trihydroxypregna-1,4-diene-3,20-dione",CC12CC(C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C)O,loss of weight,CID000074989,ATOVAQUONE,C1CC(CCC1C2=CC=C(C=C2)Cl)C3=C(C4=CC=CC=C4C(=O)C3=O)O
CID000004894,"11,17,21-Trihydroxypregna-1,4-diene-3,20-dione",CC12CC(C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C)O,gastric inflammation,CID003468412,SCHEMBL1176571,CC1C=CC=CCCC=CC=CC=CC=CC(CC(C(C(CC(=O)CC(C(CCC(CC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)C(=O)O)O)OC2C(C(C(C(O2)C)O)N)O
CID000004894,"11,17,21-Trihydroxypregna-1,4-diene-3,20-dione",CC12CC(C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C)O,weight gain,CID000170361,Varenicline,C1C2CNCC1C3=CC4=NC=CN=C4C=C23
CID000004894,"11,17,21-Trihydroxypregna-1,4-diene-3,20-dione",CC12CC(C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C)O,body temperature increased,CID006398525,,C(C1C(C(C(C(O1)OC2(C(C(C(O2)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)COS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.[Al].[Al].[Al].[Al].[Al].[Al].[Al].[Al].[Al]
CID000004894,"11,17,21-Trihydroxypregna-1,4-diene-3,20-dione",CC12CC(C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C)O,acute pancreatitis,CID000060787,sequinavir,CC(C)(C)NC(=O)C1CC2CCCCC2CN1CC(C(CC3=CC=CC=C3)NC(=O)C(CC(=O)N)NC(=O)C4=NC5=CC=CC=C5C=C4)O
CID000003333,felodipine,CCOC(=O)C1=C(NC(=C(C1C2=C(C(=CC=C2)Cl)Cl)C(=O)OC)C)C,cardiac enlargement,CID006398525,,C(C1C(C(C(C(O1)OC2(C(C(C(O2)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)COS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.[Al].[Al].[Al].[Al].[Al].[Al].[Al].[Al].[Al]
CID000003333,felodipine,CCOC(=O)C1=C(NC(=C(C1C2=C(C(=CC=C2)Cl)Cl)C(=O)OC)C)C,cellulitis,CID000019090,megestrol,CC1=CC2C(CCC3(C2CCC3(C(=O)C)O)C)C4(C1=CC(=O)CC4)C
CID000003333,felodipine,CCOC(=O)C1=C(NC(=C(C1C2=C(C(=CC=C2)Cl)Cl)C(=O)OC)C)C,cholecystitis,CID000004691,"3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine",C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4
CID000003333,felodipine,CCOC(=O)C1=C(NC(=C(C1C2=C(C(=CC=C2)Cl)Cl)C(=O)OC)C)C,edema,CID000170361,Varenicline,C1C2CNCC1C3=CC4=NC=CN=C4C=C23
CID000003333,felodipine,CCOC(=O)C1=C(NC(=C(C1C2=C(C(=CC=C2)Cl)Cl)C(=O)OC)C)C,apoplexy,CID000004585,"2-methyl-4-(4-methylpiperazin-1-yl)-5H-thieno[3,2-c][1,5]benzodiazepine",CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C
CID000003333,felodipine,CCOC(=O)C1=C(NC(=C(C1C2=C(C(=CC=C2)Cl)Cl)C(=O)OC)C)C,erythema,CID000004201,minoxidil,C1CCN(CC1)C2=NC(=N)N(C(=C2)N)O
CID000003333,felodipine,CCOC(=O)C1=C(NC(=C(C1C2=C(C(=CC=C2)Cl)Cl)C(=O)OC)C)C,angiitis,CID000004205,mirtazapine,CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4
CID000003333,felodipine,CCOC(=O)C1=C(NC(=C(C1C2=C(C(=CC=C2)Cl)Cl)C(=O)OC)C)C,Dyspnea exertional,CID000005394,temozolomide,CN1C(=O)N2C=NC(=C2N=N1)C(=O)N
CID000003333,felodipine,CCOC(=O)C1=C(NC(=C(C1C2=C(C(=CC=C2)Cl)Cl)C(=O)OC)C)C,Aspartate Aminotransferase Increase,CID000004170,metolazone,CC1NC2=CC(=C(C=C2C(=O)N1C3=CC=CC=C3C)S(=O)(=O)N)Cl
CID000003333,felodipine,CCOC(=O)C1=C(NC(=C(C1C2=C(C(=CC=C2)Cl)Cl)C(=O)OC)C)C,cholecystitis,CID003468412,SCHEMBL1176571,CC1C=CC=CCCC=CC=CC=CC=CC(CC(C(C(CC(=O)CC(C(CCC(CC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)C(=O)O)O)OC2C(C(C(C(O2)C)O)N)O
CID000005487,tizanidine,C1CN=C(N1)NC2=C(C=CC3=NSN=C32)Cl,apoplexy,CID000060854,Ziprasidone,C1CN(CCN1CCC2=C(C=C3C(=C2)CC(=O)N3)Cl)C4=NSC5=CC=CC=C54
CID000005487,tizanidine,C1CN=C(N1)NC2=C(C=CC3=NSN=C32)Cl,cellulitis,CID006398525,,C(C1C(C(C(C(O1)OC2(C(C(C(O2)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)COS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.[Al].[Al].[Al].[Al].[Al].[Al].[Al].[Al].[Al]
CID000005487,tizanidine,C1CN=C(N1)NC2=C(C=CC3=NSN=C32)Cl,abnormal ECG,CID000170361,Varenicline,C1C2CNCC1C3=CC4=NC=CN=C4C=C23
CID000005487,tizanidine,C1CN=C(N1)NC2=C(C=CC3=NSN=C32)Cl,Supraventricular tachycardia,CID003468412,SCHEMBL1176571,CC1C=CC=CCCC=CC=CC=CC=CC(CC(C(C(CC(=O)CC(C(CCC(CC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)C(=O)O)O)OC2C(C(C(C(O2)C)O)N)O
CID000005487,tizanidine,C1CN=C(N1)NC2=C(C=CC3=NSN=C32)Cl,dysarthria,CID000019090,megestrol,CC1=CC2C(CCC3(C2CCC3(C(=O)C)O)C)C4(C1=CC(=O)CC4)C
CID000002284,baclofen,C1=CC(=CC=C1C(CC(=O)O)CN)Cl,drug toxicity NOS,CID000060854,Ziprasidone,C1CN(CCN1CCC2=C(C=C3C(=C2)CC(=O)N3)Cl)C4=NSC5=CC=CC=C54
CID000002284,baclofen,C1=CC(=CC=C1C(CC(=O)O)CN)Cl,cholecystitis,CID003468412,SCHEMBL1176571,CC1C=CC=CCCC=CC=CC=CC=CC(CC(C(C(CC(=O)CC(C(CCC(CC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)C(=O)O)O)OC2C(C(C(C(O2)C)O)N)O
CID000002284,baclofen,C1=CC(=CC=C1C(CC(=O)O)CN)Cl,gastric inflammation,CID000004205,mirtazapine,CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4
CID000002284,baclofen,C1=CC(=CC=C1C(CC(=O)O)CN)Cl,Supraventricular tachycardia,CID000004691,"3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine",C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4
CID000002284,baclofen,C1=CC(=CC=C1C(CC(=O)O)CN)Cl,angiitis,CID006398525,,C(C1C(C(C(C(O1)OC2(C(C(C(O2)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)COS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.[Al].[Al].[Al].[Al].[Al].[Al].[Al].[Al].[Al]
CID000002284,baclofen,C1=CC(=CC=C1C(CC(=O)O)CN)Cl,cholecystectomies,CID000004585,"2-methyl-4-(4-methylpiperazin-1-yl)-5H-thieno[3,2-c][1,5]benzodiazepine",CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C
CID000002284,baclofen,C1=CC(=CC=C1C(CC(=O)O)CN)Cl,dysarthria,CID000019090,megestrol,CC1=CC2C(CCC3(C2CCC3(C(=O)C)O)C)C4(C1=CC(=O)CC4)C
CID000002284,baclofen,C1=CC(=CC=C1C(CC(=O)O)CN)Cl,Adenopathy,CID000170361,Varenicline,C1C2CNCC1C3=CC4=NC=CN=C4C=C23
CID000000085,Carnitine,C[N+](C)(C)CC(CC(=O)O)O,failure to thrive,CID000004205,mirtazapine,CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4
CID000000085,Carnitine,C[N+](C)(C)CC(CC(=O)O)O,colitis,CID006398525,,C(C1C(C(C(C(O1)OC2(C(C(C(O2)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)COS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.[Al].[Al].[Al].[Al].[Al].[Al].[Al].[Al].[Al]
CID000000085,Carnitine,C[N+](C)(C)CC(CC(=O)O)O,enlarged liver,CID003468412,SCHEMBL1176571,CC1C=CC=CCCC=CC=CC=CC=CC(CC(C(C(CC(=O)CC(C(CCC(CC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)C(=O)O)O)OC2C(C(C(C(O2)C)O)N)O
CID000003310,33419-42-0,CC1OCC2C(O1)C(C(C(O2)OC3C4COC(=O)C4C(C5=CC6=C(C=C35)OCO6)C7=CC(=C(C(=C7)OC)O)OC)O)O,hypernatraemia,CID000005394,temozolomide,CN1C(=O)N2C=NC(=C2N=N1)C(=O)N
CID000003310,"5-[(7,8-dihydroxy-2-methyl-4,4a,6,7,8,8a-hexahydropyrano[3,2-d][1,3]dioxin-6-yl)oxy]-9-(4-hydroxy-3,5-dimethoxyphenyl)-5a,6,8a,9-tetrahydro-5H-[2]benzofuro[6,5-f][1,3]benzodioxol-8-one",CC1OCC2C(O1)C(C(C(O2)OC3C4COC(=O)C4C(C5=CC6=C(C=C35)OCO6)C7=CC(=C(C(=C7)OC)O)OC)O)O,Back Ache,CID000019090,megestrol,CC1=CC2C(CCC3(C2CCC3(C(=O)C)O)C)C4(C1=CC(=O)CC4)C
CID000003310,33419-42-0,CC1OCC2C(O1)C(C(C(O2)OC3C4COC(=O)C4C(C5=CC6=C(C=C35)OCO6)C7=CC(=C(C(=C7)OC)O)OC)O)O,angiitis,CID000004691,"3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine",C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4
CID000003310,33419-42-0,CC1OCC2C(O1)C(C(C(O2)OC3C4COC(=O)C4C(C5=CC6=C(C=C35)OCO6)C7=CC(=C(C(=C7)OC)O)OC)O)O,cholecystitis,CID003468412,SCHEMBL1176571,CC1C=CC=CCCC=CC=CC=CC=CC(CC(C(C(CC(=O)CC(C(CCC(CC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)C(=O)O)O)OC2C(C(C(C(O2)C)O)N)O
CID000003310,33419-42-0,CC1OCC2C(O1)C(C(C(O2)OC3C4COC(=O)C4C(C5=CC6=C(C=C35)OCO6)C7=CC(=C(C(=C7)OC)O)OC)O)O,Adenopathy,CID006398525,,C(C1C(C(C(C(O1)OC2(C(C(C(O2)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)COS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.[Al].[Al].[Al].[Al].[Al].[Al].[Al].[Al].[Al]
CID000003310,33419-42-0,CC1OCC2C(O1)C(C(C(O2)OC3C4COC(=O)C4C(C5=CC6=C(C=C35)OCO6)C7=CC(=C(C(=C7)OC)O)OC)O)O,loss of weight,CID000004585,"2-methyl-4-(4-methylpiperazin-1-yl)-5H-thieno[3,2-c][1,5]benzodiazepine",CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C
CID000003310,33419-42-0,CC1OCC2C(O1)C(C(C(O2)OC3C4COC(=O)C4C(C5=CC6=C(C=C35)OCO6)C7=CC(=C(C(=C7)OC)O)OC)O)O,apoplexy,CID000004205,mirtazapine,CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4
CID000074989,ATOVAQUONE,C1CC(CCC1C2=CC=C(C=C2)Cl)C3=C(C4=CC=CC=C4C(=O)C3=O)O,hypermagnesemia,CID003468412,SCHEMBL1176571,CC1C=CC=CCCC=CC=CC=CC=CC(CC(C(C(CC(=O)CC(C(CCC(CC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)C(=O)O)O)OC2C(C(C(C(O2)C)O)N)O
CID000002949,MLS003115428,CC12CCC3C(C1CCC2(C#C)O)CCC4=CC5=C(CC34C)C=NO5,loss of weight,CID000004585,"2-methyl-4-(4-methylpiperazin-1-yl)-5H-thieno[3,2-c][1,5]benzodiazepine",CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C
CID000002609,Lilly 99638,C1C(=C(N2C(S1)C(C2=O)NC(=O)C(C3=CC=CC=C3)N)C(=O)O)Cl,eruption,CID000004585,"2-methyl-4-(4-methylpiperazin-1-yl)-5H-thieno[3,2-c][1,5]benzodiazepine",CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C
CID000002609,Lilly 99638,C1C(=C(N2C(S1)C(C2=O)NC(=O)C(C3=CC=CC=C3)N)C(=O)O)Cl,dysarthria,CID000004205,mirtazapine,CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4
CID000002609,Lilly 99638,C1C(=C(N2C(S1)C(C2=O)NC(=O)C(C3=CC=CC=C3)N)C(=O)O)Cl,apoplexy,CID000004691,"3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine",C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4
CID000002609,Lilly 99638,C1C(=C(N2C(S1)C(C2=O)NC(=O)C(C3=CC=CC=C3)N)C(=O)O)Cl,Pain,CID003468412,SCHEMBL1176571,CC1C=CC=CCCC=CC=CC=CC=CC(CC(C(C(CC(=O)CC(C(CCC(CC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)C(=O)O)O)OC2C(C(C(C(O2)C)O)N)O
CID000002609,Lilly 99638,C1C(=C(N2C(S1)C(C2=O)NC(=O)C(C3=CC=CC=C3)N)C(=O)O)Cl,apoplexy,CID000003042,dicyclomine,CCN(CC)CCOC(=O)C1(CCCCC1)C2CCCCC2
CID000004585,"2-methyl-4-(4-methylpiperazin-1-yl)-5H-thieno[3,2-c][1,5]benzodiazepine",CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C,gastric inflammation,CID000170361,Varenicline,C1C2CNCC1C3=CC4=NC=CN=C4C=C23
CID000004585,"2-methyl-4-(4-methylpiperazin-1-yl)-5H-thieno[3,2-c][1,5]benzodiazepine",CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C,erythema,CID003468412,SCHEMBL1176571,CC1C=CC=CCCC=CC=CC=CC=CC(CC(C(C(CC(=O)CC(C(CCC(CC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)C(=O)O)O)OC2C(C(C(C(O2)C)O)N)O
CID000004585,"2-methyl-4-(4-methylpiperazin-1-yl)-5H-thieno[3,2-c][1,5]benzodiazepine",CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C,Scleroderma,CID000005394,temozolomide,CN1C(=O)N2C=NC(=C2N=N1)C(=O)N
CID000004585,"2-methyl-4-(4-methylpiperazin-1-yl)-5H-thieno[3,2-c][1,5]benzodiazepine",CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C,Hallucination,CID000004745,SCHEMBL7711911,CCCN1CC(CC2C1CC3=CNC4=CC=CC2=C34)CSC
CID000004585,"2-methyl-4-(4-methylpiperazin-1-yl)-5H-thieno[3,2-c][1,5]benzodiazepine",CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C,cholecystitis,CID000060854,Ziprasidone,C1CN(CCN1CCC2=C(C=C3C(=C2)CC(=O)N3)Cl)C4=NSC5=CC=CC=C54
CID000004585,"2-methyl-4-(4-methylpiperazin-1-yl)-5H-thieno[3,2-c][1,5]benzodiazepine",CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C,apoplexy,CID000004614,oxaprozin,C1=CC=C(C=C1)C2=C(OC(=N2)CCC(=O)O)C3=CC=CC=C3
CID000004585,"2-methyl-4-(4-methylpiperazin-1-yl)-5H-thieno[3,2-c][1,5]benzodiazepine",CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C,agitated,CID000115237,Paliperidone,CC1=C(C(=O)N2CCCC(C2=N1)O)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F
CID000004585,"2-methyl-4-(4-methylpiperazin-1-yl)-5H-thieno[3,2-c][1,5]benzodiazepine",CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C,cholecystitis,CID000004691,"3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine",C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4
CID000004585,"2-methyl-4-(4-methylpiperazin-1-yl)-5H-thieno[3,2-c][1,5]benzodiazepine",CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C,nephrotic syndrome,CID000060787,sequinavir,CC(C)(C)NC(=O)C1CC2CCCCC2CN1CC(C(CC3=CC=CC=C3)NC(=O)C(CC(=O)N)NC(=O)C4=NC5=CC=CC=C5C=C4)O
CID000004585,"2-methyl-4-(4-methylpiperazin-1-yl)-5H-thieno[3,2-c][1,5]benzodiazepine",CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C,gastric inflammation,CID000019090,megestrol,CC1=CC2C(CCC3(C2CCC3(C(=O)C)O)C)C4(C1=CC(=O)CC4)C
CID000060854,Ziprasidone,C1CN(CCN1CCC2=C(C=C3C(=C2)CC(=O)N3)Cl)C4=NSC5=CC=CC=C54,weight gain,CID000115237,Paliperidone,CC1=C(C(=O)N2CCCC(C2=N1)O)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F
CID000060854,Ziprasidone,C1CN(CCN1CCC2=C(C=C3C(=C2)CC(=O)N3)Cl)C4=NSC5=CC=CC=C54,elevated cholesterol,CID003468412,SCHEMBL1176571,CC1C=CC=CCCC=CC=CC=CC=CC(CC(C(C(CC(=O)CC(C(CCC(CC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)C(=O)O)O)OC2C(C(C(C(O2)C)O)N)O
CID000060854,Ziprasidone,C1CN(CCN1CCC2=C(C=C3C(=C2)CC(=O)N3)Cl)C4=NSC5=CC=CC=C54,loss of weight,CID000170361,Varenicline,C1C2CNCC1C3=CC4=NC=CN=C4C=C23
CID000003042,dicyclomine,CCN(CC)CCOC(=O)C1(CCCCC1)C2CCCCC2,gastric inflammation,CID000004691,"3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine",C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4
CID000003042,dicyclomine,CCN(CC)CCOC(=O)C1(CCCCC1)C2CCCCC2,abnormal ECG,CID000004205,mirtazapine,CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4
CID000003042,dicyclomine,CCN(CC)CCOC(=O)C1(CCCCC1)C2CCCCC2,drug toxicity NOS,CID000019090,megestrol,CC1=CC2C(CCC3(C2CCC3(C(=O)C)O)C)C4(C1=CC(=O)CC4)C
CID000003042,dicyclomine,CCN(CC)CCOC(=O)C1(CCCCC1)C2CCCCC2,loss of weight,CID000170361,Varenicline,C1C2CNCC1C3=CC4=NC=CN=C4C=C23
CID000004691,"3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine",C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4,Dyspnea exertional,CID000004745,SCHEMBL7711911,CCCN1CC(CC2C1CC3=CNC4=CC=CC2=C34)CSC
CID000004691,"3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine",C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4,Pain,CID005311082,"2-[(1R,4S,10S,13S,19S)-19-[4-(diaminomethylideneamino)butyl]-10-(1H-indol-3-ylmethyl)-3,9,12,15,18,21,27-heptaoxo-24,25-dithia-2,8,11,14,17,20-hexazatricyclo[18.6.1.04,8]heptacosan-13-yl]acetic acid",C1CC2C(=O)NC3CSSCCC(=O)N(C3=O)C(C(=O)NCC(=O)NC(C(=O)NC(C(=O)N2C1)CC4=CNC5=CC=CC=C54)CC(=O)O)CCCCN=C(N)N
CID000004691,"3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine",C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4,gastric inflammation,CID003468412,SCHEMBL1176571,CC1C=CC=CCCC=CC=CC=CC=CC(CC(C(C(CC(=O)CC(C(CCC(CC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)C(=O)O)O)OC2C(C(C(C(O2)C)O)N)O
CID000004691,"3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine",C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4,elevated cholesterol,CID000115237,Paliperidone,CC1=C(C(=O)N2CCCC(C2=N1)O)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F
CID000004691,"3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine",C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4,cholecystitis,CID000170361,Varenicline,C1C2CNCC1C3=CC4=NC=CN=C4C=C23
CID000004691,"3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine",C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4,gastric inflammation,CID000019090,megestrol,CC1=CC2C(CCC3(C2CCC3(C(=O)C)O)C)C4(C1=CC(=O)CC4)C
CID000004691,"3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine",C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4,gastric inflammation,CID000005394,temozolomide,CN1C(=O)N2C=NC(=C2N=N1)C(=O)N
CID000004205,mirtazapine,CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4,apoplexy,CID003468412,SCHEMBL1176571,CC1C=CC=CCCC=CC=CC=CC=CC(CC(C(C(CC(=O)CC(C(CCC(CC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)C(=O)O)O)OC2C(C(C(C(O2)C)O)N)O
CID000004205,mirtazapine,CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4,thrombocytopenia,CID000005394,temozolomide,CN1C(=O)N2C=NC(=C2N=N1)C(=O)N
CID000004205,mirtazapine,CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4,abnormal EEG,CID000170361,Varenicline,C1C2CNCC1C3=CC4=NC=CN=C4C=C23
CID000004205,mirtazapine,CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4,gastric inflammation,CID000004614,oxaprozin,C1=CC=C(C=C1)C2=C(OC(=N2)CCC(=O)O)C3=CC=CC=C3
CID000004205,mirtazapine,CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4,abnormal ECG,CID000115237,Paliperidone,CC1=C(C(=O)N2CCCC(C2=N1)O)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F
CID000004205,mirtazapine,CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4,panic attack,CID000004745,SCHEMBL7711911,CCCN1CC(CC2C1CC3=CNC4=CC=CC2=C34)CSC
CID000004205,mirtazapine,CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4,gastric inflammation,CID000019090,megestrol,CC1=CC2C(CCC3(C2CCC3(C(=O)C)O)C)C4(C1=CC(=O)CC4)C
CID000004170,metolazone,CC1NC2=CC(=C(C=C2C(=O)N1C3=CC=CC=C3C)S(=O)(=O)N)Cl,drug toxicity NOS,CID000019090,megestrol,CC1=CC2C(CCC3(C2CCC3(C(=O)C)O)C)C4(C1=CC(=O)CC4)C
CID000004170,metolazone,CC1NC2=CC(=C(C=C2C(=O)N1C3=CC=CC=C3C)S(=O)(=O)N)Cl,apoplexy,CID000004201,minoxidil,C1CCN(CC1)C2=NC(=N)N(C(=C2)N)O
CID000004170,metolazone,CC1NC2=CC(=C(C=C2C(=O)N1C3=CC=CC=C3C)S(=O)(=O)N)Cl,sleep disorder,CID000170361,Varenicline,C1C2CNCC1C3=CC4=NC=CN=C4C=C23
CID000004170,metolazone,CC1NC2=CC(=C(C=C2C(=O)N1C3=CC=CC=C3C)S(=O)(=O)N)Cl,hepatitis,CID000036811,dobutamine,CC(CCC1=CC=C(C=C1)O)NCCC2=CC(=C(C=C2)O)O
CID000004170,metolazone,CC1NC2=CC(=C(C=C2C(=O)N1C3=CC=CC=C3C)S(=O)(=O)N)Cl,gastric inflammation,CID003468412,SCHEMBL1176571,CC1C=CC=CCCC=CC=CC=CC=CC(CC(C(C(CC(=O)CC(C(CCC(CC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)C(=O)O)O)OC2C(C(C(C(O2)C)O)N)O
CID000005394,temozolomide,CN1C(=O)N2C=NC(=C2N=N1)C(=O)N,Bacteraemia,CID003468412,SCHEMBL1176571,CC1C=CC=CCCC=CC=CC=CC=CC(CC(C(C(CC(=O)CC(C(CCC(CC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)C(=O)O)O)OC2C(C(C(C(O2)C)O)N)O
CID000005394,temozolomide,CN1C(=O)N2C=NC(=C2N=N1)C(=O)N,gastric inflammation,CID000019090,megestrol,CC1=CC2C(CCC3(C2CCC3(C(=O)C)O)C)C4(C1=CC(=O)CC4)C
CID000004614,oxaprozin,C1=CC=C(C=C1)C2=C(OC(=N2)CCC(=O)O)C3=CC=CC=C3,eruption,CID000170361,Varenicline,C1C2CNCC1C3=CC4=NC=CN=C4C=C23
CID000004614,oxaprozin,C1=CC=C(C=C1)C2=C(OC(=N2)CCC(=O)O)C3=CC=CC=C3,loss of weight,CID000019090,megestrol,CC1=CC2C(CCC3(C2CCC3(C(=O)C)O)C)C4(C1=CC(=O)CC4)C
CID000115237,Paliperidone,CC1=C(C(=O)N2CCCC(C2=N1)O)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F,weight gain,CID000170361,Varenicline,C1C2CNCC1C3=CC4=NC=CN=C4C=C23
CID000019090,megestrol,CC1=CC2C(CCC3(C2CCC3(C(=O)C)O)C)C4(C1=CC(=O)CC4)C,edema,CID000170361,Varenicline,C1C2CNCC1C3=CC4=NC=CN=C4C=C23
